Psyllid ID: psy7820

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160---
Protein Sequence
SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP
Secondary Structure (PSIPRED)
cccccccccHHHHHHHHHHccccccccEEEEEEEEEccEEEEEEEccHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEcccccccccccccccccccEEEEEccccHHcccccccccHHHHHHHHHHHHHHHccc
Secondary Structure Prediction (SSPRO)
ccccccEccHHHHHHHHHHHccccccEccEEEEEccccEEEEEEEcccEEHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEccccccccHHHccHHHHccccEccHHHHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
srvqvegvpstALREISVLkelkhpnvirlhdvipvDFKLFLVFEFLRQDLKDflqttpvpvppaLAKSYLYQLLEALRYCHSRriihrdlkpqnilinksgalkladfglsraftipmnrythevvtlwyrppeillgakVYSTTVDIWSAGCIFSEMIQIP
Flexible Loop (DISEMBL)
srvqvegvpstalreisvlkelkhpnvirlHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHrdlkpqniLINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP
Low Complexity Region (SEG)
SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP
Disordered region (IsUnstruct)
************LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI***
Disordered Region (DISOPRED)
*RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP
Disordered Region (DISEMBL)
*********STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP
Disordered Region (DISPRO)
******GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	163	2.2.26 [Sep-21-2011]
Q00526	305	Cyclin-dependent kinase 3	yes	N/A	0.969	0.518	0.666	4e-60
P43450	298	Cyclin-dependent kinase 2	N/A	N/A	0.969	0.530	0.666	2e-59
P23437	297	Cyclin-dependent kinase 2	N/A	N/A	0.969	0.531	0.660	3e-59
O55076	298	Cyclin-dependent kinase 2	yes	N/A	0.969	0.530	0.660	5e-59
P24941	298	Cyclin-dependent kinase 2	no	N/A	0.957	0.523	0.664	5e-59
Q5E9Y0	298	Cyclin-dependent kinase 2	no	N/A	0.957	0.523	0.658	9e-59
Q63699	298	Cyclin-dependent kinase 2	yes	N/A	0.957	0.523	0.658	1e-58
P97377	346	Cyclin-dependent kinase 2	no	N/A	0.950	0.447	0.662	2e-58
P48963	298	Cyclin-dependent kinase 2	N/A	N/A	0.969	0.530	0.654	3e-58
P51166	292	Cyclin-dependent kinase 5	N/A	N/A	0.944	0.527	0.636	4e-57

>sp|Q00526|CDK3_HUMAN Cyclin-dependent kinase 3 OS=Homo sapiens GN=CDK3 PE=1 SV=1

 Score =  230 bits (586), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 106/159 (66%), Positives = 135/159 (84%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VP 61
           +++EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 39  LEMEGVPSTAIREISLLKELKHPNIVRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSE 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  
Sbjct: 99  LPLHLIKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRT 158

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG+K Y+T VDIWS GCIF+EM+
Sbjct: 159 YTHEVVTLWYRAPEILLGSKFYTTAVDIWSIGCIFAEMV 197

Serine/threonine-protein kinase that plays a critical role in the control of the eukaryotic cell cycle; involved in G0-G1 and G1-S cell cycle transitions. Interacts with CCNC/cyclin-C during interphase. Phosphorylates histone H1, ATF1, RB1 and CABLES1. ATF1 phosphorylation triggers ATF1 transactivation and transcriptional activities, and promotes cell proliferation and transformation. CDK3/cyclin-C mediated RB1 phosphorylation is required for G0-G1 transition. Promotes G1-S transition probably by contributing to the activation of E2F1, E2F2 and E2F3 in a RB1-independent manner.
Homo sapiens (taxid: 9606)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2

>sp|P43450|CDK2_CARAU Cyclin-dependent kinase 2 OS=Carassius auratus GN=cdk2 PE=2 SV=1

 Score =  228 bits (580), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/159 (66%), Positives = 129/159 (81%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
            + EGVPSTA+REIS+LKEL HPN+++LHDVI  + KL+LVFEFL QDLK F+ ++ V  
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLHDVIHTENKLYLVFEFLHQDLKRFMDSSTVTG 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +   L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G +KLADFGL+RAF +P+  
Sbjct: 99  ISLPLVKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAQGEIKLADFGLARAFGVPVRT 158

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EMI
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMI 197

Involved in the control of the cell cycle. Interacts with cyclins A, B1, B3, D, or E. Activity of CDK2 is maximal during S phase and G2.

Carassius auratus (taxid: 7957)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P23437|CDK2_XENLA Cyclin-dependent kinase 2 OS=Xenopus laevis GN=cdk2 PE=1 SV=3

 Score =  227 bits (578), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 105/159 (66%), Positives = 129/159 (81%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + +  
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLNQDLKKFMDGSNISG 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +  AL KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  
Sbjct: 99  ISLALVKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINSDGAIKLADFGLARAFGVPVRT 158

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +THEVVTLWYR PEILLG K YST VDIWS GCIF+EMI
Sbjct: 159 FTHEVVTLWYRAPEILLGCKFYSTAVDIWSLGCIFAEMI 197

Involved in the control of the cell cycle. Interacts with cyclins A, B, D, or E. Activity of CDK2 is maximal during S phase and G2.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|O55076|CDK2_CRIGR Cyclin-dependent kinase 2 OS=Cricetulus griseus GN=CDK2 PE=2 SV=1

 Score =  226 bits (576), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 105/159 (66%), Positives = 129/159 (81%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + V  
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAVTG 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+  
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVPVRT 158

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Cricetulus griseus (taxid: 10029)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P24941|CDK2_HUMAN Cyclin-dependent kinase 2 OS=Homo sapiens GN=CDK2 PE=1 SV=2

 Score =  226 bits (576), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q5E9Y0|CDK2_BOVIN Cyclin-dependent kinase 2 OS=Bos taurus GN=CDK2 PE=2 SV=1

 Score =  225 bits (574), Expect = 9e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 130/161 (80%), Gaps = 5/161 (3%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINADGSIKLADFGLARAFGVPV 156

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|Q63699|CDK2_RAT Cyclin-dependent kinase 2 OS=Rattus norvegicus GN=Cdk2 PE=1 SV=1

 Score =  224 bits (572), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 130/161 (80%), Gaps = 5/161 (3%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+
Sbjct: 99  LPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVPV 156

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P97377|CDK2_MOUSE Cyclin-dependent kinase 2 OS=Mus musculus GN=Cdk2 PE=1 SV=2

 Score =  224 bits (572), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 106/160 (66%), Positives = 129/160 (80%), Gaps = 5/160 (3%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVPV 156

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P48963|CDK2_MESAU Cyclin-dependent kinase 2 OS=Mesocricetus auratus GN=CDK2 PE=2 SV=1

 Score =  224 bits (570), Expect = 3e-58,   Method: Compositional matrix adjust.
 Identities = 104/159 (65%), Positives = 128/159 (80%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFE L QDLK F+  + V  
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFELLHQDLKKFMDASAVTG 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+  
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVPVRT 158

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

Serine/threonine-protein kinase involved in the control of the cell cycle; essential for meiosis, but dispensable for mitosis. Phosphorylates CTNNB1, USP37, p53/TP53, NPM1, CDK7, RB1, BRCA2, MYC, NPAT, EZH2. Interacts with cyclins A, B1, B3, D, or E. Triggers duplication of centrosomes and DNA. Acts at the G1-S transition to promote the E2F transcriptional program and the initiation of DNA synthesis, and modulates G2 progression; controls the timing of entry into mitosis/meiosis by controlling the subsequent activation of cyclin B/CDK1 by phosphorylation, and coordinates the activation of cyclin B/CDK1 at the centrosome and in the nucleus. Crucial role in orchestrating a fine balance between cellular proliferation, cell death, and DNA repair in human embryonic stem cells (hESCs). Activity of CDK2 is maximal during S phase and G2; activated by interaction with cyclin E during the early stages of DNA synthesis to permit G1-S transition, and subsequently activated by cyclin A2 (cyclin A1 in germ cells) during the late stages of DNA replication to drive the transition from S phase to mitosis, the G2 phase. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. Phosphorylates CABLES1 (By similarity). Cyclin E/CDK2 prevents oxidative stress-mediated Ras-induced senescence by phosphorylating MYC. Involved in G1-S phase DNA damage checkpoint that prevents cells with damaged DNA from initiating mitosis; regulates homologous recombination-dependent repair by phosphorylating BRCA2, this phosphorylation is low in S phase when recombination is active, but increases as cells progress towards mitosis. In response to DNA damage, double-strand break repair by homologous recombination a reduction of CDK2-mediated BRCA2 phosphorylation. Phosphorylation of RB1 disturbs its interaction with E2F1. NPM1 phosphorylation by cyclin E/CDK2 promotes its dissociates from unduplicated centrosomes, thus initiating centrosome duplication. Cyclin E/CDK2-mediated phosphorylation of NPAT at G1-S transition and until prophase stimulates the NPAT-mediated activation of histone gene transcription during S phase. Required for vitamin D-mediated growth inhibition by being itself inactivated. Involved in the nitric oxide- (NO) mediated signaling in a nitrosylation/activation-dependent manner. USP37 is activated by phosphorylation and thus triggers G1-S transition. CTNNB1 phosphorylation regulates insulin internalization.

Mesocricetus auratus (taxid: 10036)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

>sp|P51166|CDK5_XENLA Cyclin-dependent kinase 5 OS=Xenopus laevis GN=cdk5 PE=2 SV=1

 Score =  220 bits (560), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 98/154 (63%), Positives = 127/154 (82%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           + KS++YQLL+ L +CHSR ++HRDLKPQN+LIN++G LKLADFGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFMYQLLKGLAFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E+
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

Proline-directed serine/threonine-protein kinase essential for neuronal cell cycle arrest and differentiation and may be involved in apoptotic cell death in neuronal diseases by triggering abortive cell cycle re-entry. Interacts with D1 and D3-type G1 cyclins. Regulates several neuronal development and physiological processes including neuronal survival, migration and differentiation, axonal and neurite growth, synaptogenesis, oligodendrocytes differentiation, synaptic plasticity and neurotransmission, by phosphorylating key proteins. In the mature central nervous system (CNS), regulates neurotransmitter movements by phosphorylating substrates associated with neurotransmitter release and synapse plasticity; synaptic vesicle exocytosis, vesicles fusion with the presynaptic membrane, and endocytosis. May regulate endothelial cell migration and angiogenesis via the modulation of lamellipodia formation.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 2

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	163
452820524	300	cyclin-dependent serine/threonine protei	0.963	0.523	0.708	9e-60
452820525	315	cyclin-dependent serine/threonine protei	0.963	0.498	0.708	9e-60
194216630	305	PREDICTED: cyclin-dependent kinase 3-lik	0.969	0.518	0.666	2e-59
344291410	305	PREDICTED: cyclin-dependent kinase 3-lik	0.969	0.518	0.672	3e-59
332260214	290	PREDICTED: cyclin-dependent kinase 3 [No	0.969	0.544	0.666	1e-58
114670580	325	PREDICTED: cyclin-dependent kinase 3 iso	0.969	0.486	0.666	1e-58
291413434	305	PREDICTED: cyclin-dependent kinase 3-lik	0.969	0.518	0.660	1e-58
444727821	317	Cyclin-dependent kinase 3 [Tupaia chinen	0.969	0.498	0.666	1e-58
397484298	333	PREDICTED: cyclin-dependent kinase 3 [Pa	0.969	0.474	0.666	2e-58
119609759	333	cyclin-dependent kinase 3, isoform CRA_a	0.969	0.474	0.666	2e-58

>gi|452820524|gb|EME27565.1| cyclin-dependent serine/threonine protein kinase isoform 1 [Galdieria sulphuraria]

 Score =  234 bits (597), Expect = 9e-60,   Method: Compositional matrix adjust.
 Identities = 112/158 (70%), Positives = 132/158 (83%), Gaps = 1/158 (0%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPV 62
           + EGVPSTA+REIS+LKEL+HPN++RL DVI +D KL+LVFE+L QDLK F+ + P   +
Sbjct: 40  EEEGVPSTAIREISILKELQHPNIVRLRDVIHLDSKLYLVFEYLEQDLKHFMDSLPPGNL 99

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
            P L KSYLYQLL  L YCH+ RI+HRDLKPQN+LI+K G LKLADFGL+RAF IP+  Y
Sbjct: 100 DPLLIKSYLYQLLNGLAYCHANRILHRDLKPQNLLIDKRGFLKLADFGLARAFGIPVRHY 159

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           THEVVTLWYR PEILLGA+ YST VDIWSAGCIF+EMI
Sbjct: 160 THEVVTLWYRAPEILLGAQRYSTAVDIWSAGCIFAEMI 197

Source: Galdieria sulphuraria

Species: Galdieria sulphuraria

Genus: Galdieria

Family: Cyanidiaceae

Order: Cyanidiales

Class: Bangiophyceae

Superkingdom: Eukaryota

>gi|452820525|gb|EME27566.1| cyclin-dependent serine/threonine protein kinase isoform 2 [Galdieria sulphuraria]

 Score =  234 bits (597), Expect = 9e-60,   Method: Compositional matrix adjust.
 Identities = 112/158 (70%), Positives = 132/158 (83%), Gaps = 1/158 (0%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPV 62
           + EGVPSTA+REIS+LKEL+HPN++RL DVI +D KL+LVFE+L QDLK F+ + P   +
Sbjct: 40  EEEGVPSTAIREISILKELQHPNIVRLRDVIHLDSKLYLVFEYLEQDLKHFMDSLPPGNL 99

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
            P L KSYLYQLL  L YCH+ RI+HRDLKPQN+LI+K G LKLADFGL+RAF IP+  Y
Sbjct: 100 DPLLIKSYLYQLLNGLAYCHANRILHRDLKPQNLLIDKRGFLKLADFGLARAFGIPVRHY 159

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           THEVVTLWYR PEILLGA+ YST VDIWSAGCIF+EMI
Sbjct: 160 THEVVTLWYRAPEILLGAQRYSTAVDIWSAGCIFAEMI 197

Source: Galdieria sulphuraria

Species: Galdieria sulphuraria

Genus: Galdieria

Family: Cyanidiaceae

Order: Cyanidiales

Class: Bangiophyceae

Superkingdom: Eukaryota

>gi|194216630|ref|XP_001491953.2| PREDICTED: cyclin-dependent kinase 3-like [Equus caballus]

 Score =  233 bits (594), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/159 (66%), Positives = 134/159 (84%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
           ++ EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 39  LETEGVPSTAIREISLLKELKHPNIVRLLDVVHSEKKLYLVFEFLSQDLKKYMDSTPASE 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  
Sbjct: 99  LPTHLVKSYLFQLLQGVNFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRT 158

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG+K YST VD+WS GCIF+EM+
Sbjct: 159 YTHEVVTLWYRAPEILLGSKFYSTAVDVWSIGCIFAEMV 197

Source: Equus caballus

Species: Equus caballus

Genus: Equus

Family: Equidae

Order: Perissodactyla

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|344291410|ref|XP_003417428.1| PREDICTED: cyclin-dependent kinase 3-like [Loxodonta africana]

 Score =  233 bits (593), Expect = 3e-59,   Method: Compositional matrix adjust.
 Identities = 107/159 (67%), Positives = 133/159 (83%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
           ++ EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 39  LETEGVPSTAIREISLLKELKHPNIVRLLDVVHSEKKLYLVFEFLSQDLKKYMDSTPASE 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYLYQLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  
Sbjct: 99  LPLHLVKSYLYQLLQGVNFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRT 158

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG K YST VD+WS GCIF+EM+
Sbjct: 159 YTHEVVTLWYRAPEILLGCKFYSTAVDVWSIGCIFAEMV 197

Source: Loxodonta africana

Species: Loxodonta africana

Genus: Loxodonta

Family: Elephantidae

Order: Proboscidea

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|332260214|ref|XP_003279179.1| PREDICTED: cyclin-dependent kinase 3 [Nomascus leucogenys]

 Score =  231 bits (588), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 106/159 (66%), Positives = 135/159 (84%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VP 61
           +++EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 59  LEMEGVPSTAIREISLLKELKHPNIVRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSE 118

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  
Sbjct: 119 LPLHLIKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRT 178

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG+K Y+T VDIWS GCIF+EM+
Sbjct: 179 YTHEVVTLWYRAPEILLGSKFYTTAVDIWSIGCIFAEMV 217

Source: Nomascus leucogenys

Species: Nomascus leucogenys

Genus: Nomascus

Family: Hylobatidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|114670580|ref|XP_523720.2| PREDICTED: cyclin-dependent kinase 3 isoform 6 [Pan troglodytes]

 Score =  230 bits (587), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 106/159 (66%), Positives = 135/159 (84%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VP 61
           +++EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 59  LEMEGVPSTAIREISLLKELKHPNIVRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSE 118

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  
Sbjct: 119 LPLHLIKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRT 178

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG+K Y+T VDIWS GCIF+EM+
Sbjct: 179 YTHEVVTLWYRAPEILLGSKFYTTAVDIWSIGCIFAEMV 217

Source: Pan troglodytes

Species: Pan troglodytes

Genus: Pan

Family: Hominidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|291413434|ref|XP_002722978.1| PREDICTED: cyclin-dependent kinase 3-like [Oryctolagus cuniculus]

 Score =  230 bits (587), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 105/159 (66%), Positives = 133/159 (83%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
           ++ EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 39  LETEGVPSTAIREISLLKELKHPNIVRLLDVVHNEKKLYLVFEFLSQDLKKYMDSTPASQ 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LI++ GA+KLADFGL+RAF +P+  
Sbjct: 99  LPMHLVKSYLFQLLQGVNFCHSHRVIHRDLKPQNLLISERGAIKLADFGLARAFGVPLRT 158

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG K YST VD+WS GCIF+EM+
Sbjct: 159 YTHEVVTLWYRAPEILLGCKFYSTAVDVWSVGCIFAEMV 197

Source: Oryctolagus cuniculus

Species: Oryctolagus cuniculus

Genus: Oryctolagus

Family: Leporidae

Order: Lagomorpha

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|444727821|gb|ELW68299.1| Cyclin-dependent kinase 3 [Tupaia chinensis]

 Score =  230 bits (586), Expect = 1e-58,   Method: Compositional matrix adjust.
 Identities = 106/159 (66%), Positives = 132/159 (83%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
           ++ EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 51  LETEGVPSTAIREISLLKELKHPNIVRLLDVVHSEKKLYLVFEFLSQDLKKYMDSTPASE 110

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL QLL+ + +CHS R+IHRDLKPQN+LIN  GA+KLADFGL+RAF +P+  
Sbjct: 111 LPLHLVKSYLSQLLQGVTFCHSHRVIHRDLKPQNLLINDLGAIKLADFGLARAFGVPLRT 170

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG+K YST VD+WS GCIF+EM+
Sbjct: 171 YTHEVVTLWYRAPEILLGSKFYSTAVDVWSVGCIFAEMV 209

Source: Tupaia chinensis

Species: Tupaia chinensis

Genus: Tupaia

Family: Tupaiidae

Order: Scandentia

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|397484298|ref|XP_003813314.1| PREDICTED: cyclin-dependent kinase 3 [Pan paniscus]

 Score =  230 bits (586), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 106/159 (66%), Positives = 135/159 (84%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VP 61
           +++EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 67  LEMEGVPSTAIREISLLKELKHPNIVRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSE 126

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  
Sbjct: 127 LPLHLIKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRT 186

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG+K Y+T VDIWS GCIF+EM+
Sbjct: 187 YTHEVVTLWYRAPEILLGSKFYTTAVDIWSIGCIFAEMV 225

Source: Pan paniscus

Species: Pan paniscus

Genus: Pan

Family: Hominidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

>gi|119609759|gb|EAW89353.1| cyclin-dependent kinase 3, isoform CRA_a [Homo sapiens] gi|119609760|gb|EAW89354.1| cyclin-dependent kinase 3, isoform CRA_a [Homo sapiens] gi|119609761|gb|EAW89355.1| cyclin-dependent kinase 3, isoform CRA_a [Homo sapiens]

 Score =  230 bits (586), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 106/159 (66%), Positives = 135/159 (84%), Gaps = 1/159 (0%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VP 61
           +++EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct: 67  LEMEGVPSTAIREISLLKELKHPNIVRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSE 126

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  
Sbjct: 127 LPLHLIKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRT 186

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTHEVVTLWYR PEILLG+K Y+T VDIWS GCIF+EM+
Sbjct: 187 YTHEVVTLWYRAPEILLGSKFYTTAVDIWSIGCIFAEMV 225

Source: Homo sapiens

Species: Homo sapiens

Genus: Homo

Family: Hominidae

Order: Primates

Class: Mammalia

Phylum: Chordata

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	163
UNIPROTKB|Q00526	305	CDK3 "Cyclin-dependent kinase	0.969	0.518	0.666	2.5e-56
UNIPROTKB|F1RW06	305	CDK3 "Uncharacterized protein"	0.969	0.518	0.660	3.3e-56
UNIPROTKB|K7EJ83	213	CDK3 "Cyclin-dependent kinase	0.957	0.732	0.675	5.3e-56
UNIPROTKB|P43450	298	cdk2 "Cyclin-dependent kinase	0.963	0.526	0.670	6.8e-56
UNIPROTKB|E2QW70	298	CDK2 "Uncharacterized protein"	0.963	0.526	0.664	1.4e-55
UNIPROTKB|P24941	298	CDK2 "Cyclin-dependent kinase	0.963	0.526	0.664	1.4e-55
UNIPROTKB|O55076	298	CDK2 "Cyclin-dependent kinase	0.963	0.526	0.664	1.4e-55
ZFIN|ZDB-GENE-040426-2741	298	cdk2 "cyclin-dependent kinase	0.963	0.526	0.670	1.8e-55
UNIPROTKB|Q5E9Y0	298	CDK2 "Cyclin-dependent kinase	0.963	0.526	0.658	2.9e-55
UNIPROTKB|G3V5T9	346	CDK2 "Cyclin-dependent kinase	0.957	0.450	0.668	2.9e-55

UNIPROTKB|Q00526 CDK3 "Cyclin-dependent kinase 3" [Homo sapiens (taxid:9606)]

 Score = 580 (209.2 bits), Expect = 2.5e-56, P = 2.5e-56
 Identities = 106/159 (66%), Positives = 135/159 (84%)

Query:     3 VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VP 61
             +++EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   
Sbjct:    39 LEMEGVPSTAIREISLLKELKHPNIVRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSE 98

Query:    62 VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
             +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  
Sbjct:    99 LPLHLIKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRT 158

Query:   122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG+K Y+T VDIWS GCIF+EM+
Sbjct:   159 YTHEVVTLWYRAPEILLGSKFYTTAVDIWSIGCIFAEMV 197

GO:0005524 "ATP binding" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0045023 "G0 to G1 transition" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

UNIPROTKB|F1RW06 CDK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 579 (208.9 bits), Expect = 3.3e-56, P = 3.3e-56
 Identities = 105/159 (66%), Positives = 132/159 (83%)

Query:     3 VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP- 61
             ++ EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++  TP   
Sbjct:    39 LETEGVPSTAIREISLLKELKHPNIVRLLDVVHSEKKLYLVFEFLSQDLKKYMDATPASE 98

Query:    62 VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
             +P  L KSYL+QLL+ + +CHS R+IHRDLKPQN+LI++ GA+KLADFGL+RAF +P+  
Sbjct:    99 LPLHLVKSYLFQLLQGVNFCHSHRVIHRDLKPQNLLISELGAIKLADFGLARAFGVPLRT 158

Query:   122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VD+WS GCIF+EM+
Sbjct:   159 YTHEVVTLWYRAPEILLGCKFYSTAVDVWSIGCIFAEMV 197

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|K7EJ83 CDK3 "Cyclin-dependent kinase 3" [Homo sapiens (taxid:9606)]

 Score = 577 (208.2 bits), Expect = 5.3e-56, P = 5.3e-56
 Identities = 106/157 (67%), Positives = 133/157 (84%)

Query:     5 VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVP 63
             +EGVPSTA+REIS+LKELKHPN++RL DV+  + KL+LVFEFL QDLK ++ +TP   +P
Sbjct:     1 MEGVPSTAIREISLLKELKHPNIVRLLDVVHNERKLYLVFEFLSQDLKKYMDSTPGSELP 60

Query:    64 PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
               L KSYL+QLL+ + +CHS R+IHRDLKPQN+LIN+ GA+KLADFGL+RAF +P+  YT
Sbjct:    61 LHLIKSYLFQLLQGVSFCHSHRVIHRDLKPQNLLINELGAIKLADFGLARAFGVPLRTYT 120

Query:   124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             HEVVTLWYR PEILLG+K Y+T VDIWS GCIF+EM+
Sbjct:   121 HEVVTLWYRAPEILLGSKFYTTAVDIWSIGCIFAEMV 157

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P43450 cdk2 "Cyclin-dependent kinase 2" [Carassius auratus (taxid:7957)]

 Score = 576 (207.8 bits), Expect = 6.8e-56, P = 6.8e-56
 Identities = 106/158 (67%), Positives = 129/158 (81%)

Query:     4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP-V 62
             + EGVPSTA+REIS+LKEL HPN+++LHDVI  + KL+LVFEFL QDLK F+ ++ V  +
Sbjct:    40 ETEGVPSTAIREISLLKELNHPNIVKLHDVIHTENKLYLVFEFLHQDLKRFMDSSTVTGI 99

Query:    63 PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
                L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G +KLADFGL+RAF +P+  Y
Sbjct:   100 SLPLVKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAQGEIKLADFGLARAFGVPVRTY 159

Query:   123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             THEVVTLWYR PEILLG K YST VDIWS GCIF+EMI
Sbjct:   160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMI 197

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

UNIPROTKB|E2QW70 CDK2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 573 (206.8 bits), Expect = 1.4e-55, P = 1.4e-55
 Identities = 105/158 (66%), Positives = 129/158 (81%)

Query:     4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP-V 62
             + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + +  +
Sbjct:    40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI 99

Query:    63 PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
             P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y
Sbjct:   100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGAIKLADFGLARAFGVPVRTY 159

Query:   123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             THEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct:   160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

GO:0060968 "regulation of gene silencing" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0035173 "histone kinase activity" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0015030 "Cajal body" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0005768 "endosome" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|P24941 CDK2 "Cyclin-dependent kinase 2" [Homo sapiens (taxid:9606)]

 Score = 573 (206.8 bits), Expect = 1.4e-55, P = 1.4e-55
 Identities = 105/158 (66%), Positives = 129/158 (81%)

Query:     4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP-V 62
             + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + +  +
Sbjct:    40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI 99

Query:    63 PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
             P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y
Sbjct:   100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159

Query:   123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             THEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct:   160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

GO:0005524 "ATP binding" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0005667 "transcription factor complex" evidence=IEA

GO:0006813 "potassium ion transport" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=IDA

GO:0035173 "histone kinase activity" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IDA;TAS

GO:0007126 "meiosis" evidence=TAS

GO:0051298 "centrosome duplication" evidence=TAS

GO:0006260 "DNA replication" evidence=TAS

GO:0060968 "regulation of gene silencing" evidence=IDA

GO:0031571 "mitotic G1 DNA damage checkpoint" evidence=TAS

GO:0071732 "cellular response to nitric oxide" evidence=TAS

GO:0005813 "centrosome" evidence=TAS

GO:0015030 "Cajal body" evidence=IDA

GO:0005768 "endosome" evidence=IDA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0008284 "positive regulation of cell proliferation" evidence=IDA

GO:0000086 "G2/M transition of mitotic cell cycle" evidence=NAS

GO:0030332 "cyclin binding" evidence=IDA

GO:0000075 "cell cycle checkpoint" evidence=TAS

GO:0000082 "G1/S transition of mitotic cell cycle" evidence=TAS

GO:0000084 "S phase of mitotic cell cycle" evidence=TAS

GO:0000085 "G2 phase of mitotic cell cycle" evidence=TAS

GO:0000216 "M/G1 transition of mitotic cell cycle" evidence=TAS

GO:0000278 "mitotic cell cycle" evidence=TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005829 "cytosol" evidence=TAS

GO:0006977 "DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest" evidence=TAS

GO:0007596 "blood coagulation" evidence=TAS

GO:0031145 "anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process" evidence=TAS

GO:0051439 "regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle" evidence=TAS

GO:0007265 "Ras protein signal transduction" evidence=IEP

GO:0016572 "histone phosphorylation" evidence=IDA

UNIPROTKB|O55076 CDK2 "Cyclin-dependent kinase 2" [Cricetulus griseus (taxid:10029)]

 Score = 573 (206.8 bits), Expect = 1.4e-55, P = 1.4e-55
 Identities = 105/158 (66%), Positives = 129/158 (81%)

Query:     4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP-V 62
             + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + V  +
Sbjct:    40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAVTGI 99

Query:    63 PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
             P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+  Y
Sbjct:   100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAEGSIKLADFGLARAFGVPVRTY 159

Query:   123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             THEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct:   160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0030496 "midbody" evidence=IDA

ZFIN|ZDB-GENE-040426-2741 cdk2 "cyclin-dependent kinase 2" [Danio rerio (taxid:7955)]

 Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
 Identities = 106/158 (67%), Positives = 128/158 (81%)

Query:     4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP-V 62
             + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+ +T V  +
Sbjct:    40 ETEGVPSTAIREISLLKELNHPNIVKLRDVIHTENKLYLVFEFLHQDLKRFMDSTSVSGI 99

Query:    63 PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
                L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G +KLADFGL+RAF +P+  Y
Sbjct:   100 SLPLVKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINAQGEIKLADFGLARAFGVPVRTY 159

Query:   123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             THEVVTLWYR PEILLG K YST VDIWS GCIF+EMI
Sbjct:   160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMI 197

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|Q5E9Y0 CDK2 "Cyclin-dependent kinase 2" [Bos taurus (taxid:9913)]

 Score = 570 (205.7 bits), Expect = 2.9e-55, P = 2.9e-55
 Identities = 104/158 (65%), Positives = 129/158 (81%)

Query:     4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP-V 62
             + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + +  +
Sbjct:    40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI 99

Query:    63 PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
             P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  G++KLADFGL+RAF +P+  Y
Sbjct:   100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINADGSIKLADFGLARAFGVPVRTY 159

Query:   123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             THEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct:   160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

GO:0006468 "protein phosphorylation" evidence=ISS

GO:0000307 "cyclin-dependent protein kinase holoenzyme complex" evidence=ISS

GO:0045893 "positive regulation of transcription, DNA-dependent" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0007049 "cell cycle" evidence=ISS

GO:0006813 "potassium ion transport" evidence=ISS

GO:0005667 "transcription factor complex" evidence=ISS

GO:0005634 "nucleus" evidence=ISS

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS

GO:0015030 "Cajal body" evidence=IEA

GO:0005815 "microtubule organizing center" evidence=IEA

GO:0005768 "endosome" evidence=IEA

GO:0060968 "regulation of gene silencing" evidence=IEA

GO:0035173 "histone kinase activity" evidence=IEA

GO:0032298 "positive regulation of DNA-dependent DNA replication initiation" evidence=IEA

GO:0030332 "cyclin binding" evidence=IEA

GO:0008284 "positive regulation of cell proliferation" evidence=IEA

GO:0007265 "Ras protein signal transduction" evidence=IEA

GO:0000806 "Y chromosome" evidence=IEA

GO:0000805 "X chromosome" evidence=IEA

GO:0000793 "condensed chromosome" evidence=IEA

GO:0000781 "chromosome, telomeric region" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0046872 "metal ion binding" evidence=IEA

GO:0007126 "meiosis" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|G3V5T9 CDK2 "Cyclin-dependent kinase 2, isoform CRA_c" [Homo sapiens (taxid:9606)]

 Score = 570 (205.7 bits), Expect = 2.9e-55, P = 2.9e-55
 Identities = 105/157 (66%), Positives = 128/157 (81%)

Query:     4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP-V 62
             + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  + +  +
Sbjct:    40 ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI 99

Query:    63 PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
             P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y
Sbjct:   100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159

Query:   123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             THEVVTLWYR PEILLG K YST VDIWS GCIF+EM
Sbjct:   160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEM 196

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q63699	CDK2_RAT	2, ., 7, ., 1, 1, ., 2, 2	0.6583	0.9570	0.5234	yes	N/A
Q00526	CDK3_HUMAN	2, ., 7, ., 1, 1, ., 2, 2	0.6666	0.9693	0.5180	yes	N/A
Q27032	CDC2H_THEPA	2, ., 7, ., 1, 1, ., 2, 3	0.6410	0.9570	0.5234	yes	N/A
Q26671	CDC2H_THEAN	2, ., 7, ., 1, 1, ., 2, 3	0.6410	0.9570	0.5234	yes	N/A
P23573	CDC2C_DROME	2, ., 7, ., 1, 1, ., 2, 3	0.6178	0.9631	0.5	yes	N/A
O55076	CDK2_CRIGR	2, ., 7, ., 1, 1, ., 2, 2	0.6603	0.9693	0.5302	yes	N/A
P61075	CDC2H_PLAF7	2, ., 7, ., 1, 1, ., 2, 3	0.6153	0.9570	0.5416	yes	N/A
P29618	CDKA1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 3	0.6265	0.9570	0.5306	yes	N/A
P34117	CDK5_DICDI	2, ., 7, ., 1, 1, ., 2, 2	0.6298	0.9447	0.5273	yes	N/A
P04551	CDK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 3	0.5722	0.9693	0.5319	yes	N/A
P00546	CDK1_YEAST	2, ., 7, ., 1, 1, ., 2, 2	0.6114	0.9447	0.5167	yes	N/A
O96821	CDC2H_PLAKH	2, ., 7, ., 1, 1, ., 2, 3	0.6153	0.9570	0.5416	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	163
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-105
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-96
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-88
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	7e-85
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-84
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-82
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-77
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-74
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-74
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-73
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-71
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-70
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-66
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-66
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-64
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-64
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	8e-64
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-63
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-62
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-60
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-59
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-59
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-59
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-58
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	4e-58
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-57
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-56
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	8e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-54
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-53
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	3e-52
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-50
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-48
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-48
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	5e-47
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-45
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-43
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-43
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-42
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-42
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-40
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-40
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-40
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	7e-40
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-39
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-39
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-38
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-36
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-36
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-35
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-35
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-34
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-33
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-33
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	3e-32
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-32
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-32
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-31
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-31
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-31
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	8e-31
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	9e-31
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-30
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-29
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-28
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	4e-28
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-27
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-27
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	6e-26
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-25
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-25
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-24
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-24
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-24
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-24
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-23
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-23
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-23
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-22
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-22
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	5e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-22
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-21
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-20
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-20
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-20
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	5e-20
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-20
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-19
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-19
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-19
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-19
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-18
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-18
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-18
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-18
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-18
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	3e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-18
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	7e-18
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-17
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-17
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-17
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-17
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-17
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-17
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-17
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-17
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-17
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-17
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-17
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-17
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	8e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-16
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-16
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-16
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-16
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-15
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-15
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-15
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-15
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-15
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-15
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-15
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-14
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-14
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-14
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-14
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	4e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	8e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-14
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-13
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-13
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-13
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-13
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-13
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	4e-13
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-13
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	7e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	8e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-13
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-13
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-12
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-12
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-12
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-12
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-12
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-12
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-12
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-12
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-12
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-12
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	5e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	7e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-12
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-11
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-11
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-11
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-11
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	3e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-10
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-10
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-10
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-10
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-10
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	3e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-10
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	6e-10
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-09
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-09
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-08
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-08
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	6e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	9e-08
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-07
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	6e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	9e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-06
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	3e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-05
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	4e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	5e-05
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	8e-05
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	0.002

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  301 bits (774), Expect = e-105
 Identities = 109/155 (70%), Positives = 126/155 (81%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PSTALREIS+LKELKHPN+++L DVI  + KL+LVFE+   DLK +L   P P+ P 
Sbjct: 39  EGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPN 98

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L KS +YQLL  L YCHS RI+HRDLKPQNILIN+ G LKLADFGL+RAF IP+  YTHE
Sbjct: 99  LIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE 158

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVTLWYR PEILLG+K YST VDIWS GCIF+EMI
Sbjct: 159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  278 bits (714), Expect = 4e-96
 Identities = 104/157 (66%), Positives = 131/157 (83%), Gaps = 1/157 (0%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV-PVPP 64
           EGVPSTA+REIS+LKEL HPN++RL DV+  + KL+LVFEFL  DLK ++ ++P+  + P
Sbjct: 39  EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP 98

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
            L KSYLYQLL+ + YCHS R++HRDLKPQN+LI++ GALKLADFGL+RAF +P+  YTH
Sbjct: 99  PLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH 158

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           EVVTLWYR PEILLG++ YST VDIWS GCIF+EM+ 
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  258 bits (660), Expect = 6e-88
 Identities = 106/158 (67%), Positives = 130/158 (82%), Gaps = 1/158 (0%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP-V 62
           + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  +P+  +
Sbjct: 38  ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGI 97

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
           P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y
Sbjct: 98  PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 157

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           THEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  250 bits (640), Expect = 7e-85
 Identities = 97/157 (61%), Positives = 124/157 (78%), Gaps = 2/157 (1%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP--VP 63
           EGVPSTA+REIS+LKEL+HPN++ L DV+  + +L+L+FEFL  DLK +L + P    + 
Sbjct: 40  EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD 99

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             L KSYLYQ+L+ + +CHSRR++HRDLKPQN+LI+  G +KLADFGL+RAF IP+  YT
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           HEVVTLWYR PE+LLG+  YST VDIWS G IF+EM 
Sbjct: 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMA 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  248 bits (634), Expect = 6e-84
 Identities = 95/154 (61%), Positives = 126/154 (81%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EGVPS+ALREI +LKELKH N++RL+DV+  D KL LVFE+  QDLK +  +    + P 
Sbjct: 40  EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPE 99

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           + KS+++QLL+ L +CHS  ++HRDLKPQN+LINK+G LKLADFGL+RAF IP+  Y+ E
Sbjct: 100 IVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E+
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  242 bits (619), Expect = 9e-82
 Identities = 94/157 (59%), Positives = 125/157 (79%), Gaps = 2/157 (1%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT--TPVPVP 63
           EG PSTA+REIS++KELKH N++RLHDVI  + KL LVFE++ +DLK ++ T      + 
Sbjct: 39  EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD 98

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
           P   KS+ YQLL+ + +CH  R++HRDLKPQN+LINK G LKLADFGL+RAF IP+N ++
Sbjct: 99  PNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +EVVTLWYR P++LLG++ YST++DIWS GCI +EMI
Sbjct: 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  232 bits (592), Expect = 2e-77
 Identities = 97/157 (61%), Positives = 126/157 (80%), Gaps = 2/157 (1%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPP 64
           EGVPSTA+REIS+LKE++H N++RL DV+  + +L+LVFE+L  DLK  + ++P     P
Sbjct: 42  EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNP 101

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYT 123
            L K+YLYQ+L  + YCHS R++HRDLKPQN+LI++   ALKLADFGL+RAF IP+  +T
Sbjct: 102 RLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFT 161

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           HEVVTLWYR PEILLG++ YST VDIWS GCIF+EM+
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198

Length = 294

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  224 bits (574), Expect = 1e-74
 Identities = 84/156 (53%), Positives = 113/156 (72%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG P TA+RE S+LK+LKH N++ LHD+I     L LVFE+L  DLK ++      +   
Sbjct: 44  EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMH 103

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             + +L+QLL  L YCH RR++HRDLKPQN+LI++ G LKLADFGL+RA ++P   Y++E
Sbjct: 104 NVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNE 163

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVTLWYRPP++LLG+  YST++D+W  GCIF EM  
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  223 bits (570), Expect = 3e-74
 Identities = 94/159 (59%), Positives = 117/159 (73%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP 61
           R + EG+P TALREI +LKEL HPN+I+L DV      L+LVFEF+  DL   ++     
Sbjct: 35  RFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG 94

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +P +L KSYLYQLL+ L +CHS  I+HRDLKP+N+LIN  G LKLADFGL+R+F  P+  
Sbjct: 95  LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP 154

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           YTH VVT WYR PE+LLG K YST VDIWS GCIF+E++
Sbjct: 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELL 193

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  220 bits (563), Expect = 7e-73
 Identities = 81/159 (50%), Positives = 108/159 (67%), Gaps = 1/159 (0%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           +G+  TALREI +L+ELKHPN+I L DV      + LVFEF+  DL+  ++   + + PA
Sbjct: 43  DGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPA 102

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             KSY+   L  L Y HS  I+HRDLKP N+LI   G LKLADFGL+R+F  P  + TH+
Sbjct: 103 DIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQ 162

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE-MIQIP 163
           VVT WYR PE+L GA+ Y   VD+WS GCIF+E ++++P
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  215 bits (550), Expect = 4e-71
 Identities = 78/158 (49%), Positives = 108/158 (68%), Gaps = 3/158 (1%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTPVPVP 63
           EG P TA+REI +L++L+HPN++RL +++    K  +++VFE++  DL   L +  V   
Sbjct: 39  EGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFT 98

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RY 122
            +  K Y+ QLLE L+Y HS  I+HRD+K  NILIN  G LKLADFGL+R +T   +  Y
Sbjct: 99  ESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY 158

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T+ V+TLWYRPPE+LLGA  Y   VD+WS GCI +E+ 
Sbjct: 159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  213 bits (545), Expect = 3e-70
 Identities = 89/167 (53%), Positives = 118/167 (70%), Gaps = 11/167 (6%)

Query: 6   EGVPSTALREISVLKELKH-PNVIRLHDVIPVDFK-----LFLVFEFLRQDLKDFLQTT- 58
           EG+P TALREIS+L+ L     ++RL DV  V+ K     L+LVFE+L  DLK F+ +  
Sbjct: 41  EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNG 100

Query: 59  ---PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRA 114
                P+P    KS++YQLL+ + +CH   ++HRDLKPQN+L++K  G LK+AD GL RA
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160

Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           F+IP+  YTHE+VTLWYR PE+LLG+  YST VDIWS GCIF+EM +
Sbjct: 161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR 207

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  202 bits (515), Expect = 7e-66
 Identities = 73/156 (46%), Positives = 103/156 (66%), Gaps = 1/156 (0%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
            G+P+ ALREI  L+  +HP V++L DV P      LV E++  DL + L+    P+P A
Sbjct: 40  GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEA 99

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTH 124
             KSY+  LL+ + Y H+  I+HRDLKP N+LI+  G LK+ADFGL+R F+    R Y+H
Sbjct: 100 QVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +V T WYR PE+L GA+ Y   VD+W+ GCIF+E++
Sbjct: 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL 195

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  202 bits (515), Expect = 9e-66
 Identities = 73/159 (45%), Positives = 108/159 (67%), Gaps = 4/159 (2%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQDLKDFLQTTPVPV 62
           EG P T+LREI++L +L+HPN++ + +V+    +D K+++V E++  DLK  ++T   P 
Sbjct: 45  EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLD-KIYMVMEYVEHDLKSLMETMKQPF 103

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
             +  K  + QLL  + + H   I+HRDLK  N+L+N  G LK+ DFGL+R +  P+  Y
Sbjct: 104 LQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY 163

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           T  VVTLWYR PE+LLGAK YST +D+WS GCIF+E++ 
Sbjct: 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  197 bits (503), Expect = 5e-64
 Identities = 81/163 (49%), Positives = 109/163 (66%), Gaps = 11/163 (6%)

Query: 6   EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQT 57
           EG+P + LREI++LK+L+   HPN++RL DV        + KL LVFE + QDL  +L  
Sbjct: 39  EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSK 98

Query: 58  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            P P +PP   K  + QLL  + + HS RI+HRDLKPQNIL+   G +K+ADFGL+R ++
Sbjct: 99  CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158

Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+E+
Sbjct: 159 FEM-ALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  197 bits (502), Expect = 6e-64
 Identities = 88/155 (56%), Positives = 115/155 (74%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG P TA+RE+S+LK+LKH N++ LHD+I  +  L LVFE+L +DLK +L      +   
Sbjct: 45  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMH 104

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K +L+QLL  L YCH R+++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y++E
Sbjct: 105 NVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNE 164

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVTLWYRPP+ILLG+  YST +D+W  GCIF EM 
Sbjct: 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMS 199

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  195 bits (499), Expect = 8e-64
 Identities = 72/161 (44%), Positives = 100/161 (62%), Gaps = 4/161 (2%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 59
            + +++      LREI +LK+LKHPN++RL+DV   + KL+LV E+    DL D L+   
Sbjct: 33  KKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRG 92

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
             +    A+ YL Q+L AL Y HS+ I+HRDLKP+NIL+++ G +KLADFGL+R      
Sbjct: 93  -RLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE 151

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            + T  V T  Y  PE+LLG K Y   VDIWS G I  E++
Sbjct: 152 -KLTTFVGTPEYMAPEVLLG-KGYGKAVDIWSLGVILYELL 190

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  194 bits (495), Expect = 7e-63
 Identities = 85/154 (55%), Positives = 112/154 (72%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG P TA+RE+S+LK LKH N++ LHD+I  +  L LVFE+L  DLK +L      +   
Sbjct: 44  EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMH 103

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K +++QLL  L YCH R+I+HRDLKPQN+LIN+ G LKLADFGL+RA ++P   Y++E
Sbjct: 104 NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNE 163

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           VVTLWYRPP++LLG+  YST +D+W  GCI  EM
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEM 197

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  194 bits (494), Expect = 1e-62
 Identities = 85/154 (55%), Positives = 115/154 (74%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG P TA+RE+S+LK+LKH N++ LHD++  D  L LVFE+L +DLK ++      +   
Sbjct: 45  EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMH 104

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K +LYQ+L  L YCH R+++HRDLKPQN+LIN+ G LKLADFGL+RA ++P   Y++E
Sbjct: 105 NVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNE 164

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           VVTLWYRPP++LLG+  YST +D+W  GCIF EM
Sbjct: 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  188 bits (479), Expect = 2e-60
 Identities = 85/156 (54%), Positives = 111/156 (71%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EGVP TA+RE S+LK LKH N++ LHD+I     L  VFE++  DL  ++   P  + P 
Sbjct: 44  EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY 103

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             + +++QLL  L Y H + I+HRDLKPQN+LI+  G LKLADFGL+RA +IP   Y+ E
Sbjct: 104 NVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVTLWYRPP++LLGA  YS+ +DIW AGCIF EM+Q
Sbjct: 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  186 bits (474), Expect = 1e-59
 Identities = 71/156 (45%), Positives = 105/156 (67%), Gaps = 1/156 (0%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           E V  TALRE+ VL++L+H N++ L +      +L+LVFE++ + L + L+ +P  +PP 
Sbjct: 41  EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPD 100

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTH 124
             +SY++QLL+A+ YCHS  IIHRD+KP+NIL+++SG LKL DFG +RA         T 
Sbjct: 101 AVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            V T WYR PE+L+G   Y   VD+W+ GCI +E++
Sbjct: 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELL 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  184 bits (469), Expect = 3e-59
 Identities = 67/160 (41%), Positives = 92/160 (57%), Gaps = 2/160 (1%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPV 60
           R +      TA REI +L+ L HPN++RL D       L+LV E+    DL D+L +   
Sbjct: 35  RSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYL-SRGG 93

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
           P+    AK    Q+L  L Y HS  IIHRDLKP+NIL++++G +K+ADFGL++      +
Sbjct: 94  PLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS 153

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  V T WY  PE+LLG   Y   VD+WS G I  E++
Sbjct: 154 SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELL 193

Length = 260

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  184 bits (470), Expect = 7e-59
 Identities = 70/157 (44%), Positives = 101/157 (64%), Gaps = 2/157 (1%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQDLKDFLQTTPVPVP 63
           +G+P ++LREI++L  L+HPN++ L +V+       +FLV E+  QDL   L   P P  
Sbjct: 47  DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS 106

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
            +  K  + QLL  L+Y H   IIHRDLK  N+L+   G LK+ADFGL+R + +P    T
Sbjct: 107 ESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT 166

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +VVTLWYR PE+LLG   Y+T +D+W+ GCI +E++
Sbjct: 167 PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELL 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  183 bits (466), Expect = 2e-58
 Identities = 86/156 (55%), Positives = 113/156 (72%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG P TA+RE S+LK LKH N++ LHD+I     L LVFE++  DL  ++   P  + P 
Sbjct: 44  EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPE 103

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K +L+QLL  L Y H R I+HRDLKPQN+LI+ +G LKLADFGL+RA ++P + Y++E
Sbjct: 104 NVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVTLWYRPP++LLG+  YST +D+W  GCIF EMIQ
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  182 bits (465), Expect = 4e-58
 Identities = 80/166 (48%), Positives = 101/166 (60%), Gaps = 12/166 (7%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPV------DFK--LFLVFEFLRQDLKDFLQT 57
           EG P TALREI +L+ LKH NV+ L ++          +K   +LVFEF   DL   L  
Sbjct: 52  EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN 111

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
             V    +  K  +  LL  L Y H  +I+HRD+K  NILI K G LKLADFGL+RAF++
Sbjct: 112 KNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSL 171

Query: 118 PM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                 NRYT+ VVTLWYRPPE+LLG + Y   +D+W AGCI +EM
Sbjct: 172 SKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  181 bits (461), Expect = 2e-57
 Identities = 71/173 (41%), Positives = 107/173 (61%), Gaps = 13/173 (7%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDL----KDF 54
            + Q  G+  +A REI++L+ELKH NV+ L +V     D  ++L+F++   DL    K  
Sbjct: 38  DKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFH 97

Query: 55  LQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFG 110
            Q   V +PP++ KS L+Q+L  + Y HS  ++HRDLKP NIL+     + G +K+ D G
Sbjct: 98  RQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLG 157

Query: 111 LSRAFTIPMNRYTHE---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           L+R F  P+         VVT+WYR PE+LLGA+ Y+  +DIW+ GCIF+E++
Sbjct: 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  177 bits (451), Expect = 6e-56
 Identities = 75/174 (43%), Positives = 103/174 (59%), Gaps = 19/174 (10%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--------LFLVFEFLRQDLKDFLQT 57
           +G P TALREI +LK+LKHPNV+ L D+              +++V  ++  DL   L+ 
Sbjct: 48  DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN 107

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT- 116
             V +  +  K Y+ QLLE + Y H   I+HRD+K  NILI+  G LK+ADFGL+R +  
Sbjct: 108 PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167

Query: 117 -IPMN---------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             P           +YT+ VVT WYRPPE+LLG + Y+T VDIW  GC+F+EM 
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF 221

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  174 bits (443), Expect = 8e-55
 Identities = 74/165 (44%), Positives = 107/165 (64%), Gaps = 11/165 (6%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVI-----PVDFK-----LFLVFEFLRQDLKDFL 55
           EG P TA+REI +L++L H N++ L +++      +DFK      +LVFE++  DL   L
Sbjct: 47  EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLL 106

Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
           ++  V       KS++ QLLE L YCH +  +HRD+K  NIL+N  G +KLADFGL+R +
Sbjct: 107 ESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLY 166

Query: 116 TIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               +R YT++V+TLWYRPPE+LLG + Y   +D+WS GCI  E+
Sbjct: 167 NSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGEL 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  170 bits (432), Expect = 3e-54
 Identities = 66/153 (43%), Positives = 89/153 (58%), Gaps = 2/153 (1%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
            LREI +LK+L HPN+++L+ V   +  L+LV E+     LKD L+     +        
Sbjct: 38  LLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRI 97

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           L Q+LE L Y HS  IIHRDLKP+NIL++  +G +KLADFGLS+  T   +     V T 
Sbjct: 98  LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            Y  PE+LLG   YS   DIWS G I  E+ ++
Sbjct: 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYELPEL 190

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  172 bits (438), Expect = 1e-53
 Identities = 67/157 (42%), Positives = 98/157 (62%), Gaps = 9/157 (5%)

Query: 12  ALREISVLKELKHPNVIRLHDVI----PVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L+ L+H N+I L D++    P DF  +++V E +  DL   +++ P P+    
Sbjct: 46  ILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKS-PQPLTDDH 104

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---T 123
            + +LYQ+L  L+Y HS  +IHRDLKP NIL+N +  LK+ DFGL+R      +     T
Sbjct: 105 IQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT 164

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             VVT WYR PE+LL +  Y+  +DIWS GCIF+E++
Sbjct: 165 EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  167 bits (424), Expect = 3e-52
 Identities = 70/149 (46%), Positives = 97/149 (65%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
           ALREI +LK+LKHPN++ L +V     KL LVFE+    + + L+  P  VP  L K  +
Sbjct: 47  ALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKII 106

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
           +Q L+A+ +CH    IHRD+KP+NILI K G +KL DFG +R  T P + YT  V T WY
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWY 166

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           R PE+L+G   Y   VD+W+ GC+F+E++
Sbjct: 167 RAPELLVGDTQYGPPVDVWAIGCVFAELL 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  163 bits (413), Expect = 2e-50
 Identities = 87/171 (50%), Positives = 114/171 (66%), Gaps = 13/171 (7%)

Query: 2   RVQV--EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDL 51
           RVQ   EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + QDL
Sbjct: 36  RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 95

Query: 52  KDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 110
             +L   P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFG
Sbjct: 96  TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 155

Query: 111 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           L+R ++  M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM +
Sbjct: 156 LARIYSFQM-ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFR 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  156 bits (398), Expect = 3e-48
 Identities = 59/151 (39%), Positives = 93/151 (61%), Gaps = 3/151 (1%)

Query: 11  TALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-TPVPVPPALAK 68
             LRE+  L++L  HPN+++L +V   + +L+ VFE++  +L   ++     P   ++ +
Sbjct: 43  MNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIR 102

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
           S +YQ+L+ L + H     HRDLKP+N+L++    +K+ADFGL+R        YT  V T
Sbjct: 103 SIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLARE-IRSRPPYTDYVST 161

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            WYR PEILL +  YS+ VDIW+ GCI +E+
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAEL 192

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  157 bits (399), Expect = 8e-48
 Identities = 72/161 (44%), Positives = 97/161 (60%), Gaps = 22/161 (13%)

Query: 14  REISVLKELK-HPNVIRLHDVIPV--DFKLFLVFEFLRQDL-----KDFLQTTPVPVPPA 65
           REI  L+EL  HPN+++L +VI    D  ++LVFE++  DL      + L+         
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-------- 106

Query: 66  LAKSY-LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-----IPM 119
           + K Y +YQLL+AL+Y HS  +IHRDLKP NIL+N    +KLADFGL+R+ +        
Sbjct: 107 VHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPEN 166

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              T  V T WYR PEILLG+  Y+  VD+WS GCI  EM+
Sbjct: 167 PVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEML 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  154 bits (390), Expect = 5e-47
 Identities = 67/153 (43%), Positives = 99/153 (64%)

Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           V   A+REI +LK+L+H N++ L +V     +L+LVFEF+   + D L+  P  +  +  
Sbjct: 43  VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRV 102

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           + YL+Q+L  + +CHS  IIHRD+KP+NIL+++SG +KL DFG +R    P   YT  V 
Sbjct: 103 RKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA 162

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PE+L+G   Y   VDIW+ GC+ +EM+
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  150 bits (379), Expect = 2e-45
 Identities = 78/171 (45%), Positives = 110/171 (64%), Gaps = 13/171 (7%)

Query: 2   RVQV--EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDL 51
           RVQ   +G+P + +RE+++LK L+   HPN++RL DV        + K+ LVFE + QDL
Sbjct: 34  RVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDL 93

Query: 52  KDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 110
           + +L   P P +P    K  + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFG
Sbjct: 94  RTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153

Query: 111 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           L+R ++  M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM +
Sbjct: 154 LARIYSCQM-ALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFR 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  146 bits (371), Expect = 1e-43
 Identities = 65/164 (39%), Positives = 99/164 (60%), Gaps = 12/164 (7%)

Query: 8   VPSTA---LREISVLKELKHPNVIRLHDVI--PV-DFK-LFLVFEFLRQDLKDFLQTTPV 60
           VP+ A   LRE+ +L+  KH N+I + D++  P  DFK +++V + +  DL   + +   
Sbjct: 44  VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ- 102

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTI 117
           P+     + +LYQLL  L+Y HS  +IHRDLKP N+L+N+   L++ DFG++R       
Sbjct: 103 PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162

Query: 118 PMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               + T  V T WYR PE+LL    Y+T +D+WS GCIF+EM+
Sbjct: 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  145 bits (367), Expect = 1e-43
 Identities = 69/155 (44%), Positives = 100/155 (64%), Gaps = 2/155 (1%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           E V  T LRE+ +L+ LK  N++ L +      KL+LVFE++ +++ + L+  P  VPP 
Sbjct: 41  EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE 100

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTH 124
             +SY+YQL++A+ +CH   I+HRD+KP+N+LI+ +  LKL DFG +R  +   N  YT 
Sbjct: 101 KVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            V T WYR PE+LLGA  Y   VD+WS GCI  E+
Sbjct: 161 YVATRWYRSPELLLGAP-YGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  145 bits (367), Expect = 4e-43
 Identities = 66/169 (39%), Positives = 94/169 (55%), Gaps = 17/169 (10%)

Query: 7   GVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           G+  T LRE+ ++ E+KH N++ L DV +  DF + LV + +  DLK  +    + +  +
Sbjct: 62  GIHFTTLRELKIMNEIKHENIMGLVDVYVEGDF-INLVMDIMASDLKKVVDRK-IRLTES 119

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM------ 119
             K  L Q+L  L   H    +HRDL P NI IN  G  K+ADFGL+R +  P       
Sbjct: 120 QVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLS 179

Query: 120 --------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                      T +VVTLWYR PE+L+GA+ Y   VD+WS GCIF+E++
Sbjct: 180 KDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228

Length = 335

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  140 bits (355), Expect = 5e-42
 Identities = 55/157 (35%), Positives = 78/157 (49%), Gaps = 15/157 (9%)

Query: 13  LREISVLKELKHPNVIR-LHDVIPVDFKLFLVF-EF-----LRQDLKDFLQTTPVPVPPA 65
            REI +L  L+HPN++R        +     +F E+     L   LK F       +P  
Sbjct: 47  EREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-----KLPEP 101

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTH 124
           + + Y  Q+LE L Y HS  I+HRD+K  NIL++  G +KLADFG ++    I     T 
Sbjct: 102 VIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTG 161

Query: 125 EVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            V  T ++  PE++ G + Y    DIWS GC   EM 
Sbjct: 162 SVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMA 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  142 bits (360), Expect = 9e-42
 Identities = 63/156 (40%), Positives = 100/156 (64%), Gaps = 7/156 (4%)

Query: 12  ALREISVLKELKHPNVIRLHDVIP---VDF--KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
             RE+ +L   KH NV+   D++    +D   ++++V E ++ DL   +  +P P+    
Sbjct: 46  VFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKII-VSPQPLSSDH 104

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-THE 125
            K +LYQ+L  L+Y HS  I+HRD+KP N+L+N +  LK+ DFGL+R      +++ T E
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PEIL+G++ Y++ VDIWS GCIF+E++ 
Sbjct: 165 VVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG 200

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  137 bits (347), Expect = 1e-40
 Identities = 67/155 (43%), Positives = 91/155 (58%), Gaps = 9/155 (5%)

Query: 11  TALREISVLKELK-HPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
             LREI  L+ L  HPN++RL +V+      +L LVFE +  +L + ++    P+P    
Sbjct: 43  NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRV 102

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHE 125
           KSY+YQLL++L + H   I HRD+KP+NILI K   LKLADFG  R      P   YT  
Sbjct: 103 KSYMYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPP---YTEY 158

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           + T WYR PE LL    Y   +DIW+ GC+F E++
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  137 bits (347), Expect = 2e-40
 Identities = 71/176 (40%), Positives = 108/176 (61%), Gaps = 17/176 (9%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQ--- 56
           +++  G+  +A REI++L+ELKHPNVI L  V     D K++L+F++   DL   ++   
Sbjct: 35  QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 94

Query: 57  -----TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLA 107
                  PV +P  + KS LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+A
Sbjct: 95  ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154

Query: 108 DFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           D G +R F  P+         VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E++
Sbjct: 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  136 bits (345), Expect = 6e-40
 Identities = 66/149 (44%), Positives = 93/149 (62%), Gaps = 6/149 (4%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           RE+ +LK L+H N+I L D+     + ++ V E L  DL   L + P+       + +LY
Sbjct: 58  RELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLE--KQFIQYFLY 115

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           Q+L  L+Y HS  ++HRDLKP NILIN++  LK+ DFGL+R   I   + T  V T +YR
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR---IQDPQMTGYVSTRYYR 172

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            PEI+L  + Y   VDIWSAGCIF+EM++
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLE 201

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  137 bits (346), Expect = 7e-40
 Identities = 63/153 (41%), Positives = 95/153 (62%), Gaps = 6/153 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           LREI +L+ L H NVI + D++P      F  +++V+E +  DL   +  +   +     
Sbjct: 52  LREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQII-RSSQTLSDDHC 110

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           + +LYQLL  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R  +   +  T  VV
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV 170

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PE+LL    Y+T +D+WS GCIF+E++
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL 203

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  134 bits (338), Expect = 4e-39
 Identities = 70/176 (39%), Positives = 109/176 (61%), Gaps = 17/176 (9%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQ--- 56
           +++  G+  +A REI++L+ELKHPNVI L  V     D K++L+F++   DL   ++   
Sbjct: 35  QIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHR 94

Query: 57  -----TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLA 107
                  P+ +P ++ KS LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+A
Sbjct: 95  ASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154

Query: 108 DFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           D G +R F  P+         VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E++
Sbjct: 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  133 bits (338), Expect = 8e-39
 Identities = 63/158 (39%), Positives = 94/158 (59%), Gaps = 12/158 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVD----FK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L+  KH N+I + D+I       F  +++V E +  DL   ++T  +      
Sbjct: 50  TLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLS--NDH 107

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---- 122
            + +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R    P + +    
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI-ADPEHDHTGFL 166

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T  V T WYR PEI+L +K Y+  +DIWS GCI +EM+
Sbjct: 167 TEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  132 bits (334), Expect = 5e-38
 Identities = 64/158 (40%), Positives = 86/158 (54%), Gaps = 19/158 (12%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK + H NVI L DV      L      +LV   +  DL + ++         L+
Sbjct: 63  RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK------LS 116

Query: 68  KSY----LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             +    +YQ+L  L+Y HS  IIHRDLKP NI +N+   LK+ DFGL+R     M  Y 
Sbjct: 117 DDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY- 175

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             V T WYR PEI+L    Y+ TVDIWS GCI +E++ 
Sbjct: 176 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  129 bits (327), Expect = 7e-38
 Identities = 59/155 (38%), Positives = 88/155 (56%), Gaps = 11/155 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQT-TPVPVPPA 65
           AL E+ +LK+L HPN+I+ ++      KL +V E+     L Q +K   +   P P    
Sbjct: 46  ALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQI 105

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L   +  QL  AL+Y HSR+I+HRD+KPQNI +  +G +KL DFG+S+  +  ++     
Sbjct: 106 L--DWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD-LAKT 162

Query: 126 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           VV T +Y  PE+    K Y+   DIWS GC+  E+
Sbjct: 163 VVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYEL 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  127 bits (321), Expect = 3e-36
 Identities = 63/161 (39%), Positives = 96/161 (59%), Gaps = 16/161 (9%)

Query: 12  ALREISVLKELK-HPNVIRLHD---VIPVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
           ALRE+ +L+  + H N+  L+D   V P +F  L+L  E +  DL   +++   P+  A 
Sbjct: 48  ALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG-QPLTDAH 106

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-------M 119
            +S++YQ+L  L+Y HS  ++HRDLKP N+L+N    LK+ DFGL+R F+         M
Sbjct: 107 FQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM 166

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y   V T WYR PEI+L  + Y+  +D+WS GCI +E++
Sbjct: 167 TEY---VATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  127 bits (320), Expect = 4e-36
 Identities = 61/170 (35%), Positives = 99/170 (58%), Gaps = 26/170 (15%)

Query: 12  ALREISVLKELKHPNVIRLHDVI-------------PVDFK-LFLVFEFLRQDLKDFLQT 57
           ALREI +++ L H N++++++V+               +   +++V E++  DL + L+ 
Sbjct: 49  ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ 108

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFT 116
            P+      A+ ++YQLL  L+Y HS  ++HRDLKP N+ IN     LK+ DFGL+R   
Sbjct: 109 GPLS--EEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLAR--- 163

Query: 117 IPMNRYTHE------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           I    Y+H+      +VT WYR P +LL    Y+  +D+W+AGCIF+EM+
Sbjct: 164 IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 213

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  125 bits (315), Expect = 2e-35
 Identities = 68/163 (41%), Positives = 95/163 (58%), Gaps = 12/163 (7%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDV-----IPVDFKLF-LVFEFLRQDLKDFLQT 57
           Q E     A RE+++LK ++H NVI L DV        +F+ F LV  +++ DL+  +  
Sbjct: 53  QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG- 111

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
              P+     +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R    
Sbjct: 112 --HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169

Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM+
Sbjct: 170 EMTGY---VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  124 bits (312), Expect = 5e-35
 Identities = 68/163 (41%), Positives = 92/163 (56%), Gaps = 11/163 (6%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQT 57
           Q E     A RE+ +LK +KH NVI L DV   D  L      +LV  F+  DL   ++ 
Sbjct: 53  QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH 112

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
             +       +  +YQ+L+ L+Y H+  IIHRDLKP N+ +N+   LK+ DFGL+R    
Sbjct: 113 EKLS--EDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170

Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM+
Sbjct: 171 EMTGY---VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  120 bits (304), Expect = 2e-34
 Identities = 54/150 (36%), Positives = 80/150 (53%), Gaps = 3/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           + EI +LK+ KHPN+++ +       +L++V EF     LKD L++T   +  +      
Sbjct: 45  INEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVC 104

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            +LL+ L Y HS  IIHRD+K  NIL+   G +KL DFGLS   +    R    V T ++
Sbjct: 105 KELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-NTMVGTPYW 163

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++ G K Y    DIWS G    E+ +
Sbjct: 164 MAPEVING-KPYDYKADIWSLGITAIELAE 192

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 1e-33
 Identities = 55/152 (36%), Positives = 80/152 (52%), Gaps = 5/152 (3%)

Query: 11  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
             L E ++L  + HP +++LH     + KL+LV E+    +L   L           A+ 
Sbjct: 39  HTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR-FSEERARF 97

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 128
           Y  +++ AL Y HS  II+RDLKP+NIL++  G +KL DFGL++         T+    T
Sbjct: 98  YAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKEL-SSEGSRTNTFCGT 156

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y  PE+LLG K Y   VD WS G +  EM+
Sbjct: 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEML 187

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  117 bits (295), Expect = 6e-33
 Identities = 59/159 (37%), Positives = 85/159 (53%), Gaps = 11/159 (6%)

Query: 11  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
             L E  +L + + P V++L+        L+LV E+L   DL   L+     +   +A+ 
Sbjct: 39  QVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS-LDEDVARI 97

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-------FTIPMNRY 122
           Y+ +++ AL Y HS  IIHRDLKP NILI+ +G LKL DFGLS+              + 
Sbjct: 98  YIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE 157

Query: 123 THEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              +V T  Y  PE++LG + +S TVD WS GCI  E +
Sbjct: 158 DKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFL 195

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  117 bits (296), Expect = 1e-32
 Identities = 63/158 (39%), Positives = 95/158 (60%), Gaps = 12/158 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVI----PVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           LREI +L+ L+HP+++ +  ++      +FK +++VFE +  DL   ++     + P   
Sbjct: 47  LREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHH 105

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF---TIPMNRYTH 124
           + +LYQLL AL+Y H+  + HRDLKP+NIL N    LK+ DFGL+R     T     +T 
Sbjct: 106 QFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTD 165

Query: 125 EVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMI 160
            V T WYR PE L G+    Y+  +DIWS GCIF+E++
Sbjct: 166 YVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVL 202

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  115 bits (291), Expect = 2e-32
 Identities = 60/169 (35%), Positives = 94/169 (55%), Gaps = 17/169 (10%)

Query: 2   RVQVEGVPSTAL----REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLK 52
           ++ +E +   AL    +EI +LK LKHPN+++    I     L+++ E+     LRQ +K
Sbjct: 32  QISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIK 91

Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F      P P +L   Y+YQ+L+ L Y H + +IHRD+K  NIL  K G +KLADFG++
Sbjct: 92  KF-----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA 146

Query: 113 RAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 +++    VV T ++  PE++  +   ST  DIWS GC   E++
Sbjct: 147 TKLND-VSKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELL 193

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (294), Expect = 3e-32
 Identities = 60/163 (36%), Positives = 90/163 (55%), Gaps = 13/163 (7%)

Query: 11  TALREISVLKELKHP-NVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP--VPVPPAL 66
             LREI +L  L HP N+++L+D    +  L+LV E++    L+D L+      P+  + 
Sbjct: 43  RFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE 102

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFT------IPM 119
           A   L Q+L AL Y HS+ IIHRD+KP+NIL+++ G  +KL DFGL++            
Sbjct: 103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIP 162

Query: 120 NRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMI 160
              +  V T  Y  PE+LLG  +   S++ DIWS G    E++
Sbjct: 163 ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL 205

Length = 384

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  114 bits (288), Expect = 5e-32
 Identities = 45/154 (29%), Positives = 79/154 (51%), Gaps = 13/154 (8%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           LRE  ++++L HPNV++L  V   +  L++V E++   DL  +L+     +  +   S+ 
Sbjct: 49  LREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFA 108

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
            Q+   + Y  S+  IHRDL  +N L+ ++  +K++DFGLSR   +  + Y  +      
Sbjct: 109 LQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD--LYDDDYYRKRGGKLP 166

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGC----IFS 157
             W   PE L     +++  D+WS G     IF+
Sbjct: 167 IRWM-APESLK-EGKFTSKSDVWSFGVLLWEIFT 198

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  115 bits (289), Expect = 7e-32
 Identities = 51/150 (34%), Positives = 84/150 (56%), Gaps = 2/150 (1%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           + EI ++K+ KHPN++  +D   V  +L++V E++    L D +    V +         
Sbjct: 63  INEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVC 122

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            ++L+ L Y HS+ +IHRD+K  NIL++K G++KLADFG +   T   ++    V T ++
Sbjct: 123 REVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYW 182

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EM +
Sbjct: 183 MAPEVIKR-KDYGPKVDIWSLGIMCIEMAE 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  115 bits (289), Expect = 2e-31
 Identities = 64/163 (39%), Positives = 87/163 (53%), Gaps = 27/163 (16%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      +LV E +  +L   +Q         
Sbjct: 62  AYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD------- 114

Query: 66  LAK---SYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR----AFTI 117
           L     SYL YQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +F +
Sbjct: 115 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 174

Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                T  VVT +YR PE++LG   Y   VDIWS GCI  EMI
Sbjct: 175 -----TPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  112 bits (282), Expect = 3e-31
 Identities = 45/153 (29%), Positives = 80/153 (52%), Gaps = 10/153 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 70
           LRE  ++++L HPN+++L  V   +  L +V E++   DL D+L+   P  +  +   S+
Sbjct: 49  LREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSF 108

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTIPMNRYTHEVVTL 129
             Q+   + Y  S+  IHRDL  +N L+ ++  +K++DFGLSR  +     +     + +
Sbjct: 109 ALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI 168

Query: 130 -WYRPPEILLGAKVYSTTVDIWSAGC----IFS 157
            W   PE L     +++  D+WS G     IF+
Sbjct: 169 RWM-APESLK-EGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  111 bits (281), Expect = 5e-31
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 12/154 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++K+L HPN++RL  V      L++V E++   DL DFL+     +         
Sbjct: 49  LEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMA 108

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
            Q+ + + Y  S+  +HRDL  +N L+ ++  +K++DFGLSR      + Y         
Sbjct: 109 LQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD-IYEDDYYRKRGGGKLP 167

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGC----IFS 157
             W   PE L     +++  D+WS G     IF+
Sbjct: 168 IKWM-APESLK-DGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  113 bits (283), Expect = 8e-31
 Identities = 64/154 (41%), Positives = 91/154 (59%), Gaps = 11/154 (7%)

Query: 14  REISVLKELKHPNVIRLHDVI-PV----DF-KLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV  P     +F +++LV   +  DL + ++   +       
Sbjct: 63  RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLS--DEHV 120

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y   V 
Sbjct: 121 QFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGY---VA 177

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           T WYR PEI+L    Y+ TVDIWS GCI +E+++
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK 211

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  111 bits (280), Expect = 9e-31
 Identities = 58/153 (37%), Positives = 81/153 (52%), Gaps = 9/153 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFL-QTTPVPVPPAL 66
           L+EI +LK+L HPNVI+       + +L +V E      L + +K F  Q   +P    +
Sbjct: 50  LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP-ERTI 108

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
            K Y  QL  AL + HS+RI+HRD+KP N+ I  +G +KL D GL R F+         V
Sbjct: 109 WK-YFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 167

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            T +Y  PE +     Y+   DIWS GC+  EM
Sbjct: 168 GTPYYMSPERIHENG-YNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  108 bits (273), Expect = 8e-30
 Identities = 52/154 (33%), Positives = 79/154 (51%), Gaps = 8/154 (5%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
            E+ VL+ LKHPN+++ + V     K+++  E+     L++ L+   + +   + + Y  
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI-LDEHVIRVYTL 106

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHEVVT 128
           QLLE L Y HS  I+HRD+KP NI ++ +G +KL DFG    L    T           T
Sbjct: 107 QLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166

Query: 129 LWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMI 160
             Y  PE++ G K   +    DIWS GC+  EM 
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA 200

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  110 bits (275), Expect = 2e-29
 Identities = 63/153 (41%), Positives = 86/153 (56%), Gaps = 11/153 (7%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV      L      +LV   +  DL + ++   +       
Sbjct: 65  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 122

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 123 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 179

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  107 bits (270), Expect = 3e-29
 Identities = 53/156 (33%), Positives = 80/156 (51%), Gaps = 12/156 (7%)

Query: 15  EISVLKELKHPNVIRLHD--VIPVDFKLFLVFEFL-RQDLKDFLQ---TTPVPVPPALAK 68
           E+++L+ELKHPN++R +D  +   +  L++V E+    DL   +Q        +      
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIW 108

Query: 69  SYLYQLLEALRYCHSR-----RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             L QLL AL  CH+R      ++HRDLKP NI ++ +  +KL DFGL++      +   
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             V T +Y  PE L     Y    DIWS GC+  E+
Sbjct: 169 TYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYEL 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  108 bits (270), Expect = 2e-28
 Identities = 66/164 (40%), Positives = 94/164 (57%), Gaps = 13/164 (7%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVD-FK-----LFL--VFEFLRQDLKDFLQ---T 57
           P    RE+ ++K L H N+I L D    + FK     +FL  V EF+ Q +  +++    
Sbjct: 103 PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR 162

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFT 116
               +P  L K Y YQL  AL Y HS+ I HRDLKPQN+LI+  +  LKL DFG ++   
Sbjct: 163 NNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL- 221

Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +   R    + + +YR PE++LGA  Y+T +D+WS GCI +EMI
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  104 bits (261), Expect = 4e-28
 Identities = 52/147 (35%), Positives = 78/147 (53%), Gaps = 6/147 (4%)

Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
              LRE+  L+  + P V++ +     + ++ +V E++    L D L+       P LA 
Sbjct: 44  KQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY 103

Query: 69  SYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEV 126
               Q+L+ L Y H+ R IIHRD+KP N+LIN  G +K+ADFG+S+     +    T  V
Sbjct: 104 -IARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-V 161

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAG 153
            T+ Y  PE + G + YS   DIWS G
Sbjct: 162 GTVTYMSPERIQG-ESYSYAADIWSLG 187

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-27
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 20/162 (12%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP--------VP 63
           L+E  V+K+L HPNV+RL  V   +  L+LV E++   DL D+L+ +           + 
Sbjct: 44  LKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLS 103

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
                S+  Q+ + + Y  S++ +HRDL  +N L+ +   +K++DFGLSR      + Y 
Sbjct: 104 LKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYYR 162

Query: 124 HEVVTL----WYRPPEILLGAKVYSTTVDIWSAGC----IFS 157
            +        W   PE L    ++++  D+WS G     IF+
Sbjct: 163 KKTGGKLPIRWM-APESLKD-GIFTSKSDVWSFGVLLWEIFT 202

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  102 bits (256), Expect = 2e-27
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 13/152 (8%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-----LKDFLQTTPVPVPPALAK 68
           +EI++L +L+HPN+++       +  L++  E +        LK +        P  + +
Sbjct: 51  QEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-----GSFPEPVIR 105

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
            Y  Q+L  L Y H R  +HRD+K  NIL++ +G +KLADFG+++   +    +      
Sbjct: 106 LYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKG 163

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           + ++  PE++     Y    DIWS GC   EM
Sbjct: 164 SPYWMAPEVIAQQGGYGLAADIWSLGCTVLEM 195

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  100 bits (251), Expect = 6e-26
 Identities = 59/156 (37%), Positives = 86/156 (55%), Gaps = 11/156 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ +LK + H N+I L +V        +F+ ++LV E +  +L    Q   + +   
Sbjct: 67  AYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANL---CQVIHMELDHE 123

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 124 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPY 182

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  E+++
Sbjct: 183 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVK 217

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 98.2 bits (244), Expect = 1e-25
 Identities = 56/152 (36%), Positives = 81/152 (53%), Gaps = 7/152 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALA 67
           ++EI +LK+L HPNVI+ +     D +L +V E      L + +K F +   + +P    
Sbjct: 50  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPEKTV 108

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
             Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V 
Sbjct: 109 WKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T +Y  PE  +    Y+   DIWS GC+  EM
Sbjct: 169 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 98.2 bits (244), Expect = 1e-25
 Identities = 57/152 (37%), Positives = 81/152 (53%), Gaps = 7/152 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALA 67
           ++EI +LK+L HPNVI+  D    D +L +V E      L Q +K F +   + +P    
Sbjct: 50  VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRL-IPERTV 108

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
             Y  QL  A+ + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V 
Sbjct: 109 WKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T +Y  PE  +    Y+   DIWS GC+  EM
Sbjct: 169 TPYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 97.3 bits (243), Expect = 3e-25
 Identities = 50/171 (29%), Positives = 78/171 (45%), Gaps = 24/171 (14%)

Query: 12  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
              E  VL  L  HP +I+L+     +  L+ V E+    +L  +++     +     + 
Sbjct: 48  VKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGS-LDEKCTRF 106

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-------------- 115
           Y  ++L AL Y HS+ IIHRDLKP+NIL++K   +K+ DFG ++                
Sbjct: 107 YAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166

Query: 116 ----TIPMNRYTHE--VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                I  NR      V T  Y  PE+L        + D+W+ GCI  +M+
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQML 216

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 96.2 bits (240), Expect = 6e-25
 Identities = 53/159 (33%), Positives = 83/159 (52%), Gaps = 4/159 (2%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP 61
           V VE      ++EIS+LK+   P +++ +     +  L++V E+     + D ++ T   
Sbjct: 36  VPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT 95

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +      + LYQ L+ L Y HS + IHRD+K  NIL+N+ G  KLADFG+S   T  M  
Sbjct: 96  LTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-A 154

Query: 122 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             + V+ T ++  PE++     Y+   DIWS G    EM
Sbjct: 155 KRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 95.8 bits (239), Expect = 8e-25
 Identities = 46/156 (29%), Positives = 79/156 (50%), Gaps = 18/156 (11%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYL 71
             E  +L+E  HP +++L+        ++++ E+ L  +L   L+          A+ Y+
Sbjct: 41  FSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYI 99

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-------RAFTIPMNRYTH 124
             ++ A  Y H+R II+RDLKP+N+L++ +G +KL DFG +       + +T        
Sbjct: 100 ACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF------- 152

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              T  Y  PEI+L  K Y  +VD WS G +  E++
Sbjct: 153 -CGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELL 186

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.9 bits (236), Expect = 2e-24
 Identities = 50/150 (33%), Positives = 81/150 (54%), Gaps = 6/150 (4%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI +LK L+H  +++ +  +  D  L +  E++    +KD L+     +   + + Y  Q
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYG-ALTETVTRKYTRQ 112

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV--TLW 130
           +LE + Y HS  I+HRD+K  NIL + +G +KL DFG S R  TI  +    + V  T +
Sbjct: 113 ILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPY 172

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +  PE++ G + Y    D+WS GC   EM+
Sbjct: 173 WMSPEVISG-EGYGRKADVWSVGCTVVEML 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 96.5 bits (240), Expect = 2e-24
 Identities = 54/157 (34%), Positives = 80/157 (50%), Gaps = 2/157 (1%)

Query: 7   GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
           G   T L E  +L+ + HP+VIR+ D +       +V      DL  +L     P+P   
Sbjct: 99  GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQ 158

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
           A     Q+LE LRY H++RIIHRD+K +NI IN    + + D G ++ F +    +    
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPVVAPAFLGLA 217

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP 163
            T+    PE+L   K Y++  DIWSAG +  EM+  P
Sbjct: 218 GTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYP 253

Length = 357

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 95.9 bits (239), Expect = 2e-24
 Identities = 53/150 (35%), Positives = 76/150 (50%), Gaps = 8/150 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L   K   +++L      D  L+L  E++   D +  L    V +    A+ Y+
Sbjct: 49  LTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV-LSEDHARFYM 107

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 130
            ++ EA+   H    IHRDLKP+N LI+ SG +KL DFGLS+        Y + VV +  
Sbjct: 108 AEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV----TYANSVVGSPD 163

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L G   Y  TVD WS GC+  E +
Sbjct: 164 YMAPEVLRGKG-YDFTVDYWSLGCMLYEFL 192

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 94.9 bits (236), Expect = 3e-24
 Identities = 54/166 (32%), Positives = 79/166 (47%), Gaps = 32/166 (19%)

Query: 12  ALR-EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ-----------TTP 59
           ALR EI  LK+L H N+++           +L FE   + L  FL+            T 
Sbjct: 54  ALRSEIETLKDLDHLNIVQ-----------YLGFETTEEYLSIFLEYVPGGSIGSCLRTY 102

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
                 L + +  Q+LE L Y HS+ I+HRDLK  N+L++  G  K++DFG+S+      
Sbjct: 103 GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKK---SD 159

Query: 120 NRYTHEVVT------LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           + Y ++          W  P  I   ++ YS  VDIWS GC+  EM
Sbjct: 160 DIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEM 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 94.1 bits (234), Expect = 4e-24
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 9/153 (5%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPAL 66
           A+ EI +L  + HPN+I   +      KL +V E+     L + +    +     +P   
Sbjct: 46  AVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISK-RKKKRKLIPEQE 104

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
                 QLL  L+  H ++I+HRDLK  NIL+  +  +K+ D G+S+     M +   ++
Sbjct: 105 IWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT--QI 162

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            T  Y  PE+  G + YS   DIWS GC+  EM
Sbjct: 163 GTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEM 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 6e-24
 Identities = 49/137 (35%), Positives = 72/137 (52%), Gaps = 7/137 (5%)

Query: 25  PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 83
           P V +L+        L+LV E+L   D    ++T    +P   AK Y+ +++  +   H 
Sbjct: 57  PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 84  RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 143
           R IIHRD+KP+N+LI+++G LKL DFGLSR       ++   V T  Y  PE +LG    
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN-KKF---VGTPDYLAPETILG-VGD 170

Query: 144 STTVDIWSAGCIFSEMI 160
               D WS GC+  E +
Sbjct: 171 DKMSDWWSLGCVIFEFL 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 95.1 bits (236), Expect = 8e-24
 Identities = 59/155 (38%), Positives = 86/155 (55%), Gaps = 11/155 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ +++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHE 126

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 185

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT +YR PE++LG   Y   VDIWS GCI  EMI
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 92.8 bits (231), Expect = 1e-23
 Identities = 48/150 (32%), Positives = 75/150 (50%), Gaps = 6/150 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+EL HP ++ L      +  ++LV + L   DL+  L    V       K ++
Sbjct: 48  LNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWI 106

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 130
            +++ AL Y HS+ IIHRD+KP NIL+++ G + + DF ++       +  T     T  
Sbjct: 107 CEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKV--TPDTLTTSTSGTPG 164

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L   + YS  VD WS G    E +
Sbjct: 165 YMAPEVLC-RQGYSVAVDWWSLGVTAYECL 193

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 92.2 bits (229), Expect = 2e-23
 Identities = 48/150 (32%), Positives = 80/150 (53%), Gaps = 3/150 (2%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL-KDFLQTTPVPVPPALAKS 69
           + +E++VL  +KHPN+++  +    +  L++V ++    DL K       V  P      
Sbjct: 46  SRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD 105

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           +  Q+  AL++ H R+I+HRD+K QNI + K G +KL DFG++R     +      + T 
Sbjct: 106 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTP 165

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +Y  PEI    + Y+   DIW+ GC+  EM
Sbjct: 166 YYLSPEICEN-RPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 93.2 bits (231), Expect = 3e-23
 Identities = 59/156 (37%), Positives = 84/156 (53%), Gaps = 11/156 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      +LV E +  +L   +Q   + +   
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ---MELDHE 119

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 178

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 179 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 91.7 bits (228), Expect = 4e-23
 Identities = 49/153 (32%), Positives = 77/153 (50%), Gaps = 5/153 (3%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           EI +L E KHPN++ L++    + KL+++ EF     L   +      +     +    Q
Sbjct: 52  EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +LEAL + HS ++IHRDLK  NIL+   G +KLADFG+S      + +    + T ++  
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171

Query: 134 PEILL----GAKVYSTTVDIWSAGCIFSEMIQI 162
           PE++         Y    DIWS G    E+ Q+
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQM 204

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 91.8 bits (229), Expect = 4e-23
 Identities = 58/166 (34%), Positives = 89/166 (53%), Gaps = 26/166 (15%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT---P 59
           QVE V    L E  +L+ ++HP ++ L+     D  L+LV E++   +L   L+ +   P
Sbjct: 44  QVEHV----LNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFP 99

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-----RA 114
            PV    A+ Y  Q++ AL Y HS  I++RDLKP+N+L++  G +K+ DFG +     R 
Sbjct: 100 EPV----ARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT 155

Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +T+     T E     Y  PEI+L  K Y   VD W+ G +  EM+
Sbjct: 156 YTLCG---TPE-----YLAPEIILS-KGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 91.0 bits (226), Expect = 6e-23
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 19/158 (12%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF----------LRQDLKDFLQTTPVP 61
           AL EI +L  L+HPN+I  ++    D  L +  E+          +RQ  + F       
Sbjct: 46  ALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF------- 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
               +   YL+Q++ A+ Y H   I+HRD+K  NI + K+G +KL DFG+S+      + 
Sbjct: 99  -EEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM 157

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               V T +Y  PE+  G K Y+   DIW+ GC+  E+
Sbjct: 158 AETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 90.0 bits (224), Expect = 2e-22
 Identities = 44/148 (29%), Positives = 72/148 (48%), Gaps = 4/148 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           +EI  L + + P + + +       KL+++ E+       D L+  P  +        L 
Sbjct: 48  QEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILR 105

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L  L Y H    IHRD+K  NIL+++ G +KLADFG+S   T  M++    V T ++ 
Sbjct: 106 EVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWM 165

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE++  +  Y    DIWS G    E+ 
Sbjct: 166 APEVIKQSG-YDEKADIWSLGITAIELA 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 89.6 bits (222), Expect = 3e-22
 Identities = 51/150 (34%), Positives = 82/150 (54%), Gaps = 4/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E KHPN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 64  INEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 121

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 122 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EM++
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEMVE 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 88.4 bits (219), Expect = 5e-22
 Identities = 53/155 (34%), Positives = 81/155 (52%), Gaps = 5/155 (3%)

Query: 11  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP-VPPALAK 68
            A  E  VLK L HPN+I  ++    D  L +V E+     L +++Q      +      
Sbjct: 45  AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTIL 104

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVV 127
            +  Q+L AL + H++ I+HRDLK QNIL++K    +K+ DFG+S+  +     YT  V 
Sbjct: 105 HFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT-VVG 163

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           T  Y  PE+  G K Y+   DIW+ GC+  E+  +
Sbjct: 164 TPCYISPELCEG-KPYNQKSDIWALGCVLYELASL 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 88.7 bits (220), Expect = 5e-22
 Identities = 46/153 (30%), Positives = 81/153 (52%), Gaps = 7/153 (4%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REI++LKEL+H N+++          L +  E++       L          L ++++ Q
Sbjct: 55  REIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQ 114

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---AFTIPMNRYTHEVV--- 127
           +L+ L Y H+R IIHRD+K  NIL++  G +K++DFG+S+   A ++             
Sbjct: 115 ILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQG 174

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           ++++  PE+ +    Y+   DIWS GC+  EM+
Sbjct: 175 SVFWMAPEV-VKQTSYTRKADIWSLGCLVVEML 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 7e-22
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 14/155 (9%)

Query: 14  REISVLKELKH---PNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPA 65
           RE+++L +L+    PN+ + +       +L+++ E+     +R  +K        P+   
Sbjct: 48  REVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK------AGPIAEK 101

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                + ++L AL+Y H   +IHRD+K  NIL+  +G +KL DFG++       ++ +  
Sbjct: 102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF 161

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           V T ++  PE++   K Y T  DIWS G    EM 
Sbjct: 162 VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 88.1 bits (218), Expect = 7e-22
 Identities = 48/153 (31%), Positives = 79/153 (51%), Gaps = 7/153 (4%)

Query: 11  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP----VPPAL 66
            + +E  +L ++KHPN++   +    D  L++V E+   D  D +Q   +      P   
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC--DGGDLMQKIKLQRGKLFPEDT 101

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
              +  Q+   +++ H +R++HRD+K +NI + ++G +KL DFG +R  T P       V
Sbjct: 102 ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV 161

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            T +Y PPEI      Y+   DIWS GCI  E+
Sbjct: 162 GTPYYVPPEIWENMP-YNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 88.2 bits (219), Expect = 8e-22
 Identities = 46/149 (30%), Positives = 77/149 (51%), Gaps = 7/149 (4%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPV-PPALAK 68
             +E+  + +  HPNV++ +    V  +L+LV  +L    L D ++++ P      A+  
Sbjct: 46  LRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA 105

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HE 125
           + L ++L+ L Y HS   IHRD+K  NIL+ + G++K+ADFG+S +     +R       
Sbjct: 106 TVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT 165

Query: 126 VV-TLWYRPPEILLGAKVYSTTVDIWSAG 153
            V T  +  PE++     Y    DIWS G
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFG 194

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 87.4 bits (217), Expect = 1e-21
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 3/149 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           +EIS+LKE +HPN++          KL++V E+     L+D  Q T  P+          
Sbjct: 49  QEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR 108

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           + L+ L Y H    IHRD+K  NIL+ + G +KLADFG+S   T  + +    + T ++ 
Sbjct: 109 ETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM 168

Query: 133 PPEILLGAKV--YSTTVDIWSAGCIFSEM 159
            PE+    +   Y    DIW+ G    E+
Sbjct: 169 APEVAAVERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 87.2 bits (216), Expect = 2e-21
 Identities = 52/162 (32%), Positives = 80/162 (49%), Gaps = 12/162 (7%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVP 63
           E V     +EI ++  L HP++IR+      D  F LF+  E++       L +      
Sbjct: 44  EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV--EWMAGGSVSHLLSKYGAFK 101

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 122
            A+  +Y  QLL  L Y H  +IIHRD+K  N+LI+ +G  L++ADFG +          
Sbjct: 102 EAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG- 160

Query: 123 THE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             E     + T+ +  PE+L G + Y  + D+WS GC+  EM
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEM 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 87.5 bits (216), Expect = 3e-21
 Identities = 52/150 (34%), Positives = 84/150 (56%), Gaps = 4/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V+KELK+PN++   D   V  +LF+V E+L    L D +  T   +  A   +  
Sbjct: 64  INEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVC 121

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + H+ ++IHRD+K  N+L+   G++KL DFG     T   ++ +  V T ++
Sbjct: 122 RECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EM++
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEMVE 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 87.1 bits (216), Expect = 3e-21
 Identities = 46/148 (31%), Positives = 82/148 (55%), Gaps = 4/148 (2%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +HPN++ ++    V  +L++V EFL    L D +  T +     +A +    
Sbjct: 66  EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMN-EEQIA-TVCLA 123

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL + H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183

Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           PE ++    Y T VDIWS G +  EM+ 
Sbjct: 184 PE-VISRLPYGTEVDIWSLGIMVIEMVD 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 85.5 bits (212), Expect = 7e-21
 Identities = 47/164 (28%), Positives = 72/164 (43%), Gaps = 7/164 (4%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF--LRQDLKDFLQTT 58
              ++  +    L+E +++  L H N+IRL+ V+ +   L +V E   L   L    +  
Sbjct: 32  KSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVV-LTHPLMMVTELAPLGSLLDRLRKDA 90

Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
                 +    Y  Q+   +RY  S+R IHRDL  +NIL+     +K+ DFGL RA    
Sbjct: 91  LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150

Query: 119 MNRYT---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            + Y    H  V   +  PE L     +S   D+W  G    EM
Sbjct: 151 EDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 84.1 bits (208), Expect = 3e-20
 Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 14/171 (8%)

Query: 2   RVQVEGVPSTALR-------EISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQDLKD 53
           R+ ++ +P    R       EI++   LKH N+++ L       F    + +     L  
Sbjct: 35  RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA 94

Query: 54  FLQTT--PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFG 110
            L++   P+         Y  Q+LE L+Y H  +I+HRD+K  N+L+N  SG +K++DFG
Sbjct: 95  LLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFG 154

Query: 111 LSRAFTIPMNRYTHEVV-TLWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEM 159
            S+     +N  T     TL Y  PE++  G + Y    DIWS GC   EM
Sbjct: 155 TSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEM 204

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.9 bits (210), Expect = 3e-20
 Identities = 53/147 (36%), Positives = 82/147 (55%), Gaps = 3/147 (2%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L E+ HP +++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 48  ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 106

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 166

Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +  + ++ + D WS G +  EM+
Sbjct: 167 PEV-VNRRGHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 83.9 bits (207), Expect = 3e-20
 Identities = 52/153 (33%), Positives = 75/153 (49%), Gaps = 5/153 (3%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYLYQ 73
           EI +L    HPN+++L D    +  L+++ EF      D  +     P+     +    Q
Sbjct: 52  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
            LEAL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++  
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 171

Query: 134 PEILL----GAKVYSTTVDIWSAGCIFSEMIQI 162
           PE+++      + Y    D+WS G    EM QI
Sbjct: 172 PEVVMCETSKDRPYDYKADVWSLGITLIEMAQI 204

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 84.3 bits (208), Expect = 4e-20
 Identities = 53/154 (34%), Positives = 78/154 (50%), Gaps = 7/154 (4%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD--FLQTTPVPVPPALAKSYLY 72
           EI +L    HP +++L      D KL+++ EF      D   L+       P + +    
Sbjct: 59  EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-QVICR 117

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           Q+LEAL+Y HS +IIHRDLK  N+L+   G +KLADFG+S      + R    + T ++ 
Sbjct: 118 QMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWM 177

Query: 133 PPEILLGAKV----YSTTVDIWSAGCIFSEMIQI 162
            PE+++   +    Y    DIWS G    EM QI
Sbjct: 178 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 211

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 84.5 bits (209), Expect = 4e-20
 Identities = 52/157 (33%), Positives = 83/157 (52%), Gaps = 23/157 (14%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL----------RQDLKDFLQTTPVPVPP 64
           E ++L+ +KHP ++ L        KL+L+ E+L          R+ +  F++ T      
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI--FMEDT------ 101

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
             A  YL ++  AL + H + II+RDLKP+NIL++  G +KL DFGL +  +I     TH
Sbjct: 102 --ACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTH 158

Query: 125 EVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               T+ Y  PEIL+ +  +   VD WS G +  +M+
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDML 194

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 83.3 bits (206), Expect = 4e-20
 Identities = 45/154 (29%), Positives = 82/154 (53%), Gaps = 8/154 (5%)

Query: 15  EISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLR----QDLKDFLQTTPVPVPPALAKS 69
           E++++KE L+HPN++R +     + +L++V + +      +  + L+            +
Sbjct: 58  EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117

Query: 70  YLYQLLEALRYCH-SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
              Q++ ALRY H  +RI+HRDL P NI++ +   + + DFGL++    P ++ T  V T
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ-PESKLTSVVGT 176

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           + Y  PEI+     Y    D+W+ GCI  +M  +
Sbjct: 177 ILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTL 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 84.5 bits (209), Expect = 5e-20
 Identities = 51/144 (35%), Positives = 78/144 (54%), Gaps = 8/144 (5%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REI +L+++ HPNV++ HD+   + ++ ++ EF+       L+ T +     LA     Q
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG---SLEGTHIADEQFLA-DVARQ 176

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L  + Y H R I+HRD+KP N+LIN +  +K+ADFG+SR     M+     V T+ Y  
Sbjct: 177 ILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMS 236

Query: 134 PEIL---LGAKVYSTTV-DIWSAG 153
           PE +   L    Y     DIWS G
Sbjct: 237 PERINTDLNHGAYDGYAGDIWSLG 260

Length = 353

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 82.9 bits (205), Expect = 5e-20
 Identities = 43/153 (28%), Positives = 73/153 (47%), Gaps = 9/153 (5%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPAL 66
           A+ E  VL +L    +IR ++      KL +V E+     L + LK        P+P   
Sbjct: 46  AIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR---PLPEDQ 102

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
              +  Q+L  L + HS++I+HRD+K  N+ ++    +K+ D G+++  +   N     V
Sbjct: 103 VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV 162

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            T +Y  PE L   K Y+   D+W+ G +  E 
Sbjct: 163 GTPYYLSPE-LCEDKPYNEKSDVWALGVVLYEC 194

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 83.2 bits (205), Expect = 7e-20
 Identities = 51/150 (34%), Positives = 82/150 (54%), Gaps = 4/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 122

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EMI+
Sbjct: 183 MAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 82.5 bits (204), Expect = 1e-19
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 9/153 (5%)

Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +L+ L H N+++   V   P    L L+ E+L    L+D+LQ     +       +
Sbjct: 55  REIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLF 114

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 126
             Q+ + + Y  S+R IHRDL  +NIL+     +K++DFGL++      + Y      E 
Sbjct: 115 SSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              WY  PE L  +K  S + D+WS G    E+
Sbjct: 175 PIFWY-APECLRTSKFSSAS-DVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 84.1 bits (208), Expect = 1e-19
 Identities = 53/158 (33%), Positives = 82/158 (51%), Gaps = 16/158 (10%)

Query: 14  REISVLKELKHPNVIRLHD--VIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 70
           RE ++   L HPN++ L D    P    LF VFE++  + L++ L      +P       
Sbjct: 27  RETALCARLYHPNIVALLDSGEAPPGL-LFAVFEYVPGRTLREVLAADG-ALPAGETGRL 84

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLS------RAFTIPMNR 121
           + Q+L+AL   H++ I+HRDLKPQNI+++++G     K+ DFG+       R   +    
Sbjct: 85  MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLT 144

Query: 122 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
            T EV+ T  Y  PE L G  V   + D+++ G IF E
Sbjct: 145 RTTEVLGTPTYCAPEQLRGEPVTPNS-DLYAWGLIFLE 181

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 82.8 bits (204), Expect = 2e-19
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           ++E+  L++LKHPN I        +   +LV E+      D L+    P+      +  +
Sbjct: 69  IKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH 128

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
             L+ L Y HS  +IHRD+K  NIL+ + G +KLADFG S + + P N +   V T ++ 
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASKSSPANSF---VGTPYWM 184

Query: 133 PPEILLGAK--VYSTTVDIWSAG--CI 155
            PE++L      Y   VD+WS G  CI
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCI 211

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 81.3 bits (201), Expect = 2e-19
 Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 18/161 (11%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL- 71
           +E+  LK L+H ++I L  V  V   ++++ E + +  L  FL++   P    L  + L 
Sbjct: 51  KEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS---PEGQVLPVASLI 107

Query: 72  ---YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HE 125
               Q+ E + Y   +  IHRDL  +NIL+ +    K+ADFGL+R     +  Y     +
Sbjct: 108 DMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV--YLSSDKK 165

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI---QIP 163
           +   W  P         +ST  D+WS G +  EM    Q+P
Sbjct: 166 IPYKWTAPEAA--SHGTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 81.2 bits (200), Expect = 3e-19
 Identities = 49/151 (32%), Positives = 80/151 (52%), Gaps = 8/151 (5%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP----VPVPPALAKS 69
           +E+ +L ++KHPN++        + +LF+V E+   D  D ++       V        S
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYC--DGGDLMKRINRQRGVLFSEDQILS 105

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-KLADFGLSRAFTIPMNRYTHEVVT 128
           +  Q+   L++ H R+I+HRD+K QNI ++K+G + KL DFG++R     M      V T
Sbjct: 106 WFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGT 165

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +Y  PEI    + Y+   DIWS GC+  E+
Sbjct: 166 PYYLSPEICQN-RPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 80.8 bits (200), Expect = 4e-19
 Identities = 48/166 (28%), Positives = 88/166 (53%), Gaps = 17/166 (10%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPP 64
           P   L+E  ++K+L+H  +++L+ V   +  +++V E++ +  L DFL++     + +P 
Sbjct: 45  PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ 104

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 123
            +  +   Q+ E + Y  SR  IHRDL  +NIL+ ++   K+ADFGL+R   I  + YT 
Sbjct: 105 LVDMAA--QIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR--LIEDDEYTA 160

Query: 124 HEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI---QIP 163
            E       W  P     G   ++   D+WS G + +E++   ++P
Sbjct: 161 REGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 80.9 bits (199), Expect = 6e-19
 Identities = 50/150 (33%), Positives = 82/150 (54%), Gaps = 4/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 64  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 121

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 122 RECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 181

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EM++
Sbjct: 182 MAPEVVT-RKAYGPKVDIWSLGIMAIEMVE 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 81.6 bits (201), Expect = 7e-19
 Identities = 50/147 (34%), Positives = 72/147 (48%), Gaps = 5/147 (3%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT-PVPVPPALAKSYLYQ 73
           E  +L+ + HP++I+L      +    L+    + DL  +L     + +   LA      
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAICDILAIER--S 190

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWYR 132
           +L A++Y H  RIIHRD+K +NI IN  G + L DFG +     I  N+Y     T+   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE LL    Y   VDIWSAG +  EM
Sbjct: 251 APE-LLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 1e-18
 Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 8/147 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           ++E+  L++L+HPN I        +   +LV E+      D L+    P+      +  +
Sbjct: 63  IKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICH 122

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
             L+ L Y HS   IHRD+K  NIL+ + G +KLADFG S +   P N +   V T ++ 
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG-SASLVSPANSF---VGTPYWM 178

Query: 133 PPEILLGAK--VYSTTVDIWSAG--CI 155
            PE++L      Y   VD+WS G  CI
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCI 205

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 1e-18
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 33/169 (19%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       +V E + + DLK +L       +  P   PP
Sbjct: 57  LNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116

Query: 65  ALAKSYLY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
            L K      ++ + + Y  +++ +HRDL  +N ++ +   +K+ DFG++R      + Y
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR------DIY 170

Query: 123 THEVVTLWYRP------------PEILLGAKVYSTTVDIWSAGCIFSEM 159
             +    +YR             PE L    V++T  D+WS G +  EM
Sbjct: 171 ETD----YYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 79.8 bits (197), Expect = 2e-18
 Identities = 51/156 (32%), Positives = 84/156 (53%), Gaps = 24/156 (15%)

Query: 15  EISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
           E  VLKE+ HP +IRL    HD       L+++ E++   +L  +L+ +      +    
Sbjct: 51  EKRVLKEVSHPFIIRLFWTEHD----QRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLF 105

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-----RAFTIPMNRYTH 124
           Y  +++ AL Y HS+ I++RDLKP+NIL++K G +KL DFG +     R +T+       
Sbjct: 106 YASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL------- 158

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              T  Y  PE+ + +K ++  VD W+ G +  EM+
Sbjct: 159 -CGTPEYLAPEV-IQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 79.0 bits (195), Expect = 2e-18
 Identities = 44/152 (28%), Positives = 80/152 (52%), Gaps = 11/152 (7%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E  V+ +L HPN+++L+ V      +F+V E++    L ++L+     +           
Sbjct: 49  EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 130
           + EA+ Y  S   IHRDL  +N L+ +   +K++DFGL+R + +  ++YT    T +   
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLAR-YVLD-DQYTSSQGTKFPVK 166

Query: 131 YRPPEILLGAKVYSTTVDIWSAGC----IFSE 158
           + PPE+   ++ +S+  D+WS G     +FSE
Sbjct: 167 WAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 79.2 bits (195), Expect = 2e-18
 Identities = 51/152 (33%), Positives = 75/152 (49%), Gaps = 6/152 (3%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT---TPVPVPPALA 67
           A +E  +L +L HP +++ H          ++ E+   +DL   L+    T   +     
Sbjct: 49  ANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQV 108

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
             +  QLL  + Y H RRI+HRDLK +NI + K+  LK+ DFG+SR      +  T    
Sbjct: 109 CEWFIQLLLGVHYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGVSRLLMGSCDLATTFTG 167

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T +Y  PE  L  + Y +  DIWS GCI  EM
Sbjct: 168 TPYYMSPEA-LKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 78.8 bits (194), Expect = 2e-18
 Identities = 43/151 (28%), Positives = 82/151 (54%), Gaps = 7/151 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L H  +++L+ V      +++V E++    L ++L+       P+      
Sbjct: 47  IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMC 106

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + E + Y  S++ IHRDL  +N L++  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSR--YVLDDEYTSSVGSKFP 164

Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             + PPE+LL +K +S+  D+W+ G +  E+
Sbjct: 165 VRWSPPEVLLYSK-FSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 80.3 bits (198), Expect = 3e-18
 Identities = 56/162 (34%), Positives = 83/162 (51%), Gaps = 8/162 (4%)

Query: 2   RVQVE-GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV 60
           RV V+ G  ++++ E  +L+ L HP V+ L DV  V     LV    R DL  +L     
Sbjct: 196 RVVVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLR 255

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----RAFT 116
           P+  A   +   QLL A+ Y H   IIHRD+K +N+L+N    + L DFG +     +++
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315

Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
            P   +     T+    PE+L G   Y+ +VDIWSAG +  E
Sbjct: 316 TPF--HYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 80.6 bits (198), Expect = 3e-18
 Identities = 58/177 (32%), Positives = 83/177 (46%), Gaps = 34/177 (19%)

Query: 15  EISVLKELKHPNVIRLHD--VIPVDFKLFLVFEFLRQ-DLKDFLQTTPV---PVPPALAK 68
           E++V++ELKH N++R  D  +   + KL+++ EF    DL   +Q        +      
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 69  SYLYQLLEALRYCHS-------RRIIHRDLKPQNIL-----------------INKSGAL 104
               QLL AL YCH+        R++HRDLKPQNI                  +N     
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 105 KLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEM 159
           K+ DFGLS+   I +    H  V T +Y  PE+LL   K Y    D+W+ GCI  E+
Sbjct: 182 KIGDFGLSK--NIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Length = 1021

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 79.3 bits (195), Expect = 3e-18
 Identities = 48/143 (33%), Positives = 71/143 (49%), Gaps = 1/143 (0%)

Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA 77
           +LK +KHP ++ LH       KL+ V +F+      F        P   A+ Y  ++  A
Sbjct: 49  LLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASA 108

Query: 78  LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL 137
           L Y HS  I++RDLKP+NIL++  G + L DFGL +      +  T    T  Y  PE++
Sbjct: 109 LGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168

Query: 138 LGAKVYSTTVDIWSAGCIFSEMI 160
              + Y  TVD W  G +  EM+
Sbjct: 169 R-KQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (196), Expect = 4e-18
 Identities = 40/128 (31%), Positives = 50/128 (39%), Gaps = 30/128 (23%)

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS--------- 112
            P   A+ Y+ +L+ AL   H    IHRD+KP NILI+  G +KLADFGL          
Sbjct: 98  FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157

Query: 113 ----------------RAFTIPMNRYTH----EVVTLWYRPPEILLGAKVYSTTVDIWSA 152
                                   +        V T  Y  PE+L G   Y    D WS 
Sbjct: 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSL 216

Query: 153 GCIFSEMI 160
           G I  EM+
Sbjct: 217 GVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 78.2 bits (192), Expect = 7e-18
 Identities = 48/151 (31%), Positives = 75/151 (49%), Gaps = 6/151 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           ++E+  L+ +KHPN I        +   +LV E+      D L+    P+      +  +
Sbjct: 73  IKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITH 132

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
             L+ L Y HS  +IHRD+K  NIL+ + G +KLADFG S +   P N +   V T ++ 
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-SASIASPANSF---VGTPYWM 188

Query: 133 PPEILLGAK--VYSTTVDIWSAGCIFSEMIQ 161
            PE++L      Y   VD+WS G    E+ +
Sbjct: 189 APEVILAMDEGQYDGKVDVWSLGITCIELAE 219

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (192), Expect = 1e-17
 Identities = 41/94 (43%), Positives = 59/94 (62%), Gaps = 2/94 (2%)

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
           AK Y+ +L+ AL + H   I++RDLKP+NIL++ +G + L DFGLS+A  +  N+ T+  
Sbjct: 98  AKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTF 156

Query: 127 V-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             T  Y  PE+LL  K Y+  VD WS G +  EM
Sbjct: 157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.8 bits (192), Expect = 1e-17
 Identities = 44/139 (31%), Positives = 70/139 (50%), Gaps = 3/139 (2%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           KHP + +LH       +LF V E++   DL   +Q +        A+ Y  +++  L++ 
Sbjct: 54  KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR-FDEPRARFYAAEIVLGLQFL 112

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           H R II+RDLK  N+L++  G +K+ADFG+ +   +     +    T  Y  PEIL    
Sbjct: 113 HERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP 172

Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y   VD W+ G +  EM+
Sbjct: 173 -YGPAVDWWALGVLLYEML 190

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 77.1 bits (190), Expect = 1e-17
 Identities = 39/88 (44%), Positives = 52/88 (59%), Gaps = 5/88 (5%)

Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRP 133
           L+ L Y HSR+IIHRD+KP NIL+ + G +KL DFG+S      +   +T    T +Y  
Sbjct: 115 LKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTG---TSFYMA 171

Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           PE + G K YS T D+WS G    E+ Q
Sbjct: 172 PERIQG-KPYSITSDVWSLGLTLLEVAQ 198

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 77.4 bits (190), Expect = 1e-17
 Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 6/149 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           ++E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  +
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
             L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++ 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWM 178

Query: 133 PPEILLGAK--VYSTTVDIWSAGCIFSEM 159
            PE++L      Y   VD+WS G    E+
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 76.4 bits (188), Expect = 2e-17
 Identities = 46/160 (28%), Positives = 85/160 (53%), Gaps = 15/160 (9%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPP 64
           P   L E +++K+L+HP ++RL+ V+  +  ++++ E++    L DFL+T     + +  
Sbjct: 45  PEAFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINK 103

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
            +  +   Q+ E + +   +  IHRDL+  NIL++++   K+ADFGL+R   I  N YT 
Sbjct: 104 LIDMAA--QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR--LIEDNEYTA 159

Query: 125 E----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                    W  P  I  G   ++   D+WS G + +E++
Sbjct: 160 REGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 197

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 76.2 bits (187), Expect = 2e-17
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 15/159 (9%)

Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPA 65
              L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++   +  P+P  
Sbjct: 46  EAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKL 104

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 123
           +   +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT  
Sbjct: 105 I--DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAR 160

Query: 124 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              +    W  P  I  G+  ++   D+WS G +  E++
Sbjct: 161 EGAKFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIV 197

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 76.5 bits (188), Expect = 3e-17
 Identities = 51/144 (35%), Positives = 75/144 (52%), Gaps = 3/144 (2%)

Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 76
           +LK LKHP ++ LH       KL+ V +++   +L   LQ     + P  A+ Y  ++  
Sbjct: 49  LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR-ARFYAAEVAS 107

Query: 77  ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 136
           A+ Y HS  II+RDLKP+NIL++  G + L DFGL +    P    +    T  Y  PE+
Sbjct: 108 AIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEV 167

Query: 137 LLGAKVYSTTVDIWSAGCIFSEMI 160
            L  + Y  TVD W  G +  EM+
Sbjct: 168 -LRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 75.8 bits (187), Expect = 3e-17
 Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 13/153 (8%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALA 67
           LRE+ +L +   P ++  +     +  + +  E+     L + LK+     P  +   +A
Sbjct: 47  LRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIA 106

Query: 68  KSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
                 +L+ L Y H   +IIHRD+KP NIL+N  G +KL DFG+S      + +    V
Sbjct: 107 ----VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFV 160

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            T  Y  PE + G   YS   DIWS G    E+
Sbjct: 161 GTSSYMAPERIQGND-YSVKSDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 75.7 bits (186), Expect = 3e-17
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 50  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 109

Query: 72  -YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV---V 127
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT       
Sbjct: 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 167

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            + +  PE L   K +S   D+W+ G +  E+
Sbjct: 168 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 75.1 bits (185), Expect = 5e-17
 Identities = 47/152 (30%), Positives = 71/152 (46%), Gaps = 9/152 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           LRE SV+ +L HP ++RL  V   +  L LV E      L  +L+     +P +  K   
Sbjct: 44  LREASVMAQLDHPCIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELA 101

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---- 127
           +Q+   + Y  S+  +HRDL  +N+L+      K++DFG+SRA     + Y         
Sbjct: 102 HQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             WY P  I  G   +S+  D+WS G    E 
Sbjct: 162 LKWYAPECINYG--KFSSKSDVWSYGVTLWEA 191

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 76.2 bits (187), Expect = 7e-17
 Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 17/162 (10%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF---------LRQDLKDFLQTTPVPV 62
           A  E+  L    H  +++  D    D KL L+ E+         ++Q LK+ L     P 
Sbjct: 112 ARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHL-----PF 166

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMN 120
                    YQ++ AL   HSR+++HRDLK  NI +  +G +KL DFG S+ ++  + ++
Sbjct: 167 QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD 226

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             +    T +Y  PE L   K YS   D+WS G I  E++ +
Sbjct: 227 VASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTL 267

Length = 478

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 7e-17
 Identities = 50/180 (27%), Positives = 78/180 (43%), Gaps = 32/180 (17%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPV-PPALAKS 69
            L E  +L  L HP +  L+     +  L LV ++    +L   LQ  P       +A+ 
Sbjct: 48  VLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARF 107

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS----------------R 113
           Y  ++L AL Y H   I++RDLKP+NIL+++SG + L+DF LS                 
Sbjct: 108 YAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKG 167

Query: 114 AFTIPMNRYTHEVV-------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +    +N    E               T  Y  PE++ G   + + VD W+ G +  EM+
Sbjct: 168 SRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 74.8 bits (184), Expect = 7e-17
 Identities = 45/170 (26%), Positives = 82/170 (48%), Gaps = 25/170 (14%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E  ++K+L+HP +I+L+ V  ++  +++V E ++   L ++LQ        A  
Sbjct: 45  PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGG------AGR 98

Query: 68  KSYLYQLLE-------ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
              L QL++        + Y  ++  IHRDL  +N+L+ ++   K+ADFGL+R      +
Sbjct: 99  ALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIK--ED 156

Query: 121 RYTHEVVTL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI---QIP 163
            Y           W  P   L     +S   D+WS G + +E++   ++P
Sbjct: 157 IYEAREGAKFPIKWTAPEAALYNR--FSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 74.7 bits (183), Expect = 7e-17
 Identities = 50/152 (32%), Positives = 82/152 (53%), Gaps = 8/152 (5%)

Query: 15  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           EI +LK L H  +++ +  +  P++  L +  E +    +KD L++    +   + + Y 
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKYT 112

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVV--T 128
            Q+LE + Y HS  I+HRD+K  NIL +  G +KL DFG S+   TI ++    + V  T
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            ++  PE++ G + Y    DIWS GC   EM+
Sbjct: 173 PYWMSPEVISG-EGYGRKADIWSVGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 74.7 bits (183), Expect = 8e-17
 Identities = 50/152 (32%), Positives = 83/152 (54%), Gaps = 8/152 (5%)

Query: 15  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           EI +LK L+H  +++ +  +  P + KL +  E++    +KD L+     +   + + Y 
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA-LTENVTRRYT 112

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV--T 128
            Q+L+ + Y HS  I+HRD+K  NIL + +G +KL DFG S R  TI M+    + V  T
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGT 172

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            ++  PE++ G + Y    D+WS  C   EM+
Sbjct: 173 PYWMSPEVISG-EGYGRKADVWSVACTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 75.6 bits (186), Expect = 8e-17
 Identities = 48/151 (31%), Positives = 72/151 (47%), Gaps = 17/151 (11%)

Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPALAKS 69
           +LK +KHP ++ LH       KL+ V +++         Q  + F +          A+ 
Sbjct: 49  LLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR--------ARF 100

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  ++  AL Y HS  II+RDLKP+NIL++  G + L DFGL +         +    T 
Sbjct: 101 YAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y  PE+L   + Y  TVD W  G +  EM+
Sbjct: 161 EYLAPEVLR-KQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 74.4 bits (183), Expect = 1e-16
 Identities = 35/103 (33%), Positives = 60/103 (58%), Gaps = 2/103 (1%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L+E  ++++  HP++++L  VI  +  +++V E     +L+ +LQ     +  A    Y 
Sbjct: 55  LQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 114
           YQL  AL Y  S+R +HRD+  +N+L++    +KL DFGLSR 
Sbjct: 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRY 156

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 75.3 bits (185), Expect = 1e-16
 Identities = 51/150 (34%), Positives = 72/150 (48%), Gaps = 8/150 (5%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REI +LK + H  +I L         + +V    + DL  ++  +  P+P   A +   +
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRSG-PLPLEQAITIQRR 193

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE----VVTL 129
           LLEAL Y H R IIHRD+K +NI +++     L DFG   A  +  +  T +      TL
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKLDAHPDTPQCYGWSGTL 251

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               PE LL    Y    DIWSAG +  EM
Sbjct: 252 ETNSPE-LLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 75.1 bits (184), Expect = 1e-16
 Identities = 45/137 (32%), Positives = 69/137 (50%), Gaps = 1/137 (0%)

Query: 24  HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 83
           HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H 
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114

Query: 84  RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 143
           R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   Y
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-Y 173

Query: 144 STTVDIWSAGCIFSEMI 160
             +VD W+ G +  EM+
Sbjct: 174 GFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 74.3 bits (182), Expect = 1e-16
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 108

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE+ +    Y +  DIWS G    E+
Sbjct: 169 APEV-IKQSAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.3 bits (182), Expect = 1e-16
 Identities = 49/152 (32%), Positives = 82/152 (53%), Gaps = 8/152 (5%)

Query: 15  EISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           EI +LK L+H  +++ +  +    +  L +  E++    +KD L+     +  ++ + Y 
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKYT 112

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVV--T 128
            Q+LE + Y HS  I+HRD+K  NIL + +G +KL DFG S+   TI M+      V  T
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            ++  PE++ G + Y    D+WS GC   EM+
Sbjct: 173 PYWMSPEVISG-EGYGRKADVWSLGCTVVEML 203

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 74.7 bits (183), Expect = 2e-16
 Identities = 49/144 (34%), Positives = 74/144 (51%), Gaps = 3/144 (2%)

Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 76
           +LK +KHP ++ LH       KL+ V +++   +L   LQ     + P  A+ Y  ++  
Sbjct: 49  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIAS 107

Query: 77  ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 136
           AL Y HS  I++RDLKP+NIL++  G + L DFGL +         +    T  Y  PE+
Sbjct: 108 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 137 LLGAKVYSTTVDIWSAGCIFSEMI 160
            L  + Y  TVD W  G +  EM+
Sbjct: 168 -LHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 74.6 bits (183), Expect = 2e-16
 Identities = 49/139 (35%), Positives = 75/139 (53%), Gaps = 3/139 (2%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           +HP +  L+        LF V E+L   DL   +Q+      P  A  Y  +++  L++ 
Sbjct: 54  EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPR-ATFYAAEIICGLQFL 112

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           HS+ I++RDLK  NIL++  G +K+ADFG+ +   +   +      T  Y  PEILLG K
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK 172

Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y+T+VD WS G +  EM+
Sbjct: 173 -YNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.1 bits (182), Expect = 2e-16
 Identities = 50/162 (30%), Positives = 80/162 (49%), Gaps = 6/162 (3%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV 60
           R++       AL E  +L+++    ++ L         L LV   +   DLK  +     
Sbjct: 30  RLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE 89

Query: 61  PV-PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           P  P A A  Y  Q++  L + H RRI++RDLKP+N+L++  G ++++D GL  A  +  
Sbjct: 90  PGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGL--AVELKG 147

Query: 120 NRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +       T  Y  PE+L G +VY  +VD ++ GC   EMI
Sbjct: 148 GKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMI 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 74.1 bits (182), Expect = 2e-16
 Identities = 51/178 (28%), Positives = 84/178 (47%), Gaps = 33/178 (18%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ---------------T 57
           RE +++ E  HPN+++L  V  V   + L+FE++   DL +FL+               +
Sbjct: 57  REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116

Query: 58  TPVPVPPALAKSYLYQLLEALR------YCHSRRIIHRDLKPQNILINKSGALKLADFGL 111
                   L  S   QL  A +      Y   R+ +HRDL  +N L+ ++  +K+ADFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176

Query: 112 SRAFTIPMNRY----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGC----IFSEMIQ 161
           SR   I    Y     ++ + + + PPE +   + Y+T  D+W+ G     IFS  +Q
Sbjct: 177 SR--NIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQ 231

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 73.8 bits (181), Expect = 2e-16
 Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 9/154 (5%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           +EI +L+ L H N+++   +   D    + L+ EFL    LK++L      +       Y
Sbjct: 55  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKY 114

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 126
             Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A       YT     + 
Sbjct: 115 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDS 174

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              WY  PE L+ +K Y  + D+WS G    E++
Sbjct: 175 PVFWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.7 bits (181), Expect = 4e-16
 Identities = 49/162 (30%), Positives = 83/162 (51%), Gaps = 18/162 (11%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPV 62
           QV+ V     +E S+L EL HP ++ +      + +++ + EF +  +L   L+      
Sbjct: 61  QVQHV----AQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG-RF 115

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
           P  +AK Y  +L+ A  Y HS+ II+RDLKP+N+L++  G +K+ DFG ++       + 
Sbjct: 116 PNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-------KV 168

Query: 123 THEVVTLW----YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                TL     Y  PE+ + +K +   VD W+ G +  E I
Sbjct: 169 PDRTFTLCGTPEYLAPEV-IQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.7 bits (178), Expect = 4e-16
 Identities = 46/154 (29%), Positives = 76/154 (49%), Gaps = 10/154 (6%)

Query: 12  ALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPA 65
           A +E  +L +LKHPN++   +     D  L++V  F     L   LK   +     +P  
Sbjct: 46  AEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLK---EQKGKLLPEN 102

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
               +  Q+  AL+Y H + I+HRDLK QN+ + ++  +K+ D G++R      +  +  
Sbjct: 103 QVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTL 162

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           + T +Y  PE L   K Y+   D+W+ GC   EM
Sbjct: 163 IGTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 72.7 bits (178), Expect = 5e-16
 Identities = 49/151 (32%), Positives = 83/151 (54%), Gaps = 11/151 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAK 68
           L E +V+ +L H N++RL  VI +   L++V E + + +L +FL+T     V V   L  
Sbjct: 47  LEETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL-- 103

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            +   + E + Y  S++++HRDL  +NIL+++ G  K++DFGL+R     M     ++  
Sbjct: 104 QFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--SMGVDNSKLPV 161

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            W   PE L   K +S+  D+WS G +  E+
Sbjct: 162 KW-TAPEALKHKK-FSSKSDVWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 73.7 bits (181), Expect = 5e-16
 Identities = 49/141 (34%), Positives = 71/141 (50%), Gaps = 7/141 (4%)

Query: 25  PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 83
             +++LH     D  L++V E++   DL + +  +   +P   A+ Y  +++ AL   HS
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM--SNYDIPEKWARFYTAEVVLALDAIHS 160

Query: 84  RRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWYRPPEILL---G 139
              IHRD+KP N+L++KSG LKLADFG   +     M R    V T  Y  PE+L    G
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 140 AKVYSTTVDIWSAGCIFSEMI 160
              Y    D WS G    EM+
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 72.4 bits (177), Expect = 6e-16
 Identities = 47/147 (31%), Positives = 76/147 (51%), Gaps = 4/147 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           +EI+VL +   P + R +       KL+++ E+L      D L+  P P+      + L 
Sbjct: 51  QEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILR 108

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS R IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 109 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE+ +    Y    DIWS G    E+
Sbjct: 169 APEV-IKQSAYDFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (178), Expect = 7e-16
 Identities = 48/163 (29%), Positives = 77/163 (47%), Gaps = 6/163 (3%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV 60
           R++     + AL E  +L+++    V+ L         L LV   +   DLK  +     
Sbjct: 37  RIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN 96

Query: 61  P-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           P      A  Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  IP 
Sbjct: 97  PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGL--AVEIPE 154

Query: 120 N-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
                  V T+ Y  PE++   + Y+ + D W  GC+  EMI+
Sbjct: 155 GETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIE 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 8e-16
 Identities = 44/160 (27%), Positives = 72/160 (45%), Gaps = 15/160 (9%)

Query: 15  EISVLKEL-KHPNVIRLH------DVIPVDFKLFLVFEFLR----QDLKDFLQTTPVPVP 63
           E ++L++   HPN+   +      +    D +L+LV E        DL   L+     + 
Sbjct: 52  EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
                  L + L  L Y H  ++IHRD+K QNIL+ K+  +KL DFG+S      + R  
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171

Query: 124 HEVVTLWYRPPEILLGAK----VYSTTVDIWSAGCIFSEM 159
             + T ++  PE++   +     Y    D+WS G    E+
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 72.5 bits (178), Expect = 1e-15
 Identities = 47/139 (33%), Positives = 74/139 (53%), Gaps = 3/139 (2%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           +HP +  L         LF V E+L   DL   +Q++      A A+ Y  +++  L++ 
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFL 112

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           H + II+RDLK  N+L++K G +K+ADFG+ +       + +    T  Y  PEIL G K
Sbjct: 113 HKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK 172

Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y+ +VD WS G +  EM+
Sbjct: 173 -YNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 71.7 bits (176), Expect = 1e-15
 Identities = 43/154 (27%), Positives = 76/154 (49%), Gaps = 16/154 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPV-PPALAKSY 70
           L E SV+  L+HPN+++L  V+     L++V E++ +  L D+L++    V   A    +
Sbjct: 48  LAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGF 107

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 129
              + E + Y   +  +HRDL  +N+L+++    K++DFGL++           +   L 
Sbjct: 108 ALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-----ASQGQDSGKLP 162

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGC----IFS 157
             W  P  +    K +ST  D+WS G     I+S
Sbjct: 163 VKWTAPEALRE--KKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 72.2 bits (177), Expect = 1e-15
 Identities = 47/138 (34%), Positives = 72/138 (52%), Gaps = 3/138 (2%)

Query: 24  HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           HP ++ LH     + +LF V EF+   DL   +Q     +P   A+ Y  ++  AL + H
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR-KLPEEHARFYSAEISLALNFLH 113

Query: 83  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 114 ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED- 172

Query: 143 YSTTVDIWSAGCIFSEMI 160
           Y  +VD W+ G +  EM+
Sbjct: 173 YGFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 72.2 bits (177), Expect = 1e-15
 Identities = 46/128 (35%), Positives = 63/128 (49%), Gaps = 7/128 (5%)

Query: 40  LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI 98
           L+LV E+    DL   L          +A+ YL +L+ A+   H    +HRD+KP+N+LI
Sbjct: 76  LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI 135

Query: 99  NKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWYRPPEILL-----GAKVYSTTVDIWSA 152
           +++G +KLADFG +   T   M      V T  Y  PE+L      G   Y    D WS 
Sbjct: 136 DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSL 195

Query: 153 GCIFSEMI 160
           G I  EMI
Sbjct: 196 GVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 71.2 bits (174), Expect = 2e-15
 Identities = 48/162 (29%), Positives = 88/162 (54%), Gaps = 17/162 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 68
           L E +++K L+H  ++RL+ V+  +  ++++ E++ +  L DFL++     V +P  +  
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-- 106

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----H 124
            +  Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT     
Sbjct: 107 DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGA 164

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI---QIP 163
           +    W  P  I  G+  ++   D+WS G +  E++   +IP
Sbjct: 165 KFPIKWTAPEAINFGS--FTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 71.2 bits (175), Expect = 2e-15
 Identities = 49/160 (30%), Positives = 75/160 (46%), Gaps = 26/160 (16%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-------TTPVPVPP 64
           L+E+ +L  L  PN+ RL  V  VD  L ++ E++   DL  FLQ               
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKS 126

Query: 65  ALAKSYLY---QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
               + LY   Q+   +RY  S   +HRDL  +N L+ K+  +K+ADFG+SR      N 
Sbjct: 127 LSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR------NL 180

Query: 122 YTHEVVTLWYRPP--------EILLGAKVYSTTVDIWSAG 153
           Y+ +   +  R P        E +L  K ++T  D+W+ G
Sbjct: 181 YSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFG 219

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.9 bits (174), Expect = 3e-15
 Identities = 49/167 (29%), Positives = 84/167 (50%), Gaps = 24/167 (14%)

Query: 15  EISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-----------TTPVP 61
           E+ ++K + KH N+I L  V   +  L++V E+    +L+DFL+             P P
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRP 124

Query: 62  VPPALAK----SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
               L +    S+ YQ+   + +  S++ IHRDL  +N+L+ +   +K+ADFGL+R   I
Sbjct: 125 PEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR--DI 182

Query: 118 PMNRY----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               Y    T+  + + +  PE L   +VY+   D+WS G +  E+ 
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 70.7 bits (173), Expect = 3e-15
 Identities = 45/156 (28%), Positives = 73/156 (46%), Gaps = 17/156 (10%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALAKS 69
           E+ +LK LKH N+++       D  + +  EF     +   L  F      P+P  +   
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-----GPLPEPVFCK 106

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-- 127
           Y  Q+L+ + Y H+  ++HRD+K  N+++  +G +KL DFG +R         TH  +  
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK 166

Query: 128 ----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               T ++  PE+ +    Y    DIWS GC   EM
Sbjct: 167 SMHGTPYWMAPEV-INESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 71.2 bits (174), Expect = 3e-15
 Identities = 44/137 (32%), Positives = 70/137 (51%), Gaps = 1/137 (0%)

Query: 24  HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 83
           +P ++ LH       +LFLV E++      F       +P   A+ Y  ++  AL + H 
Sbjct: 55  NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114

Query: 84  RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY 143
           R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G + Y
Sbjct: 115 RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-Y 173

Query: 144 STTVDIWSAGCIFSEMI 160
             +VD W+ G +  EM+
Sbjct: 174 GFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 71.1 bits (174), Expect = 3e-15
 Identities = 47/139 (33%), Positives = 73/139 (52%), Gaps = 3/139 (2%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           ++P +  L+        LF V EFL   DL   +Q          A  Y  +++  L++ 
Sbjct: 54  ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFL 112

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           HS+ II+RDLK  N+++++ G +K+ADFG+ +      NR +    T  Y  PEIL G K
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK 172

Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y+ +VD WS G +  EM+
Sbjct: 173 -YTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 70.0 bits (171), Expect = 3e-15
 Identities = 48/154 (31%), Positives = 76/154 (49%), Gaps = 14/154 (9%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L+E  +LK+  HPN++RL  V      +++V E ++  D   FL+T      P L    L
Sbjct: 41  LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG----PRLKVKEL 96

Query: 72  YQLLE----ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---H 124
            Q++E     + Y  S+  IHRDL  +N L+ +   LK++DFG+SR     +   T    
Sbjct: 97  IQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
           ++   W  P  +  G   YS+  D+WS G +  E
Sbjct: 157 QIPVKWTAPEALNYGR--YSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 70.0 bits (171), Expect = 4e-15
 Identities = 46/152 (30%), Positives = 78/152 (51%), Gaps = 11/152 (7%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E  V+ +L HP +++L+ V      + LVFEF+    L D+L+                 
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW--- 130
           + E + Y  S  +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T +   
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR-FVLD-DQYTSSTGTKFPVK 166

Query: 131 YRPPEILLGAKVYSTTVDIWSAGC----IFSE 158
           +  PE+   +K YS+  D+WS G     +FSE
Sbjct: 167 WSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 4e-15
 Identities = 44/147 (29%), Positives = 80/147 (54%), Gaps = 4/147 (2%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ ++    V  +L+++ EFL+   L D +  +   +      +    
Sbjct: 68  EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQTRLNEEQIATVCES 125

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL Y HS+ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMA 185

Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +    Y T VDIWS G +  EM+
Sbjct: 186 PEV-ISRTPYGTEVDIWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 70.4 bits (172), Expect = 4e-15
 Identities = 50/168 (29%), Positives = 78/168 (46%), Gaps = 29/168 (17%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP--------VP 63
           L+EI ++  LK+PN+IRL  V   D  L ++ E++   DL  FL    +         +P
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 64  PALAKSYLY---QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
                + LY   Q+   ++Y  S   +HRDL  +N L+     +K+ADFG+SR      N
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR------N 178

Query: 121 RYTHEVVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            Y+ +   +         W     ILLG   ++T  D+W+ G    EM
Sbjct: 179 LYSGDYYRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 70.1 bits (171), Expect = 5e-15
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++  H NV+ +++   V  +L++V EFL    L D +  T   +      +    
Sbjct: 69  EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLS 126

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMA 186

Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +    Y T VDIWS G +  EMI
Sbjct: 187 PEV-ISRLPYGTEVDIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 70.9 bits (173), Expect = 6e-15
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 6/151 (3%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP--PAL--AKSY 70
           EI  L  L H N++++ +++  +   +++ +    DL  F+          P L   ++ 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAI 272

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TL 129
           + QLL A+ Y H +++IHRD+K +NI +N  G + L DFG +  F      + +  V T+
Sbjct: 273 MKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               PEIL G   Y    DIWS G I  +M+
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 69.2 bits (169), Expect = 1e-14
 Identities = 50/149 (33%), Positives = 75/149 (50%), Gaps = 3/149 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E +VL ++  P ++ L        KL+LV  F+   +L   LQ        + A+ Y 
Sbjct: 41  LAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR-FDLSRARFYT 99

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            +LL AL   H   +I+RDLKP+NIL++  G + L DFGL +      ++      T  Y
Sbjct: 100 AELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+LLG   Y+  VD W+ G +  EM+
Sbjct: 160 LAPELLLGHG-YTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.7 bits (168), Expect = 1e-14
 Identities = 42/160 (26%), Positives = 75/160 (46%), Gaps = 25/160 (15%)

Query: 15  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-----------RQDLKDFLQTTPVPV 62
           E  VL+ ++  P ++ LH     D KL L+ +++           R+   +         
Sbjct: 54  ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE--------- 104

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
             +  + Y+ +++ AL + H   II+RD+K +NIL++  G + L DFGLS+ F       
Sbjct: 105 --SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER 162

Query: 123 THEVV-TLWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMI 160
            +    T+ Y  PE++ G    +   VD WS G +  E++
Sbjct: 163 AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 69.0 bits (169), Expect = 2e-14
 Identities = 39/115 (33%), Positives = 57/115 (49%), Gaps = 16/115 (13%)

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM- 119
            +P  +A+ Y  + + AL Y H+  I+HRDLKP N+LI   G +KL DFGLS+   + + 
Sbjct: 97  ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156

Query: 120 -NRYTHEVV-------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            N Y   +              T  Y  PE++L  + Y   VD W+ G I  E +
Sbjct: 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 68.6 bits (168), Expect = 2e-14
 Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 39/174 (22%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL---------------QT 57
           +E  ++ +L+HPN++ L  V   +    ++FE+L   DL +FL               +T
Sbjct: 57  QEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDET 116

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
               +  +       Q+   + Y  S   +HRDL  +N L+ +   +K++DFGLSR    
Sbjct: 117 VKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI-- 174

Query: 118 PMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAGCIFSEM 159
               Y+ +    +YR            PPE +L  K ++T  DIWS G +  E+
Sbjct: 175 ----YSAD----YYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.6 bits (168), Expect = 2e-14
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 13/155 (8%)

Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V        L LV E+L    L+D+LQ     +       Y
Sbjct: 54  REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLY 113

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--- 127
             Q+ + + Y  S+R +HRDL  +NIL+     +K+ DFGL++   +P ++  ++V    
Sbjct: 114 ASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK--VLPQDKEYYKVREPG 171

Query: 128 ---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY P    L    +S   D+WS G +  E+
Sbjct: 172 ESPIFWYAPES--LTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 68.4 bits (167), Expect = 3e-14
 Identities = 47/168 (27%), Positives = 74/168 (44%), Gaps = 28/168 (16%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA---- 67
           L+EI ++  LK PN+IRL  V      L ++ E++   DL  FL           A    
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 68  ------KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
                      Q+   ++Y  S   +HRDL  +N L+ K+  +K+ADFG+SR      N 
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR------NL 180

Query: 122 YTHEVVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y+ +   +         W     ILLG   ++T  D+W+ G    E++
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGK--FTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 68.5 bits (167), Expect = 3e-14
 Identities = 51/141 (36%), Positives = 69/141 (48%), Gaps = 7/141 (4%)

Query: 25  PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 83
           P V++L      D  L++V E++   DL + +      VP   A+ Y  +++ AL   HS
Sbjct: 103 PWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHS 160

Query: 84  RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYRPPEILL---G 139
              IHRD+KP N+L++KSG LKLADFG         M R    V T  Y  PE+L    G
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 140 AKVYSTTVDIWSAGCIFSEMI 160
              Y    D WS G    EM+
Sbjct: 221 DGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 68.5 bits (167), Expect = 3e-14
 Identities = 51/141 (36%), Positives = 69/141 (48%), Gaps = 7/141 (4%)

Query: 25  PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 83
           P V++L      D  L++V E++   DL + +      VP   AK Y  +++ AL   HS
Sbjct: 103 PWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHS 160

Query: 84  RRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYTHEVVTLWYRPPEILL---G 139
             +IHRD+KP N+L++K G LKLADFG         M R    V T  Y  PE+L    G
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGG 220

Query: 140 AKVYSTTVDIWSAGCIFSEMI 160
              Y    D WS G    EM+
Sbjct: 221 DGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.7 bits (165), Expect = 3e-14
 Identities = 45/147 (30%), Positives = 78/147 (53%), Gaps = 4/147 (2%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T   +      +    
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIAAVCLA 124

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 184

Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE L+    Y   VDIWS G +  EM+
Sbjct: 185 PE-LISRLPYGPEVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 67.7 bits (165), Expect = 4e-14
 Identities = 44/177 (24%), Positives = 81/177 (45%), Gaps = 29/177 (16%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK--- 68
           L E ++LK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 51  LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110

Query: 69  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                               S+ +Q+   ++Y    +++HRDL  +N+L+ +   +K++D
Sbjct: 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISD 170

Query: 109 FGLSRAF---TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           FGLSR        + R    +   W       L   +Y+T  D+WS G +  E++ +
Sbjct: 171 FGLSRDVYEEDSYVKRSKGRIPVKWMAIES--LFDHIYTTQSDVWSFGVLLWEIVTL 225

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 67.5 bits (165), Expect = 4e-14
 Identities = 44/143 (30%), Positives = 71/143 (49%), Gaps = 6/143 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           LRE+ ++ E + P ++  +     +  + +  EF+     D +     P+P  +      
Sbjct: 51  LRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAV 110

Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 130
            ++E L Y ++  RI+HRD+KP NIL+N  G +KL DFG+S      +N      V T  
Sbjct: 111 AVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTST 167

Query: 131 YRPPEILLGAKVYSTTVDIWSAG 153
           Y  PE + G K Y+   D+WS G
Sbjct: 168 YMSPERIQGGK-YTVKSDVWSLG 189

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 66.6 bits (163), Expect = 8e-14
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 6/152 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + ++ E++    L  FL+              L
Sbjct: 53  LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGML 112

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH---EVVT 128
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR        YT    ++  
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPI 172

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            W  P  I    + +++  D+WS G +  E++
Sbjct: 173 RWTAPEAI--AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 66.4 bits (162), Expect = 9e-14
 Identities = 43/147 (29%), Positives = 72/147 (48%), Gaps = 7/147 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + E+ +L +   P +I  +    V+ ++ +  EF+     D  +  P  V   +A +   
Sbjct: 47  MSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--- 103

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
            +++ L Y  S +I+HRD+KP N+L+N  G +KL DFG+S      +      V T  Y 
Sbjct: 104 -VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA--KTYVGTNAYM 160

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE + G + Y    D+WS G  F E+
Sbjct: 161 APERISGEQ-YGIHSDVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 66.5 bits (162), Expect = 9e-14
 Identities = 46/158 (29%), Positives = 77/158 (48%), Gaps = 19/158 (12%)

Query: 14  REISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 70
           +EI++LK L H N+++            L L+ E++    L+D+L    +     LA+  
Sbjct: 55  KEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKL----NLAQLL 110

Query: 71  LY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
           L+  Q+ E + Y HS+  IHRDL  +N+L++    +K+ DFGL++A  +P     + V  
Sbjct: 111 LFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVRE 168

Query: 128 -----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                  WY   E L   K    + D+WS G    E++
Sbjct: 169 DGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 66.6 bits (162), Expect = 9e-14
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 16/161 (9%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPV-------PP 64
           RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+   P  V       P 
Sbjct: 56  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPA 115

Query: 65  ALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPM 119
            L +S +     Q+   + Y  S+  +HRDL  +N L+ ++  +K+ DFG+SR  ++   
Sbjct: 116 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 175

Query: 120 NRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            R   H ++ + + PPE ++  K ++T  D+WS G +  E+
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEI 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 66.5 bits (162), Expect = 1e-13
 Identities = 48/168 (28%), Positives = 85/168 (50%), Gaps = 24/168 (14%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVP------- 63
           + E+ ++K + KH N+I L  V   +  L+++ E+  + +L++FL+    P P       
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124

Query: 64  ---------PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 114
                      L  S  YQ+   + Y  SRR IHRDL  +N+L+ +   +K+ADFGL+R 
Sbjct: 125 KVPEEQLSFKDLV-SCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARG 183

Query: 115 FTIPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               ++ Y   ++  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 184 VH-DIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 66.2 bits (161), Expect = 1e-13
 Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 4/147 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           +EI+VL +   P V + +       KL+++ E+L      D L+  P         + L 
Sbjct: 51  QEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLK 108

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 109 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 168

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE+ +    Y +  DIWS G    E+
Sbjct: 169 APEV-IQQSAYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 66.2 bits (161), Expect = 1e-13
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 13/158 (8%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL--QTTPVPVPPA 65
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +       P 
Sbjct: 45  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 103

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-- 123
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 104 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 160

Query: 124 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +    W  P   L G   ++   D+WS G + +E+
Sbjct: 161 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 196

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 66.2 bits (161), Expect = 1e-13
 Identities = 52/155 (33%), Positives = 76/155 (49%), Gaps = 18/155 (11%)

Query: 15  EISVLKELK-HPNVIRLH------DVIPVDFKLFLVFEFLR----QDL-KDFLQTTPVPV 62
           E ++LK L  HPNV++ +      DV   D +L+LV E        DL K FL+      
Sbjct: 64  EYNILKALSDHPNVVKFYGMYYKKDVKNGD-QLWLVLELCNGGSVTDLVKGFLKRGERME 122

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
            P +A   L++ L  L++ H  + IHRD+K  NIL+   G +KL DFG+S   T    R 
Sbjct: 123 EPIIA-YILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181

Query: 123 THEVVTLWYRPPEILLGAK----VYSTTVDIWSAG 153
              V T ++  PE++   +     Y    D+WS G
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLG 216

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 65.8 bits (160), Expect = 2e-13
 Identities = 44/152 (28%), Positives = 76/152 (50%), Gaps = 4/152 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           +EI ++K+ KH N++          KL++  EF     L+D    T  P+  +       
Sbjct: 55  QEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG-PLSESQIAYVSR 113

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           + L+ L Y HS+  +HRD+K  NIL+  +G +KLADFG+S   T  + +    + T ++ 
Sbjct: 114 ETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWM 173

Query: 133 PPEILLGAKV--YSTTVDIWSAGCIFSEMIQI 162
            PE+    +   Y+   DIW+ G    E+ ++
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 65.8 bits (160), Expect = 2e-13
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 19/165 (11%)

Query: 15  EISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKSY- 70
           E+ VL +L  HPN+I L         L++  E+    +L DFL+ + V    PA AK + 
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 71  ------LYQLLE-------ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
                   QLL+        ++Y   ++ IHRDL  +N+L+ ++ A K+ADFGLSR   +
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171

Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            + +    +   W       L   VY+T  D+WS G +  E++ +
Sbjct: 172 YVKKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIVSL 214

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 65.8 bits (160), Expect = 2e-13
 Identities = 44/175 (25%), Positives = 84/175 (48%), Gaps = 26/175 (14%)

Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 68  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR---ARRPPGME 124

Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
             Y                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 184

Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 185 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 238

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 65.8 bits (160), Expect = 3e-13
 Identities = 44/147 (29%), Positives = 71/147 (48%), Gaps = 6/147 (4%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L  + HP  + L+     +  L+LV EF +  +   FL+      P  +   Y  Q
Sbjct: 81  ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQ 139

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           ++    Y  S  I++RDLKP+N+L++K G +K+ DFG ++   +    YT    T  Y  
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAK--VVDTRTYTL-CGTPEYIA 196

Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PEILL    +    D W+ G    E++
Sbjct: 197 PEILLNVG-HGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 65.8 bits (160), Expect = 3e-13
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 110

Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 167

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 168 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 65.3 bits (159), Expect = 3e-13
 Identities = 45/139 (32%), Positives = 68/139 (48%), Gaps = 3/139 (2%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           KHP +  LH       +LF V E++   DL   +Q +        ++ Y  ++  AL + 
Sbjct: 54  KHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFL 112

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           H   +I+RDLK  NIL++  G  KLADFG+ +   +     T    T  Y  PEIL   +
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE 172

Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  +VD W+ G +  EM+
Sbjct: 173 -YGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 64.7 bits (157), Expect = 4e-13
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 19/165 (11%)

Query: 15  EISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKSY- 70
           E+ VL +L  HPN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 45  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104

Query: 71  ------LYQLLE-------ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
                   QLL         + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   +
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 164

Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            + +    +   W       L   VY+T  D+WS G +  E++ +
Sbjct: 165 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 207

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 65.0 bits (158), Expect = 4e-13
 Identities = 48/153 (31%), Positives = 74/153 (48%), Gaps = 14/153 (9%)

Query: 15  EISVLKEL-KHPNVIRLHDVI-----PVDFKLFLVFEFLR----QDLKDFLQTTPVPVPP 64
           E ++L+ L  HPNV++ + +       V  +L+LV E        +L   L      +  
Sbjct: 68  EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDE 127

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           A+    LY  L  L++ H+ RIIHRD+K  NIL+   G +KL DFG+S   T    R   
Sbjct: 128 AMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNT 187

Query: 125 EVVTLWYRPPEILLGAKVYSTT----VDIWSAG 153
            V T ++  PE++   + Y  +     D+WS G
Sbjct: 188 SVGTPFWMAPEVIACEQQYDYSYDARCDVWSLG 220

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 64.5 bits (157), Expect = 4e-13
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 7/151 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      L++V EF+    L ++L+     +   +  S  
Sbjct: 47  IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMC 106

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV---VT 128
             + E + Y      IHRDL  +N L++ +G +K++DFG++R + +  + YT        
Sbjct: 107 QDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR-YVLD-DEYTSSSGAKFP 164

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           + + PPE+   +K YS+  D+WS G +  E+
Sbjct: 165 VKWSPPEVFNFSK-YSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 64.6 bits (157), Expect = 4e-13
 Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 4/92 (4%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVT 128
           Y  Q+   + + HS  I++RD+KP+N+L++  G  +L+D GL  A  +   +  T    T
Sbjct: 100 YSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGL--AVELKDGKTITQRAGT 157

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y  PEIL   + YS  VD ++ GC   EM+
Sbjct: 158 NGYMAPEILK-EEPYSYPVDWFAMGCSIYEMV 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 64.3 bits (156), Expect = 5e-13
 Identities = 44/152 (28%), Positives = 75/152 (49%), Gaps = 4/152 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           +EI ++KE KH N++          KL++  E+     L+D    T  P+          
Sbjct: 55  QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG-PLSELQIAYVCR 113

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           + L+ L Y HS+  +HRD+K  NIL+  +G +KLADFG++   T  + +    + T ++ 
Sbjct: 114 ETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWM 173

Query: 133 PPEILLGAKV--YSTTVDIWSAGCIFSEMIQI 162
            PE+    K   Y+   DIW+ G    E+ ++
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 64.3 bits (156), Expect = 6e-13
 Identities = 48/179 (26%), Positives = 87/179 (48%), Gaps = 21/179 (11%)

Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDL 51
           +RV ++ V   A        L E SV+KE    +V+RL  V+       ++ E + R DL
Sbjct: 37  TRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDL 96

Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  PV  PP+L K      ++ + + Y ++ + +HRDL  +N ++ +  
Sbjct: 97  KSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 156

Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +K+ DFG++R    T    +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 157 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 6e-13
 Identities = 45/155 (29%), Positives = 75/155 (48%), Gaps = 16/155 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L+E  +LK+  HPN+++L  V      +++V E +    L  FL+     +     K  L
Sbjct: 40  LQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLL 96

Query: 72  YQLLEA---LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----- 123
              L+A   + Y  S+  IHRDL  +N L+ ++  LK++DFG+SR     +  YT     
Sbjct: 97  QMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI--YTVSDGL 154

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
            ++   W  P  +  G   Y++  D+WS G +  E
Sbjct: 155 KQIPIKWTAPEALNYGR--YTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 64.3 bits (156), Expect = 6e-13
 Identities = 49/165 (29%), Positives = 83/165 (50%), Gaps = 20/165 (12%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL-QTTP------VPVPPA 65
           +E S++ EL HPN++ L  V+  +  + ++FE+L Q DL +FL   +P            
Sbjct: 56  QEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDG 115

Query: 66  LAKSYL---------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-F 115
             KS L          Q+   + Y  S   +H+DL  +NILI +   +K++D GLSR  +
Sbjct: 116 TVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIY 175

Query: 116 TIPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    R     ++ + + PPE ++  K +S+  DIWS G +  E+
Sbjct: 176 SADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 64.4 bits (157), Expect = 7e-13
 Identities = 38/108 (35%), Positives = 57/108 (52%), Gaps = 9/108 (8%)

Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA 114
            T P  +   +A S    +++AL Y HS+  +IHRD+KP N+LIN++G +KL DFG+S  
Sbjct: 98  LTIPEDILGKIAVS----IVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153

Query: 115 FTIPMNRYTHEVVTLWYRPPEIL---LGAKVYSTTVDIWSAGCIFSEM 159
               + + T +     Y  PE +   L  K Y    D+WS G    E+
Sbjct: 154 LVDSVAK-TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 64.3 bits (156), Expect = 7e-13
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 43/175 (24%)

Query: 13  LREISVLKELKHPNVIRLHDVI-----------PVDFKLFLVFEFLRQ-DLKDFL----- 55
           L E   +KE  HPNV+RL  V            PV     ++  F++  DL  FL     
Sbjct: 48  LSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV-----VILPFMKHGDLHSFLLYSRL 102

Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
              P  +P  +   ++  +   + Y  S+  IHRDL  +N ++N++  + +ADFGLS+  
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162

Query: 116 TIPMNRYTHEVVTLWYRPPEIL-----------LGAKVYSTTVDIWSAGCIFSEM 159
                 Y  +    +YR   I            L  +VY+T  D+WS G    E+
Sbjct: 163 ------YNGD----YYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.2 bits (156), Expect = 8e-13
 Identities = 35/93 (37%), Positives = 51/93 (54%), Gaps = 4/93 (4%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVT 128
           Y  +L   L      RI++RDLKP+NIL++  G ++++D GL  A  IP        V T
Sbjct: 107 YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGL--AVQIPEGETVRGRVGT 164

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           + Y  PE++   K Y+ + D W  GC+  EMIQ
Sbjct: 165 VGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQ 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 63.7 bits (155), Expect = 8e-13
 Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 9/155 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+I L  V+     + ++ EF+    L  FL+              L
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGML 112

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------E 125
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+      +
Sbjct: 113 RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGK 172

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +   W  P  I    + +++  D+WS G +  E++
Sbjct: 173 IPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.9 bits (155), Expect = 8e-13
 Identities = 46/162 (28%), Positives = 80/162 (49%), Gaps = 19/162 (11%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-----TTPVPV 62
           P + L E  ++K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 45  PESFLEEAQIMKKLRHDKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPN 103

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      IHRDL+  NIL+      K+ADFGL+R   I  N Y
Sbjct: 104 LVDMAA----QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR--LIEDNEY 157

Query: 123 T----HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T     +    W  P   L G   ++   D+WS G + +E++
Sbjct: 158 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 63.8 bits (155), Expect = 8e-13
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 7/153 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+I L  V+     + +V E++    L  FL+              L
Sbjct: 53  LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGML 112

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTH---EVV 127
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++ 
Sbjct: 113 RGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 172

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +++  D+WS G +  E++
Sbjct: 173 IRWTAPEAI--AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 63.5 bits (154), Expect = 9e-13
 Identities = 48/152 (31%), Positives = 84/152 (55%), Gaps = 11/152 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPV--PPALA 67
           L E SV+ +L+H N+++L  VI V+ K  L++V E++ +  L D+L++    V     L 
Sbjct: 47  LAEASVMTQLRHSNLVQLLGVI-VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLL 105

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           K  L  + EA+ Y  +   +HRDL  +N+L+++    K++DFGL++  +   +  T ++ 
Sbjct: 106 KFSL-DVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP 162

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             W  P    L  K +ST  D+WS G +  E+
Sbjct: 163 VKWTAPEA--LREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.9 bits (155), Expect = 1e-12
 Identities = 47/176 (26%), Positives = 88/176 (50%), Gaps = 28/176 (15%)

Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 65  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARR---PPGME 121

Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 122 YSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 181

Query: 110 GLSRAFTIPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R     ++ Y   T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 182 GLARDVN-NIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 63.9 bits (155), Expect = 1e-12
 Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 6/149 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI 110

Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +L  L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 167

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    E+
Sbjct: 168 YMSPERLQGTH-YSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 63.5 bits (154), Expect = 1e-12
 Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 6/163 (3%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLK-DFLQTTP 59
           R++     S AL E  +L+++    V+ L         L LV   +   DLK        
Sbjct: 37  RIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE 96

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
                  A  Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  +P 
Sbjct: 97  AGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPE 154

Query: 120 NRYTH-EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            +     V T+ Y  PE++   + Y+ + D W+ GC+  EMI 
Sbjct: 155 GQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIA 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 63.3 bits (154), Expect = 1e-12
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 1/91 (1%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q++  L + H RRII+RDLKP+N+L++  G ++++D GL+       ++      T 
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTP 161

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE+L G + Y  +VD ++ G    EMI
Sbjct: 162 GFMAPELLQGEE-YDFSVDYFALGVTLYEMI 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 63.2 bits (154), Expect = 2e-12
 Identities = 38/86 (44%), Positives = 45/86 (52%), Gaps = 7/86 (8%)

Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRP 133
           L  LR  H   I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  Y  
Sbjct: 112 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMS 166

Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEM 159
           PE L G   Y+   DIWS G    EM
Sbjct: 167 PERLQGTH-YTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 63.6 bits (155), Expect = 2e-12
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 6/140 (4%)

Query: 27  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 85
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ YL +++ A+   H   
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 86  IIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWYRPPEILL----GA 140
            +HRD+KP N+L++K+G ++LADFG   R       +    V T  Y  PEIL     G 
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGK 182

Query: 141 KVYSTTVDIWSAGCIFSEMI 160
             Y    D WS G    EM+
Sbjct: 183 GRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 63.7 bits (155), Expect = 2e-12
 Identities = 34/84 (40%), Positives = 48/84 (57%), Gaps = 5/84 (5%)

Query: 39  KLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL 97
            ++LV E+L   D+K  L          +A  Y+ ++  AL Y H   IIHRDLKP N+L
Sbjct: 78  NVYLVMEYLIGGDVKSLLHIYGYFDEE-MAVKYISEVALALDYLHRHGIIHRDLKPDNML 136

Query: 98  INKSGALKLADFGLSRAFTIPMNR 121
           I+  G +KL DFGLS+   + +NR
Sbjct: 137 ISNEGHIKLTDFGLSK---VTLNR 157

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 62.8 bits (153), Expect = 2e-12
 Identities = 44/164 (26%), Positives = 77/164 (46%), Gaps = 21/164 (12%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---------TPVPVP 63
           RE  +L   +H N+++ + V        +VFE++   DL  FL++         +P    
Sbjct: 57  REAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPM 116

Query: 64  PALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
             L  S L     Q+   + Y  S+  +HRDL  +N L+     +K+ DFG+SR   +  
Sbjct: 117 GELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR--DVYT 174

Query: 120 NRY----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             Y     H ++ + + PPE ++  K ++T  D+WS G +  E+
Sbjct: 175 TDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 63.3 bits (154), Expect = 2e-12
 Identities = 36/112 (32%), Positives = 57/112 (50%), Gaps = 7/112 (6%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L E  +  V++L+        L+ V +++   D+   L    +     LA+ Y+ +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGI-FEEDLARFYIAE 109

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L  A+   H    IHRD+KP NILI++ G +KL DFGL   F     R+TH+
Sbjct: 110 LTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTHD 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.1 bits (153), Expect = 2e-12
 Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 19/164 (11%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-----------TPVP 61
           RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+             P  
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 115

Query: 62  VPPALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFT 116
               L  S +     Q+   + Y  S+  +HRDL  +N L+  +  +K+ DFG+SR  ++
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175

Query: 117 IPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               R   H ++ + + PPE ++  K ++T  D+WS G I  E+
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEI 218

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.8 bits (153), Expect = 2e-12
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 4/139 (2%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           +HP ++ L      +  +  V E+    DL   + T     P A    Y   ++  L+Y 
Sbjct: 60  RHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRA--VFYAACVVLGLQYL 117

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           H  +I++RDLK  N+L++  G +K+ADFGL +      +R +    T  +  PE+L    
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS 177

Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y+  VD W  G +  EM+
Sbjct: 178 -YTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 62.7 bits (152), Expect = 3e-12
 Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 19/165 (11%)

Query: 15  EISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYL 71
           E+ VL +L  HPN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 57  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116

Query: 72  -------YQLL-------EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
                   QLL         + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   +
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176

Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            + +    +   W       L   VY+T  D+WS G +  E++ +
Sbjct: 177 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 219

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 62.3 bits (151), Expect = 3e-12
 Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 6/163 (3%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV 60
           R++     S AL E  +L+++    V+ L         L LV   +   DLK  +     
Sbjct: 37  RIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN 96

Query: 61  P-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           P      A  Y  ++L  L   H    ++RDLKP+NIL++  G ++++D GL  A  IP 
Sbjct: 97  PGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGL--AVKIPE 154

Query: 120 NRYTH-EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
                  V T+ Y  PE+L   + Y+ + D W  GC+  EMI+
Sbjct: 155 GESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIE 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 62.6 bits (152), Expect = 3e-12
 Identities = 45/139 (32%), Positives = 69/139 (49%), Gaps = 3/139 (2%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
            HP + +L+       +LF V EF+   DL   +Q +      A A+ Y  ++  AL + 
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFL 112

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           H + II+RDLK  N+L++  G  KLADFG+ +         +    T  Y  PEI L   
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEI-LQEM 171

Query: 142 VYSTTVDIWSAGCIFSEMI 160
           +Y  +VD W+ G +  EM+
Sbjct: 172 LYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 62.4 bits (151), Expect = 3e-12
 Identities = 46/160 (28%), Positives = 82/160 (51%), Gaps = 15/160 (9%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 64
           P   L+E  ++K+L+H  ++ L+ V+  +  +++V EF+ +  L DFL+      + +P 
Sbjct: 45  PEAFLQEAQIMKKLRHDKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQ 103

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 123
            +  +   Q+ + + Y      IHRDL+  NIL+  +   K+ADFGL+R   I  N YT 
Sbjct: 104 LVDMAA--QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR--LIEDNEYTA 159

Query: 124 ---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               +    W  P   L G   ++   D+WS G + +E++
Sbjct: 160 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELV 197

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 62.0 bits (150), Expect = 5e-12
 Identities = 43/148 (29%), Positives = 67/148 (45%), Gaps = 1/148 (0%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  VLK  +HP +  L        +L  V E++      F  +          + Y  
Sbjct: 43  LTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA 102

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           +++ AL Y HS +I++RDLK +N++++K G +K+ DFGL +              T  Y 
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYL 162

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE+L     Y   VD W  G +  EM+
Sbjct: 163 APEVLEDND-YGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.6 bits (149), Expect = 6e-12
 Identities = 41/149 (27%), Positives = 72/149 (48%), Gaps = 3/149 (2%)

Query: 15  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           E  VL+ ++  P ++ LH     D KL L+ +++         +          + Y  +
Sbjct: 54  ERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGE 113

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 132
           ++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F        +    T+ Y 
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 133 PPEILLGAKV-YSTTVDIWSAGCIFSEMI 160
            P+I+ G    +   VD WS G +  E++
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 61.5 bits (149), Expect = 7e-12
 Identities = 46/179 (25%), Positives = 78/179 (43%), Gaps = 38/179 (21%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL---------------- 55
           L+E+ +L  LK PN+IRL  V   +  L ++ E++   DL  FL                
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 56  -QTTPVPVP--PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
                +P     +L      Q+   ++Y  S   +HRDL  +N L+ ++  +K+ADFG+S
Sbjct: 127 PPAHCLPAISYSSLL-HVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 113 RAFTIPMNRYTHEVVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           R      N Y  +   +         W     IL+G   ++T  D+W+ G    E++ +
Sbjct: 186 R------NLYAGDYYRIQGRAVLPIRWMAWECILMGK--FTTASDVWAFGVTLWEILML 236

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 61.6 bits (149), Expect = 9e-12
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 14/144 (9%)

Query: 27  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 85
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ Y+ +++ A+   H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 86  IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTHEVVTLWYRPPEILL-- 138
            +HRD+KP N+L++ +G ++LADFG      + MN     + +  V T  Y  PEIL   
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG----SCLKMNQDGTVQSSVAVGTPDYISPEILQAM 178

Query: 139 --GAKVYSTTVDIWSAGCIFSEMI 160
             G   Y    D WS G    EM+
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 61.2 bits (148), Expect = 1e-11
 Identities = 46/172 (26%), Positives = 85/172 (49%), Gaps = 26/172 (15%)

Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 62  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARR---PPGMD 118

Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            S+                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 119 YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178

Query: 110 GLSR-AFTIP-MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           GL+R    I    + T+  + + +  PE L   +VY+   D+WS G +  E+
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 61.0 bits (148), Expect = 1e-11
 Identities = 44/149 (29%), Positives = 68/149 (45%), Gaps = 3/149 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  VL+  +HP +  L        +L  V E+    +L   L    V      A+ Y 
Sbjct: 43  LTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDR-ARFYG 101

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            +++ AL Y HS  +++RDLK +N++++K G +K+ DFGL +              T  Y
Sbjct: 102 AEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 161

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+L     Y   VD W  G +  EM+
Sbjct: 162 LAPEVLEDND-YGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 60.7 bits (147), Expect = 1e-11
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 24/159 (15%)

Query: 15  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-----------RQDLKDFLQTTPVPV 62
           E +VL+ ++  P ++ LH     + KL L+ +++           R +  +         
Sbjct: 54  ERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSE--------- 104

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
                + Y  +++ AL + H   I++RD+K +NIL++  G + L DFGLS+ F       
Sbjct: 105 --DEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER 162

Query: 123 THEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T+    T+ Y  PEI+ G   +   VD WS G +  E++
Sbjct: 163 TYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 60.8 bits (147), Expect = 2e-11
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 12/143 (8%)

Query: 27  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 85
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ YL +++ A+   H   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 86  IIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHEVVTLWYRPPEILL--- 138
            +HRD+KP NIL++ +G ++LADFG    L    T+   + +  V T  Y  PEIL    
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV---QSSVAVGTPDYISPEILQAME 179

Query: 139 -GAKVYSTTVDIWSAGCIFSEMI 160
            G   Y    D WS G    EM+
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.0 bits (145), Expect = 2e-11
 Identities = 48/160 (30%), Positives = 76/160 (47%), Gaps = 27/160 (16%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE---------FLRQDLKDFLQTTPVPVP 63
           L E  +LK+  HPN+++L  V      +++V E         FLR+  KD L+T      
Sbjct: 40  LSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKT------ 92

Query: 64  PALAKSYLYQLLEA---LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IP 118
               K  +   L+A   + Y  S+  IHRDL  +N L+ ++  LK++DFG+SR     I 
Sbjct: 93  ----KQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY 148

Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
            +    ++   W  P  +  G   YS+  D+WS G +  E
Sbjct: 149 SSSGLKQIPIKWTAPEALNYGR--YSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.7 bits (147), Expect = 2e-11
 Identities = 39/119 (32%), Positives = 61/119 (51%), Gaps = 10/119 (8%)

Query: 47  LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL 106
           LRQ++K   +T         A     Q+L A+ + HS+ +IHRD+K  NIL+  +G +KL
Sbjct: 126 LRQEIKSRAKTNR-TFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 107 ADFGLSRAFTIPMNRYTHEV-----VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            DFG S+ +       + +V      T +Y  PEI    K YS   D++S G +  E++
Sbjct: 185 GDFGFSKMYA---ATVSDDVGRTFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELL 239

Length = 496

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.4 bits (146), Expect = 2e-11
 Identities = 29/93 (31%), Positives = 56/93 (60%), Gaps = 4/93 (4%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 128
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +  H  V T
Sbjct: 102 YATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGT 158

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             Y  PE+L     Y ++ D +S GC+  ++++
Sbjct: 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 60.0 bits (145), Expect = 2e-11
 Identities = 40/153 (26%), Positives = 70/153 (45%), Gaps = 7/153 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  H N+IRL  V+       ++ E++    L  +L+              L
Sbjct: 54  LSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGML 113

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTH---EVV 127
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++ 
Sbjct: 114 RGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIP 173

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +++  D+WS G +  E++
Sbjct: 174 IRWTAPEAI--AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 59.6 bits (144), Expect = 3e-11
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 6/145 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           +RE  ++ +L +P ++R+  V   +  L LV E      L  FL      +  +     +
Sbjct: 43  MREAEIMHQLDNPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM 101

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + Y       W 
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWP 161

Query: 131 --YRPPEILLGAKVYSTTVDIWSAG 153
             +  PE +   K +S+  D+WS G
Sbjct: 162 LKWYAPECINFRK-FSSRSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 59.6 bits (144), Expect = 3e-11
 Identities = 38/112 (33%), Positives = 58/112 (51%), Gaps = 7/112 (6%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L E  +  V+RL+        L+ V +++   D+   L    +  P  LA+ Y+ +
Sbjct: 51  ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAE 109

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L  A+   H    IHRD+KP NILI++ G +KL DFGL   F     R+TH+
Sbjct: 110 LTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF-----RWTHD 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 59.2 bits (143), Expect = 4e-11
 Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 22/165 (13%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT--------------- 57
           RE  +L  L+H +++R + V      L +VFE++R  DL  FL++               
Sbjct: 56  REAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVA 115

Query: 58  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AF 115
              + +   LA +   Q+   + Y  S   +HRDL  +N L+ +   +K+ DFG+SR  +
Sbjct: 116 PGQLTLGQMLAIAS--QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY 173

Query: 116 TIPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    R     ++ + + PPE +L  K ++T  DIWS G +  E+
Sbjct: 174 STDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.8 bits (142), Expect = 6e-11
 Identities = 48/174 (27%), Positives = 81/174 (46%), Gaps = 39/174 (22%)

Query: 13  LREISVLKELKHPNVIRLHDV---------IPVDFKLFLVFEFLRQ-DLKDFLQTT---- 58
           LRE + +KE  HPNVI+L  V         +P+     ++  F++  DL  FL  +    
Sbjct: 49  LREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM---VILPFMKHGDLHTFLLMSRIGE 105

Query: 59  -PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
            P  +P      ++  +   + Y  S+  IHRDL  +N ++N++  + +ADFGLS+    
Sbjct: 106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI-- 163

Query: 118 PMNRYTHEVVTLWYR-------PPEIL----LGAKVYSTTVDIWSAGCIFSEMI 160
               Y+ +    +YR       P + L    L   VY+T  D+W+ G    E++
Sbjct: 164 ----YSGD----YYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIM 209

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 58.9 bits (142), Expect = 6e-11
 Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 1/148 (0%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  
Sbjct: 43  VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA 102

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y 
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYL 162

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE+L     Y   VD W  G +  EM+
Sbjct: 163 APEVLEDND-YGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.0 bits (143), Expect = 6e-11
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 3/139 (2%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           K P + +LH       +L+ V E++   DL   +Q       P  A  Y  ++   L + 
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH-AVFYAAEIAIGLFFL 117

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           HS+ II+RDLK  N++++  G +K+ADFG+ +              T  Y  PEI+   +
Sbjct: 118 HSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIA-YQ 176

Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  +VD W+ G +  EM+
Sbjct: 177 PYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.8 bits (142), Expect = 6e-11
 Identities = 29/93 (31%), Positives = 56/93 (60%), Gaps = 4/93 (4%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 128
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +  H  V T
Sbjct: 102 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGT 158

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             Y  PE+L     Y ++ D +S GC+  ++++
Sbjct: 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 58.5 bits (141), Expect = 1e-10
 Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 5/96 (5%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIP--MNRYTHEV 126
           Y +Q+   + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P  + + +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
              W  P  I    KVY+T  D+WS G +  E+  +
Sbjct: 239 PLKWMAPESIF--DKVYTTQSDVWSFGVLLWEIFSL 272

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 1e-10
 Identities = 32/129 (24%), Positives = 46/129 (35%), Gaps = 39/129 (30%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-------------- 115
           Y+ + + A+   H    IHRD+KP N+L++  G +KL+DFGL                  
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSH 165

Query: 116 --------TIPMNRYTHEVVTLW----------------YRPPEILLGAKVYSTTVDIWS 151
                    I     +      W                Y  PE+ L    Y+   D WS
Sbjct: 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL-QTGYNKECDWWS 224

Query: 152 AGCIFSEMI 160
            G I  EM+
Sbjct: 225 LGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 57.9 bits (140), Expect = 1e-10
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 43/179 (24%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKL---------FLVFEFLRQ-D 50
           +  ++E      L E + +K+  HPNV++L   I V F+           ++  F++  D
Sbjct: 41  TYSEIEEF----LSEAACMKDFDHPNVMKL---IGVCFEASSLQKIPKPMVILPFMKHGD 93

Query: 51  LKDFL-----QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALK 105
           L  FL        P  +P      ++  +   + Y  +R  IHRDL  +N ++ +   + 
Sbjct: 94  LHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVC 153

Query: 106 LADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL-----------LGAKVYSTTVDIWSAG 153
           +ADFGLS+   I    Y        YR   I            L  +VY++  D+W+ G
Sbjct: 154 VADFGLSK--KIYSGDY--------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 57.8 bits (139), Expect = 1e-10
 Identities = 43/161 (26%), Positives = 78/161 (48%), Gaps = 13/161 (8%)

Query: 14  REISVLKELKHPNVIRLH-------DVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPA 65
           +EI++LK+  H   I  +       +   +D +L+LV EF     + D ++ T       
Sbjct: 51  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 110

Query: 66  LAKSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
              +Y+  ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R   
Sbjct: 111 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 170

Query: 125 EVVTLWYRPPEILLGAK----VYSTTVDIWSAGCIFSEMIQ 161
            + T ++  PE++   +     Y    D+WS G    EM +
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 211

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 58.1 bits (140), Expect = 1e-10
 Identities = 55/199 (27%), Positives = 76/199 (38%), Gaps = 60/199 (30%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L E  +  V++L+        L+ V +++   D+   L    V  P  LA+ Y+ +
Sbjct: 51  ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV-FPEVLARFYIAE 109

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--------- 124
           L  A+   H    IHRD+KP NILI+  G +KL DFGL   F     R+TH         
Sbjct: 110 LTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGF-----RWTHNSKYYQKGS 164

Query: 125 -------EVVTLW------------------------------------YRPPEILLGAK 141
                  E   LW                                    Y  PE+LL  K
Sbjct: 165 HIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RK 223

Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y+   D WS G I  EM+
Sbjct: 224 GYTQLCDWWSVGVILFEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 57.4 bits (139), Expect = 2e-10
 Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 1/96 (1%)

Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA 77
           VLK    P +++ +     D  +F+  E +   L   L+    P+P  +       +++A
Sbjct: 67  VLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKA 126

Query: 78  LRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLS 112
           L Y   +  +IHRD+KP NIL++ SG +KL DFG+S
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.2 bits (139), Expect = 2e-10
 Identities = 40/140 (28%), Positives = 70/140 (50%), Gaps = 8/140 (5%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
            +PN I+L+  +       L+ ++++  DL D L+     +  A  K  + QL+EAL   
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDL 125

Query: 82  HSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           H   IIH D+K +N+L +++   + L D+GL +    P     ++  TL Y  PE + G 
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS---CYD-GTLDYFSPEKIKG- 180

Query: 141 KVYSTTVDIWSAGCIFSEMI 160
             Y  + D W+ G +  E++
Sbjct: 181 HNYDVSFDWWAVGVLTYELL 200

Length = 267

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 57.1 bits (138), Expect = 2e-10
 Identities = 40/172 (23%), Positives = 77/172 (44%), Gaps = 17/172 (9%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT- 58
            + + E + S   RE+ + ++L H NV+RL  +       +++ E+    DLK FL+ T 
Sbjct: 44  QKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATK 103

Query: 59  -------PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 111
                  P P+      +   Q+   + +  + R +HRDL  +N L++    +K++   L
Sbjct: 104 SKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163

Query: 112 SRAFTIPMNRYTHEVVTLW----YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           S+      N   +++        +  PE +     +ST  D+WS G +  E+
Sbjct: 164 SKD---VYNSEYYKLRNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 56.7 bits (137), Expect = 3e-10
 Identities = 46/164 (28%), Positives = 77/164 (46%), Gaps = 23/164 (14%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKL---FLVFEFLRQ-DLKDFL-QTTPVPV-PPAL 66
           L E  ++ +  H N++RL   I V F+    F++ E +   DLK FL +  P P  P +L
Sbjct: 57  LMEALIMSKFNHQNIVRL---IGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL 113

Query: 67  AKSYLYQL----LEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPM 119
               L        +  +Y      IHRD+  +N L+   G     K+ADFG++R   I  
Sbjct: 114 TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR--DIYR 171

Query: 120 NRYTHE----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             Y  +    ++ + + PPE  L   ++++  D+WS G +  E+
Sbjct: 172 ASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 56.6 bits (136), Expect = 4e-10
 Identities = 30/95 (31%), Positives = 54/95 (56%), Gaps = 3/95 (3%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIP-MNRYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P   R     +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.2 bits (135), Expect = 5e-10
 Identities = 29/93 (31%), Positives = 50/93 (53%), Gaps = 4/93 (4%)

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L  L + H+ ++IHRD+K QN+L+ ++  +KL DFG+S      + R    + T ++ 
Sbjct: 129 EILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 188

Query: 133 PPEILLGAK----VYSTTVDIWSAGCIFSEMIQ 161
            PE++   +     Y    DIWS G    EM +
Sbjct: 189 APEVIACDENPDATYDYRSDIWSLGITAIEMAE 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.0 bits (135), Expect = 6e-10
 Identities = 39/105 (37%), Positives = 53/105 (50%), Gaps = 8/105 (7%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL---QTTPVPVPPALAKSY 70
           E  VL E   P V+ L+        L+L+ EFL   DL   L    T    V     + Y
Sbjct: 51  ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFY 106

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
           + + + A+   H    IHRD+KP NILI++ G +KL+DFGLS  F
Sbjct: 107 MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 55.7 bits (134), Expect = 6e-10
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 7/150 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           LRE +V+++L +P ++R+  +   +    LV E      L  FLQ     V        +
Sbjct: 44  LREANVMQQLDNPYIVRMIGICEAE-SWMLVMELAELGPLNKFLQKNK-HVTEKNITELV 101

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 102 HQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWP 161

Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 162 VKWYAPECMNYYK-FSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 55.8 bits (135), Expect = 7e-10
 Identities = 26/71 (36%), Positives = 39/71 (54%), Gaps = 3/71 (4%)

Query: 85  RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKV 142
           +IIHRD+KP NIL++++G +KL DFG+S      + + T +     Y  PE +       
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSARDG 186

Query: 143 YSTTVDIWSAG 153
           Y    D+WS G
Sbjct: 187 YDVRSDVWSLG 197

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.0 bits (135), Expect = 7e-10
 Identities = 32/94 (34%), Positives = 53/94 (56%), Gaps = 5/94 (5%)

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIP--MNRYTHE 125
           SY +Q+   + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P  + +    
Sbjct: 177 SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 236

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +   W  P  I    KVY+T  D+WS G +  E+
Sbjct: 237 LPLKWMAPESIF--DKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.4 bits (133), Expect = 1e-09
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 3/159 (1%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP 61
           +Q + V  T + +  +  + K P + +LH       +L+ V E++   DL   +Q     
Sbjct: 39  IQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKF 98

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
             P  A  Y  ++   L + H R II+RDLK  N++++  G +K+ADFG+ +   +    
Sbjct: 99  KEPQ-AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT 157

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 T  Y  PEI +  + Y  +VD W+ G +  EM+
Sbjct: 158 TRTFCGTPDYIAPEI-IAYQPYGKSVDWWAYGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.5 bits (131), Expect = 2e-09
 Identities = 37/159 (23%), Positives = 72/159 (45%), Gaps = 11/159 (6%)

Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVP---VPPAL 66
           +  + E+ +L +   P ++  +    ++  +++  E++     D L    V    +P  +
Sbjct: 44  NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDV 103

Query: 67  AKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            +   Y +++ L++      IIHRD+KP N+L+N +G +KL DFG+S      + +    
Sbjct: 104 LRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN-- 161

Query: 126 VVTLWYRPPEIL-----LGAKVYSTTVDIWSAGCIFSEM 159
           +    Y  PE +          Y+   D+WS G    EM
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.3 bits (131), Expect = 2e-09
 Identities = 52/174 (29%), Positives = 84/174 (48%), Gaps = 22/174 (12%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           S +QV    +  L+E  +L  L H N++  LH  I      F+++ ++   +LK FLQ  
Sbjct: 48  SEIQV----TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQC 103

Query: 58  --TPVPVPPALAKSYLY----QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGL 111
                  P AL+   L     Q+   + Y H R +IH+D+  +N +I++   +K+ D  L
Sbjct: 104 RLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL 163

Query: 112 SRAFTIPMNRYTHEVVTLWYRP-----PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           SR    PM+ Y H +     RP      E L+  K YS+  D+WS G +  E++
Sbjct: 164 SRDL-FPMD-Y-HCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 54.6 bits (131), Expect = 2e-09
 Identities = 42/149 (28%), Positives = 67/149 (44%), Gaps = 2/149 (1%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  
Sbjct: 43  LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGA 102

Query: 73  QLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
           +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  Y
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEY 162

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+L     Y   VD W  G +  EM+
Sbjct: 163 LAPEVLEDND-YGRAVDWWGLGVVMYEMM 190

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 54.3 bits (131), Expect = 2e-09
 Identities = 36/145 (24%), Positives = 69/145 (47%), Gaps = 7/145 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L E  V+  + HP+V+RL  +     ++ L+ + +    L D+++     +      ++ 
Sbjct: 57  LDEAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWC 115

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVT 128
            Q+ + + Y   +R++HRDL  +N+L+     +K+ DFGL++   +    Y  E   V  
Sbjct: 116 VQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPI 175

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAG 153
            W     IL    +Y+   D+WS G
Sbjct: 176 KWMALESILHR--IYTHKSDVWSYG 198

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 53.1 bits (127), Expect = 6e-09
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 5/144 (3%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           K P + +LH       +L+ V E++   DL   +Q       P  A  Y  ++   L + 
Sbjct: 59  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH-AVFYAAEIAIGLFFL 117

Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           HS+ II+RDLK  N++++  G +K+ADFG+ +              T  Y  PEI +  +
Sbjct: 118 HSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEI-IAYQ 176

Query: 142 VYSTTVDIWSAGCIFSEMI--QIP 163
            Y  +VD W+ G +  EM+  Q P
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.3 bits (125), Expect = 1e-08
 Identities = 28/97 (28%), Positives = 48/97 (49%), Gaps = 5/97 (5%)

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
           S+ YQ+   + +  S+  +HRDL  +N+L+ +   +K+ DFGL+R      N  +     
Sbjct: 241 SFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTF 300

Query: 129 L---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           L   W  P  I     +Y+T  D+WS G +  E+  +
Sbjct: 301 LPVKWMAPESIF--DNLYTTLSDVWSYGILLWEIFSL 335

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 51.9 bits (124), Expect = 1e-08
 Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 27/182 (14%)

Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 37  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 96

Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N ++    
Sbjct: 97  KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 156

Query: 103 ALKLADFGLSRAFTIPMNRYTHE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS 157
            +K+ DFG++R   I    Y  +     +   W  P  +  G  V++T+ D+WS G +  
Sbjct: 157 TVKIGDFGMTR--DIYETDYYRKGGKGLLPVRWMAPESLKDG--VFTTSSDMWSFGVVLW 212

Query: 158 EM 159
           E+
Sbjct: 213 EI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.3 bits (123), Expect = 3e-08
 Identities = 40/160 (25%), Positives = 69/160 (43%), Gaps = 22/160 (13%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFE---------FLRQDLKDFLQTTPVPV 62
           + E+ ++  L  H N++ L     +   + ++ E         FLR+  + FL    +  
Sbjct: 86  MSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDL-- 143

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
                 S+ YQ+ + + +  S+  IHRDL  +N+L+     +K+ DFGL+R      N  
Sbjct: 144 -----LSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV 198

Query: 123 THEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                 L   W  P  I     VY+   D+WS G +  E+
Sbjct: 199 VKGNARLPVKWMAPESIFNC--VYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 50.2 bits (120), Expect = 5e-08
 Identities = 41/156 (26%), Positives = 83/156 (53%), Gaps = 11/156 (7%)

Query: 13  LREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKS 69
           L+E  ++K+  HPNV+ L  + +P +    +V  +++  DL++F+++ T  P    L   
Sbjct: 44  LKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLI-G 102

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-----AFTIPMNRYTH 124
           +  Q+ + + Y  S++ +HRDL  +N ++++S  +K+ADFGL+R      +    N    
Sbjct: 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGA 162

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           ++   W       L  + ++T  D+WS G +  E++
Sbjct: 163 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 196

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 50.2 bits (120), Expect = 6e-08
 Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 27/168 (16%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL-----QTTPVPVPPAL 66
           L+E  ++    HPN+++L  V  ++   +++ E +   DL  +L     +      PP L
Sbjct: 47  LKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFG---PPLL 103

Query: 67  AKSYLYQL-LEALRYCH---SRRIIHRDLKPQNILINKSG-----ALKLADFGLSRAFTI 117
               L  + L+  + C        IHRDL  +N L+++ G      +K+ DFGL+R   I
Sbjct: 104 TLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR--DI 161

Query: 118 PMNRYTHE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  +     +   W  P  +L G   ++T  D+WS G +  E++
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLLDG--KFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 50.3 bits (120), Expect = 6e-08
 Identities = 30/97 (30%), Positives = 45/97 (46%), Gaps = 5/97 (5%)

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
           S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R      N        
Sbjct: 218 SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 129 L---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           L   W  P  I     VY+   D+WS G +  E+  +
Sbjct: 278 LPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFSL 312

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 50.2 bits (120), Expect = 9e-08
 Identities = 26/67 (38%), Positives = 36/67 (53%), Gaps = 11/67 (16%)

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
           Q+L AL   HS  I+HRD+KPQNI+ +  SG+ K+ D G +    + +N          Y
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN----------Y 312

Query: 132 RPPEILL 138
            P E LL
Sbjct: 313 IPKEFLL 319

Length = 566

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.8 bits (119), Expect = 1e-07
 Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 30/177 (16%)

Query: 13  LREISVLKELKHPNVIRLH----DVIPVDFKL-FLVFEFLRQDLKDFLQTTPVPVPPALA 67
           LRE  +  +L HP ++ ++    D  PV + + ++    L+  LK   Q   +    A  
Sbjct: 50  LREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK 109

Query: 68  KSY------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA------- 114
            S        +++   + Y HS+ ++HRDLKP NIL+   G + + D+G +         
Sbjct: 110 TSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169

Query: 115 ---FTIPMNRYTHE--------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                +      +         V T  Y  PE LLG    S + DI++ G I  +M+
Sbjct: 170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQML 225

Length = 932

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 49.7 bits (118), Expect = 1e-07
 Identities = 25/72 (34%), Positives = 40/72 (55%), Gaps = 1/72 (1%)

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEV 126
           K  + Q+L  LR  H   I+HRD+KP+N+L+   G +K+ DFG +      +N    + +
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGM 371

Query: 127 VTLWYRPPEILL 138
           +   Y PPE L+
Sbjct: 372 LDPRYSPPEELV 383

Length = 507

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 1e-07
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 5/96 (5%)

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           + YQ+   + +  S+  +HRDL  +N+LI +   +K+ DFGL+R      N  +     L
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303

Query: 130 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
              W  P  I     +Y+T  D+WS G +  E+  +
Sbjct: 304 PLKWMAPESIF--NNLYTTLSDVWSFGILLWEIFTL 337

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.3 bits (118), Expect = 1e-07
 Identities = 44/158 (27%), Positives = 70/158 (44%), Gaps = 16/158 (10%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLY 72
           EI   ++L+HPN++       VD +L++V   +     +D L+T  P  +P       L 
Sbjct: 49  EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-------HE 125
            +L AL Y HS+  IHR +K  +IL++  G + L+    S +      R           
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168

Query: 126 VVTLWYRPPEIL----LGAKVYSTTVDIWSAGCIFSEM 159
           V  L +  PE+L     G   Y+   DI+S G    E+
Sbjct: 169 VKNLPWLSPEVLQQNLQG---YNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 48.5 bits (115), Expect = 2e-07
 Identities = 40/163 (24%), Positives = 69/163 (42%), Gaps = 33/163 (20%)

Query: 22  LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL---------------QTTPVPVPPA 65
           L+HPN++ L  V+  +  L ++F +    DL +FL               +T    + PA
Sbjct: 65  LQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                + Q+   + +  S  ++H+DL  +N+L+     +K++D GL R        Y  +
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREV------YAAD 178

Query: 126 VVTL---------WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              L         W  P  I+ G   +S   DIWS G +  E+
Sbjct: 179 YYKLMGNSLLPIRWMSPEAIMYGK--FSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.5 bits (115), Expect = 2e-07
 Identities = 27/91 (29%), Positives = 45/91 (49%), Gaps = 5/91 (5%)

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 117 QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 177 WMALESIL--HRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 48.4 bits (115), Expect = 3e-07
 Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 20/153 (13%)

Query: 22  LKHPNVIRLHDVIPVDFKLFLVFEFL-----RQDLKDFLQTTPVPVPPALAKSYLYQLLE 76
            +HPN++    V      L+++  F+        LK +    P  +  AL  + L+  L 
Sbjct: 56  FRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF---PEGMSEALIGNILFGALR 112

Query: 77  ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV---------- 126
            L Y H    IHR++K  +ILI+  G + L+  GLS  +++  N    +V          
Sbjct: 113 GLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTS 170

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           V  W  P  +      Y+   DI+S G    E+
Sbjct: 171 VLPWLSPELLRQDLYGYNVKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 47.7 bits (113), Expect = 6e-07
 Identities = 35/107 (32%), Positives = 51/107 (47%), Gaps = 23/107 (21%)

Query: 71  LYQLLEALRYCHSR-RIIHRDLKPQNILINKSGA----------------LKLADFGLSR 113
           ++Q   AL Y H+   ++H DLKP+NIL+  S                  +++ D G   
Sbjct: 237 IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--- 293

Query: 114 AFTIPMNRYTHEVVTLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEM 159
                 +  T  V T  YR PE++LG   +YST  D+WS GCI  E+
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYEL 338

Length = 467

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 47.3 bits (112), Expect = 6e-07
 Identities = 37/143 (25%), Positives = 64/143 (44%), Gaps = 7/143 (4%)

Query: 22  LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRY 80
           L H  ++RL  + P    L LV +      L D ++     + P    ++  Q+ + + Y
Sbjct: 66  LDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY 124

Query: 81  CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVTLWYRPPEIL 137
               R++HR+L  +NIL+     +++ADFG++        +Y    H+    W     IL
Sbjct: 125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 138 LGAKVYSTTVDIWSAGCIFSEMI 160
            G   Y+   D+WS G    EM+
Sbjct: 185 FGR--YTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 46.8 bits (111), Expect = 8e-07
 Identities = 40/142 (28%), Positives = 60/142 (42%), Gaps = 16/142 (11%)

Query: 25  PNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALR 79
           PN++ LH  I  +  +FLV +      L   +  FL      +P    K +  +++ AL 
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN-----IPEECVKRWAAEMVVALD 99

Query: 80  YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG 139
             H   I+ RDL P NIL++  G ++L  F          +    E V   Y  PE+  G
Sbjct: 100 ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDG---EAVENMYCAPEV--G 154

Query: 140 AKVYSTTV-DIWSAGCIFSEMI 160
                T   D WS G I  E++
Sbjct: 155 GISEETEACDWWSLGAILFELL 176

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 47.1 bits (112), Expect = 9e-07
 Identities = 27/97 (27%), Positives = 44/97 (45%), Gaps = 11/97 (11%)

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
            +  Q+ + + +  S+  IHRD+  +N+L+      K+ DFGL+R     MN   + V  
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI---MNDSNYVVKG 272

Query: 128 -----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                  W  P  I     VY+   D+WS G +  E+
Sbjct: 273 NARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 46.5 bits (110), Expect = 1e-06
 Identities = 34/158 (21%), Positives = 59/158 (37%), Gaps = 19/158 (12%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYL 71
           L E   L +  H N++RL  VI     + +V E++     D FL+     +        L
Sbjct: 54  LAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGML 113

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---- 127
             L   ++Y      +H+ L    +L+N     K++ F         +     E +    
Sbjct: 114 PGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR-------RLQEDKSEAIYTTM 166

Query: 128 -----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 LW  P  I      +S+  D+WS G +  E++
Sbjct: 167 SGKSPVLWAAPEAIQYHH--FSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 1e-06
 Identities = 27/102 (26%), Positives = 54/102 (52%), Gaps = 2/102 (1%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  ++  + HP+++RL  V  +   + LV + +    L D++      +   L  ++ 
Sbjct: 57  MDEALIMASMDHPHLVRLLGVC-LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC 115

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
            Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL+R
Sbjct: 116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 45.8 bits (108), Expect = 2e-06
 Identities = 26/95 (27%), Positives = 46/95 (48%), Gaps = 5/95 (5%)

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--- 125
           ++  Q+ + + Y    R++HRDL  +N+L+     +K+ DFGL+R   I    Y  +   
Sbjct: 113 NWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           V   W     IL   + ++   D+WS G    E++
Sbjct: 173 VPIKWMALESIL--HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 44.4 bits (105), Expect = 7e-06
 Identities = 36/155 (23%), Positives = 67/155 (43%), Gaps = 14/155 (9%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
              S++ +L H ++++L+ V   D +  +V E+++   L  FL      V          
Sbjct: 50  ETASLMSQLSHKHLVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAK 108

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA-------LKLADFGLSRAFTIPMNRYTHE 125
           QL  AL Y   ++++H ++  +NIL+ + G        +KL+D G+     I +      
Sbjct: 109 QLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP----ITVLSREER 164

Query: 126 VVTLWYRPPEILLGAKVYSTT-VDIWSAGCIFSEM 159
           V  + +  PE +   +   T   D WS G    E+
Sbjct: 165 VERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI 199

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.3 bits (104), Expect = 7e-06
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 2/73 (2%)

Query: 40  LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI 98
           L+L+ EFL   D+   L            + Y+ + + A+   H    IHRD+KP N+L+
Sbjct: 76  LYLIMEFLPGGDMMTLLMKKDTLTEEE-TQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134

Query: 99  NKSGALKLADFGL 111
           +  G +KL+DFGL
Sbjct: 135 DSKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 43.5 bits (102), Expect = 1e-05
 Identities = 26/73 (35%), Positives = 40/73 (54%), Gaps = 2/73 (2%)

Query: 40  LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI 98
           L+L+ EFL   D+   L         A  + Y+ + + A+   H    IHRD+KP N+L+
Sbjct: 76  LYLIMEFLPGGDMMTLLMKKDTLSEEA-TQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL 134

Query: 99  NKSGALKLADFGL 111
           +  G +KL+DFGL
Sbjct: 135 DAKGHVKLSDFGL 147

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 42.6 bits (100), Expect = 3e-05
 Identities = 21/77 (27%), Positives = 40/77 (51%), Gaps = 1/77 (1%)

Query: 41  FLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK 100
           F++ E L ++ K+  +         L K+ +  +L  L Y H   I H D+KP+NI+++ 
Sbjct: 103 FILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDG 161

Query: 101 SGALKLADFGLSRAFTI 117
           +    + D+G++  F I
Sbjct: 162 NNRGYIIDYGIASHFII 178

Length = 294

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.2 bits (99), Expect = 4e-05
 Identities = 43/157 (27%), Positives = 70/157 (44%), Gaps = 14/157 (8%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E+ V K   HPN++        D +L++V  F+     KD + T  +     LA +Y+ Q
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108

Query: 74  -LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEV-- 126
            +L+AL Y H    +HR +K  +ILI+  G + L+  GL    ++  +    R  H+   
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166

Query: 127 ----VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               V  W  P  +    + Y    DI+S G    E+
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 42.2 bits (100), Expect = 4e-05
 Identities = 24/85 (28%), Positives = 41/85 (48%), Gaps = 13/85 (15%)

Query: 30  LHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH 88
           ++DV P +  +  V E++  +DLKD L+  P           + ++ E +   H   I+H
Sbjct: 403 IYDVDPEEKTI--VMEYIGGKDLKDVLEGNP---------ELVRKVGEIVAKLHKAGIVH 451

Query: 89  RDLKPQNILINKSGALKLADFGLSR 113
            DL   N ++ +   L L DFGL +
Sbjct: 452 GDLTTSNFIV-RDDRLYLIDFGLGK 475

Length = 535

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.8 bits (98), Expect = 5e-05
 Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 33/172 (19%)

Query: 11  TALREISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPA 65
             L+E+   +EL HPNV++      + IP      LV EF    DLK++L++    V   
Sbjct: 41  LFLQEVQPYRELNHPNVLQCLGQCIESIP----YLLVLEFCPLGDLKNYLRSNRGMVAQM 96

Query: 66  LAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
             K  L     ++   L + H    IH DL  +N  +    ++K+ D+GL+      + +
Sbjct: 97  AQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLA------LEQ 150

Query: 122 YTHE--------VVTLWYRPPEIL------LGAKVYSTTVDIWSAGCIFSEM 159
           Y  +         V L +  PE++      L  K  +   +IWS G    E+
Sbjct: 151 YPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.1 bits (96), Expect = 8e-05
 Identities = 39/157 (24%), Positives = 73/157 (46%), Gaps = 24/157 (15%)

Query: 17  SVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR---QDLKDFLQTTPVPVPPA--LAKSYL 71
           S+++++ H +++ L+ V   D +  +V EF+     DL    ++  +  P    +AK   
Sbjct: 56  SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAK--- 112

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGA-------LKLADFGLSRAFTIPMNRYTH 124
            QL  AL Y   + ++H ++  +NIL+ + G        +KL+D G      IP+   + 
Sbjct: 113 -QLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG------IPITVLSR 165

Query: 125 E--VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +  V  + +  PE +  +K  S   D WS G    E+
Sbjct: 166 QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 37.2 bits (86), Expect = 0.002
 Identities = 24/92 (26%), Positives = 40/92 (43%), Gaps = 7/92 (7%)

Query: 29  RLHDV----IPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY--LYQLLEALRYCH 82
           RLH V    +P+  +L    + LRQ      +     +   LA+ +  L   L AL    
Sbjct: 104 RLHSVPPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLAELWERLLAALLALLPAL 163

Query: 83  SRRIIHRDLKPQNILINKSGALK-LADFGLSR 113
              ++H DL P N+L++  G +  + DF  + 
Sbjct: 164 PLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAG 195

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	163
KOG0598|consensus	357		100.0
KOG0595|consensus	429		100.0
KOG0615|consensus	475		100.0
KOG0575|consensus	592		100.0
KOG0616|consensus	355		100.0
KOG0591|consensus	375		100.0
KOG0581|consensus	364		100.0
KOG0192|consensus	362		100.0
KOG0593|consensus	396		100.0
KOG0583|consensus	370		100.0
KOG0600|consensus	560		100.0
KOG0197|consensus	468		100.0
KOG0663|consensus	419		100.0
KOG0661|consensus	538		100.0
KOG0611|consensus	668		100.0
KOG0592|consensus	604		100.0
KOG0659|consensus	318		100.0
KOG0594|consensus	323		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0597|consensus	808		100.0
KOG0198|consensus	313		100.0
KOG0578|consensus	550		100.0
KOG0589|consensus	426		100.0
KOG1187|consensus	361		100.0
KOG0605|consensus	550		100.0
KOG0585|consensus	576		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0599|consensus	411		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0588|consensus	786		100.0
KOG0694|consensus	694		100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0658|consensus	364		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG4721|consensus	904		100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0610|consensus	459		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0582|consensus	516		100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0193|consensus	678		100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0580|consensus	281		100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG1095|consensus	1025		100.0
KOG0660|consensus	359		100.0
KOG0194|consensus	474		100.0
KOG0032|consensus	382		100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0986|consensus	591		100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG4717|consensus	864		100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.98
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.98
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.98
PLN00009	294	cyclin-dependent kinase A; Provisional	99.98
KOG0586|consensus	596		99.98
KOG1026|consensus	774		99.98
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.98
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.98
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.98
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.98
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.98
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.98
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.98
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.98
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.98
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.98
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.98
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.98
KOG0662|consensus	292		99.98
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.98
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.98
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.98
KOG0614|consensus	732		99.98
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.98
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.98
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.98
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.98
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.98
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.98
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.98
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.98
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.98
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.98
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.97
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.97
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.97
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.97
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.97
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.97
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.97
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.97
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.97
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.97
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.97
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.97
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.97
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.97
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.97
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.97
KOG0033|consensus	355		99.97
KOG0666|consensus	438		99.97
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.97
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.97
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.97
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.97
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.97
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.97
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.97
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.97
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.97
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.97
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.97
KOG0690|consensus	516		99.97
KOG0577|consensus	948		99.97
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.97
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.97
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.97
KOG0579|consensus	1187		99.97
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.97
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.97
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.97
KOG0584|consensus	632		99.97
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.97
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.97
KOG0612|consensus	1317		99.97
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.97
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.97
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.97
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.97
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.97
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.97
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.97
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.97
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.97
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.97
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.97
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.97
KOG0667|consensus	586		99.97
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.97
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.97
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.97
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.97
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.97
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.97
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.97
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.97
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.97
KOG4250|consensus	732		99.97
KOG0201|consensus	467		99.97
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.97
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.97
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.97
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.97
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.97
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.97
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.97
KOG1989|consensus	738		99.97
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.97
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.97
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.97
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.97
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.97
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.97
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.97
KOG0596|consensus	677		99.97
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.97
KOG0574|consensus	502		99.97
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.97
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.97
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.97
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.97
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.97
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.97
KOG0607|consensus	463		99.97
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.97
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.97
KOG0608|consensus	1034		99.97
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.97
PTZ00283	496	serine/threonine protein kinase; Provisional	99.97
KOG4236|consensus	888		99.97
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.97
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.97
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.97
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.97
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.97
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.97
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.97
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.97
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.97
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.97
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.97
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.97
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.97
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.97
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.97
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.97
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.97
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.97
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.97
KOG1152|consensus	772		99.97
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.97
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.97
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.97
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.97
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.97
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.97
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.97
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.97
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.97
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.97
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.97
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.97
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.97
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.97
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.97
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.97
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.97
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.97
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.97
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.97
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.97
KOG1094|consensus	807		99.97
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.97
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.97
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.97
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.97
KOG0604|consensus	400		99.97
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.97
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.97
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.97
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.97
PTZ00284	467	protein kinase; Provisional	99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.97
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.97
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.97
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.97
KOG2345|consensus	302		99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.97
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.97
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.96
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.96
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.96
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.96
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.96
KOG0669|consensus	376		99.96
KOG0984|consensus	282		99.96
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.96
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.96
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.96
KOG0196|consensus	996		99.96
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.96
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.96
KOG0603|consensus	612		99.96
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.96
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.96
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.96
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.96
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.96
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.96
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.96
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.96
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.96
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.96
PHA02882	294	putative serine/threonine kinase; Provisional	99.96
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.96
KOG4278|consensus	1157		99.96
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.96
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.96
KOG0983|consensus	391		99.96
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.96
KOG0696|consensus	683		99.96
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.96
KOG4257|consensus	974		99.96
KOG4645|consensus	1509		99.95
KOG0665|consensus	369		99.95
KOG4279|consensus	1226		99.95
KOG0695|consensus	593		99.95
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.95
KOG2052|consensus	513		99.95
KOG0200|consensus	609		99.95
KOG3653|consensus	534		99.95
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.94
KOG0199|consensus	1039		99.94
KOG1027|consensus	903		99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG1151|consensus	775		99.94
KOG0587|consensus	953		99.94
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG0664|consensus	449		99.94
KOG0668|consensus	338		99.94
KOG0671|consensus	415		99.94
KOG1025|consensus	1177		99.93
KOG1035|consensus	1351		99.93
KOG1006|consensus	361		99.93
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.92
KOG0670|consensus	752		99.91
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.9
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.9
KOG1345|consensus	378		99.89
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.89
KOG0576|consensus	829		99.89
KOG1290|consensus	590		99.89
KOG1167|consensus	418		99.88
KOG1024|consensus	563		99.87
KOG1164|consensus	322		99.86
KOG1165|consensus	449		99.85
KOG1163|consensus	341		99.85
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
PRK09188	365	serine/threonine protein kinase; Provisional	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG0590|consensus	601		99.8
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.77
KOG0603|consensus	612		99.77
PRK10345	210	hypothetical protein; Provisional	99.76
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.75
KOG1240|consensus	1431		99.75
KOG1166|consensus	974		99.75
KOG1023|consensus	484		99.74
KOG1033|consensus	516		99.7
KOG4158|consensus	598		99.68
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.68
PRK14879	211	serine/threonine protein kinase; Provisional	99.66
KOG0195|consensus	448		99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.64
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.63
smart00090	237	RIO RIO-like kinase.	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
KOG1243|consensus	690		99.62
KOG0606|consensus	1205		99.49
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.49
KOG0590|consensus	601		99.46
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.46
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.38
KOG3087|consensus	229		99.37
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.33
KOG0601|consensus	524		99.29
KOG1266|consensus	458		99.24
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.24
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.24
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.2
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.18
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.16
PRK09902	216	hypothetical protein; Provisional	99.04
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.88
KOG3741|consensus	655		98.87
COG4248	637	Uncharacterized protein with protein kinase and he	98.85
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.84
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.83
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.8
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.79
KOG0601|consensus	524		98.73
KOG0606|consensus	1205		98.56
KOG2137|consensus	700		98.53
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.49
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.34
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.29
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.27
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.22
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.14
KOG1235|consensus	538		98.07
KOG0576|consensus	829		97.91
PLN02876	822	acyl-CoA dehydrogenase	97.8
KOG1035|consensus	1351		97.63
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.57
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	97.53
KOG2268|consensus	465		97.52
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.5
PF01636	239	APH: Phosphotransferase enzyme family This family	97.38
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.2
KOG2270|consensus	520		96.85
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.74
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.32
PTZ00384	383	choline kinase; Provisional	96.08
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.08
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.0
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	95.79
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.75
PRK05231	319	homoserine kinase; Provisional	95.75
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.72
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	95.66
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.59
PRK10271	188	thiK thiamine kinase; Provisional	95.41
KOG1826|consensus	2724		95.29
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.12
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.11
KOG1093|consensus	725		95.03
PRK10593	297	hypothetical protein; Provisional	94.76
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	94.35
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	94.17
PLN02236	344	choline kinase	94.15
COG2334	331	Putative homoserine kinase type II (protein kinase	94.1
COG3231	266	Aph Aminoglycoside phosphotransferase [Translation	94.0
PRK14559	645	putative protein serine/threonine phosphatase; Pro	93.83
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	93.22
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.93
PRK11768	325	serine/threonine protein kinase; Provisional	92.39
PRK06148	1013	hypothetical protein; Provisional	91.9

>KOG0598|consensus

Probab=100.00  E-value=4.8e-42  Score=240.04  Aligned_cols=153  Identities=36%  Similarity=0.544  Sum_probs=141.3

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .....+..|..+|.+++||+||+++..|++.+.+|+|+||+.| .|+.++.+++ .+++..++.++.+|+.||.|||++|
T Consensus        67 ~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~g  145 (357)
T KOG0598|consen   67 KEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSKG  145 (357)
T ss_pred             hhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhCC
Confidence            3467788999999999999999999999999999999999986 8888888766 8999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|||+||+|||+|.+|+++|+|||+++..-.........|||+.|+|||++.+.+ |+..+|+||||+++|+|++
T Consensus       146 IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~  220 (357)
T KOG0598|consen  146 IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLT  220 (357)
T ss_pred             eeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhh
Confidence            99999999999999999999999999986665666667789999999999998865 8999999999999999996

>KOG0595|consensus

Probab=100.00  E-value=1.8e-41  Score=239.76  Aligned_cols=151  Identities=39%  Similarity=0.678  Sum_probs=136.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+-+..|+.+|+.++|+|||.+++++++++.+|+|||||. |+|.+++.+.+ .+++.+++.++.|++.|+++||+++|+
T Consensus        53 ~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~~Ii  131 (429)
T KOG0595|consen   53 VELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHENNII  131 (429)
T ss_pred             HHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4456789999999999999999999999999999999998 59999988776 899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccC------CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKS------GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|+||+||+++..      -.+||.|||+++... +.......||++-|||||++...+ |+.|+|+||+|+++|++++
T Consensus       132 HRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~-~~~~a~tlcGSplYMAPEV~~~~~-YdAKADLWSiG~Ilyq~l~  209 (429)
T KOG0595|consen  132 HRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ-PGSMAETLCGSPLYMAPEVIMSQQ-YDAKADLWSIGTILYQCLT  209 (429)
T ss_pred             eccCCcceEEeccCCCCCCCceEEecccchhhhCC-chhHHHHhhCCccccCHHHHHhcc-ccchhhHHHHHHHHHHHHh
Confidence            99999999999775      358999999998877 445566789999999999997655 8999999999999999997


Q ss_pred             C
Q psy7820         162 I  162 (163)
Q Consensus       162 ~  162 (163)
                      .
T Consensus       210 g  210 (429)
T KOG0595|consen  210 G  210 (429)
T ss_pred             C
Confidence            3

>KOG0615|consensus

Probab=100.00  E-value=4.7e-41  Score=238.01  Aligned_cols=152  Identities=35%  Similarity=0.582  Sum_probs=135.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+..+|+++|++++|||||+++++|+..++.|+||||++| +|++.+...+ .+.+...+.++.|++.++.|||++||
T Consensus       219 ~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~GI  297 (475)
T KOG0615|consen  219 KTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQGI  297 (475)
T ss_pred             chhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHcCc
Confidence            334567999999999999999999999999999999999985 9999988765 78888889999999999999999999


Q ss_pred             eecCCCCCcEEEccC---CceEEeecccccccccCCCcccccccCccccCcccccCCc--CCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||||+||++..+   -.+||.|||+++..+ .+..++..|||+.|.|||++.+..  .+..+.|+||+||+||-+|+
T Consensus       298 ~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g-~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs  376 (475)
T KOG0615|consen  298 IHRDIKPENILLSNDAEDCLLKITDFGLAKVSG-EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS  376 (475)
T ss_pred             ccccCCcceEEeccCCcceEEEecccchhhccc-cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence            999999999999776   678999999998877 567788999999999999987543  23458899999999999886

>KOG0575|consensus

Probab=100.00  E-value=3.3e-40  Score=242.87  Aligned_cols=158  Identities=31%  Similarity=0.531  Sum_probs=145.4

Q ss_pred             ccccCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q psy7820           2 RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         2 ~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      .++++...+.+.+|+++.++++|||||+++++|++..++|+|.|.|.. +|..++. ....+++..++.+++||+.|+.|
T Consensus        55 ~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkY  133 (592)
T KOG0575|consen   55 LLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKY  133 (592)
T ss_pred             HhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHH
Confidence            467788899999999999999999999999999999999999999985 6666555 55699999999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          81 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ||+.+|+|||+|..|++++++.++||+|||+|.....+..+-...||||.|+|||++...+ ++..+||||+||++|-||
T Consensus       134 LH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL  212 (592)
T KOG0575|consen  134 LHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLL  212 (592)
T ss_pred             HHhcCceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhh
Confidence            9999999999999999999999999999999999887767777889999999999998655 699999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      .
T Consensus       213 ~  213 (592)
T KOG0575|consen  213 V  213 (592)
T ss_pred             h
Confidence            5

>KOG0616|consensus

Probab=100.00  E-value=1.5e-39  Score=222.20  Aligned_cols=152  Identities=30%  Similarity=0.521  Sum_probs=138.6

Q ss_pred             cCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           5 VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         5 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .-.+.++..+|.++|+.+.||+++++++.+.+...+|+||||++| .+++++.+.+ ++++..++.++.+++.|++|||+
T Consensus        84 klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~  162 (355)
T KOG0616|consen   84 KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHS  162 (355)
T ss_pred             HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHh
Confidence            344567789999999999999999999999999999999999986 8888877765 99999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +++++||+||+|+++|.+|.+||+|||+++...   ......||||.|+|||.+.+.+ +..++|+||||+++|||+.
T Consensus       163 ~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~---~rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMla  236 (355)
T KOG0616|consen  163 LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS---GRTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLA  236 (355)
T ss_pred             cCeeeccCChHHeeeccCCcEEEEeccceEEec---CcEEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHc
Confidence            999999999999999999999999999998755   3456789999999999998754 7999999999999999984

>KOG0591|consensus

Probab=100.00  E-value=1.2e-40  Score=226.60  Aligned_cols=153  Identities=35%  Similarity=0.603  Sum_probs=135.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeee-eeeeCc-EEEEEecchh-ccHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHD-VIPVDF-KLFLVFEFLR-QDLKDFLQ---TTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~-~~~~~~-~~~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..+...|+.+|++++||||+++++ .|.++. -++|+||+|. |+|.+.+.   ++...+++..++.++.|++.+++.+|
T Consensus        62 rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH  141 (375)
T KOG0591|consen   62 RQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCH  141 (375)
T ss_pred             HHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHh
Confidence            456789999999999999999998 455554 4899999998 68888774   45568899999999999999999999


Q ss_pred             h--CC--ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          83 S--RR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        83 ~--~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      .  ..  +.|+||||.||+++.+|.+|++|||+++.+........+..|||+||+||.+.+.+ |+.+|||||+||++||
T Consensus       142 ~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyE  220 (375)
T KOG0591|consen  142 SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYE  220 (375)
T ss_pred             ccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHH
Confidence            8  44  89999999999999999999999999999887777777889999999999998765 8999999999999999


Q ss_pred             HhcC
Q psy7820         159 MIQI  162 (163)
Q Consensus       159 ll~~  162 (163)
                      |..+
T Consensus       221 McaL  224 (375)
T KOG0591|consen  221 MCAL  224 (375)
T ss_pred             HHhc
Confidence            9753

>KOG0581|consensus

Probab=100.00  E-value=1.1e-39  Score=228.50  Aligned_cols=152  Identities=30%  Similarity=0.520  Sum_probs=135.7

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      +....++.+|++++++++||+||++|+.|..++ .++|+|||+.| +|.+.+... +.+++..+..++.++++||.|||.
T Consensus       118 ~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~  196 (364)
T KOG0581|consen  118 PALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHE  196 (364)
T ss_pred             HHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhh
Confidence            344567789999999999999999999999998 59999999986 777666655 589999999999999999999995


Q ss_pred             -CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 -RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 -~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                       .+|+||||||+|++++.+|.+||+|||.+......  ......||..||+||++.+.. |+.++||||||+.++|+.+
T Consensus       197 ~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~  272 (364)
T KOG0581|consen  197 ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAI  272 (364)
T ss_pred             ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh--hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhh
Confidence             99999999999999999999999999998766533  446788999999999998865 7999999999999999986

>KOG0192|consensus

Probab=100.00  E-value=1.4e-38  Score=229.82  Aligned_cols=154  Identities=32%  Similarity=0.504  Sum_probs=137.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-EEEEEecchh-ccHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLR-QDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+|.+|+.+|.+++|||||+++|++.... ..++||||++ |+|.+++.. ....++...++.++.||+.|+.|||+++
T Consensus        83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~  162 (362)
T KOG0192|consen   83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG  162 (362)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            458999999999999999999999998887 7999999998 588888877 4679999999999999999999999999


Q ss_pred             -ceecCCCCCcEEEccCC-ceEEeecccccccccCCCcccccccCccccCcccccC-CcCCCcchhhHHHHHHHHHHhcC
Q psy7820          86 -IIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        86 -i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                       ++|+|+||+|++++.++ ++||+|||+++.............||..|||||++.+ ..+++.++||||+|+++|||+|.
T Consensus       163 ~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~  242 (362)
T KOG0192|consen  163 PIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTG  242 (362)
T ss_pred             CeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHC
Confidence             99999999999999998 9999999999776643334445688999999999985 35689999999999999999973

>KOG0593|consensus

Probab=100.00  E-value=1.1e-39  Score=223.71  Aligned_cols=154  Identities=47%  Similarity=0.888  Sum_probs=144.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      +..-+++|+++|++++|+|+|.++++|+....+++|+|||+.+.++.+...+..++...+..++.|++.++.|+|+++++
T Consensus        44 VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~I  123 (396)
T KOG0593|consen   44 VKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCI  123 (396)
T ss_pred             HHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCee
Confidence            44557899999999999999999999999999999999999999999999998999999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||++..+|.+|+||||+|+....++..-+.-..|..|.|||.+.+..+|....||||+||++.||++
T Consensus       124 HRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~  197 (396)
T KOG0593|consen  124 HRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT  197 (396)
T ss_pred             cccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc
Confidence            99999999999999999999999999888766666666678899999999998889999999999999999997

>KOG0583|consensus

Probab=100.00  E-value=2.8e-38  Score=229.73  Aligned_cols=153  Identities=38%  Similarity=0.636  Sum_probs=139.4

Q ss_pred             chhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+.+|+.+++.++ ||||+++++++.+...+++||||+.| +|++++.+ .+.+.+..+..+++|+++|++|+|++|
T Consensus        62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~g  140 (370)
T KOG0583|consen   62 LDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRG  140 (370)
T ss_pred             cchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCC
Confidence            3445668999999998 99999999999999999999999985 99999998 669999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccC-CceEEeecccccccccCCCcccccccCccccCcccccCCc-CCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++||||||+|++++.+ +++||+|||++.............+|++.|+|||++.+.. ....++|+||+|++||.|++
T Consensus       141 i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~  218 (370)
T KOG0583|consen  141 IVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLC  218 (370)
T ss_pred             EeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHh
Confidence            9999999999999999 9999999999987643456677889999999999998866 44689999999999999996

>KOG0600|consensus

Probab=100.00  E-value=1.1e-37  Score=225.61  Aligned_cols=156  Identities=51%  Similarity=0.958  Sum_probs=142.0

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      +..+.-..+|+.+|++++||||+++.++..+.  +.+|+|+||++.+|.-++...+-.+++.+++.++.|++.|++|+|+
T Consensus       157 ~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~  236 (560)
T KOG0600|consen  157 EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHS  236 (560)
T ss_pred             CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhh
Confidence            34455568999999999999999999998776  6899999999999999999988899999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+|||..||++|.+|.+||.|||+++.+..... ..+....|..|.|||.+.+...|+...|+||.||++.||++
T Consensus       237 ~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~  315 (560)
T KOG0600|consen  237 RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL  315 (560)
T ss_pred             cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc
Confidence            9999999999999999999999999999997764433 35666779999999999998889999999999999999985

>KOG0197|consensus

Probab=100.00  E-value=8.6e-38  Score=227.21  Aligned_cols=155  Identities=28%  Similarity=0.465  Sum_probs=135.2

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      -..++|.+|+++|++++|++||+++++|..++.++|||||++ |+|++++.. .+..++..+.+.++.||++|++||+++
T Consensus       243 m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~  322 (468)
T KOG0197|consen  243 MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK  322 (468)
T ss_pred             cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC
Confidence            345789999999999999999999999999999999999998 799999997 567889999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      +++|||+...||++++++.+||+|||+++......- .....--...|.|||.+.... ++.+|||||+|++||||+|.
T Consensus       323 ~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~  400 (468)
T KOG0197|consen  323 NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTY  400 (468)
T ss_pred             CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhcc
Confidence            999999999999999999999999999985432211 111111255799999998765 89999999999999999984

>KOG0663|consensus

Probab=100.00  E-value=4.2e-37  Score=213.36  Aligned_cols=156  Identities=47%  Similarity=0.903  Sum_probs=145.4

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ++.+-.-++|+.+|.+++|||||.+.+++...  +.+|+|||||+.+|...+.+.++++...+++.++.|+++|++|||.
T Consensus       116 ~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~  195 (419)
T KOG0663|consen  116 EGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHD  195 (419)
T ss_pred             CCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhh
Confidence            34445568999999999999999999998654  4799999999999999999988999999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|+|+|+||+|++++..|.+||+|||+|+.++.+....+...-|..|.|||.+.+...|+...|+||+||++.||++
T Consensus       196 ~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~  273 (419)
T KOG0663|consen  196 NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLT  273 (419)
T ss_pred             ceeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHh
Confidence            999999999999999999999999999999999988888888889999999999999999999999999999999986

>KOG0661|consensus

Probab=100.00  E-value=1.5e-37  Score=223.60  Aligned_cols=149  Identities=40%  Similarity=0.763  Sum_probs=135.4

Q ss_pred             HHHHHHHhcCC-CCCeeeeeeeeeeCc-EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7820          13 LREISVLKELK-HPNVIRLHDVIPVDF-KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   90 (163)
Q Consensus        13 ~~e~~~l~~~~-h~~i~~~~~~~~~~~-~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~   90 (163)
                      ++|+.-|++++ ||||+++.+++.+.+ .+|+|||+++.+|.+++...+..+++.+++.|+.||++||.|+|++|++|||
T Consensus        56 LREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRD  135 (538)
T KOG0661|consen   56 LREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRD  135 (538)
T ss_pred             HHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCccccc
Confidence            58999999997 999999999999988 9999999999999999999988999999999999999999999999999999


Q ss_pred             CCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          91 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        91 i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      +||+||++..+..+||.|||+++..... ..-+.-..|..|.|||++.....|+.+.|+||+||+++|+.++
T Consensus       136 lKPENiLi~~~~~iKiaDFGLARev~Sk-pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sL  206 (538)
T KOG0661|consen  136 LKPENILISGNDVIKIADFGLAREVRSK-PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSL  206 (538)
T ss_pred             CChhheEecccceeEecccccccccccC-CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHh
Confidence            9999999999999999999999865422 2233345588899999998888899999999999999999864

>KOG0611|consensus

Probab=100.00  E-value=2.5e-37  Score=220.00  Aligned_cols=161  Identities=29%  Similarity=0.580  Sum_probs=147.6

Q ss_pred             CccccCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q psy7820           1 SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         1 ~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ++|+.+++.-++.+|+++|..++||||+.+|++|+..+.+.|||||.. |.|.+++...+ .+++..+..+++||++++.
T Consensus        89 dkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVh  167 (668)
T KOG0611|consen   89 DKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG-SLSEREARHFFRQIVSAVH  167 (668)
T ss_pred             hhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHH
Confidence            467778888889999999999999999999999999999999999997 59999998776 8999999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      |+|+++++|+|+|.+||++|.++++||.|||++..+. .......+||++-|.+||...+..+-.+..|-||||++||-+
T Consensus       168 YCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~-~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtL  246 (668)
T KOG0611|consen  168 YCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA-DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTL  246 (668)
T ss_pred             HHhhccceecccchhheeecCCCCeeeeccchhhhhc-cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHH
Confidence            9999999999999999999999999999999987665 346677899999999999998877668999999999999998


Q ss_pred             h--cCC
Q psy7820         160 I--QIP  163 (163)
Q Consensus       160 l--~~~  163 (163)
                      +  |||
T Consensus       247 VyGtMP  252 (668)
T KOG0611|consen  247 VYGTMP  252 (668)
T ss_pred             hhcccc
Confidence            8  565

>KOG0592|consensus

Probab=100.00  E-value=5.2e-37  Score=223.72  Aligned_cols=153  Identities=33%  Similarity=0.563  Sum_probs=135.1

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....-+..|-+.|.++ .||+|++++..|+++..+|+|+||++ |+|++++.+.+ .+++.-++.++.+|+.+++|||++
T Consensus       115 ~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~  193 (604)
T KOG0592|consen  115 KKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSN  193 (604)
T ss_pred             cccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhc
Confidence            3344456799999999 79999999999999999999999998 69999998875 899999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCC-----------Cc--ccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-----------NR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      ||+||||||+||+++.+++++|.|||.++......           ..  ...++||..|++||++.+.. .++.+|+||
T Consensus       194 GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWA  272 (604)
T KOG0592|consen  194 GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWA  272 (604)
T ss_pred             CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHH
Confidence            99999999999999999999999999887664221           11  15678999999999997754 699999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      |||++|+|+.
T Consensus       273 lGCilyQmla  282 (604)
T KOG0592|consen  273 LGCILYQMLA  282 (604)
T ss_pred             HHHHHHHHhc
Confidence            9999999995

>KOG0659|consensus

Probab=100.00  E-value=4.5e-37  Score=207.32  Aligned_cols=155  Identities=52%  Similarity=0.947  Sum_probs=146.1

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ++....+++|+..|+.++|+||+.+.++|...+.+.+|+||++-+|...+.+....++...++.++.++++|++|||++.
T Consensus        42 dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~  121 (318)
T KOG0659|consen   42 DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW  121 (318)
T ss_pred             cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh
Confidence            34456689999999999999999999999999999999999999999999999889999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      |.|+|+||.|++++.+|.+|+.|||+++.++.+.........|..|.|||.+.+.+.|+...|+||.||++.||+
T Consensus       122 IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl  196 (318)
T KOG0659|consen  122 ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL  196 (318)
T ss_pred             hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH
Confidence            999999999999999999999999999999877777776677899999999999888999999999999999987

>KOG0594|consensus

Probab=100.00  E-value=1.5e-36  Score=211.92  Aligned_cols=156  Identities=65%  Similarity=1.109  Sum_probs=144.3

Q ss_pred             CCchhhHHHHHHHHhcCCCCC-eeeeeeeeeeCc------EEEEEecchhccHHHHHhcCC---CCCCHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELKHPN-VIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTP---VPVPPALAKSYLYQLL   75 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~~i~   75 (163)
                      ++.+...++|+.+++.++|+| |+++++++.+..      .+++|+|++..+|..++...+   ..++...++.++.|++
T Consensus        51 EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll  130 (323)
T KOG0594|consen   51 EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLL  130 (323)
T ss_pred             cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHH
Confidence            567888999999999999999 999999998877      899999999999999987765   4688889999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820          76 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus        76 ~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                      .|+.|||+++|+|||+||+|++++.+|.+|++|||+++.+..+........+|..|.|||++.+...|+...||||+||+
T Consensus       131 ~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcI  210 (323)
T KOG0594|consen  131 RGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCI  210 (323)
T ss_pred             HHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHH
Confidence            99999999999999999999999999999999999999888777777777889999999999998779999999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +.||++
T Consensus       211 faEm~~  216 (323)
T KOG0594|consen  211 FAEMFT  216 (323)
T ss_pred             HHHHHh
Confidence            999986

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.6e-36  Score=214.94  Aligned_cols=153  Identities=55%  Similarity=0.980  Sum_probs=136.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|+++++.++|+|++++++++.+++..++||||+++++.+.+....+.+++..+..++.|++.|+.|||+.|++|
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH  126 (303)
T cd07869          47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILH  126 (303)
T ss_pred             chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            34678899999999999999999999999999999999999999998877778899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.++.++|+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       127 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  199 (303)
T cd07869         127 RDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ  199 (303)
T ss_pred             CCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999886554333333445678899999998765557899999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6e-36  Score=212.50  Aligned_cols=154  Identities=54%  Similarity=0.992  Sum_probs=136.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ....+.+|++++++++|+||+++++++.+++..++|||++++++.+++...+..+++..+..++.|++.|+.|||++|++
T Consensus        46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv  125 (288)
T cd07871          46 APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL  125 (288)
T ss_pred             cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            34567899999999999999999999999999999999999999998877666788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|+|
T Consensus       126 H~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~  199 (288)
T cd07871         126 HRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT  199 (288)
T ss_pred             cCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999887654333333445678899999998765557999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0597|consensus

Probab=100.00  E-value=8.1e-37  Score=224.25  Aligned_cols=150  Identities=38%  Similarity=0.665  Sum_probs=140.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ..+.+|+++++.++||||+.+++.|++..++|+|.||+.|+|...+...+ .++++.+..++.++++++.|||+.+|.|+
T Consensus        46 ~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~rilhr  124 (808)
T KOG0597|consen   46 KNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVGDLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSNRILHR  124 (808)
T ss_pred             HHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhhhHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhcCcccc
Confidence            34789999999999999999999999999999999999999998887655 89999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||.||+++.+|.+|++|||+++.......-.+..-|||.|||||...+ .+|+..+|+|||||++||+..
T Consensus       125 d~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~  195 (808)
T KOG0597|consen  125 DMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYV  195 (808)
T ss_pred             cCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhc
Confidence            99999999999999999999999998877777788889999999999985 568999999999999999974

>KOG0198|consensus

Probab=100.00  E-value=1.3e-36  Score=214.46  Aligned_cols=154  Identities=32%  Similarity=0.548  Sum_probs=133.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc--EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .+.+.+|+.+|.+++|||||+++|......  .+++.|||+++ +|.+++.+.++.+++..++.+..|++.|+.|||++|
T Consensus        58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g  137 (313)
T KOG0198|consen   58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG  137 (313)
T ss_pred             HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345889999999999999999999854444  69999999985 999999988778999999999999999999999999


Q ss_pred             ceecCCCCCcEEEcc-CCceEEeeccccccccc---CCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINK-SGALKLADFGLSRAFTI---PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~---~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++. ++.+||.|||.+.....   .........||+.|+|||++.+.......+||||+||++.||+|
T Consensus       138 ~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~T  217 (313)
T KOG0198|consen  138 IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLT  217 (313)
T ss_pred             EeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccC
Confidence            999999999999999 79999999998876652   22334567889999999999853223459999999999999998


Q ss_pred             C
Q psy7820         162 I  162 (163)
Q Consensus       162 ~  162 (163)
                      .
T Consensus       218 g  218 (313)
T KOG0198|consen  218 G  218 (313)
T ss_pred             C
Confidence            3

>KOG0578|consensus

Probab=100.00  E-value=1.8e-36  Score=221.60  Aligned_cols=150  Identities=32%  Similarity=0.594  Sum_probs=137.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+-+.+|+.+|+..+|+|||++++.+-.++.+|+||||++| +|.+.+...  .+++.++..++.++++||+|||.+||+
T Consensus       314 keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l~aL~fLH~~gIi  391 (550)
T KOG0578|consen  314 KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREILQGLKFLHARGII  391 (550)
T ss_pred             hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHHHHHHHHHhccee
Confidence            34467999999999999999999999998999999999986 777766543  589999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|||.+||+++.+|.+||+|||++..+.....+....+||++|||||+..... |+++.||||||++++||++
T Consensus       392 HrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWSLGIMaIEMve  464 (550)
T KOG0578|consen  392 HRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKP-YGPKVDIWSLGIMAIEMVE  464 (550)
T ss_pred             eeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcc-cCccccchhhhhHHHHHhc
Confidence            999999999999999999999999998887777888899999999999987654 8999999999999999985

>KOG0589|consensus

Probab=100.00  E-value=1.9e-36  Score=219.21  Aligned_cols=154  Identities=34%  Similarity=0.576  Sum_probs=140.6

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcE-EEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFK-LFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..+..++|+.++++++||||+.+.+.|..++. .+|+|+||+| ++.+.+.+.. ..++++.+..|+.|++.++.|||++
T Consensus        46 ~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~  125 (426)
T KOG0589|consen   46 ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN  125 (426)
T ss_pred             hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh
Confidence            34467899999999999999999999999887 9999999986 8888887765 6789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      .++|+|+|+.||++..++.+++.|||+++.............||+.|++||.+.+. +|..++|||||||++|||.++
T Consensus       126 ~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~-pYn~KSDiWsLGC~~yEm~~l  202 (426)
T KOG0589|consen  126 RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDI-PYNEKSDIWSLGCCLYEMCTL  202 (426)
T ss_pred             hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCC-CCCccCcchhhcchHHHHHhc
Confidence            99999999999999999999999999999888665566677899999999999875 489999999999999999875

>KOG1187|consensus

Probab=100.00  E-value=8.9e-36  Score=216.20  Aligned_cols=153  Identities=29%  Similarity=0.404  Sum_probs=133.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-EEEEEecchh-ccHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLR-QDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+|.+|++++.+++|+|+++++|||.+.+ ...+|+||++ |+|.+++..... .++|..+++|+.++++||+|||...
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~  194 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC  194 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence            456999999999999999999999999988 5999999998 699999988776 8999999999999999999999754


Q ss_pred             ---ceecCCCCCcEEEccCCceEEeeccccccccc-CCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 ---IIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 ---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                         ++|+||||+||++|.+.++|++|||++..... .........||.+|++||+..... .+.++||||+|+++.|++|
T Consensus       195 ~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDVySFGVvllElit  273 (361)
T KOG1187|consen  195 PPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGK-LTEKSDVYSFGVVLLELIT  273 (361)
T ss_pred             CCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCC-cCcccccccchHHHHHHHh
Confidence               99999999999999999999999999965443 222111117899999999997644 6999999999999999987


Q ss_pred             C
Q psy7820         162 I  162 (163)
Q Consensus       162 ~  162 (163)
                      .
T Consensus       274 g  274 (361)
T KOG1187|consen  274 G  274 (361)
T ss_pred             C
Confidence            3

>KOG0605|consensus

Probab=100.00  E-value=9.6e-36  Score=216.75  Aligned_cols=154  Identities=33%  Similarity=0.520  Sum_probs=134.4

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..+..++..|-++|...+.+++|+++..|++.+++||||||++| ++..++.+.+ .+++..++.++.+++-||+.+|+.
T Consensus       182 ~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~  260 (550)
T KOG0605|consen  182 KNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQL  260 (550)
T ss_pred             hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHc
Confidence            34567788999999999999999999999999999999999986 8888887765 899999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeeccccccccc------------------------CCC----c---------------
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTI------------------------PMN----R---------------  121 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~------------------------~~~----~---------------  121 (163)
                      |++|+||||+|+++|.+|++||.|||++.....                        ...    .               
T Consensus       261 gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~n  340 (550)
T KOG0605|consen  261 GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRN  340 (550)
T ss_pred             CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhh
Confidence            999999999999999999999999998843211                        000    0               


Q ss_pred             ----ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         122 ----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       122 ----~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                          ....+|||.|+|||++.+.+ |+...|+|||||++||||.
T Consensus       341 rr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLv  383 (550)
T KOG0605|consen  341 RRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLV  383 (550)
T ss_pred             hhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHh
Confidence                02458999999999999876 7999999999999999984

>KOG0585|consensus

Probab=100.00  E-value=4.9e-36  Score=215.94  Aligned_cols=152  Identities=32%  Similarity=0.556  Sum_probs=126.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .++..+|+.+|+++.|+|+|+++++..+.  ..+|+|+|||...-..+.-.....+++.+++.++++++.||+|||.+|+
T Consensus       152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qgi  231 (576)
T KOG0585|consen  152 IEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGI  231 (576)
T ss_pred             HHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCe
Confidence            36788999999999999999999998764  4899999999854433333222238999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-----CcccccccCccccCcccccC---CcCCCcchhhHHHHHHHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-----NRYTHEVVTLWYRPPEILLG---AKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~---~~~~~~~~Di~slG~~l~~  158 (163)
                      +||||||+|++++.+|++||.|||.+.......     .......|||.|+|||...+   ...-+.+.||||+||+||.
T Consensus       232 iHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYC  311 (576)
T KOG0585|consen  232 IHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYC  311 (576)
T ss_pred             eccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHH
Confidence            999999999999999999999999987653221     22345789999999999876   2234678999999999999


Q ss_pred             Hh
Q psy7820         159 MI  160 (163)
Q Consensus       159 ll  160 (163)
                      |+
T Consensus       312 ll  313 (576)
T KOG0585|consen  312 LL  313 (576)
T ss_pred             hh
Confidence            98

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-35  Score=214.06  Aligned_cols=151  Identities=28%  Similarity=0.421  Sum_probs=132.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+||+++++.+..++.+++||||+++ +|.+.+... ..+++..+..++.|++.+++|||+.|++
T Consensus        39 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iv  117 (323)
T cd05571          39 VAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVV  117 (323)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            34577899999999999999999999999999999999986 787777654 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.++|+|||++.............+|++.|+|||.+.+.. ++.++|+||+||++|||++
T Consensus       118 HrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt  190 (323)
T cd05571         118 YRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMC  190 (323)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhc
Confidence            999999999999999999999998865433333344567899999999987654 6999999999999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0599|consensus

Probab=100.00  E-value=5.3e-36  Score=203.70  Aligned_cols=152  Identities=33%  Similarity=0.605  Sum_probs=137.4

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+...+|+.+|+++ .||+|+++.+.++++..+|+|+|.++ |.|+|++...- .++++....++.|+..+++|||.++
T Consensus        65 ~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~~  143 (411)
T KOG0599|consen   65 MREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHARN  143 (411)
T ss_pred             HHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHhh
Confidence            345678899999999 59999999999999999999999998 79999987654 8899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc-----CCcCCCcchhhHHHHHHHHHHh
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL-----GAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      |+|+|+||+||+++++.+++|.|||+++... ++.+.+..||||+|+|||.++     +...|+...|+||.|+++|-+|
T Consensus       144 IVHRDLKpENILlddn~~i~isDFGFa~~l~-~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL  222 (411)
T KOG0599|consen  144 IVHRDLKPENILLDDNMNIKISDFGFACQLE-PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL  222 (411)
T ss_pred             hhhcccChhheeeccccceEEeccceeeccC-CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence            9999999999999999999999999998876 567889999999999999984     2333788999999999999987


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      .
T Consensus       223 a  223 (411)
T KOG0599|consen  223 A  223 (411)
T ss_pred             c
Confidence            3

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.3e-35  Score=211.85  Aligned_cols=151  Identities=28%  Similarity=0.434  Sum_probs=131.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+++++.++||||+++++.+..++.+|+||||+++ +|...+... ..+++..++.++.|++.|+.|||++|++
T Consensus        39 ~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~iv  117 (323)
T cd05595          39 VAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVV  117 (323)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34567899999999999999999999999999999999986 777766654 3788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 H~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~  190 (323)
T cd05595         118 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMC  190 (323)
T ss_pred             ecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHh
Confidence            999999999999999999999998765433333334556899999999987654 6999999999999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=210.73  Aligned_cols=152  Identities=33%  Similarity=0.483  Sum_probs=133.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++++++++|+||+++++.+.+++..++||||+++ +|.+.+... +.+++..+..++.|++.++.|||++|+
T Consensus        36 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  114 (312)
T cd05585          36 EVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNV  114 (312)
T ss_pred             HHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            345677899999999999999999999999999999999985 888887654 478999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       115 ~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~t  188 (312)
T cd05585         115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLT  188 (312)
T ss_pred             EeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHh
Confidence            9999999999999999999999998875433333334456899999999987754 6999999999999999986

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0588|consensus

Probab=100.00  E-value=2.8e-35  Score=219.04  Aligned_cols=154  Identities=34%  Similarity=0.636  Sum_probs=140.9

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +.++..+.+|+-+|+.+.|||++++|++++++.++|+|.||++| .|++++...+ ++++..+.++++||+.|+.|+|..
T Consensus        53 ~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~  131 (786)
T KOG0588|consen   53 SSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF  131 (786)
T ss_pred             cccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh
Confidence            34566788999999999999999999999999999999999985 8999888766 888888999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|+|+||+|.+++..+++||.|||.|.... ++.-....||++-|.|||++++.++...++||||.||+||.|||
T Consensus       132 ~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt  207 (786)
T KOG0588|consen  132 NICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT  207 (786)
T ss_pred             cceeccCCchhhhhhcccCEeeeccceeeccc-CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh
Confidence            99999999999999999999999999987644 45567778999999999999998888899999999999999997

>KOG0694|consensus

Probab=100.00  E-value=1.7e-35  Score=220.61  Aligned_cols=156  Identities=25%  Similarity=0.382  Sum_probs=138.9

Q ss_pred             ccCCchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           4 QVEGVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         4 ~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ...+..+.++.|.+++... +||++++++..|++..++|+||||+.|+...++ ...+.+++..+..++..++.||.|||
T Consensus       407 l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH  485 (694)
T KOG0694|consen  407 LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLH  485 (694)
T ss_pred             eccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHH
Confidence            3455667788999999999 599999999999999999999999987443333 33358999999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++||++||+|.+||++|.+|.+||.|||+++..-..+......|||+.|+|||++.+.. |+...|+|||||++||||.
T Consensus       486 ~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~  563 (694)
T KOG0694|consen  486 ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLV  563 (694)
T ss_pred             hcCceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHc
Confidence            99999999999999999999999999999987665667778899999999999998765 8999999999999999994

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.3e-35  Score=210.41  Aligned_cols=151  Identities=29%  Similarity=0.450  Sum_probs=131.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+++++.++|+||+++++.+..++.+++||||+++ +|.+.+... ..+++..+..++.|++.|++|||++|++
T Consensus        39 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~iv  117 (328)
T cd05593          39 VAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIV  117 (328)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            45678899999999999999999999999999999999986 777776654 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 HrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ellt  190 (328)
T cd05593         118 YRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMC  190 (328)
T ss_pred             ecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhh
Confidence            999999999999999999999998865432223334457899999999987654 6999999999999999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-34  Score=212.04  Aligned_cols=150  Identities=28%  Similarity=0.455  Sum_probs=130.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|.+++++++|++|+++++.+.++..+|+||||++| +|.+.+... +.+++..+..++.|++.|++|||++|++|
T Consensus        46 ~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givH  124 (363)
T cd05628          46 GHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIH  124 (363)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEe
Confidence            4577899999999999999999999999999999999986 888887764 47899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC-----------------------------------cccccccCccccC
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN-----------------------------------RYTHEVVTLWYRP  133 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~  133 (163)
                      +||||+||+++.++.++|+|||++........                                   .....+|++.|+|
T Consensus       125 rDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a  204 (363)
T cd05628         125 RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIA  204 (363)
T ss_pred             cCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccC
Confidence            99999999999999999999998864321100                                   0123478999999


Q ss_pred             cccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         134 PEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       134 pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||.+.+.. ++.++|+||+||++|||++
T Consensus       205 PE~~~~~~-~~~~~DvwSlGvil~ell~  231 (363)
T cd05628         205 PEVFMQTG-YNKLCDWWSLGVIMYEMLI  231 (363)
T ss_pred             HHHHcCCC-CCCchhhhhhHHHHHHHHh
Confidence            99987654 7999999999999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.9e-35  Score=209.85  Aligned_cols=150  Identities=32%  Similarity=0.462  Sum_probs=131.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|+++++.++|+||+++++.+..++.+|+||||+++ +|.+.+...+ .+++..+..++.|++.++.|||++|++|
T Consensus        45 ~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~ivH  123 (323)
T cd05584          45 AHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQGIIY  123 (323)
T ss_pred             HHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            4567899999999999999999999999999999999986 8877776544 6788888999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       124 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  195 (323)
T cd05584         124 RDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLT  195 (323)
T ss_pred             CCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhc
Confidence            99999999999999999999998865443333344457899999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.3e-35  Score=212.49  Aligned_cols=149  Identities=29%  Similarity=0.485  Sum_probs=131.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++.++||||+++++++.+++..++||||+++ +|.+++.... .+++..+..++.|++.++.|||+.|+
T Consensus        74 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i  152 (340)
T PTZ00426         74 QVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSLNI  152 (340)
T ss_pred             hHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345677899999999999999999999999999999999975 8888876544 78899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++.....   ......|++.|+|||.+.+.. ++.++|+||+||++|+|++
T Consensus       153 vHrDLkp~NILl~~~~~ikL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~  223 (340)
T PTZ00426        153 VYRDLKPENLLLDKDGFIKMTDFGFAKVVDT---RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILV  223 (340)
T ss_pred             EccCCCHHHEEECCCCCEEEecCCCCeecCC---CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhc
Confidence            9999999999999999999999999876432   233457899999999987654 6899999999999999996

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=9.7e-35  Score=209.87  Aligned_cols=149  Identities=30%  Similarity=0.510  Sum_probs=131.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...++.+|++++++++|+||+++++.+.+++.+++||||+.+ +|.+.+... +.+++..+..++.|++.++.|||++|+
T Consensus        61 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i  139 (329)
T PTZ00263         61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDI  139 (329)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345678999999999999999999999999999999999985 888887764 478899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+.....   ......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       140 vH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt  210 (329)
T PTZ00263        140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---RTFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIA  210 (329)
T ss_pred             eecCCCHHHEEECCCCCEEEeeccCceEcCC---CcceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHc
Confidence            9999999999999999999999999876542   223457899999999987655 6899999999999999996

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=207.40  Aligned_cols=148  Identities=32%  Similarity=0.505  Sum_probs=131.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++||||+++++++.++..+++||||+++ +|.+++...+ .+++..+..++.|++.++.+||++|++
T Consensus        45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~  123 (291)
T cd05612          45 EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSKEIV  123 (291)
T ss_pred             HHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678899999999999999999999999999999999985 8888887654 788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+.....   ......|++.|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus       124 H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~  193 (291)
T cd05612         124 YRDLKPENILLDKEGHIKLTDFGFAKKLRD---RTWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLV  193 (291)
T ss_pred             ecCCCHHHeEECCCCCEEEEecCcchhccC---CcccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999998876542   223456799999999987655 6999999999999999986

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.2e-34  Score=205.44  Aligned_cols=153  Identities=54%  Similarity=1.020  Sum_probs=135.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++|+|++++++++..++..++||||+++++.+.+...+..++...+..++.|++.++.+||++|++|
T Consensus        48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH  127 (309)
T cd07872          48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLH  127 (309)
T ss_pred             chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            34577899999999999999999999999999999999999999988877767899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+..............++..|+|||.+.+...++.++|+||+|+++|+|+|
T Consensus       128 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t  200 (309)
T cd07872         128 RDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS  200 (309)
T ss_pred             CCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999987654433333344568899999998765557999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0658|consensus

Probab=100.00  E-value=1.1e-35  Score=208.04  Aligned_cols=147  Identities=37%  Similarity=0.720  Sum_probs=127.4

Q ss_pred             HHHHHHHhcCCCCCeeeeeeeeeeCc-----EEEEEecchhccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          13 LREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      -+|+++|+.++|||||++..+|....     +..+||||++.+|.+.+..   .+..++...++-+..|+.+|+.|||+.
T Consensus        65 nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~  144 (364)
T KOG0658|consen   65 NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH  144 (364)
T ss_pred             cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc
Confidence            47999999999999999999985422     4579999999999888874   356788888899999999999999999


Q ss_pred             CceecCCCCCcEEEccC-CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          85 RIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ||+||||||.|+++|.+ |.+||+|||.|+....... ...=..+..|.|||.+.+...|+.+.||||.||++.||+
T Consensus       145 ~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep-niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl  220 (364)
T KOG0658|consen  145 GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELL  220 (364)
T ss_pred             CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC-ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHh
Confidence            99999999999999987 8999999999987764322 233344889999999999988999999999999999997

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-34  Score=211.15  Aligned_cols=151  Identities=30%  Similarity=0.467  Sum_probs=132.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++||||+++++++..+...++++|++.+++..++.... .+++..++.++.|++.|+.|||++|++|
T Consensus       127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~~IvH  205 (391)
T PHA03212        127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHENRIIH  205 (391)
T ss_pred             hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            345788999999999999999999999999999999999999988886654 6889999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccC-CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.++.++|+|||++...... ........|++.|+|||++.+.. ++.++|+||+|+++|+|++
T Consensus       206 rDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt  278 (391)
T PHA03212        206 RDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMAT  278 (391)
T ss_pred             CCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHH
Confidence            999999999999999999999998643221 22233457899999999987654 7999999999999999996

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-34  Score=208.80  Aligned_cols=151  Identities=28%  Similarity=0.430  Sum_probs=130.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i   86 (163)
                      ..++.+|.++++.++|+||+++++.+..++.+++||||+++ +|...+... ..+++..+..++.|++.++.|||+ .|+
T Consensus        39 ~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~i  117 (325)
T cd05594          39 VAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNV  117 (325)
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence            35567899999999999999999999999999999999986 777766554 478999999999999999999997 799


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++..............|++.|+|||++.+.. ++.++|+||+|+++|+|++
T Consensus       118 vHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t  191 (325)
T cd05594         118 VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMC  191 (325)
T ss_pred             EecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCC-CCCccccccccceeeeecc
Confidence            9999999999999999999999998865433333334456899999999987654 6999999999999999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.1e-34  Score=210.97  Aligned_cols=151  Identities=33%  Similarity=0.500  Sum_probs=129.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++|+||+++++.+.+++.+++||||+++ +|.+.+... +.+++..+..++.|++.++++||++|++
T Consensus        45 ~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~iv  123 (382)
T cd05625          45 VAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFI  123 (382)
T ss_pred             HHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34678899999999999999999999999999999999985 888887654 4788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccC-----------------------------------------------CC
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIP-----------------------------------------------MN  120 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-----------------------------------------------~~  120 (163)
                      |+||||+||+++.++.++|+|||++......                                               ..
T Consensus       124 HrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (382)
T cd05625         124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRC  203 (382)
T ss_pred             cCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccc
Confidence            9999999999999999999999986432100                                               00


Q ss_pred             cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       121 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ......|++.|+|||++.+.. ++.++|+||+||++|||++
T Consensus       204 ~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~ellt  243 (382)
T cd05625         204 LAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLV  243 (382)
T ss_pred             cccccccCcccCCHHHhcCCC-CCCeeeEEechHHHHHHHh
Confidence            011246889999999987655 7999999999999999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.5e-34  Score=202.12  Aligned_cols=153  Identities=44%  Similarity=0.895  Sum_probs=133.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ....+.+|+++++.++|+||+++++++..++..++||||+++++.+.+......+++..++.++.|++.++.+||+.+++
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~  122 (287)
T cd07848          43 VKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIV  122 (287)
T ss_pred             chhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            44567899999999999999999999999999999999999877777766666889999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+........ ......|+..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       123 H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~  196 (287)
T cd07848         123 HRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSD  196 (287)
T ss_pred             cCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHh
Confidence            999999999999999999999999876543221 222346788999999987655 6999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4721|consensus

Probab=100.00  E-value=7.4e-35  Score=214.40  Aligned_cols=151  Identities=31%  Similarity=0.516  Sum_probs=132.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      +.+--..++.-|++++|+||+++.++|....+++||||||. |.|...+.... .+.......|..+|+.|+.|||.+.|
T Consensus       155 V~elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~hKI  233 (904)
T KOG4721|consen  155 VRELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHLHKI  233 (904)
T ss_pred             HhhhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHHhhH
Confidence            33444568888999999999999999999999999999998 46666665544 77788889999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|+|.-||++..+..+||+|||-++-.... .....++||..|||||++++.. .+.|.||||+||+||||||
T Consensus       234 IHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT  306 (904)
T KOG4721|consen  234 IHRDLKSPNILISYDDVVKISDFGTSKELSDK-STKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLT  306 (904)
T ss_pred             hhhccCCCceEeeccceEEeccccchHhhhhh-hhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHHHh
Confidence            99999999999999999999999988766644 3345789999999999998865 7999999999999999997

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=209.94  Aligned_cols=150  Identities=29%  Similarity=0.477  Sum_probs=129.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|.++++.++|+||+++++.+.++..+|+||||+++ +|.+++...+ .+++..+..++.|++.|++|||+.|++|
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~ivH  124 (364)
T cd05599          46 AHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKLGYIH  124 (364)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            4567899999999999999999999999999999999985 8888776544 7899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC--------------------------------------cccccccCcc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN--------------------------------------RYTHEVVTLW  130 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--------------------------------------~~~~~~~~~~  130 (163)
                      +||+|+||+++.++.++|+|||++........                                      .....+|++.
T Consensus       125 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  204 (364)
T cd05599         125 RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPD  204 (364)
T ss_pred             ccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCcc
Confidence            99999999999999999999998764321100                                      0012358999


Q ss_pred             ccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       131 ~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|||++.+.. ++.++|+||+||++|+|++
T Consensus       205 y~aPE~~~~~~-~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         205 YIAPEVFLQTG-YNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccCHHHHcCCC-CCCeeeeecchhHHHHhhc
Confidence            99999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=5.5e-34  Score=205.23  Aligned_cols=152  Identities=31%  Similarity=0.438  Sum_probs=131.2

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+..|.++++.+ +|+|++++++++.+++.+|+||||+++ +|.+.+.... .+++..+..++.|++.+++|||+++
T Consensus        38 ~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~~  116 (320)
T cd05590          38 DVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDKG  116 (320)
T ss_pred             HHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345567888888877 699999999999999999999999986 8877776554 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       117 ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~  191 (320)
T cd05590         117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVLLYEMLC  191 (320)
T ss_pred             eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCC-CCCccchhhhHHHHHHHhh
Confidence            99999999999999999999999998865433333344557899999999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=3.8e-34  Score=202.58  Aligned_cols=153  Identities=60%  Similarity=1.093  Sum_probs=135.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++|+|++++++++.+.+..++++||+++++.+.+....+.+++..++.++.|+++++.+||+.+++|
T Consensus        43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H  122 (284)
T cd07839          43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLH  122 (284)
T ss_pred             ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            35677899999999999999999999999999999999999999888776668999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++.++|+|||.+..............++..|+|||.+.+...++.++|+||+|+++|+|+|
T Consensus       123 ~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~t  195 (284)
T cd07839         123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN  195 (284)
T ss_pred             CCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999887655433333344567889999998776657899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=211.04  Aligned_cols=151  Identities=34%  Similarity=0.476  Sum_probs=129.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+||+++++.+.++..+|+||||++| +|.+++... ..+++..+..++.|++.+++|||+.|++
T Consensus        45 ~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~giv  123 (377)
T cd05629          45 LAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFI  123 (377)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34577899999999999999999999999999999999975 888887654 4788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCC--------------C---------------------------------
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPM--------------N---------------------------------  120 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------~---------------------------------  120 (163)
                      |+||||+||+++.++.++++|||++.......              .                                 
T Consensus       124 HrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (377)
T cd05629         124 HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRL  203 (377)
T ss_pred             ccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence            99999999999999999999999885321100              0                                 


Q ss_pred             cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       121 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ......|++.|+|||.+.+.. ++.++|+||+||++|||++
T Consensus       204 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt  243 (377)
T cd05629         204 MAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLI  243 (377)
T ss_pred             cccccCCCccccCHHHHccCC-CCCceeeEecchhhhhhhc
Confidence            001246899999999987654 6999999999999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=4.3e-34  Score=206.48  Aligned_cols=150  Identities=33%  Similarity=0.524  Sum_probs=131.1

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+..|..+++++ +|+||+++++++.+.+.+|+||||+++ +|.+++... ..+++..+..++.|++.++.|||++|++
T Consensus        40 ~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~iv  118 (329)
T cd05588          40 DWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGII  118 (329)
T ss_pred             HHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            4567899999999 799999999999999999999999986 887777654 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..............|+..|+|||++.+.. ++.++|+||+|+++|+|++
T Consensus       119 H~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~  191 (329)
T cd05588         119 YRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMA  191 (329)
T ss_pred             ecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHH
Confidence            999999999999999999999998865333333344567899999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0610|consensus

Probab=100.00  E-value=7.9e-34  Score=201.52  Aligned_cols=152  Identities=33%  Similarity=0.450  Sum_probs=132.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...++..|.+||+.++||+++.+|..|+.+++.|++||||+| +|..++.+++ ..+++..++.++.+++-||+|||..|
T Consensus       120 Kl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG  199 (459)
T KOG0610|consen  120 KLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG  199 (459)
T ss_pred             HHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc
Confidence            345678899999999999999999999999999999999986 8888887765 46899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeeccccccccc---------------------------------C--------------
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTI---------------------------------P--------------  118 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~---------------------------------~--------------  118 (163)
                      |++||+||+||++.++|++.+.||.++.....                                 .              
T Consensus       200 ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~  279 (459)
T KOG0610|consen  200 IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS  279 (459)
T ss_pred             eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence            99999999999999999999999986532210                                 0              


Q ss_pred             ---------CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820         119 ---------MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus       119 ---------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                               ......+.||..|+|||++++++ .+...|+|++|+++||||
T Consensus       280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmL  329 (459)
T KOG0610|consen  280 LPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEML  329 (459)
T ss_pred             chhhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHH
Confidence                     01123457888999999999987 699999999999999998

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.1e-34  Score=211.44  Aligned_cols=151  Identities=32%  Similarity=0.487  Sum_probs=129.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++|+||+++++.+.+++.+++||||+++ +|.+++...+ .+++..+..++.|++.|++|||++|++
T Consensus        45 ~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~~iv  123 (376)
T cd05598          45 AAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKMGFI  123 (376)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45577899999999999999999999999999999999985 8888876644 788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccC-------------------------------------------CCcccc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIP-------------------------------------------MNRYTH  124 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-------------------------------------------~~~~~~  124 (163)
                      |+||||+||+++.++.++|+|||++......                                           ......
T Consensus       124 HrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (376)
T cd05598         124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHS  203 (376)
T ss_pred             eCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccc
Confidence            9999999999999999999999987422100                                           000113


Q ss_pred             cccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       125 ~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ..|++.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       204 ~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell~  239 (376)
T cd05598         204 LVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cCCCccccCHHHHcCCC-CCcceeeeeccceeeehhh
Confidence            46899999999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.1e-33  Score=201.87  Aligned_cols=153  Identities=56%  Similarity=1.026  Sum_probs=135.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++|+||+++++++.+++..++|+||+++++.+.+......+++..+..++.|+++++.+||+.+++|
T Consensus        48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H  127 (301)
T cd07873          48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLH  127 (301)
T ss_pred             hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            34677899999999999999999999999999999999999999988877778899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++++|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|+|
T Consensus       128 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t  200 (301)
T cd07873         128 RDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST  200 (301)
T ss_pred             CCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999887654333333344568889999998765557889999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=206.96  Aligned_cols=149  Identities=34%  Similarity=0.534  Sum_probs=132.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++.++|+||+++++++.+++..|+||||++| +|.+++...+ .+++..+..++.|++.++.+||+.|+
T Consensus        44 ~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i  122 (333)
T cd05600          44 EVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHELGY  122 (333)
T ss_pred             HHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345678899999999999999999999999999999999985 8888876544 78899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++.....   ......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       123 vH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~  193 (333)
T cd05600         123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCMLYEFLC  193 (333)
T ss_pred             cccCCCHHHEEECCCCCEEEEeCcCCccccc---ccCCcccCccccChhHhcCCC-CCCccceecchHHHhhhhh
Confidence            9999999999999999999999998875442   234456899999999987764 7999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.6e-34  Score=209.54  Aligned_cols=151  Identities=32%  Similarity=0.493  Sum_probs=129.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|.+++++++|+||+++++.+.+++.+++||||++| +|.+++.... .+++..+..++.|++.++++||+.|++
T Consensus        45 ~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~giv  123 (381)
T cd05626          45 VAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKMGFI  123 (381)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34578899999999999999999999999999999999985 8888776544 788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCC-----------------------------------------------C
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPM-----------------------------------------------N  120 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------------------------------------------~  120 (163)
                      |+||||+||+++.++.++|+|||++.......                                               .
T Consensus       124 HrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (381)
T cd05626         124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRC  203 (381)
T ss_pred             ecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhcccccccccc
Confidence            99999999999999999999999864321000                                               0


Q ss_pred             cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       121 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ......|++.|+|||.+.+.. ++.++||||+||++|||++
T Consensus       204 ~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~ellt  243 (381)
T cd05626         204 LAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLV  243 (381)
T ss_pred             ccccccCCccccCHHHHcCCC-CCCccceeehhhHHHHHHh
Confidence            012346899999999987654 7999999999999999997

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-33  Score=199.82  Aligned_cols=151  Identities=28%  Similarity=0.440  Sum_probs=131.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      +.+..|++++++++|+|++++.+.+..+...++||||+++ +|.+.+..   ....+++..++.++.|++.++.|||+.+
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  117 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR  117 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4567899999999999999999999999999999999985 77766643   3456899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~  192 (280)
T cd05608         118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIA  192 (280)
T ss_pred             cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHh
Confidence            99999999999999999999999998876544333334456789999999997654 6899999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.4e-34  Score=208.07  Aligned_cols=150  Identities=35%  Similarity=0.501  Sum_probs=131.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++|+||+++++.+.+++.+|+||||+++ +|.+.+.+. ..+++..+..++.|++.++.|||+.|++|
T Consensus        43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  121 (318)
T cd05582          43 VRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIY  121 (318)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            4467899999999999999999999999999999999985 888887654 47899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       122 ~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t  193 (318)
T cd05582         122 RDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLT  193 (318)
T ss_pred             CCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeecc
Confidence            99999999999999999999998876543333344567899999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.1e-34  Score=205.05  Aligned_cols=151  Identities=31%  Similarity=0.442  Sum_probs=130.7

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+..|.++++.+ +|+||+++++++.+++.+|+||||+++ +|...+.... .+++..+..++.|++.|+.|||++|+
T Consensus        39 ~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~i  117 (321)
T cd05591          39 VDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRHGV  117 (321)
T ss_pred             HHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34567899999877 799999999999999999999999986 8877776544 78899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 vHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t  191 (321)
T cd05591         118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMA  191 (321)
T ss_pred             eccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhc
Confidence            9999999999999999999999998875443333344556899999999987654 7999999999999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=9.8e-34  Score=203.62  Aligned_cols=150  Identities=33%  Similarity=0.499  Sum_probs=128.8

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+..|..++... +|+||+++++.+..++.+++||||++| +|.+.+... ..+++..+..++.|++.|+.|||+.+++
T Consensus        40 ~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~iv  118 (316)
T cd05592          40 ECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGII  118 (316)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            4456677777765 799999999999999999999999985 887777654 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       119 H~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~  191 (316)
T cd05592         119 YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLI  191 (316)
T ss_pred             eCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHh
Confidence            999999999999999999999999875433333344557899999999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=6.2e-34  Score=205.81  Aligned_cols=152  Identities=28%  Similarity=0.431  Sum_probs=131.4

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|.++++.+ +|++|+++++.+..++.+++||||+++ +|.+++.... .+++..+..++.|++.++.|||++|+
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i  126 (332)
T cd05614          48 VEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKLGI  126 (332)
T ss_pred             HHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            44577899999999 589999999999999999999999985 8888876544 78899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.++.++|+|||++....... .......|+..|+|||.+.+...++.++|+||+|+++|+|+|
T Consensus       127 vHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ellt  202 (332)
T cd05614         127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLT  202 (332)
T ss_pred             EecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhc
Confidence            999999999999999999999999987543222 222345689999999998765556889999999999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.6e-34  Score=205.54  Aligned_cols=150  Identities=33%  Similarity=0.530  Sum_probs=130.3

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|..++.++ +|+||+++++++.+++.+++||||+++ +|...+... ..+++..++.++.|++.++.|||++|++
T Consensus        40 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~iv  118 (329)
T cd05618          40 DWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGII  118 (329)
T ss_pred             HHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4467888888877 799999999999999999999999985 777776554 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       119 H~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~  191 (329)
T cd05618         119 YRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMA  191 (329)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhh
Confidence            999999999999999999999998865433333344567899999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.4e-33  Score=212.69  Aligned_cols=151  Identities=30%  Similarity=0.519  Sum_probs=131.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+.+|+++++.++||||+++++++..++..|+||||++| +|.+.+..   ....+++..+..++.|++.++.+||+.+
T Consensus       110 ~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~  189 (478)
T PTZ00267        110 AYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK  189 (478)
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4567899999999999999999999999999999999985 88877643   2446889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.++|+|||++........  .....+|++.|+|||++.+.. ++.++|+||+|+++|+|++
T Consensus       190 ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~t  266 (478)
T PTZ00267        190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLT  266 (478)
T ss_pred             EEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCC-CCcHHhHHHHHHHHHHHHh
Confidence            99999999999999999999999999876543221  233456899999999987654 7999999999999999997

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=8.6e-34  Score=204.78  Aligned_cols=151  Identities=32%  Similarity=0.501  Sum_probs=131.2

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|..++.++ +|++++++++++.+.+.+|+||||+++ +|...+... ..+++..++.++.|++.|++|||++|+
T Consensus        39 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i  117 (327)
T cd05617          39 IDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGI  117 (327)
T ss_pred             HHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34577899999998 699999999999999999999999986 787776654 378999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++.............+|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 vHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~  191 (327)
T cd05617         118 IYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMA  191 (327)
T ss_pred             eccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHh
Confidence            9999999999999999999999998865433333344567899999999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-33  Score=200.10  Aligned_cols=150  Identities=30%  Similarity=0.446  Sum_probs=130.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|++++++++|++++++++.+.+++..++|+||+++ +|.+.+... ...+++..+..++.|++.+++|||+.+++
T Consensus        45 ~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii  124 (285)
T cd05631          45 AMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIV  124 (285)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            3567899999999999999999999999999999999985 777776543 34688999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++...... .......|+..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       125 H~dikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~  196 (285)
T cd05631         125 YRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQ  196 (285)
T ss_pred             eCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-CeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHh
Confidence            9999999999999999999999998764322 2223456799999999997654 7999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-33  Score=206.23  Aligned_cols=151  Identities=34%  Similarity=0.540  Sum_probs=133.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .....|+.++++++|+||+++++++..++..++|+|++.+++.+++......+++..++.++.|++.++.|||++|++|+
T Consensus       102 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  181 (357)
T PHA03209        102 GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHR  181 (357)
T ss_pred             cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            44567999999999999999999999999999999999999999988777789999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      ||||+||+++.++.++|+|||.+...... .......|+..|+|||.+.+.. ++.++|+||+|+++|||++.
T Consensus       182 Dlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~  252 (357)
T PHA03209        182 DVKTENIFINDVDQVCIGDLGAAQFPVVA-PAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAY  252 (357)
T ss_pred             CCCHHHEEECCCCCEEEecCccccccccC-cccccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHc
Confidence            99999999999999999999988643321 2223456789999999987654 79999999999999999863

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-33  Score=210.40  Aligned_cols=151  Identities=34%  Similarity=0.459  Sum_probs=133.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ..+.+|++++++++|+||+++++++..++..++++|++.+++..++......+++..++.++.|++.+|.|||++|++|+
T Consensus       205 ~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHr  284 (461)
T PHA03211        205 ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHR  284 (461)
T ss_pred             cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEC
Confidence            45678999999999999999999999999999999999999999987766689999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||+||+++.++.++|+|||++........  ......|+..|++||++.+.. ++.++|||||||++|||++
T Consensus       285 DLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~  357 (461)
T PHA03211        285 DIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAV  357 (461)
T ss_pred             cCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHH
Confidence            9999999999999999999999875432211  122346899999999997754 7999999999999999974

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.8e-33  Score=198.14  Aligned_cols=153  Identities=61%  Similarity=1.092  Sum_probs=133.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|+.++++++|+|++++++++.+++..++||||+++++.+++....  ..+++..++.++.|++.++.|||+.++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i  122 (285)
T cd07861          43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRV  122 (285)
T ss_pred             hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            356788999999999999999999999999999999999988888875433  578999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++|+|||.+.....+........+++.|+|||.+.+...++.++|+||+|+++|+|+|
T Consensus       123 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t  197 (285)
T cd07861         123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT  197 (285)
T ss_pred             eecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999887654333333334557889999998765557899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8e-34  Score=207.93  Aligned_cols=151  Identities=33%  Similarity=0.485  Sum_probs=130.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|..+++.++||||+++++.+.++..+|+||||+++ +|.+++...  .+++..+..++.|++.++++||+++++
T Consensus        87 ~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~~Iv  164 (370)
T cd05621          87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSMGLI  164 (370)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34467899999999999999999999999999999999985 888887643  578889999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCc---CCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAK---VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~---~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.+||+|||++........ ......|++.|+|||.+.+..   .++.++|+||+|+++|+|++
T Consensus       165 HrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~  242 (370)
T cd05621         165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLV  242 (370)
T ss_pred             ecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHh
Confidence            999999999999999999999999876542221 223456899999999986532   36789999999999999996

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.1e-34  Score=208.36  Aligned_cols=151  Identities=28%  Similarity=0.449  Sum_probs=130.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|.+++..++|++++++++.+.+++.+|+||||++| +|.+++...+ .+++..+..++.|++.++.+||+.|++
T Consensus        45 ~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~giv  123 (360)
T cd05627          45 VAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQLGFI  123 (360)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            45677899999999999999999999999999999999986 8888876544 789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-----------------------------------cccccccCcccc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----------------------------------RYTHEVVTLWYR  132 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~  132 (163)
                      |+||||+||+++.++.++|+|||++........                                   .....+|++.|+
T Consensus       124 HrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  203 (360)
T cd05627         124 HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYI  203 (360)
T ss_pred             ccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCcccc
Confidence            999999999999999999999998764321100                                   011346899999


Q ss_pred             CcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         133 PPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       133 ~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |||++.+.. ++.++|+||+||++|+|++
T Consensus       204 APE~~~~~~-~~~~~DiwSlGvilyel~t  231 (360)
T cd05627         204 APEVFMQTG-YNKLCDWWSLGVIMYEMLI  231 (360)
T ss_pred             CHHHHcCCC-CCCcceeccccceeeeccc
Confidence            999987755 7999999999999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.2e-33  Score=203.74  Aligned_cols=149  Identities=34%  Similarity=0.519  Sum_probs=127.2

Q ss_pred             hHHHHHH-HHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          11 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        11 ~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ++..|.. +++.++|+||+++++.+.+.+.+++||||+.+ +|...+... ..+++..+..++.|++.++.|||++|++|
T Consensus        41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~givH  119 (323)
T cd05575          41 HIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSLNIIY  119 (323)
T ss_pred             HHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3444544 45778999999999999999999999999986 887777654 47889999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       120 ~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~  191 (323)
T cd05575         120 RDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLY  191 (323)
T ss_pred             CCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhc
Confidence            99999999999999999999998865433333344557899999999987654 7999999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-33  Score=202.11  Aligned_cols=151  Identities=33%  Similarity=0.469  Sum_probs=130.0

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ......|.+++... +|++++++++.+.+++.+|+||||+.+ +|...+... ..+++..+..++.|++.+++|||++|+
T Consensus        39 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  117 (316)
T cd05620          39 VECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGI  117 (316)
T ss_pred             HHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            34566788888765 899999999999999999999999986 888777654 478899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 vHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~  191 (316)
T cd05620         118 IYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLI  191 (316)
T ss_pred             EecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHh
Confidence            9999999999999999999999998764332333344567899999999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-33  Score=203.49  Aligned_cols=149  Identities=34%  Similarity=0.511  Sum_probs=126.6

Q ss_pred             hHHHHHH-HHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          11 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        11 ~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ++..|.. +++.++|+||+++++.+.+.+..++||||+++ +|...+... ..+++..+..++.|++.++.|||+.|++|
T Consensus        41 ~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivH  119 (321)
T cd05603          41 HIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE-RCFLEPRARFYAAEVASAIGYLHSLNIIY  119 (321)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3444544 57888999999999999999999999999986 777776554 47888999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       120 ~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~  191 (321)
T cd05603         120 RDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLY  191 (321)
T ss_pred             ccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhc
Confidence            99999999999999999999998865433333334456899999999987654 7999999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-33  Score=203.59  Aligned_cols=152  Identities=38%  Similarity=0.753  Sum_probs=128.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC-----cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|++++++++|+||+++++++...     ..+|+||||+++++.+.+.... .+++..+..++.|++.|+.|||+
T Consensus        43 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~  121 (338)
T cd07859          43 ATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHT  121 (338)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHH
Confidence            34578999999999999999999987543     3589999999999988887554 68999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHH
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~l  159 (163)
                      +|++|+||+|+||+++.++.++|+|||.+........   ......|++.|+|||.+.+. ..++.++|+||+|+++|+|
T Consensus       122 ~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el  201 (338)
T cd07859         122 ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEV  201 (338)
T ss_pred             CCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHH
Confidence            9999999999999999999999999999875432211   12334678899999997652 3478999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       202 ~t  203 (338)
T cd07859         202 LT  203 (338)
T ss_pred             Hc
Confidence            97

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=207.43  Aligned_cols=152  Identities=34%  Similarity=0.529  Sum_probs=134.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|.++++.++|+|++++++.+.+++..++||||+++ +|.+++... +.+++..++.++.|++.|+.|||+.|+
T Consensus        44 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gi  122 (350)
T cd05573          44 QIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGF  122 (350)
T ss_pred             HHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            445678899999999999999999999999999999999975 888888766 578999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-----------------------------CcccccccCccccCcccc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-----------------------------NRYTHEVVTLWYRPPEIL  137 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~pe~~  137 (163)
                      +|+||+|+||+++.++.++|+|||.+.......                             .......|++.|+|||.+
T Consensus       123 iH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  202 (350)
T cd05573         123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVL  202 (350)
T ss_pred             eccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHH
Confidence            999999999999999999999999887654332                             123345679999999999


Q ss_pred             cCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         138 LGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       138 ~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .+.. ++.++||||+||++|+|++
T Consensus       203 ~~~~-~~~~~DiwSlG~il~ell~  225 (350)
T cd05573         203 RGTP-YGLECDWWSLGVILYEMLY  225 (350)
T ss_pred             cCCC-CCCceeeEecchhhhhhcc
Confidence            8764 6999999999999999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.8e-33  Score=200.40  Aligned_cols=153  Identities=46%  Similarity=0.910  Sum_probs=128.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee--CcEEEEEecchhccHHHHHhcC--------CCCCCHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQDLKDFLQTT--------PVPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~i~~~l   78 (163)
                      ...+.+|++++++++|+||+++++.+..  +..+++++|++++++.+.+...        ...+++..++.++.|++.|+
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al  121 (317)
T cd07868          42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI  121 (317)
T ss_pred             cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999854  4578999999999888876532        23588999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEE----ccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~----~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      .|||++|++|+||||+||++    +.++.+||+|||.+.......   .......+++.|+|||.+.+...++.++|+||
T Consensus       122 ~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  201 (317)
T cd07868         122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA  201 (317)
T ss_pred             HHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHH
Confidence            99999999999999999999    456789999999987654322   12234567889999999877655799999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +||++|+|++
T Consensus       202 lG~il~el~~  211 (317)
T cd07868         202 IGCIFAELLT  211 (317)
T ss_pred             HHHHHHHHHh
Confidence            9999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0582|consensus

Probab=100.00  E-value=3e-33  Score=200.24  Aligned_cols=153  Identities=33%  Similarity=0.523  Sum_probs=133.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      -+.+.+|+..++.++||||++++..|..+..+|+||+++. |++++.+... +..+++..+..+++++++||.|||++|.
T Consensus        68 ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~  147 (516)
T KOG0582|consen   68 LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGH  147 (516)
T ss_pred             HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCc
Confidence            3567899999999999999999999999999999999998 5888888653 4568999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcc----cccccCccccCccccc-CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----THEVVTLWYRPPEILL-GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~----~~~~~~~~~~~pe~~~-~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|||+|+.||+++.+|.++|.|||.+......+...    ....|++.|++||+++ +..-|+.|+||||+|++..|+.+
T Consensus       148 IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~  227 (516)
T KOG0582|consen  148 IHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAH  227 (516)
T ss_pred             eecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhc
Confidence            999999999999999999999999775554433332    4558899999999954 33348999999999999999875

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-33  Score=197.27  Aligned_cols=152  Identities=53%  Similarity=0.979  Sum_probs=133.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ..+.+|++++++++|+||+++++++.+++..++||||++++|.+++...+..+++..++.++.|+++++.|||+.+++|+
T Consensus        48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~  127 (291)
T cd07844          48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHR  127 (291)
T ss_pred             hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            45678999999999999999999999999999999999999999888776688999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+|+||+++.++.++++|||.+..............++..|+|||...+...++.++|+||+|+++|+|++
T Consensus       128 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~  199 (291)
T cd07844         128 DLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT  199 (291)
T ss_pred             cCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999886554332222333457789999998765557899999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=4.5e-33  Score=200.75  Aligned_cols=152  Identities=28%  Similarity=0.399  Sum_probs=130.2

Q ss_pred             chhhHHHHHHHHhcCCC-CCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+.+..|.+++..+.| ++++++++++.+.+.+|+||||+++ +|.+.+... ..+++..+..++.|++.+++|||++|
T Consensus        43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05587          43 DVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKG  121 (324)
T ss_pred             HHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            34567789999999975 5688999999999999999999985 887777654 37889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|+|
T Consensus       122 ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ellt  196 (324)
T cd05587         122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLA  196 (324)
T ss_pred             eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHh
Confidence            99999999999999999999999998765433333344567899999999987654 6999999999999999996

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.7e-33  Score=203.02  Aligned_cols=148  Identities=33%  Similarity=0.495  Sum_probs=126.1

Q ss_pred             HHHHH-HHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          12 ALREI-SVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        12 ~~~e~-~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      +..|. .+++.++|+||+++++.+.+++.+++||||+++ +|.+.+... ..+++..+..++.|++.++.|||+.|++|+
T Consensus        42 ~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHr  120 (325)
T cd05602          42 IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYR  120 (325)
T ss_pred             HHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence            34443 356778999999999999999999999999986 777777654 467888889999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       121 Dlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~  191 (325)
T cd05602         121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLY  191 (325)
T ss_pred             CCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhc
Confidence            9999999999999999999998865433333344567899999999987654 7899999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-33  Score=202.48  Aligned_cols=152  Identities=30%  Similarity=0.442  Sum_probs=131.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|..+++.++|+||+++++.+.+++.+|+||||++| +|.+++......+++..+..++.|++.+++|||+++++|
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  125 (331)
T cd05597          46 ACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH  125 (331)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEE
Confidence            4477899999999999999999999999999999999975 998888776668899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccC----CcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+........ ......|++.|+|||++..    ...++.++|+||+|+++|+|++
T Consensus       126 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~  203 (331)
T cd05597         126 RDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLY  203 (331)
T ss_pred             CCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhh
Confidence            99999999999999999999998865543222 1223468999999999863    2346889999999999999986

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=3.4e-33  Score=200.99  Aligned_cols=151  Identities=31%  Similarity=0.472  Sum_probs=130.8

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+..|.++++.+ +|+|++++++++.+.+.+++||||+++ +|.+.+... ..+++..+..++.|++.++.|||+.++
T Consensus        39 ~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i  117 (318)
T cd05570          39 VECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGI  117 (318)
T ss_pred             HHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            44567888999888 699999999999999999999999985 787777654 478999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++.............+|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 vH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~  191 (318)
T cd05570         118 IYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLA  191 (318)
T ss_pred             EccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhh
Confidence            9999999999999999999999998865333333334456899999999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.1e-33  Score=200.38  Aligned_cols=151  Identities=34%  Similarity=0.496  Sum_probs=130.1

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ......|.++++.. +||||+++++++.+.+.+++||||+++ +|.+.+... ..+++..+..++.|++.++.|||+.|+
T Consensus        39 ~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i  117 (316)
T cd05619          39 VECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGI  117 (316)
T ss_pred             HHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34566788888765 899999999999999999999999985 888877654 478899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 vHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~  191 (316)
T cd05619         118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLI  191 (316)
T ss_pred             EeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHh
Confidence            9999999999999999999999998865433333344557899999999987654 6999999999999999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=3.6e-33  Score=201.17  Aligned_cols=150  Identities=29%  Similarity=0.409  Sum_probs=129.8

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .....|.+++..+ .|++++++++++.+.+.+++||||+++ +|.+.+.... .+++..+..++.|++.+++|||++|++
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~iv  123 (323)
T cd05616          45 ECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSKGII  123 (323)
T ss_pred             HHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            3466788888888 589999999999999999999999985 8887776543 788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+||++|+|+|
T Consensus       124 HrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt  196 (323)
T cd05616         124 YRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLA  196 (323)
T ss_pred             ecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHh
Confidence            999999999999999999999998865443333344567899999999987654 7999999999999999997

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.8e-33  Score=205.79  Aligned_cols=150  Identities=33%  Similarity=0.459  Sum_probs=131.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ....+|++++++++|+||+++++.+......+++||++.+++.+++.. ...+++..++.++.|++.++.|||++|++|+
T Consensus       131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~LH~~givHr  209 (392)
T PHA03207        131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYLHGRGIIHR  209 (392)
T ss_pred             ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            345789999999999999999999999999999999999999998843 4578999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||+||+++.++.++|+|||++........  ......|++.|+|||++.... ++.++|+||+||++|+|++
T Consensus       210 Dlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~  282 (392)
T PHA03207        210 DVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSV  282 (392)
T ss_pred             CCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHH
Confidence            9999999999999999999999876543222  223456899999999987654 7999999999999999986

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.8e-33  Score=205.16  Aligned_cols=150  Identities=33%  Similarity=0.492  Sum_probs=129.0

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|..+++.++||||+++++.+.++...++||||++| +|.+++...  .+++..+..++.|++.++++||++|++|
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH  165 (371)
T cd05622          88 AFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMGFIH  165 (371)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence            3467899999999999999999999999999999999985 888877643  5788888999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCc---CCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAK---VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~---~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||++....... .......|++.|+|||.+.+..   .++.++|+||+||++|+|++
T Consensus       166 rDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~  242 (371)
T cd05622         166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (371)
T ss_pred             CCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHh
Confidence            9999999999999999999999987654222 1223456899999999986432   26889999999999999996

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-34  Score=205.78  Aligned_cols=150  Identities=33%  Similarity=0.470  Sum_probs=128.6

Q ss_pred             hHHHHHHHHhcC---CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          11 TALREISVLKEL---KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        11 ~~~~e~~~l~~~---~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      +...|..++...   +|++|+++++.+.+...+|+||||+++ +|.+.+... +.+++..+..++.|+++++.|||++|+
T Consensus        39 ~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qil~al~~LH~~~i  117 (330)
T cd05586          39 HTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GRFSEDRAKFYIAELVLALEHLHKYDI  117 (330)
T ss_pred             HHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345567777665   699999999999999999999999985 887777654 478999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++..............|+..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       118 vHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~ellt  192 (330)
T cd05586         118 VYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCC  192 (330)
T ss_pred             EeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEecc
Confidence            999999999999999999999999987544333334456789999999998765557899999999999999986

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-33  Score=203.08  Aligned_cols=149  Identities=34%  Similarity=0.534  Sum_probs=127.2

Q ss_pred             hHHHHHH-HHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          11 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        11 ~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ++..|.. +++.++|+||+++++.+..++..++||||+++ ++...+... ..+++..+..++.|++.++.|||+.|++|
T Consensus        41 ~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~givH  119 (325)
T cd05604          41 HIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE-RSFPEPRARFYAAEIASALGYLHSINIVY  119 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            3445544 46778999999999999999999999999986 777766544 47899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       120 ~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~  191 (325)
T cd05604         120 RDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLY  191 (325)
T ss_pred             cCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhc
Confidence            99999999999999999999998865433333344567899999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.4e-33  Score=200.80  Aligned_cols=149  Identities=27%  Similarity=0.421  Sum_probs=126.7

Q ss_pred             hhHHHHHHHH---hcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820          10 STALREISVL---KELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus        10 ~~~~~e~~~l---~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+.+|.+++   +.++|+||+++++++.+++..|+||||+++ +|...+..  +.+++..+..++.|++.++.|||+.|
T Consensus        44 ~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~  121 (324)
T cd05589          44 ESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENK  121 (324)
T ss_pred             HHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4566666665   456799999999999999999999999986 77666543  46899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       122 ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~  196 (324)
T cd05589         122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLV  196 (324)
T ss_pred             eEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCC-CCcccchhhHHHHHHHHHh
Confidence            99999999999999999999999998765433333344567899999999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=9.6e-33  Score=198.23  Aligned_cols=153  Identities=45%  Similarity=0.909  Sum_probs=128.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeee--eCcEEEEEecchhccHHHHHhcC--------CCCCCHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFLRQDLKDFLQTT--------PVPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~i~~~l   78 (163)
                      ...+.+|++++++++|+|++++++++.  .+..+++++||+++++.+.+...        ...+++..+..++.|++.|+
T Consensus        42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL  121 (317)
T cd07867          42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI  121 (317)
T ss_pred             cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHH
Confidence            346788999999999999999999984  35688999999999888877422        23578899999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEE----ccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~----~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      .|||+.+++|+||+|+||++    +.++.++|+|||++........   ......+++.|+|||.+.+...++.++|+||
T Consensus       122 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwS  201 (317)
T cd07867         122 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA  201 (317)
T ss_pred             HHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHh
Confidence            99999999999999999999    4567899999999876543322   2234466889999999876555789999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +|+++|+|+|
T Consensus       202 lG~il~el~t  211 (317)
T cd07867         202 IGCIFAELLT  211 (317)
T ss_pred             HHHHHHHHHh
Confidence            9999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=9.9e-33  Score=195.03  Aligned_cols=150  Identities=29%  Similarity=0.416  Sum_probs=129.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+..|++++++++|+|++++++.+.++..+++||||++| +|.+.+.... ..+++..+..++.|++.++++||+.|++
T Consensus        38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv  117 (277)
T cd05607          38 KMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIV  117 (277)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence            3456799999999999999999999999999999999985 8877775433 4688999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       118 H~dikp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~  189 (277)
T cd05607         118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDG-KTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVA  189 (277)
T ss_pred             EccCChHhEEEcCCCCEEEeeceeeeecCCC-ceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHh
Confidence            9999999999999999999999988765432 2223456788999999987655 7999999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.7e-32  Score=194.94  Aligned_cols=152  Identities=53%  Similarity=0.945  Sum_probs=132.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ..+.+|+++++.++|+|++++++++..++..++|+|++.+++.+.+......+++..+..++.|++.++.+||+.+++|+
T Consensus        48 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~  127 (291)
T cd07870          48 FTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR  127 (291)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            46778999999999999999999999999999999999989988887666677888889999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+|+||+++.++.++|+|||.+..............++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       128 dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~  199 (291)
T cd07870         128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ  199 (291)
T ss_pred             CCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999886544333333344568889999998764446889999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.8e-33  Score=203.87  Aligned_cols=150  Identities=32%  Similarity=0.496  Sum_probs=128.7

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|..+++.++|+||+++++++.++..+++||||++| +|.+++...  .+++..+..++.|++.|++|||+.|++|
T Consensus        88 ~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~~ivH  165 (370)
T cd05596          88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSMGFIH  165 (370)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            3467899999999999999999999999999999999985 888877543  5788888999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCC---cCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGA---KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~---~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+........ ......|++.|+|||.+.+.   ..++.++|+||+||++|+|++
T Consensus       166 rDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyellt  242 (370)
T cd05596         166 RDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  242 (370)
T ss_pred             cCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHh
Confidence            99999999999999999999999876542221 22345689999999998643   236889999999999999996

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0193|consensus

Probab=100.00  E-value=9.8e-34  Score=208.94  Aligned_cols=153  Identities=22%  Similarity=0.341  Sum_probs=135.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .-+.|.+|+..+++-+|.||+-+.|++...+. .||+-||+| +|+.++......++..+.+.|+.|+++|+.|||.++|
T Consensus       431 qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~I  509 (678)
T KOG0193|consen  431 QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNI  509 (678)
T ss_pred             HHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhh
Confidence            34678999999999999999999999988776 999999998 9999998888899999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|+|..||++.+++.+||.|||++.....-  ........|...|+|||+++.  .-+|+..+||||+|+++|||+|
T Consensus       510 IHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELlt  588 (678)
T KOG0193|consen  510 IHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLT  588 (678)
T ss_pred             hhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHh
Confidence            99999999999999999999999998654422  223344556778999999873  3468999999999999999996

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5e-33  Score=201.15  Aligned_cols=152  Identities=30%  Similarity=0.440  Sum_probs=131.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|..+++.++|++++++++.+.+++.+++||||+++ +|.+++......+++..+..++.|++.++.+||+.+++|
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiH  125 (332)
T cd05623          46 ACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVH  125 (332)
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            3467899999999999999999999999999999999974 999998876668899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccC----CcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.++.++|+|||++........ ......|++.|+|||++..    ...++.++|+||+|+++|||++
T Consensus       126 rDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~  203 (332)
T cd05623         126 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLY  203 (332)
T ss_pred             cCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhc
Confidence            99999999999999999999998865432221 2223568999999999852    3346889999999999999986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.1e-33  Score=202.15  Aligned_cols=152  Identities=28%  Similarity=0.427  Sum_probs=131.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|..+++.++|++|+++++++.+++..|+||||++| +|.+++......+++..+..++.|++.++++||++|++|
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiH  125 (331)
T cd05624          46 ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVH  125 (331)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence            3467889999999999999999999999999999999975 898888776668899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCC----cCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGA----KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~----~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.++.++|+|||++........ ......|++.|+|||.+.+.    ..++.++|+||+|+++|+|++
T Consensus       126 rDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~  203 (331)
T cd05624         126 RDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLY  203 (331)
T ss_pred             ccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhh
Confidence            99999999999999999999999866543222 12234689999999998642    236889999999999999996

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.2e-33  Score=199.10  Aligned_cols=150  Identities=28%  Similarity=0.423  Sum_probs=129.2

Q ss_pred             hhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+..|.++++.+. |++++++++++.+.+.+|+||||+++ +|.+++... +.+++..+..++.|++.|+.|||++|++
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iv  123 (323)
T cd05615          45 ECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGII  123 (323)
T ss_pred             HHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678899998885 57888999999999999999999985 887777654 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       124 HrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ellt  196 (323)
T cd05615         124 YRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLA  196 (323)
T ss_pred             ccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHh
Confidence            999999999999999999999998875443333344556899999999987644 7999999999999999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-33  Score=203.23  Aligned_cols=153  Identities=32%  Similarity=0.435  Sum_probs=132.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|..+++.++|+||+++++++.+++..++||||+++ +|.+++......+++..+..++.|++.++.+||+.+++
T Consensus        45 ~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~  124 (330)
T cd05601          45 VSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYV  124 (330)
T ss_pred             HHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            34577899999999999999999999999999999999975 89998887766899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccC-----CcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLG-----AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~-----~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+........ ......|++.|+|||.+..     ...++.++|+||+|+++|+|++
T Consensus       125 H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~  204 (330)
T cd05601         125 HRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY  204 (330)
T ss_pred             cccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeecc
Confidence            999999999999999999999999876543222 2233467899999999863     2346889999999999999986

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.6e-32  Score=198.89  Aligned_cols=151  Identities=28%  Similarity=0.519  Sum_probs=124.8

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeC-cEEEEEecchhc-cHHHHHhcCC---------------------------
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVD-FKLFLVFEFLRQ-DLKDFLQTTP---------------------------   59 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~~---------------------------   59 (163)
                      ..+.+|+++++++ +|+||+++++++... +.++++|||+++ +|.+++....                           
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (338)
T cd05102          55 KALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVD  134 (338)
T ss_pred             HHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccc
Confidence            4578999999999 899999999988654 468999999985 8888876431                           


Q ss_pred             ----------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceE
Q psy7820          60 ----------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALK  105 (163)
Q Consensus        60 ----------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~  105 (163)
                                                        ..+++..+..++.|++.|++|||++|++|+||||+||+++.++.++
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~k  214 (338)
T cd05102         135 RRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVK  214 (338)
T ss_pred             cccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEE
Confidence                                              2467788899999999999999999999999999999999999999


Q ss_pred             EeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         106 LADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       106 l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|||+++.......  ......++..|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       215 l~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~  271 (338)
T cd05102         215 ICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFS  271 (338)
T ss_pred             EeecccccccccCcchhcccCCCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHh
Confidence            999998875432211  112233457899999987654 6999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.6e-32  Score=196.26  Aligned_cols=151  Identities=28%  Similarity=0.475  Sum_probs=126.7

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC------------------CCCCHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------------------VPVPPALAKSY   70 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------------~~~~~~~~~~~   70 (163)
                      .++.+|++++++++|+||+++++++.+.+..+++|||+++ +|.+++....                  ..+++..+..+
T Consensus        64 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  143 (304)
T cd05096          64 NDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHV  143 (304)
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHH
Confidence            4678999999999999999999999999999999999975 8888875421                  23577788999


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchh
Q psy7820          71 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVD  148 (163)
Q Consensus        71 ~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D  148 (163)
                      +.|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........  ......++..|+|||.+.+.. ++.++|
T Consensus       144 ~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  222 (304)
T cd05096         144 ALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASD  222 (304)
T ss_pred             HHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhh
Confidence            99999999999999999999999999999999999999998875432211  111223467899999987654 799999


Q ss_pred             hHHHHHHHHHHhc
Q psy7820         149 IWSAGCIFSEMIQ  161 (163)
Q Consensus       149 i~slG~~l~~ll~  161 (163)
                      +||+|+++|+|++
T Consensus       223 v~slG~~l~el~~  235 (304)
T cd05096         223 VWAFGVTLWEILM  235 (304)
T ss_pred             hHHHHHHHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.5e-32  Score=192.57  Aligned_cols=153  Identities=46%  Similarity=0.856  Sum_probs=133.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++|+|++++++++..+...++++||+++++++.+......+++..++.++.|++.++.+||+.|++|
T Consensus        44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H  123 (286)
T cd07847          44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH  123 (286)
T ss_pred             cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence            34578899999999999999999999999999999999998766666655567899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++.++|+|||.+..............++..|++||.+.+...++.++|+||+|+++|+|++
T Consensus       124 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~  196 (286)
T cd07847         124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLT  196 (286)
T ss_pred             cCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHh
Confidence            9999999999999999999999987655433223334567789999998765557899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-32  Score=202.00  Aligned_cols=151  Identities=40%  Similarity=0.776  Sum_probs=130.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCc-----EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .++.+|+++++.++|+||+++++++....     ..|+|+||+.+++.+.+... ..+++..+..++.|++.++.|||+.
T Consensus        44 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~  122 (372)
T cd07853          44 KRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSP-QPLSSDHVKVFLYQILRGLKYLHSA  122 (372)
T ss_pred             HHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            46788999999999999999999998776     78999999998888877654 4789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||++....... .......++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       123 ~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  200 (372)
T cd07853         123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLG  200 (372)
T ss_pred             CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHc
Confidence            99999999999999999999999999887543221 222334568889999998776657899999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-32  Score=197.22  Aligned_cols=149  Identities=31%  Similarity=0.509  Sum_probs=130.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i   86 (163)
                      ..++.+|++++++++|+|++++++++..++..++||||+++ +|.+++.... .+++..+..++.+++.++.|||+. ++
T Consensus        47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~i  125 (331)
T cd06649          47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREKHQI  125 (331)
T ss_pred             HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhcCCE
Confidence            45688999999999999999999999999999999999986 8888776544 688999999999999999999986 69


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++......  ......|+..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       126 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~t  197 (331)
T cd06649         126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAI  197 (331)
T ss_pred             EcCCCChhhEEEcCCCcEEEccCccccccccc--ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHh
Confidence            99999999999999999999999988655322  223346789999999987654 7999999999999999986

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0580|consensus

Probab=100.00  E-value=5.1e-34  Score=190.02  Aligned_cols=158  Identities=35%  Similarity=0.580  Sum_probs=142.5

Q ss_pred             CccccCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC-CCCCHHHHHHHHHHHHHHH
Q psy7820           1 SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         1 ~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l   78 (163)
                      |++...+...++.+|+++-..++||||+++|++|.+...+|+++||.+ |+++..+.... ..+++.....++.|++.|+
T Consensus        58 sqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al  137 (281)
T KOG0580|consen   58 SQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANAL  137 (281)
T ss_pred             HHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHH
Confidence            356677888899999999999999999999999999999999999997 68888888543 4688999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      .|+|.++++|+||+|+|++++.+|..|+.|||.+....  .++....|||..|.|||...+.. ++...|+|++|++.||
T Consensus       138 ~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p--~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~ye  214 (281)
T KOG0580|consen  138 LYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP--SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYE  214 (281)
T ss_pred             HHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC--CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHH
Confidence            99999999999999999999999999999999886543  56777889999999999988765 6999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      ++-
T Consensus       215 flv  217 (281)
T KOG0580|consen  215 FLV  217 (281)
T ss_pred             HHh
Confidence            873

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.5e-32  Score=193.90  Aligned_cols=150  Identities=52%  Similarity=0.938  Sum_probs=126.8

Q ss_pred             hhHHHHHHHHhcC---CCCCeeeeeeeee-----eCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKEL---KHPNVIRLHDVIP-----VDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus        10 ~~~~~e~~~l~~~---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ..+.+|+++++.+   +||||+++++++.     ....+++++|++.+++.+++.... ..+++..++.++.|++.|+.|
T Consensus        46 ~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~  125 (290)
T cd07862          46 LSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDF  125 (290)
T ss_pred             HHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHH
Confidence            4566788777766   6999999999875     345689999999999988886543 458899999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          81 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ||++|++|+||+|+||+++.++.++++|||.+...... .......|++.|+|||.+.+.. ++.++|+||+|+++|+|+
T Consensus       126 lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~  203 (290)
T cd07862         126 LHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMF  203 (290)
T ss_pred             HHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-cccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHH
Confidence            99999999999999999999999999999998765432 2233456789999999987654 689999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       204 ~  204 (290)
T cd07862         204 R  204 (290)
T ss_pred             c
Confidence            6

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.2e-32  Score=193.65  Aligned_cols=152  Identities=45%  Similarity=0.866  Sum_probs=133.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|+.++++++|+|++++++++...  +..++++|++++++.+.+......+++..++.++.|++.++.|||+.+++
T Consensus        49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~  128 (293)
T cd07843          49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWIL  128 (293)
T ss_pred             hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3567899999999999999999998877  89999999999999888877666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++++|||.+..............++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       129 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~  202 (293)
T cd07843         129 HRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT  202 (293)
T ss_pred             eccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999887765443333444567889999998765556899999999999999986

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG1095|consensus

Probab=100.00  E-value=3.4e-33  Score=218.68  Aligned_cols=160  Identities=26%  Similarity=0.507  Sum_probs=138.9

Q ss_pred             ccccCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC------CCCCCHHHHHHHHHHH
Q psy7820           2 RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT------PVPVPPALAKSYLYQL   74 (163)
Q Consensus         2 ~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~~i   74 (163)
                      |...++...+|.+|+.+|++++||||++++|++-+.+..+|++||++| +|+.++.+.      +..+...+.+.++.||
T Consensus       732 ~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dv  811 (1025)
T KOG1095|consen  732 RLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDV  811 (1025)
T ss_pred             ccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHH
Confidence            344566778899999999999999999999999999999999999985 999999988      6789999999999999


Q ss_pred             HHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccC-CCccccc-ccCccccCcccccCCcCCCcchhhHHH
Q psy7820          75 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHE-VVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        75 ~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~-~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      ++|+.||+++.++|+||...|+|++....+||.|||+++..... ....... .-...|||||.+++. .++.++||||+
T Consensus       812 A~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~-iFtskSDvWsF  890 (1025)
T KOG1095|consen  812 AKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDG-IFTSKSDVWSF  890 (1025)
T ss_pred             hhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhc-ccccccchhhh
Confidence            99999999999999999999999999999999999999844322 1111111 224689999999874 48999999999


Q ss_pred             HHHHHHHhcC
Q psy7820         153 GCIFSEMIQI  162 (163)
Q Consensus       153 G~~l~~ll~~  162 (163)
                      ||++||++|+
T Consensus       891 GVllWEifsl  900 (1025)
T KOG1095|consen  891 GVLLWEIFSL  900 (1025)
T ss_pred             HHHHHHHHhC
Confidence            9999999984

>KOG0660|consensus

Probab=100.00  E-value=5.9e-33  Score=194.10  Aligned_cols=153  Identities=41%  Similarity=0.756  Sum_probs=133.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeee-----CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ...+..+|+.+|+.++|+||+.+.+++..     -..+|+|+|+++-+|.+.+..+. .++..-+..++.|++.|+.|+|
T Consensus        64 ~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiH  142 (359)
T KOG0660|consen   64 DAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIH  142 (359)
T ss_pred             HHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhh
Confidence            34677899999999999999999999865     33689999999888888877654 5888889999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +.|++|+|+||.|++++.+..+||+|||+++.....  ...++.-..|..|.|||.......|+...||||+||++.||+
T Consensus       143 SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL  222 (359)
T KOG0660|consen  143 SANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEML  222 (359)
T ss_pred             cccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHH
Confidence            999999999999999999999999999999877532  122344455888999999988788999999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       223 ~  223 (359)
T KOG0660|consen  223 T  223 (359)
T ss_pred             c
Confidence            7

>KOG0194|consensus

Probab=100.00  E-value=1.5e-33  Score=207.30  Aligned_cols=153  Identities=31%  Similarity=0.543  Sum_probs=134.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...++++|++++++++|+||+++||+...+..+++|||+|.| +|.+++.+.++.++..+...++.+.+.|++|||++++
T Consensus       204 ~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~  283 (474)
T KOG0194|consen  204 QIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNC  283 (474)
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCC
Confidence            456789999999999999999999999999999999999985 9999999988889999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||-..|++++.++.+||+|||+++............--...|+|||.+... .++.++||||+|+++||+++
T Consensus       284 IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~  357 (474)
T KOG0194|consen  284 IHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFE  357 (474)
T ss_pred             cchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeec
Confidence            999999999999999999999999987654111111111225689999999765 58999999999999999885

>KOG0032|consensus

Probab=100.00  E-value=2.8e-32  Score=198.63  Aligned_cols=149  Identities=35%  Similarity=0.586  Sum_probs=135.7

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|+++|+++. |||++.+++.|++...+++|||+|.| .|++.+...  .+++..+..++.|++.++.|||+.|+
T Consensus        79 ~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gv  156 (382)
T KOG0032|consen   79 REDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGV  156 (382)
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            467889999999998 99999999999999999999999985 999999876  39999999999999999999999999


Q ss_pred             eecCCCCCcEEEccC----CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKS----GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|+||+|+++...    +.++++|||++..... .......+|+++|+|||++.... ++...|+||+|+++|.|++
T Consensus       157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS~Gvi~yiLL~  233 (382)
T KOG0032|consen  157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWSIGVILYILLS  233 (382)
T ss_pred             eeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCC-CCcccchhHHHHHHHHHhh
Confidence            999999999999543    4799999999988775 56677889999999999987644 7999999999999999986

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.2e-32  Score=204.22  Aligned_cols=150  Identities=41%  Similarity=0.706  Sum_probs=125.7

Q ss_pred             hHHHHHHHHhcCCCCCeeeeeeeeeeC--------cEEEEEecchhccHHHHHh---cCCCCCCHHHHHHHHHHHHHHHH
Q psy7820          11 TALREISVLKELKHPNVIRLHDVIPVD--------FKLFLVFEFLRQDLKDFLQ---TTPVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ...+|+.+++.++|+|++++++++...        ..+++||||+++++.+++.   .....+++..++.++.|++.|+.
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~  184 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA  184 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence            445799999999999999999886432        2577999999998877664   34557899999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCC-ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      |||+.|++|+||||+||+++.++ .+||+|||++...... .......|++.|+|||.+.+...++.++|+||+||++|+
T Consensus       185 yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~e  263 (440)
T PTZ00036        185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG-QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAE  263 (440)
T ss_pred             HHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCC-CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHH
Confidence            99999999999999999998765 6999999998765422 223345678999999998765557999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |++
T Consensus       264 llt  266 (440)
T PTZ00036        264 MIL  266 (440)
T ss_pred             HHh
Confidence            996

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-32  Score=189.96  Aligned_cols=154  Identities=31%  Similarity=0.463  Sum_probs=133.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++++++++|+|++++++.+.+++.++++||++++ ++.+++......+++..+..++.|++.++.+||+.++
T Consensus        43 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i  122 (262)
T cd06613          43 DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK  122 (262)
T ss_pred             hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            346688999999999999999999999999999999999986 7877777665688999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCC--cCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............++..|++||...+.  ..++.++|+||+|+++|+|+|
T Consensus       123 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~t  199 (262)
T cd06613         123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAE  199 (262)
T ss_pred             eecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHh
Confidence            999999999999999999999999887655333333445668889999998654  246889999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.9e-32  Score=194.21  Aligned_cols=153  Identities=52%  Similarity=0.900  Sum_probs=133.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+..|++++++++|+|++++++++.++...++|||++.++|.+.+......+++..+..++.|+++++.+||++|++|
T Consensus        46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H  125 (298)
T cd07841          46 NFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILH  125 (298)
T ss_pred             hHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            34567899999999999999999999999999999999977998888765557899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+..............++..|.|||.+.+...++.++|+||+|+++|+|++
T Consensus       126 ~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~  198 (298)
T cd07841         126 RDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL  198 (298)
T ss_pred             cCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc
Confidence            9999999999999999999999987665433333334457789999998665557899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.4e-32  Score=193.71  Aligned_cols=149  Identities=18%  Similarity=0.233  Sum_probs=127.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .+.+.+|++++++++||||+++++++.+    ...++++|||+.+ +|.+.+... ..+++.....++.+++.++.+||+
T Consensus        62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~  140 (283)
T PHA02988         62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYK  140 (283)
T ss_pred             HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHh
Confidence            3567799999999999999999999876    3478999999986 788887664 478889999999999999999998


Q ss_pred             C-CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHHhc
Q psy7820          84 R-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~ll~  161 (163)
                      . +++|+||+|+||+++.++.+|++|||++......   .....++..|+|||.+.+. ..++.++||||+|+++|||++
T Consensus       141 ~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~  217 (283)
T PHA02988        141 YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP---PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFT  217 (283)
T ss_pred             cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc---cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHH
Confidence            4 9999999999999999999999999988754422   2234568899999998652 347999999999999999997

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.2e-32  Score=189.12  Aligned_cols=152  Identities=28%  Similarity=0.461  Sum_probs=129.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+||+++++++..++..++||||+++ +|.+++...+..+++..++.++.|++.++.|||+.+++
T Consensus        37 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~  116 (252)
T cd05084          37 KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCI  116 (252)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            35688999999999999999999999999999999999985 88888876666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+.........  ......+..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       117 H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~  191 (252)
T cd05084         117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFS  191 (252)
T ss_pred             ccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999988654321111  01112245699999986654 6999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.7e-32  Score=190.26  Aligned_cols=154  Identities=27%  Similarity=0.450  Sum_probs=134.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....++.+|++++++++|+|++++++++.+++..++++||+++ +|.+++... ...+++..+..++.+++.++.+||+.
T Consensus        41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~  120 (256)
T cd08529          41 REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK  120 (256)
T ss_pred             HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3456678899999999999999999999999999999999975 888888664 45788999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+|++|+||+++.++.++++|||.+..............++..|+|||+..+.. ++.++|+||+|+++++|++
T Consensus       121 ~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  196 (256)
T cd08529         121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCT  196 (256)
T ss_pred             CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHh
Confidence            999999999999999999999999998876654433334456788999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-32  Score=193.42  Aligned_cols=150  Identities=29%  Similarity=0.453  Sum_probs=129.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|+++++.++|+||+++++.+.+++..++||||+++ +|.+.+... ...+++..+..++.|++.+++|||+.|++
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  124 (285)
T cd05605          45 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIV  124 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            4467899999999999999999999999999999999985 787776543 34689999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+...... .......|+..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       125 H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~  196 (285)
T cd05605         125 YRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIE  196 (285)
T ss_pred             ecCCCHHHEEECCCCCEEEeeCCCceecCCC-CccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHH
Confidence            9999999999999999999999988654321 2223456789999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-32  Score=192.83  Aligned_cols=154  Identities=32%  Similarity=0.503  Sum_probs=133.3

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+++.+|++++++++|+|++++++.+..+...++||||+++ ++.+++......+++..++.++.|++.++.+||+.++
T Consensus        45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i  124 (280)
T cd06611          45 ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKV  124 (280)
T ss_pred             HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345678899999999999999999999999999999999986 8888877766679999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............++..|++||.+..    ...++.++|+||+|+++|+|++
T Consensus       125 ~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~  203 (280)
T cd06611         125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQ  203 (280)
T ss_pred             ccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHh
Confidence            99999999999999999999999987665433333344567889999999742    2346789999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.2e-32  Score=190.90  Aligned_cols=153  Identities=33%  Similarity=0.537  Sum_probs=130.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|+++++.++|+|++++++.+..++..++++||+++ ++...+......+++..+..++.|++.++.+||+.|++
T Consensus        46 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~  125 (282)
T cd06643          46 LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKII  125 (282)
T ss_pred             HHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34678899999999999999999999999999999999986 66666665556789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc----CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||++..............++..|+|||.+.    ....++.++|+||+|+++|+|++
T Consensus       126 H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~  203 (282)
T cd06643         126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQ  203 (282)
T ss_pred             ecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHcc
Confidence            999999999999999999999998876543333333456788999999974    22336789999999999999986

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6e-32  Score=192.19  Aligned_cols=153  Identities=32%  Similarity=0.500  Sum_probs=130.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+.+++.++|+|++++++.+..++..++||||+++ ++...+.+....+++..+..++.|++.++.+||+.+++
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~  132 (292)
T cd06644          53 LEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKII  132 (292)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCee
Confidence            35677899999999999999999999999999999999986 66666665556789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++|+|||.+..............++..|++||.+.+    ...++.++|+||+|+++|+|++
T Consensus       133 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~  210 (292)
T cd06644         133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ  210 (292)
T ss_pred             ecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhc
Confidence            9999999999999999999999987654433333344566888999999742    2346889999999999999996

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-32  Score=206.60  Aligned_cols=152  Identities=29%  Similarity=0.470  Sum_probs=129.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP----VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...+.+|++++++++|+||+++++++..++..|++++++.+++..++....    .......+..++.|++.+|.|||++
T Consensus       207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~  286 (501)
T PHA03210        207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK  286 (501)
T ss_pred             HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence            345778999999999999999999999999999999999988888875432    2234566778999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||||+||+++.++.++|+|||++........ ......|+..|++||.+.+.. ++.++||||+||++|||++
T Consensus       287 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~  363 (501)
T PHA03210        287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLS  363 (501)
T ss_pred             CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999876543222 223457899999999987754 7999999999999999996

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.8e-32  Score=190.95  Aligned_cols=151  Identities=21%  Similarity=0.345  Sum_probs=128.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|+.++++++|+|++++++++..++..++||||+++ +|.+++......+++..++.++.|++.++++||+++++|
T Consensus        51 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH  130 (266)
T cd05064          51 RGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVH  130 (266)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            4678999999999999999999999999999999999986 788788776668899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++++|||.+........ ......++..|+|||...+.. ++.++|+||+|+++||+++
T Consensus       131 ~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~  203 (266)
T cd05064         131 KGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVMWEVMS  203 (266)
T ss_pred             ccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHHHHHhc
Confidence            99999999999999999999997654321111 111222356799999987644 6999999999999999774

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5e-32  Score=190.19  Aligned_cols=151  Identities=29%  Similarity=0.472  Sum_probs=130.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|+.+++.++|+|++++++.+..++.+++++||+++ +|.+.+... +.+++..++.++.|++.++.|||+.|++|
T Consensus        51 ~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H  129 (267)
T cd06645          51 AVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMH  129 (267)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            4567899999999999999999999999999999999986 887776544 47899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc--CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++.++++|||.+..............|+..|+|||.+.  ....++.++|+||+|+++|+|++
T Consensus       130 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~  204 (267)
T cd06645         130 RDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAE  204 (267)
T ss_pred             CCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhc
Confidence            99999999999999999999998876544333344557789999999974  22346889999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4e-32  Score=198.31  Aligned_cols=149  Identities=38%  Similarity=0.658  Sum_probs=127.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ...++.+|+.+++.++|+||+++++++...+      .+|+||||+++++.+.+..   .+++..+..++.|++.++.||
T Consensus        63 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~L  139 (359)
T cd07876          63 HAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKHL  139 (359)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHHH
Confidence            3456778999999999999999999986543      5799999999988877643   578888999999999999999


Q ss_pred             HhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          82 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+.|++|+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       140 H~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~t  217 (359)
T cd07876         140 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVK  217 (359)
T ss_pred             HhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC-ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHh
Confidence            9999999999999999999999999999988654321 2233456788999999987654 7999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.6e-32  Score=195.77  Aligned_cols=149  Identities=31%  Similarity=0.512  Sum_probs=129.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i   86 (163)
                      ..++.+|++++++++|+||+++++++.+++.+++||||+++ +|.+++...+ .+++..+..++.+++.++.|||+. ++
T Consensus        47 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~~~i  125 (333)
T cd06650          47 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKI  125 (333)
T ss_pred             HHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcCCE
Confidence            35688999999999999999999999999999999999985 8888876543 688999999999999999999975 79


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++......  ......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       126 vH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~  197 (333)
T cd06650         126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAI  197 (333)
T ss_pred             EecCCChhhEEEcCCCCEEEeeCCcchhhhhh--ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999988654322  122345788999999987654 6899999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4e-32  Score=192.26  Aligned_cols=153  Identities=67%  Similarity=1.166  Sum_probs=133.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++|+|++++++++.+++..+++|||+.+++..++... ...+++..+..++.+++.++.|||+.+++
T Consensus        43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~  122 (284)
T cd07860          43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL  122 (284)
T ss_pred             chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            35688999999999999999999999999999999999988888887654 35789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+..............++..|+|||...+...++.++|+||+|+++|+|+|
T Consensus       123 H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t  196 (284)
T cd07860         123 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT  196 (284)
T ss_pred             cCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999887654333333334557889999998765556889999999999999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.7e-32  Score=198.08  Aligned_cols=148  Identities=32%  Similarity=0.530  Sum_probs=124.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+||+++++++.+++.+++||||+.+ +|.+.     ...++..+..++.|++.++.|||++|++
T Consensus       116 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~iv  190 (353)
T PLN00034        116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIV  190 (353)
T ss_pred             HHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            35678999999999999999999999999999999999986 55331     2456777888999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCC----cCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA----KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~----~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..............|+..|++||.+...    ...+.++||||||+++|||++
T Consensus       191 HrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~  268 (353)
T PLN00034        191 HRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL  268 (353)
T ss_pred             ecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHh
Confidence            99999999999999999999999987654333333445789999999987431    223568999999999999986

>KOG0986|consensus

Probab=100.00  E-value=1.1e-32  Score=197.96  Aligned_cols=158  Identities=29%  Similarity=0.457  Sum_probs=140.5

Q ss_pred             ccccCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHH
Q psy7820           2 RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         2 ~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ||++.+-..-.++|.++|++++.++||.+-..|++.+.+++|+..+.| +|..++.+.+ ..+++..+..++.+|+-|++
T Consensus       222 RiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLe  301 (591)
T KOG0986|consen  222 RIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLE  301 (591)
T ss_pred             HHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHH
Confidence            344555555678999999999999999999999999999999999975 8888887765 46899999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      +||+.+|+++|+||+||++|+.|+++|+|+|++..+... ...+...||.+|||||++.+.. |+.+.|+|||||++|||
T Consensus       302 hlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g-~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYem  379 (591)
T KOG0986|consen  302 HLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG-KPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEM  379 (591)
T ss_pred             HHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC-CccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHH
Confidence            999999999999999999999999999999999877643 3445568999999999998876 89999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      +.
T Consensus       380 i~  381 (591)
T KOG0986|consen  380 IA  381 (591)
T ss_pred             Hc
Confidence            85

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.9e-32  Score=188.27  Aligned_cols=151  Identities=25%  Similarity=0.416  Sum_probs=127.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++|+||+++++++.. ...++||||+++ +|.+++......+++..++.++.|++.++.+||++|++
T Consensus        39 ~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  117 (257)
T cd05115          39 RDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV  117 (257)
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCee
Confidence            3568899999999999999999998864 578999999985 88888876666889999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++++|||.+.........   .....++..|+|||...... ++.++|+||+|+++|++++
T Consensus       118 H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~  193 (257)
T cd05115         118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFS  193 (257)
T ss_pred             ecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhc
Confidence            9999999999999999999999988754432211   11112246799999986544 6899999999999999985

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.1e-31  Score=187.22  Aligned_cols=152  Identities=32%  Similarity=0.539  Sum_probs=135.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+|++++++.+.++...++++|++++ +|.+.+......+++..+..++.+++.++.+||+.+++
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~  121 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI  121 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            56788999999999999999999999999999999999986 88888876666889999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+..............++..|++||.+.+.. ++.++|+||+|+++|+|++
T Consensus       122 H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~il~~l~~  194 (256)
T cd06612         122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGITAIEMAE  194 (256)
T ss_pred             cCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999998876654433344455788999999987654 6899999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.5e-32  Score=188.23  Aligned_cols=152  Identities=26%  Similarity=0.483  Sum_probs=130.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++..+...+++||++.+ ++.+++......+++..++.++.|++.++.+||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05113          43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI  122 (256)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            35688999999999999999999999998899999999975 88888876555789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|.||+++.++.++++|||.+........ ......++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       123 H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~  196 (256)
T cd05113         123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYS  196 (256)
T ss_pred             ccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhc
Confidence            999999999999999999999998765432211 111223356799999987644 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG4717|consensus

Probab=100.00  E-value=3.3e-32  Score=198.79  Aligned_cols=152  Identities=38%  Similarity=0.688  Sum_probs=140.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++.|+.++|||||++|++..++-.+|+|+|.-.+ +|++++-++...+.+..+.+++.||+.++.|+|+.-++
T Consensus        61 t~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVV  140 (864)
T KOG4717|consen   61 TGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVV  140 (864)
T ss_pred             hhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhh
Confidence            35678999999999999999999999999999999998874 99999999998999999999999999999999999999


Q ss_pred             ecCCCCCcEEEcc-CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|+||+|+++.+ -|-+|+.|||++..+. ++......||+..|-|||.+.+..+..+..|||||||+||-+++
T Consensus       141 HRDLKPENVVFFEKlGlVKLTDFGFSNkf~-PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC  214 (864)
T KOG4717|consen  141 HRDLKPENVVFFEKLGLVKLTDFGFSNKFQ-PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC  214 (864)
T ss_pred             cccCCcceeEEeeecCceEeeeccccccCC-CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh
Confidence            9999999998865 4889999999988765 67888899999999999999998877899999999999998774

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1e-31  Score=190.14  Aligned_cols=153  Identities=60%  Similarity=1.107  Sum_probs=133.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|++++++++|+|++++++++.+.+..++|+|++++++.+++....  ..+++..+..++.|++.++.+||+.|+
T Consensus        42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  121 (284)
T cd07836          42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV  121 (284)
T ss_pred             hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            456778999999999999999999999999999999999999888876544  468999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............++..|++||.+.+...++.++|+||+|+++|+|++
T Consensus       122 ~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~  196 (284)
T cd07836         122 LHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT  196 (284)
T ss_pred             eeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999887554333333344567889999998665556899999999999999986

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-31  Score=187.16  Aligned_cols=152  Identities=26%  Similarity=0.452  Sum_probs=129.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+++++.++|+|++++++++...+..++++|++++ +|.+++....+.+++..++.++.|++.++.+||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~  122 (256)
T cd05059          43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35688999999999999999999999999999999999975 89998877666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcc-cccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+.......... ....++..|+|||...+.. ++.++|+||+|+++|++++
T Consensus       123 H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~  196 (256)
T cd05059         123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFS  196 (256)
T ss_pred             cccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhc
Confidence            99999999999999999999999886543221111 1112245799999987654 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.1e-31  Score=189.98  Aligned_cols=154  Identities=46%  Similarity=0.886  Sum_probs=135.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ....+.+|+.++++++|+|++++++++.++...++|+|++.++|.+.+......+++..++.++.|++.++.+||+.|++
T Consensus        42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  121 (286)
T cd07832          42 IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIM  121 (286)
T ss_pred             hhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            35678899999999999999999999999999999999996699998877667899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+........ ......++..|+|||.+.+...++.++|+||+|+++++|++
T Consensus       122 H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~t  196 (286)
T cd07832         122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN  196 (286)
T ss_pred             cCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHc
Confidence            999999999999999999999998876543321 12334568889999998766657899999999999999986

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.98  E-value=1.4e-31  Score=186.97  Aligned_cols=152  Identities=26%  Similarity=0.478  Sum_probs=130.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+|++++++++..++..+++|||+++ +|.+.+....+.+++..+..++.+++.++++||+.|++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  122 (256)
T cd05114          43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI  122 (256)
T ss_pred             HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45788999999999999999999999999999999999985 88888876556789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+......... .....++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       123 H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~l~el~~  196 (256)
T cd05114         123 HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFT  196 (256)
T ss_pred             ccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCc-cchhhhhHHHHHHHHHHHc
Confidence            9999999999999999999999988654322111 11223356799999987654 6899999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.98  E-value=1.3e-31  Score=186.94  Aligned_cols=152  Identities=33%  Similarity=0.572  Sum_probs=133.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|++++++++|+|++++++++.+++..+++|||+++ +|.+.+... +..+++..+..++.+++.++.+||+.|+
T Consensus        43 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  122 (256)
T cd08221          43 RRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45688999999999999999999999999999999999985 999888765 4568999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............+++.|.|||...+.. ++.++|+||+|+++|+|++
T Consensus       123 ~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~  196 (256)
T cd08221         123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLT  196 (256)
T ss_pred             cccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHH
Confidence            9999999999999999999999998876554333334456788999999987655 6899999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=1.2e-31  Score=188.10  Aligned_cols=147  Identities=23%  Similarity=0.340  Sum_probs=125.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|+.+++.++||||+++++++..+...+++||++++ ++..++....+.+++..++.++.|++++++|||+++++|
T Consensus        49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  128 (262)
T cd05077          49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVH  128 (262)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeEC
Confidence            3567889999999999999999999998899999999986 666666655667899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCc-------eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          89 RDLKPQNILINKSGA-------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~-------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +||+|+||+++.++.       ++++|||.+.....    .....++..|+|||.+.+...++.++||||+|+++|+|+
T Consensus       129 ~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~  203 (262)
T cd05077         129 GNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEIC  203 (262)
T ss_pred             CCCCcccEEEecCCccCCCCceeEeCCCCCCccccC----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHH
Confidence            999999999987664       89999998755431    123345778999999875455799999999999999997

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.98  E-value=1.8e-31  Score=189.84  Aligned_cols=153  Identities=61%  Similarity=1.127  Sum_probs=130.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|++++++++|+|++++++++.++...++|+||+++++.+.+..... ..++..+..++.|++.++.+||+++++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~  124 (294)
T PLN00009         45 PSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVL  124 (294)
T ss_pred             hHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            4567899999999999999999999999999999999999888888765443 367888889999999999999999999


Q ss_pred             ecCCCCCcEEEcc-CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++. ++.++++|||.+..............++..|+|||.+.+...++.++|+||+|+++|+|+|
T Consensus       125 H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~t  199 (294)
T PLN00009        125 HRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN  199 (294)
T ss_pred             CCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999985 4578999999987654333333334557889999998765557899999999999999987

>KOG0586|consensus

Probab=99.98  E-value=1.8e-32  Score=202.31  Aligned_cols=149  Identities=34%  Similarity=0.608  Sum_probs=137.5

Q ss_pred             hHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          11 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .+-+|+++++.++||||++++++.+.+..+|+||||+.+ .+++++.+.+ ...+..+..++.|++++++|||+++++|+
T Consensus       101 k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g-r~~e~~ar~~F~q~vsaveYcH~k~ivHr  179 (596)
T KOG0586|consen  101 KLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG-RMKEKEARAKFRQIVSAVEYCHSKNIVHR  179 (596)
T ss_pred             HHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc-cchhhhhhhhhHHHHHHHHHHhhcceecc
Confidence            367899999999999999999999999999999999975 8888888766 66678999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|++++.+.++||+|||++..+. .......+||++.|.|||++.+.+...+..|+||+|+++|-|+.
T Consensus       180 dLk~eNilL~~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~  250 (596)
T KOG0586|consen  180 DLKAENILLDENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVE  250 (596)
T ss_pred             ccchhhcccccccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeee
Confidence            999999999999999999999998877 55667889999999999999988878899999999999999874

>KOG1026|consensus

Probab=99.98  E-value=2.3e-32  Score=208.05  Aligned_cols=153  Identities=31%  Similarity=0.559  Sum_probs=133.6

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC---------C----CCCHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------V----PVPPALAKSYLYQ   73 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------~----~~~~~~~~~~~~~   73 (163)
                      ...+|.+|++++..++|+|||+++|+|..++..++|+||+. |+|..++....         +    +++..+.+.++.|
T Consensus       532 ~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~Q  611 (774)
T KOG1026|consen  532 ARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQ  611 (774)
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHH
Confidence            56789999999999999999999999999999999999997 79999996432         2    3888999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccC-CCccc-ccccCccccCcccccCCcCCCcchhhHH
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYT-HEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~-~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      |+.|++||.++-++|+|+-+.|.+++++-.+||.|||+++..... ..+.. ...-..+|||||.+...+ |+.+|||||
T Consensus       612 IAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs  690 (774)
T KOG1026|consen  612 IAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWS  690 (774)
T ss_pred             HHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhh
Confidence            999999999999999999999999999999999999999865421 22222 223367899999998766 799999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +||+|||+++
T Consensus       691 ~GVvLWEIFs  700 (774)
T KOG1026|consen  691 FGVVLWEIFS  700 (774)
T ss_pred             hhhhhhhhhc
Confidence            9999999987

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.98  E-value=1.6e-31  Score=187.10  Aligned_cols=150  Identities=31%  Similarity=0.552  Sum_probs=129.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|++++++++|+|++++++++.+++..++++|++++ ++.+.+... +.+++..+..++.+++.++.+||+.|++|
T Consensus        49 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H  127 (263)
T cd06625          49 NALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVH  127 (263)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            4578899999999999999999999999999999999986 787777654 36888999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcc---cccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+..........   ....++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       128 ~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~  202 (263)
T cd06625         128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLT  202 (263)
T ss_pred             CCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHh
Confidence            9999999999999999999999886543221111   2345678899999998755 6999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.98  E-value=9.2e-32  Score=197.45  Aligned_cols=151  Identities=26%  Similarity=0.456  Sum_probs=127.0

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC----------------------------
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----------------------------   59 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------------   59 (163)
                      +.+.+|+++++.+ +||||+++++++.+++..++||||+++ +|.+++....                            
T Consensus        83 ~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (375)
T cd05104          83 EALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSC  162 (375)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccc
Confidence            4578899999999 899999999999999999999999985 8888875422                            


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7820          60 ----------------------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKP   93 (163)
Q Consensus        60 ----------------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~   93 (163)
                                                                    ..+++..+..++.|++.++.|||+.+++|+||||
T Consensus       163 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  242 (375)
T cd05104         163 DSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAA  242 (375)
T ss_pred             hhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCch
Confidence                                                          2467888999999999999999999999999999


Q ss_pred             CcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          94 QNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        94 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+++.++.++++|||++.........  .....++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       243 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt  311 (375)
T cd05104         243 RNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFS  311 (375)
T ss_pred             hhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHh
Confidence            9999999999999999998755422211  11122355799999987654 7999999999999999986

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.98  E-value=1.5e-31  Score=189.29  Aligned_cols=152  Identities=28%  Similarity=0.501  Sum_probs=128.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      ..++.+|++++++++|+|++++++++...+..++++||+++ +|.+++....               ..+++..++.++.
T Consensus        52 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  131 (283)
T cd05048          52 QQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI  131 (283)
T ss_pred             HHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHH
Confidence            34578899999999999999999999999999999999985 8888886532               3578889999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      |++.++.+||+.+++|+||+|+||+++.++.++|+|||++.......  .......+++.|+|||.+.+.. ++.++|+|
T Consensus       132 ~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~  210 (283)
T cd05048         132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIW  210 (283)
T ss_pred             HHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHH
Confidence            99999999999999999999999999999999999999886543221  1122334567899999987654 69999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|||++
T Consensus       211 slG~il~el~~  221 (283)
T cd05048         211 SFGVVLWEIFS  221 (283)
T ss_pred             HHHHHHHHHHc
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.98  E-value=1.3e-31  Score=186.94  Aligned_cols=152  Identities=30%  Similarity=0.529  Sum_probs=133.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC--------CCCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT--------PVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--------~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ..++.+|++.++.++|+|++++++++.+++.++++||+++ ++|.+++...        ...+++..+..++.+++.++.
T Consensus        40 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~  119 (262)
T cd00192          40 RKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME  119 (262)
T ss_pred             HHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHH
Confidence            4677899999999999999999999999999999999996 5999988776        468899999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      +||+++++|+||+|+||+++.++.++++|||.+.......  .......++..|+|||.+.... ++.++|+||+|+++|
T Consensus       120 ~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  198 (262)
T cd00192         120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLW  198 (262)
T ss_pred             HHHcCCcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCC-cchhhccHHHHHHHH
Confidence            9999999999999999999999999999999887665332  2233345577899999987654 699999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       199 ~l~~  202 (262)
T cd00192         199 EIFT  202 (262)
T ss_pred             HHHh
Confidence            9986

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.98  E-value=1.9e-31  Score=188.95  Aligned_cols=154  Identities=45%  Similarity=0.908  Sum_probs=134.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ....+.+|++++++++|+|++++++++..++..++++||+++++.+.+......+++..+..++.+++.++.+||+.+++
T Consensus        43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  122 (288)
T cd07833          43 VKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNII  122 (288)
T ss_pred             chhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            44678899999999999999999999999999999999999877777666666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+........ ......++..|+|||...+...++.++|+||+|+++|+|++
T Consensus       123 H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~  197 (288)
T cd07833         123 HRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLD  197 (288)
T ss_pred             cCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999998876554332 22344567889999998876457999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.98  E-value=8.5e-32  Score=197.54  Aligned_cols=151  Identities=23%  Similarity=0.440  Sum_probs=126.3

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC----------------------------
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----------------------------   59 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------------   59 (163)
                      +.+.+|+++++.+ +|+||+++++.+.+++..++||||+++ +|.+++....                            
T Consensus        86 ~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (374)
T cd05106          86 EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK  165 (374)
T ss_pred             HHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcc
Confidence            4578899999999 899999999999999999999999985 8888874321                            


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEE
Q psy7820          60 -----------------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI   98 (163)
Q Consensus        60 -----------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~   98 (163)
                                                               ..+++..+..++.|++.++.|||++|++|+||+|+||++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~  245 (374)
T cd05106         166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL  245 (374)
T ss_pred             cccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE
Confidence                                                     246788899999999999999999999999999999999


Q ss_pred             ccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          99 NKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        99 ~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.++.++|+|||++.........  .....++..|+|||++.+.. ++.++|+||+|+++|+|++
T Consensus       246 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt  309 (374)
T cd05106         246 TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFS  309 (374)
T ss_pred             eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHh
Confidence            99999999999998654322111  11122356799999987644 7999999999999999985

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.98  E-value=5.7e-32  Score=189.50  Aligned_cols=152  Identities=35%  Similarity=0.615  Sum_probs=128.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|++.+++++|+||+++++++...+..++|+|+++ |+|.+++... ...+++..+..++.|++.|+.|||++++
T Consensus        45 ~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~i  124 (259)
T PF07714_consen   45 EEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNI  124 (259)
T ss_dssp             HHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             ceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4678999999999999999999999998888999999998 5999999887 6688999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+++++.||+++.++.+||+|||++.......  ...........|+|||.+.+.. ++.++||||+|+++||+++
T Consensus       125 iH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~  200 (259)
T PF07714_consen  125 IHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILT  200 (259)
T ss_dssp             EEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccc
Confidence            999999999999999999999999887663211  1122234467899999987755 6999999999999999997

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.98  E-value=1.3e-31  Score=189.47  Aligned_cols=154  Identities=66%  Similarity=1.191  Sum_probs=133.3

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++.++|+|++++++++.+++..++++||+++++.+++.... ..+++..++.++.|++.++.+||+.++
T Consensus        41 ~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~  120 (283)
T cd07835          41 VPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV  120 (283)
T ss_pred             chhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            3456889999999999999999999999999999999999888888876544 468999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       121 ~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~  195 (283)
T cd07835         121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN  195 (283)
T ss_pred             eCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999986554332222333457889999988765557899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.98  E-value=6.9e-32  Score=196.77  Aligned_cols=148  Identities=39%  Similarity=0.674  Sum_probs=127.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+.+++.++|+||+++++++...      ...+++||++++++.+.+..   .+++..+..++.|++.|+.|||
T Consensus        60 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH  136 (355)
T cd07874          60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  136 (355)
T ss_pred             HHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH
Confidence            35677899999999999999999988643      35799999999988887753   5788889999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|++|+||||+||+++.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       137 ~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~  213 (355)
T cd07874         137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR  213 (355)
T ss_pred             hCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc-cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999998765432 2233456789999999987654 6999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.98  E-value=8.1e-32  Score=190.78  Aligned_cols=153  Identities=43%  Similarity=0.861  Sum_probs=131.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|+++++.++|+|++++++++.+++..++|+||+++++++.+......+++..++.++.|++.++.|||+.+++|
T Consensus        44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h  123 (286)
T cd07846          44 KKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIH  123 (286)
T ss_pred             hHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            45678899999999999999999999999999999999998655555544556899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++.++++|||.+..............++..|++||...+...++.++|+||+|+++|+|++
T Consensus       124 ~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~  196 (286)
T cd07846         124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT  196 (286)
T ss_pred             cCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHc
Confidence            9999999999999999999999887654333333334567889999998765556889999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.98  E-value=1.8e-31  Score=191.12  Aligned_cols=152  Identities=45%  Similarity=0.878  Sum_probs=131.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|++++++++|+|++++++++...  +.+++|+|++++++.+.+......+++..+..++.|++.++.+||+.|++
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~  130 (309)
T cd07845          51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFII  130 (309)
T ss_pred             chhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3466899999999999999999998654  57899999999988888877666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       131 H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  204 (309)
T cd07845         131 HRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLA  204 (309)
T ss_pred             cCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHh
Confidence            99999999999999999999999987665433333333457789999998765557899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.98  E-value=2.3e-31  Score=189.23  Aligned_cols=151  Identities=27%  Similarity=0.471  Sum_probs=129.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLYQ   73 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~~   73 (163)
                      ..+.+|++++++++|+|++++++++..++..++||||+++ +|.+++....               +.+++..++.++.|
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  131 (291)
T cd05094          52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ  131 (291)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHH
Confidence            4678999999999999999999999999999999999975 8888886432               34788999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      ++.++++||+++++|+||+|.||+++.++.++++|||.+........  ......++..|+|||.+.+.. ++.++|+||
T Consensus       132 i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s  210 (291)
T cd05094         132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWS  210 (291)
T ss_pred             HHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHH
Confidence            99999999999999999999999999999999999998865442211  112234467899999987654 689999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +|+++|+|+|
T Consensus       211 lG~il~el~t  220 (291)
T cd05094         211 FGVILWEIFT  220 (291)
T ss_pred             HHHHHHHHHh
Confidence            9999999987

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0662|consensus

Probab=99.98  E-value=2.6e-32  Score=176.02  Aligned_cols=157  Identities=61%  Similarity=1.089  Sum_probs=144.5

Q ss_pred             cCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           5 VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         5 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .++.++...+|+-+++.++|.||+++++....+..+-+|+|+|.++|..+...-++.++.+.+..++.|+++++.++|++
T Consensus        41 degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh  120 (292)
T KOG0662|consen   41 DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH  120 (292)
T ss_pred             CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh
Confidence            36778899999999999999999999999999999999999999999999888888999999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++.|+|+||.|.+++.+|..|+.|||+++.++.+..-......|..|.||.++.+.+.|+.+.|+||-||++.|+.+
T Consensus       121 nvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelan  197 (292)
T KOG0662|consen  121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN  197 (292)
T ss_pred             hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhh
Confidence            99999999999999999999999999999988775444344558889999999999999999999999999999863

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.98  E-value=1e-31  Score=196.54  Aligned_cols=148  Identities=39%  Similarity=0.672  Sum_probs=127.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+.+++.++|+||+++++++...      ..+|+||||+++++.+.+..   .+++..+..++.|++.|+.+||
T Consensus        67 ~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH  143 (364)
T cd07875          67 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  143 (364)
T ss_pred             HHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHHHh
Confidence            45677899999999999999999987543      35799999999988887753   5788889999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||+|+||+++.++.++|+|||++...... .......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       144 ~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~  220 (364)
T cd07875         144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK  220 (364)
T ss_pred             hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC-CcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHh
Confidence            999999999999999999999999999998765432 2223446788999999987754 6999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.98  E-value=2.2e-31  Score=186.94  Aligned_cols=152  Identities=26%  Similarity=0.473  Sum_probs=131.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+.++++++|+|++++++.+..++..+++||++++ +|.+++....+.+++..+..++.+++.++.+||+.+++
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~  128 (266)
T cd05033          49 RLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV  128 (266)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            34678899999999999999999999999999999999985 89998877666889999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|.||+++.++.++++|||.+.........  .....++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       129 H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l~~l~~  203 (266)
T cd05033         129 HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMS  203 (266)
T ss_pred             cCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCC-CccccchHHHHHHHHHHHc
Confidence            9999999999999999999999998776421111  11223356799999987654 6999999999999999885

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.98  E-value=2.6e-31  Score=188.47  Aligned_cols=150  Identities=47%  Similarity=0.879  Sum_probs=125.9

Q ss_pred             hhHHHHHHHHhcC---CCCCeeeeeeeeee-----CcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKEL---KHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus        10 ~~~~~e~~~l~~~---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ..+.+|+++++.+   +|+||+++++++..     ...+++++|++.+++.+++.... ..+++..+..++.|++.++.|
T Consensus        44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  123 (288)
T cd07863          44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDF  123 (288)
T ss_pred             hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence            3566788877766   69999999998764     34689999999998888886543 458999999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          81 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ||+.|++|+||+|+||+++.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+|+++|+|+
T Consensus       124 lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~  201 (288)
T cd07863         124 LHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ-MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMF  201 (288)
T ss_pred             HHhCCeecCCCCHHHEEECCCCCEEECccCccccccCc-ccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHH
Confidence            99999999999999999999999999999988755422 2223445688899999987654 799999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       202 ~  202 (288)
T cd07863         202 R  202 (288)
T ss_pred             h
Confidence            5

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0614|consensus

Probab=99.98  E-value=4.9e-33  Score=202.32  Aligned_cols=156  Identities=26%  Similarity=0.387  Sum_probs=140.1

Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         4 ~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ....+.+++..|-++|..++.++||++|..|.+++++|++||.|-| .+...+.+. +.+++.+.+.++.-++.+++|||
T Consensus       459 VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH  537 (732)
T KOG0614|consen  459 VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLH  537 (732)
T ss_pred             cchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHH
Confidence            3445677888999999999999999999999999999999999976 666665554 58999999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      .+||+++|+||+|.+++.+|.+|++|||++++... +.+...+|||+.|+|||.+.+.+ .+.+.|.||||+++||+|+.
T Consensus       538 ~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G  615 (732)
T KOG0614|consen  538 RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-GRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTG  615 (732)
T ss_pred             hcCceeccCChhheeeccCCceEEeehhhHHHhcc-CCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcC
Confidence            99999999999999999999999999999998874 45566789999999999999876 69999999999999999973

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.98  E-value=2.2e-31  Score=189.02  Aligned_cols=152  Identities=26%  Similarity=0.487  Sum_probs=129.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC------------CCCCHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------------VPVPPALAKSYLYQLL   75 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~~i~   75 (163)
                      ...+.+|++++++++|+|++++++++..++.+++++||+++ +|.+++...+            ..+++..++.++.|++
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~  130 (288)
T cd05093          51 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA  130 (288)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHH
Confidence            34678999999999999999999999999999999999985 8888876432            3589999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          76 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        76 ~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      .++++||++|++|+|++|+||+++.++.++++|||.+........  ......++..|+|||.+.+.. ++.++|+||+|
T Consensus       131 ~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG  209 (288)
T cd05093         131 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLG  209 (288)
T ss_pred             HHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCC-CCchhhHHHHH
Confidence            999999999999999999999999999999999998875432211  112223466899999987654 69999999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      +++|+|++
T Consensus       210 ~il~~l~t  217 (288)
T cd05093         210 VVLWEIFT  217 (288)
T ss_pred             HHHHHHHh
Confidence            99999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.98  E-value=1.8e-31  Score=189.62  Aligned_cols=149  Identities=32%  Similarity=0.547  Sum_probs=131.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++++++++|+||+++++.+.++...++|||+++ ++|.+.+... +.+++..+..++.|++.++.+||+.|+
T Consensus        44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i  122 (290)
T cd05580          44 QVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDI  122 (290)
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            44667889999999999999999999999999999999996 5888887665 478999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|.||+++.++.++|+|||.+......   .....+++.|++||.+.+.. .+.++|+||+|+++|+|++
T Consensus       123 ~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  193 (290)
T cd05580         123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILIYEMLA  193 (290)
T ss_pred             ecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CCCCCCCccccChhhhcCCC-CCccccHHHHHHHHHHHHh
Confidence            99999999999999999999999988765432   33446788999999987654 6899999999999999996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.98  E-value=1.9e-31  Score=187.20  Aligned_cols=151  Identities=36%  Similarity=0.615  Sum_probs=130.0

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .++.+|+++++.++|+|++++++++.+++..++++|++++ ++.+++..   ....+++..+..++.+++.++.|||+++
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~  126 (267)
T cd08228          47 QDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR  126 (267)
T ss_pred             HHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            4578899999999999999999999999999999999985 77776642   3346789999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++++|||.+..............++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       127 i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~  201 (267)
T cd08228         127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAA  201 (267)
T ss_pred             eeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhc
Confidence            99999999999999999999999998876543322233446788899999987655 6899999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.98  E-value=3e-31  Score=186.25  Aligned_cols=152  Identities=29%  Similarity=0.440  Sum_probs=129.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|+.++++++|+|++++++.+..++.+++|+||+++ +|.+.+... +.+++..+..++.|++.++.+||+.+++
T Consensus        50 ~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (267)
T cd06646          50 FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKM  128 (267)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34567899999999999999999999999999999999986 787777544 4788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+..............++..|+|||.+..  ...++.++|+||+|+++|+|++
T Consensus       129 H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~  204 (267)
T cd06646         129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE  204 (267)
T ss_pred             ccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999998765433332334467889999998742  2336789999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.98  E-value=1.6e-31  Score=187.90  Aligned_cols=152  Identities=24%  Similarity=0.355  Sum_probs=125.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV----PVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..+.+|+++++.++|+||+++++.+.++...++|||++++ +|.+++.....    ..++.....++.|++.+++|||++
T Consensus        40 ~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  119 (269)
T cd05042          40 LLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA  119 (269)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc
Confidence            4578899999999999999999999999999999999985 89888866432    346777889999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccC------CcCCCcchhhHHHHHHH
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLG------AKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~------~~~~~~~~Di~slG~~l  156 (163)
                      +++|+||+|+||+++.++.++++|||.+.......  .......++..|+|||+...      ...++.++|+||+|+++
T Consensus       120 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  199 (269)
T cd05042         120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM  199 (269)
T ss_pred             CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence            99999999999999999999999999876432211  11122234567999998642      22358899999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|++
T Consensus       200 ~el~~  204 (269)
T cd05042         200 WELFT  204 (269)
T ss_pred             HHHHh
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.98  E-value=3.4e-31  Score=184.28  Aligned_cols=151  Identities=26%  Similarity=0.468  Sum_probs=128.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++|+|++++++++...+..++|||++++ ++.+++......+++..+..++.+++.++.++|+.|++|
T Consensus        37 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H  116 (250)
T cd05085          37 IKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH  116 (250)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            3578899999999999999999999999999999999985 888888766667899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++.++++|||.+......... .....++..|+|||...+.. ++.++|+||+|+++|++++
T Consensus       117 ~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~~~~  189 (250)
T cd05085         117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFS  189 (250)
T ss_pred             cccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHHHHHhc
Confidence            999999999999999999999988654322111 11223356799999986544 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.98  E-value=1.8e-31  Score=186.21  Aligned_cols=153  Identities=31%  Similarity=0.565  Sum_probs=133.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+++.+|+.+++.++|+|++++++.+.+++.+++++||+++ ++.+.+... +..+++..+..++.+++.++.+||+.|
T Consensus        41 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  120 (255)
T cd08219          41 AVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR  120 (255)
T ss_pred             HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            345678899999999999999999999999999999999985 888887653 345789999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+||+++.++.++++|||.+..............++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       121 i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~  195 (255)
T cd08219         121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCT  195 (255)
T ss_pred             cccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhh
Confidence            99999999999999999999999998876554433334456788899999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.98  E-value=2.3e-31  Score=208.89  Aligned_cols=152  Identities=26%  Similarity=0.431  Sum_probs=128.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC----------CCCCCHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT----------PVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----------~~~~~~~~~~~~~~~i~~~   77 (163)
                      ..++.+|++++++++|||++++++++.+++..+++|||++| +|.+.+...          ....+...++.++.|++++
T Consensus        46 ~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~A  125 (932)
T PRK13184         46 KKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT  125 (932)
T ss_pred             HHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHH
Confidence            45688999999999999999999999999999999999986 888877531          1235567788999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccC------------------CCcccccccCccccCcccccC
Q psy7820          78 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP------------------MNRYTHEVVTLWYRPPEILLG  139 (163)
Q Consensus        78 l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~------------------~~~~~~~~~~~~~~~pe~~~~  139 (163)
                      +++||+.|++|+||||+||+++.++.++++|||.+......                  ........|++.|+|||...+
T Consensus       126 L~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g  205 (932)
T PRK13184        126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG  205 (932)
T ss_pred             HHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC
Confidence            99999999999999999999999999999999998765211                  011123468999999999876


Q ss_pred             CcCCCcchhhHHHHHHHHHHhc
Q psy7820         140 AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       140 ~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .. ++.++|+||+|+++|+|+|
T Consensus       206 ~~-~S~kSDIWSLGVILyELLT  226 (932)
T PRK13184        206 VP-ASESTDIYALGVILYQMLT  226 (932)
T ss_pred             CC-CCcHhHHHHHHHHHHHHHH
Confidence            55 6999999999999999997

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.98  E-value=2.9e-31  Score=186.49  Aligned_cols=151  Identities=26%  Similarity=0.462  Sum_probs=129.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|+.++++++|||++++++++..++..+++||++++ +|.+++....+.++..++..++.|++.++.+||+.+++|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h  129 (267)
T cd05066          50 RDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVH  129 (267)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            4678899999999999999999999999999999999985 898888877667899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCccc---ccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+|++++.++.++++|||.+...........   ...++..|++||.+.+.. ++.++|+||+|+++|++++
T Consensus       130 ~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~  204 (267)
T cd05066         130 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMS  204 (267)
T ss_pred             hhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhc
Confidence            99999999999999999999998876543222111   112245799999987654 6999999999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.98  E-value=3.5e-31  Score=188.78  Aligned_cols=150  Identities=33%  Similarity=0.547  Sum_probs=130.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|+.+++.++|+|++++++.+..+...++|+||+++ +|.+++..  ..+++..+..++.|++.++.+||+.|++
T Consensus        61 ~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~  138 (296)
T cd06654          61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVI  138 (296)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45678899999999999999999999999999999999985 88887754  3578889999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       139 H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~  211 (296)
T cd06654         139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIE  211 (296)
T ss_pred             cCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHh
Confidence            999999999999999999999998775443322233456788999999987644 6899999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.5e-31  Score=186.60  Aligned_cols=150  Identities=29%  Similarity=0.468  Sum_probs=133.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|+++++.++|+|++++.+++.++...++|+|++++ ++.+.+...  .+++..+..++.|++.++.+||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~  120 (274)
T cd06609          43 IEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKI  120 (274)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            35678899999999999999999999999999999999986 888887654  788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+|++++.++.++++|||.+..............++..|++||...+.. ++.++|+||+|+++|+|+|
T Consensus       121 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~t  193 (274)
T cd06609         121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAK  193 (274)
T ss_pred             cCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999877665444444556788899999987755 7999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=5.2e-31  Score=186.00  Aligned_cols=147  Identities=26%  Similarity=0.353  Sum_probs=124.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|+.+++.++|+||+++++++.++...++||||+++ +|..++....+.+++..+..++.|++.+++|||+++++|
T Consensus        61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH  140 (274)
T cd05076          61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVH  140 (274)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccC
Confidence            4577899999999999999999999999999999999986 777777665667899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCC-------ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          89 RDLKPQNILINKSG-------ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        89 ~~i~~~ni~~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +||+|.||+++..+       .+++.|||.+.....    .....++..|+|||.+.+...++.++|+||+|+++||++
T Consensus       141 ~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~  215 (274)
T cd05076         141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC  215 (274)
T ss_pred             CCCCcccEEEeccCcccCccceeeecCCcccccccc----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence            99999999997654       379999998754321    122345778999999876455799999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=2.9e-31  Score=185.34  Aligned_cols=148  Identities=22%  Similarity=0.336  Sum_probs=127.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+.++++++|+|++++++++.. +..++|+||+++ +|.+++......++...+..++.|++.++.|||++|++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  123 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV  123 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence            4678899999999999999999999887 778999999985 88888876665789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCC-------ceEEeecccccccccCCCcccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHH
Q psy7820          88 HRDLKPQNILINKSG-------ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        88 h~~i~~~ni~~~~~~-------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~l  159 (163)
                      |+||+|+||+++.++       .++++|||.+.....    .....++..|++||.+.+. ..++.++|+||+|+++|++
T Consensus       124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l  199 (259)
T cd05037         124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEI  199 (259)
T ss_pred             cccCccceEEEecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHH
Confidence            999999999999887       799999998876442    1223446679999998765 3478999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       200 ~~  201 (259)
T cd05037         200 CS  201 (259)
T ss_pred             Hh
Confidence            86

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.97  E-value=2.5e-31  Score=186.57  Aligned_cols=152  Identities=36%  Similarity=0.607  Sum_probs=131.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..++.+|+++++.++|+|++++++++..++..++++|++++ +|.+++..   ....+++..++.++.+++.++.+||++
T Consensus        46 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~  125 (267)
T cd08229          46 RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR  125 (267)
T ss_pred             HHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            35678899999999999999999999999999999999986 88877653   345689999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++++|||.+..............++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       126 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~  201 (267)
T cd08229         126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAA  201 (267)
T ss_pred             CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999998776543333233446788999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=5.2e-31  Score=184.82  Aligned_cols=153  Identities=36%  Similarity=0.594  Sum_probs=132.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ...++.+|++++++++|++++++++.+..++..+++|||+++ +|..++..   ....+++..++.++.++++++.+||+
T Consensus        45 ~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~  124 (267)
T cd08224          45 ARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS  124 (267)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh
Confidence            356788999999999999999999999999999999999985 88877753   34568899999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .|++|+|++|+||+++.++.++++|||.+..............++..|.|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       125 ~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~  201 (267)
T cd08224         125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAA  201 (267)
T ss_pred             CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHH
Confidence            9999999999999999999999999998866543333334456788899999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.97  E-value=3.4e-31  Score=185.38  Aligned_cols=152  Identities=28%  Similarity=0.469  Sum_probs=131.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++..|+++++.++|+|++++++++.+++..+++|||+++ +|.+++... +..+++..+..++.+++.++.+||+.|+
T Consensus        46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i  125 (261)
T cd05148          46 QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNS  125 (261)
T ss_pred             HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            45688999999999999999999999999999999999985 999998764 3468899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       126 ~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~~l~~l~~  199 (261)
T cd05148         126 IHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGILLYEMFT  199 (261)
T ss_pred             eccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCC-CCchhhHHHHHHHHHHHHc
Confidence            9999999999999999999999998876543332233334466799999987644 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=3.8e-31  Score=185.10  Aligned_cols=150  Identities=19%  Similarity=0.276  Sum_probs=128.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|..+++.++|+|++++++.+..+...++||||+++ +|.+++......+++..++.++.|++.++.|||+++++
T Consensus        43 ~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ii  122 (258)
T cd05078          43 SESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLT  122 (258)
T ss_pred             HHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            35678899999999999999999999998999999999985 88888877666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCc--------eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          88 HRDLKPQNILINKSGA--------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      |+||+|+||+++.++.        ++++|||.+.....    .....++..|+|||.+.+...++.++|+||+|+++|+|
T Consensus       123 H~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l  198 (258)
T cd05078         123 HGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEI  198 (258)
T ss_pred             cCCCccceEEEecccccccCCCceEEecccccccccCC----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHH
Confidence            9999999999987765        58999998754331    12245678899999987655568999999999999999


Q ss_pred             hcC
Q psy7820         160 IQI  162 (163)
Q Consensus       160 l~~  162 (163)
                      ++.
T Consensus       199 ~~g  201 (258)
T cd05078         199 FSG  201 (258)
T ss_pred             HcC
Confidence            873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.97  E-value=3.4e-31  Score=190.01  Aligned_cols=155  Identities=43%  Similarity=0.882  Sum_probs=131.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHH
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTT----PVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ...+.+.+|++++++++|+|++++++++.+.  ..+++|+|++++++.+.+...    ...+++..++.++.|++.++.|
T Consensus        44 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  123 (316)
T cd07842          44 GISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHY  123 (316)
T ss_pred             CccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHH
Confidence            3456778899999999999999999999888  789999999998887776432    2368899999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEcc----CCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          81 CHSRRIIHRDLKPQNILINK----SGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~----~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      ||+.+++|+||+|+||+++.    ++.++++|||++........   ......++..|+|||...+...++.++|+||+|
T Consensus       124 lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  203 (316)
T cd07842         124 LHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIG  203 (316)
T ss_pred             HHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHH
Confidence            99999999999999999999    89999999998876543322   122335678899999987655578999999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      +++++|++
T Consensus       204 ~~l~~l~~  211 (316)
T cd07842         204 CIFAELLT  211 (316)
T ss_pred             HHHHHHHh
Confidence            99999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.97  E-value=3.9e-31  Score=187.63  Aligned_cols=150  Identities=29%  Similarity=0.460  Sum_probs=129.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|+.++++++|++++++.+.+.+++.+++||||+++ +|.+.+... ...+++..+..++.|++.++.|||+.+++
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ii  124 (285)
T cd05630          45 SMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIV  124 (285)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence            3467899999999999999999999999999999999985 887777543 34688999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++++|||.+...... .......|+..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       125 H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~  196 (285)
T cd05630         125 YRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIA  196 (285)
T ss_pred             eCCCCHHHEEECCCCCEEEeeccceeecCCC-ccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHh
Confidence            9999999999999999999999988654322 2223346789999999987654 7999999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.97  E-value=3.2e-31  Score=187.80  Aligned_cols=152  Identities=26%  Similarity=0.504  Sum_probs=129.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..++.+|+++++.++|+|++++.+++...  ...+++|||++| +|.+++......+++..+..++.+++.++.+||++|
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g  129 (284)
T cd05079          50 IADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ  129 (284)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45688999999999999999999998775  578999999985 888888766557899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+||+++.++.++++|||.+.........   .....++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       130 i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt  207 (284)
T cd05079         130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLT  207 (284)
T ss_pred             eeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhc
Confidence            999999999999999999999999988765432211   12234466799999987654 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.97  E-value=4.5e-31  Score=187.26  Aligned_cols=150  Identities=29%  Similarity=0.453  Sum_probs=129.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|+++++.++|++++++.+.+.+++..++++||+.+ ++.+.+... ...+++..+..++.|++.++.|||+.|++
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ii  124 (285)
T cd05632          45 SMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTV  124 (285)
T ss_pred             HHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            3467899999999999999999999999999999999986 787777543 34689999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|.||+++.++.++|+|||.+...... .......|+..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       125 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~  196 (285)
T cd05632         125 YRDLKPENILLDDYGHIRISDLGLAVKIPEG-ESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIE  196 (285)
T ss_pred             ecCCCHHHEEECCCCCEEEecCCcceecCCC-CcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHh
Confidence            9999999999999999999999988654322 2223446789999999987654 7999999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.97  E-value=6.8e-31  Score=183.40  Aligned_cols=152  Identities=29%  Similarity=0.536  Sum_probs=130.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee-CcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .+.+.+|++++++++|+|++++.+.+.. ...+++++|++++ ++.+.+... +..+++.+++.++.+++.++.+||+.|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~  122 (257)
T cd08223          43 RKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH  122 (257)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3467889999999999999999998764 4478999999985 888887653 346899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++++|||.+..............+++.|+|||...+.. ++.++|+||+|+++++|++
T Consensus       123 i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~  197 (257)
T cd08223         123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMAT  197 (257)
T ss_pred             eeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHc
Confidence            99999999999999999999999998876544333344456788999999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.97  E-value=2.4e-31  Score=185.75  Aligned_cols=148  Identities=40%  Similarity=0.695  Sum_probs=130.9

Q ss_pred             HHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7820          13 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDL   91 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i   91 (163)
                      .+|+.+++.++|+||+++++++.++...+++||++++ ++.+++.. ...++...+..++.|++.++.+||+.+++|+||
T Consensus        46 ~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~di  124 (260)
T PF00069_consen   46 IREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLHSKGIVHRDI  124 (260)
T ss_dssp             HHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSB
T ss_pred             hhhhhccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccc
Confidence            4589999999999999999999999999999999997 89888873 347899999999999999999999999999999


Q ss_pred             CCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          92 KPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        92 ~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+++.++.++++|||.+..............++..|.|||........+.++|+||+|+++|+|++
T Consensus       125 kp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  194 (260)
T PF00069_consen  125 KPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLT  194 (260)
T ss_dssp             SGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999987543334445566778899999998733447999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.97  E-value=1.9e-31  Score=193.68  Aligned_cols=147  Identities=41%  Similarity=0.728  Sum_probs=126.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .++.+|++++++++|+||+++++++...      ...+++++++.+++.+.+..  ..+++..+..++.|++.++.|||+
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~  136 (343)
T cd07878          59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYIHS  136 (343)
T ss_pred             HHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999987543      35789999998888777653  368999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .|++|+||+|+||+++.++.++|+|||++.....   ......++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       137 ~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  211 (343)
T cd07878         137 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLK  211 (343)
T ss_pred             CCeecccCChhhEEECCCCCEEEcCCccceecCC---CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHH
Confidence            9999999999999999999999999999876542   23345678899999998775557899999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.97  E-value=5.8e-31  Score=187.68  Aligned_cols=151  Identities=33%  Similarity=0.570  Sum_probs=130.3

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+.+++.++|+|++++++.+..++.+++|+||+.+ +|..++..  ..+++..+..++.+++.++.+||+.|+
T Consensus        59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i  136 (296)
T cd06655          59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQV  136 (296)
T ss_pred             hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345678899999999999999999999999999999999986 77776654  257899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+..............++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       137 ~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~llt  210 (296)
T cd06655         137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVE  210 (296)
T ss_pred             ccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999998765543322233446788999999987654 6899999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.97  E-value=5.7e-31  Score=187.27  Aligned_cols=154  Identities=56%  Similarity=1.025  Sum_probs=130.8

Q ss_pred             chhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcE-----EEEEecchhccHHHHHhcC----CCCCCHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELK-HPNVIRLHDVIPVDFK-----LFLVFEFLRQDLKDFLQTT----PVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~-----~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~   77 (163)
                      ....+.+|+.+++++. |+|++++++++...+.     .|++|||+++++.+++...    ...+++..++.++.|++.+
T Consensus        43 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~  122 (295)
T cd07837          43 IPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG  122 (295)
T ss_pred             CchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence            3456788999999995 6999999999877665     8999999999888887543    2357999999999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEcc-CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          78 LRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        78 l~~lh~~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      +.|||+.|++|+|++|+||+++. ++.++++|||.+..............+++.|+|||.+.+...++.++|+||+|+++
T Consensus       123 L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l  202 (295)
T cd07837         123 VAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIF  202 (295)
T ss_pred             HHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHH
Confidence            99999999999999999999998 88999999998876554433334445678899999987655578999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|++
T Consensus       203 ~~l~~  207 (295)
T cd07837         203 AEMSR  207 (295)
T ss_pred             HHHHc
Confidence            99986

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.97  E-value=5.1e-31  Score=194.66  Aligned_cols=152  Identities=23%  Similarity=0.455  Sum_probs=127.2

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------------------
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------------------   59 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------------------   59 (163)
                      .+.+.+|+++++++. ||||+++++++.+.+..++||||+++ +|.+++....                           
T Consensus        84 ~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (400)
T cd05105          84 KQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADEST  163 (400)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccc
Confidence            356889999999995 99999999999999999999999985 8888775321                           


Q ss_pred             --------------------------------------------------------------------CCCCHHHHHHHH
Q psy7820          60 --------------------------------------------------------------------VPVPPALAKSYL   71 (163)
Q Consensus        60 --------------------------------------------------------------------~~~~~~~~~~~~   71 (163)
                                                                                          ..+++..+..++
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~  243 (400)
T cd05105         164 RSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFT  243 (400)
T ss_pred             cchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHH
Confidence                                                                                236777888999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhh
Q psy7820          72 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        72 ~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      .|++.++.|||+.+++|+||+|.||+++.++.++++|||++........  ......++..|+|||.+.+.. ++.++||
T Consensus       244 ~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di  322 (400)
T cd05105         244 YQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDV  322 (400)
T ss_pred             HHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhH
Confidence            9999999999999999999999999999999999999999875432211  122234567899999987654 6999999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+|+++|+|++
T Consensus       323 wSlGvil~ellt  334 (400)
T cd05105         323 WSYGILLWEIFS  334 (400)
T ss_pred             HHHHHHHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.97  E-value=5.6e-31  Score=186.42  Aligned_cols=151  Identities=29%  Similarity=0.511  Sum_probs=127.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC----------------CCCCCHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT----------------PVPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----------------~~~~~~~~~~~~~~   72 (163)
                      .++.+|++++++++|+|++++++++..+...+++|||+++ +|.+++...                ...+++..+..++.
T Consensus        52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  131 (283)
T cd05090          52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI  131 (283)
T ss_pred             HHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence            4678899999999999999999999999999999999985 888887432                12478888999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      +++.++.|||+++++|+|++|+||+++.++.++++|||.+.......  .......++..|+|||.+.+.. ++.++|+|
T Consensus       132 ~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~  210 (283)
T cd05090         132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIW  210 (283)
T ss_pred             HHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhH
Confidence            99999999999999999999999999999999999999886543221  1122333456799999987654 69999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       211 slG~il~el~~  221 (283)
T cd05090         211 SFGVVLWEIFS  221 (283)
T ss_pred             HHHHHHHHHHc
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.97  E-value=4.8e-31  Score=186.24  Aligned_cols=151  Identities=24%  Similarity=0.437  Sum_probs=126.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~   79 (163)
                      .++.+|+.+++.++|+|++++++++.++...++||||+++ +|.+++....         ..++...+..++.+++.++.
T Consensus        54 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  133 (277)
T cd05062          54 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA  133 (277)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999999999999999985 8888875432         23567888999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      +||+.+++|+|++|+||+++.++.++++|||.+.........  .....++..|+|||.+.+.. ++.++|+||||+++|
T Consensus       134 ~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~  212 (277)
T cd05062         134 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLW  212 (277)
T ss_pred             HHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHH
Confidence            999999999999999999999999999999988654322111  11223466799999987644 699999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       213 el~~  216 (277)
T cd05062         213 EIAT  216 (277)
T ss_pred             HHHc
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0033|consensus

Probab=99.97  E-value=1.5e-31  Score=179.50  Aligned_cols=153  Identities=37%  Similarity=0.567  Sum_probs=133.0

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .+..+++.+|+++-+.++||||+++.+.....++.|+|+|++.| ++..-+-.. .-.++..+-..++||+.++.|+|.+
T Consensus        51 ~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n  129 (355)
T KOG0033|consen   51 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSN  129 (355)
T ss_pred             cccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhc
Confidence            34667889999999999999999999999999999999999987 776666544 3678888999999999999999999


Q ss_pred             CceecCCCCCcEEEccC---CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+|+|++|.|+++...   .-+|++|||++.... .+.......|+|+|++||+.+..+ ++..+|||+-||+||-+|.
T Consensus       130 ~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~  207 (355)
T KOG0033|consen  130 GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLV  207 (355)
T ss_pred             CceeccCChhheeeeeccCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHh
Confidence            99999999999999443   458999999998766 445556778899999999998754 7999999999999999883

>KOG0666|consensus

Probab=99.97  E-value=1.2e-31  Score=185.26  Aligned_cols=156  Identities=44%  Similarity=0.877  Sum_probs=138.0

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeee-CcEEEEEecchhccHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQDLKDFLQTT----PVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      +......+|+.+++.++|+|++.+..+|-. +..+++++||.+.+|...+.-.    ...++...++.+++||+.|+.||
T Consensus        69 GiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YL  148 (438)
T KOG0666|consen   69 GISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYL  148 (438)
T ss_pred             CcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHH
Confidence            556678899999999999999999999876 7799999999999999888543    24688999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEccC----CceEEeecccccccccCCCccc---ccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          82 HSRRIIHRDLKPQNILINKS----GALKLADFGLSRAFTIPMNRYT---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~----~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      |++=+.|+|+||.||++..+    |.+||.|+|+++.+..+.....   ....|..|.|||.+.+...|++..|+||+||
T Consensus       149 H~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGC  228 (438)
T KOG0666|consen  149 HSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGC  228 (438)
T ss_pred             hhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHH
Confidence            99999999999999999887    8999999999998876644432   2344889999999999999999999999999


Q ss_pred             HHHHHhcC
Q psy7820         155 IFSEMIQI  162 (163)
Q Consensus       155 ~l~~ll~~  162 (163)
                      ++.||+|+
T Consensus       229 IfaElLtl  236 (438)
T KOG0666|consen  229 IFAELLTL  236 (438)
T ss_pred             HHHHHHcc
Confidence            99999985

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.97  E-value=5.7e-31  Score=185.95  Aligned_cols=152  Identities=26%  Similarity=0.462  Sum_probs=128.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-------------CCCCHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-------------VPVPPALAKSYLYQL   74 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-------------~~~~~~~~~~~~~~i   74 (163)
                      ..++.+|++++++++|+|++++++++..++..+++|||+++ +|.+++...+             ..+++..+..++.++
T Consensus        52 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i  131 (280)
T cd05049          52 RKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI  131 (280)
T ss_pred             HHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHH
Confidence            35788999999999999999999999999999999999985 8888886532             347888899999999


Q ss_pred             HHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          75 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        75 ~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      +.++.+||+.|++|+||+|+||+++.++.++++|||.+.......  .......+++.|+|||.+.+.. ++.++|+||+
T Consensus       132 ~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~sl  210 (280)
T cd05049         132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSF  210 (280)
T ss_pred             HHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHH
Confidence            999999999999999999999999999999999999886543211  1112223467899999987654 7999999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      |+++|+|++
T Consensus       211 G~il~e~~~  219 (280)
T cd05049         211 GVVLWEIFT  219 (280)
T ss_pred             HHHHHHHHh
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.97  E-value=4.7e-31  Score=189.65  Aligned_cols=151  Identities=23%  Similarity=0.438  Sum_probs=127.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+.+++.++|+||+++++++..+ ..+++++++. |++.+.+......++...+..++.|++.+++|||+.|++
T Consensus        53 ~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ii  131 (316)
T cd05108          53 NKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLV  131 (316)
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCee
Confidence            45678899999999999999999998765 4678899987 599999887776788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcc--cccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..........  ....++..|++||.+.+.. ++.++|+||+|+++|||++
T Consensus       132 H~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t  206 (316)
T cd05108         132 HRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMT  206 (316)
T ss_pred             ccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHc
Confidence            99999999999999999999999987654322211  1122356799999987654 6999999999999999875

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.97  E-value=6.2e-31  Score=184.43  Aligned_cols=151  Identities=30%  Similarity=0.497  Sum_probs=128.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .++.+|+++++.++|+|++++++++..++.++++|||+++ +|.+++... ...+++..++.++.|++.++.+||+++++
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~  126 (263)
T cd05052          47 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI  126 (263)
T ss_pred             HHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            4678899999999999999999999999999999999975 888888654 34688999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++++|||.+......... ......+..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       127 H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t  200 (263)
T cd05052         127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT  200 (263)
T ss_pred             ecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHc
Confidence            9999999999999999999999988765432211 11122355799999986654 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.97  E-value=7.1e-31  Score=187.80  Aligned_cols=152  Identities=49%  Similarity=0.861  Sum_probs=129.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCc--------EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDF--------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ..+.+|++++++++|+|++++++++.+.+        ..++|+|++++++.+.+......+++..++.++.|++.++.+|
T Consensus        56 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~l  135 (310)
T cd07865          56 ITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYI  135 (310)
T ss_pred             hHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            34578999999999999999999986543        4699999999999888877766789999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc----ccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          82 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      |+.|++|+||+|+||+++.++.++|+|||.+.........    .....++..|+|||.+.+...++.++|+||+|+++|
T Consensus       136 H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~  215 (310)
T cd07865         136 HRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMA  215 (310)
T ss_pred             HHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHH
Confidence            9999999999999999999999999999988765432211    122345778999999876555688999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       216 el~t  219 (310)
T cd07865         216 EMWT  219 (310)
T ss_pred             HHHh
Confidence            9986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.97  E-value=2.9e-31  Score=189.76  Aligned_cols=150  Identities=29%  Similarity=0.461  Sum_probs=126.1

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      .++.+|++++.++ +|+|++++++++.+++.+++++||+++ +|.+++....               ..+++.+++.++.
T Consensus        52 ~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  131 (303)
T cd05088          52 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA  131 (303)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHH
Confidence            4577899999999 899999999999999999999999985 8888886432               3578899999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      |++.++++||+.|++|+||+|+||+++.++.++|+|||++...... ........+..|+|||...+.. ++.++|+||+
T Consensus       132 qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~sl  209 (303)
T cd05088         132 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSY  209 (303)
T ss_pred             HHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchh-hhcccCCCcccccCHHHHhccC-Ccccccchhh
Confidence            9999999999999999999999999999999999999987543211 1111122356799999986544 6899999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      |+++|+|+|
T Consensus       210 G~il~ellt  218 (303)
T cd05088         210 GVLLWEIVS  218 (303)
T ss_pred             hhHHHHHHh
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.97  E-value=3e-31  Score=187.44  Aligned_cols=154  Identities=59%  Similarity=1.042  Sum_probs=135.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ....+.+|++++++++|+|++++++++..+...++++||+++++.+.+......+++..+..++.+++.++.+||+.+++
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~  120 (283)
T cd05118          41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL  120 (283)
T ss_pred             hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34577889999999999999999999999999999999999999998887667889999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+..............++..|.+||...+...++.++|+||+|+++|+|+|
T Consensus       121 H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~t  194 (283)
T cd05118         121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLS  194 (283)
T ss_pred             ecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHh
Confidence            99999999999999999999999887665443223334567789999998765457999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.3e-30  Score=182.62  Aligned_cols=152  Identities=26%  Similarity=0.503  Sum_probs=129.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|++++++++|+|++++++++..++..+++||+++ ++|.+++.... ..+++..+..++.+++.++.+||+.|+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  124 (261)
T cd05068          45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY  124 (261)
T ss_pred             HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4568899999999999999999999999999999999996 59998886543 468999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+......... ......+..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       125 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t  199 (261)
T cd05068         125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             eeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999988765522111 11112235799999987654 6999999999999999986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.97  E-value=9.9e-31  Score=183.73  Aligned_cols=152  Identities=24%  Similarity=0.428  Sum_probs=129.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+|++++.+++...+..+++||++++ +|.+++....+.+++..+..++.+++.++++||+.|++
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~  129 (268)
T cd05063          50 RQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYV  129 (268)
T ss_pred             HHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34578899999999999999999999999999999999985 88888877666889999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCccc---ccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~---~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+...........   ....+..|++||.+.... ++.++|+||+|+++|++++
T Consensus       130 H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il~ell~  205 (268)
T cd05063         130 HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVMWEVMS  205 (268)
T ss_pred             ccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHHHHHHh
Confidence            999999999999999999999998865542221111   111245699999987654 6999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.97  E-value=1.1e-30  Score=187.08  Aligned_cols=148  Identities=32%  Similarity=0.521  Sum_probs=129.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~   87 (163)
                      .++.+|++++++++|+||+++++.+.+++.+++++||+++ +|.+++... +.+++..+..++.|+++++.|||+ .+++
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~  122 (308)
T cd06615          44 NQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIM  122 (308)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEE
Confidence            4578899999999999999999999999999999999986 888887655 478899999999999999999997 6999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+.......  .....++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       123 H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~l~~l~~  193 (308)
T cd06615         123 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--ANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAI  193 (308)
T ss_pred             ECCCChHHEEEecCCcEEEccCCCcccccccc--cccCCCCcCccChhHhcCCC-CCccchHHHHHHHHHHHHh
Confidence            99999999999999999999999876543221  23346688999999986644 6899999999999999986

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.97  E-value=6.6e-31  Score=184.08  Aligned_cols=152  Identities=29%  Similarity=0.496  Sum_probs=132.2

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .....+.+|+.+++.++|+|++++++.+.++...++++||+++ +|.+++.... .+++..+..++.|+++++.+||+.+
T Consensus        35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~~  113 (262)
T cd05572          35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG-LFDEYTARFYIACVVLAFEYLHNRG  113 (262)
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            3446788999999999999999999999999999999999985 8888887653 6889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+||+++.++.++++|||.+....... ......++..|++||.+.+.. ++.++|+||+|+++|+|++
T Consensus       114 ~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~il~~l~~  187 (262)
T cd05572         114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGILLYELLT  187 (262)
T ss_pred             cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCccChhHhcCCC-CCChhhhhhhHHHHHHHHh
Confidence            9999999999999999999999999887655332 223346688899999986644 6899999999999999985

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.97  E-value=1.6e-30  Score=186.14  Aligned_cols=148  Identities=30%  Similarity=0.524  Sum_probs=130.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .++.+|+++++.++|+|++++.+++.+++..++|+||+.|++.+.+......+++..+..++.|++.++.|||+.+++|+
T Consensus        60 ~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~  139 (307)
T cd06607          60 QDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR  139 (307)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence            45788999999999999999999999999999999999999888887666678999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|.||+++.++.++++|||.+......    ....++..|+|||.+.+  ...++.++|+||+|+++|+|+|
T Consensus       140 dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t  209 (307)
T cd06607         140 DIKAGNILLTEPGTVKLADFGSASLVSPA----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (307)
T ss_pred             CCCcccEEECCCCCEEEeecCcceecCCC----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc
Confidence            99999999999999999999987654322    23456788999998742  3347889999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0690|consensus

Probab=99.97  E-value=2.3e-32  Score=190.11  Aligned_cols=152  Identities=30%  Similarity=0.434  Sum_probs=138.6

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+.|-++|+.++||++..+...|++++.+++||||..| .|+.++..+. .+++...+.+-..|++++.|||+++|
T Consensus       211 EVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~~i  289 (516)
T KOG0690|consen  211 EVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSRNI  289 (516)
T ss_pred             HhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhCCe
Confidence            345678899999999999999999999999999999999975 8888887765 78888888999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +++|+|.+|.++|.+|++||.|||+++-.-..+......||||.|+|||++.+.. |+...|+|.+||++|||++
T Consensus       290 vYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnD-YgraVDWWG~GVVMYEMmC  363 (516)
T KOG0690|consen  290 VYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDND-YGRAVDWWGVGVVMYEMMC  363 (516)
T ss_pred             eeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhcccc-ccceeehhhhhHHHHHHHh
Confidence            9999999999999999999999999976655667788899999999999998766 7999999999999999996

>KOG0577|consensus

Probab=99.97  E-value=1.5e-32  Score=203.12  Aligned_cols=150  Identities=31%  Similarity=0.506  Sum_probs=136.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...++++|++.|++++|||.+.+.+++-.+...|+|||||-|+-.|.+.....++.+..+..|..+.+.|+.|||+.+.+
T Consensus        69 KWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~I  148 (948)
T KOG0577|consen   69 KWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRI  148 (948)
T ss_pred             HHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHH
Confidence            35678999999999999999999999999999999999999988888888888999999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc--CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|||..||++...|.+|+.|||.++...    ....+.|||+|||||++.  +.+.|+-+.||||||+++.|+..
T Consensus       149 HRDiKAGNILLse~g~VKLaDFGSAsi~~----PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAE  220 (948)
T KOG0577|consen  149 HRDIKAGNILLSEPGLVKLADFGSASIMA----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  220 (948)
T ss_pred             hhhccccceEecCCCeeeeccccchhhcC----chhcccCCccccchhHheeccccccCCccceeeccchhhhhhh
Confidence            99999999999999999999999886543    345788999999999984  55668999999999999999864

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.97  E-value=1e-30  Score=186.43  Aligned_cols=151  Identities=32%  Similarity=0.536  Sum_probs=130.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+.+|+.+++.++|+|++++++.+..++..++|+||+++ ++.+++.+  ..+++..+..++.+++.++.+||+.++
T Consensus        59 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i  136 (297)
T cd06656          59 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQV  136 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345678899999999999999999999999999999999986 88887754  357888999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............+++.|++||...+.. ++.++|+||+|+++|++++
T Consensus       137 ~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvil~~l~t  210 (297)
T cd06656         137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVE  210 (297)
T ss_pred             ccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999998876543333333456788999999987644 6899999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=7.6e-31  Score=185.77  Aligned_cols=151  Identities=30%  Similarity=0.534  Sum_probs=126.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeee--CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+|++++++++|+|++++++++..  ...+++++||+++ +|.+++......+++..+..++.|++.++.+||+.|+
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i  129 (284)
T cd05081          50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRY  129 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            467899999999999999999998643  3478999999975 9999887766678999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcc---cccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+..........   ....+...|+|||...+.. ++.++|+||+|++++||++
T Consensus       130 ~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~  206 (284)
T cd05081         130 VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT  206 (284)
T ss_pred             eeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhh
Confidence            999999999999999999999999987654322110   1112234589999987654 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.97  E-value=1.1e-30  Score=184.75  Aligned_cols=150  Identities=23%  Similarity=0.405  Sum_probs=126.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++..|+..+++++|+||+++++++.. ...++++|+++ |+|.+++......+++..+..++.|++.++.|||+.+++|
T Consensus        54 ~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH  132 (279)
T cd05111          54 QEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH  132 (279)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence            456678888899999999999998754 45778999987 5999999877778999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++++|||.+........  ......++..|++||...+.. ++.++|+||+|+++||+++
T Consensus       133 ~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t  206 (279)
T cd05111         133 RNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMS  206 (279)
T ss_pred             cccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHc
Confidence            99999999999999999999998875432211  112234566899999987644 7999999999999999986

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.97  E-value=9.7e-31  Score=183.84  Aligned_cols=154  Identities=30%  Similarity=0.444  Sum_probs=129.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHHhC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPV--PPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+.+|+.+++.++|+|++++++++..++..++++|++++ +|.+++......+  ++..+..++.|++.++.+||+.
T Consensus        48 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~  127 (268)
T cd06624          48 YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN  127 (268)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence            345678999999999999999999999999999999999985 8888887654445  7888889999999999999999


Q ss_pred             CceecCCCCCcEEEcc-CCceEEeecccccccccCCCcccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+|++|+||+++. ++.++|+|||.+..............++..|+|||..... ..++.++|+||+|+++|+|++
T Consensus       128 ~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~  206 (268)
T cd06624         128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMAT  206 (268)
T ss_pred             CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHh
Confidence            9999999999999976 6789999999886544222223334568899999997543 236889999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.97  E-value=9.6e-31  Score=187.02  Aligned_cols=151  Identities=24%  Similarity=0.458  Sum_probs=128.4

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      +++.+|+++++++ +|+||+++++++...+..++++||+. ++|.+++.... ..+++.++..++.+++.++.|||++++
T Consensus        83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i  162 (302)
T cd05055          83 EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNC  162 (302)
T ss_pred             HHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4578899999999 79999999999999999999999998 48888886543 348999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+.........  .....++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       163 vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t  238 (302)
T cd05055         163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFS  238 (302)
T ss_pred             ehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHh
Confidence            99999999999999999999999988654422211  11223466799999987655 6999999999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0579|consensus

Probab=99.97  E-value=5.1e-32  Score=201.92  Aligned_cols=158  Identities=32%  Similarity=0.493  Sum_probs=137.2

Q ss_pred             cCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           5 VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL-QTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         5 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .+..-++++-|++||..|+||+|+++++.|..++.+|++.|+|+|+-.+.+ ..-+-.+.+.++.-++.+++.++.|||+
T Consensus        69 seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs  148 (1187)
T KOG0579|consen   69 SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHS  148 (1187)
T ss_pred             chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhh
Confidence            344456788899999999999999999999999999999999998555544 4445578999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc----CCcCCCcchhhHHHHHHHHHH
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Di~slG~~l~~l  159 (163)
                      ++|+|+|+|..||++..+|.+++.|||.+.+........-.+.|||+|||||+..    ...+|+.++||||||++|.||
T Consensus       149 ~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEM  228 (1187)
T KOG0579|consen  149 QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEM  228 (1187)
T ss_pred             cchhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHH
Confidence            9999999999999999999999999998876554445556789999999999963    445799999999999999999


Q ss_pred             hcC
Q psy7820         160 IQI  162 (163)
Q Consensus       160 l~~  162 (163)
                      .++
T Consensus       229 Aqi  231 (1187)
T KOG0579|consen  229 AQI  231 (1187)
T ss_pred             hcc
Confidence            864

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=8.6e-31  Score=183.88  Aligned_cols=150  Identities=30%  Similarity=0.580  Sum_probs=129.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      +.+.+|+.++++++|+|++++++++..++..++++||+++ +|.+++... +.+++..+..++.+++.++++||+.|++|
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH  129 (267)
T cd06628          51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIH  129 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCccc
Confidence            4577899999999999999999999999999999999986 888777654 47888999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCC------CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPM------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++++|||.+.......      .......++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       130 ~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~  207 (267)
T cd06628         130 RDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLT  207 (267)
T ss_pred             ccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhh
Confidence            9999999999999999999999887654211      1112235678899999987654 6899999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.97  E-value=1.2e-30  Score=182.22  Aligned_cols=150  Identities=27%  Similarity=0.501  Sum_probs=126.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeee-eeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+.+|+.++++++|++++++++++ ..++..++++|++++ +|.+++.... ..+++..++.++.+++.++.+||++
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  121 (256)
T cd05082          42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN  121 (256)
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345688999999999999999999975 455678999999985 8988887644 3478999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++++|||.+.......   ....++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       122 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~  194 (256)
T cd05082         122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---DTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYS  194 (256)
T ss_pred             CEeccccchheEEEcCCCcEEecCCccceeccccC---CCCccceeecCHHHHccCC-CCchhhhHHHHHHHHHHHh
Confidence            99999999999999999999999999886543221   2233356799999987654 6899999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.97  E-value=9.9e-31  Score=185.04  Aligned_cols=154  Identities=49%  Similarity=0.928  Sum_probs=133.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+.+|++++++++|+|++++++++...  +..++|+||+++++...+......+++..++.++.+++.++++||+.|
T Consensus        41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~  120 (287)
T cd07840          41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG  120 (287)
T ss_pred             chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678899999999999999999999888  899999999999998888776568899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|.||+++.++.++++|||.+........ ......++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       121 ~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t  197 (287)
T cd07840         121 ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL  197 (287)
T ss_pred             ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999998876654321 12233457789999987665557899999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0584|consensus

Probab=99.97  E-value=1.8e-31  Score=197.50  Aligned_cols=152  Identities=30%  Similarity=0.455  Sum_probs=132.7

Q ss_pred             cCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCc--EEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           5 VEGVPSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         5 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      .+...+++..|+++|+.++|+||+++|+.+.+..  .+-+|+|.+. |+|..++.+.+ ..+.+.++.|++||++||.||
T Consensus        81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yL  159 (632)
T KOG0584|consen   81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYL  159 (632)
T ss_pred             ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhh
Confidence            3445578999999999999999999999997755  5889999997 68888887765 888999999999999999999


Q ss_pred             HhC--CceecCCCCCcEEEccC-CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          82 HSR--RIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        82 h~~--~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      |++  -|+|+|||-+||+++.+ |.+||+|+|+|.....  ...+...|||.|||||....  .|+...||||+|+++.|
T Consensus       160 Hs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~--s~aksvIGTPEFMAPEmYEE--~YnE~VDVYaFGMCmLE  235 (632)
T KOG0584|consen  160 HSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK--SHAKSVIGTPEFMAPEMYEE--NYNELVDVYAFGMCMLE  235 (632)
T ss_pred             hcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc--cccceeccCccccChHHHhh--hcchhhhhhhhhHHHHH
Confidence            987  49999999999999655 8999999999976553  33445799999999999863  38999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |+|
T Consensus       236 MvT  238 (632)
T KOG0584|consen  236 MVT  238 (632)
T ss_pred             HHh
Confidence            997

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.97  E-value=1.1e-30  Score=189.01  Aligned_cols=150  Identities=42%  Similarity=0.756  Sum_probs=130.0

Q ss_pred             hHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7820          11 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   90 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~   90 (163)
                      .+.+|++++++++|+|++++++++..++..+++||++.+++.+.+.... .+++..+..++.|++.++++||+.|++|+|
T Consensus        66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d  144 (335)
T PTZ00024         66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKWYFMHRD  144 (335)
T ss_pred             hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccccCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence            5778999999999999999999999999999999999999988886543 688999999999999999999999999999


Q ss_pred             CCCCcEEEccCCceEEeecccccccccC--------------CCcccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          91 LKPQNILINKSGALKLADFGLSRAFTIP--------------MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        91 i~~~ni~~~~~~~~~l~d~~~~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      |+|.||+++.++.++++|||.+......              ........++..|+|||.+.+...++.++|+||+|+++
T Consensus       145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l  224 (335)
T PTZ00024        145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF  224 (335)
T ss_pred             ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence            9999999999999999999988655411              11122234577899999987655578999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|++
T Consensus       225 ~el~t  229 (335)
T PTZ00024        225 AELLT  229 (335)
T ss_pred             HHHHh
Confidence            99986

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.97  E-value=8.4e-31  Score=186.83  Aligned_cols=150  Identities=28%  Similarity=0.460  Sum_probs=125.7

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      .++.+|+++++++ +|||++++++++...+.+++++|++++ +|.+++....               ..+++..++.++.
T Consensus        47 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  126 (297)
T cd05089          47 RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS  126 (297)
T ss_pred             HHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHH
Confidence            4678899999999 799999999999999999999999984 8988886432               3578889999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      |++.++++||+.|++|+||+|+||+++.++.++++|||++....... .......+..|++||...+.. ++.++|+|||
T Consensus       127 qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSl  204 (297)
T cd05089         127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSV-YTTKSDVWSF  204 (297)
T ss_pred             HHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcccccee-ccCCCCcCccccCchhhccCC-CCchhhHHHH
Confidence            99999999999999999999999999999999999999876432111 111122245799999986544 6999999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      |+++|+|++
T Consensus       205 G~il~el~t  213 (297)
T cd05089         205 GVLLWEIVS  213 (297)
T ss_pred             HHHHHHHHc
Confidence            999999986

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0612|consensus

Probab=99.97  E-value=7.1e-32  Score=210.18  Aligned_cols=151  Identities=31%  Similarity=0.471  Sum_probs=136.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..-|..|-++|...+.+.|+.++..|+++.++|+||||++| +|+.++.+.. .+++.-++.++..|+-||.-+|+.|++
T Consensus       119 tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyV  197 (1317)
T KOG0612|consen  119 TACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYV  197 (1317)
T ss_pred             HHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccce
Confidence            34577889999999999999999999999999999999985 9999999887 899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccC-CCcccccccCccccCccccc----CCcCCCcchhhHHHHHHHHHHh
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ||||||+||++|..|++|+.|||.+-+.... .-.....+|||.|++||++.    +...|++..|+||+||++|||+
T Consensus       198 HRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl  275 (1317)
T KOG0612|consen  198 HRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEML  275 (1317)
T ss_pred             eccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHH
Confidence            9999999999999999999999998877743 44456779999999999984    2245899999999999999998

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.97  E-value=9.5e-31  Score=184.18  Aligned_cols=150  Identities=29%  Similarity=0.470  Sum_probs=125.7

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      ..+.+|+++++++ +|+|++++++++...+..+++||++++ +|.+++....               ..+++..++.++.
T Consensus        40 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  119 (270)
T cd05047          40 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA  119 (270)
T ss_pred             HHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHH
Confidence            4677899999999 799999999999999999999999984 8988886432               2478899999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      |++.++++||+.|++|+||+|+||+++.++.++++|||++....... .......+..|+|||...... ++.++|+||+
T Consensus       120 ~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~~y~apE~~~~~~-~~~~~Di~sl  197 (270)
T cd05047         120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSV-YTTNSDVWSY  197 (270)
T ss_pred             HHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhh-hccCCCCccccCChHHHccCC-CCchhhHHHH
Confidence            99999999999999999999999999999999999999875332111 111122255799999986544 6899999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      |+++|+|++
T Consensus       198 G~il~el~~  206 (270)
T cd05047         198 GVLLWEIVS  206 (270)
T ss_pred             HHHHHHHHc
Confidence            999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.97  E-value=2.5e-31  Score=189.21  Aligned_cols=150  Identities=30%  Similarity=0.546  Sum_probs=129.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|+..++.++|+|++++++.+..++..++++|++++ ++.+++..  +.+++..+..++.+++.++.+||+.+++
T Consensus        63 ~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~iv  140 (292)
T cd06658          63 RELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVI  140 (292)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            45678999999999999999999999999999999999986 66666543  3688999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+..............++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       141 H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~  213 (292)
T cd06658         141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMID  213 (292)
T ss_pred             ecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999998865443333333456788999999987644 6899999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.97  E-value=1.3e-30  Score=188.11  Aligned_cols=152  Identities=25%  Similarity=0.330  Sum_probs=125.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|+++++.++||||+++++++.+++..++|+||+++ ++.+++... ...+++..++.++.|++.|+.|||+++++
T Consensus        44 ~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ii  123 (327)
T cd08227          44 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYV  123 (327)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            3466799999999999999999999999999999999985 888887643 34588999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-------cccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHH
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-------RYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~l  159 (163)
                      |+||+|+||+++.++.+++.||+..........       ......++..|+|||.+.+. ..++.++|+||+|+++|+|
T Consensus       124 H~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el  203 (327)
T cd08227         124 HRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACEL  203 (327)
T ss_pred             cCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHH
Confidence            999999999999999999999975433221111       01122446679999998753 3478999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       204 ~~  205 (327)
T cd08227         204 AN  205 (327)
T ss_pred             HH
Confidence            86

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.97  E-value=1.1e-30  Score=182.34  Aligned_cols=152  Identities=31%  Similarity=0.473  Sum_probs=129.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...++.+|++++++++|+|++++++.+.+ ...++++|+++ ++|.+.+.... ..+++..+..++.|++.++++||+.|
T Consensus        39 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~  117 (257)
T cd05040          39 IMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR  117 (257)
T ss_pred             HHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC
Confidence            34567899999999999999999999988 88999999997 48998887655 57899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++++|||.+........   ......++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       118 i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t  195 (257)
T cd05040         118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFT  195 (257)
T ss_pred             ccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHh
Confidence            99999999999999999999999998876543211   111234567899999986644 6999999999999999986

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.97  E-value=5.7e-31  Score=185.94  Aligned_cols=155  Identities=70%  Similarity=1.190  Sum_probs=136.0

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .....+.+|++++++++|+|++++++++.+.+..++|+|++++++.+++......+++..+..++.+++.++.+||+.|+
T Consensus        40 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i  119 (282)
T cd07829          40 GIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI  119 (282)
T ss_pred             cccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34566788999999999999999999999999999999999999999998765678999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++|+|||.+..............++..|+|||.+.+...++.++|+||+|++++++++
T Consensus       120 ~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~  194 (282)
T cd07829         120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMIT  194 (282)
T ss_pred             ccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHh
Confidence            999999999999999999999999887665433333334456789999998766457999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.97  E-value=1e-30  Score=184.93  Aligned_cols=152  Identities=28%  Similarity=0.477  Sum_probs=128.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC--------------CCCCHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP--------------VPVPPALAKSYLYQ   73 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------------~~~~~~~~~~~~~~   73 (163)
                      ..++.+|+++++.++|+||+++++++.+++..++++|++++ +|.+++....              ..+++..++.++.|
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  130 (280)
T cd05092          51 RQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ  130 (280)
T ss_pred             HHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHH
Confidence            35688999999999999999999999999999999999985 8888876543              24788999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      ++.+++|||+.|++|+||+|+||+++.++.++++|||.+........  ......+++.|+|||...+.. ++.++|+||
T Consensus       131 i~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s  209 (280)
T cd05092         131 IASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWS  209 (280)
T ss_pred             HHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHH
Confidence            99999999999999999999999999999999999998865432111  111223356799999987655 699999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      ||+++|+|++
T Consensus       210 lG~il~el~~  219 (280)
T cd05092         210 FGVVLWEIFT  219 (280)
T ss_pred             HHHHHHHHHc
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.4e-30  Score=183.84  Aligned_cols=151  Identities=28%  Similarity=0.546  Sum_probs=131.3

Q ss_pred             hhhHHHHHHHHhcCC---CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..++.+|++++++++   |+|++++++++.++...+++|||+++ +|.+++...  .+++..+..++.+++.++.+||+.
T Consensus        43 ~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~  120 (277)
T cd06917          43 VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV  120 (277)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            356788999999996   99999999999999999999999986 787776543  788999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+|++|+||+++.++.++++|||.+..............|+..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       121 ~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~  197 (277)
T cd06917         121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT  197 (277)
T ss_pred             CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh
Confidence            99999999999999999999999999887665443334445678889999998765556899999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.97  E-value=1.6e-30  Score=181.00  Aligned_cols=152  Identities=26%  Similarity=0.447  Sum_probs=129.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+||+++++++.+....++++|++.+ ++.+++......++...+..++.+++.++.+||+++++
T Consensus        36 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~  115 (251)
T cd05041          36 KRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI  115 (251)
T ss_pred             HHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            45688999999999999999999999999999999999975 88888876666788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcc--cccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+..........  .....+..|.|||.+.+.. ++.++|+||+|+++|+|+|
T Consensus       116 h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t  190 (251)
T cd05041         116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFS  190 (251)
T ss_pred             hhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHh
Confidence            99999999999999999999999886543211111  1112245699999986644 6999999999999999996

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.97  E-value=1.4e-30  Score=184.22  Aligned_cols=145  Identities=28%  Similarity=0.477  Sum_probs=125.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .++.+|++++++++|+|++++++.+...+..++|+||+++..++..    ..+++..+..++.|++.++.|||+.|++|+
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~  119 (279)
T cd06619          44 KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHR  119 (279)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeC
Confidence            4678999999999999999999999999999999999997333322    256788889999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+|+||+++.++.++++|||++......  ......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       120 dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~  188 (279)
T cd06619         120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELAL  188 (279)
T ss_pred             CCCHHHEEECCCCCEEEeeCCcceecccc--cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHh
Confidence            99999999999999999999988654422  223456788999999987654 6999999999999999986

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.97  E-value=1.1e-30  Score=182.91  Aligned_cols=152  Identities=26%  Similarity=0.459  Sum_probs=129.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|+.+++.++|+|++++++.+.+++..++++|++++ +|.+++... ...++...++.++.+++.+++|||+.++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i  124 (261)
T cd05072          45 VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNY  124 (261)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            45778999999999999999999999999999999999975 898888653 4567888999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+......... .....++..|+|||...+.. ++.++|+||+|+++|+|+|
T Consensus       125 ~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t  199 (261)
T cd05072         125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVT  199 (261)
T ss_pred             eccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHc
Confidence            99999999999999999999999998765432211 11223456799999986644 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.97  E-value=1.8e-30  Score=183.49  Aligned_cols=149  Identities=44%  Similarity=0.777  Sum_probs=128.3

Q ss_pred             hHHHHHHHHhcCC-CCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          11 TALREISVLKELK-HPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        11 ~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+|+.+++++. |+|++++++++.++  +.+++|+||+++++.+.+......+++..+..++.|++.++++||+.+++
T Consensus        43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~  122 (282)
T cd07831          43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIF  122 (282)
T ss_pred             hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence            3457889999885 99999999999887  89999999999999998887666889999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++. +.++|+|||.+........ .....++..|+|||.......++.++|+||+|+++|+|++
T Consensus       123 H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~  194 (282)
T cd07831         123 HRDIKPENILIKD-DILKLADFGSCRGIYSKPP-YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS  194 (282)
T ss_pred             ecccCHHHEEEcC-CCeEEEecccccccccCCC-cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence            9999999999999 9999999998876542221 2233467889999987554556889999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.97  E-value=1.4e-30  Score=183.19  Aligned_cols=152  Identities=26%  Similarity=0.466  Sum_probs=128.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++..|+.++++++|+|++++.+++.+++..++++|++++ +|.+++....+.+++..++.++.|++.++.+||++|++
T Consensus        49 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~  128 (269)
T cd05065          49 RRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYV  128 (269)
T ss_pred             HHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            45688899999999999999999999999999999999986 88888877666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcc--cc-cc--cCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--TH-EV--VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~--~~-~~--~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+..........  .. ..  .+..|++||.+.+.. ++.++|+||+|+++||+++
T Consensus       129 H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~  206 (269)
T cd05065         129 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMS  206 (269)
T ss_pred             ecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhc
Confidence            99999999999999999999999876543221111  11 11  134699999987654 6999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0667|consensus

Probab=99.97  E-value=3.4e-31  Score=196.88  Aligned_cols=148  Identities=35%  Similarity=0.615  Sum_probs=128.7

Q ss_pred             hhHHHHHHHHhcCC-C-----CCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELK-H-----PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h-----~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .+...|+.+|..++ |     -|+|+++++|...++.|||+|.++.+|.+++.... ..++...++.++.||+.+|.+||
T Consensus       227 ~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~  306 (586)
T KOG0667|consen  227 RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLH  306 (586)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            34567999999996 4     48999999999999999999999999999997754 56889999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCC--ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          83 SRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +.+|+|+|+||+|||+...+  .+||+|||.++.......   .-..+..|.|||++.+.+ |+.+.|||||||++.||.
T Consensus       307 ~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy---tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~  382 (586)
T KOG0667|consen  307 ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY---TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELF  382 (586)
T ss_pred             hCCeeeccCChhheeeccCCcCceeEEecccccccCCcce---eeeeccccccchhhccCC-CCCccceeehhhhHHhHh
Confidence            99999999999999996543  689999999987553322   334477899999999865 899999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       383 t  383 (586)
T KOG0667|consen  383 T  383 (586)
T ss_pred             c
Confidence            6

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.97  E-value=2.2e-30  Score=182.93  Aligned_cols=150  Identities=30%  Similarity=0.495  Sum_probs=130.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+.++++++|+|++++++.+.++...++|||++++ +|.+++..  +.+++..+..++.+++.++.+||+.+++
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~iv  123 (277)
T cd06640          46 IEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKI  123 (277)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            34678899999999999999999999999999999999986 88887764  3678889999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+..............++..|.|||...+.. .+.++|+||+|+++|+|+|
T Consensus       124 H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~t  196 (277)
T cd06640         124 HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAK  196 (277)
T ss_pred             CcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHH
Confidence            999999999999999999999998866543332333445678899999987654 6999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.97  E-value=1.5e-30  Score=184.63  Aligned_cols=150  Identities=29%  Similarity=0.559  Sum_probs=130.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|+.+++.++|+|++++++++..++..++++|++++ +|.+.+..  ..+++..+..++.+++.++++||+.|++
T Consensus        60 ~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~  137 (285)
T cd06648          60 RELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVI  137 (285)
T ss_pred             HHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34578899999999999999999999999999999999976 88887766  4688999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|.||+++.++.++++|||.+..............++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       138 H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~  210 (285)
T cd06648         138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVD  210 (285)
T ss_pred             cCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHh
Confidence            999999999999999999999998765443333333456788999999987644 7899999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.97  E-value=1.4e-30  Score=183.13  Aligned_cols=153  Identities=19%  Similarity=0.345  Sum_probs=126.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...+.+|+.+++.++|||++++++.+.+....++||||+++ +|.+++....   ...+...++.++.|++.|++|||+.
T Consensus        39 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~  118 (268)
T cd05086          39 QNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH  118 (268)
T ss_pred             HHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            45788999999999999999999999999999999999985 8988886542   3456677888999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCC------cCCCcchhhHHHHHHH
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGA------KVYSTTVDIWSAGCIF  156 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~------~~~~~~~Di~slG~~l  156 (163)
                      +++|+||+|+||+++.++.++++|||.+......  ........++..|+|||+....      ..++.++|+||+|+++
T Consensus       119 ~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  198 (268)
T cd05086         119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTL  198 (268)
T ss_pred             CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHH
Confidence            9999999999999999999999999987532211  1112234567889999987421      2247899999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |||++
T Consensus       199 ~el~~  203 (268)
T cd05086         199 WELFE  203 (268)
T ss_pred             HHHHh
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.97  E-value=4.7e-31  Score=188.20  Aligned_cols=151  Identities=29%  Similarity=0.532  Sum_probs=130.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+.+++.++|+|++++++.+..++..++++|++++ ++...+..  ..+++..++.++.|++.++.+||+.|+
T Consensus        61 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~i  138 (297)
T cd06659          61 RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGV  138 (297)
T ss_pred             hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            345678899999999999999999999999999999999986 77665543  367899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+..............++..|+|||.+.+.. ++.++|+||+|+++++|++
T Consensus       139 vH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~  212 (297)
T cd06659         139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVD  212 (297)
T ss_pred             ecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999998865543333344556788999999987654 6999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.97  E-value=1.1e-30  Score=182.30  Aligned_cols=153  Identities=31%  Similarity=0.607  Sum_probs=132.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|++++++++|+|++++.+.+.+.+..++|+|++.+ ++.+.+.... ..+++..+..++.|++.++.+||++++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  122 (256)
T cd08218          43 REESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            45788999999999999999999999999999999999975 8888886543 467899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      +|+|++|+||+++.++.++++|||.+..............++..|+|||...+.. .+.++|+||+|+++++|++.
T Consensus       123 ~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g  197 (256)
T cd08218         123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTL  197 (256)
T ss_pred             ecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcC
Confidence            9999999999999999999999998876554333333445688899999987654 68899999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.97  E-value=1.3e-30  Score=185.45  Aligned_cols=152  Identities=29%  Similarity=0.474  Sum_probs=128.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC----------CCCCHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----------VPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~i~~~   77 (163)
                      ..++.+|++++++++|+|++++++++..++..++++|++.+ +|.+++....          ..+++..++.++.|++.+
T Consensus        63 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~a  142 (296)
T cd05051          63 REDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASG  142 (296)
T ss_pred             HHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHH
Confidence            45677899999999999999999999999999999999985 8888876543          268899999999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820          78 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus        78 l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                      +.+||+.+++|+||+|+||+++.++.++++|||.+........  ......++..|+|||...+.. ++.++|+||+|++
T Consensus       143 l~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~  221 (296)
T cd05051         143 MRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVT  221 (296)
T ss_pred             HHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHH
Confidence            9999999999999999999999999999999998865432211  112233466899999987644 6999999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|+|++
T Consensus       222 l~el~~  227 (296)
T cd05051         222 LWEILT  227 (296)
T ss_pred             HHHHHh
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.97  E-value=2.1e-30  Score=183.45  Aligned_cols=150  Identities=28%  Similarity=0.470  Sum_probs=125.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.+|++++++++|+|++++++++...  ..++++||++++ +|.+++...  .+++..++.++.+++.++.+||+++
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~~  127 (283)
T cd05080          50 TSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQH  127 (283)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678899999999999999999987653  468999999985 888877653  5899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++++|||.+.........   .....++..|++||...+.. ++.++|+||+|+++|+|+|
T Consensus       128 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~t  205 (283)
T cd05080         128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLT  205 (283)
T ss_pred             eeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHh
Confidence            999999999999999999999999988765432211   11223355699999987654 6899999999999999997

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.97  E-value=1.4e-30  Score=186.43  Aligned_cols=151  Identities=28%  Similarity=0.507  Sum_probs=127.1

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      .++..|+++++++ +|+|++++++++..++..++++||+++ +|.+++....               ..+++.+++.++.
T Consensus        68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  147 (307)
T cd05098          68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY  147 (307)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence            4577899999999 799999999999999999999999985 9998886532               2478899999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      |++.++++||+.|++|+||+|+||+++.++.++++|||.+.........  .....++..|+|||...+.. ++.++|+|
T Consensus       148 qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dvw  226 (307)
T cd05098         148 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVW  226 (307)
T ss_pred             HHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHH
Confidence            9999999999999999999999999999999999999988654321111  11122346799999987654 69999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       227 slG~~l~el~~  237 (307)
T cd05098         227 SFGVLLWEIFT  237 (307)
T ss_pred             HHHHHHHHHHc
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.97  E-value=1.9e-30  Score=184.01  Aligned_cols=152  Identities=33%  Similarity=0.572  Sum_probs=133.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|+++++.++|+|++++++.+..++..++++|++++ +|.+++......++...+..++.+++.++.+||+.|++
T Consensus        59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~  138 (286)
T cd06614          59 KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI  138 (286)
T ss_pred             HHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45688999999999999999999999999999999999994 99988887655789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|.||+++.++.++++|||.+..............++..|++||.+.+.. ++.++|+||+|+++|+|++
T Consensus       139 H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~  211 (286)
T cd06614         139 HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAE  211 (286)
T ss_pred             eCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHh
Confidence            999999999999999999999998765543322223345678899999987644 6999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG4250|consensus

Probab=99.97  E-value=3.8e-31  Score=198.17  Aligned_cols=155  Identities=35%  Similarity=0.523  Sum_probs=133.4

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------EEEEEecchhc-cHHHHHhcCC--CCCCHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLE   76 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~i~~   76 (163)
                      .+..++..+|+++|++++|+|||+++++-++..      ...++||||.| +|...+....  -.+++...+.++.++++
T Consensus        52 ~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~  131 (732)
T KOG4250|consen   52 LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVS  131 (732)
T ss_pred             cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHH
Confidence            345566789999999999999999999976654      45799999985 8888876542  47899999999999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEcc--CC--ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          77 ALRYCHSRRIIHRDLKPQNILINK--SG--ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        77 ~l~~lh~~~i~h~~i~~~ni~~~~--~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      |+.|||++||+||||||.||++..  +|  .-||+|||.|+..... ....+..||..|.+||..-..+.|+...|.||+
T Consensus       132 al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~-s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~  210 (732)
T KOG4250|consen  132 ALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN-SLFTSLVGTEEYLHPELYERQKKYTATVDLWSF  210 (732)
T ss_pred             HHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC-CeeeeecCchhhcChHHHhhccCcCceeehhhh
Confidence            999999999999999999999843  34  3599999999877754 478899999999999998755668999999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      ||++|+..|
T Consensus       211 GvtlY~caT  219 (732)
T KOG4250|consen  211 GVTLYECAT  219 (732)
T ss_pred             hhHHHHHhc
Confidence            999999987

>KOG0201|consensus

Probab=99.97  E-value=2e-32  Score=195.50  Aligned_cols=154  Identities=32%  Similarity=0.488  Sum_probs=137.8

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +...+++.+|+.+|.+++++||.++|+.+-.+..++++||||.| ++.+.+...+ .+++..+.-+++++..++.|||.+
T Consensus        52 ~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~  130 (467)
T KOG0201|consen   52 EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSE  130 (467)
T ss_pred             chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhc
Confidence            44567788999999999999999999999999999999999986 7777776554 557887888899999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.+|+|||+.||++..+|.++++|||++............+.||+.|||||++.+.. |+.++||||||++.+||.+
T Consensus       131 ~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~-Y~~KADIWSLGITaiEla~  206 (467)
T KOG0201|consen  131 KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSG-YDTKADIWSLGITAIELAK  206 (467)
T ss_pred             ceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcccc-ccchhhhhhhhHHHHHHhc
Confidence            999999999999999999999999999987776656667889999999999998644 8999999999999999986

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.97  E-value=1.7e-30  Score=181.97  Aligned_cols=152  Identities=25%  Similarity=0.446  Sum_probs=126.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeee-eCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|..+++.++|+|++++++++. .++..++++|++. ++|.+++.......+...+..++.++++++.+||+.++
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  119 (262)
T cd05058          40 VEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKF  119 (262)
T ss_pred             HHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            346778999999999999999999764 4556889999998 49999887766567788888999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC----CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+.......    .......++..|+|||...+.. ++.++|+||+|+++|||++
T Consensus       120 ~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~  197 (262)
T cd05058         120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT  197 (262)
T ss_pred             cccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHHHHHHc
Confidence            999999999999999999999999886543211    1111223466799999986644 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.97  E-value=1.9e-30  Score=185.51  Aligned_cols=151  Identities=28%  Similarity=0.500  Sum_probs=127.6

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      .++.+|+.+++.+ +|+|++++++.+...+..+++|||+.+ +|.+++....               ..++...+..++.
T Consensus        65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (304)
T cd05101          65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY  144 (304)
T ss_pred             HHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHH
Confidence            4678899999999 899999999999999999999999985 8888886532               2467788899999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      |++.++.|||+.|++|+||+|+||+++.++.++++|||.+.........  .....++..|+|||...+.. ++.++|+|
T Consensus       145 qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~  223 (304)
T cd05101         145 QVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVW  223 (304)
T ss_pred             HHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHH
Confidence            9999999999999999999999999999999999999998765432211  11223356799999987644 68999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       224 slG~~l~el~~  234 (304)
T cd05101         224 SFGVLMWEIFT  234 (304)
T ss_pred             HHHHHHHHHHc
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.97  E-value=1.2e-30  Score=185.58  Aligned_cols=151  Identities=29%  Similarity=0.528  Sum_probs=127.0

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---------------CCCCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---------------TPVPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---------------~~~~~~~~~~~~~~~   72 (163)
                      .++.+|+++++++ +|+|++++++++..++.++++|||+++ +|..++..               ....+++..++.++.
T Consensus        60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  139 (293)
T cd05053          60 SDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY  139 (293)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHH
Confidence            4577899999999 799999999999999999999999975 88888753               234688999999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      |++.++.|||+.+++|+||+|+||+++.++.++++|||.+.........  .....++..|+|||...+.. ++.++|+|
T Consensus       140 qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~  218 (293)
T cd05053         140 QVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVW  218 (293)
T ss_pred             HHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC-cCccccee
Confidence            9999999999999999999999999999999999999988765432111  11122356799999976544 69999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|++++
T Consensus       219 slG~il~el~~  229 (293)
T cd05053         219 SFGVLLWEIFT  229 (293)
T ss_pred             ehhhHHHHHhc
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.97  E-value=2e-30  Score=184.79  Aligned_cols=151  Identities=29%  Similarity=0.479  Sum_probs=126.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC----------CCCCHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----------VPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------~~~~~~~~~~~~~~i~~~l   78 (163)
                      .++.+|++++++++|+|++++++++..++..+++||++.+ +|.+++....          ..+++.++..++.|++.++
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al  143 (296)
T cd05095          64 NDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGM  143 (296)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999999999999999985 8888876532          2366788999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      ++||+.|++|+||+|+||+++.++.++++|||.+.........  .....++..|++||...+.. ++.++|+||+|+++
T Consensus       144 ~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l  222 (296)
T cd05095         144 KYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTL  222 (296)
T ss_pred             HHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHH
Confidence            9999999999999999999999999999999988754322111  11122356799999876544 79999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |||++
T Consensus       223 ~el~~  227 (296)
T cd05095         223 WEILT  227 (296)
T ss_pred             HHHHH
Confidence            99986

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.97  E-value=2.4e-30  Score=181.61  Aligned_cols=150  Identities=31%  Similarity=0.520  Sum_probs=126.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+|++++++++|+|++++++++.+.  ..+++++|++++ +|.+++... ..+++...+.++.+++.++++||+.++
T Consensus        49 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i  127 (265)
T cd06652          49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMI  127 (265)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4577899999999999999999998764  478899999985 888877654 367888899999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccC---CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIP---MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|.||+++.++.++++|||.+......   ........++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       128 ~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~  204 (265)
T cd06652         128 VHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVVEMLT  204 (265)
T ss_pred             ecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHHHHhh
Confidence            99999999999999999999999988654321   11222345688899999987654 6899999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.97  E-value=9.5e-31  Score=184.74  Aligned_cols=149  Identities=31%  Similarity=0.515  Sum_probs=129.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++|+|++++++.+..+...++|+||+++ ++.+.+..  ..+++..+..++.+++.++.|||+.+++|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH  124 (277)
T cd06642          47 EDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIH  124 (277)
T ss_pred             HHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeec
Confidence            4678999999999999999999999999999999999986 77777653  46889999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++.++++|||.+..............++..|++||.+.+.. ++.++|+||+|+++|+|++
T Consensus       125 ~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t  196 (277)
T cd06642         125 RDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAK  196 (277)
T ss_pred             cCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHHHHHHh
Confidence            99999999999999999999998866543322223345688899999987654 6899999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.97  E-value=1.9e-30  Score=183.31  Aligned_cols=151  Identities=30%  Similarity=0.471  Sum_probs=130.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+..|++++++++|+|++++++.+...+..|+|+||+++ +|.+.+.... ..+++..+..++.|++.++.+||+.|+
T Consensus        37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i  116 (277)
T cd05577          37 EQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRI  116 (277)
T ss_pred             hHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567899999999999999999999999999999999985 8888876543 368999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+..... ........++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       117 ~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~  189 (277)
T cd05577         117 VYRDLKPENVLLDDHGNVRISDLGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIA  189 (277)
T ss_pred             ccCCCCHHHEEECCCCCEEEccCcchhhhcc-CCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhh
Confidence            9999999999999999999999998765442 22223345677899999987655 6899999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG1989|consensus

Probab=99.97  E-value=3.2e-31  Score=202.14  Aligned_cols=153  Identities=28%  Similarity=0.493  Sum_probs=125.8

Q ss_pred             chhhHHHHHHHHhcCC-CCCeeeeeeeee------e-CcEEEEEecchh-ccHHHHHhcC-CCCCCHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELK-HPNVIRLHDVIP------V-DFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~-h~~i~~~~~~~~------~-~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~   77 (163)
                      .-....+|+++|++|+ |+|||.+++...      . ...+.|+||||. |+|.++++.. ...+.+..+++|++|++.|
T Consensus        77 ~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~A  156 (738)
T KOG1989|consen   77 ALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEA  156 (738)
T ss_pred             HHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHH
Confidence            3455789999999996 999999999321      1 236889999999 5999999854 2459999999999999999


Q ss_pred             HHHHHhCC--ceecCCCCCcEEEccCCceEEeecccccccccCCCc---------ccccccCccccCccccc--CCcCCC
Q psy7820          78 LRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---------YTHEVVTLWYRPPEILL--GAKVYS  144 (163)
Q Consensus        78 l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~~~pe~~~--~~~~~~  144 (163)
                      +.+||...  ++|||||-+|+|++.+|+.||||||.+.........         .-....|+-|++||.+.  ++.+.+
T Consensus       157 Va~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~  236 (738)
T KOG1989|consen  157 VAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG  236 (738)
T ss_pred             HHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc
Confidence            99999887  999999999999999999999999988765433311         11224488999999973  334579


Q ss_pred             cchhhHHHHHHHHHHh
Q psy7820         145 TTVDIWSAGCIFSEMI  160 (163)
Q Consensus       145 ~~~Di~slG~~l~~ll  160 (163)
                      .|+|||||||+||.|.
T Consensus       237 eKsDIWALGclLYkLC  252 (738)
T KOG1989|consen  237 EKSDIWALGCLLYKLC  252 (738)
T ss_pred             chhHHHHHHHHHHHHH
Confidence            9999999999999987

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.97  E-value=2.4e-30  Score=185.86  Aligned_cols=151  Identities=28%  Similarity=0.512  Sum_probs=126.5

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      .++.+|+++++++ +|+||+++++++..++.+++++||+++ +|.+++....               ..+++.++..++.
T Consensus        62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  141 (314)
T cd05099          62 ADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAY  141 (314)
T ss_pred             HHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHH
Confidence            4577899999999 699999999999999999999999985 8888886532               3578889999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      |++.++.|||++|++|+|++|+||+++.++.++++|||.++........  .....++..|+|||.+.+.. ++.++|+|
T Consensus       142 qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diw  220 (314)
T cd05099         142 QVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV-YTHQSDVW  220 (314)
T ss_pred             HHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC-cCccchhh
Confidence            9999999999999999999999999999999999999998755422111  11112245799999987644 69999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       221 slG~~l~el~~  231 (314)
T cd05099         221 SFGILMWEIFT  231 (314)
T ss_pred             HHHHHHHHHHh
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.1e-30  Score=182.74  Aligned_cols=151  Identities=25%  Similarity=0.455  Sum_probs=127.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ..+.+|+++++.++|+|++++++++..++..+++||+++ ++|.+++....         ..+++..+..++.|++.++.
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  133 (277)
T cd05032          54 IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA  133 (277)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHH
Confidence            457789999999999999999999999999999999997 58888875432         24678889999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      |||+.+++|+||+|+||+++.++.++++|||.+.......  .......++..|+|||...+.. ++.++|+||+|+++|
T Consensus       134 ~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  212 (277)
T cd05032         134 YLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLW  212 (277)
T ss_pred             HHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHH
Confidence            9999999999999999999999999999999886543221  1122334467899999987654 699999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      |++|
T Consensus       213 el~t  216 (277)
T cd05032         213 EMAT  216 (277)
T ss_pred             Hhhc
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.1e-30  Score=180.25  Aligned_cols=150  Identities=31%  Similarity=0.471  Sum_probs=126.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+|++++++++.. ...+++||++.+ +|.+++.... .+++..+..++.|++.++++||+.+++
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~~i~  117 (257)
T cd05060          40 KKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESKHFV  117 (257)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence            4567889999999999999999998764 468999999975 8988887655 789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccc---cccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~---~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++++|||.+............   ..++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       118 H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~  193 (257)
T cd05060         118 HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFS  193 (257)
T ss_pred             ccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHc
Confidence            9999999999999999999999988765433222111   12245799999987654 6999999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.97  E-value=4.2e-30  Score=184.81  Aligned_cols=148  Identities=30%  Similarity=0.519  Sum_probs=130.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .++.+|++++++++|+|++++++++.++...++||||+.|++.+.+......+++..+..++.+++.++.+||+.+++|+
T Consensus        70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~  149 (317)
T cd06635          70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR  149 (317)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            46788999999999999999999999999999999999999888887766789999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+++.++.++++|||.+.....    .....++..|+|||.+..  ...++.++|+||+|+++|+|++
T Consensus       150 dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~  219 (317)
T cd06635         150 DIKAGNILLTEPGQVKLADFGSASIASP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  219 (317)
T ss_pred             CCCcccEEECCCCCEEEecCCCccccCC----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh
Confidence            9999999999999999999998754332    223456788999999742  2346889999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.97  E-value=2e-30  Score=184.23  Aligned_cols=151  Identities=27%  Similarity=0.516  Sum_probs=127.0

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-----------------------CCCCCHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-----------------------PVPVPPA   65 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-----------------------~~~~~~~   65 (163)
                      .++.+|+.+++.++||||+++++.+..++..++++||+.+ +|.+++...                       ...+++.
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  127 (290)
T cd05045          48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG  127 (290)
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHH
Confidence            4578899999999999999999999999999999999984 888876532                       1347888


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCC
Q psy7820          66 LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVY  143 (163)
Q Consensus        66 ~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~  143 (163)
                      .++.++.|++.++++||+.+++|+||+|+||+++.++.++|+|||.+........  ......++..|++||...+.. +
T Consensus       128 ~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~  206 (290)
T cd05045         128 DLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-Y  206 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-c
Confidence            9999999999999999999999999999999999999999999998865432211  112223456799999986644 6


Q ss_pred             CcchhhHHHHHHHHHHhc
Q psy7820         144 STTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       144 ~~~~Di~slG~~l~~ll~  161 (163)
                      +.++|+||+|+++++|++
T Consensus       207 ~~~~Di~slG~~l~el~t  224 (290)
T cd05045         207 TTQSDVWSFGVLLWEIVT  224 (290)
T ss_pred             chHhHHHHHHHHHHHHHh
Confidence            999999999999999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.97  E-value=3.3e-30  Score=181.39  Aligned_cols=153  Identities=27%  Similarity=0.448  Sum_probs=128.9

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeC------cEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVD------FKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~------~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ..++.+|+.+++++ +|+|++++++++...      ..+++++||+++ ++.+++... ...+++..+..++.|++.++.
T Consensus        46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~  125 (272)
T cd06637          46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS  125 (272)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence            45678999999999 699999999998653      468999999985 888887764 346889999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCI  155 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~  155 (163)
                      |||+++++|+|++|+||+++.++.++++|||++..............|+..|+|||++.+    ...++.++|+||+|++
T Consensus       126 ~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~  205 (272)
T cd06637         126 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGIT  205 (272)
T ss_pred             HHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHH
Confidence            999999999999999999999999999999998765433333444567889999999753    2246889999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|+|++
T Consensus       206 l~el~~  211 (272)
T cd06637         206 AIEMAE  211 (272)
T ss_pred             HHHHHh
Confidence            999996

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.97  E-value=1.9e-30  Score=183.62  Aligned_cols=151  Identities=25%  Similarity=0.456  Sum_probs=126.7

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC---------------CCCCCHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---------------PVPVPPALAKSYLYQ   73 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------~~~~~~~~~~~~~~~   73 (163)
                      +++.+|..+++.++|+||+++++++.+.+..++++||+.+ ++.+++...               ...++...+..++.|
T Consensus        53 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  132 (283)
T cd05091          53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ  132 (283)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHH
Confidence            4578899999999999999999999999999999999985 788777422               134788889999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      ++.++.+||+.|++|+||||+||+++.++.++++|||+++......  .......+++.|+|||...+.. ++.++|+||
T Consensus       133 l~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s  211 (283)
T cd05091         133 IAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWS  211 (283)
T ss_pred             HHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHH
Confidence            9999999999999999999999999999999999999876543221  1112233467899999987654 699999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +|+++|||++
T Consensus       212 lG~~l~el~~  221 (283)
T cd05091         212 YGVVLWEVFS  221 (283)
T ss_pred             HHHHHHHHHc
Confidence            9999999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=3.3e-30  Score=182.16  Aligned_cols=150  Identities=23%  Similarity=0.462  Sum_probs=128.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|+.++++++|+|++++++++.. +..++++|++++ ++.+++....+.+++..+..++.|++.++++||+.+++|
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H  132 (279)
T cd05057          54 KEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVH  132 (279)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence            467789999999999999999999887 788999999974 999998877667999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCccc--ccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~--~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++++|||.++..........  ...++..|++||...... ++.++|+||+|+++||+++
T Consensus       133 ~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~~  206 (279)
T cd05057         133 RDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTVWELMT  206 (279)
T ss_pred             cccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHHHHHhc
Confidence            99999999999999999999998876542221111  112245799999986544 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.97  E-value=2.2e-30  Score=181.04  Aligned_cols=150  Identities=28%  Similarity=0.449  Sum_probs=125.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+.+++.++|+|++++++++.. +..+++||++++ +|.+++... ..+++..+..++.|++.++++||++|++
T Consensus        40 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~  117 (257)
T cd05116          40 KDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFV  117 (257)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            4567889999999999999999998864 467899999985 788877654 4788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|.||+++.++.++++|||.+.........   .....++..|+|||.+.... ++.++|+||+|+++|||++
T Consensus       118 H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t  193 (257)
T cd05116         118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             ecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHHHHHHh
Confidence            9999999999999999999999988765433221   11223356899999986544 6889999999999999986

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>KOG0596|consensus

Probab=99.97  E-value=1.4e-30  Score=190.89  Aligned_cols=152  Identities=35%  Similarity=0.508  Sum_probs=130.5

Q ss_pred             chhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...-+.+|+.+|.+++ |.+|+++++|-..++++|+|||+-+.+|...+.......+...++.+..|++.++..+|+.||
T Consensus       402 tl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gI  481 (677)
T KOG0596|consen  402 TLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGI  481 (677)
T ss_pred             HHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhce
Confidence            3456789999999995 899999999999999999999988889999998877666655788899999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCc----------CCCcchhhHHHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAK----------VYSTTVDIWSAGC  154 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~----------~~~~~~Di~slG~  154 (163)
                      +|.|+||.|+++ ..|.+||+|||++.......+.  ...-+||+.||+||.+....          ..+.++|||||||
T Consensus       482 VHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGC  560 (677)
T KOG0596|consen  482 VHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGC  560 (677)
T ss_pred             eecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhh
Confidence            999999999998 7799999999999887655433  23458899999999985221          1467899999999


Q ss_pred             HHHHHh
Q psy7820         155 IFSEMI  160 (163)
Q Consensus       155 ~l~~ll  160 (163)
                      +||+|+
T Consensus       561 ILYqMv  566 (677)
T KOG0596|consen  561 ILYQMV  566 (677)
T ss_pred             HHHHHH
Confidence            999997

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.97  E-value=2.7e-30  Score=181.25  Aligned_cols=150  Identities=29%  Similarity=0.519  Sum_probs=129.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|++++++++|+|++++.+++.+++..++++|++++ +|.+++.+. +.+++..+..++.|++.++++||+.+++|
T Consensus        47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  125 (265)
T cd06631          47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVH  125 (265)
T ss_pred             HHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            4578899999999999999999999999999999999986 888777654 36789999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccC------CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIP------MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|.||+++.++.++++|||.+......      ........++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       126 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~  203 (265)
T cd06631         126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMAT  203 (265)
T ss_pred             CCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHh
Confidence            999999999999999999999988654311      11122345688899999987654 6899999999999999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0574|consensus

Probab=99.97  E-value=4.4e-32  Score=187.12  Aligned_cols=158  Identities=30%  Similarity=0.486  Sum_probs=144.2

Q ss_pred             cccCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           3 VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         3 ~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      +-.+..-.++++|+.++++++.+++|++|+.+-....+|+|||||+ |+..+.+.....++++..+..++.+.++|++||
T Consensus        66 VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YL  145 (502)
T KOG0574|consen   66 VPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYL  145 (502)
T ss_pred             cCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHH
Confidence            4456677889999999999999999999998777778999999998 799999988888999999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          82 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |...-+|+|||..||+++.+|..|+.|||.+-....-..+.....||+-|+|||++..-+ |+.++||||||++..||.+
T Consensus       146 H~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAE  224 (502)
T KOG0574|consen  146 HDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAE  224 (502)
T ss_pred             HHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhc
Confidence            999999999999999999999999999999877766667777889999999999997655 7999999999999999875

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.97  E-value=2.9e-30  Score=184.16  Aligned_cols=154  Identities=45%  Similarity=0.912  Sum_probs=130.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCc----------EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDF----------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~   77 (163)
                      ....+.+|++++++++|+|++++++++.+..          .+++++|++++++...+......+++..+..++.|++.+
T Consensus        49 ~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~a  128 (302)
T cd07864          49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG  128 (302)
T ss_pred             chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            3346678999999999999999999987654          799999999998888887766678999999999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          78 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        78 l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      +.+||+.|++|+|++|.||+++.++.++++|||.+......... .....++..|++||.+.+...++.++|+||+|+++
T Consensus       129 L~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~  208 (302)
T cd07864         129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCIL  208 (302)
T ss_pred             HHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHH
Confidence            99999999999999999999999999999999988765432211 11223467899999886555568999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      ++|++
T Consensus       209 ~el~~  213 (302)
T cd07864         209 GELFT  213 (302)
T ss_pred             HHHHh
Confidence            99985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.97  E-value=2.7e-30  Score=182.48  Aligned_cols=151  Identities=25%  Similarity=0.464  Sum_probs=125.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------VPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..+.+|+.++++++|+|++++++++.+.+..+++||++++ +|.+++....      ..+++..++.++.|++.+++|||
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH  133 (277)
T cd05036          54 SDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE  133 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999988899999999975 8888876543      25789999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCC---ceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          83 SRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      +++++|+||+|+||+++.++   .++++|||.+........  .......+..|+|||.+.+.. ++.++|+||+|+++|
T Consensus       134 ~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~  212 (277)
T cd05036         134 ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLW  212 (277)
T ss_pred             HCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHH
Confidence            99999999999999998765   589999998876532111  111222245799999987654 799999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       213 el~~  216 (277)
T cd05036         213 EIFS  216 (277)
T ss_pred             HHHc
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.97  E-value=3.4e-30  Score=181.24  Aligned_cols=152  Identities=23%  Similarity=0.327  Sum_probs=124.7

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .++.+|+.++++++|+|++++++.+.+....++||||+++ +|.+++....    ...++..+..++.|++.++.|||+.
T Consensus        40 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~  119 (269)
T cd05087          40 MKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN  119 (269)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC
Confidence            3678899999999999999999999998899999999984 8888876432    2456777888999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCc------CCCcchhhHHHHHHH
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAK------VYSTTVDIWSAGCIF  156 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~------~~~~~~Di~slG~~l  156 (163)
                      +++|+|++|+|++++.++.++++|||.+........  ......++..|+|||.+.+..      .++.++|+||+|+++
T Consensus       120 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  199 (269)
T cd05087         120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI  199 (269)
T ss_pred             CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence            999999999999999999999999998864332111  112234567899999975321      247899999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |||++
T Consensus       200 ~el~~  204 (269)
T cd05087         200 WELFE  204 (269)
T ss_pred             HHHHh
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.5e-30  Score=185.77  Aligned_cols=153  Identities=32%  Similarity=0.461  Sum_probs=130.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+..|+++++.++|+|++++++.+.++...+++||++.+ +|.+++... ...+++..+..++.|+++++.|||+.|
T Consensus        44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  123 (316)
T cd05574          44 KVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG  123 (316)
T ss_pred             HHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678899999999999999999999999999999999986 888887654 357899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC-----------------------------cccccccCccccCccc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----------------------------RYTHEVVTLWYRPPEI  136 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~pe~  136 (163)
                      ++|+||+|+||+++.++.+++.|||.+........                             ......|+..|+|||.
T Consensus       124 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~  203 (316)
T cd05574         124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEV  203 (316)
T ss_pred             eeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHH
Confidence            99999999999999999999999998765432110                             1112356788999999


Q ss_pred             ccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         137 LLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       137 ~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ..+.. ++.++|+||+|+++|+|++
T Consensus       204 ~~~~~-~~~~~Di~slG~ll~~l~~  227 (316)
T cd05574         204 ISGDG-HGSAVDWWTLGILLYEMLY  227 (316)
T ss_pred             HcCCC-CCchHHHHHHHHHHHHHhh
Confidence            87655 6999999999999999986

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.97  E-value=3e-30  Score=181.31  Aligned_cols=153  Identities=25%  Similarity=0.494  Sum_probs=128.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC------CCCCCHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT------PVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~------~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ...++.+|+++++.++|+||+++++++..++..++++|++++ +|.+++...      ...+++..+..++.+++.++.|
T Consensus        42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  121 (269)
T cd05044          42 EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY  121 (269)
T ss_pred             hHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHH
Confidence            355788999999999999999999999999999999999985 888888642      2347889999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccCC-----ceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          81 CHSRRIIHRDLKPQNILINKSG-----ALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~~-----~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      ||+.+++|+|++|+||+++.++     .++++|||++.......  .......++..|+|||.+.+.. ++.++|+||||
T Consensus       122 lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG  200 (269)
T cd05044         122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFG  200 (269)
T ss_pred             HHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHH
Confidence            9999999999999999999887     89999999886543221  1111223467899999987655 69999999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      +++|+|++
T Consensus       201 ~il~ellt  208 (269)
T cd05044         201 VLMWEILT  208 (269)
T ss_pred             HHHHHHHH
Confidence            99999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.9e-30  Score=183.82  Aligned_cols=151  Identities=30%  Similarity=0.474  Sum_probs=126.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-----------CCCCHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-----------VPVPPALAKSYLYQLLEA   77 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------~~~~~~~~~~~~~~i~~~   77 (163)
                      .++.+|++++++++|+|++++++++...+..++||||+.+ +|.+++....           ..+++..++.++.+++.+
T Consensus        62 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  141 (295)
T cd05097          62 NDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASG  141 (295)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHH
Confidence            3577899999999999999999999999999999999985 8888775432           136788899999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820          78 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus        78 l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                      +.+||+.|++|+|++|+||+++.++.++++|||.+........  ......++..|+|||...+.. ++.++|+||+|++
T Consensus       142 l~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~  220 (295)
T cd05097         142 MKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVT  220 (295)
T ss_pred             HHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHH
Confidence            9999999999999999999999999999999998865432211  111223356899999987654 6999999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +++|++
T Consensus       221 l~el~~  226 (295)
T cd05097         221 LWEMFT  226 (295)
T ss_pred             HHHHHH
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>KOG0607|consensus

Probab=99.97  E-value=4.6e-31  Score=182.95  Aligned_cols=154  Identities=28%  Similarity=0.481  Sum_probs=131.3

Q ss_pred             CchhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +...++.+|++++.+++ |+||+.++++|+++..+|+|||.+.| .+++++.+.. -+++..+.++..+|+.++.|||++
T Consensus       117 HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~k  195 (463)
T KOG0607|consen  117 HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRK-HFNEREASRVVKDIASALDFLHTK  195 (463)
T ss_pred             hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhc
Confidence            45567889999999994 99999999999999999999999985 9999998765 788999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCC---ceEEeecccccccccC-------CCcccccccCccccCccccc----CCcCCCcchhhH
Q psy7820          85 RIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIP-------MNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIW  150 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Di~  150 (163)
                      ||.|+|+||+||+-...+   -+||+||.+.+.....       .......+|+..|||||+..    ....|+.+.|.|
T Consensus       196 gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlw  275 (463)
T KOG0607|consen  196 GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLW  275 (463)
T ss_pred             CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHH
Confidence            999999999999985544   4799999877554321       23345678888999999963    334589999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |||+++|-||.
T Consensus       276 SLGvIlYImLs  286 (463)
T KOG0607|consen  276 SLGVILYIMLS  286 (463)
T ss_pred             HHHHHHHHHHh
Confidence            99999999985

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.97  E-value=4.1e-30  Score=179.41  Aligned_cols=152  Identities=27%  Similarity=0.465  Sum_probs=130.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|++++++++++......++++|++.+ +|.+++....+.+++..+..++.+++.++.+||+.+++
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~  122 (256)
T cd05112          43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35688999999999999999999999999999999999985 88888876666788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+........ ......++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       123 h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~  196 (256)
T cd05112         123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFS  196 (256)
T ss_pred             ccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHc
Confidence            999999999999999999999998765432211 111223356899999987654 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.97  E-value=3.8e-30  Score=181.83  Aligned_cols=151  Identities=23%  Similarity=0.404  Sum_probs=126.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|..+++.++|+|++++++++... ..++++|+++ |++.+.+....+.+++..++.++.|++.++.|||+++++
T Consensus        53 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ii  131 (279)
T cd05109          53 NKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV  131 (279)
T ss_pred             HHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34577899999999999999999998754 5678999997 599988877666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||+++........  .....++..|++||...+.. ++.++|+||+|+++|||++
T Consensus       132 H~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t  206 (279)
T cd05109         132 HRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMT  206 (279)
T ss_pred             ccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHc
Confidence            9999999999999999999999988765422211  11122356799999987654 6999999999999999986

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG0608|consensus

Probab=99.97  E-value=1.5e-30  Score=193.86  Aligned_cols=153  Identities=31%  Similarity=0.478  Sum_probs=132.1

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .+..+...|-+||...+.+.+|++|..|.+.+.+|+||||++| ++..++.+.+ -+.+..++.++.++..+++.+|+.|
T Consensus       671 nQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkmG  749 (1034)
T KOG0608|consen  671 NQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKMG  749 (1034)
T ss_pred             hhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhcc
Confidence            4455677899999999999999999999999999999999986 8888887765 7888889999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccc--------cCCCcc----------------------------------c
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFT--------IPMNRY----------------------------------T  123 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~--------~~~~~~----------------------------------~  123 (163)
                      ++|+||||+||++|.+|++||.|||++..+-        ..+...                                  .
T Consensus       750 FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ah  829 (1034)
T KOG0608|consen  750 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAH  829 (1034)
T ss_pred             ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhh
Confidence            9999999999999999999999999885431        111000                                  1


Q ss_pred             ccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       124 ~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ...||+.|++||++...+ ++...|+||.||+||||+-
T Consensus       830 slvgt~nyiapevl~r~g-~~q~cdwws~gvil~em~~  866 (1034)
T KOG0608|consen  830 SLVGTPNYIAPEVLARTG-YTQLCDWWSVGVILYEMLV  866 (1034)
T ss_pred             hhcCCCcccChHHhcccC-ccccchhhHhhHHHHHHhh
Confidence            347899999999998766 6999999999999999983

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.97  E-value=6.4e-30  Score=183.61  Aligned_cols=148  Identities=31%  Similarity=0.531  Sum_probs=130.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .++.+|+++++.++|+|++++++++.++...+++|||+.+++.+.+......+++..+..++.|++.++.+||+.|++|+
T Consensus        66 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~  145 (313)
T cd06633          66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR  145 (313)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            45788999999999999999999999999999999999999988887767788999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+++.++.++++|||.+....    ......++..|+|||.+..  ...++.++|+||+|+++|+|++
T Consensus       146 dl~p~nili~~~~~~kL~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~  215 (313)
T cd06633         146 DIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  215 (313)
T ss_pred             CCChhhEEECCCCCEEEeecCCCcccC----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999875432    2223456888999999742  2346889999999999999985

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2e-30  Score=196.03  Aligned_cols=152  Identities=26%  Similarity=0.417  Sum_probs=128.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc--------EEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF--------KLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLE   76 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--------~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~   76 (163)
                      ...+.+|+.++..++|+|++++++.+...+        .+++||||+.+ +|.+.+...   ...+++..+..++.|++.
T Consensus        75 ~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~  154 (496)
T PTZ00283         75 KNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLL  154 (496)
T ss_pred             HHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHH
Confidence            345778999999999999999998775332        47899999985 898887542   346889999999999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          77 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        77 ~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      ++.|||+.+++|+||||+||+++.++.++|+|||+++.....  ........|++.|+|||.+.+.. ++.++||||+|+
T Consensus       155 aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGv  233 (496)
T PTZ00283        155 AVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGV  233 (496)
T ss_pred             HHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHH
Confidence            999999999999999999999999999999999998765422  12233457899999999997654 799999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       234 ilyeLlt  240 (496)
T PTZ00283        234 LLYELLT  240 (496)
T ss_pred             HHHHHHH
Confidence            9999996

>KOG4236|consensus

Probab=99.97  E-value=2.3e-31  Score=194.83  Aligned_cols=150  Identities=31%  Similarity=0.545  Sum_probs=134.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|+.||+++.||+||.+.-.|++.+.+|+|||.+.|+.+..+.. +.+++++...+.++.||+-+++|||-+||+
T Consensus       607 esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIv  686 (888)
T KOG4236|consen  607 ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIV  686 (888)
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhccee
Confidence            3567899999999999999999999999999999999999988888754 567999999999999999999999999999


Q ss_pred             ecCCCCCcEEEccC---CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          88 HRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        88 h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      |+|+||+|+++...   .++|++|||+++..++. ...+...||+.|+|||++++.+ |..+-|+||+||++|.-|
T Consensus       687 HCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsL  760 (888)
T KOG4236|consen  687 HCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSL  760 (888)
T ss_pred             eccCCchheeeccCCCCCceeeccccceeecchh-hhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEe
Confidence            99999999999544   47899999999988854 4466789999999999998866 799999999999988654

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=5.6e-30  Score=178.82  Aligned_cols=149  Identities=28%  Similarity=0.523  Sum_probs=129.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|+.++++++|+|++++++++.+++..++|||++++ +|.+++.... ..+++..++.++.|++.++.+||+.++
T Consensus        44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i  123 (256)
T cd05039          44 AQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNF  123 (256)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45788999999999999999999999988999999999985 9988886544 368999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+........   ....+..|.|||...... ++.++|+||+|+++|++++
T Consensus       124 ~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~ape~~~~~~-~~~~~Di~slG~il~~l~~  194 (256)
T cd05039         124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---SGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYS  194 (256)
T ss_pred             cchhcccceEEEeCCCCEEEcccccccccccccc---cCCCcccccCchhhcCCc-CCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999998876542211   223356799999987544 6899999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.97  E-value=4.6e-30  Score=179.65  Aligned_cols=152  Identities=27%  Similarity=0.483  Sum_probs=129.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|+.++++++|+|++++++++..+...+++||++++ +|.+++.... ..++...+..++.+++.++.+||++++
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i  124 (261)
T cd05034          45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNY  124 (261)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45788999999999999999999999998899999999985 8988887644 468999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+....... ........+..|+|||.+.+.. .+.++|+||+|++++++++
T Consensus       125 ~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t  199 (261)
T cd05034         125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVT  199 (261)
T ss_pred             ccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHh
Confidence            999999999999999999999999876554211 1111222346799999987654 6999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.97  E-value=3.5e-30  Score=179.69  Aligned_cols=152  Identities=29%  Similarity=0.520  Sum_probs=131.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++.++|+|++++++++.++...++++||+++ ++.+++...+ .+++..+..++.|++.++.+||+.|+
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i  123 (258)
T cd06632          45 AVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDRNT  123 (258)
T ss_pred             HHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            345688999999999999999999999999999999999986 8888776543 68899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+....... ......++..|++||.......++.++|+||+|+++|+|++
T Consensus       124 ~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~  197 (258)
T cd06632         124 VHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMAT  197 (258)
T ss_pred             ccCCCCHHHEEECCCCCEEEccCccceeccccc-cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence            999999999999999999999999886654322 22345568889999998654446899999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.97  E-value=7.2e-30  Score=179.30  Aligned_cols=150  Identities=31%  Similarity=0.560  Sum_probs=127.0

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeee--CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+|+.++++++|+|++++++++.+  +..+++++|++++ +|.+.+.... .+++...+.++.|++.++.+||+.++
T Consensus        49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~i  127 (266)
T cd06651          49 SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSNMI  127 (266)
T ss_pred             HHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            457789999999999999999999875  3578999999985 8888876544 68889999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++|+|||++.......   .......++..|+|||.+.+.. ++.++|+||+|+++|++++
T Consensus       128 ~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~el~~  204 (266)
T cd06651         128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVVEMLT  204 (266)
T ss_pred             eeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHHHHHH
Confidence            999999999999999999999999886543211   1122344678899999987654 6899999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.97  E-value=1.3e-30  Score=182.23  Aligned_cols=151  Identities=32%  Similarity=0.518  Sum_probs=132.3

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...++.+|++++++++|||++++++.+.++...++|+|++.| +|.+.+... ..+++..+..++.+++.++.+||+.++
T Consensus        43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i  121 (258)
T cd05578          43 SVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGI  121 (258)
T ss_pred             HHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            456788999999999999999999999999999999999986 888877665 578999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+....... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       122 ~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~  194 (258)
T cd05578         122 IHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLR  194 (258)
T ss_pred             eccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHh
Confidence            999999999999999999999999887654322 223445678899999987655 6999999999999999985

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.97  E-value=2.4e-30  Score=181.64  Aligned_cols=151  Identities=31%  Similarity=0.557  Sum_probs=128.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+|++++++++.+++..++++|++.+ +|.+.+... ..+++..+..++.|++.++.+||++|++
T Consensus        47 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~  125 (268)
T cd06630          47 VEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQII  125 (268)
T ss_pred             HHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45788999999999999999999999999999999999986 787777654 4788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCC-ceEEeecccccccccCCCc----ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNR----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|.||+++.++ .++++|||.+.........    .....++..|+|||.+.+.. ++.++|+||+|+++++|++
T Consensus       126 H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~  203 (268)
T cd06630         126 HRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMAT  203 (268)
T ss_pred             cCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHHHHHHHh
Confidence            999999999998776 5899999988665432111    12235678899999987644 6899999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.2e-30  Score=181.31  Aligned_cols=153  Identities=27%  Similarity=0.465  Sum_probs=128.4

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeC------cEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVD------FKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~------~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~   77 (163)
                      .+++.+|+++++++ +|+|++++++++.+.      ..++++|||+++ ++.+.+...   +..+++..+..++.|++.+
T Consensus        46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~a  125 (275)
T cd06608          46 EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRG  125 (275)
T ss_pred             HHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHH
Confidence            35688999999999 799999999998653      358999999986 777776542   4578999999999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHH
Q psy7820          78 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAG  153 (163)
Q Consensus        78 l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG  153 (163)
                      +.|||+.+++|+|++|+||+++.++.++++|||.+..............++..|+|||.+..    ...++.++|+||+|
T Consensus       126 l~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG  205 (275)
T cd06608         126 LAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLG  205 (275)
T ss_pred             HHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhH
Confidence            99999999999999999999999999999999988765433333445567889999998743    23367899999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      +++|+|++
T Consensus       206 ~il~~l~~  213 (275)
T cd06608         206 ITAIELAD  213 (275)
T ss_pred             HHHHHHHh
Confidence            99999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.97  E-value=3.7e-30  Score=184.19  Aligned_cols=153  Identities=48%  Similarity=0.886  Sum_probs=129.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC--------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD--------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ...+.+|+++++.++|+||+++++++.+.        ..+++++||+.+++...+......+++..+..++.|+++++.+
T Consensus        51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~  130 (311)
T cd07866          51 PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINY  130 (311)
T ss_pred             chhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence            34578899999999999999999987443        3579999999998888887766689999999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc-----------ccccccCccccCcccccCCcCCCcchhh
Q psy7820          81 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-----------YTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-----------~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      ||+.|++|+|++|+||+++.++.++++|||.+.........           .....+++.|+|||...+...++.++|+
T Consensus       131 lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv  210 (311)
T cd07866         131 LHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDI  210 (311)
T ss_pred             HHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHh
Confidence            99999999999999999999999999999988655432211           1122456779999998765557899999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+|+++|+|++
T Consensus       211 ~slG~il~el~~  222 (311)
T cd07866         211 WGIGCVFAEMFT  222 (311)
T ss_pred             HHHHHHHHHHHh
Confidence            999999999986

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.97  E-value=2e-30  Score=181.72  Aligned_cols=150  Identities=30%  Similarity=0.525  Sum_probs=131.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i   86 (163)
                      ..++.+|++++++++|+|++++++.+..+...++++|++++ +|.+++......+++..+..++.+++.++.+||+ .++
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i  122 (265)
T cd06605          43 QKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI  122 (265)
T ss_pred             HHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCe
Confidence            35678899999999999999999999999999999999995 8888887665688999999999999999999999 999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+.........  ...++..|+|||...+. .++.++|+||+|+++|+|++
T Consensus       123 ~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~  194 (265)
T cd06605         123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK--TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELAT  194 (265)
T ss_pred             ecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh--cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999987655422221  25567889999998765 47999999999999999996

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.97  E-value=6.6e-30  Score=178.23  Aligned_cols=152  Identities=28%  Similarity=0.499  Sum_probs=130.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|++.++.++|+|++++++.+.+++..+++||++++ ++.+.+...... +++..+..++.|++.++.+||+.++
T Consensus        45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~  124 (258)
T smart00219       45 IEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF  124 (258)
T ss_pred             HHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            45788999999999999999999999999999999999986 888888765434 8999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCccc-ccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~-~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+........... ...++..|++||...+. .++.++|+||+|+++++|++
T Consensus       125 ~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i~~~l~~  199 (258)
T smart00219      125 IHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVLLWEIFT  199 (258)
T ss_pred             eecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccC-CCCcchhHHHHHHHHHHHHh
Confidence            9999999999999999999999998876553311111 12256789999998554 46999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.97  E-value=7e-30  Score=179.10  Aligned_cols=151  Identities=26%  Similarity=0.457  Sum_probs=126.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|+++++.++|+|++++++.+.. ...+++||++++ ++.+++.... ..+++..+..++.+++.++.+||+.++
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i  123 (262)
T cd05071          45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY  123 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4568899999999999999999998754 567899999985 8988887543 457889999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|.||+++.++.++|+|||.+......... .....++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       124 ~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt  198 (262)
T cd05071         124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTT  198 (262)
T ss_pred             cccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHc
Confidence            99999999999999999999999988655432211 11233466799999986544 6999999999999999986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.97  E-value=7.6e-30  Score=182.52  Aligned_cols=151  Identities=30%  Similarity=0.507  Sum_probs=127.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|+++++.++|+|++++++.+..++.+++|||+++| +|.+++... +.+++..+..++.+++.++.|||+.+++
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~  123 (305)
T cd05609          45 IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIV  123 (305)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            34677899999999999999999999999999999999986 888777654 4788999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC---------------cccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN---------------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      |+|++|.||+++.++.++++|||.++.......               ......++..|+|||.+.+.. ++.++|+||+
T Consensus       124 H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~sl  202 (305)
T cd05609         124 HRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAM  202 (305)
T ss_pred             ccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHH
Confidence            999999999999999999999998753211000               011234577899999987654 6999999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      |+++|+|++
T Consensus       203 G~vl~el~~  211 (305)
T cd05609         203 GIILYEFLV  211 (305)
T ss_pred             HHHHHHHHh
Confidence            999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.97  E-value=4.2e-30  Score=187.31  Aligned_cols=148  Identities=40%  Similarity=0.686  Sum_probs=126.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+.++++++|+|++++++++...      ...|+|+|++.+++.+.+...   +++..+..++.|++.++++||
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH  135 (353)
T cd07850          59 AKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD---LDHERMSYLLYQMLCGIKHLH  135 (353)
T ss_pred             HHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc---CCHHHHHHHHHHHHHHHHHHH
Confidence            34567899999999999999999988643      357999999999988887643   788899999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|++|+||+|+||+++.++.++++|||.+....... ......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       136 ~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~  212 (353)
T cd07850         136 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIR  212 (353)
T ss_pred             hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-CCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHH
Confidence            9999999999999999999999999999987654322 223345688899999987654 6999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.97  E-value=5.9e-30  Score=181.08  Aligned_cols=147  Identities=26%  Similarity=0.456  Sum_probs=122.7

Q ss_pred             HHHHHHHHhcC---CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          12 ALREISVLKEL---KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        12 ~~~e~~~l~~~---~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      +.+|..+++.+   +|++++.+++.+..++..++||||+++ +|.+++... +.+++..+..++.|++.++.+||+.+++
T Consensus        41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~iv  119 (279)
T cd05633          41 ALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVV  119 (279)
T ss_pred             HHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcC
Confidence            34555444443   689999999999999999999999986 777776654 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++++|||.+......  ......|+..|+|||.......++.++|+||+|+++|+|++
T Consensus       120 H~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~  191 (279)
T cd05633         120 YRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLR  191 (279)
T ss_pred             CCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHh
Confidence            9999999999999999999999988654322  22334678899999998644446899999999999999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=7e-30  Score=179.18  Aligned_cols=150  Identities=29%  Similarity=0.534  Sum_probs=127.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+|++++++++|+|++++++++.+.  +.+++++|++++ +|.+.+.... .+++..+..++.+++.++.+||+.++
T Consensus        49 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~~i  127 (264)
T cd06653          49 NALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSNMI  127 (264)
T ss_pred             HHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            4678899999999999999999998764  468899999986 8888876544 58899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+.......   .......++..|+|||...+.. ++.++|+||+|+++|++++
T Consensus       128 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  204 (264)
T cd06653         128 VHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLT  204 (264)
T ss_pred             ecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHh
Confidence            999999999999999999999999887653211   1112345688899999987755 6899999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.97  E-value=6.3e-30  Score=185.36  Aligned_cols=151  Identities=26%  Similarity=0.502  Sum_probs=124.7

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeee-CcEEEEEecchhc-cHHHHHhcCC---------------------------
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTP---------------------------   59 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~---------------------------   59 (163)
                      ..+.+|+++++++ +|+||+++++++.. +..+++++||+++ +|.+.+....                           
T Consensus        55 ~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (337)
T cd05054          55 KALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLD  134 (337)
T ss_pred             HHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccc
Confidence            3567899999999 79999999998765 4578999999986 8887774321                           


Q ss_pred             ---------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEE
Q psy7820          60 ---------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL  106 (163)
Q Consensus        60 ---------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l  106 (163)
                                                       ..+++..+..++.|++.++.|||+.|++|+||+|.||+++.++.++|
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL  214 (337)
T cd05054         135 SVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKI  214 (337)
T ss_pred             cCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEE
Confidence                                             25788999999999999999999999999999999999999999999


Q ss_pred             eecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         107 ADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       107 ~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|||++.........  .....++..|+|||++.+.. ++.++||||+||++|+|++
T Consensus       215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t  270 (337)
T cd05054         215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFS  270 (337)
T ss_pred             eccccchhcccCcchhhccCCCCCccccCcHHhcCCC-CCccccHHHHHHHHHHHHH
Confidence            999998765322211  12233456799999987654 7999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=4.5e-30  Score=182.00  Aligned_cols=150  Identities=23%  Similarity=0.491  Sum_probs=127.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKSYLYQLLEALRYCHS-RR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~-~~   85 (163)
                      ..+.+|++++++++|+|++++++.+..++.+++|+||+++ ++..++...  ...+++..+..++.++++++.|||+ .+
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~  123 (286)
T cd06622          44 NQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN  123 (286)
T ss_pred             HHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4678899999999999999999999999999999999986 777666553  3478999999999999999999996 59


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCc-----CCCcchhhHHHHHHHHHHh
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-----~~~~~~Di~slG~~l~~ll  160 (163)
                      ++|+||+|+||+++.++.++++|||.+......  ......++..|++||...+..     .++.++|+||+|+++|+|+
T Consensus       124 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~  201 (286)
T cd06622         124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA  201 (286)
T ss_pred             EeeCCCCHHHEEECCCCCEEEeecCCcccccCC--ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence            999999999999999999999999988654322  223345677899999975432     2478999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       202 ~  202 (286)
T cd06622         202 L  202 (286)
T ss_pred             h
Confidence            6

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.97  E-value=1.1e-29  Score=177.92  Aligned_cols=151  Identities=26%  Similarity=0.470  Sum_probs=126.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|+++++.++|+|++++++++.. +..+++||++++ +|.+++.... ..+++..+..++.+++.++.+||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05069          45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            3567899999999999999999998854 567899999985 8998886543 357889999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+........ ......++..|++||...+.. .+.++|+||+|+++|+|++
T Consensus       124 ~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t  198 (260)
T cd05069         124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVT  198 (260)
T ss_pred             eecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999998866542221 112223456799999987654 6999999999999999986

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.97  E-value=1e-29  Score=177.93  Aligned_cols=151  Identities=26%  Similarity=0.466  Sum_probs=126.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|++++++++|++++++++++.. ...+++||++++ +|.+++... ...+++..++.++.+++.++.+||+.++
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i  123 (260)
T cd05070          45 PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            4678899999999999999999998854 468899999985 888888654 3458899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+........ ......++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       124 ~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~  198 (260)
T cd05070         124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVT  198 (260)
T ss_pred             ccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHh
Confidence            9999999999999999999999999876543221 111223356799999986544 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG1152|consensus

Probab=99.97  E-value=4.1e-31  Score=194.64  Aligned_cols=144  Identities=31%  Similarity=0.509  Sum_probs=130.9

Q ss_pred             HHHHHHhcCC---CCCeeeeeeeeeeCcEEEEEecchh-c-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          14 REISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLR-Q-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        14 ~e~~~l~~~~---h~~i~~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .|++||..++   |+||+|+.++|++++++|++||.-. | +|++++...+ .+++..+..|+.|++.++++||++||+|
T Consensus       615 ~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~~ivh  693 (772)
T KOG1152|consen  615 SEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQGIVH  693 (772)
T ss_pred             hhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhccccccccCcee
Confidence            5899999996   9999999999999999999999875 5 9999998877 8999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ||||-+|+.++.+|-+|++|||.+....  ....-.+.||.+|.|||++.+.+.....-||||||++||-++
T Consensus       694 rdikdenvivd~~g~~klidfgsaa~~k--sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytiv  763 (772)
T KOG1152|consen  694 RDIKDENVIVDSNGFVKLIDFGSAAYTK--SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIV  763 (772)
T ss_pred             cccccccEEEecCCeEEEeeccchhhhc--CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEE
Confidence            9999999999999999999999876544  344557789999999999999887789999999999998654

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=6.9e-30  Score=180.05  Aligned_cols=152  Identities=25%  Similarity=0.440  Sum_probs=128.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC--------CCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP--------VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--------~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ..++.+|++++++++|+|++++++++.+.+..++|||++++ +|.+++....        ..+++..+..++.|++.++.
T Consensus        52 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~  131 (275)
T cd05046          52 QSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD  131 (275)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999999999999999984 8888886543        15789999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccC-CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      |||+.+++|+||+|+||+++.++.++++|||.+...... ........++..|++||...+.. .+.++|+||+|+++|+
T Consensus       132 ~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~  210 (275)
T cd05046         132 HLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWE  210 (275)
T ss_pred             HhhhcCcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHH
Confidence            999999999999999999999999999999987643321 11222334467799999986654 5899999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      +++
T Consensus       211 l~~  213 (275)
T cd05046         211 VFT  213 (275)
T ss_pred             HHh
Confidence            986

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.97  E-value=5.9e-30  Score=182.20  Aligned_cols=151  Identities=28%  Similarity=0.518  Sum_probs=128.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+.+++.++|+|++++++.+..++..+++|||+++ ++.+.+..  ..+++..+..++.|++.++++||+.|+
T Consensus        60 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~gi  137 (292)
T cd06657          60 RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGV  137 (292)
T ss_pred             HHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345678899999999999999999999999999999999986 66665533  367889999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|.||+++.++.++++|||.+..............++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       138 vH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil~el~t  211 (292)
T cd06657         138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVD  211 (292)
T ss_pred             ecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999998765543322233456788899999986544 6899999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=5.9e-30  Score=182.99  Aligned_cols=149  Identities=23%  Similarity=0.425  Sum_probs=126.3

Q ss_pred             hHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          11 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ++.+|+.+++.++|+|++++++++... ..++++|+++ |++.+++......+++..+..++.|++.++.|||+++++|+
T Consensus        55 ~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~  133 (303)
T cd05110          55 EFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHR  133 (303)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeecc
Confidence            577899999999999999999998654 4678999998 58999988777678999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+|+||+++.++.++++|||.+........  ......++..|++||...+.. ++.++|+||+|+++|||++
T Consensus       134 dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t  206 (303)
T cd05110         134 DLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMT  206 (303)
T ss_pred             ccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999876542221  111223356899999987644 6999999999999999986

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.97  E-value=7.7e-30  Score=179.44  Aligned_cols=151  Identities=27%  Similarity=0.516  Sum_probs=126.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++|+|++++++++.++ ..+++||++++ +|.+++......+++..++.++.+++.++.+||+.+++
T Consensus        51 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~  129 (270)
T cd05056          51 REKFLQEAYIMRQFDHPHIVKLIGVITEN-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV  129 (270)
T ss_pred             HHHHHHHHHHHHhCCCCchhceeEEEcCC-CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45688999999999999999999998764 57899999985 89998877666789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++++|||.+......... .....++..|+|||.+.... ++.++|+||+|+++|++++
T Consensus       130 H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~  203 (270)
T cd05056         130 HRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILM  203 (270)
T ss_pred             ccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCC-CCchhhhHHHHHHHHHHHH
Confidence            9999999999999999999999988654432111 11222345799999986544 6899999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.97  E-value=9.8e-30  Score=178.01  Aligned_cols=152  Identities=33%  Similarity=0.564  Sum_probs=133.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~   85 (163)
                      ...++.+|++.+++++|+|++++++++..++..++++|++++ +|.+.+... ..+++..+..++.|++.++.+||+ .+
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~  120 (264)
T cd06623          42 FRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRH  120 (264)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence            356788999999999999999999999999999999999995 888887655 478999999999999999999999 99


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+||+++.++.++++|||.+..............++..|+|||...+. .++.++|+||||+++|+|++
T Consensus       121 ~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~t  195 (264)
T cd06623         121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECAL  195 (264)
T ss_pred             CccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999887665433333344567889999998765 46899999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.97  E-value=1.1e-29  Score=178.03  Aligned_cols=154  Identities=30%  Similarity=0.481  Sum_probs=132.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+.+|+++++.++|+|++++++.+..++..++++|++++ ++.+.+...  ...+++..+..++.|++.++.+||+.
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~  121 (267)
T cd06610          42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN  121 (267)
T ss_pred             HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            346688999999999999999999999999999999999986 888887653  24689999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCc----ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      |++|+|++|+||+++.++.++++|||.+.........    .....++..|++||.+.....++.++|+||+|+++|+|+
T Consensus       122 ~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~  201 (267)
T cd06610         122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA  201 (267)
T ss_pred             CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence            9999999999999999999999999988766543222    123356888999999876545799999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       202 ~  202 (267)
T cd06610         202 T  202 (267)
T ss_pred             h
Confidence            7

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.97  E-value=1.1e-29  Score=177.75  Aligned_cols=151  Identities=26%  Similarity=0.517  Sum_probs=126.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|++++++++|+|++++++++. .+..++++|++.+ ++.+.+... +..+++..+..++.+++.++++||+.|+
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i  123 (260)
T cd05067          45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence            467889999999999999999999874 4568999999975 888887653 3468899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++++|||.+....... .......++..|+|||...... ++.++|+||+|+++|++++
T Consensus       124 ~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~  198 (260)
T cd05067         124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVT  198 (260)
T ss_pred             ecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHh
Confidence            999999999999999999999999886654221 1122233456899999987654 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.97  E-value=4.5e-30  Score=186.11  Aligned_cols=152  Identities=41%  Similarity=0.814  Sum_probs=129.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC-----cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|+.+++.++|+|++++++++...     ...++++||+.+++.+.+... +.+++..+..++.|++.++.+||+
T Consensus        48 ~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~  126 (337)
T cd07858          48 AKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYIHS  126 (337)
T ss_pred             hHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34577899999999999999999988654     358999999999998887754 478999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .+++|+|++|+||+++.++.++|+|||.+..............++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       127 ~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  204 (337)
T cd07858         127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLG  204 (337)
T ss_pred             CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHc
Confidence            999999999999999999999999999887654332223334567889999998754447899999999999999985

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.97  E-value=9.9e-30  Score=180.17  Aligned_cols=152  Identities=29%  Similarity=0.458  Sum_probs=126.0

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeee-----eCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIP-----VDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      .++.+|+.+++++ +|+|++++++++.     .++..+++|||+++ +|.+.+..   ....+++..+..++.+++.++.
T Consensus        59 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~  138 (286)
T cd06638          59 EEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ  138 (286)
T ss_pred             HHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHH
Confidence            5677899999999 6999999999873     45679999999985 78776642   3356889999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCI  155 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~  155 (163)
                      +||+.+++|+|++|+||+++.++.++++|||.+..............|+..|+|||.+..    ...++.++|+||+|++
T Consensus       139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi  218 (286)
T cd06638         139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGIT  218 (286)
T ss_pred             HHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHH
Confidence            999999999999999999999999999999988665432222334467889999999753    2336889999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|+|++
T Consensus       219 ~~el~~  224 (286)
T cd06638         219 AIELGD  224 (286)
T ss_pred             HHHHhc
Confidence            999986

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.97  E-value=8.2e-30  Score=184.67  Aligned_cols=150  Identities=45%  Similarity=0.831  Sum_probs=127.4

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeC--cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+|+.+++++ +|+||+++++++...  ...++|+|+++++|...+...  .+++..++.++.|++.++.+||+.|+
T Consensus        51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i  128 (337)
T cd07852          51 QRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNV  128 (337)
T ss_pred             hhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            4567899999999 999999999998643  368999999999998887654  67888889999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC-----cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+........     ......++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       129 ~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~t  208 (337)
T cd07852         129 IHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLL  208 (337)
T ss_pred             ecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHh
Confidence            9999999999999999999999998875543221     12233567889999998665557899999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.97  E-value=4.1e-30  Score=186.09  Aligned_cols=152  Identities=38%  Similarity=0.797  Sum_probs=128.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee----CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...+.+|+.++++++|+|++++++++..    +..+++|+||+++++.+.+.... .+++..+..++.|++.++.+||+.
T Consensus        48 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~  126 (334)
T cd07855          48 AKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSA  126 (334)
T ss_pred             hHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhhhhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            4557789999999999999999998753    35789999999999888876544 689999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCC----cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +++|+||+|+||+++.++.++|+|||.+........    ......++..|.|||.+.+...++.++|+||+|+++|+|+
T Consensus       127 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~  206 (334)
T cd07855         127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML  206 (334)
T ss_pred             CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH
Confidence            999999999999999999999999998865432211    1123466888999999866555789999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       207 ~  207 (334)
T cd07855         207 G  207 (334)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.97  E-value=9.9e-30  Score=184.07  Aligned_cols=151  Identities=28%  Similarity=0.496  Sum_probs=126.4

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      .++.+|+++++++ +|+||+++++.+..++..++++||+++ +|.+++....               ..++...+..++.
T Consensus        62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  141 (334)
T cd05100          62 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAY  141 (334)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence            4678899999999 799999999999999999999999985 8888876432               2467888899999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      |++.++.|||+.|++|+||+|+||+++.++.++|+|||.++........  .....++..|+|||.+.+.. ++.++|+|
T Consensus       142 qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~  220 (334)
T cd05100         142 QVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVW  220 (334)
T ss_pred             HHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhH
Confidence            9999999999999999999999999999999999999988654422111  11112245799999987654 68999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       221 slG~il~el~~  231 (334)
T cd05100         221 SFGVLLWEIFT  231 (334)
T ss_pred             HHHHHHHHHHh
Confidence            99999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.97  E-value=1e-29  Score=179.77  Aligned_cols=141  Identities=25%  Similarity=0.447  Sum_probs=120.5

Q ss_pred             HHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcE
Q psy7820          18 VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNI   96 (163)
Q Consensus        18 ~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni   96 (163)
                      .++...|++++++.+.+.+.+..++|+||+.| +|.+.+.. .+.+++..++.++.|++.++.|||+.+++|+|++|+||
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni  128 (278)
T cd05606          50 LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI  128 (278)
T ss_pred             HHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence            34445799999999999999999999999986 77776654 34789999999999999999999999999999999999


Q ss_pred             EEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          97 LINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        97 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +++.++.++++|||.+.....  .......|+..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       129 li~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~  191 (278)
T cd05606         129 LLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR  191 (278)
T ss_pred             EECCCCCEEEccCcCccccCc--cCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHh
Confidence            999999999999998765432  222344678899999998755447899999999999999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.97  E-value=8.9e-30  Score=182.45  Aligned_cols=149  Identities=30%  Similarity=0.509  Sum_probs=129.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..++.+|+++++.++|+|++++.+++..+...++|+||+.+++.+.+......+++..+..++.+++.++.+||+.+++|
T Consensus        59 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H  138 (308)
T cd06634          59 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH  138 (308)
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            34577899999999999999999999999999999999999888887766667899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|.||+++.++.++++|||.+.....    .....++..|+|||.+.+  ....+.++|+||+|+++|+|++
T Consensus       139 ~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  209 (308)
T cd06634         139 RDVKAGNILLSEPGLVKLGDFGSASIMAP----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (308)
T ss_pred             CCCCHHhEEECCCCcEEECCcccceeecC----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence            99999999999999999999998765432    223456788999999742  2336889999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.97  E-value=4e-30  Score=185.66  Aligned_cols=153  Identities=41%  Similarity=0.783  Sum_probs=133.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-----EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ....+.+|+++++.++|+|++++.+++....     ..|++||++++++.+.+.... .+++..++.++.+++.++.+||
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH  120 (330)
T cd07834          42 DAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLH  120 (330)
T ss_pred             hhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            3457889999999999999999999987765     789999999988888876554 8899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      +.|++|+||+|.||+++.++.++++|||.+.......   .......++..|+|||.+.+...++.++|+||+|+++|+|
T Consensus       121 ~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l  200 (330)
T cd07834         121 SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL  200 (330)
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence            9999999999999999999999999999988765433   1233445678899999988764579999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       201 ~~  202 (330)
T cd07834         201 LT  202 (330)
T ss_pred             Hc
Confidence            86

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=5.3e-30  Score=202.24  Aligned_cols=152  Identities=38%  Similarity=0.619  Sum_probs=125.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee--CcEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ...+..|+.++++++||||++++++|.+  ...+|+||||+++ +|.+++...   .+.+++..++.++.||+.+|.|||
T Consensus        56 ~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLH  135 (1021)
T PTZ00266         56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCH  135 (1021)
T ss_pred             HHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999998854  4579999999985 888887642   357899999999999999999999


Q ss_pred             hC-------CceecCCCCCcEEEccC-----------------CceEEeecccccccccCCCcccccccCccccCccccc
Q psy7820          83 SR-------RIIHRDLKPQNILINKS-----------------GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL  138 (163)
Q Consensus        83 ~~-------~i~h~~i~~~ni~~~~~-----------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  138 (163)
                      +.       +|+|+||+|+||+++.+                 +.++|+|||++...... .......|++.|+|||++.
T Consensus       136 s~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~-s~~~s~vGTp~YmAPEvL~  214 (1021)
T PTZ00266        136 NLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE-SMAHSCVGTPYYWSPELLL  214 (1021)
T ss_pred             hcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc-ccccccCCCccccCHHHHh
Confidence            84       49999999999999642                 34899999998765422 2223456899999999986


Q ss_pred             CC-cCCCcchhhHHHHHHHHHHhc
Q psy7820         139 GA-KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       139 ~~-~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +. ..++.++|||||||++|+|+|
T Consensus       215 ge~~~~s~KSDVWSLG~ILYELLT  238 (1021)
T PTZ00266        215 HETKSYDDKSDMWALGCIIYELCS  238 (1021)
T ss_pred             ccCCCCCchhHHHHHHHHHHHHHH
Confidence            43 347899999999999999997

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.97  E-value=4.5e-30  Score=179.63  Aligned_cols=152  Identities=39%  Similarity=0.607  Sum_probs=131.3

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++++++++|+|++++++.+..+...|+++|++++ +|.+.+...+ .+++..+..++.|++.++.+||+.++
T Consensus        36 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~~i  114 (265)
T cd05579          36 QVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALEYLHSNGI  114 (265)
T ss_pred             HHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence            345678899999999999999999999999999999999986 8888776654 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC--------cccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      +|+||+|+||+++.++.++++|||++........        ......++..|++||...+.. .+.++|+||+|+++++
T Consensus       115 ~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~  193 (265)
T cd05579         115 IHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYE  193 (265)
T ss_pred             ecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHH
Confidence            9999999999999999999999998765443211        223345678899999987655 6899999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      +++
T Consensus       194 l~~  196 (265)
T cd05579         194 FLV  196 (265)
T ss_pred             HHh
Confidence            986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.97  E-value=1.3e-29  Score=180.02  Aligned_cols=151  Identities=24%  Similarity=0.439  Sum_probs=124.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~   79 (163)
                      .++.+|..+++.++|+|++++++++.++...+++|||++ |+|.+++....         ...+...+..++.|++.++.
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  133 (288)
T cd05061          54 IEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA  133 (288)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHH
Confidence            356789999999999999999999999999999999998 49988886422         23456778889999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      |||+++++|+||+|+||+++.++.++++|||.++.......  ......++..|++||...+.. ++.++|+||+|+++|
T Consensus       134 ~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~  212 (288)
T cd05061         134 YLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLW  212 (288)
T ss_pred             HHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHH
Confidence            99999999999999999999999999999998865432111  111223356799999987644 699999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      ||++
T Consensus       213 el~~  216 (288)
T cd05061         213 EITS  216 (288)
T ss_pred             HHHh
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.97  E-value=1.8e-29  Score=179.43  Aligned_cols=153  Identities=30%  Similarity=0.489  Sum_probs=126.9

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeC-----cEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVD-----FKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~-----~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l   78 (163)
                      ..++.+|+.+++++ +|+|++++++++...     +..++|+||+++ +|.+++..   ....+++..++.++.|++.++
T Consensus        62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al  141 (291)
T cd06639          62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL  141 (291)
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHH
Confidence            45667899999999 799999999998653     368999999986 88777643   345789999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCc----CCCcchhhHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK----VYSTTVDIWSAGC  154 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~~Di~slG~  154 (163)
                      ++||+.+++|+||+|+||+++.++.++++|||.+..............++..|+|||.+....    .++.++|+||+|+
T Consensus       142 ~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGv  221 (291)
T cd06639         142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGI  221 (291)
T ss_pred             HHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHH
Confidence            999999999999999999999999999999998876543322233445688899999975432    2578999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       222 i~~el~~  228 (291)
T cd06639         222 TAIELGD  228 (291)
T ss_pred             HHHHHhh
Confidence            9999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.97  E-value=1.1e-29  Score=178.65  Aligned_cols=152  Identities=28%  Similarity=0.440  Sum_probs=124.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchh-ccHHHHHhc-----CCCCCCHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLR-QDLKDFLQT-----TPVPVPPALAKSYLYQLLE   76 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~~~~~~i~~   76 (163)
                      ...+.+|+++++.++|+|++++++++...      ...++++||++ |++.+++..     ....+++..+..++.|++.
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  123 (272)
T cd05075          44 MEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS  123 (272)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHH
Confidence            45678899999999999999999976421      24689999998 488777642     2345789999999999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          77 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        77 ~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      ++.|||+++++|+|++|+||+++.++.++|+|||.+........  ......+++.|++||...+.. ++.++|+||+|+
T Consensus       124 ~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~slG~  202 (272)
T cd05075         124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRV-YTTKSDVWSFGV  202 (272)
T ss_pred             HHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCC-cChHHHHHHHHH
Confidence            99999999999999999999999999999999999876542211  112223466799999987654 699999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       203 il~el~~  209 (272)
T cd05075         203 TMWEIAT  209 (272)
T ss_pred             HHHHHHc
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.97  E-value=2e-29  Score=174.98  Aligned_cols=152  Identities=34%  Similarity=0.545  Sum_probs=134.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++.+++++|++++++.+.+..+...++++|++++ +|.+.+......+++..+..++.+++.++.+||+.|+
T Consensus        40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i  119 (253)
T cd05122          40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI  119 (253)
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence            446788999999999999999999999999999999999995 8888887765688999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++|+|||.+........ .....++..|++||...+.. .+.++|+||+|+++++|++
T Consensus       120 ~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~  192 (253)
T cd05122         120 IHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAE  192 (253)
T ss_pred             ecCCCCHHHEEEccCCeEEEeecccccccccccc-ccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHh
Confidence            9999999999999999999999998876654322 23455688899999987655 6899999999999999986

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.97  E-value=8.9e-30  Score=178.11  Aligned_cols=152  Identities=35%  Similarity=0.590  Sum_probs=129.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee--CcEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|++++++++|+|++++++++..  +...++++||+++ +|.+++...   ...+++..++.++.+++.++.+||
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH  122 (265)
T cd08217          43 KQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECH  122 (265)
T ss_pred             HHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHh
Confidence            4567789999999999999999997753  4578999999985 888887543   457899999999999999999999


Q ss_pred             -----hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          83 -----SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        83 -----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                           +.+++|+|++|+||+++.++.++++|||.+..............++..|+|||.+.+.. ++.++|+||+|++++
T Consensus       123 ~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~  201 (265)
T cd08217         123 NRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIY  201 (265)
T ss_pred             cCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHH
Confidence                 99999999999999999999999999998876654333233456788999999987655 689999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       202 ~l~~  205 (265)
T cd08217         202 ELCA  205 (265)
T ss_pred             HHHH
Confidence            9986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.97  E-value=1.2e-29  Score=177.01  Aligned_cols=151  Identities=33%  Similarity=0.539  Sum_probs=129.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|+++++.++|+|++++++.+..++..++|+|++++ +|.+++... +..+++..+..++.+++.++.+||++|+
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i  122 (256)
T cd08220          43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLI  122 (256)
T ss_pred             HHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            45688999999999999999999999999999999999986 888888764 3458999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCC-ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++ .++++|||.+........ .....++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       123 ~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~  196 (256)
T cd08220         123 LHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-AYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELAS  196 (256)
T ss_pred             ecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-ccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHh
Confidence            9999999999998654 579999998876553322 22345688899999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.6e-29  Score=175.93  Aligned_cols=152  Identities=34%  Similarity=0.638  Sum_probs=134.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...++.+|++++++++|+|++++.+++.+++..++++|++++ +|.+.+... ..+++..+..++.+++.++.+||+.|+
T Consensus        42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i  120 (254)
T cd06627          42 ALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGV  120 (254)
T ss_pred             HHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence            445688999999999999999999999999999999999986 888777655 578999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............++..|++||...+.. .+.++|+||+|+++++|++
T Consensus       121 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~  194 (254)
T cd06627         121 IHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLT  194 (254)
T ss_pred             ccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHh
Confidence            9999999999999999999999999887664443334456788899999987655 6899999999999999986

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG1094|consensus

Probab=99.97  E-value=1.2e-30  Score=192.51  Aligned_cols=152  Identities=30%  Similarity=0.489  Sum_probs=131.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+|.+|+++|.+++||||+++.++|..++.+++|+||++ |+|.+++.++.-+ .+.+....++.||++|++||.+.++
T Consensus       579 r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nf  658 (807)
T KOG1094|consen  579 RNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNF  658 (807)
T ss_pred             HHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhch
Confidence            4678999999999999999999999999999999999998 6999999887433 4677778899999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|+.+.|++++.+.++||+|||.++....+.  .......-..+|+|+|.+...+ ++.++|+|++|+++||+++
T Consensus       659 VHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~  734 (807)
T KOG1094|consen  659 VHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFM  734 (807)
T ss_pred             hhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHH
Confidence            999999999999999999999999988554321  1122233367899999998766 7999999999999999985

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.97  E-value=1e-29  Score=180.34  Aligned_cols=152  Identities=28%  Similarity=0.568  Sum_probs=126.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------------CCCCHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------------VPVPPAL   66 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------------~~~~~~~   66 (163)
                      ..++.+|+.++++++|+|++++++++.++...++++|++++ +|.+++....                     ..+++..
T Consensus        52 ~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  131 (288)
T cd05050          52 QADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE  131 (288)
T ss_pred             HHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHH
Confidence            35578899999999999999999999999999999999985 8888886421                     2467888


Q ss_pred             HHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCC
Q psy7820          67 AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYS  144 (163)
Q Consensus        67 ~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~  144 (163)
                      ++.++.+++.++.+||+.+++|+||+|.||+++.++.++++|||.+.......  ........+..|+|||...+.. ++
T Consensus       132 ~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~  210 (288)
T cd05050         132 QLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YT  210 (288)
T ss_pred             HHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CC
Confidence            89999999999999999999999999999999999999999999876543221  1111223356799999986654 79


Q ss_pred             cchhhHHHHHHHHHHhc
Q psy7820         145 TTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       145 ~~~Di~slG~~l~~ll~  161 (163)
                      .++|+||+|+++|+|++
T Consensus       211 ~~~Dv~slG~il~el~~  227 (288)
T cd05050         211 TESDVWAYGVVLWEIFS  227 (288)
T ss_pred             chhHHHHHHHHHHHHHh
Confidence            99999999999999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.97  E-value=1.1e-29  Score=179.61  Aligned_cols=153  Identities=28%  Similarity=0.449  Sum_probs=127.4

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeee------eCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIP------VDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~------~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ..++..|+.+++++ +|+|++++++++.      .+..++++|||+++ ++.+++... ...+++..++.++.|++.++.
T Consensus        56 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~  135 (282)
T cd06636          56 EEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA  135 (282)
T ss_pred             HHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence            35677899999999 6999999999984      34578999999986 888877653 346788889999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCI  155 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~  155 (163)
                      |||+.|++|+|++|+||+++.++.++|+|||.+..............++..|+|||.+..    ...++.++|+||+|++
T Consensus       136 ~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~  215 (282)
T cd06636         136 HLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGIT  215 (282)
T ss_pred             HHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHH
Confidence            999999999999999999999999999999987755433333344567889999999752    2346889999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|+|++
T Consensus       216 l~el~~  221 (282)
T cd06636         216 AIEMAE  221 (282)
T ss_pred             HHHHHh
Confidence            999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.97  E-value=1.3e-29  Score=180.52  Aligned_cols=150  Identities=33%  Similarity=0.561  Sum_probs=129.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|+.++++++|+|++++++.+..++..++|+||+++ ++.+++.+.  .+++..+..++.+++.++.+||+.|++
T Consensus        60 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~gi~  137 (293)
T cd06647          60 KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVI  137 (293)
T ss_pred             HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence            45678899999999999999999999999999999999985 888877653  467888899999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|+||+++.++.++|+|||.+..............++..|++||.+.... ++.++|+||+|+++|++++
T Consensus       138 H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~ll~~ll~  210 (293)
T cd06647         138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVE  210 (293)
T ss_pred             eccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999998765543333333446788899999987644 6899999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.97  E-value=1.9e-29  Score=178.16  Aligned_cols=149  Identities=31%  Similarity=0.522  Sum_probs=128.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|+.++++++|+|++++++.+.++...++|+||+++ ++...+..  ..+++..+..++.+++.++.+||+.|++|
T Consensus        47 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h  124 (277)
T cd06641          47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIH  124 (277)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeec
Confidence            4678899999999999999999999999999999999986 77777653  36789999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++.++++|||.+..............++..|+|||...+.. .+.++|+||+|+++|+|++
T Consensus       125 ~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~  196 (277)
T cd06641         125 RDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAK  196 (277)
T ss_pred             CCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHc
Confidence            99999999999999999999998765543322233345678899999987644 6899999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG0604|consensus

Probab=99.97  E-value=2.1e-30  Score=178.08  Aligned_cols=154  Identities=30%  Similarity=0.433  Sum_probs=131.5

Q ss_pred             CCchhhHHHHHHHHhcC-CCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKEL-KHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l   78 (163)
                      -.+.+...+|+++--.. .|+|||.++++++.    -.++.+|||.++| .|++.+...+ +.+.+..+..|+.||..++
T Consensus        95 L~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av  174 (400)
T KOG0604|consen   95 LLDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAV  174 (400)
T ss_pred             HhcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHH
Confidence            34556778899887777 59999999999764    3478999999986 8998887765 4689999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEcc---CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                      .|||+.+|.|+|+||+|++...   |..+|++|||+++.... .......|.|++|.|||++...+ |+...|+||+||+
T Consensus       175 ~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~-~~~L~TPc~TPyYvaPevlg~eK-ydkscdmwSlgVi  252 (400)
T KOG0604|consen  175 RYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE-PGDLMTPCFTPYYVAPEVLGPEK-YDKSCDMWSLGVI  252 (400)
T ss_pred             HHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC-CccccCCcccccccCHHHhCchh-cCCCCCccchhHH
Confidence            9999999999999999999965   44689999999977554 34466778899999999987765 8999999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|-||+
T Consensus       253 mYIlLC  258 (400)
T KOG0604|consen  253 MYILLC  258 (400)
T ss_pred             HHHhhc
Confidence            999985

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.97  E-value=1.2e-29  Score=182.01  Aligned_cols=154  Identities=27%  Similarity=0.395  Sum_probs=128.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+.+|+++++.++|+||+++++++.+++..+++|||+++ ++.+++... +..+++..+..++.|++.|+.|||+.+
T Consensus        42 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~  121 (314)
T cd08216          42 DLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG  121 (314)
T ss_pred             HHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345788999999999999999999999999999999999985 787877653 346889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC-------cccccccCccccCcccccCC-cCCCcchhhHHHHHHHH
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-------RYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~  157 (163)
                      ++|+|++|+||+++.++.+++.||+.+........       ......++..|+|||.+... ..++.++|+||+|+++|
T Consensus       122 ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~  201 (314)
T cd08216         122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC  201 (314)
T ss_pred             eecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHH
Confidence            99999999999999999999999997754432111       11223446679999998653 23688999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       202 el~~  205 (314)
T cd08216         202 ELAN  205 (314)
T ss_pred             HHHh
Confidence            9986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.97  E-value=2.1e-29  Score=175.75  Aligned_cols=149  Identities=30%  Similarity=0.574  Sum_probs=125.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+.+|+.+++.++|+|++++++++..+ ..+++||++++ +|.+++.... ..+++..+..++.|++.++.+||+.|
T Consensus        42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~  120 (254)
T cd05083          42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK  120 (254)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            345688999999999999999999998765 47899999985 9988887543 35789999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+||+++.++.++++|||.+.......   .....+..|.|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       121 ~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~  192 (254)
T cd05083         121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFS  192 (254)
T ss_pred             eeccccCcceEEEcCCCcEEECCCccceeccccC---CCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999886543221   1222356799999986544 6899999999999999985

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.97  E-value=9.8e-30  Score=184.23  Aligned_cols=152  Identities=40%  Similarity=0.749  Sum_probs=127.6

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeC-----cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ...++.+|+.++++++|+|++++++++...     ...++++|++++++.+.+..  ..+++..+..++.|++.++.+||
T Consensus        46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH  123 (336)
T cd07849          46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKYIH  123 (336)
T ss_pred             hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999987544     35899999999988877754  36889999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      +.|++|+||+|+||+++.++.++++|||++........   ......++..|+|||.+.+...++.++|+||+|+++|+|
T Consensus       124 ~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el  203 (336)
T cd07849         124 SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM  203 (336)
T ss_pred             hCCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHH
Confidence            99999999999999999999999999998865442221   112345688899999876555578999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       204 ~~  205 (336)
T cd07849         204 LS  205 (336)
T ss_pred             Hh
Confidence            86

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.97  E-value=2.2e-29  Score=177.19  Aligned_cols=151  Identities=30%  Similarity=0.522  Sum_probs=129.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      +.+.+|+.+++.++|+|++++++++..++.+++|+|++.+ +|.+.+... +.+++..+..++.+++.++.+||+.+++|
T Consensus        53 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H  131 (272)
T cd06629          53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILH  131 (272)
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence            4577899999999999999999999999999999999986 888777665 47889999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCc-CCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~-~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++.++++|||.+........  ......++..|++||...... .++.++|+||+|+++|++++
T Consensus       132 ~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~  207 (272)
T cd06629         132 RDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA  207 (272)
T ss_pred             cCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence            99999999999999999999998865432211  122345678899999986543 36889999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>PTZ00284 protein kinase; Provisional

Probab=99.97  E-value=1e-29  Score=191.32  Aligned_cols=147  Identities=27%  Similarity=0.458  Sum_probs=122.5

Q ss_pred             hhHHHHHHHHhcCCC------CCeeeeeeeeeeC-cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKH------PNVIRLHDVIPVD-FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h------~~i~~~~~~~~~~-~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .+...|+++++.++|      .+++++++++..+ +.+++||+++++++.+++.+. +.+++..+..++.|++.|+.|||
T Consensus       170 ~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH  248 (467)
T PTZ00284        170 RDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFH  248 (467)
T ss_pred             HHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            445668888877754      4588999988764 478999999988999988765 47899999999999999999999


Q ss_pred             h-CCceecCCCCCcEEEccCC----------------ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCc
Q psy7820          83 S-RRIIHRDLKPQNILINKSG----------------ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  145 (163)
Q Consensus        83 ~-~~i~h~~i~~~ni~~~~~~----------------~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  145 (163)
                      + .|++|+||||+||+++.++                .+||+|||.+....   .......|++.|+|||++.+.. ++.
T Consensus       249 ~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~-~~~  324 (467)
T PTZ00284        249 TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLG-WMY  324 (467)
T ss_pred             hcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCC-CCc
Confidence            7 5999999999999998765                48999999875432   2334567899999999998754 799


Q ss_pred             chhhHHHHHHHHHHhc
Q psy7820         146 TVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       146 ~~Di~slG~~l~~ll~  161 (163)
                      ++||||+||++|||++
T Consensus       325 ~~DiwSlGvil~ellt  340 (467)
T PTZ00284        325 STDMWSMGCIIYELYT  340 (467)
T ss_pred             HHHHHHHHHHHHHHHh
Confidence            9999999999999996

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=1.1e-29  Score=179.59  Aligned_cols=152  Identities=29%  Similarity=0.499  Sum_probs=129.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee--CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..++.+|+++++.++|+|++++++++..  +...++++|++++ ++.+++......+++..+..++.+++.++.+||+.|
T Consensus        50 ~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~  129 (284)
T cd05038          50 RSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR  129 (284)
T ss_pred             HHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4578899999999999999999999877  5579999999975 999998876667899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+||+++.++.++++|||.+.........   .....++..|.+||...+.. ++.++|+||+|+++++|++
T Consensus       130 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~el~t  207 (284)
T cd05038         130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVTLYELFT  207 (284)
T ss_pred             eecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCC-CCcccchHHHhhhhheeec
Confidence            999999999999999999999999988765522111   11123355699999987654 6899999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.97  E-value=1.2e-29  Score=177.03  Aligned_cols=153  Identities=32%  Similarity=0.562  Sum_probs=131.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+.+.+|+++++.++|+|++++++.+..++..++++|++++ +|.+.+.... ..+++..+..++.+++.++.+||+.+
T Consensus        42 ~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~  121 (257)
T cd08225          42 EKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK  121 (257)
T ss_pred             hhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678999999999999999999999999999999999975 8888886543 35789999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCc-eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|.||+++.++. ++++|||.+..............|+..|+|||...+.. ++.++|+||+|+++++|++
T Consensus       122 i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~  197 (257)
T cd08225         122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCT  197 (257)
T ss_pred             cccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999988864 69999998876554333333445788899999987654 6899999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.97  E-value=1.5e-29  Score=177.15  Aligned_cols=153  Identities=33%  Similarity=0.549  Sum_probs=131.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++.++|+|++++++.+...+.+++++||+++ +|.+.+... ..+++..+..++.+++.++.+||+.|+
T Consensus        42 ~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i  120 (264)
T cd06626          42 TIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGI  120 (264)
T ss_pred             HHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence            456788999999999999999999999999999999999985 888777654 367888999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCccc----ccccCccccCcccccCCc--CCCcchhhHHHHHHHHHHh
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~----~~~~~~~~~~pe~~~~~~--~~~~~~Di~slG~~l~~ll  160 (163)
                      +|+|++|+||+++.++.++++|||.+...........    ...++..|++||.+.+..  ..+.++|+||+|+++|+++
T Consensus       121 ~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~  200 (264)
T cd06626         121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMA  200 (264)
T ss_pred             ccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHH
Confidence            9999999999999999999999998876553322221    245678899999987543  2688999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       201 ~  201 (264)
T cd06626         201 T  201 (264)
T ss_pred             h
Confidence            5

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.97  E-value=1.3e-29  Score=179.56  Aligned_cols=150  Identities=30%  Similarity=0.539  Sum_probs=129.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~   85 (163)
                      ...++.+|+++++.++|+|++++++.+.....+++|+||+++ +|.+.+.. .+.+++..+..++.+++.++.|||+ .+
T Consensus        46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~  124 (284)
T cd06620          46 VRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHR  124 (284)
T ss_pred             HHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            346788999999999999999999999999999999999986 77666654 3478899999999999999999996 69


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+||+++.++.++++|||++.......  .....++..|+|||.+.+.. ++.++|+||+|+++|+++|
T Consensus       125 i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~t  197 (284)
T cd06620         125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFVGTSTYMSPERIQGGK-YTVKSDVWSLGISIIELAL  197 (284)
T ss_pred             eeccCCCHHHEEECCCCcEEEccCCcccchhhhc--cCccccCcccCCHHHHccCC-CCccchHHHHHHHHHHHHh
Confidence            9999999999999999999999999876543221  22346788999999987654 6899999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.97  E-value=2.5e-29  Score=178.53  Aligned_cols=152  Identities=29%  Similarity=0.453  Sum_probs=129.0

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|+++++++ +|++|+++++.++.+...++|+|++++ +|.+++.... .+++..+..++.|++.++.+||+.|+
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~i  126 (290)
T cd05613          48 TEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGI  126 (290)
T ss_pred             HHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            45677899999999 589999999999999999999999985 8888876654 68889999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+....... .......++..|++||...+. ..++.++|+||+|+++|+|++
T Consensus       127 ~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~  203 (290)
T cd05613         127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT  203 (290)
T ss_pred             eccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc
Confidence            999999999999999999999999886543221 112234568889999998643 235789999999999999986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG2345|consensus

Probab=99.97  E-value=3.4e-30  Score=172.76  Aligned_cols=155  Identities=29%  Similarity=0.448  Sum_probs=127.2

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeee-----CcEEEEEecchh-ccHHHHHhc---CCCCCCHHHHHHHHHHHHHH
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPV-----DFKLFLVFEFLR-QDLKDFLQT---TPVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~   77 (163)
                      +..+..++|++..++++|||+++++++.-.     .+..|++++|.. |++.+.+..   ++..+++.+++.++..+++|
T Consensus        60 ~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~g  139 (302)
T KOG2345|consen   60 EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRG  139 (302)
T ss_pred             HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHH
Confidence            455678899999999999999999998643     235899999986 789998864   44578999999999999999


Q ss_pred             HHHHHhCC--ceecCCCCCcEEEccCCceEEeecccccccccCCCc---------ccccccCccccCccccc--CCcCCC
Q psy7820          78 LRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---------YTHEVVTLWYRPPEILL--GAKVYS  144 (163)
Q Consensus        78 l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---------~~~~~~~~~~~~pe~~~--~~~~~~  144 (163)
                      +++||+..  +.|+||||.||++...+.+++.|||.++........         ......+..|.|||.+.  .....+
T Consensus       140 L~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~  219 (302)
T KOG2345|consen  140 LEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTIT  219 (302)
T ss_pred             HHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccc
Confidence            99999998  999999999999999999999999988655422111         11223488899999984  222368


Q ss_pred             cchhhHHHHHHHHHHhc
Q psy7820         145 TTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       145 ~~~Di~slG~~l~~ll~  161 (163)
                      .++|||||||+||.|+-
T Consensus       220 ertDIWSLGCtLYa~mf  236 (302)
T KOG2345|consen  220 ERTDIWSLGCTLYAMMF  236 (302)
T ss_pred             cccchhhhhHHHHHHHH
Confidence            99999999999999873

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=2.8e-29  Score=185.42  Aligned_cols=151  Identities=25%  Similarity=0.465  Sum_probs=126.4

Q ss_pred             hhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC----------------------------
Q psy7820          10 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----------------------------   59 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------------   59 (163)
                      ..+.+|++++.++. |+||+++++++..++..++|+||+++ +|.+++....                            
T Consensus        85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (401)
T cd05107          85 QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQR  164 (401)
T ss_pred             HHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccc
Confidence            46788999999997 99999999999999999999999985 9988885431                            


Q ss_pred             ---------------------------------------------------------------------CCCCHHHHHHH
Q psy7820          60 ---------------------------------------------------------------------VPVPPALAKSY   70 (163)
Q Consensus        60 ---------------------------------------------------------------------~~~~~~~~~~~   70 (163)
                                                                                           ..++...+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  244 (401)
T cd05107         165 KSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGF  244 (401)
T ss_pred             ccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHH
Confidence                                                                                 13566678889


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchh
Q psy7820          71 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVD  148 (163)
Q Consensus        71 ~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~D  148 (163)
                      +.|++.++.|||+.+++|+|++|.||+++.++.++++|||++.......  .......++..|++||.+.+.. ++.++|
T Consensus       245 ~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  323 (401)
T cd05107         245 SYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSD  323 (401)
T ss_pred             HHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhH
Confidence            9999999999999999999999999999999999999999987543211  1122334567899999987644 689999


Q ss_pred             hHHHHHHHHHHhc
Q psy7820         149 IWSAGCIFSEMIQ  161 (163)
Q Consensus       149 i~slG~~l~~ll~  161 (163)
                      +||+|+++|||++
T Consensus       324 vwslGvil~e~l~  336 (401)
T cd05107         324 VWSFGILLWEIFT  336 (401)
T ss_pred             HHHHHHHHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.97  E-value=2.4e-29  Score=176.90  Aligned_cols=151  Identities=25%  Similarity=0.427  Sum_probs=124.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcE------EEEEecchhc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFK------LFLVFEFLRQ-DLKDFLQTT-----PVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~------~~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~   77 (163)
                      ..+.+|++.++.++|+|++++++++...+.      .++++||+++ ++...+...     ...+++..+..++.|++.+
T Consensus        46 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~a  125 (273)
T cd05035          46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG  125 (273)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHH
Confidence            467889999999999999999998765443      7999999985 887776432     2368899999999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820          78 LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus        78 l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                      +.|||+.+++|+|++|+||+++.++.++++|||.+.........  .....++..|++||...+.. ++.++|+||+|++
T Consensus       126 L~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~SlG~i  204 (273)
T cd05035         126 MEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVT  204 (273)
T ss_pred             HHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCC-CCcccchHHHHHH
Confidence            99999999999999999999999999999999998765432211  11122356799999986544 6999999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|||++
T Consensus       205 l~el~~  210 (273)
T cd05035         205 MWEIAT  210 (273)
T ss_pred             HHHHHh
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.97  E-value=2e-29  Score=175.66  Aligned_cols=154  Identities=36%  Similarity=0.636  Sum_probs=134.3

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ....++.+|+++++.++|+|++++.+.+..++..++++|++++ +|.+.+...   +..+++..+..++.+++.++.+||
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh  120 (258)
T cd08215          41 KEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH  120 (258)
T ss_pred             HHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            3445678999999999999999999999999999999999986 888888765   368899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|++|+|++|+||+++.++.++++|||.+..............+++.|+|||...+.. ++.++|+||+|+++++|++
T Consensus       121 ~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~  198 (258)
T cd08215         121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCT  198 (258)
T ss_pred             hCCEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHc
Confidence            99999999999999999999999999998876654432333456788899999977654 6899999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.9e-29  Score=175.37  Aligned_cols=152  Identities=36%  Similarity=0.580  Sum_probs=132.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+..|++++++++|+|++++++.+..+...+++||+++ ++|.+++.... .+++..+..++.|+++++.+||+.++
T Consensus        36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~~~  114 (250)
T cd05123          36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEYLHSLGI  114 (250)
T ss_pred             HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34578899999999999999999999999999999999996 58888887654 68899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+..............++..|.+||...+.. .+.++|+||+|+++|++++
T Consensus       115 ~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~  188 (250)
T cd05123         115 IYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLT  188 (250)
T ss_pred             eecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHH
Confidence            9999999999999999999999998876553322333455688899999987654 5899999999999999986

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.9e-29  Score=174.60  Aligned_cols=145  Identities=26%  Similarity=0.370  Sum_probs=122.8

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   90 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~   90 (163)
                      ..+|...+....|+|++++++++.+++..+++|||++| +|.+.+.... .+++..+..++.|++.++.+||+.|++|+|
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~~i~H~d  110 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHREGIVCRD  110 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence            44566666666799999999999999999999999985 8888876544 688999999999999999999999999999


Q ss_pred             CCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          91 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        91 i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+++.++.++++|||.+......   .....++..|++||...... ++.++|+||+|+++|+|++
T Consensus       111 lkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~  177 (237)
T cd05576         111 LNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFELLT  177 (237)
T ss_pred             CCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCcccCCCC-CCchhhHHHHHHHHHHHHH
Confidence            9999999999999999999977554422   12233466799999986544 6899999999999999986

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=3.6e-29  Score=175.22  Aligned_cols=151  Identities=28%  Similarity=0.492  Sum_probs=126.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|++++++++|+|++++++.+.. ...+++|||+++ ++.+++... +...++..+..++.+++.++++||+.|+
T Consensus        45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i  123 (260)
T cd05073          45 VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNY  123 (260)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            3568899999999999999999999887 778999999975 999888653 3467888899999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCc-ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+|++++.++.++++|||.+......... .....++..|+|||.+.... ++.++|+||+|+++|++++
T Consensus       124 ~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~t  198 (260)
T cd05073         124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVT  198 (260)
T ss_pred             cccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCC-cCccccchHHHHHHHHHHh
Confidence            99999999999999999999999988654322111 11223356799999987644 6899999999999999996

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.96  E-value=5.1e-29  Score=176.39  Aligned_cols=151  Identities=51%  Similarity=0.919  Sum_probs=127.7

Q ss_pred             hhhHHHHHHHHhcC---CCCCeeeeeeeeeeCcE-----EEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL---KHPNVIRLHDVIPVDFK-----LFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~---~h~~i~~~~~~~~~~~~-----~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ...+.+|+.+++++   +|+|++++++++.+.+.     +++++|++.+++.+++.... ..+++..++.++.|+++++.
T Consensus        42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~  121 (287)
T cd07838          42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVD  121 (287)
T ss_pred             hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHH
Confidence            34566788877766   59999999999988776     99999999988888776543 36899999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      +||+.+++|+|++|+||+++.++.++++|||.+....... ......++..|++||.+.+.. ++.++|+||+|+++|+|
T Consensus       122 ~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l  199 (287)
T cd07838         122 FLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-ALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAEL  199 (287)
T ss_pred             HHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc-ccccccccccccChHHhccCC-CCCcchhhhHHHHHHHH
Confidence            9999999999999999999999999999999887654332 222334577899999987654 68999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       200 ~~  201 (287)
T cd07838         200 FR  201 (287)
T ss_pred             Hh
Confidence            86

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.96  E-value=5.3e-29  Score=176.77  Aligned_cols=151  Identities=30%  Similarity=0.498  Sum_probs=126.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQ---TTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ...++.+|++++++++|+||+++++++.+.  +.+++||||+++ +|.+++.   .....++...+..++.+++.++.||
T Consensus        42 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~l  121 (287)
T cd06621          42 LQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL  121 (287)
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            345688999999999999999999988653  478999999985 7776653   2345688999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          82 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+.|++|+|++|+||+++.++.++++|||++.......  .....++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       122 H~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~  198 (287)
T cd06621         122 HSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQ  198 (287)
T ss_pred             HHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc--cccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999876544222  12345677899999987644 6999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.96  E-value=5.1e-29  Score=175.11  Aligned_cols=150  Identities=29%  Similarity=0.594  Sum_probs=128.1

Q ss_pred             hhHHHHHHHHhc-CCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHh-
Q psy7820          10 STALREISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ---TTPVPVPPALAKSYLYQLLEALRYCHS-   83 (163)
Q Consensus        10 ~~~~~e~~~l~~-~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lh~-   83 (163)
                      .++.+|+.++.+ ++|+|++++++++..++..+++|||+++ ++.+.+.   .....+++..++.++.+++.++.+||+ 
T Consensus        53 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~  132 (269)
T cd08528          53 GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE  132 (269)
T ss_pred             HHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC
Confidence            456788888876 6999999999999999999999999986 7777663   345578999999999999999999996 


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .+++|+|++|.||+++.++.++++|||.+....... ......++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       133 ~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~  208 (269)
T cd08528         133 KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCT  208 (269)
T ss_pred             CceeecCCCHHHEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHh
Confidence            789999999999999999999999999987654332 333456788899999987654 6999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.96  E-value=5.5e-29  Score=175.13  Aligned_cols=133  Identities=30%  Similarity=0.517  Sum_probs=118.1

Q ss_pred             CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC
Q psy7820          23 KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS  101 (163)
Q Consensus        23 ~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~  101 (163)
                      +|+|++++++.+..++..++||||+++ +|.+++.... .+++..++.++.|+++++.+||+.|++|+||+|.||+++.+
T Consensus        67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~  145 (267)
T PHA03390         67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRA  145 (267)
T ss_pred             cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCC
Confidence            699999999999999999999999975 9988887654 88999999999999999999999999999999999999999


Q ss_pred             C-ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         102 G-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       102 ~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      + .++++|||.+......    ....++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       146 ~~~~~l~dfg~~~~~~~~----~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~  201 (267)
T PHA03390        146 KDRIYLCDYGLCKIIGTP----SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLT  201 (267)
T ss_pred             CCeEEEecCccceecCCC----ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHH
Confidence            8 9999999988655422    1235688899999987654 6899999999999999996

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.96  E-value=4e-29  Score=176.76  Aligned_cols=151  Identities=26%  Similarity=0.500  Sum_probs=124.4

Q ss_pred             hhHHHHHHH-HhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q psy7820          10 STALREISV-LKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSR-   84 (163)
Q Consensus        10 ~~~~~e~~~-l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~-   84 (163)
                      .++..|... ++..+|+|++++++++..++..++++||+++++.+++..   ....+++..++.++.|++.++.+||++ 
T Consensus        44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~  123 (283)
T cd06617          44 KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL  123 (283)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence            345566665 555689999999999999999999999999888776643   335789999999999999999999997 


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCC---cCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA---KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +++|+|++|+||+++.++.++|+|||.+....... ......++..|+|||.+.+.   ..++.++|+||+|+++|+|++
T Consensus       124 ~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~  202 (283)
T cd06617         124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT  202 (283)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeeccccccccccc-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHh
Confidence            99999999999999999999999999887654221 12234567889999987542   236889999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0669|consensus

Probab=99.96  E-value=5.1e-30  Score=172.88  Aligned_cols=159  Identities=48%  Similarity=0.843  Sum_probs=140.6

Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCeeeeeeeeeeC--------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHH
Q psy7820           4 QVEGVPSTALREISVLKELKHPNVIRLHDVIPVD--------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLL   75 (163)
Q Consensus         4 ~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~   75 (163)
                      ++++.+...++|+++|+.++|+|++++++.|...        ..+|+|+++|+.+|...+.+....++...+..++..+.
T Consensus        55 eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm  134 (376)
T KOG0669|consen   55 EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLM  134 (376)
T ss_pred             cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHH
Confidence            3678888899999999999999999999998532        35899999999999999999888999999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc----ccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          76 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR----YTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        76 ~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      .|+.|+|...++|+|+|+.|++++.+|.+++.|||+++.+....+.    -+....|..|.+||.+.+...++++.|+|+
T Consensus       135 ~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWg  214 (376)
T KOG0669|consen  135 NGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWG  214 (376)
T ss_pred             HHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHh
Confidence            9999999999999999999999999999999999999776533222    223344788999999999888999999999


Q ss_pred             HHHHHHHHhcC
Q psy7820         152 AGCIFSEMIQI  162 (163)
Q Consensus       152 lG~~l~~ll~~  162 (163)
                      -||++.||.|.
T Consensus       215 AgCimaeMwtr  225 (376)
T KOG0669|consen  215 AGCIMAEMWTR  225 (376)
T ss_pred             HHHHHHHHHcc
Confidence            99999999974

>KOG0984|consensus

Probab=99.96  E-value=7.7e-30  Score=167.33  Aligned_cols=153  Identities=26%  Similarity=0.466  Sum_probs=125.7

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL---QTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..+.+.|+++..+. .+|++|.+|+...+.+.+|+.||.+.-++..+.   .+.++..++..+-+++.+++.++.|||++
T Consensus        88 q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k  167 (282)
T KOG0984|consen   88 QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK  167 (282)
T ss_pred             HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH
Confidence            45567788887777 689999999998888999999999987666554   45678899999999999999999999965


Q ss_pred             -CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc---CCcCCCcchhhHHHHHHHHHHh
Q psy7820          85 -RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        85 -~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~~Di~slG~~l~~ll  160 (163)
                       +++|+|+||+||+++.+|++|+||||++-........ +...|-..|+|||.+.   +.+.|+.++|+||||+++.||.
T Consensus       168 L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAk-t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA  246 (282)
T KOG0984|consen  168 LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAK-TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMA  246 (282)
T ss_pred             hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHH-HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhh
Confidence             9999999999999999999999999987544432221 2234555699999974   2334899999999999999997


Q ss_pred             cC
Q psy7820         161 QI  162 (163)
Q Consensus       161 ~~  162 (163)
                      ++
T Consensus       247 ~l  248 (282)
T KOG0984|consen  247 IL  248 (282)
T ss_pred             hc
Confidence            63

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.96  E-value=4.9e-29  Score=176.84  Aligned_cols=152  Identities=24%  Similarity=0.444  Sum_probs=126.3

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhccHHHHH---h-cCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL---Q-TTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~---~-~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|+.++.++. |+|++++++++..++..+++||++.+++.++.   . .....+++..+..++.+++.+++|||+
T Consensus        46 ~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~  125 (288)
T cd06616          46 QKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE  125 (288)
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence            346788999999995 99999999999988899999999987554433   2 223578999999999999999999997


Q ss_pred             C-CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCC--cCCCcchhhHHHHHHHHHHh
Q psy7820          84 R-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        84 ~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~Di~slG~~l~~ll  160 (163)
                      . +++|+||+|+||+++.++.++++|||++....... ......++..|+|||.+.+.  ..++.++|+||+|+++|+|+
T Consensus       126 ~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~  204 (288)
T cd06616         126 ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVA  204 (288)
T ss_pred             cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC-ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHH
Confidence            4 99999999999999999999999999886544322 22233568889999998765  35789999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       205 ~  205 (288)
T cd06616         205 T  205 (288)
T ss_pred             h
Confidence            5

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.96  E-value=3.5e-29  Score=177.02  Aligned_cols=149  Identities=40%  Similarity=0.792  Sum_probs=129.7

Q ss_pred             HHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          12 ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        12 ~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ..+|++.+++++ |+|++++++++.+++..++|||++.+++.+.+.... ..+++..+..++.|++.++.+||++|++|+
T Consensus        44 ~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~  123 (283)
T cd07830          44 NLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHR  123 (283)
T ss_pred             HHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence            456999999998 999999999999999999999999889988887654 578999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+++.++.++++|||.+...... .......++..|+|||.+.+...++.++|+||+|+++++|++
T Consensus       124 dl~~~ni~i~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~  194 (283)
T cd07830         124 DLKPENLLVSGPEVVKIADFGLAREIRSR-PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYT  194 (283)
T ss_pred             CCChhhEEEcCCCCEEEeecccceeccCC-CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHh
Confidence            99999999999999999999988655422 122234567889999998665557999999999999999986

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.96  E-value=5.6e-29  Score=180.02  Aligned_cols=152  Identities=39%  Similarity=0.731  Sum_probs=126.8

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeC----cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVD----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|+++++++ +|+||+++++.+...    ..+++++++++++|.+.+... ..+++..++.++.|++.++++||+
T Consensus        45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~  123 (332)
T cd07857          45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSG-QPLTDAHFQSFIYQILCGLKYIHS  123 (332)
T ss_pred             HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecccCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            34577899999999 599999999875432    467899999998998887654 478999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCC----cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      .|++|+||+|+||+++.++.++|+|||.+........    ......|+..|+|||...+...++.++|+||+|+++|+|
T Consensus       124 ~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l  203 (332)
T cd07857         124 ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL  203 (332)
T ss_pred             CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence            9999999999999999999999999998875542211    122345788899999987655579999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       204 ~~  205 (332)
T cd07857         204 LG  205 (332)
T ss_pred             Hh
Confidence            85

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0196|consensus

Probab=99.96  E-value=1.2e-30  Score=197.44  Aligned_cols=155  Identities=26%  Similarity=0.448  Sum_probs=138.4

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +.+..+|+.|+.||-+++||||+++.|++.....+.||.||++ |+|..++....+.+...++..+++.|++|+.||.+.
T Consensus       671 ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm  750 (996)
T KOG0196|consen  671 EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM  750 (996)
T ss_pred             HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc
Confidence            4567889999999999999999999999999999999999998 699999999999999999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCccccc-cc--CccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-VV--TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~-~~--~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+|+-..||+++.+..+|+.|||+++............ .|  ..+|.|||.+.-.+ ++.++|+||+|+++||.++
T Consensus       751 ~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGIVmWEVmS  829 (996)
T KOG0196|consen  751 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMS  829 (996)
T ss_pred             CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcc-cCchhhccccceEEEEecc
Confidence            99999999999999999999999999998775444222222 22  46899999997655 7999999999999999885

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.96  E-value=6.8e-29  Score=175.48  Aligned_cols=152  Identities=24%  Similarity=0.378  Sum_probs=126.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee-CcEEEEEecchh-ccHHHHHhcCC-------CCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLR-QDLKDFLQTTP-------VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~~-------~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ...+.+|+.++++++|+|++++++++.. +...++++++++ +++.+++....       ..+++..++.++.+++.+++
T Consensus        52 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~  131 (280)
T cd05043          52 VTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMS  131 (280)
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            3557889999999999999999998655 567899999997 58888875432       45889999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      |||+.+++|+||+|+||+++.++.++++|||+++........  .....++..|+|||.+.+.. ++.++|+||+|+++|
T Consensus       132 ~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~  210 (280)
T cd05043         132 YLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLW  210 (280)
T ss_pred             HHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHH
Confidence            999999999999999999999999999999998754322111  11223456799999987654 699999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      ++++
T Consensus       211 el~~  214 (280)
T cd05043         211 ELMT  214 (280)
T ss_pred             HHhc
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.96  E-value=9e-29  Score=172.27  Aligned_cols=151  Identities=33%  Similarity=0.573  Sum_probs=133.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .+.+.+|++++++++|+|++++++.+...  ..+++++|++++ ++.+++.... .+++..+..++.+++.++.+||+.+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~  121 (260)
T cd06606          43 LEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSNG  121 (260)
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            56788999999999999999999999988  899999999965 8888877655 8899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+||+++.++.++|+|||.+........  ......++..|.+||...... .+.++|+||+|+++++|++
T Consensus       122 ~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~  198 (260)
T cd06606         122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMAT  198 (260)
T ss_pred             ccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999998876654432  133456688899999987655 6999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0603|consensus

Probab=99.96  E-value=1.7e-29  Score=187.45  Aligned_cols=147  Identities=31%  Similarity=0.548  Sum_probs=122.7

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+..+|..++... +|+|++++.+.+.++...|+|||.+.| .+++.+.....  ....+..|+.+|++++.+||.+|+
T Consensus       359 ~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~--~~~e~~~w~~~lv~Av~~LH~~gv  436 (612)
T KOG0603|consen  359 ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPE--FCSEASQWAAELVSAVDYLHEQGV  436 (612)
T ss_pred             ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcch--hHHHHHHHHHHHHHHHHHHHhcCe
Confidence            45566788777777 799999999999999999999999986 66666655432  225566799999999999999999


Q ss_pred             eecCCCCCcEEE-ccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILI-NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~-~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|||++|+||++ +..++++|+|||.++.....   ....+-|..|.|||+.... .++.++||||||++||+||+
T Consensus       437 vhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---~~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvlLy~ML~  508 (612)
T KOG0603|consen  437 VHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---CDTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVLLYEMLT  508 (612)
T ss_pred             eecCCChhheeecCCCCcEEEEEechhhhCchh---hcccchhhcccChhhhccC-CCCcchhhHHHHHHHHHHHh
Confidence            999999999999 68999999999988654422   2334558889999998854 48999999999999999996

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=8e-29  Score=173.36  Aligned_cols=144  Identities=35%  Similarity=0.531  Sum_probs=122.1

Q ss_pred             HHHHHHHHh-cCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          12 ALREISVLK-ELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        12 ~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      +..|..++. ..+|+|++++++.+..++.+++++||+++ +|.+++... +.+++..+..++.|++.++.+||+.+++|+
T Consensus        43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~  121 (260)
T cd05611          43 VKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHR  121 (260)
T ss_pred             HHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence            344544444 44899999999999999999999999986 887777654 478899999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|.||+++.++.++++|||.+.....    .....++..|++||...+.. ++.++|+||+|+++|+|++
T Consensus       122 dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~  188 (260)
T cd05611         122 DIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLF  188 (260)
T ss_pred             CCCHHHeEECCCCcEEEeecccceeccc----cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHH
Confidence            9999999999999999999998765432    22345678899999987655 6899999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.96  E-value=9.3e-29  Score=178.60  Aligned_cols=152  Identities=23%  Similarity=0.350  Sum_probs=124.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      +.+.+|+.+++.++|+||+++++++..++..++++|++.+ ++.+++.... ..+++..+..++.|++.++.|||+.+++
T Consensus        44 ~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv  123 (328)
T cd08226          44 KALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYI  123 (328)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            5678899999999999999999999999999999999985 8888776542 3588999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcc-------cccccCccccCcccccCC-cCCCcchhhHHHHHHHHHH
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-------THEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-------~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~l  159 (163)
                      |+||+|+||+++.++.+++.||+.+..........       ....++..|++||.+.+. ..++.++|+||+|+++|+|
T Consensus       124 HrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el  203 (328)
T cd08226         124 HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACEL  203 (328)
T ss_pred             cCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHH
Confidence            99999999999999999999997543222111110       111235569999998653 2368999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       204 ~~  205 (328)
T cd08226         204 AT  205 (328)
T ss_pred             Hh
Confidence            86

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.96  E-value=1.7e-28  Score=177.29  Aligned_cols=149  Identities=44%  Similarity=0.774  Sum_probs=126.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeee-CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++++++++|||++++.+++.. +...++++|++++++...+..  ..+++..+..++.|+++++.+||+.++
T Consensus        52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i  129 (328)
T cd07856          52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGV  129 (328)
T ss_pred             hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            34567889999999999999999999865 557899999998888877654  357788888999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|.|++++.++.++++|||.+.....   ......++..|++||.+.+...++.++|+||+|+++|+|+|
T Consensus       130 iH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~t  201 (328)
T cd07856         130 VHRDLKPSNILINENCDLKICDFGLARIQDP---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLE  201 (328)
T ss_pred             ccCCCCHHHEeECCCCCEEeCccccccccCC---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999998865432   12233457789999997664457999999999999999996

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.96  E-value=4.4e-29  Score=176.06  Aligned_cols=151  Identities=32%  Similarity=0.554  Sum_probs=130.6

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+..|.++++++. |+|++++++.+..++..+++||+++ ++|.+.+.+.+ .+++..++.++.|++.++.+||+.|+
T Consensus        45 ~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~~~  123 (280)
T cd05581          45 VKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSKGI  123 (280)
T ss_pred             HHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356788999999998 9999999999999999999999996 58988887654 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC--------------------cccccccCccccCcccccCCcCCCcc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--------------------RYTHEVVTLWYRPPEILLGAKVYSTT  146 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--------------------~~~~~~~~~~~~~pe~~~~~~~~~~~  146 (163)
                      +|+|++|+||+++.++.++++|||.+........                    ......++..|++||...... .+.+
T Consensus       124 ~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~  202 (280)
T cd05581         124 IHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKS  202 (280)
T ss_pred             eecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChh
Confidence            9999999999999999999999998876543321                    122334578899999987654 6899


Q ss_pred             hhhHHHHHHHHHHhc
Q psy7820         147 VDIWSAGCIFSEMIQ  161 (163)
Q Consensus       147 ~Di~slG~~l~~ll~  161 (163)
                      +|+||+|++++++++
T Consensus       203 ~Di~slG~~l~~l~~  217 (280)
T cd05581         203 SDLWALGCIIYQMLT  217 (280)
T ss_pred             hhHHHHHHHHHHHHh
Confidence            999999999999986

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.6e-28  Score=178.57  Aligned_cols=147  Identities=41%  Similarity=0.719  Sum_probs=124.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..+.+|++++++++|+||+++++++...      ...+++++++.+++.+.+..  ..+++..++.++.|++.|+.+||+
T Consensus        61 ~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~  138 (345)
T cd07877          61 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS  138 (345)
T ss_pred             HHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999988643      34789999887888777654  258899999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .|++|+|++|+||+++.++.++++|||.+.....   ......++..|+|||...+...++.++|+||+|+++|+|++
T Consensus       139 ~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~  213 (345)
T cd07877         139 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT  213 (345)
T ss_pred             CCeeecCCChHHEEEcCCCCEEEecccccccccc---cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999998865432   22334567889999998764557899999999999999986

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.96  E-value=9.6e-29  Score=172.28  Aligned_cols=150  Identities=32%  Similarity=0.536  Sum_probs=129.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..++.+|++++++++|+|++++.+++.++...++++|++++ +|.+++...   +..+++..+..++.+++.++.+||+.
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~  122 (256)
T cd08530          43 REDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ  122 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            44677899999999999999999999999999999999976 888877552   34688999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+|++|+||+++.++.++++|||.+......  ......++..|.+||...+.. ++.++|+||+|+++++|++
T Consensus       123 ~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~  196 (256)
T cd08530         123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMAT  196 (256)
T ss_pred             CcccCCCCcceEEEecCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999988765533  222345688899999987644 6899999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.96  E-value=1.2e-28  Score=175.65  Aligned_cols=151  Identities=26%  Similarity=0.472  Sum_probs=126.1

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCce
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~   87 (163)
                      .++..|..++.+. .|+|++++++++.++...+++||++++++.+........+++..+..++.+++.++.|||+ .+++
T Consensus        58 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~  137 (296)
T cd06618          58 KRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVI  137 (296)
T ss_pred             HHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEe
Confidence            3456677767666 5999999999999999999999999888877776655688999999999999999999997 6999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCC---cCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA---KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~---~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+........ .....++..|++||.+.+.   ..++.++|+||+|+++|+|++
T Consensus       138 H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~  213 (296)
T cd06618         138 HRDVKPSNILLDASGNVKLCDFGISGRLVDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELAT  213 (296)
T ss_pred             cCCCcHHHEEEcCCCCEEECccccchhccCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHh
Confidence            999999999999999999999998865543222 2233457789999998643   236889999999999999986

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.96  E-value=1.7e-28  Score=178.21  Aligned_cols=151  Identities=26%  Similarity=0.492  Sum_probs=122.5

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeee-CcEEEEEecchhc-cHHHHHhcCC---------------------------
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTP---------------------------   59 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~---------------------------   59 (163)
                      ..+.+|+.+++++ +|+|++++++++.. +..++++|||+++ +|.+++....                           
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  134 (343)
T cd05103          55 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDL  134 (343)
T ss_pred             HHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhh
Confidence            4577899999999 68999999998755 4578999999985 8888875421                           


Q ss_pred             ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc
Q psy7820          60 ---------------------------------------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK  100 (163)
Q Consensus        60 ---------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~  100 (163)
                                                             ..++...+..++.|+++++.|||+++++|+||+|.||+++.
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~  214 (343)
T cd05103         135 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE  214 (343)
T ss_pred             hhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcC
Confidence                                                   13567788889999999999999999999999999999999


Q ss_pred             CCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         101 SGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       101 ~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++.++++|||++........  ......++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       215 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~  276 (343)
T cd05103         215 NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS  276 (343)
T ss_pred             CCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHH
Confidence            99999999998865432211  111223356799999986644 6999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.4e-28  Score=178.70  Aligned_cols=148  Identities=43%  Similarity=0.762  Sum_probs=126.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+++++.++|+||+++++++..+.      .+++|+|++++++.+.+..  ..+++..++.++.|++.++++||
T Consensus        58 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH  135 (343)
T cd07880          58 AKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIH  135 (343)
T ss_pred             HHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Confidence            345778999999999999999999987643      4689999997788877654  36889999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|++|+||+|+||+++.++.++++|||.+......   .....+++.|++||.+.+...++.++|+||+|+++|++++
T Consensus       136 ~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~  211 (343)
T cd07880         136 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE---MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT  211 (343)
T ss_pred             hCCeecCCCCHHHEEEcCCCCEEEeecccccccccC---ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999999988754422   2234557889999998764446899999999999999986

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.3e-28  Score=178.73  Aligned_cols=147  Identities=43%  Similarity=0.764  Sum_probs=124.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ...+.+|+++++.++|+|++++++++...      ..+++++|++..++.....   ..+++..+..++.|++.++.+||
T Consensus        58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH  134 (342)
T cd07879          58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKYIH  134 (342)
T ss_pred             hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHHHH
Confidence            34578899999999999999999998654      2569999999877766542   36789999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.+++|+||+|+||+++.++.++++|||.+.....   ......++..|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       135 ~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~  210 (342)
T cd07879         135 SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLT  210 (342)
T ss_pred             HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC---CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999998865432   22234557789999998764457899999999999999986

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.96  E-value=3.2e-28  Score=173.44  Aligned_cols=146  Identities=21%  Similarity=0.285  Sum_probs=116.6

Q ss_pred             HHHHHHhcCCCCCeeeeeeeeeeCc----EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          14 REISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        14 ~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .+...+..+.|+++++++++.....    ..+++++.+..++.+.+... ...++..+..++.|++.++.+||+.+++|+
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr  150 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGISHG  150 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            3444556678999999999765443    45788888877776665543 245788889999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCC-------CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPM-------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||+||+++.++.++|+|||+++......       .......|++.|+|||...+.. ++.++|+||+|+++|||++
T Consensus       151 DiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~  228 (294)
T PHA02882        151 DIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAG  228 (294)
T ss_pred             CCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999987653211       1112346899999999987654 7999999999999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.96  E-value=8.9e-29  Score=173.11  Aligned_cols=150  Identities=33%  Similarity=0.534  Sum_probs=127.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .++..|+.+++.++|||++++++++.++...++++||+++ ++.+.+..   ....+++..++.++.|++.++.+||+.|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~  126 (260)
T cd08222          47 VQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR  126 (260)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC
Confidence            3566799999999999999999999999999999999986 77776643   3457899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|++|+|++++. +.++++|||.+..............+++.|++||...+.. ++.++|+||+|+++|+|++
T Consensus       127 i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~  200 (260)
T cd08222         127 ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG-YDSKSDIWSLGCILYEMCC  200 (260)
T ss_pred             ccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999964 6799999998876544333333445678899999986544 6889999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4278|consensus

Probab=99.96  E-value=2.1e-29  Score=187.77  Aligned_cols=150  Identities=31%  Similarity=0.536  Sum_probs=131.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .++|+.|+.+|+.++|||+|++.++|..+..+|||+||+. |+|++++.+.+ ..++.-.++.++.||.++++||.++++
T Consensus       307 veEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknF  386 (1157)
T KOG4278|consen  307 VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNF  386 (1157)
T ss_pred             HHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhh
Confidence            4679999999999999999999999999999999999987 79999998765 456777788999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCccccccc---CccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~---~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|+-..|.+++++..+|+.|||+++......  -+.+.|   ...|.+||-+.-.. ++.++|+|++||+|||+.|
T Consensus       387 IHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT--YTAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFGVLLWEIAT  461 (1157)
T KOG4278|consen  387 IHRDLAARNCLVGENHIVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIAT  461 (1157)
T ss_pred             hhhhhhhhhccccccceEEeeccchhhhhcCCc--eecccCccCcccccCcccccccc-cccchhhHHHHHHHHHHHh
Confidence            999999999999999999999999998766332  112222   56799999986544 7999999999999999987

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.96  E-value=1.3e-28  Score=178.78  Aligned_cols=152  Identities=38%  Similarity=0.783  Sum_probs=124.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeC--------------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVD--------------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ   73 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~   73 (163)
                      ....+.+|++++++++|+|++++++.+...              ...++++||+++++.+.+..  ..+++..++.++.|
T Consensus        45 ~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~q  122 (342)
T cd07854          45 SVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQ  122 (342)
T ss_pred             hHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHH
Confidence            345678899999999999999999876554              35799999999888877754  36889999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEcc-CCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhh
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      ++.|+.+||+.|++|+||+|+||+++. ++.++++|||.+........   ......++..|+|||.+.+...++.++|+
T Consensus       123 i~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  202 (342)
T cd07854         123 LLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDM  202 (342)
T ss_pred             HHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhH
Confidence            999999999999999999999999975 45789999998865432211   11223457789999987654557889999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+|+++|+|++
T Consensus       203 wSlGvil~el~~  214 (342)
T cd07854         203 WAAGCIFAEMLT  214 (342)
T ss_pred             HHHHHHHHHHHh
Confidence            999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.96  E-value=2.5e-28  Score=173.29  Aligned_cols=152  Identities=29%  Similarity=0.458  Sum_probs=128.4

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|+++++++ +|++++++.+.+..+...++||||+.+ +|.+.+... ..+++..+..++.|+++++.+||+.++
T Consensus        48 ~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~  126 (288)
T cd05583          48 AEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGI  126 (288)
T ss_pred             HHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            45677899999999 599999999999999999999999985 888877654 368889999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCc-CCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~-~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|.||+++.++.++++|||.+........ ......++..|++||...+.. ..+.++|+||+|+++|+|++
T Consensus       127 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~t  203 (288)
T cd05583         127 IYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT  203 (288)
T ss_pred             eccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHh
Confidence            9999999999999999999999998765442221 122335688899999976533 25789999999999999996

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0983|consensus

Probab=99.96  E-value=3.4e-29  Score=170.56  Aligned_cols=151  Identities=24%  Similarity=0.449  Sum_probs=126.7

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCce
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH-SRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~   87 (163)
                      .+++..++++.+. ++|+||+++|+|-.+..+++.||.+.-....++..-.+++++.-+-.+...+++++.||- ++|++
T Consensus       135 kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~vi  214 (391)
T KOG0983|consen  135 KRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVI  214 (391)
T ss_pred             HHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhccee
Confidence            4456667776666 489999999999999999999998886666666666678999999999999999999998 56999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|+||+||++|..|++|+||||++-+......+.+ ..|-+.||+||.+.-  ...|+.++|+||||+.++|+.|
T Consensus       215 HRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr-sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaT  289 (391)
T KOG0983|consen  215 HRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR-SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELAT  289 (391)
T ss_pred             ecccCccceEEccCCCEEeecccccceeeccccccc-ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhc
Confidence            999999999999999999999999877665443333 345678999999852  3458999999999999999987

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.96  E-value=1.1e-28  Score=179.15  Aligned_cols=147  Identities=41%  Similarity=0.708  Sum_probs=127.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcE------EEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFK------LFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~------~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .++.+|+.++++++|+|++++.+++...+.      .++|+|+++++|.+.+..  ..+++..+..++.|++.++.+||+
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~  136 (343)
T cd07851          59 KRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS  136 (343)
T ss_pred             HHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999998866554      899999998899888765  368999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .|++|+|++|+||+++.++.++|+|||.+......   .....++..|+|||...+...++.++|+||+|+++|++++
T Consensus       137 ~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt  211 (343)
T cd07851         137 AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT  211 (343)
T ss_pred             CCeecCCCCHHHeEECCCCCEEEcccccccccccc---ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh
Confidence            99999999999999999999999999998765432   2334557789999998654456899999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0696|consensus

Probab=99.96  E-value=2.9e-29  Score=179.45  Aligned_cols=150  Identities=29%  Similarity=0.438  Sum_probs=133.4

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      +-.+.|-++|..- +-|+++.++.+|++.+.+|+||||+.| +|..++..-+ .+.+..+..++..|+-++-+||++||+
T Consensus       394 ectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~kgIi  472 (683)
T KOG0696|consen  394 ECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSKGII  472 (683)
T ss_pred             cceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcCCee
Confidence            3356788888777 568999999999999999999999975 8888887665 788888889999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+|.+|+|++.+|++||.|||.++---......+..|||+.|+|||.+.- ++|+.+.|+||+||+|||||.
T Consensus       473 YRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmla  545 (683)
T KOG0696|consen  473 YRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLA  545 (683)
T ss_pred             eeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHc
Confidence            9999999999999999999999998766666666788999999999999875 458999999999999999984

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.96  E-value=8.2e-28  Score=169.26  Aligned_cols=152  Identities=28%  Similarity=0.470  Sum_probs=121.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------EEEEEecchh-ccHHHHHhcC-----CCCCCHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLR-QDLKDFLQTT-----PVPVPPALAKSYLYQLLE   76 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~~~~~~i~~   76 (163)
                      .+++.+|++++++++|+|++++++++....      ..+++++++. +++.+++...     ...++...++.++.|++.
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~  124 (273)
T cd05074          45 IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS  124 (273)
T ss_pred             HHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Confidence            446788999999999999999999875432      3478889987 4777665422     235788899999999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          77 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        77 ~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      +++|||+.|++|+||+|+||+++.++.++++|||.+........  ......+++.|++||...+.. ++.++|+||+|+
T Consensus       125 ~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~  203 (273)
T cd05074         125 GMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGV  203 (273)
T ss_pred             HHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHH
Confidence            99999999999999999999999999999999998876542211  111223356799999986654 689999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       204 il~el~~  210 (273)
T cd05074         204 TMWEIMT  210 (273)
T ss_pred             HHHHHhh
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG4257|consensus

Probab=99.96  E-value=2.4e-28  Score=181.85  Aligned_cols=153  Identities=29%  Similarity=0.521  Sum_probs=133.4

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.|++|+-++++++||||++++|+|.++ ..|||||.++ |.|..++......++..+...++.|++.++.|||+..
T Consensus       433 d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr  511 (974)
T KOG4257|consen  433 DDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR  511 (974)
T ss_pred             hhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc
Confidence            4567899999999999999999999999775 6999999998 7999999999889999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCccccccc--CccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~--~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      ++|+||-..||++....-+|+.|||+++......---.. .|  ...|++||.+.-.. ++..+|+|-+||++||++.+
T Consensus       512 fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS-~~kLPIKWmaPESINfRr-FTtASDVWMFgVCmWEIl~l  588 (974)
T KOG4257|consen  512 FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKAS-RGKLPIKWMAPESINFRR-FTTASDVWMFGVCMWEILSL  588 (974)
T ss_pred             hhhhhhhhhheeecCcceeeecccchhhhccccchhhcc-ccccceeecCccccchhc-ccchhhHHHHHHHHHHHHHh
Confidence            999999999999999999999999999876543211111 22  55799999975444 79999999999999999853

>KOG4645|consensus

Probab=99.95  E-value=2.4e-29  Score=198.33  Aligned_cols=153  Identities=31%  Similarity=0.484  Sum_probs=129.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .+.+.+|..+|..++|||+|++|++-...+..+|-||||+|+.+..+.+.+...++.....+-.|++.|+.|||+.||+|
T Consensus      1278 ~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVH 1357 (1509)
T KOG4645|consen 1278 FKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVH 1357 (1509)
T ss_pred             CcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCcee
Confidence            34567899999999999999999998888899999999986444444445557788888888899999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCC----CcccccccCccccCcccccCCc--CCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~--~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||.||+++.+|.+|.+|||.+.+.....    .+.....||+-|||||++.+..  ....++|||||||++.||+|
T Consensus      1358 RDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~t 1436 (1509)
T KOG4645|consen 1358 RDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMAT 1436 (1509)
T ss_pred             cCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeec
Confidence            9999999999999999999999987765332    3345668899999999996533  24678999999999999997

>KOG0665|consensus

Probab=99.95  E-value=3.4e-28  Score=168.19  Aligned_cols=148  Identities=39%  Similarity=0.667  Sum_probs=130.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .++..+|..++..++|+|+++++.+|....      ..|+|||++..++.+.+.   ..++-+++..++.|++.|+++||
T Consensus        59 akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lh  135 (369)
T KOG0665|consen   59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLH  135 (369)
T ss_pred             chhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHH
Confidence            456788999999999999999999986543      579999999999998887   36778889999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.||.|+|+||+||++..+...||.|||+++..... ...+.-..+..|.|||++.+-. +....||||+||++.||++
T Consensus       136 s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~  212 (369)
T KOG0665|consen  136 SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELIL  212 (369)
T ss_pred             hcceeecccCcccceecchhheeeccchhhcccCcc-cccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhh
Confidence            999999999999999999999999999999876533 2444556688899999998876 8999999999999999986

>KOG4279|consensus

Probab=99.95  E-value=2e-28  Score=184.34  Aligned_cols=156  Identities=29%  Similarity=0.469  Sum_probs=134.7

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCC--CHHHHHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPV--PPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ++...-+..|+.+-++++|.|||++.|.+..++++-|.||-++| +|.+++...=+++  .+.+...+..||+.|+.|||
T Consensus       613 sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLH  692 (1226)
T KOG4279|consen  613 SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLH  692 (1226)
T ss_pred             chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhh
Confidence            34445578899999999999999999999999999999999986 8888887655566  77888889999999999999


Q ss_pred             hCCceecCCCCCcEEEccC-CceEEeecccccccccCCCcccccccCccccCcccccC-CcCCCcchhhHHHHHHHHHHh
Q psy7820          83 SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ++.|+|+|||-+|++++.. |.+||.|||-+++...-..-...+.||..|||||++.. ...|...+||||+||++.||.
T Consensus       693 en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMA  772 (1226)
T KOG4279|consen  693 ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMA  772 (1226)
T ss_pred             hcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeec
Confidence            9999999999999999885 78999999999887654444556788999999999853 334899999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      |
T Consensus       773 T  773 (1226)
T KOG4279|consen  773 T  773 (1226)
T ss_pred             c
Confidence            7

>KOG0695|consensus

Probab=99.95  E-value=1.9e-27  Score=166.60  Aligned_cols=148  Identities=32%  Similarity=0.527  Sum_probs=134.8

Q ss_pred             HHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          12 ALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        12 ~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ...|..++.+. +||++|-++.+|+++..+++|.||+.| +|..+..++. .++++-+..+...|+-++.|||++||+++
T Consensus       297 vqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~rgiiyr  375 (593)
T KOG0695|consen  297 VQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHERGIIYR  375 (593)
T ss_pred             HHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhcCeeee
Confidence            46788888888 699999999999999999999999985 8877777665 78899999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|.+|++++..|++|+.|+|.++..-.++......|||+.|+|||.+++.. |..+.|+|+||++++||+.
T Consensus       376 dlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemma  446 (593)
T KOG0695|consen  376 DLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMA  446 (593)
T ss_pred             eccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHc
Confidence            9999999999999999999999887766777777889999999999999876 7999999999999999984

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.95  E-value=6.4e-27  Score=161.31  Aligned_cols=150  Identities=47%  Similarity=0.726  Sum_probs=132.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++.+++++|+|++++.+.+......++++|++++ ++..++.... .++...+..++.+++.++.+||+.+++
T Consensus        31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~  109 (244)
T smart00220       31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEYLHSNGII  109 (244)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHcCee
Confidence            56888999999999999999999999999999999999987 8888876654 388999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|++|.||+++.++.++++|||.+....... ......++..|++||...+.. ++.++|+||+|++++++++
T Consensus       110 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~  181 (244)
T smart00220      110 HRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEVLLGKG-YGKAVDVWSLGVILYELLT  181 (244)
T ss_pred             cCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHHHccCC-CCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999887665332 334455688899999987544 6889999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG2052|consensus

Probab=99.95  E-value=3.6e-27  Score=169.16  Aligned_cols=157  Identities=25%  Similarity=0.348  Sum_probs=131.5

Q ss_pred             ccccCCchhhHHHHHHHHhcC--CCCCeeeeeeeeeeCc----EEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHH
Q psy7820           2 RVQVEGVPSTALREISVLKEL--KHPNVIRLHDVIPVDF----KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQL   74 (163)
Q Consensus         2 ~~~~~~~~~~~~~e~~~l~~~--~h~~i~~~~~~~~~~~----~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i   74 (163)
                      ||-..+..+.+.+|.++++..  +|+||+.+++.-..+.    .+|+|++|.+ |+|+|++..  ..++.+..++++.++
T Consensus       240 KiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~  317 (513)
T KOG2052|consen  240 KIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSI  317 (513)
T ss_pred             EEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHH
Confidence            345567778889999999998  8999999998854332    6899999998 799999987  478999999999999


Q ss_pred             HHHHHHHH--------hCCceecCCCCCcEEEccCCceEEeecccccccccCC----CcccccccCccccCcccccCCcC
Q psy7820          75 LEALRYCH--------SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVTLWYRPPEILLGAKV  142 (163)
Q Consensus        75 ~~~l~~lh--------~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~  142 (163)
                      ++||++||        +-.|.|||||+.||++..+|.+.|.|+|++.+.....    ......+||.+|||||++...-.
T Consensus       318 AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin  397 (513)
T KOG2052|consen  318 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETIN  397 (513)
T ss_pred             hhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcC
Confidence            99999999        3358999999999999999999999999997765442    33556789999999999854211


Q ss_pred             ---C--CcchhhHHHHHHHHHHh
Q psy7820         143 ---Y--STTVDIWSAGCIFSEMI  160 (163)
Q Consensus       143 ---~--~~~~Di~slG~~l~~ll  160 (163)
                         +  -..+||||+|.++||+.
T Consensus       398 ~~~Fesyk~ADIYafgLVlWEia  420 (513)
T KOG2052|consen  398 MKHFESYKRADIYAFGLVLWEIA  420 (513)
T ss_pred             hhhhhhhhHHHHHHHHHHHHHHH
Confidence               1  24799999999999986

>KOG0200|consensus

Probab=99.95  E-value=3.7e-27  Score=181.66  Aligned_cols=155  Identities=30%  Similarity=0.538  Sum_probs=132.8

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC---------------CCCCHHHHHH
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKS   69 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------------~~~~~~~~~~   69 (163)
                      ...+.+..|+++++.+ +|+|++.+.+++...+.+++|.||+. |+|..++....               ..+.....+.
T Consensus       343 ~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLls  422 (609)
T KOG0200|consen  343 SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLS  422 (609)
T ss_pred             HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHH
Confidence            3456789999999999 69999999999999999999999998 69999998766               3488999999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcc-cccc--cCccccCcccccCCcCCCcc
Q psy7820          70 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-THEV--VTLWYRPPEILLGAKVYSTT  146 (163)
Q Consensus        70 ~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-~~~~--~~~~~~~pe~~~~~~~~~~~  146 (163)
                      ++.||+.|++||++..++|||+-..||++..+..+||+|||+++.......-. ....  =...|+|||.+.. ..|+.+
T Consensus       423 fa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~k  501 (609)
T KOG0200|consen  423 FAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSK  501 (609)
T ss_pred             HHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-Cccccc
Confidence            99999999999999999999999999999999999999999998543221111 1111  1446999999987 458999


Q ss_pred             hhhHHHHHHHHHHhcC
Q psy7820         147 VDIWSAGCIFSEMIQI  162 (163)
Q Consensus       147 ~Di~slG~~l~~ll~~  162 (163)
                      +|+||+|++|||++|+
T Consensus       502 SDVWSfGI~L~EifsL  517 (609)
T KOG0200|consen  502 SDVWSFGILLWEIFTL  517 (609)
T ss_pred             chhhHHHHHHHHHhhC
Confidence            9999999999999985

>KOG3653|consensus

Probab=99.95  E-value=2.6e-27  Score=170.96  Aligned_cols=155  Identities=25%  Similarity=0.313  Sum_probs=129.4

Q ss_pred             cCCchhhHHHHHHHHhcC--CCCCeeeeeeeeeeCc----EEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q psy7820           5 VEGVPSTALREISVLKEL--KHPNVIRLHDVIPVDF----KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         5 ~~~~~~~~~~e~~~l~~~--~h~~i~~~~~~~~~~~----~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~   77 (163)
                      -++....+.+|-++++..  +|+||+++++.-+.+.    .++||+++.+ |+|.+++...  ..++....+++..++.|
T Consensus       242 p~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarG  319 (534)
T KOG3653|consen  242 PEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARG  319 (534)
T ss_pred             CHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHH
Confidence            345567788899888876  7999999999976655    8999999998 7999999864  67899999999999999


Q ss_pred             HHHHH---------hCCceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCCcCC---
Q psy7820          78 LRYCH---------SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVY---  143 (163)
Q Consensus        78 l~~lh---------~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~---  143 (163)
                      |+|||         +..|.|||||+.||++..|+++.|+|||++.++...  ......-.||.+|||||++.+.--+   
T Consensus       320 La~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~  399 (534)
T KOG3653|consen  320 LAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDR  399 (534)
T ss_pred             HHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccH
Confidence            99999         446999999999999999999999999999877522  2223345789999999998653322   


Q ss_pred             --CcchhhHHHHHHHHHHhc
Q psy7820         144 --STTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       144 --~~~~Di~slG~~l~~ll~  161 (163)
                        -.+.||||+|.++|||++
T Consensus       400 ~Afkr~DvYamgLVLWEi~S  419 (534)
T KOG3653|consen  400 DAFKRIDVYAMGLVLWEIAS  419 (534)
T ss_pred             HHHHHHHHHHHHHHHHHHHh
Confidence              247999999999999985

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.94  E-value=1.1e-26  Score=187.91  Aligned_cols=139  Identities=22%  Similarity=0.399  Sum_probs=117.7

Q ss_pred             HHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcee
Q psy7820          13 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH---SRRIIH   88 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h   88 (163)
                      ..|++.+++++||||+++++++.+++..++||||+++ +|.+++.    .+++..+..++.++++|++|||   +.+++|
T Consensus       731 ~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH  806 (968)
T PLN00113        731 SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVV  806 (968)
T ss_pred             HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence            4678999999999999999999999999999999985 8888875    4788999999999999999999   679999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+++.++..++. ++......    ......++..|+|||+..+.. ++.++||||+|+++|||+|
T Consensus       807 ~dlkp~Nil~~~~~~~~~~-~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~t  873 (968)
T PLN00113        807 GNLSPEKIIIDGKDEPHLR-LSLPGLLC----TDTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLT  873 (968)
T ss_pred             CCCCHHhEEECCCCceEEE-eccccccc----cCCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHh
Confidence            9999999999998887775 54432221    112235688999999987654 7999999999999999997

>KOG0199|consensus

Probab=99.94  E-value=2.5e-27  Score=178.15  Aligned_cols=153  Identities=31%  Similarity=0.477  Sum_probs=132.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+|++|+.+|.+|+|+|++++||++.+ ....+|+|.++ |+|++.+.+ ....+-......++.||++++.||..++
T Consensus       154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr  232 (1039)
T KOG0199|consen  154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR  232 (1039)
T ss_pred             hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence            56789999999999999999999999988 56889999998 699999987 5567888999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCc--cccc-ccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHE-VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~-~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      ++|+|+-..|+++.....+||+|||+.+..+.....  +... --.+.|-|||.++..+ ++.++|+|++||++|||+|.
T Consensus       233 lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFty  311 (1039)
T KOG0199|consen  233 LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTY  311 (1039)
T ss_pred             hhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhcc
Confidence            999999999999999999999999999877643211  1111 1145688999998765 79999999999999999973

>KOG1027|consensus

Probab=99.94  E-value=1.9e-27  Score=181.03  Aligned_cols=151  Identities=34%  Similarity=0.460  Sum_probs=126.6

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV---PVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .-+.+|+..|+.- +||||+++++.-.+....||+.|.|..+|.+++.....   .......+..+.|+++|+++||+.+
T Consensus       547 ~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~  626 (903)
T KOG1027|consen  547 DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK  626 (903)
T ss_pred             HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc
Confidence            3457899999999 69999999999999999999999999999999987411   1111445678899999999999999


Q ss_pred             ceecCCCCCcEEEcc---C--CceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          86 IIHRDLKPQNILINK---S--GALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        86 i~h~~i~~~ni~~~~---~--~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      |+|+|+||.||+++.   +  ..++|.|||++++.......   .....|+.+|+|||++.+... ....||||+||++|
T Consensus       627 iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfy  705 (903)
T KOG1027|consen  627 IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFY  705 (903)
T ss_pred             cccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEE
Confidence            999999999999976   3  46899999999887755433   334577999999999987664 78999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +.++
T Consensus       706 Yvlt  709 (903)
T KOG1027|consen  706 YVLT  709 (903)
T ss_pred             EEec
Confidence            9885

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.4e-25  Score=151.27  Aligned_cols=150  Identities=44%  Similarity=0.688  Sum_probs=131.0

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|++.++.++|++++++++++......++++|+++ +++.+++......++...+..++.++++++.+||+.|++|
T Consensus        36 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H  115 (215)
T cd00180          36 EELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIH  115 (215)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            578899999999999999999999999999999999999 5888888765457889999999999999999999999999


Q ss_pred             cCCCCCcEEEcc-CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          89 RDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        89 ~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      +|++|.||+++. ++.++++||+.+..............+...|.+||........+.++|+|++|++++++
T Consensus       116 ~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             cCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence            999999999999 89999999998876654432233455678899999987653468999999999999886

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1151|consensus

Probab=99.94  E-value=1e-26  Score=167.84  Aligned_cols=157  Identities=33%  Similarity=0.537  Sum_probs=130.0

Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCeeeeeeeee-eCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           4 QVEGVPSTALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         4 ~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      +++.+.....+|.++-+.++|+-||++|++|. +.+.++-|+|||+|+-+++..+....++++.+..|+.||+.++.||.
T Consensus       506 KKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLN  585 (775)
T KOG1151|consen  506 KKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLN  585 (775)
T ss_pred             hhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHh
Confidence            34566677889999999999999999999986 45678999999999777777777779999999999999999999999


Q ss_pred             hC--CceecCCCCCcEEEcc---CCceEEeecccccccccCCCc-------ccccccCccccCcccccCC---cCCCcch
Q psy7820          83 SR--RIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNR-------YTHEVVTLWYRPPEILLGA---KVYSTTV  147 (163)
Q Consensus        83 ~~--~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~---~~~~~~~  147 (163)
                      ..  -|+|.|+||.||++-.   -|.+||.|||+++........       .....||-.|+|||.+.-.   +..+.+.
T Consensus       586 EikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKV  665 (775)
T KOG1151|consen  586 EIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKV  665 (775)
T ss_pred             ccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccce
Confidence            54  6999999999999944   367899999999876543222       2344678889999998532   2368899


Q ss_pred             hhHHHHHHHHHHh
Q psy7820         148 DIWSAGCIFSEMI  160 (163)
Q Consensus       148 Di~slG~~l~~ll  160 (163)
                      ||||+||++|+.+
T Consensus       666 DVWSvGVIFyQCl  678 (775)
T KOG1151|consen  666 DVWSVGVIFYQCL  678 (775)
T ss_pred             eeEeeehhhhhhh
Confidence            9999999999865

>KOG0587|consensus

Probab=99.94  E-value=2.9e-26  Score=175.40  Aligned_cols=154  Identities=28%  Similarity=0.449  Sum_probs=132.7

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeee-----eCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIP-----VDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~-----~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      .-++...|.++++.. .|||++.+++++.     .++.+|+|||+|.| +..+++.+- +..++|+-+..|++.++.|+.
T Consensus        58 ~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~  137 (953)
T KOG0587|consen   58 EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLA  137 (953)
T ss_pred             ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHH
Confidence            345678899999999 6999999999984     35689999999985 888877543 567899999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCI  155 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~  155 (163)
                      +||...++|+|+|-.||++..++.+|++|||++.....-........|++.|||||++.-    ...|+.++|+||||++
T Consensus       138 HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGIT  217 (953)
T KOG0587|consen  138 HLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGIT  217 (953)
T ss_pred             HHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccce
Confidence            999999999999999999999999999999998877766666778899999999999842    2237889999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      ..||-.
T Consensus       218 aIElad  223 (953)
T KOG0587|consen  218 AIEMAE  223 (953)
T ss_pred             eehhcC
Confidence            998753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.94  E-value=8.9e-26  Score=154.29  Aligned_cols=154  Identities=44%  Similarity=0.683  Sum_probs=131.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++.+++++|+|++++++++......++++|++++ +|.+++......+++..+..++.+++.++.+||+.++
T Consensus        40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i  119 (225)
T smart00221       40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI  119 (225)
T ss_pred             HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            456788999999999999999999999988899999999997 8988887655337899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|.|++++.++.++++|||.+....... .......+...|++||...+...++.++|+|++|+++++|++
T Consensus       120 ~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~  195 (225)
T smart00221      120 VHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLW  195 (225)
T ss_pred             ecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHH
Confidence            999999999999999999999999887665432 122344567789999998433446889999999999999986

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=3.2e-27  Score=187.37  Aligned_cols=142  Identities=20%  Similarity=0.271  Sum_probs=109.4

Q ss_pred             HhcCCC-CCeeeeeeeee-------eCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7820          19 LKELKH-PNVIRLHDVIP-------VDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   90 (163)
Q Consensus        19 l~~~~h-~~i~~~~~~~~-------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~   90 (163)
                      .+.++| .||+++.+.|.       ..+.++.++|+++++|.+++......+++..++.++.||+.||.|||++||+|+|
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            344556 68888888872       2346788899988899999987666799999999999999999999999999999


Q ss_pred             CCCCcEEEccCC-------------------ceEEeecccccccccCC----------------CcccccccCccccCcc
Q psy7820          91 LKPQNILINKSG-------------------ALKLADFGLSRAFTIPM----------------NRYTHEVVTLWYRPPE  135 (163)
Q Consensus        91 i~~~ni~~~~~~-------------------~~~l~d~~~~~~~~~~~----------------~~~~~~~~~~~~~~pe  135 (163)
                      |||+||+++..+                   .+|++|||+++......                .......|++.|+|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            999999996544                   45555666554321000                0001134678899999


Q ss_pred             cccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         136 ILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       136 ~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++.+.. ++.++||||+||++|||++
T Consensus       186 ~~~~~~-~~~~sDVwSlGviL~ELl~  210 (793)
T PLN00181        186 EDNGSS-SNCASDVYRLGVLLFELFC  210 (793)
T ss_pred             hhccCC-CCchhhhhhHHHHHHHHhh
Confidence            987755 6999999999999999986

>KOG0664|consensus

Probab=99.94  E-value=2.9e-28  Score=166.41  Aligned_cols=151  Identities=42%  Similarity=0.825  Sum_probs=127.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCc-----EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .++-+|+.+|..++|.|++...++.....     .+|+++|.+..+|... ..+++.++..-++-++.||+.|+.|||+.
T Consensus        97 krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKI-IVSPQ~Ls~DHvKVFlYQILRGLKYLHsA  175 (449)
T KOG0664|consen   97 KRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKI-IVSPQALTPDHVKVFVYQILRGLKYLHTA  175 (449)
T ss_pred             HHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhhe-eccCCCCCcchhhhhHHHHHhhhHHHhhc
Confidence            45678999999999999999988875432     4678888777777654 44566888888888999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeeccccccccc-CCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|.|+||||.|.+++.+-.+||+|||+++.-.. ....++....|.+|.+||.+++...|+...||||+||++.|++.
T Consensus       176 ~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLg  253 (449)
T KOG0664|consen  176 NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQ  253 (449)
T ss_pred             chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHh
Confidence            999999999999999999999999999976442 23345555668899999999998889999999999999999985

>KOG0668|consensus

Probab=99.94  E-value=1.3e-26  Score=154.53  Aligned_cols=154  Identities=34%  Similarity=0.694  Sum_probs=127.5

Q ss_pred             cccCCchhhHHHHHHHHhcCC-CCCeeeeeeeeeeCc--EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q psy7820           3 VQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         3 ~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l   78 (163)
                      +.++-....+.+|+.+|+.+. ++||+++.+++.+..  ...+|+|++.. +......    .+....+..++.++++++
T Consensus        70 iLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkAL  145 (338)
T KOG0668|consen   70 ILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKAL  145 (338)
T ss_pred             eechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHH
Confidence            334445667889999999996 999999999997754  57899999986 4444333    566778899999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCC-ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      .|+|++||.|+|+||.|+|++... .++++|.|++.++. ++.+-.....+.+|--||.+.+-+.|+.+-|+||+||++.
T Consensus       146 dyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA  224 (338)
T KOG0668|consen  146 DYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA  224 (338)
T ss_pred             hHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHH
Confidence            999999999999999999998764 58999999998765 3344444455777889999998888999999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      .|+.
T Consensus       225 ~miF  228 (338)
T KOG0668|consen  225 SMIF  228 (338)
T ss_pred             HHHh
Confidence            9873

>KOG0671|consensus

Probab=99.94  E-value=6.9e-27  Score=164.89  Aligned_cols=152  Identities=35%  Similarity=0.595  Sum_probs=127.2

Q ss_pred             CCchhhHHHHHHHHhcCC-C-C----CeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELK-H-P----NVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~-h-~----~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l   78 (163)
                      ..+.+..+.|+++|+++. + |    -++.+.++|.-.++++||+|.++.++.+++.+.+ .+++-..++.++.|+++++
T Consensus       126 ~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv  205 (415)
T KOG0671|consen  126 DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESV  205 (415)
T ss_pred             HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHH
Confidence            345677788999999993 2 2    2677777899999999999999889999998744 5788999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEcc--------------------CCceEEeecccccccccCCCcccccccCccccCccccc
Q psy7820          79 RYCHSRRIIHRDLKPQNILINK--------------------SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL  138 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~--------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~  138 (163)
                      .+||+.+++|.|+||+||++-.                    +..++++|||.+....+.-   .....|.-|.|||++.
T Consensus       206 ~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h---s~iVsTRHYRAPEViL  282 (415)
T KOG0671|consen  206 AFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH---STIVSTRHYRAPEVIL  282 (415)
T ss_pred             HHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc---ceeeeccccCCchhee
Confidence            9999999999999999999832                    2358999999887655322   3345588899999999


Q ss_pred             CCcCCCcchhhHHHHHHHHHHhc
Q psy7820         139 GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       139 ~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.+ ++.+.|+||+||+|+|+.|
T Consensus       283 gLG-wS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  283 GLG-WSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             ccC-cCCccCceeeeeEEEEeec
Confidence            876 8999999999999999875

>KOG1025|consensus

Probab=99.93  E-value=1.5e-26  Score=176.48  Aligned_cols=153  Identities=24%  Similarity=0.432  Sum_probs=134.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+++.|+-+|.+++|+|++|+.+++.... +.||++|++ |.|+++...+.+.+-....+.|..||++|+.|||++.+
T Consensus       741 ~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrl  819 (1177)
T KOG1025|consen  741 ASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRL  819 (1177)
T ss_pred             hhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcch
Confidence            3567899999999999999999999997765 889999998 69999999999999999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCccccccc--CccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~--~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      +||||-..|+++..-+.+|+.|||+++.......+-....|  .+.|++-|.+... .+++++||||+||++||++|.
T Consensus       820 VHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTF  896 (1177)
T KOG1025|consen  820 VHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTF  896 (1177)
T ss_pred             hhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhc
Confidence            99999999999999999999999999876644444333333  4568999988764 489999999999999999983

>KOG1035|consensus

Probab=99.93  E-value=1e-25  Score=177.26  Aligned_cols=122  Identities=30%  Similarity=0.508  Sum_probs=103.0

Q ss_pred             EEEEEecchhccHHHHHhcCCCCC-CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccc-
Q psy7820          39 KLFLVFEFLRQDLKDFLQTTPVPV-PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-  116 (163)
Q Consensus        39 ~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~-  116 (163)
                      .+||-||||+.++++.+...+... .....++++++|+.|+.|+|++|++|||+||.||+++.++.+||+|||++.... 
T Consensus       670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~  749 (1351)
T KOG1035|consen  670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKE  749 (1351)
T ss_pred             EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhh
Confidence            479999999997777776655333 577789999999999999999999999999999999999999999999997611 


Q ss_pred             -----------------cCCCcccccccCccccCcccccCCc--CCCcchhhHHHHHHHHHHh
Q psy7820         117 -----------------IPMNRYTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus       117 -----------------~~~~~~~~~~~~~~~~~pe~~~~~~--~~~~~~Di~slG~~l~~ll  160 (163)
                                       ......+...||.-|+|||++.+..  .|+.|.|+||||+++|||+
T Consensus       750 ~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~  812 (1351)
T KOG1035|consen  750 NLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML  812 (1351)
T ss_pred             hhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh
Confidence                             0111345668899999999997655  6899999999999999997

>KOG1006|consensus

Probab=99.93  E-value=3.5e-27  Score=160.05  Aligned_cols=155  Identities=24%  Similarity=0.409  Sum_probs=124.1

Q ss_pred             CCchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHh----cCCCCCCHHHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ----TTPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~----~~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      +....+++.|.+...+- +.||||++||..=.++--|+.||.+.-++..+..    .....+++.-+..+..-.+.++.|
T Consensus       103 ~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~y  182 (361)
T KOG1006|consen  103 EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDY  182 (361)
T ss_pred             hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHH
Confidence            34456788888888777 6899999999977777899999999876555442    234578888888888888999999


Q ss_pred             HH-hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcC-CCcchhhHHHHHHHHH
Q psy7820          81 CH-SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV-YSTTVDIWSAGCIFSE  158 (163)
Q Consensus        81 lh-~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~~Di~slG~~l~~  158 (163)
                      |- ...++|+|+||+||++++.|.+|+||||++-..... ...+...|-..|+|||.+..... |+.+||+||||++|||
T Consensus       183 LK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S-iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~E  261 (361)
T KOG1006|consen  183 LKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS-IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYE  261 (361)
T ss_pred             HHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHH-HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEee
Confidence            98 458999999999999999999999999987544322 22334455667999999865443 8999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      +.|
T Consensus       262 vAt  264 (361)
T KOG1006|consen  262 VAT  264 (361)
T ss_pred             eec
Confidence            876

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.92  E-value=2.6e-24  Score=167.84  Aligned_cols=144  Identities=29%  Similarity=0.354  Sum_probs=123.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|+++++.++|+||+++++.+.....+|+||||+.| +|.+++...+ .+++..++.++.|++.+|.|||+.+++|
T Consensus        49 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~gIiH  127 (669)
T cd05610          49 HQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRHGIIH  127 (669)
T ss_pred             HHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEe
Confidence            5678899999999999999999999999999999999975 8888876543 6888999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      +||+|+||+++.++.++|+|||+++.............+++.|.+||......+....+++|++|+
T Consensus       128 rDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~  193 (669)
T cd05610         128 RDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGF  193 (669)
T ss_pred             CCccHHHEEEcCCCCEEEEeCCCCccccCCcccccccccCccccCccccccCCCCceeeeeeecCc
Confidence            999999999999999999999999766544444455677899999998765554566778888874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0670|consensus

Probab=99.91  E-value=2.2e-25  Score=163.18  Aligned_cols=146  Identities=36%  Similarity=0.588  Sum_probs=124.5

Q ss_pred             HHHHHHHhcCC------CCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          13 LREISVLKELK------HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        13 ~~e~~~l~~~~------h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +.|+++|++++      -.++++++..|....++|+|+|.+..+|...+.+-+  ..+.-.++..++.|+.-+|..|-++
T Consensus       476 l~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c  555 (752)
T KOG0670|consen  476 LKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC  555 (752)
T ss_pred             hHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc
Confidence            57999999995      358999999999999999999999999999998754  4577888999999999999999999


Q ss_pred             CceecCCCCCcEEEccC-CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|.||||+||++++. +.+||||||.|.+.....  .+.-..+.-|.|||.+.+.. |+...|+||+||+|||+.|
T Consensus       556 ~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene--itPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYt  630 (752)
T KOG0670|consen  556 GVLHADIKPDNILVNESKNILKLCDFGSASFASENE--ITPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYT  630 (752)
T ss_pred             CeeecccCccceEeccCcceeeeccCcccccccccc--ccHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeec
Confidence            99999999999999876 567999999988766332  21112244589999999865 7999999999999999876

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.90  E-value=5.4e-23  Score=154.75  Aligned_cols=151  Identities=26%  Similarity=0.397  Sum_probs=111.2

Q ss_pred             hHHHHHHHHhcCCCCCe-----eeeeeeeee--------CcEEEEEecchhc-cHHHHHhcCC-----------------
Q psy7820          11 TALREISVLKELKHPNV-----IRLHDVIPV--------DFKLFLVFEFLRQ-DLKDFLQTTP-----------------   59 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i-----~~~~~~~~~--------~~~~~lv~e~~~~-~l~~~~~~~~-----------------   59 (163)
                      ....|+.++.+++|.++     +++.++|..        .+..++|+||+++ +|.+++....                 
T Consensus       218 ~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l  297 (507)
T PLN03224        218 TGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKI  297 (507)
T ss_pred             hhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCch
Confidence            34457777777766544     667777643        3568999999985 8888775421                 


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCcccc
Q psy7820          60 ------VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYR  132 (163)
Q Consensus        60 ------~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~  132 (163)
                            ...++..++.++.+++.++.+||+.+++|+|+||+||+++.++.++++|||++........ ......+++.|+
T Consensus       298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~  377 (507)
T PLN03224        298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS  377 (507)
T ss_pred             hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence                  1235667888999999999999999999999999999999999999999998865432211 111223378899


Q ss_pred             CcccccCCcC-------------------C--CcchhhHHHHHHHHHHhc
Q psy7820         133 PPEILLGAKV-------------------Y--STTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       133 ~pe~~~~~~~-------------------~--~~~~Di~slG~~l~~ll~  161 (163)
                      +||.+.....                   +  ..+.|+||+||++++|++
T Consensus       378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~  427 (507)
T PLN03224        378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCV  427 (507)
T ss_pred             ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHh
Confidence            9999753210                   1  124699999999999985

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.90  E-value=3.8e-23  Score=158.36  Aligned_cols=127  Identities=29%  Similarity=0.475  Sum_probs=95.9

Q ss_pred             eeCcEEEEEecchhc-cHHHHHhcCCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCceecCCCCC
Q psy7820          35 PVDFKLFLVFEFLRQ-DLKDFLQTTPVP-------------------VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQ   94 (163)
Q Consensus        35 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~   94 (163)
                      ..+...++|+||+++ +|.+++......                   .....+..++.|++.++.|||+++++|+||||+
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~  284 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ  284 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence            455689999999985 788877643211                   123345678999999999999999999999999


Q ss_pred             cEEEcc-CCceEEeecccccccccCC-CcccccccCccccCcccccCCcC---------------------CCcchhhHH
Q psy7820          95 NILINK-SGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKV---------------------YSTTVDIWS  151 (163)
Q Consensus        95 ni~~~~-~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~---------------------~~~~~Di~s  151 (163)
                      ||+++. ++.+||+|||++....... .......+++.|+|||.+.....                     +..++||||
T Consensus       285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS  364 (566)
T PLN03225        285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS  364 (566)
T ss_pred             HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence            999986 5789999999987543221 22344567899999997532211                     234569999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +||++|||++
T Consensus       365 lGviL~el~~  374 (566)
T PLN03225        365 AGLIFLQMAF  374 (566)
T ss_pred             HHHHHHHHHh
Confidence            9999999985

>KOG1345|consensus

Probab=99.89  E-value=5.3e-24  Score=145.14  Aligned_cols=148  Identities=30%  Similarity=0.434  Sum_probs=115.8

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeee-eeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDV-IPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~-~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+|.+|...=-.+ .|.||+.-|+. |++.+.+++++|+++ |+|.+-+..  ..+-+...+.++.|+++++.|||+++
T Consensus        64 ~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHskn  141 (378)
T KOG1345|consen   64 QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKN  141 (378)
T ss_pred             HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccc
Confidence            34567777666666 48999988875 888999999999998 688887665  35678888999999999999999999


Q ss_pred             ceecCCCCCcEEEccC--CceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHHHHHHH
Q psy7820          86 IIHRDLKPQNILINKS--GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~l~~l  159 (163)
                      ++|+|||.+||++-+.  .++|++|||.....+.-......   +..|-+||....    .-...+.+|+|++|+++|..
T Consensus       142 lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~~~~---~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~c  218 (378)
T KOG1345|consen  142 LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKYLEY---VNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYC  218 (378)
T ss_pred             hhhcccccceEEEecCCccEEEeeecccccccCceehhhhh---hcccCCcHHHhhccccceEecccccchheeeeeeee
Confidence            9999999999999543  47999999988766533332222   334677777531    11257899999999999998


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ||
T Consensus       219 lt  220 (378)
T KOG1345|consen  219 LT  220 (378)
T ss_pred             ec
Confidence            86

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.89  E-value=1.3e-22  Score=134.46  Aligned_cols=99  Identities=30%  Similarity=0.396  Sum_probs=86.0

Q ss_pred             ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccC
Q psy7820          49 QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT  128 (163)
Q Consensus        49 ~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  128 (163)
                      |+|.+.+...+..+++..++.++.|++.|+.|||+.+      ||+||+++.++.+++  ||.+......     ...|+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-----~~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-----QSRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-----cCCCc
Confidence            5788888776667999999999999999999999998      999999999999999  9987665432     12578


Q ss_pred             ccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       129 ~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|+|||++.+.. ++.++||||+|+++|||+|
T Consensus        68 ~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt   99 (176)
T smart00750       68 PYFMAPEVIQGQS-YTEKADIYSLGITLYEALD   99 (176)
T ss_pred             ccccChHHhcCCC-CcchhhHHHHHHHHHHHHh
Confidence            9999999997755 7999999999999999996

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0576|consensus

Probab=99.89  E-value=2.5e-24  Score=161.11  Aligned_cols=154  Identities=27%  Similarity=0.411  Sum_probs=134.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      +..-..+|+-+++.++|+||+.+++.+-..+..|++||||+|+-++.+....+++++.++...++...+++.|||+.|-.
T Consensus        55 d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~  134 (829)
T KOG0576|consen   55 DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKI  134 (829)
T ss_pred             cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcc
Confidence            34446789999999999999999999998899999999999744455555556999999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc--CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |||||-.||++...|.+|+.|||.+..+..-..+...+.||++|++||+.-  ...-|...+|+|++|+...|+-.
T Consensus       135 hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~e  210 (829)
T KOG0576|consen  135 HRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGE  210 (829)
T ss_pred             cccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhh
Confidence            999999999999999999999999988887778888999999999999962  22237999999999999888654

>KOG1290|consensus

Probab=99.89  E-value=2.9e-22  Score=145.64  Aligned_cols=94  Identities=31%  Similarity=0.497  Sum_probs=82.5

Q ss_pred             cCCchhhHHHHHHHHhcCC--------CCCeeeeeeeeeeC----cEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHH
Q psy7820           5 VEGVPSTALREISVLKELK--------HPNVIRLHDVIPVD----FKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYL   71 (163)
Q Consensus         5 ~~~~~~~~~~e~~~l~~~~--------h~~i~~~~~~~~~~----~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~   71 (163)
                      .+++.+..+.|+.+|++++        ..++|++++.|...    -++++|+|+++.+|+.++.... ..++...+++|+
T Consensus       114 AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~  193 (590)
T KOG1290|consen  114 AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEIC  193 (590)
T ss_pred             hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHH
Confidence            4567788899999999994        24799999999753    4899999999999999997654 578899999999


Q ss_pred             HHHHHHHHHHH-hCCceecCCCCCcEEE
Q psy7820          72 YQLLEALRYCH-SRRIIHRDLKPQNILI   98 (163)
Q Consensus        72 ~~i~~~l~~lh-~~~i~h~~i~~~ni~~   98 (163)
                      .|++.||.||| +.||+|.||||+||++
T Consensus       194 ~qvL~GLdYLH~ecgIIHTDlKPENvLl  221 (590)
T KOG1290|consen  194 RQVLTGLDYLHRECGIIHTDLKPENVLL  221 (590)
T ss_pred             HHHHHHHHHHHHhcCccccCCCcceeee
Confidence            99999999999 5699999999999998

>KOG1167|consensus

Probab=99.88  E-value=4.1e-23  Score=147.34  Aligned_cols=153  Identities=31%  Similarity=0.529  Sum_probs=127.1

Q ss_pred             cCCchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           5 VEGVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         5 ~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..+.+.++.+|+++|..+ -+.||+++.+++..++.+.+|+||.+. ...++..    .++...+..+++.+.+++.++|
T Consensus        74 ~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h  149 (418)
T KOG1167|consen   74 RTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLH  149 (418)
T ss_pred             cccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhh
Confidence            445677899999999999 589999999999999999999999996 6666555    5568888999999999999999


Q ss_pred             hCCceecCCCCCcEEEccC-CceEEeeccccccccc----------------C---------------------------
Q psy7820          83 SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTI----------------P---------------------------  118 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~----------------~---------------------------  118 (163)
                      ++||+|+|+||+|++++.. +.-.|+|||++.....                +                           
T Consensus       150 ~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~  229 (418)
T KOG1167|consen  150 KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDG  229 (418)
T ss_pred             ccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCC
Confidence            9999999999999999865 5679999998862110                0                           


Q ss_pred             -CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         119 -MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       119 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                       ........||++|.|||++...+.-+++.|+||.|+++.-+++
T Consensus       230 r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls  273 (418)
T KOG1167|consen  230 RPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLS  273 (418)
T ss_pred             ccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhc
Confidence             0001234689999999999887766889999999999988775

>KOG1024|consensus

Probab=99.87  E-value=2.4e-21  Score=138.12  Aligned_cols=152  Identities=25%  Similarity=0.345  Sum_probs=123.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeee-eeCcEEEEEecchh-ccHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLR-QDLKDFLQT-------TPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ..+++|.-.+..+.|+|+....+++ ++....++++++.. |+|..++..       ..+.+...+...++.|++.+++|
T Consensus       332 ~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~h  411 (563)
T KOG1024|consen  332 NLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEH  411 (563)
T ss_pred             HHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHH
Confidence            3467888888899999999999986 45557788888887 799999872       23457778888999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccCCceEEeecccccccccC-CCccccccc-CccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          81 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~-~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      ||+++++|.||-..|.++++..++|++|=.+++..... .+-...... ...||+||.+.+.. |+..+|+||+|+++||
T Consensus       412 lh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~-yssasDvWsfGVllWE  490 (563)
T KOG1024|consen  412 LHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH-YSSASDVWSFGVLLWE  490 (563)
T ss_pred             HHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh-hcchhhhHHHHHHHHH
Confidence            99999999999999999999999999998887655422 111112111 45799999987755 7999999999999999


Q ss_pred             HhcC
Q psy7820         159 MIQI  162 (163)
Q Consensus       159 ll~~  162 (163)
                      |+|+
T Consensus       491 Lmtl  494 (563)
T KOG1024|consen  491 LMTL  494 (563)
T ss_pred             HHhc
Confidence            9985

>KOG1164|consensus

Probab=99.86  E-value=5.4e-21  Score=137.92  Aligned_cols=150  Identities=29%  Similarity=0.345  Sum_probs=126.9

Q ss_pred             hHHHHHHHHhcCCC----CCeeeeeeee-eeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          11 TALREISVLKELKH----PNVIRLHDVI-PVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        11 ~~~~e~~~l~~~~h----~~i~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .+..|..++..+..    .+++++++.. ..+.+.|+||+.++.+|.++....+ +.++..++..++.|++.+|+++|+.
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~  141 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK  141 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc
Confidence            67889999999962    6899999999 5778999999999999999886555 7899999999999999999999999


Q ss_pred             CceecCCCCCcEEEccC-----CceEEeeccccc--ccccCC----C---c-ccccccCccccCcccccCCcCCCcchhh
Q psy7820          85 RIIHRDLKPQNILINKS-----GALKLADFGLSR--AFTIPM----N---R-YTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~-----~~~~l~d~~~~~--~~~~~~----~---~-~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      |++|+||||+|++++..     ..+.++|||+++  +.....    .   . .....||..|.++....+.. .+.+.|+
T Consensus       142 G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDl  220 (322)
T KOG1164|consen  142 GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDL  220 (322)
T ss_pred             CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhh
Confidence            99999999999999865     358999999998  332111    1   1 12345899999999998876 4999999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||++.++.+++.
T Consensus       221 es~~Y~l~el~~  232 (322)
T KOG1164|consen  221 ESLFYMLLELLK  232 (322)
T ss_pred             hhHHHHHHHHhc
Confidence            999999999883

>KOG1165|consensus

Probab=99.85  E-value=9.3e-21  Score=132.59  Aligned_cols=153  Identities=21%  Similarity=0.308  Sum_probs=134.9

Q ss_pred             CchhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      +..+++..|.+.++.+. .++|+..|.+-.++.+..+|+|.++.+|.|+..-.+-.++.+++..++.|++..++++|++.
T Consensus        65 S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~  144 (449)
T KOG1165|consen   65 SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD  144 (449)
T ss_pred             CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc
Confidence            34467889999999995 79999999999999999999999998888888777779999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCC-----ceEEeecccccccccC-------CCcccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          86 IIHRDLKPQNILINKSG-----ALKLADFGLSRAFTIP-------MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~-----~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      ++++||||+|+++++-+     .+-++|||.++.+-.+       ..+-.+..||.+||+.....+... +.+.|+-|||
T Consensus       145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLG  223 (449)
T KOG1165|consen  145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALG  223 (449)
T ss_pred             eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhh
Confidence            99999999999997654     4789999999876544       344567789999999999888764 9999999999


Q ss_pred             HHHHHHh
Q psy7820         154 CIFSEMI  160 (163)
Q Consensus       154 ~~l~~ll  160 (163)
                      -++++.|
T Consensus       224 HvFmYFL  230 (449)
T KOG1165|consen  224 HVFMYFL  230 (449)
T ss_pred             hhhhhhc
Confidence            9999988

>KOG1163|consensus

Probab=99.85  E-value=3e-21  Score=129.91  Aligned_cols=151  Identities=24%  Similarity=0.289  Sum_probs=130.7

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++..|..+++.++ ...|+.+..+..+..+..+|||.++.+|.++.+-..-.++.++++.++-|++..++|+|.++++
T Consensus        54 hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fi  133 (341)
T KOG1163|consen   54 HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFI  133 (341)
T ss_pred             CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccc
Confidence            356788999999996 5899999999999999999999999888888887777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccC---CceEEeecccccccccC-------CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          88 HRDLKPQNILINKS---GALKLADFGLSRAFTIP-------MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        88 h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~-------~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      |+||||+|++++-+   +.+.++|||+++++...       ..+.+...||.+|.+-....+... +.+.|+-|+|.+|.
T Consensus       134 HRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLm  212 (341)
T KOG1163|consen  134 HRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLM  212 (341)
T ss_pred             cccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceee
Confidence            99999999999765   45799999999877533       345667789999999888766553 88999999999987


Q ss_pred             HHh
Q psy7820         158 EMI  160 (163)
Q Consensus       158 ~ll  160 (163)
                      ++.
T Consensus       213 Yfn  215 (341)
T KOG1163|consen  213 YFN  215 (341)
T ss_pred             eee
Confidence            764

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.83  E-value=2.3e-19  Score=128.02  Aligned_cols=154  Identities=40%  Similarity=0.641  Sum_probs=129.7

Q ss_pred             chhhHHHHHHHHhcCCCC-CeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           8 VPSTALREISVLKELKHP-NVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~-~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ....+.+|..++..+.|+ +++++.+.+...+..+++++++.+ ++.+.+....  ..++......++.+++.++.++|+
T Consensus        40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~  119 (384)
T COG0515          40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS  119 (384)
T ss_pred             HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            356788999999999887 799999999888888999999986 6665555443  268899999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCC-ceEEeecccccccccCCC------cccccccCccccCcccccCC--cCCCcchhhHHHHH
Q psy7820          84 RRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMN------RYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGC  154 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~------~~~~~~~~~~~~~pe~~~~~--~~~~~~~Di~slG~  154 (163)
                      .+++|+|++|+|++++..+ .++++|||.+........      ......++..|.+||...+.  .......|+||+|+
T Consensus       120 ~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~  199 (384)
T COG0515         120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGI  199 (384)
T ss_pred             CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHH
Confidence            9999999999999999998 699999998875543322      23566789999999998773  35799999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      +++++++
T Consensus       200 ~~~~~~~  206 (384)
T COG0515         200 TLYELLT  206 (384)
T ss_pred             HHHHHHh
Confidence            9998764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5e-20  Score=123.46  Aligned_cols=139  Identities=18%  Similarity=0.122  Sum_probs=103.9

Q ss_pred             hHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          11 TALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        11 ~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .+.+|+++|+++. ++++++++++    +..+++|||+.| +|.+....       . ...++.++..+++++|++|++|
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvH  114 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAH  114 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCcc
Confidence            4789999999995 5889999886    346899999998 55432211       1 1346789999999999999999


Q ss_pred             cCC-CCCcEEEccCCceEEeecccccccccCCCcc-----c--------ccccCccccCcccccCC-cCCCcchhhHHHH
Q psy7820          89 RDL-KPQNILINKSGALKLADFGLSRAFTIPMNRY-----T--------HEVVTLWYRPPEILLGA-KVYSTTVDIWSAG  153 (163)
Q Consensus        89 ~~i-~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~-----~--------~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG  153 (163)
                      +|+ +|+||+++.++.++|+|||++..........     +        -....+.+++|+..... .+--.+.++++.|
T Consensus       115 rDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g  194 (218)
T PRK12274        115 NDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATG  194 (218)
T ss_pred             CCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhc
Confidence            999 7999999999999999999997544332110     0        01135667777765432 2223788999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      +-+|.++|
T Consensus       195 ~~~~~~~~  202 (218)
T PRK12274        195 KPVYRFVT  202 (218)
T ss_pred             chHHHHHh
Confidence            99999997

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=8.2e-20  Score=132.63  Aligned_cols=118  Identities=28%  Similarity=0.295  Sum_probs=91.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeee-eeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~-~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|+++|++++|+|+++ +++.    +..|+||||++| +|. ....    ..   ...++.++++++.+||+.|+
T Consensus        65 ~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~-~~~~----~~---~~~~~~~i~~aL~~lH~~gI  132 (365)
T PRK09188         65 RHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLH-LARP----HG---DPAWFRSAHRALRDLHRAGI  132 (365)
T ss_pred             HHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHH-HhCc----cc---hHHHHHHHHHHHHHHHHCCC
Confidence            345889999999999999885 5432    458999999987 554 2221    11   14578899999999999999


Q ss_pred             eecCC-CCCcEEEccCCceEEeecccccccccCCCc--------ccccccCccccCccccc
Q psy7820          87 IHRDL-KPQNILINKSGALKLADFGLSRAFTIPMNR--------YTHEVVTLWYRPPEILL  138 (163)
Q Consensus        87 ~h~~i-~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--------~~~~~~~~~~~~pe~~~  138 (163)
                      +|+|| ||+||+++.++.++|+|||+++.....+..        .+...+++.|.+||...
T Consensus       133 iHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        133 THNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999 999999999999999999999866543311        13445677789999874

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.5e-20  Score=128.16  Aligned_cols=125  Identities=15%  Similarity=0.252  Sum_probs=94.8

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeC--------cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVD--------FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      +.+|++.+.++.|++++.+.+++.+.        +..+++|||++| ++.+..     ..++.    ...++..++..+|
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~~----~~~~i~~~l~~lH  152 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISED----VKAKIKASIESLH  152 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccHH----HHHHHHHHHHHHH
Confidence            67899999999999999999886543        357899999998 776652     22332    3568999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      +.|++|+|++|+|++++.+| ++++|||...........            ....... .+..++|+||||+++..+
T Consensus       153 ~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler-~y~~~~di~~lg~~~~~~  215 (232)
T PRK10359        153 QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLER-HYGIKNEIKDLGYYLLIY  215 (232)
T ss_pred             HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHh-HhcccccccceeEeehHH
Confidence            99999999999999999988 999999976543211110            0022222 356899999999987654

>KOG0590|consensus

Probab=99.80  E-value=2.1e-20  Score=143.53  Aligned_cols=149  Identities=32%  Similarity=0.517  Sum_probs=122.9

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDL   91 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i   91 (163)
                      +..|+.+=..++|+|++.....+.+.....-.||||+++|+..+... +.+....+..++.|++.|+.|+|+.|+.|+|+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            34455566677899998888888776666666999999787777654 46777888889999999999999999999999


Q ss_pred             CCCcEEEccCCceEEeecccccccccCC----CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          92 KPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        92 ~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+++..+|.+||+|||.+..+..+.    ......+|+..|+|||.+.+........|+||.|+++..|.+
T Consensus       447 K~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~  520 (601)
T KOG0590|consen  447 KLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL  520 (601)
T ss_pred             ccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence            9999999999999999999887665443    334566889999999999887755567999999999887764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.77  E-value=1e-18  Score=117.08  Aligned_cols=100  Identities=22%  Similarity=0.316  Sum_probs=78.5

Q ss_pred             HHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCceecC
Q psy7820          13 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC-HSRRIIHRD   90 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~h~~   90 (163)
                      .+|++.++++.++++.....+... . .++||||++| ++...... ...++...+..++.|++.++.++ |+.|++|+|
T Consensus        67 ~~E~~~l~~l~~~~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrD  143 (190)
T cd05147          67 EKEMRNLKRLVTAGIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHAD  143 (190)
T ss_pred             HHHHHHHHHHHHCCCCCCcEEEec-C-CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            459999999987776443333222 2 3899999997 44333333 34788999999999999999999 799999999


Q ss_pred             CCCCcEEEccCCceEEeecccccccc
Q psy7820          91 LKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        91 i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      +||+||+++ ++.++++|||++....
T Consensus       144 lkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         144 LSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCHHHEEEE-CCcEEEEEccccccCC
Confidence            999999998 5789999999987544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0603|consensus

Probab=99.77  E-value=3e-19  Score=133.48  Aligned_cols=144  Identities=33%  Similarity=0.421  Sum_probs=125.7

Q ss_pred             hHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          11 TALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        11 ~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      +...|-.++..++ ||.++++...++.....+++.++..| .+...+..+. ..++.....+...++-+++++|+.++++
T Consensus        42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l~iiy  120 (612)
T KOG0603|consen   42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKLGIAY  120 (612)
T ss_pred             ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHHHHhhcchhHHHH
Confidence            6677888999996 99999999999999999999999986 7776666555 6677778888889999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      +|+|++||+++.+|.+++.|||.++.......    .||+..|++||.+.+   ....+|+||+|++.++|+|-
T Consensus       121 rd~k~enilld~~Ghi~~tdfglske~v~~~~----~cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg  187 (612)
T KOG0603|consen  121 RDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI----ACGTYEYRAPEIING---HLSAADWWSFGVLAFELLTG  187 (612)
T ss_pred             hcccccceeecccCccccCCchhhhHhHhhhh----cccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhC
Confidence            99999999999999999999998876543222    289999999999872   68999999999999999973

>PRK10345 hypothetical protein; Provisional

Probab=99.76  E-value=1.6e-17  Score=112.58  Aligned_cols=101  Identities=27%  Similarity=0.369  Sum_probs=80.5

Q ss_pred             chhhHHHHHHHHhcC-----CCCCeeeeeeeeeeCc---EEE-EEecchh---ccHHHHHhcCCCCCCHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKEL-----KHPNVIRLHDVIPVDF---KLF-LVFEFLR---QDLKDFLQTTPVPVPPALAKSYLYQLL   75 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-----~h~~i~~~~~~~~~~~---~~~-lv~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~~i~   75 (163)
                      ..+++.+|+++++.+     +||||++++++++++.   .++ +|+|+.+   ++|.+++.+.  .+++.  ..++.+++
T Consensus        39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~~~~~L  114 (210)
T PRK10345         39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQLRQLL  114 (210)
T ss_pred             hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHHHHHHH
Confidence            456789999999999     5799999999998873   444 7899944   5999998653  35554  34577888


Q ss_pred             HHH-HHHHhCCceecCCCCCcEEEccC----CceEEee-cccc
Q psy7820          76 EAL-RYCHSRRIIHRDLKPQNILINKS----GALKLAD-FGLS  112 (163)
Q Consensus        76 ~~l-~~lh~~~i~h~~i~~~ni~~~~~----~~~~l~d-~~~~  112 (163)
                      .++ +|||+++|+|+||||+||+++..    +.++|+| ||..
T Consensus       115 ~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345        115 KKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             HHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            777 99999999999999999999753    3799999 5543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.75  E-value=6e-18  Score=113.53  Aligned_cols=101  Identities=25%  Similarity=0.285  Sum_probs=80.5

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhcc-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCceec
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRIIHR   89 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~h~   89 (163)
                      +..|.+.+.++.++++.....+....  .++||||++|. +...... ...++......++.+++.++.++|+ .|++|+
T Consensus        66 ~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHr  142 (190)
T cd05145          66 AEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHG  142 (190)
T ss_pred             HHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            35789999999988875444443332  48999999874 4333222 2467788899999999999999999 999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      |++|+||+++ ++.++++|||++....
T Consensus       143 DlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         143 DLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CCChhhEEEE-CCCEEEEEcccceecC
Confidence            9999999998 8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1240|consensus

Probab=99.75  E-value=4.3e-19  Score=139.65  Aligned_cols=147  Identities=31%  Similarity=0.483  Sum_probs=117.2

Q ss_pred             HHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7820          13 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLK   92 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~   92 (163)
                      +.|++ ...+++||.+++.-...++...|+|.+|...+|.|.+...+ -+...+.+.|+-|++.++..+|+.|++|||||
T Consensus        70 L~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvkhnLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIK  147 (1431)
T KOG1240|consen   70 LEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVKHNLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIK  147 (1431)
T ss_pred             HHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHhhhhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHcCccccccc
Confidence            33444 55668999999999988888899999999999999998877 56677778899999999999999999999999


Q ss_pred             CCcEEEccCCceEEeecccccccccCCCccccc---c----cCccccCcccccCCc---------C-CCcchhhHHHHHH
Q psy7820          93 PQNILINKSGALKLADFGLSRAFTIPMNRYTHE---V----VTLWYRPPEILLGAK---------V-YSTTVDIWSAGCI  155 (163)
Q Consensus        93 ~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~---~----~~~~~~~pe~~~~~~---------~-~~~~~Di~slG~~  155 (163)
                      .+||++..=+++.+.||...+...-+...+...   +    ....|+|||++....         + .+++.||||+||+
T Consensus       148 sENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCV  227 (1431)
T KOG1240|consen  148 SENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCV  227 (1431)
T ss_pred             cceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHH
Confidence            999999999999999998665443332222111   1    123499999985411         1 4789999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +.|+++
T Consensus       228 iaELf~  233 (1431)
T KOG1240|consen  228 IAELFL  233 (1431)
T ss_pred             HHHHHh
Confidence            999984

>KOG1166|consensus

Probab=99.75  E-value=4.2e-18  Score=134.56  Aligned_cols=158  Identities=23%  Similarity=0.296  Sum_probs=132.4

Q ss_pred             ccccCCchhhHHHHHHHHhcCC---CCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q psy7820           2 RVQVEGVPSTALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         2 ~~~~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~   77 (163)
                      |++++..+++|..-.+++.+++   -+.|.++..+....+.-++|++|.+ |+|+++++ ....+++..+..+..|++..
T Consensus       728 K~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~i  806 (974)
T KOG1166|consen  728 KVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRI  806 (974)
T ss_pred             EeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHH
Confidence            5678888899988888888887   4566777777667777889999998 79999998 44478999999999999999


Q ss_pred             HHHHHhCCceecCCCCCcEEEcc-------CCceEEeecccccccc--cCCCcccccccCccccCcccccCCcCCCcchh
Q psy7820          78 LRYCHSRRIIHRDLKPQNILINK-------SGALKLADFGLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD  148 (163)
Q Consensus        78 l~~lh~~~i~h~~i~~~ni~~~~-------~~~~~l~d~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D  148 (163)
                      ++.||..+|+||||||+|+++..       .-.++|+|||.+....  ..+..+...+++-.+.++|...++ +++...|
T Consensus       807 ve~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~gr-pWtYq~D  885 (974)
T KOG1166|consen  807 VEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGR-PWTYQID  885 (974)
T ss_pred             HHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCC-CCchhhh
Confidence            99999999999999999999943       2248999999886543  234567777889999999998775 4899999


Q ss_pred             hHHHHHHHHHHhc
Q psy7820         149 IWSAGCIFSEMIQ  161 (163)
Q Consensus       149 i~slG~~l~~ll~  161 (163)
                      .|.|+.+++.||.
T Consensus       886 yfGlAa~~h~mLF  898 (974)
T KOG1166|consen  886 YFGLAATVHVMLF  898 (974)
T ss_pred             hHHHHHHHHHHHH
Confidence            9999999999984

>KOG1023|consensus

Probab=99.74  E-value=5.7e-18  Score=125.76  Aligned_cols=143  Identities=26%  Similarity=0.397  Sum_probs=119.7

Q ss_pred             HhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eecCCCCCcE
Q psy7820          19 LKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI-IHRDLKPQNI   96 (163)
Q Consensus        19 l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-~h~~i~~~ni   96 (163)
                      |+.+.|.|+.+++|.+-++...++|.++|+ |+|.+.+......+++.-...+++++++|+.|+|.-.+ .|+.+++.|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            467899999999999999999999999998 79999999988899999999999999999999997765 9999999999


Q ss_pred             EEccCCceEEeeccccccccc--CCCcccccccCccccCcccccCCcC------CCcchhhHHHHHHHHHHhc
Q psy7820          97 LINKSGALKLADFGLSRAFTI--PMNRYTHEVVTLWYRPPEILLGAKV------YSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        97 ~~~~~~~~~l~d~~~~~~~~~--~~~~~~~~~~~~~~~~pe~~~~~~~------~~~~~Di~slG~~l~~ll~  161 (163)
                      +++..+.+|+.|||+......  ............-|.|||.+++...      .+.+.|+||+|++++|+++
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            999999999999998876542  0011111122446899999876311      3778999999999999985

>KOG1033|consensus

Probab=99.70  E-value=4.2e-18  Score=125.20  Aligned_cols=119  Identities=33%  Similarity=0.554  Sum_probs=101.4

Q ss_pred             EEEEEecchhc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeeccccccc
Q psy7820          39 KLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF  115 (163)
Q Consensus        39 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~  115 (163)
                      +.||.|++|.. +|.+++...  ....+....+.++.|++.+++|   ++.+|+|++|.||++..+..++|.|||+....
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~  406 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ  406 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence            68999999985 999998643  3455677788899999999999   99999999999999999999999999988766


Q ss_pred             ccCC------CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         116 TIPM------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       116 ~~~~------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ....      ...+...|+..|++||.+.+.. |+.++||||||++|+|++.
T Consensus       407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLI  457 (516)
T ss_pred             ccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHH
Confidence            5333      2345667899999999999866 7999999999999999984

>KOG4158|consensus

Probab=99.68  E-value=3.3e-16  Score=112.53  Aligned_cols=138  Identities=31%  Similarity=0.395  Sum_probs=104.5

Q ss_pred             CCCCeeeeeeeeee---------------------------CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHH
Q psy7820          23 KHPNVIRLHDVIPV---------------------------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLL   75 (163)
Q Consensus        23 ~h~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~   75 (163)
                      +||||++..++|.+                           +..+|+||.....+|..++....  .+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence            69999999988732                           23589999999999999998653  45666677889999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEc--cC--CceEEeeccccccccc------CCCcccccccCccccCcccccCC-----
Q psy7820          76 EALRYCHSRRIIHRDLKPQNILIN--KS--GALKLADFGLSRAFTI------PMNRYTHEVVTLWYRPPEILLGA-----  140 (163)
Q Consensus        76 ~~l~~lh~~~i~h~~i~~~ni~~~--~~--~~~~l~d~~~~~~~~~------~~~~~~~~~~~~~~~~pe~~~~~-----  140 (163)
                      .++.|||++|+.|+|+|++||++.  .|  ..+.+.|||-+-....      .....-+..|+-.-++||+.--.     
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999993  33  3578899996543321      11222334456668999997421     


Q ss_pred             cCCCcchhhHHHHHHHHHHhcC
Q psy7820         141 KVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus       141 ~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      ...-.++|.|+.|.+.||+++.
T Consensus       432 vvny~kAD~WA~GalaYEIfg~  453 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGR  453 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhcc
Confidence            1134689999999999999863

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.68  E-value=5.1e-17  Score=114.01  Aligned_cols=119  Identities=24%  Similarity=0.402  Sum_probs=81.0

Q ss_pred             EEEEecchhccHHHHHhc---CCC---CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeeccccc
Q psy7820          40 LFLVFEFLRQDLKDFLQT---TPV---PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR  113 (163)
Q Consensus        40 ~~lv~e~~~~~l~~~~~~---~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~  113 (163)
                      .+++|+...++|.+.+..   ...   .+.......+..|+++.+++||..|++|+||+|+|++++.+|.+.+.||+...
T Consensus       114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~  193 (288)
T PF14531_consen  114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLV  193 (288)
T ss_dssp             EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred             hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHe
Confidence            477888888888777532   221   22334445566899999999999999999999999999999999999998776


Q ss_pred             ccccCCCcccccccCccccCcccccCC-------cCCCcchhhHHHHHHHHHHhc
Q psy7820         114 AFTIPMNRYTHEVVTLWYRPPEILLGA-------KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       114 ~~~~~~~~~~~~~~~~~~~~pe~~~~~-------~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.+.....   ...+..|.|||.....       -.++.+.|.|+||+++|.+.+
T Consensus       194 r~g~~~~~---~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC  245 (288)
T PF14531_consen  194 RAGTRYRC---SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC  245 (288)
T ss_dssp             ETTEEEEG---GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred             ecCceeec---cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence            65532221   2335678999986432       236889999999999999985

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=6.9e-16  Score=105.03  Aligned_cols=100  Identities=22%  Similarity=0.314  Sum_probs=85.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++..+.|++++....++.+....+++|||++| ++.+.+....    . ....++.+++.++.++|+.+++|
T Consensus        44 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H  118 (211)
T PRK14879         44 ERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIH  118 (211)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCccc
Confidence            3577899999999999888777777677788999999987 8877765432    2 67889999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeeccccccc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAF  115 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~  115 (163)
                      +|++|.||+++ ++.++++|||.+...
T Consensus       119 ~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879        119 GDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             CCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99999999999 788999999987653

>KOG0195|consensus

Probab=99.66  E-value=1.7e-16  Score=109.12  Aligned_cols=151  Identities=15%  Similarity=0.232  Sum_probs=118.3

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .+..++|..|...|+-+.||||+.+.+.|.......++..|++ |+|+..+....+ -.+..++.+++.+++.|+.|||+
T Consensus       228 ~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhs  307 (448)
T KOG0195|consen  228 ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHS  307 (448)
T ss_pred             hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhh
Confidence            4566789999999999999999999999999999999999998 689888876543 35778889999999999999997


Q ss_pred             CC--ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcC--CCcchhhHHHHHHHHHH
Q psy7820          84 RR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        84 ~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~~Di~slG~~l~~l  159 (163)
                      ..  +..--+.+..+++|++.+.+|.- +=+++..    ........+.|++||.+...+.  ....+|+||+++++||+
T Consensus       308 lep~ipr~~lns~hvmidedltarism-ad~kfsf----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel  382 (448)
T KOG0195|consen  308 LEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWEL  382 (448)
T ss_pred             cchhhhhhhcccceEEecchhhhheec-ccceeee----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHh
Confidence            64  44566788899999998877752 1111111    1112233778999999865332  35689999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      -|
T Consensus       383 ~t  384 (448)
T KOG0195|consen  383 NT  384 (448)
T ss_pred             hc
Confidence            86

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.64  E-value=1.4e-15  Score=116.53  Aligned_cols=97  Identities=25%  Similarity=0.298  Sum_probs=84.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      +++.+|+++++.++|++++....+..+....++||||++| +|.+.+.         ....++.+++.++.+||+.|++|
T Consensus       381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiH  451 (535)
T PRK09605        381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVH  451 (535)
T ss_pred             HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCcc
Confidence            4578999999999999998888777777778999999987 7777654         34678899999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      +|++|.||++ .++.++++|||.+....
T Consensus       452 rDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        452 GDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             CCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            9999999999 67889999999987643

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.63  E-value=1.4e-15  Score=102.60  Aligned_cols=97  Identities=23%  Similarity=0.281  Sum_probs=78.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      +++.+|.++++.++++++.....++......+++||+++| ++.+.+.... .       .++.+++.++.++|+.|++|
T Consensus        42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH~~gi~H  113 (199)
T TIGR03724        42 ERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN-D-------ELLREIGRLVGKLHKAGIVH  113 (199)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH-H-------HHHHHHHHHHHHHHHCCeec
Confidence            4567899999999887665544455556667899999987 7777654322 1       67889999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeeccccccc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAF  115 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~  115 (163)
                      +|++|.||+++ ++.++++|||.+...
T Consensus       114 ~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724       114 GDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999999999 899999999987653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00090 RIO RIO-like kinase

Probab=99.63  E-value=1.2e-15  Score=105.55  Aligned_cols=101  Identities=24%  Similarity=0.263  Sum_probs=78.6

Q ss_pred             HHHHHHHHhcCCC--CCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ce
Q psy7820          12 ALREISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR-II   87 (163)
Q Consensus        12 ~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-i~   87 (163)
                      +..|++.++++.+  ..++++++.   . ..++|||+++| ++....... ...+...+..++.+++.++.+||+.| ++
T Consensus        97 ~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~ii  171 (237)
T smart00090       97 AEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELV  171 (237)
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEE
Confidence            5689999999975  334555543   2 34799999998 454443232 35566677889999999999999999 99


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccC
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIP  118 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  118 (163)
                      |+|++|+||+++ ++.++++|||.+.....+
T Consensus       172 H~Dikp~NIli~-~~~i~LiDFg~a~~~~~~  201 (237)
T smart00090      172 HGDLSEYNILVH-DGKVVIIDVSQSVELDHP  201 (237)
T ss_pred             eCCCChhhEEEE-CCCEEEEEChhhhccCCc
Confidence            999999999999 889999999988765543

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=4.1e-15  Score=103.07  Aligned_cols=101  Identities=24%  Similarity=0.296  Sum_probs=80.1

Q ss_pred             hhHHHHHHHHhcCCCCCe--eeeeeeeeeC-cE---EEEEecchhc--cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNV--IRLHDVIPVD-FK---LFLVFEFLRQ--DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i--~~~~~~~~~~-~~---~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      .++.+|++++..++|+++  ++.+++.... +.   .++|+|+++|  ++.+.+...  .++...    +.+++.++.+|
T Consensus        85 ~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~~----~~~i~~~l~~l  158 (239)
T PRK01723         85 TRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA--PLSEEQ----WQAIGQLIARF  158 (239)
T ss_pred             hHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC--CCCHHH----HHHHHHHHHHH
Confidence            567889999999988775  7777764332 22   3599999986  777776542  455443    56899999999


Q ss_pred             HhCCceecCCCCCcEEEccCCceEEeecccccccc
Q psy7820          82 HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      |+.|++|+|++|.||+++.++.++++|||.+....
T Consensus       159 H~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        159 HDAGVYHADLNAHNILLDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             HHCCCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence            99999999999999999999999999999887644

>KOG1243|consensus

Probab=99.62  E-value=5.7e-15  Score=111.84  Aligned_cols=145  Identities=24%  Similarity=0.371  Sum_probs=109.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH-SRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h   88 (163)
                      ....+.+..|+.++||||+++++..+..+.+|+|+|.+.. +...+.+.    ....+..-+.||+.+|.||| +++++|
T Consensus        54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P-l~~~lk~l----~~~~v~~Gl~qIl~AL~FL~~d~~lvH  128 (690)
T KOG1243|consen   54 ELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP-LETVLKEL----GKEEVCLGLFQILAALSFLNDDCNLVH  128 (690)
T ss_pred             HHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc-HHHHHHHh----HHHHHHHHHHHHHHHHHHHhccCCeee
Confidence            4467889999999999999999999999999999999864 22222221    15556667899999999997 789999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhcC
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~~  162 (163)
                      +++..+.++++..|..||.+|.++..............--..|..|+.+...   .-..|.|.||+++++++..
T Consensus       129 gNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  129 GNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             ccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            9999999999999999999998876654332211111112245666554321   2457999999999999864

>KOG0606|consensus

Probab=99.49  E-value=2.3e-14  Score=113.09  Aligned_cols=87  Identities=39%  Similarity=0.672  Sum_probs=73.6

Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC---------------cccccccCccccCcccc
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---------------RYTHEVVTLWYRPPEIL  137 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---------------~~~~~~~~~~~~~pe~~  137 (163)
                      +++.+++|||..|++|+|++|+|.++..-|++|+.|||+.+.......               ..+..+|++.|+|||++
T Consensus       151 dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVi  230 (1205)
T KOG0606|consen  151 DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVI  230 (1205)
T ss_pred             hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhh
Confidence            347899999999999999999999999999999999998865532211               12355899999999998


Q ss_pred             cCCcCCCcchhhHHHHHHHHHHh
Q psy7820         138 LGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus       138 ~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ...+ |....|+|++|+++||.+
T Consensus       231 lrqg-ygkpvdwwamGiIlyeFL  252 (1205)
T KOG0606|consen  231 LRQG-YGKPVDWWAMGIILYEFL  252 (1205)
T ss_pred             hhhc-cCCCccHHHHHHHHHHHh
Confidence            7655 799999999999999976

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.49  E-value=1.1e-13  Score=93.46  Aligned_cols=95  Identities=23%  Similarity=0.266  Sum_probs=74.0

Q ss_pred             hHHHHHHHHhcCCCC--CeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          11 TALREISVLKELKHP--NVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~--~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ....|..++..+.++  .+++.++.    +..+++|||++| ++.....       ......++.+++.++.++|+.|++
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~  147 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGII  147 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceeec----CCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCC
Confidence            367789999999776  44444432    345899999998 5543321       023456888999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      |+|++|.||+++.++.++++|||.+....
T Consensus       148 H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         148 HGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             cCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            99999999999999999999999886544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590|consensus

Probab=99.46  E-value=5.8e-15  Score=113.78  Aligned_cols=152  Identities=30%  Similarity=0.461  Sum_probs=125.2

Q ss_pred             hhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHH-hCC
Q psy7820          10 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL-QTTPVPVPPALAKSYLYQLLEALRYCH-SRR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~   85 (163)
                      .+...|..+=+.+. |.|++..++........++..++..| ++...+ .......+......++.|+..++.|+| ..+
T Consensus        65 ~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~  144 (601)
T KOG0590|consen   65 EHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG  144 (601)
T ss_pred             hhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc
Confidence            33445666667775 99999999999999999999999876 777776 333325666677889999999999999 999


Q ss_pred             ceecCCCCCcEEEccCC-ceEEeeccccccccc-CCC--ccccccc-CccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          86 IIHRDLKPQNILINKSG-ALKLADFGLSRAFTI-PMN--RYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~-~~~--~~~~~~~-~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +.|+|++|+|.+++..+ ..++.|||++..+.. .+.  .....+| ++.|.+||...+.....+..|+||.|+++.-++
T Consensus       145 ~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~  224 (601)
T KOG0590|consen  145 VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML  224 (601)
T ss_pred             cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc
Confidence            99999999999999999 999999999987765 222  2345577 899999999987555689999999999998887


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       225 ~  225 (601)
T KOG0590|consen  225 T  225 (601)
T ss_pred             c
Confidence            5

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.46  E-value=3.4e-13  Score=86.58  Aligned_cols=98  Identities=23%  Similarity=0.285  Sum_probs=82.5

Q ss_pred             hhHHHHHHHHhcCCC--CCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---
Q psy7820          10 STALREISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR---   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---   84 (163)
                      .++.+|.+.++.+++  .++++++.+...++..++++|++.|.....+       +......++.+++.++..+|..   
T Consensus        36 ~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~  108 (155)
T cd05120          36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLL  108 (155)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCce
Confidence            468899999999976  5899999999888899999999987332211       4556677889999999999985   


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      +++|+|++|.|++++..+.++++||+.+..
T Consensus       109 ~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         109 VLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEEecCCCcceEEEECCcEEEEEecccccC
Confidence            699999999999999989999999997654

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=1.3e-12  Score=87.48  Aligned_cols=98  Identities=21%  Similarity=0.252  Sum_probs=74.6

Q ss_pred             HHHHHHHhcCC--CCCeeeeeeeeeeCcEEEEEecchhcc-HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCcee
Q psy7820          13 LREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQLLEALRYC-HSRRIIH   88 (163)
Q Consensus        13 ~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~h   88 (163)
                      .+|++.|+++.  .-++++++++    ...++|||+++++ +..-..+. ..++......+..+++.++..+ |+.|++|
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVH  148 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVH  148 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            37999999995  3567777765    4567899999863 22111111 2445566677889999999998 8999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      +|+++.||++. ++.+.++|||.+....
T Consensus       149 GDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999999996 5779999999876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.38  E-value=3.1e-12  Score=83.77  Aligned_cols=97  Identities=23%  Similarity=0.266  Sum_probs=75.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ++..+|++++.+++...+.-..=+..+.+...|+|||++| .+.+.+...        ...++..+-.-+.-||..|++|
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givH  115 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVH  115 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeec
Confidence            4578899999999765655444455556667899999999 555566654        1346677888888999999999


Q ss_pred             cCCCCCcEEEccCCceEEeeccccccc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAF  115 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~  115 (163)
                      ||+.++|+++...+ +.++|||++...
T Consensus       116 GDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642         116 GDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CCCccceEEEeCCc-EEEEECCccccc
Confidence            99999999996655 999999988643

>KOG3087|consensus

Probab=99.37  E-value=3.7e-12  Score=83.36  Aligned_cols=105  Identities=24%  Similarity=0.309  Sum_probs=82.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc--cHHHHHhcCCCCCCHHHH-HHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ--DLKDFLQTTPVPVPPALA-KSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~-~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+..+|++.|.++.--.|.-..=++-+...-+|+|||++|  ++.+++......-.+... ..++.++-+.+.-||..++
T Consensus        55 ~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndi  134 (229)
T KOG3087|consen   55 KRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDI  134 (229)
T ss_pred             HHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCe
Confidence            5678899999999766665555555566667899999998  888888765544434333 6788999999999999999


Q ss_pred             eecCCCCCcEEEccCC---ceEEeecccccc
Q psy7820          87 IHRDLKPQNILINKSG---ALKLADFGLSRA  114 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~---~~~l~d~~~~~~  114 (163)
                      +|||+.++||++..++   .+.++|||++..
T Consensus       135 iHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  135 IHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999999999997665   358999998754

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.33  E-value=5.2e-12  Score=84.39  Aligned_cols=96  Identities=24%  Similarity=0.310  Sum_probs=68.8

Q ss_pred             HHHHHHHhcCCCC--CeeeeeeeeeeCcEEEEEecchhc-cHH-HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCce
Q psy7820          13 LREISVLKELKHP--NVIRLHDVIPVDFKLFLVFEFLRQ-DLK-DFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRII   87 (163)
Q Consensus        13 ~~e~~~l~~~~h~--~i~~~~~~~~~~~~~~lv~e~~~~-~l~-~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~   87 (163)
                      ..|.+.+..+.+.  .++++++.    ...+++|||+++ .+. ..+....  .. .....++.+++.++.++|+ .+++
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~iv  137 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAGLV  137 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccCcC
Confidence            3566666666433  34555543    235899999987 221 1111111  11 5567889999999999999 9999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      |+|++|+||+++ ++.++++|||.+....
T Consensus       138 H~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         138 HGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             cCCCChhhEEEE-CCcEEEEECccccccc
Confidence            999999999999 8999999999886544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601|consensus

Probab=99.29  E-value=4.6e-12  Score=94.95  Aligned_cols=151  Identities=28%  Similarity=0.322  Sum_probs=126.5

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHH----HHHHHH
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLE----ALRYCH   82 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~----~l~~lh   82 (163)
                      ...+-.+|+...+++ .|++.++.+..++..+..|+-+|.|..++..+.......++...++..+.+..+    |+..+|
T Consensus       160 ~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h  239 (524)
T KOG0601|consen  160 DSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH  239 (524)
T ss_pred             ccccccchhhcccccCccccccccCcccccCCcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC
Confidence            334445677777777 499999999999999999999999999999888877766888888888888888    999999


Q ss_pred             hCCceecCCCCCcEEEccC-CceEEeecccccccccCCCcc-----cccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          83 SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRY-----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~-----~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      ..+++|.+++|.|++...+ ...++.|||.......+....     ....+...|++||...+.  ++..+|+|++|.+.
T Consensus       240 s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~  317 (524)
T KOG0601|consen  240 SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVI  317 (524)
T ss_pred             CCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhh
Confidence            9999999999999999999 788999999888776554222     223667889999998754  69999999999998


Q ss_pred             HHHh
Q psy7820         157 SEMI  160 (163)
Q Consensus       157 ~~ll  160 (163)
                      .+..
T Consensus       318 l~~~  321 (524)
T KOG0601|consen  318 LEAI  321 (524)
T ss_pred             HhhH
Confidence            8754

>KOG1266|consensus

Probab=99.24  E-value=1.2e-11  Score=87.37  Aligned_cols=151  Identities=22%  Similarity=0.299  Sum_probs=108.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-----EEEEEecchh-ccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLR-QDLKDFLQT---TPVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      .+....-+.-|-++-|.|+++++.++.+..     ...++.||+. |++.+++.+   .+..+......+|+.||.++|.
T Consensus       111 eek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~  190 (458)
T KOG1266|consen  111 EEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALS  190 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhh
Confidence            334444556666777999999999986543     4677889987 788888865   3457888899999999999999


Q ss_pred             HHHhC--CceecCCCCCcEEEccCCceEEeeccccccccc-CC---CcccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          80 YCHSR--RIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        80 ~lh~~--~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~-~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      |||+.  -+.|+++..+.+++..+|.+|+..-.....-.. ..   .+.....+.++|.+||.-.-.. .+-.+|||++|
T Consensus       191 yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn-~~~a~dIy~fg  269 (458)
T KOG1266|consen  191 YLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN-TTGASDIYKFG  269 (458)
T ss_pred             hhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccc-cccchhhhhhh
Confidence            99977  489999999999999999888763221111000 00   1111224467888998854333 47789999999


Q ss_pred             HHHHHHh
Q psy7820         154 CIFSEMI  160 (163)
Q Consensus       154 ~~l~~ll  160 (163)
                      ++..+|.
T Consensus       270 mcAlema  276 (458)
T KOG1266|consen  270 MCALEMA  276 (458)
T ss_pred             HHHHHHH
Confidence            9988875

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.24  E-value=9.2e-11  Score=82.50  Aligned_cols=104  Identities=21%  Similarity=0.221  Sum_probs=80.4

Q ss_pred             hHHHHHHHHhcCCCCCe--eeeeeeeee-----CcEEEEEecchhc--cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHH
Q psy7820          11 TALREISVLKELKHPNV--IRLHDVIPV-----DFKLFLVFEFLRQ--DLKDFLQTT-PVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i--~~~~~~~~~-----~~~~~lv~e~~~~--~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      .+.+|.+.+.++...+|  +++.++.+.     ....++|+|++++  ++.+++... ....+......++.+++..+..
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            47899999999954444  445555543     2357899999997  687777532 2345566777899999999999


Q ss_pred             HHhCCceecCCCCCcEEEcc-------CCceEEeecccccc
Q psy7820          81 CHSRRIIHRDLKPQNILINK-------SGALKLADFGLSRA  114 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~-------~~~~~l~d~~~~~~  114 (163)
                      ||+.|++|+|+++.||+++.       +..+.++||+.+..
T Consensus       154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99999999999999999975       45789999997743

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.24  E-value=1.6e-10  Score=78.53  Aligned_cols=106  Identities=27%  Similarity=0.341  Sum_probs=84.1

Q ss_pred             chhhHHHHHHHHhcCCCC--CeeeeeeeeeeC----cEEEEEecchhc--cHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHP--NVIRLHDVIPVD----FKLFLVFEFLRQ--DLKDFLQTTPVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~--~i~~~~~~~~~~----~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ...++.+|.+.+..+...  ..++.+++.+..    ...++|+|.+++  +|.+++..... .+......++.+++..+.
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIA  132 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHH
Confidence            345688899998888543  346666665542    245899999987  67777775432 566677889999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCC---ceEEeecccccc
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSRA  114 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~  114 (163)
                      .||+.|++|+|+++.||+++.++   .+.++||+.+..
T Consensus       133 ~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  133 KLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.20  E-value=6.2e-11  Score=88.91  Aligned_cols=103  Identities=22%  Similarity=0.291  Sum_probs=69.9

Q ss_pred             hHHHHHHHHhcCC----CCCeeeeeeee-eeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHHh
Q psy7820          11 TALREISVLKELK----HPNVIRLHDVI-PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE-ALRYCHS   83 (163)
Q Consensus        11 ~~~~e~~~l~~~~----h~~i~~~~~~~-~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~lh~   83 (163)
                      ++.+|++.+.++.    +.+-+.+-..+ ......++||||++| ++.+.........+   ...++..++. .+..+|.
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHh
Confidence            4667777777763    33223322222 223356899999987 66655433222222   2345555555 4688999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      .|++|+|++|.||+++.++.++++|||.+....
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999886654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.18  E-value=8.6e-11  Score=77.21  Aligned_cols=93  Identities=24%  Similarity=0.242  Sum_probs=68.7

Q ss_pred             hhHHHHHHHHhcCCCCC-eeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-
Q psy7820          10 STALREISVLKELKHPN-VIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI-   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-   86 (163)
                      ..+.+|+.+++.+.+.+ +++++....+  ..++|||+++| ++... .    ..    ....+.+++.++..||+.++ 
T Consensus        37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~~--~~~lv~e~i~G~~l~~~-~----~~----~~~~~~~l~~~l~~LH~~~~~  105 (170)
T cd05151          37 INRENEAENSKLAAEAGIGPKLYYFDPE--TGVLITEFIEGSELLTE-D----FS----DPENLEKIAKLLKKLHSSPLP  105 (170)
T ss_pred             cCHHHHHHHHHHHHHhCCCCceEEEeCC--CCeEEEEecCCCccccc-c----cc----CHHHHHHHHHHHHHHhCCCCC
Confidence            34678999999996544 4566655433  34799999998 44321 0    11    12356789999999999885 


Q ss_pred             ----eecCCCCCcEEEccCCceEEeecccccc
Q psy7820          87 ----IHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        87 ----~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                          +|+|++|.||+++ ++.++++||+.+..
T Consensus       106 ~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151         106 DLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence                9999999999998 67899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.16  E-value=8.1e-11  Score=78.51  Aligned_cols=100  Identities=26%  Similarity=0.339  Sum_probs=64.9

Q ss_pred             hhHHHHHHHHhcCCCC--CeeeeeeeeeeCcEEEEEecchh--ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHhC
Q psy7820          10 STALREISVLKELKHP--NVIRLHDVIPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPALAKSYLYQLLEALR-YCHSR   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~--~i~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~lh~~   84 (163)
                      ..+.+|.+.|+++...  ++++++++-    ...+||||++  |.....+....  ++......++.+++..+. -+|+.
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~  126 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKA  126 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhc
Confidence            3467899999999755  567777553    3469999998  63333333221  112334556777777444 46899


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      |++|||+++.||+++.+ .+.++|||.+....
T Consensus       127 givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  127 GIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             CceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            99999999999999877 89999999876544

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=99.04  E-value=4.5e-09  Score=70.92  Aligned_cols=107  Identities=21%  Similarity=0.271  Sum_probs=82.7

Q ss_pred             chhhHHHHHHHHhcCCC--CCeeeeeeeee--eC--cEEEEEecchhc--cHHHHHhcCC-CCCCHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKH--PNVIRLHDVIP--VD--FKLFLVFEFLRQ--DLKDFLQTTP-VPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h--~~i~~~~~~~~--~~--~~~~lv~e~~~~--~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l   78 (163)
                      -...|.+|...|+++..  -.++++...-.  .+  -.-+||+|.++|  +|.+.+.+.. .+.+......++.+++..+
T Consensus        62 g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~i  141 (216)
T PRK09902         62 GRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAF  141 (216)
T ss_pred             CchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHH
Confidence            34678899999999953  33555552221  11  146899999985  8888876543 3557777788999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCCc--eEEeecccccc
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRA  114 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~  114 (163)
                      +.||+.|+.|+|+.+.||+++.++.  +.++||..++.
T Consensus       142 a~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        142 KKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9999999999999999999987777  89999987654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.88  E-value=2.3e-09  Score=81.95  Aligned_cols=102  Identities=16%  Similarity=0.209  Sum_probs=59.4

Q ss_pred             HHHHHHHHhcCC----CCCeeeeeeeeee-CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHH-HHHHHHHhC
Q psy7820          12 ALREISVLKELK----HPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLL-EALRYCHSR   84 (163)
Q Consensus        12 ~~~e~~~l~~~~----h~~i~~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~-~~l~~lh~~   84 (163)
                      +.+|+..+.+++    +...+.+-.++.+ ....++||||+.| .+.+...-.....+...   ++...+ .-+..+...
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~---la~~~v~~~~~Qif~~  279 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKL---LAERGVEVFFTQVFRD  279 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHH---HHHHHHHHHHHHHHhC
Confidence            445555555552    3333333333322 2356799999997 66553211111222222   111111 123344569


Q ss_pred             CceecCCCCCcEEEccCC----ceEEeecccccccc
Q psy7820          85 RIIHRDLKPQNILINKSG----ALKLADFGLSRAFT  116 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~  116 (163)
                      |++|+|++|.||+++.+|    .++++|||......
T Consensus       280 GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        280 GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            999999999999999988    99999999876554

>KOG3741|consensus

Probab=98.87  E-value=3.7e-08  Score=73.92  Aligned_cols=130  Identities=22%  Similarity=0.349  Sum_probs=100.8

Q ss_pred             HHHHHHhcCCCCCeeeeeeeeee----CcEEEEEecchhc--cHHHHHhcC--------------CCCCCHHHHHHHHHH
Q psy7820          14 REISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ--DLKDFLQTT--------------PVPVPPALAKSYLYQ   73 (163)
Q Consensus        14 ~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~--~l~~~~~~~--------------~~~~~~~~~~~~~~~   73 (163)
                      .-++.++++.|.|+|++.++|.+    +..+.+|++|.++  +|.++.-..              +...+++.++.++.|
T Consensus       322 ~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~Q  401 (655)
T KOG3741|consen  322 SLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQ  401 (655)
T ss_pred             HHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHH
Confidence            45789999999999999999873    2368999999985  787775322              234688999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      +..+|..+|+.|+.-+-+.|.+|++..+.+++|...|.........            .  +-+.    -..+.|.-.||
T Consensus       402 LtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~------------~--~~le----~~Qq~D~~~lG  463 (655)
T KOG3741|consen  402 LTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP------------T--EPLE----SQQQNDLRDLG  463 (655)
T ss_pred             HHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC------------C--cchh----HHhhhhHHHHH
Confidence            9999999999999999999999999998899998887654333211            0  1111    14567888888


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      .++..+.|
T Consensus       464 ~ll~aLAt  471 (655)
T KOG3741|consen  464 LLLLALAT  471 (655)
T ss_pred             HHHHHHhh
Confidence            88887765

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.85  E-value=4.3e-08  Score=72.16  Aligned_cols=121  Identities=11%  Similarity=0.079  Sum_probs=93.8

Q ss_pred             cEEEEEecchhc--cHHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecc
Q psy7820          38 FKLFLVFEFLRQ--DLKDFLQT-----TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG  110 (163)
Q Consensus        38 ~~~~lv~e~~~~--~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~  110 (163)
                      ..+.+.|+.+.|  ....+++.     +-...++.-.++.++.++.+...||..|.+-||++++|+++++++.++++|-.
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence            347889999876  45444432     22356788899999999999999999999999999999999999999999855


Q ss_pred             cccccccCCCcccccccCccccCccccc-----CCcCCCcchhhHHHHHHHHHHh
Q psy7820         111 LSRAFTIPMNRYTHEVVTLWYRPPEILL-----GAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus       111 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ..... ..........|...|.+||...     +.. .+..+|-|.||+++|++|
T Consensus       163 sfqi~-~ng~~~~cpVg~~eftPPElQ~~~sf~g~~-r~~~hD~FGLavLiF~lL  215 (637)
T COG4248         163 SFQIN-ANGTLHLCPVGVSEFTPPELQTLPSFVGFE-RTANHDNFGLAVLIFHLL  215 (637)
T ss_pred             ceeec-cCCceEecccCccccCCHHHhccccccccC-CCccccchhHHHHHHHHH
Confidence            33222 2234445567789999999964     222 478899999999999988

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.84  E-value=1.2e-08  Score=70.91  Aligned_cols=98  Identities=23%  Similarity=0.275  Sum_probs=73.2

Q ss_pred             hHHHHHHHHhcCCC--CCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          11 TALREISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        11 ~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+|.+.|+.+..  -.+++.++.    +.-.+|||+++|-.+.-+.     ++.+..-.++..|+..+...-..|++|
T Consensus       155 ~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVH  225 (304)
T COG0478         155 AAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVH  225 (304)
T ss_pred             HHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccc
Confidence            45789999999964  477887776    4567999999983333222     123334445666666666666899999


Q ss_pred             cCCCCCcEEEccCCceEEeeccccccccc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTI  117 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~  117 (163)
                      ||+++-||+++++|.+.++||-.+.....
T Consensus       226 GDlSefNIlV~~dg~~~vIDwPQ~v~~~h  254 (304)
T COG0478         226 GDLSEFNILVTEDGDIVVIDWPQAVPISH  254 (304)
T ss_pred             cCCchheEEEecCCCEEEEeCcccccCCC
Confidence            99999999999999999999987755443

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.83  E-value=2.3e-08  Score=68.27  Aligned_cols=104  Identities=22%  Similarity=0.276  Sum_probs=74.3

Q ss_pred             hhhHHHHHHHHhcCCC--CCeeeeeeeeeeC---cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKH--PNVIRLHDVIPVD---FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~---~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|.++++.+.+  ..+++++.+....   +..+++||+++| ++.+....  ..++......++.++++.+..||
T Consensus        39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH  116 (223)
T cd05154          39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALH  116 (223)
T ss_pred             cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHh
Confidence            4578899999999965  4467788777654   367899999987 44332211  24555566666666666666666


Q ss_pred             h--------------------------------------------------------CCceecCCCCCcEEEcc--CCce
Q psy7820          83 S--------------------------------------------------------RRIIHRDLKPQNILINK--SGAL  104 (163)
Q Consensus        83 ~--------------------------------------------------------~~i~h~~i~~~ni~~~~--~~~~  104 (163)
                      +                                                        ..++|+|+.|.||+++.  ++.+
T Consensus       117 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~  196 (223)
T cd05154         117 SVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVV  196 (223)
T ss_pred             CCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEE
Confidence            2                                                        34589999999999988  5668


Q ss_pred             EEeecccccc
Q psy7820         105 KLADFGLSRA  114 (163)
Q Consensus       105 ~l~d~~~~~~  114 (163)
                      .++||+.+..
T Consensus       197 ~iID~e~~~~  206 (223)
T cd05154         197 AVLDWELATL  206 (223)
T ss_pred             EEEecccccc
Confidence            8999986643

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.80  E-value=5.9e-09  Score=82.32  Aligned_cols=72  Identities=19%  Similarity=0.277  Sum_probs=53.2

Q ss_pred             cCCCCC-cEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQ-NILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~-ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .+..|. |+++..++..++.+|+.++......  .......||+.|+|||++.+.. ++.++||||+||++|||++
T Consensus       501 ~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~-~~~~~DiwSlG~il~Ellt  575 (669)
T cd05610         501 QKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKP-HGPAVDWWALGVCLFEFLT  575 (669)
T ss_pred             CCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCC-CCcHHHHHHHHHHHHHHHH
Confidence            444444 5667777777888888775543221  2233457899999999998755 7999999999999999997

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.79  E-value=5e-08  Score=66.25  Aligned_cols=65  Identities=20%  Similarity=0.408  Sum_probs=49.2

Q ss_pred             cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccc
Q psy7820          38 FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS  112 (163)
Q Consensus        38 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~  112 (163)
                      ...+++|||++| .+.+...     +++.    +...+..++..+|+.|++|||++|.|+++..+ .++++|++..
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~-----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID~~~k  181 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED-----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIIDTQGK  181 (229)
T ss_pred             eEEEEEEEEecCeecccchh-----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEECccc
Confidence            356789999998 5544321     2222    34567788999999999999999999999754 4999999744

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0601|consensus

Probab=98.73  E-value=3.4e-09  Score=79.87  Aligned_cols=146  Identities=25%  Similarity=0.236  Sum_probs=107.2

Q ss_pred             HHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7820          13 LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDL   91 (163)
Q Consensus        13 ~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i   91 (163)
                      ..|+.+...+ .|.+.++.+..+......|+-.|+|.+.....-......+++...+.+..|++.++.++|+..++|.|+
T Consensus       313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~  392 (524)
T KOG0601|consen  313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDV  392 (524)
T ss_pred             hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccc
Confidence            3466666666 588999988888887888899999976333332233446788888999999999999999999999999


Q ss_pred             CCCcEEEccC-CceEEeecccccccccCCCcccccccCccccC-cccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          92 KPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRP-PEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        92 ~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~-pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||++..+ +..++.|++.......   ........-++.| .|.+.....+..+.|++|||.-+.+..+
T Consensus       393 ~psni~i~~~~~~~~~~~~~~~t~~~~---~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~  461 (524)
T KOG0601|consen  393 KPSNILISNDGFFSKLGDFGCWTRLAF---SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAIT  461 (524)
T ss_pred             cccceeeccchhhhhccccccccccce---ecccccccccccccchhhcccccccccccccccccccccccc
Confidence            9999999886 7788999987764221   1111122333442 5666555668999999999987777654

>KOG0606|consensus

Probab=98.56  E-value=5.5e-08  Score=78.06  Aligned_cols=136  Identities=32%  Similarity=0.437  Sum_probs=103.9

Q ss_pred             CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC
Q psy7820          24 HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG  102 (163)
Q Consensus        24 h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~  102 (163)
                      +|.+++...-+......+++++++.+ ++...+.+.+ ..+.+.....+..++...++||.....|++++|.|.+...++
T Consensus       863 ~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g  941 (1205)
T KOG0606|consen  863 SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG  941 (1205)
T ss_pred             CCceecccCCCCCCCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccC
Confidence            45566555555566788999999975 8888877766 555566666778899999999999999999999999999999


Q ss_pred             ceEEeecccccccccC------------------------C-------CcccccccCccccCcccccCCcCCCcchhhHH
Q psy7820         103 ALKLADFGLSRAFTIP------------------------M-------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus       103 ~~~l~d~~~~~~~~~~------------------------~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      ..++.+++.....+.-                        .       .......+++.|.+||...+.. ....+|+|+
T Consensus       942 h~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~ 1020 (1205)
T KOG0606|consen  942 HRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWS 1020 (1205)
T ss_pred             CcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhh
Confidence            9888888732211100                        0       0112346788999999988766 589999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      .|+++++.++
T Consensus      1021 ~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 1021 SGVCLFEVLT 1030 (1205)
T ss_pred             hhhhhhhhhc
Confidence            9999999885

>KOG2137|consensus

Probab=98.53  E-value=3.8e-08  Score=75.75  Aligned_cols=94  Identities=23%  Similarity=0.406  Sum_probs=69.0

Q ss_pred             HHHHHHHHHHHHHHHHHHh-CCceecCCCCCcEEEccCCceEEeecccccccccCCCcc---------cccccCccccCc
Q psy7820          65 ALAKSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---------THEVVTLWYRPP  134 (163)
Q Consensus        65 ~~~~~~~~~i~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---------~~~~~~~~~~~p  134 (163)
                      +....=+.+++.|+.++|. .+++|++|.|++|.++.++.+|+.+|+.+.....+....         ........|.+|
T Consensus        99 e~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ap  178 (700)
T KOG2137|consen   99 EDGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAP  178 (700)
T ss_pred             cHhhhhhhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccc
Confidence            3334444566788999994 589999999999999999999999998775544321110         011224569999


Q ss_pred             ccccCCcCCCcchhhHHHHHHHHHH
Q psy7820         135 EILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus       135 e~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      |++.+.. .++++|+||+|+++|-+
T Consensus       179 E~~~~~~-~~~~sd~fSlG~li~~i  202 (700)
T KOG2137|consen  179 EYLLGTT-NTPASDVFSLGVLIYTI  202 (700)
T ss_pred             hhhcccc-ccccccceeeeeEEEEE
Confidence            9987744 68999999999987644

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.49  E-value=5.2e-07  Score=62.25  Aligned_cols=99  Identities=23%  Similarity=0.276  Sum_probs=72.4

Q ss_pred             HHHHHHHhcCC--CCCeeeeeeeeeeCcEEEEEecchhcc--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCce
Q psy7820          13 LREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRII   87 (163)
Q Consensus        13 ~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~   87 (163)
                      .+|.+-|+++.  +-.+++.+.+.    ...+|||+++..  ..-.+.+.  ++..+....+..+++..++-|-. .+++
T Consensus       116 ~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv--~~e~~e~~~~~~~~v~~~~~l~~~a~LV  189 (268)
T COG1718         116 RKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV--PLELEEAEGLYEDVVEYMRRLYKEAGLV  189 (268)
T ss_pred             HHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC--CcCchhHHHHHHHHHHHHHHHHHhcCcc
Confidence            57888888884  45567777765    346999999743  11111111  22222566778888988888887 8999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccC
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIP  118 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  118 (163)
                      |+|++.-||++. ++.+.++|++.+.....+
T Consensus       190 HgDLSEyNiL~~-~~~p~iID~~QaV~~~hp  219 (268)
T COG1718         190 HGDLSEYNILVH-DGEPYIIDVSQAVTIDHP  219 (268)
T ss_pred             cccchhhheEEE-CCeEEEEECccccccCCC
Confidence            999999999998 899999999988776644

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.34  E-value=7.7e-06  Score=56.47  Aligned_cols=105  Identities=14%  Similarity=0.143  Sum_probs=63.2

Q ss_pred             hhhHHHHHHHHhcCCCC--CeeeeeeeeeeCcEEEEEecchhcc--HHHHHh--------------c-----CC---CCC
Q psy7820           9 PSTALREISVLKELKHP--NVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQ--------------T-----TP---VPV   62 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~--~i~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~--------------~-----~~---~~~   62 (163)
                      ..+..+|.++++.+...  .+++.+++.++++...++||+++|.  +...+.              .     +.   ...
T Consensus        36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~  115 (226)
T TIGR02172        36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTS  115 (226)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence            34678999999999643  3588888888888888999999883  111110              0     00   000


Q ss_pred             CHHHHH-HHHH----------HHHHH-HHHHH----hCCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          63 PPALAK-SYLY----------QLLEA-LRYCH----SRRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        63 ~~~~~~-~~~~----------~i~~~-l~~lh----~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      +..... .+-.          .+... .++|.    ...++|+|+.|.|++++.++ +.++||+.+..
T Consensus       116 ~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       116 TFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             cHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            100000 0000          00111 11111    23468999999999999888 99999987654

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.29  E-value=4.5e-06  Score=55.94  Aligned_cols=98  Identities=23%  Similarity=0.217  Sum_probs=75.2

Q ss_pred             HHHHHHHhcCCC-CCeeeeeeeeeeCcEEEEEecchhc-cHHHHH--hcCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q psy7820          13 LREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL--QTTPVPVPPALAKSYLYQLLEALRYCHS---RR   85 (163)
Q Consensus        13 ~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~   85 (163)
                      .+|.-+++.+++ +++++++|.|   +. +++.|+.+. ++....  ...-...++..+.+++.+++..+++++.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999965 7999999999   33 357788874 443110  0011245799999999999999999996   45


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      +...|++++|+.++.++++|++|......
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            78899999999999999999999975533

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.27  E-value=1.1e-05  Score=56.25  Aligned_cols=40  Identities=20%  Similarity=0.057  Sum_probs=32.7

Q ss_pred             hhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc
Q psy7820          10 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ   49 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~   49 (163)
                      .++.+|+++++.+. +--+++++++...++..++|||+++|
T Consensus        36 ~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G   76 (244)
T cd05150          36 YELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG   76 (244)
T ss_pred             cchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence            45788999999994 55577888888777778999999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.22  E-value=7.2e-06  Score=62.79  Aligned_cols=102  Identities=22%  Similarity=0.332  Sum_probs=65.1

Q ss_pred             hHHHHHHHHhcCC-----CCCeeeeeeee-eeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHH-HHHHHH
Q psy7820          11 TALREISVLKELK-----HPNVIRLHDVI-PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE-ALRYCH   82 (163)
Q Consensus        11 ~~~~e~~~l~~~~-----h~~i~~~~~~~-~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~-~l~~lh   82 (163)
                      ++.+|+.-+.+++     .+++ ++=.++ +-.+.-.++|||+.| .+.+.........+.+.   ++..++. -++.+=
T Consensus       207 Dy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~---ia~~~~~~f~~q~~  282 (517)
T COG0661         207 DYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKE---LAELLVRAFLRQLL  282 (517)
T ss_pred             CHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHH---HHHHHHHHHHHHHH
Confidence            3456776666663     2333 222222 223457899999998 55555433224555443   3333332 233444


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      ..|++|.|.+|.|++++.+|...+.|||.....+
T Consensus       283 ~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~  316 (517)
T COG0661         283 RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD  316 (517)
T ss_pred             hcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence            5899999999999999999999999999876554

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.14  E-value=6e-05  Score=50.93  Aligned_cols=98  Identities=29%  Similarity=0.444  Sum_probs=72.1

Q ss_pred             hhhHHHHHHHHhcCC------CCCeeeeeeeeeeCcEEEEEecchh---c----cHHHHHhcCCCCCCHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELK------HPNVIRLHDVIPVDFKLFLVFEFLR---Q----DLKDFLQTTPVPVPPALAKSYLYQLL   75 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~------h~~i~~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~~~~~~~~~~i~   75 (163)
                      ..+..+|+.....+.      +.+|++++|..+++....+|+|.+.   |    +|.+++...  .++. ...+   .+-
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~--~~~~-~~~~---~L~  128 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG--GLTE-ELRQ---ALD  128 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC--CccH-HHHH---HHH
Confidence            566777887777776      7899999999999999999999762   2    777777543  3444 3333   334


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEccCC----ceEEee-cccc
Q psy7820          76 EALRYCHSRRIIHRDLKPQNILINKSG----ALKLAD-FGLS  112 (163)
Q Consensus        76 ~~l~~lh~~~i~h~~i~~~ni~~~~~~----~~~l~d-~~~~  112 (163)
                      .-.++|-+..|+..|++|.||++...+    .+.++| ||-.
T Consensus       129 ~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  129 EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence            455677889999999999999996543    467777 6643

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG1235|consensus

Probab=98.07  E-value=1.7e-05  Score=60.80  Aligned_cols=99  Identities=22%  Similarity=0.283  Sum_probs=61.3

Q ss_pred             hHHHHHHHHhcC----CCCC------eeeeeeeeeeCcEEEEEecchhc---cHHHHHhcCCCCCCHHHHHHHHHHHHHH
Q psy7820          11 TALREISVLKEL----KHPN------VIRLHDVIPVDFKLFLVFEFLRQ---DLKDFLQTTPVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus        11 ~~~~e~~~l~~~----~h~~------i~~~~~~~~~~~~~~lv~e~~~~---~l~~~~~~~~~~~~~~~~~~~~~~i~~~   77 (163)
                      +|.+|++-..++    +|-+      +++++.-+.  ..-.++|||++|   +-.+.+.+.  ..+...+   +..+.++
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i---~~~l~~~  312 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKR--GISPHDI---LNKLVEA  312 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHc--CCCHHHH---HHHHHHH
Confidence            345555554444    2444      555554443  247899999987   333444443  3444433   3333332


Q ss_pred             H-HHHHhCCceecCCCCCcEEEcc----CCceEEeecccccccc
Q psy7820          78 L-RYCHSRRIIHRDLKPQNILINK----SGALKLADFGLSRAFT  116 (163)
Q Consensus        78 l-~~lh~~~i~h~~i~~~ni~~~~----~~~~~l~d~~~~~~~~  116 (163)
                      . +.+=..|++|+|-+|.||++..    ++.+.+.|+|+.....
T Consensus       313 ~~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  313 YLEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             HHHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            1 2233578999999999999984    6689999999876554

>KOG0576|consensus

Probab=97.91  E-value=4e-06  Score=64.85  Aligned_cols=142  Identities=20%  Similarity=0.170  Sum_probs=97.5

Q ss_pred             hhHHHHHHHHhcCCCCC-eeeeeeeeeeCcEEEEEecchhcc--HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKELKHPN-VIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~lv~e~~~~~--l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....-++++|.+++||| .+..++-++.+.+.++.++++.+.  ...........+...+...+.+.-..++.++|+..-
T Consensus       278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~  357 (829)
T KOG0576|consen  278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK  357 (829)
T ss_pred             hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence            44556899999999999 566666666777899999999753  322222222233333444455556677888887765


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      +|+|    ||+. ..+..+..+++......... ..+...+++.+++||+..... +..+.|.|++|.-..+
T Consensus       358 ~~~d----~~l~-s~~~~~~~~~~v~~~L~~~~-~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~  422 (829)
T KOG0576|consen  358 VHRD----NILG-SEEEVKLLDFAVPPQLTRTM-KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQ  422 (829)
T ss_pred             cCcc----cccc-cccccccccccCCcccCccc-ccccCCCCCCCCCchhhcccc-cccCCCccCCCcchhh
Confidence            6666    5554 34778899999877666443 466777899999999876655 6889999999864333

>PLN02876 acyl-CoA dehydrogenase

Probab=97.80  E-value=0.0002  Score=58.38  Aligned_cols=40  Identities=25%  Similarity=0.350  Sum_probs=32.0

Q ss_pred             hhHHHHHHHHhcCC-CCCe--eeeeeeeeeC---cEEEEEecchhc
Q psy7820          10 STALREISVLKELK-HPNV--IRLHDVIPVD---FKLFLVFEFLRQ   49 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h~~i--~~~~~~~~~~---~~~~lv~e~~~~   49 (163)
                      ..+.+|+++++.+. |.++  ++++.++.+.   +..|+|||+++|
T Consensus        83 ~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G  128 (822)
T PLN02876         83 HAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEG  128 (822)
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCC
Confidence            46789999999995 6655  8888887664   467899999987

>KOG1035|consensus

Probab=97.63  E-value=0.00033  Score=57.95  Aligned_cols=148  Identities=20%  Similarity=0.266  Sum_probs=95.5

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeCcEE----EEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVDFKL----FLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~----~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...|...+.+..|+|+..++.+--.....    .+..++|.+ ++.+.+... +..+..+++.+..+...|+.++|+...
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~~~l  307 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHSLSL  307 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence            45688888889999999999885433222    234556665 666655544 478899999999999999999998866


Q ss_pred             eecCCCCC---cEEEccCCceEEe--ecccccccccCCCcccccccCccccCcccccCCc-CCCcchhhHHHHHHHHHHh
Q psy7820          87 IHRDLKPQ---NILINKSGALKLA--DFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        87 ~h~~i~~~---ni~~~~~~~~~l~--d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~~Di~slG~~l~~ll  160 (163)
                      .|.-+...   +.-.+..+...+.  ||+............. ...+..+.++|...... ......|+|.+|..+..+.
T Consensus       308 ~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~-~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  308 EHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS-DLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             ceeEEecccccccccCccceeecchhhhcccccCCCcccchh-hcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            55544444   2333344555555  7776655543332222 22245566776654322 1234479999999988766


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      .
T Consensus       387 ~  387 (1351)
T KOG1035|consen  387 Q  387 (1351)
T ss_pred             h
Confidence            4

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.57  E-value=0.00037  Score=48.32  Aligned_cols=32  Identities=28%  Similarity=0.439  Sum_probs=26.1

Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ..+++|+|+.+.|++++.++..-++||+.+..
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            34589999999999998766567999997644

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=97.53  E-value=0.00098  Score=49.09  Aligned_cols=106  Identities=21%  Similarity=0.247  Sum_probs=72.0

Q ss_pred             eCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          36 VDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        36 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ++.+.|++|++-.+++...     .....+++..+++++++.+.-+.++ .+-|+++.-+||+++ .|++.++||.+++.
T Consensus       297 e~~y~yl~~kdhgt~is~i-----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDHGTPISII-----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecCCceeeee-----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            3447788888776644321     1335778889999999999988855 789999999999999 99999999998875


Q ss_pred             cccCCCcccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820         115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus       115 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      ...+..-..     ...-.|..+.+..  +.+=+||-+..
T Consensus       371 ~~~q~~isy-----~rldhp~lF~G~d--d~QFeIYrlMr  403 (488)
T COG5072         371 SYSQGIISY-----NRLDHPDLFNGVD--DYQFEIYRLMR  403 (488)
T ss_pred             ccCCceeec-----cccCchhhhcCcc--ceeeeHHHHHH
Confidence            433222111     1234555555432  55555655443

>KOG2268|consensus

Probab=97.52  E-value=0.00024  Score=51.50  Aligned_cols=92  Identities=20%  Similarity=0.266  Sum_probs=65.6

Q ss_pred             HHHHHHHHhcCC-C-CCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          12 ALREISVLKELK-H-PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        12 ~~~e~~~l~~~~-h-~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+|...|+.+. | --+++.+++    ..-++|||.+.| .+.+...    ..+..+   +...+...+-.|...|++|
T Consensus       157 a~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~----v~d~~~---ly~~lm~~Iv~la~~GlIH  225 (465)
T KOG2268|consen  157 ATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH----VEDPPT---LYDDLMGLIVRLANHGLIH  225 (465)
T ss_pred             HHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee----cCChHH---HHHHHHHHHHHHHHcCcee
Confidence            457888888884 3 445666665    356789999987 5544322    122333   4445556667788999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ||+.--||+++.++.++++||-....
T Consensus       226 gDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  226 GDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             cccchheeEEecCCCEEEeechHhhc
Confidence            99999999999999999999975433

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.50  E-value=0.00097  Score=44.15  Aligned_cols=99  Identities=17%  Similarity=0.144  Sum_probs=69.1

Q ss_pred             chhhHHHHHHHHhcCCCCCe-eeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNV-IRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      -...+..|+++|..++-.++ ++++.+-+    .++.|||+.| .|.......    +...    +..++....-|-..|
T Consensus        58 ~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~L~~~~~~~----~rk~----l~~vlE~a~~LD~~G  125 (201)
T COG2112          58 PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRPLGKLEIGG----DRKH----LLRVLEKAYKLDRLG  125 (201)
T ss_pred             chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcchhhhhhcc----cHHH----HHHHHHHHHHHHHhc
Confidence            34557899999999987666 66666643    3466999998 665543321    2333    335566667788889


Q ss_pred             ceecCCC-CCcEEEccCCceEEeecccccccccC
Q psy7820          86 IIHRDLK-PQNILINKSGALKLADFGLSRAFTIP  118 (163)
Q Consensus        86 i~h~~i~-~~ni~~~~~~~~~l~d~~~~~~~~~~  118 (163)
                      |-|+.++ |...++..++.+.|+||..++....+
T Consensus       126 I~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p  159 (201)
T COG2112         126 IEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKP  159 (201)
T ss_pred             cchhhhcCCceeEEecCCcEEEEEccchhhccCC
Confidence            9999986 56666666679999999988754433

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.38  E-value=0.003  Score=43.23  Aligned_cols=31  Identities=35%  Similarity=0.598  Sum_probs=20.7

Q ss_pred             CCceecCCCCCcEEEc-cCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILIN-KSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~  114 (163)
                      ..++|+|+.|.||+++ .++.+-++||+.+..
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             cEEEEeccccccceeeeccceeEEEecccceE
Confidence            4689999999999999 555557999986644

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.20  E-value=0.0022  Score=45.06  Aligned_cols=29  Identities=28%  Similarity=0.533  Sum_probs=25.1

Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .++|+|+.|.|++++.++ +.++||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999998877 78999987644

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>KOG2270|consensus

Probab=96.85  E-value=0.0042  Score=46.03  Aligned_cols=101  Identities=23%  Similarity=0.275  Sum_probs=69.6

Q ss_pred             HHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCC
Q psy7820          13 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH-SRRIIHRDL   91 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~~i   91 (163)
                      ..|++-|++++...|+-.--+.-  ..-.|||++++.+-.-.-.-..-.++...+..+-.+++..++-|- .+.++|.|+
T Consensus       214 EKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADL  291 (520)
T KOG2270|consen  214 EKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADL  291 (520)
T ss_pred             HHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccch
Confidence            56889999997666532222221  134689999974222221222235667777888888888888775 669999999


Q ss_pred             CCCcEEEccCCceEEeecccccccc
Q psy7820          92 KPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        92 ~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                      +--|+++ .+|.+.++|.+.+.-..
T Consensus       292 SEfN~Ly-hdG~lyiIDVSQSVE~D  315 (520)
T KOG2270|consen  292 SEFNLLY-HDGKLYIIDVSQSVEHD  315 (520)
T ss_pred             hhhhheE-ECCEEEEEEccccccCC
Confidence            9999998 56789999988765443

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.74  E-value=0.009  Score=41.31  Aligned_cols=81  Identities=22%  Similarity=0.377  Sum_probs=53.2

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCcee
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH--SRRIIH   88 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh--~~~i~h   88 (163)
                      +.++.+++.++.  +|+++..=  .+..+.+|.|.|-. ...          .    ..++.--++.+...|  ..+..|
T Consensus       105 y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~----------~----~N~i~agi~~L~~fH~~~~~~lH  166 (308)
T PF07387_consen  105 YFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN----------F----SNFITAGIKDLMDFHSENQHCLH  166 (308)
T ss_pred             hhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc----------h----hHHHHHhHHHHHHhhccCCCeec
Confidence            345666666653  46666522  33467799998843 110          0    111222245667778  457899


Q ss_pred             cCCCCCcEEEccCCceEEeecc
Q psy7820          89 RDLKPQNILINKSGALKLADFG  110 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~  110 (163)
                      ||..|+|||-|..|.+|+.|-+
T Consensus       167 GD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  167 GDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             CCCChhheeecCCCCEEecChh
Confidence            9999999999999999999965

The function of this family is unknown.

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.32  E-value=0.05  Score=39.66  Aligned_cols=31  Identities=23%  Similarity=0.450  Sum_probs=27.0

Q ss_pred             CceecCCCCCcEEEccCCceEEeeccccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAF  115 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~  115 (163)
                      .++|||+++.|++++.++.+=++||+.+...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            3699999999999999998999999977543

>PTZ00384 choline kinase; Provisional

Probab=96.08  E-value=0.033  Score=41.71  Aligned_cols=30  Identities=27%  Similarity=0.251  Sum_probs=24.5

Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ..++|.|+.+.||+.+ ++.+.++||..+..
T Consensus       227 ~VfCHNDL~~gNIL~~-~~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDF-NQGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEec-CCCEEEEEeccccC
Confidence            4679999999999875 45699999987643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.08  E-value=0.015  Score=42.03  Aligned_cols=32  Identities=31%  Similarity=0.537  Sum_probs=27.6

Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ..+++|+|+++.|++++.++...++||+.+..
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            36899999999999999888778999987643

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.00  E-value=0.014  Score=40.28  Aligned_cols=31  Identities=26%  Similarity=0.403  Sum_probs=26.7

Q ss_pred             CCceecCCCCCcEEEcc-CCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILINK-SGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~  114 (163)
                      .+++|+|+.+.||+++. ++.+.++||..+..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            36899999999999997 57899999987654

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=95.79  E-value=0.071  Score=36.29  Aligned_cols=87  Identities=26%  Similarity=0.344  Sum_probs=60.1

Q ss_pred             chhhHHHHHHHHhcCC---CCCe--eeeeeeeeeC------------------cEEEEEecchhccHHHHHhcCCCCCCH
Q psy7820           8 VPSTALREISVLKELK---HPNV--IRLHDVIPVD------------------FKLFLVFEFLRQDLKDFLQTTPVPVPP   64 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~---h~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~l~~~~~~~~~~~~~   64 (163)
                      ..+.|..|-+.+.+++   +.++  ++++|+..=.                  ....||-||.+..-         .+..
T Consensus        97 y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~  167 (207)
T PF13095_consen   97 YADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI  167 (207)
T ss_pred             hcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch
Confidence            4456788888888774   4555  9999987211                  12356777665422         1222


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccc
Q psy7820          65 ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS  112 (163)
Q Consensus        65 ~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~  112 (163)
                      .    -+.++.+-+..+|+.||+-+|+++.|..     .-+++|||.+
T Consensus       168 ~----~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  168 R----DIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             h----HHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            2    3457778888899999999999999986     3589999853

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.75  E-value=0.036  Score=39.96  Aligned_cols=29  Identities=28%  Similarity=0.486  Sum_probs=24.9

Q ss_pred             CCceecCCCCCcEEEccCCceEEeeccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSR  113 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~  113 (163)
                      .+++|+|+.+.|++++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999987 678899998553

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK05231 homoserine kinase; Provisional

Probab=95.75  E-value=0.0089  Score=43.35  Aligned_cols=31  Identities=29%  Similarity=0.409  Sum_probs=26.0

Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .+++|+|+.|.|++++.+...-++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4799999999999998666568999987643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.72  E-value=0.024  Score=40.64  Aligned_cols=31  Identities=29%  Similarity=0.432  Sum_probs=26.6

Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .+++|+|+.|.|++++.++.+.++||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4799999999999999877778999986643

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=95.66  E-value=0.031  Score=39.77  Aligned_cols=47  Identities=30%  Similarity=0.412  Sum_probs=35.7

Q ss_pred             HHHHHHHHHHHHHHHhC--CceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          68 KSYLYQLLEALRYCHSR--RIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        68 ~~~~~~i~~~l~~lh~~--~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ...+..+-..+...+..  -++|+|+.|+|++.+..+.+.++|+..+..
T Consensus       135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            33444555555555544  689999999999999999999999987644

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.59  E-value=0.012  Score=42.35  Aligned_cols=31  Identities=32%  Similarity=0.390  Sum_probs=26.6

Q ss_pred             CceecCCCCCcEEEccC----CceEEeeccccccc
Q psy7820          85 RIIHRDLKPQNILINKS----GALKLADFGLSRAF  115 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~----~~~~l~d~~~~~~~  115 (163)
                      .++|+|+.+.||+++.+    +.+.++||..+...
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~  214 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYN  214 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCC
Confidence            57999999999999875    88999999877543

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10271 thiK thiamine kinase; Provisional

Probab=95.41  E-value=0.017  Score=38.77  Aligned_cols=29  Identities=28%  Similarity=0.495  Sum_probs=24.8

Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ..+|+|+.|.|+++..++ ++++|++.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            458999999999997777 88999997754

>KOG1826|consensus

Probab=95.29  E-value=0.0053  Score=53.10  Aligned_cols=145  Identities=14%  Similarity=0.027  Sum_probs=94.9

Q ss_pred             HHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchh-ccHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH-hCC-
Q psy7820          14 REISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLR-QDLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCH-SRR-   85 (163)
Q Consensus        14 ~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh-~~~-   85 (163)
                      .|...+++..|+++...+.-....  ..-+..++++. |.+.+.+.++-   ..+++.-+.....+.+...--.| ..+ 
T Consensus      1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred             hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence            444455566788877666554332  24578888887 58888876543   23444444433333233333333 222 


Q ss_pred             ---ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          86 ---IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        86 ---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                         -+|.++++.|.++..+-++++.++|+.+.............+++.|+.|+....-+ ++.++|+|..|+.+|..
T Consensus      1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             CccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHHHHHHHHHHH
Confidence               46899999999999999999999998874443344445556677788887764433 68889999999888764

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.12  E-value=0.016  Score=39.46  Aligned_cols=31  Identities=48%  Similarity=0.699  Sum_probs=21.6

Q ss_pred             CCceecCCCCCcEEE-ccCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILI-NKSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~-~~~~~~~l~d~~~~~~  114 (163)
                      ..++|+|+.|.||++ +.++.++++||..+..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            357899999999999 8889999999987754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.11  E-value=0.075  Score=38.22  Aligned_cols=43  Identities=26%  Similarity=0.153  Sum_probs=28.2

Q ss_pred             CchhhHHHHHHHHhcCC---CCCeeeeeeeeeeCcEEEEEecchhc
Q psy7820           7 GVPSTALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLRQ   49 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~lv~e~~~~   49 (163)
                      .....+..|++-|+.+.   .-.+++++.+...++.-|+++||++.
T Consensus        51 ~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   51 SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            34456889999999984   45678999988777777999999753

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093|consensus

Probab=95.03  E-value=0.17  Score=39.49  Aligned_cols=51  Identities=25%  Similarity=0.359  Sum_probs=41.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-EEEEEecchhccHHHHHhcCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLRQDLKDFLQTTP   59 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~~~l~~~~~~~~   59 (163)
                      .-++.-.+++++.+.|++.....++-+... ..-+|+|++..++.+....+.
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~~Sled~~~~~~   77 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYTMSLEDILKTGN   77 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhccchHHHHHhcc
Confidence            345667889999999999999998876544 578899999999998877654

>PRK10593 hypothetical protein; Provisional

Probab=94.76  E-value=0.14  Score=36.97  Aligned_cols=41  Identities=24%  Similarity=0.199  Sum_probs=32.9

Q ss_pred             hhhHHHHHHHHhcCCC---CCeeeeeeeeeeC---cEEEEEecchhc
Q psy7820           9 PSTALREISVLKELKH---PNVIRLHDVIPVD---FKLFLVFEFLRQ   49 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h---~~i~~~~~~~~~~---~~~~lv~e~~~~   49 (163)
                      ...+..|++.|+.+..   -.++++++.+.++   +..++|||+++|
T Consensus        51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G   97 (297)
T PRK10593         51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG   97 (297)
T ss_pred             chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence            4578899999999953   4688999887543   668999999987

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=94.35  E-value=0.16  Score=34.22  Aligned_cols=32  Identities=31%  Similarity=0.389  Sum_probs=25.6

Q ss_pred             hCCceecCCCCCcEEEccCC-----ceEEeecccccc
Q psy7820          83 SRRIIHRDLKPQNILINKSG-----ALKLADFGLSRA  114 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~-----~~~l~d~~~~~~  114 (163)
                      ...++|||+.+.|+++..++     .+.++||..+..
T Consensus       119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             ceEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            34689999999999997543     589999987644

subfamily of choline kinases

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=94.17  E-value=0.032  Score=40.38  Aligned_cols=31  Identities=13%  Similarity=0.202  Sum_probs=27.5

Q ss_pred             CceecCCCCCcEEEccCCceEEeeccccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAF  115 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~  115 (163)
                      +++|+|+.++|++++.++.+-++||..+...
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d  227 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASFA  227 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcccC
Confidence            7999999999999999999999999876543

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=94.15  E-value=0.11  Score=38.38  Aligned_cols=30  Identities=27%  Similarity=0.499  Sum_probs=25.7

Q ss_pred             CceecCCCCCcEEEcc-CCceEEeecccccc
Q psy7820          85 RIIHRDLKPQNILINK-SGALKLADFGLSRA  114 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~  114 (163)
                      .++|+|+++.||+++. ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            6899999999999986 46799999987654

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=94.10  E-value=0.12  Score=37.91  Aligned_cols=27  Identities=37%  Similarity=0.635  Sum_probs=24.4

Q ss_pred             ceecCCCCCcEEEccCCc-eEEeecccc
Q psy7820          86 IIHRDLKPQNILINKSGA-LKLADFGLS  112 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~-~~l~d~~~~  112 (163)
                      ++|+|+.|+||+++.++. +-++||+-+
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa  226 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDA  226 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccc
Confidence            899999999999999885 899999854

>COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis]

Probab=94.00  E-value=0.29  Score=34.04  Aligned_cols=99  Identities=21%  Similarity=0.168  Sum_probs=65.4

Q ss_pred             CCchhhHHHHHHHHhcCCC--CCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..-...+.+|.+.++=+.-  -..+++.+.-.+.+.-|++|+.++| ++...-.    .++.+.+   .-.++.+++.||
T Consensus        53 ~~~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~~~~~~wLl~salpG~~~s~~~~----~~~p~r~---v~~la~aLR~LH  125 (266)
T COG3231          53 SGPAAELEGEAARLRWLAGQGLGCPRVLGLEDDADQAWLLMSALPGEDASHPRY----ALDPKRA---VPLLAEALRRLH  125 (266)
T ss_pred             CcchhhhhhHHHHHHHhcccCCCCCceEeeccCcchhHHhhhhcCCCcccchhh----cCCHHHH---HHHHHHHHHHHh
Confidence            3344678899999988842  4566777777778889999999887 4433221    2223322   233455555555


Q ss_pred             hCC----------------------------------------------------------ceecCCCCCcEEEccCCce
Q psy7820          83 SRR----------------------------------------------------------IIHRDLKPQNILINKSGAL  104 (163)
Q Consensus        83 ~~~----------------------------------------------------------i~h~~i~~~ni~~~~~~~~  104 (163)
                      ...                                                          +.|||-..-|++++.....
T Consensus       126 ~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~El~d~L~~~rp~~edLVv~HGDACLPN~i~d~~rf~  205 (266)
T COG3231         126 ELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEELFDELEARRPAVEDLVVTHGDACLPNFILDGWRFS  205 (266)
T ss_pred             cCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHHHHHHHHhcCCchhhceeecCcccCcceEecCCceE
Confidence            433                                                          4799999999999888767


Q ss_pred             EEeeccc
Q psy7820         105 KLADFGL  111 (163)
Q Consensus       105 ~l~d~~~  111 (163)
                      =.+|+|-
T Consensus       206 GfIDlGr  212 (266)
T COG3231         206 GFIDLGR  212 (266)
T ss_pred             EeeecCc
Confidence            7777764

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=93.83  E-value=0.22  Score=39.89  Aligned_cols=94  Identities=15%  Similarity=0.128  Sum_probs=71.8

Q ss_pred             HHHHHhcC---CCCCeeeeeeeeeeCcEEEEEecchhc--cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          15 EISVLKEL---KHPNVIRLHDVIPVDFKLFLVFEFLRQ--DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        15 e~~~l~~~---~h~~i~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .+.-+.++   ++.+|+++|+++..++.-.+++|+...  .|.+.....  ..+..+.+.|+.||++-..-|...|+.-.
T Consensus       167 ~~~~Yl~L~~~~~~~iP~v~~~~~~~~~~i~Lle~~~~~~~l~~~w~~~--~~~~l~~l~Wl~q~~~LW~~l~~~~~~~s  244 (645)
T PRK14559        167 LAIPYLALQDQFPTEIPKIHDAWQDGDLQVILLEDRSHWQPLLDLWQDQ--TLPTLQILYWLNQMTQLWKALEPWGCCQS  244 (645)
T ss_pred             HhhhHHhccccccccCcchheeecCCCCcEEEeCCCCCCchHHHHhhhc--CCcHHHHHHHHHHHHHHHHHHHhcCeehh
Confidence            34444444   245699999999888777788888763  566655532  45567788999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecc
Q psy7820          90 DLKPQNILINKSGALKLADFG  110 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~  110 (163)
                      =+.++|+.++.+..+.+..+.
T Consensus       245 ll~~~nlrv~~~~~~~l~~l~  265 (645)
T PRK14559        245 LLELENLRVDEDQTLGLQQLY  265 (645)
T ss_pred             ccchhheeeCCCceehHhhhh
Confidence            999999999877666655543

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=93.22  E-value=0.086  Score=37.65  Aligned_cols=30  Identities=30%  Similarity=0.566  Sum_probs=24.5

Q ss_pred             CceecCCCCCcEEEccCCc-eEEeecccccc
Q psy7820          85 RIIHRDLKPQNILINKSGA-LKLADFGLSRA  114 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~-~~l~d~~~~~~  114 (163)
                      .++|+|++|.|++++.++. .-|+|++.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4799999999999987554 46999987654

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.93  E-value=0.1  Score=38.27  Aligned_cols=29  Identities=31%  Similarity=0.554  Sum_probs=24.9

Q ss_pred             ceecCCCCCcEEEcc-CCceEEeecccccc
Q psy7820          86 IIHRDLKPQNILINK-SGALKLADFGLSRA  114 (163)
Q Consensus        86 i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~  114 (163)
                      ++|+|+.+.||+++. ++.++++||..+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            789999999999975 47899999987643

>PRK11768 serine/threonine protein kinase; Provisional

Probab=92.39  E-value=0.31  Score=35.69  Aligned_cols=29  Identities=28%  Similarity=0.358  Sum_probs=23.7

Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .+++|+|+.+.|++++ + .+.++||+-+..
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            4689999999999995 4 578999986643

>PRK06148 hypothetical protein; Provisional

Probab=91.90  E-value=0.15  Score=43.01  Aligned_cols=31  Identities=32%  Similarity=0.555  Sum_probs=25.2

Q ss_pred             CCceecCCCCCcEEEccCC--ceE-Eeecccccc
Q psy7820          84 RRIIHRDLKPQNILINKSG--ALK-LADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~--~~~-l~d~~~~~~  114 (163)
                      .+++|+|+.+.||+++.++  .+. |+|||-+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            5799999999999998875  454 999986543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	163
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-60
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-60
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-60
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-60
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-60
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-60
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-60
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-60
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-60
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-60
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-60
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		6e-60
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-60
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-59
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-59
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		1e-59
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-59
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-59
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-59
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-59
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-59
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-59
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-59
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-59
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-59
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-59
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-59
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-59
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-59
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-59
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-59
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-59
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-58
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-58
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-58
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-58
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-57
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-57
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-57
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-57
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		7e-55
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-55
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-53
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		6e-50
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-49
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		8e-40
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-40
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-39
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-39
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-36
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-36
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-36
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-36
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		7e-36
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-34
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-34
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-34
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-34
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-33
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-33
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-29
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-29
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-28
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-27
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-27
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-27
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-27
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-27
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-27
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-26
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-26
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-26
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-26
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-26
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-26
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-26
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-26
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-26
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-26
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-26
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-26
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-26
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-26
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-26
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-26
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-26
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-26
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-26
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-26
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-26
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-26
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-26
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-26
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-26
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-26
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-26
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-26
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		6e-26
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-26
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-26
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		8e-26
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-25
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-25
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-25
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-25
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-25
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-25
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-25
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-25
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-25
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-25
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-25
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-25
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-25
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-25
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-25
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-25
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-25
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-25
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-25
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-25
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-25
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-25
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-25
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-25
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-25
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-25
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-25
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-25
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-25
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-25
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-25
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-25
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-25
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-25
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-25
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-25
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-25
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-25
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-25
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-25
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-25
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-25
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-25
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-25
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-25
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-25
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-25
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-25
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-25
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-25
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		9e-25
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-24
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-24
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-24
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-24
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-24
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-24
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-23
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-23
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-23
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-23
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-23
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-22
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-22
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-22
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-22
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-22
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-22
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-22
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-22
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-22
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-22
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-22
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-21
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-21
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-21
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-21
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-21
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-21
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-21
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-21
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-21
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-21
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-21
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-21
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-21
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-21
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-21
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-21
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-21
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-21
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-21
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-21
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-21
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-21
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-21
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-21
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-21
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-21
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-21
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-21
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-21
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-21
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-21
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-21
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		6e-21
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-21
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		6e-21
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		6e-21
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-21
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-21
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-21
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-21
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-21
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-21
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-21
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-21
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		8e-21
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-20
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-20
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-20
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-20
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-20
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-20
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-20
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-20
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-20
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-20
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-20
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-20
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-20
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-20
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-20
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-20
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-20
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-20
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-20
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-20
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		4e-20
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-20
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-20
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-20
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-20
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-20
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		4e-20
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-20
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-20
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-20
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-20
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-20
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-20
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-20
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-20
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-20
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-20
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		6e-20
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		7e-20
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-20
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-20
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-20
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-20
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		8e-20
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-20
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-20
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		8e-20
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		8e-20
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		8e-20
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-20
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-19
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-19
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-19
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-19
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-19
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		5e-19
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-19
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		5e-19
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		5e-19
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-19
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-19
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-19
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-19
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		7e-19
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-18
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		3e-18
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-18
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-18
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-18
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-18
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		4e-18
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-18
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-18
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-18
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-17
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-17
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-17
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-17
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-17
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-17
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-17
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-17
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-17
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-17
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-17
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-16
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-16
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-16
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-16
3soa_A	444	Full-Length Human Camkii Length = 444		2e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-16
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-16
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-16
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-16
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		3e-16
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-16
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-16
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-16
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		6e-16
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		8e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		9e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-16
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-15
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-15
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-15
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-15
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-15
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-15
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-15
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		7e-15
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-15
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		8e-15
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-14
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-14
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-14
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-14
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-14
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-14
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-14
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-14
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-14
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-14
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-14
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-14
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-14
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-14
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-14
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-14
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-14
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-14
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-14
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-14
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-14
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-14
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-14
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-14
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-14
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-14
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-14
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-14
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-14
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-14
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-14
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-14
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-14
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		5e-14
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-14
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-14
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		5e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-14
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-14
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-14
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		6e-14
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-14
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		7e-14
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-14
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		7e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		7e-14
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		7e-14
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-14
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		7e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		7e-14
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		7e-14
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-14
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		8e-14
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-14
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		8e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		8e-14
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		9e-14
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-13
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-13
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-13
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-13
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-13
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-13
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-13
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		1e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-13
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-13
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-13
2pl0_A	289	Lck Bound To Imatinib Length = 289		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-13
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-13
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-13
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-13
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-13
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-13
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-13
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-13
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-13
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-13
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-13
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-13
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-13
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		3e-13
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		3e-13
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-13
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		3e-13
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		3e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-13
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-13
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-13
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-13
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-13
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-13
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-13
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-13
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-13
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		5e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-13
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-13
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-13
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		6e-13
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-13
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		6e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		6e-13
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-13
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-13
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-13
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-13
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		6e-13
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		7e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		7e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-13
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		7e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-13
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		8e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-13
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-13
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-13
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-13
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-13
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		9e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-13
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		9e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		9e-13
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-12
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-12
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-12
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-12
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-12
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-12
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-12
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-12
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-12
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-12
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-12
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-12
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-12
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-12
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-12
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-12
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-12
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-12
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-12
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-12
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-12
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-12
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-12
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-12
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		3e-12
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-12
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-12
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-12
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-12
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		8e-12
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		8e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-12
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-11
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-11
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-11
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-11
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-11
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-11
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-11
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-11
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-11
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-11
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-11
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-11
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-11
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-11
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-11
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-11
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-11
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-11
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-11
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-11
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-11
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-11
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		4e-11
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-11
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-11
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		4e-11
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-11
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-11
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		4e-11
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-11
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-11
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		4e-11
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		4e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-11
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		4e-11
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-11
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-11
4ae6_A	343	Structure And Function Of The Human Sperm-specific		4e-11
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-11
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-11
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-11
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-11
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-11
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-11
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-11
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-11
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-11
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-11
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-11
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		5e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-11
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-11
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		6e-11
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		6e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		6e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		6e-11
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-11
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-11
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		8e-11
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-11
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		8e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-11
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		9e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-11
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-11
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-11
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		9e-11
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-10
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-10
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-10
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-10
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-10
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-10
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-10
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-10
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-10
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-10
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-10
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-10
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-10
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-10
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		7e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		8e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-10
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-10
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-10
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-10
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-09
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-09
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		2e-09
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-09
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		3e-09
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		3e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		4e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-09
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-09
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		6e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		8e-09
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		8e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		9e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		1e-08
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-08
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-08
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-08
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-08
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		2e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		5e-08
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-08
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		7e-08
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		7e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-08
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-08
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-08
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		9e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		9e-08
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		9e-08
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		9e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-08
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		9e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		9e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-07
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		1e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-07
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-07

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  226 bits (577), Expect = 3e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 41  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 100
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 101 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 159 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  226 bits (577), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  226 bits (576), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 198

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  226 bits (576), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 47  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 106
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 107 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 164
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 165 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 205

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  226 bits (576), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  226 bits (576), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  226 bits (576), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  226 bits (576), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 47  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 106
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 107 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 164
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 165 RTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMV 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  226 bits (576), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  226 bits (576), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  226 bits (576), Expect = 5e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  226 bits (575), Expect = 6e-60,   Method: Compositional matrix adjust.
 Identities = 107/161 (66%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 44  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 103
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 104 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 161
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 162 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  225 bits (574), Expect = 7e-60,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 130/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLKDF+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  224 bits (572), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  224 bits (572), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL  DLKDF+     T 
Sbjct: 42  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG 101
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 102 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 160 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  224 bits (572), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL  DLKDF+     T 
Sbjct: 43  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTG 102
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 103 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 41  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 100
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 101 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 159 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 41  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 100
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 101 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 158
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 159 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 44  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 103
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 104 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 161
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 162 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 42  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 101
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 102 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 160 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 43  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 102
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 103 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 40  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 99
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 100 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 157
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 158 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 198

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 43  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 102
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 103 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 42  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 101
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 102 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 160 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  224 bits (571), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 43  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTG 102
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 103 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  224 bits (570), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 106/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  223 bits (568), Expect = 4e-59,   Method: Compositional matrix adjust.
 Identities = 105/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 41  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 100
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+
Sbjct: 101 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 159 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  223 bits (567), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 105/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+     T 
Sbjct: 42  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 101
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+
Sbjct: 102 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 159
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 160 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 200

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  222 bits (565), Expect = 8e-59,   Method: Compositional matrix adjust.
 Identities = 105/161 (65%), Positives = 129/161 (80%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFE + QDLK F+     T 
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTG 98
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 99  IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             YTHEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  221 bits (562), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 104/161 (64%), Positives = 128/161 (79%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL  DLK F+     T 
Sbjct: 41  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG 100
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+
Sbjct: 101 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 158
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 159 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  220 bits (561), Expect = 2e-58,   Method: Compositional matrix adjust.
 Identities = 104/161 (64%), Positives = 128/161 (79%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL  DLK F+     T 
Sbjct: 43  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTG 102
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKP+N+LIN  GA+KLADFGL+RAF +P+
Sbjct: 103 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 160
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  219 bits (559), Expect = 4e-58,   Method: Compositional matrix adjust.
 Identities = 104/161 (64%), Positives = 128/161 (79%), Gaps = 5/161 (3%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TP 59
            + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFE + QDLK F+     T 
Sbjct: 43  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTG 102
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
           +P+P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+
Sbjct: 103 IPLP--LIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y HEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 161 RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 201

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  219 bits (558), Expect = 6e-58,   Method: Compositional matrix adjust.
 Identities = 98/154 (63%), Positives = 127/154 (82%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           + KS+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLADFGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E+
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  217 bits (553), Expect = 2e-57,   Method: Compositional matrix adjust.
 Identities = 97/154 (62%), Positives = 127/154 (82%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           + KS+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E+
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 195

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  216 bits (551), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 96/156 (61%), Positives = 122/156 (78%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PST +REIS+LKELKH N+++L+DVI    +L LVFE L QDLK  L      +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            AKS+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVTLWYR P++L+G+K YSTT+DIWS GCIF+EM+ 
Sbjct: 161 VVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  216 bits (551), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 96/156 (61%), Positives = 122/156 (78%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PST +REIS+LKELKH N+++L+DVI    +L LVFE L QDLK  L      +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            AKS+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVTLWYR P++L+G+K YSTT+DIWS GCIF+EM+ 
Sbjct: 161 VVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  216 bits (550), Expect = 5e-57,   Method: Compositional matrix adjust.
 Identities = 95/156 (60%), Positives = 122/156 (78%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PST +REIS+LKELKH N+++L+DVI    +L LVFE L QDLK  L      +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            AKS+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           +VTLWYR P++L+G+K YSTT+DIWS GCIF+EM+ 
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  209 bits (531), Expect = 7e-55,   Method: Compositional matrix adjust.
 Identities = 98/155 (63%), Positives = 120/155 (77%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PSTA+REIS+LKEL HPN++ L DVI  +  L LVFEF+ +DLK  L      +  +
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS 119
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K YLYQLL  + +CH  RI+HRDLKPQN+LIN  GALKLADFGL+RAF IP+  YTHE
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVTLWYR P++L+G+K YST+VDIWS GCIF+EMI
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  209 bits (531), Expect = 8e-55,   Method: Compositional matrix adjust.
 Identities = 98/155 (63%), Positives = 120/155 (77%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PSTA+REIS+LKEL HPN++ L DVI  +  L LVFEF+ +DLK  L      +  +
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS 119
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K YLYQLL  + +CH  RI+HRDLKPQN+LIN  GALKLADFGL+RAF IP+  YTHE
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVTLWYR P++L+G+K YST+VDIWS GCIF+EMI
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMI 214

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  204 bits (519), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 92/160 (57%), Positives = 123/160 (76%), Gaps = 5/160 (3%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-----TPV 60
           EG PSTA+REIS++KELKH N++RL+DVI  + KL LVFEF+  DLK ++ +     TP 
Sbjct: 44  EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPR 103
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
            +   L K + +QLL+ L +CH  +I+HRDLKPQN+LINK G LKL DFGL+RAF IP+N
Sbjct: 104 GLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            ++ EVVTLWYR P++L+G++ YST++DIWS GCI +EMI
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI 203

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  192 bits (489), Expect = 6e-50,   Method: Compositional matrix adjust.
 Identities = 87/154 (56%), Positives = 114/154 (74%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG P TA+RE+S+LK+LKH N++ LHD+I  +  L LVFE+L +DLK +L      +   
Sbjct: 41  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMH 100
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K +L+QLL  L YCH ++++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y +E
Sbjct: 101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           VVTLWYRPP+ILLG+  YST +D+W  GCIF EM
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEM 194

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  190 bits (482), Expect = 3e-49,   Method: Compositional matrix adjust.
 Identities = 88/162 (54%), Positives = 122/162 (75%), Gaps = 6/162 (3%)
Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           + EGVP TA+RE+S+LKEL+H N+I L  VI  + +L L+FE+   DLK ++   P  V 
Sbjct: 72  EEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVS 130
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIP 118
             + KS+LYQL+  + +CHSRR +HRDLKPQN+L++ S A     LK+ DFGL+RAF IP
Sbjct: 131 MRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP 190
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           + ++THE++TLWYRPPEILLG++ YST+VDIWS  CI++EM+
Sbjct: 191 IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  159 bits (401), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 87/171 (50%), Positives = 114/171 (66%), Gaps = 13/171 (7%)
Query: 2   RVQV--EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDL 51
           RVQ   EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + QDL
Sbjct: 46  RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 105
Query: 52  KDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 110
             +L   P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFG
Sbjct: 106 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165
Query: 111 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           L+R ++  M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM +
Sbjct: 166 LARIYSFQMA-LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFR 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  159 bits (401), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 87/171 (50%), Positives = 114/171 (66%), Gaps = 13/171 (7%)
Query: 2   RVQV--EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDL 51
           RVQ   EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + QDL
Sbjct: 46  RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 105
Query: 52  KDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 110
             +L   P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFG
Sbjct: 106 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165
Query: 111 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           L+R ++  M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM +
Sbjct: 166 LARIYSFQMA-LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFR 214

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  159 bits (401), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 87/171 (50%), Positives = 114/171 (66%), Gaps = 13/171 (7%)
Query: 2   RVQV--EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDL 51
           RVQ   EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + QDL
Sbjct: 46  RVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 105
Query: 52  KDFLQTTPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 110
             +L   P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFG
Sbjct: 106 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165
Query: 111 LSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           L+R ++  M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM +
Sbjct: 166 LARIYSFQMA-LTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFR 214

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  158 bits (400), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 70/155 (45%), Positives = 105/155 (67%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           +G+  TALREI +L+EL HPN+I L D       + LVF+F+  DL+  ++   + + P+
Sbjct: 53  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS 112
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K+Y+   L+ L Y H   I+HRDLKP N+L++++G LKLADFGL+++F  P   Y H+
Sbjct: 113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQ 172
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT WYR PE+L GA++Y   VD+W+ GCI +E++
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  147 bits (370), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 75/168 (44%), Positives = 100/168 (59%), Gaps = 12/168 (7%)
Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--------LFLVFEFLRQDLKDFL 55
           + EG P TALREI +L+ LKH NV+ L ++              ++LVF+F   DL   L
Sbjct: 56  EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLL 115
Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
               V    +  K  +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF
Sbjct: 116 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 116 TIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           ++      NRY + VVTLWYRPPE+LLG + Y   +D+W AGCI +EM
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  147 bits (370), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 75/168 (44%), Positives = 100/168 (59%), Gaps = 12/168 (7%)
Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--------LFLVFEFLRQDLKDFL 55
           + EG P TALREI +L+ LKH NV+ L ++              ++LVF+F   DL   L
Sbjct: 56  EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL 115
Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
               V    +  K  +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF
Sbjct: 116 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 116 TIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           ++      NRY + VVTLWYRPPE+LLG + Y   +D+W AGCI +EM
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  147 bits (370), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 75/168 (44%), Positives = 100/168 (59%), Gaps = 12/168 (7%)
Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--------LFLVFEFLRQDLKDFL 55
           + EG P TALREI +L+ LKH NV+ L ++              ++LVF+F   DL   L
Sbjct: 55  EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL 114
Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
               V    +  K  +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF
Sbjct: 115 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174
Query: 116 TIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           ++      NRY + VVTLWYRPPE+LLG + Y   +D+W AGCI +EM
Sbjct: 175 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 222

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  147 bits (370), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 75/168 (44%), Positives = 100/168 (59%), Gaps = 12/168 (7%)
Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFK--------LFLVFEFLRQDLKDFL 55
           + EG P TALREI +L+ LKH NV+ L ++              ++LVF+F   DL   L
Sbjct: 56  EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL 115
Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
               V    +  K  +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF
Sbjct: 116 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 175
Query: 116 TIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           ++      NRY + VVTLWYRPPE+LLG + Y   +D+W AGCI +EM
Sbjct: 176 SLAKNSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 223

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  145 bits (367), Expect = 7e-36,   Method: Compositional matrix adjust.
 Identities = 64/152 (42%), Positives = 97/152 (63%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           V   A+REI +LK+L+H N++ L +V     + +LVFEF+   + D L+  P  +   + 
Sbjct: 67  VKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVV 126
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           + YL+Q++  + +CHS  IIHRD+KP+NIL+++SG +KL DFG +R    P   Y  EV 
Sbjct: 127 QKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA 186
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T WYR PE+L+G   Y   VD+W+ GC+ +EM
Sbjct: 187 TRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  142 bits (357), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 68/153 (44%), Positives = 94/153 (61%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           +   ALREI +LK+LKHPN++ L +V     +L LVFE+    +   L      VP  L 
Sbjct: 45  IKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLV 104
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           KS  +Q L+A+ +CH    IHRD+KP+NILI K   +KL DFG +R  T P + Y  EV 
Sbjct: 105 KSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PE+L+G   Y   VD+W+ GC+F+E++
Sbjct: 165 TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  141 bits (356), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 75/165 (45%), Positives = 106/165 (64%), Gaps = 11/165 (6%)
Query: 6   EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQT 57
           EG+P + +RE+++L+ L+   HPNV+RL DV        + K+ LVFE + QDL+ +L  
Sbjct: 44  EGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK 103
Query: 58  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            P P +P    K  + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++
Sbjct: 104 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 163
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             M  +   VVTLWYR PE+LL    Y+T VD+WS GCIF+EM +
Sbjct: 164 YQMALFP-VVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFR 206

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  140 bits (353), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 75/165 (45%), Positives = 105/165 (63%), Gaps = 11/165 (6%)
Query: 6   EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQT 57
           EG+P + +RE+++L+ L+   HPNV+RL DV        + K+ LVFE + QDL+ +L  
Sbjct: 44  EGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK 103
Query: 58  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            P P +P    K  + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++
Sbjct: 104 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 163
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             M      VVTLWYR PE+LL    Y+T VD+WS GCIF+EM +
Sbjct: 164 YQMA-LAPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFR 206

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  140 bits (353), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 75/165 (45%), Positives = 105/165 (63%), Gaps = 11/165 (6%)
Query: 6   EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQT 57
           EG+P + +RE+++L+ L+   HPNV+RL DV        + K+ LVFE + QDL+ +L  
Sbjct: 44  EGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK 103
Query: 58  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            P P +P    K  + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++
Sbjct: 104 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 163
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             M      VVTLWYR PE+LL    Y+T VD+WS GCIF+EM +
Sbjct: 164 YQMA-LDPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFR 206

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  137 bits (346), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 74/163 (45%), Positives = 104/163 (63%), Gaps = 11/163 (6%)
Query: 8   VPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTP 59
           +P + +RE+++L+ L+   HPNV+RL DV        + K+ LVFE + QDL+ +L   P
Sbjct: 54  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP 113
Query: 60  VP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            P +P    K  + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++  
Sbjct: 114 PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ 173
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           M   T  VVTLWYR PE+LL    Y+T VD+WS GCIF+EM +
Sbjct: 174 MA-LTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFR 214

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  137 bits (344), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 71/176 (40%), Positives = 108/176 (61%), Gaps = 17/176 (9%)
Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQ--- 56
           +++  G+  +A REI++L+ELKHPNVI L  V     D K++L+F++   DL   ++   
Sbjct: 55  QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 114
Query: 57  -----TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN----KSGALKLA 107
                  PV +P  + KS LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+A
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 108 DFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           D G +R F  P+         VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E++
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  123 bits (309), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 63/158 (39%), Positives = 97/158 (61%), Gaps = 11/158 (6%)
Query: 13  LREISVLKELKHPNVIRLHDVI-PV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
           LRE+ +LK  KH N+I + D++ P     +FK +++V + +  DL   + ++  P+    
Sbjct: 101 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ-PLTLEH 159
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNR---Y 122
            + +LYQLL  L+Y HS ++IHRDLKP N+L+N++  LK+ DFG++R   T P       
Sbjct: 160 VRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 219
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T  V T WYR PE++L    Y+  +D+WS GCIF EM+
Sbjct: 220 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 257

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  122 bits (307), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 63/158 (39%), Positives = 97/158 (61%), Gaps = 11/158 (6%)
Query: 13  LREISVLKELKHPNVIRLHDVI-PV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
           LRE+ +LK  KH N+I + D++ P     +FK +++V + +  DL   + ++  P+    
Sbjct: 102 LRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSS-QPLTLEH 160
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNR---Y 122
            + +LYQLL  L+Y HS ++IHRDLKP N+L+N++  LK+ DFG++R   T P       
Sbjct: 161 VRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFM 220
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T  V T WYR PE++L    Y+  +D+WS GCIF EM+
Sbjct: 221 TEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML 258

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  119 bits (298), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 68/158 (43%), Positives = 93/158 (58%), Gaps = 19/158 (12%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDF-KLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK LKH NVI L DV        DF +++LV   +  DL + +++       AL+
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQ------ALS 129
Query: 68  KSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             ++    YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y 
Sbjct: 130 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY- 188
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             V T WYR PEI+L    Y+ TVDIWS GCI +E++Q
Sbjct: 189 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ 224

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  118 bits (296), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/158 (43%), Positives = 92/158 (58%), Gaps = 19/158 (12%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDF-KLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK LKH NVI L DV        DF +++LV   +  DL + ++        AL+
Sbjct: 76  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ------ALS 129
Query: 68  KSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             ++    YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y 
Sbjct: 130 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY- 188
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             V T WYR PEI+L    Y+ TVDIWS GCI +E++Q
Sbjct: 189 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ 224

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  117 bits (294), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 68/180 (37%), Positives = 98/180 (54%), Gaps = 31/180 (17%)
Query: 13  LREISVLKELKHPNVIRLHD-VIPVDF----KLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           LREI++L  LK   +IRLHD +IP D     +L++V E    DLK   +T P+ +     
Sbjct: 75  LREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEQHV 133
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI---------- 117
           K+ LY LL   ++ H   IIHRDLKP N L+N+  ++K+ DFGL+R              
Sbjct: 134 KTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDL 193
Query: 118 ----------PMNR-----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
                     P N+      T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E++ +
Sbjct: 194 EEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNM 253

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  117 bits (293), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 65/163 (39%), Positives = 93/163 (57%), Gaps = 12/163 (7%)
Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVI-PVD-----FKLFLVFEFLRQDLKDFLQT 57
           Q E     A RE+ +LK ++H NVI L DV  P       +  +LV  F++ DL+  +  
Sbjct: 62  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM-- 119
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
             +       +  +YQ+L+ L+Y HS  ++HRDLKP N+ +N+   LK+ DFGL+R    
Sbjct: 120 -GLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178
Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM+
Sbjct: 179 EMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  117 bits (293), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 68/163 (41%), Positives = 91/163 (55%), Gaps = 11/163 (6%)
Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQT 57
           Q E     A RE+ +LK ++H NVI L DV   D  L      +LV  F+  DL   ++ 
Sbjct: 63  QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 122
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
             +       +  +YQ+L+ LRY H+  IIHRDLKP N+ +N+   LK+ DFGL+R    
Sbjct: 123 EKLG--EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180
Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            M      VVT WYR PE++L    Y+ TVDIWS GCI +EMI
Sbjct: 181 EM---XGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  117 bits (292), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 65/163 (39%), Positives = 93/163 (57%), Gaps = 12/163 (7%)
Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVI-PVD-----FKLFLVFEFLRQDLKDFLQT 57
           Q E     A RE+ +LK ++H NVI L DV  P       +  +LV  F++ DL+  +  
Sbjct: 80  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM-- 137
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
             +       +  +YQ+L+ L+Y HS  ++HRDLKP N+ +N+   LK+ DFGL+R    
Sbjct: 138 -GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196
Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            M  Y   VVT WYR PE++L    Y+ TVDIWS GCI +EM+
Sbjct: 197 EMTGY---VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 236

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  117 bits (292), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 68/158 (43%), Positives = 92/158 (58%), Gaps = 19/158 (12%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDF-KLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK LKH NVI L DV        DF +++LV   +  DL + ++        AL+
Sbjct: 68  RELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ------ALS 121
Query: 68  KSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             ++    YQLL  L+Y HS  IIHRDLKP N+ +N+   L++ DFGL+R     M  Y 
Sbjct: 122 DEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY- 180
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             V T WYR PEI+L    Y+ TVDIWS GCI +E++Q
Sbjct: 181 --VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQ 216

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  115 bits (289), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 56/154 (36%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVI-----PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           LREI +L    HPN++ L D+      P   KL+LV E +R DL   +    + + P   
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           + ++Y +L  L   H   ++HRDL P NIL+  +  + + DF L+R  T   N+ TH V 
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVT 195
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             WYR PE+++  K ++  VD+WSAGC+ +EM  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  115 bits (288), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 56/154 (36%), Positives = 85/154 (55%), Gaps = 6/154 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVI-----PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           LREI +L    HPN++ L D+      P   KL+LV E +R DL   +    + + P   
Sbjct: 77  LREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHI 136
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           + ++Y +L  L   H   ++HRDL P NIL+  +  + + DF L+R  T   N+ TH V 
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-THYVT 195
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             WYR PE+++  K ++  VD+WSAGC+ +EM  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 70  TLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 129
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 130 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  114 bits (286), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 61/158 (38%), Positives = 92/158 (58%), Gaps = 12/158 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H NVI + D++          +++V + +  DL   L++  +      
Sbjct: 88  TLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHIC 147
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---- 122
              +LYQ+L  L+Y HS  ++HRDLKP N+LIN +  LK+ DFGL+R    P + +    
Sbjct: 148 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTGFL 204
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T  V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 205 TEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  114 bits (285), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 66/182 (36%), Positives = 98/182 (53%), Gaps = 33/182 (18%)
Query: 13  LREISVLKELKHPNVIRLHD-VIPVDFK----LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           LREI++L  L H +V+++ D VIP D +    L++V E    D K   +T PV +     
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PVYLTELHI 158
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------- 120
           K+ LY LL  ++Y HS  I+HRDLKP N L+N+  ++K+ DFGL+R    P N       
Sbjct: 159 KTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218
Query: 121 --------------------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                               + T  VVT WYR PE++L  + Y+  +D+WS GCIF+E++
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELL 278
Query: 161 QI 162
            +
Sbjct: 279 NM 280

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 64/153 (41%), Positives = 89/153 (58%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L A  Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELL 217

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  114 bits (285), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 70  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 129
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 130 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  114 bits (285), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 76  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 135
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 136 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 193
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 194 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 230

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  114 bits (285), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 127
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 128 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 127
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 128 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 131
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 132 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 127
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 128 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 70  TLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 129
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 130 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 224

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 131
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 132 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 127
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 128 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 73  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 132
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 133 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 66  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 125
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 126 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 74  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 133
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 134 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 228

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 65  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 124
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 125 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 219

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 131
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 132 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 61/158 (38%), Positives = 93/158 (58%), Gaps = 12/158 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 131
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--- 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R    P + +T   
Sbjct: 132 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFL 188
Query: 124 -HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 189 XEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 61/158 (38%), Positives = 93/158 (58%), Gaps = 12/158 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 73  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 132
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--- 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R    P + +T   
Sbjct: 133 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHTGFL 189
Query: 124 -HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 190 XEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 227

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 131
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 132 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 66  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 125
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 126 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 220

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 61/157 (38%), Positives = 90/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          ++LV   +  DL   L+T  +      
Sbjct: 88  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC 147
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 148 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  114 bits (285), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 88  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 147
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 148 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 205
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 242

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  114 bits (284), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 60/157 (38%), Positives = 91/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+T  +      
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC 127
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 128 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 222

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  113 bits (283), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 67/177 (37%), Positives = 97/177 (54%), Gaps = 28/177 (15%)
Query: 13  LREISVLKELKHPNVIRLHD-VIPVDF----KLFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           LREI++L  LK   +IRL+D +IP D     +L++V E    DLK   +T P+ +     
Sbjct: 73  LREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEHI 131
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI---------- 117
           K+ LY LL    + H   IIHRDLKP N L+N+  ++K+ DFGL+R              
Sbjct: 132 KTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 118 -------PMNRY-----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
                  P N+      T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E++ +
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  113 bits (282), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 60/167 (35%), Positives = 96/167 (57%), Gaps = 20/167 (11%)
Query: 12  ALREISVLKELKHPNVIRLHDVI-PVDFKL-------------FLVFEFLRQDLKDFLQT 57
           ALREI +++ L H N++++ +++ P   +L             ++V E++  DL + L+ 
Sbjct: 55  ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFT 116
            P+      A+ ++YQLL  L+Y HS  ++HRDLKP N+ IN     LK+ DFGL+R   
Sbjct: 115 GPLL--EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172
Query: 117 IPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              +   H    +VT WYR P +LL    Y+  +D+W+AGCIF+EM+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  112 bits (281), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 64/173 (36%), Positives = 97/173 (56%), Gaps = 26/173 (15%)
Query: 12  ALREISVLKELK-HPNVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTPVPVPPALAK 68
             REI +L EL  H N++ L +V+  D    ++LVF+++  DL   ++   +   P   +
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--PVHKQ 112
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--------TIPM- 119
             +YQL++ ++Y HS  ++HRD+KP NIL+N    +K+ADFGLSR+F         IP+ 
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 120 -NRYTHE-----------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            N  T             V T WYR PEILLG+  Y+  +D+WS GCI  E++
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 133
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VA 190
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + +++  +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 129
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGY---VA 186
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  112 bits (280), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 59/157 (37%), Positives = 90/157 (57%), Gaps = 10/157 (6%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I          +++V + +  DL   L+   +      
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHIC 131
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YT 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 132 Y--FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  112 bits (279), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 134
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VA 191
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  111 bits (278), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 134
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VA 191
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  111 bits (278), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 134
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGY---VA 191
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  111 bits (278), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 132
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VA 189
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  111 bits (278), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 138
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 139 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VA 195
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 133
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 133
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 76  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 133
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 134 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 190
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 191 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 132
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGY---VA 189
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 129
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 77  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 134
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 191
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 192 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++     +     
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--AKLTDDHV 123
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 129
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 139
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 147
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 204
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 150
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 151 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 207
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 132
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 189
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 69  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 126
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 127 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 183
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 184 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 216

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 139
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 82  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 139
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 140 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 196
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 197 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 147
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 204
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 72  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 129
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 130 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 186
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 187 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 75  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 132
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 133 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 189
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 190 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 81  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 138
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 139 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 195
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 196 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 146
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 147 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 203
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  111 bits (278), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 80  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 137
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 138 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 194
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 195 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 227

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 68  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 125
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 126 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 182
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 183 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 89  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 146
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 147 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 203
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 204 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 86/153 (56%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV      L      +LV   +  DL + ++   +       
Sbjct: 99  RELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 156
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 157 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 214 TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELL 246

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 124
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 125 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 181
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 214

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 93  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 150
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 151 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGY---VA 207
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 208 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 123
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 123
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 180
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  111 bits (277), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 67  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 124
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y   V 
Sbjct: 125 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY---VA 181
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 182 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  110 bits (275), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ D+GL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  110 bits (274), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 63/153 (41%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M   T  V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---TGXVA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  109 bits (272), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  +   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  109 bits (272), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  +   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  109 bits (272), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 88/153 (57%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 66  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 123
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  +   V 
Sbjct: 124 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGF---VA 180
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 181 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  108 bits (271), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 87/153 (56%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+  FGL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 87/153 (56%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ D GL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  108 bits (270), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 87/153 (56%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ D GL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 87/153 (56%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 90  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 147
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M      V 
Sbjct: 148 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM---XGXVA 204
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 205 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  108 bits (269), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 87/153 (56%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ D GL+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  107 bits (267), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 62/153 (40%), Positives = 87/153 (56%), Gaps = 11/153 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALA 67
           RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +       
Sbjct: 70  RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DDHV 127
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DF L+R     M  Y   V 
Sbjct: 128 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY---VA 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 185 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  105 bits (261), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 90/163 (55%), Gaps = 17/163 (10%)
Query: 12  ALREISVLKELKHPNVIRLHDVI-PVDFK----LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +LK  KH N+I + ++  P  F+    ++++ E ++ DL   + T  +      
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS--DDH 113
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----------T 116
            + ++YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R            T
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  T  V T WYR PE++L +  YS  +D+WS GCI +E+
Sbjct: 174 GQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  104 bits (259), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 58/163 (35%), Positives = 90/163 (55%), Gaps = 17/163 (10%)
Query: 12  ALREISVLKELKHPNVIRLHDVI-PVDFK----LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +LK  KH N+I + ++  P  F+    ++++ E ++ DL   + T  +      
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS--DDH 113
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----------T 116
            + ++YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R            T
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  T  V T WYR PE++L +  YS  +D+WS GCI +E+
Sbjct: 174 GQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  103 bits (257), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 58/161 (36%), Positives = 92/161 (57%), Gaps = 5/161 (3%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP 59
           S+++ EGV     REI +   L+HPN++R+++      +++L+ EF  R +L   LQ   
Sbjct: 51  SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG 110
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
                  + +++ +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S     P 
Sbjct: 111 R-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPS 167
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            R      TL Y PPE++ G K +   VD+W AG +  E +
Sbjct: 168 LRRRXMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFL 207

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  103 bits (257), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 58/161 (36%), Positives = 92/161 (57%), Gaps = 5/161 (3%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP 59
           S+++ EGV     REI +   L+HPN++R+++      +++L+ EF  R +L   LQ   
Sbjct: 50  SQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG 109
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
                  + +++ +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S     P 
Sbjct: 110 R-FDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS--VHAPS 166
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            R      TL Y PPE++ G K +   VD+W AG +  E +
Sbjct: 167 LRRRXMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFL 206

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  103 bits (256), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 56/161 (34%), Positives = 93/161 (57%), Gaps = 5/161 (3%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP 59
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+  R ++   LQ   
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS 108
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
                    +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P 
Sbjct: 109 -KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPS 165
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 166 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 205

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  102 bits (253), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/166 (37%), Positives = 88/166 (53%), Gaps = 27/166 (16%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD---LKDFLQTTPVPV-------- 62
           RE+ +++ +KHPNV        VD K F      ++D   L   L+  P  V        
Sbjct: 81  RELQIMRIVKHPNV--------VDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYA 132
Query: 63  ------PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAF 115
                 P  L K Y+YQLL +L Y HS  I HRD+KPQN+L++  SG LKL DFG S   
Sbjct: 133 KLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG-SAKI 191
Query: 116 TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            I        + + +YR PE++ GA  Y+T +DIWS GC+ +E++Q
Sbjct: 192 LIAGEPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ 237

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  102 bits (253), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 57/163 (34%), Positives = 89/163 (54%), Gaps = 17/163 (10%)
Query: 12  ALREISVLKELKHPNVIRLHDVI-PVDFK----LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +LK  KH N+I + ++  P  F+    ++++ E ++ DL   + T  +      
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS--DDH 113
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----------T 116
            + ++YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R            T
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +     V T WYR PE++L +  YS  +D+WS GCI +E+
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAEL 216

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 92/161 (57%), Gaps = 5/161 (3%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP 59
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+  R ++   LQ   
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLS 108
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
                    +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P 
Sbjct: 109 -KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS--VHAPS 165
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 166 SRRXXLXGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 205

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  101 bits (251), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 44  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 103
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 104 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 156 --VHAPSSRRTELCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 200

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 44  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 103
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 104 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 156 --VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 200

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 105 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 157 --VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 201

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 109 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 160
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 161 --VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 205

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 109 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 160
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 161 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 205

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  100 bits (249), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 44  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 103
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 104 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 156 --VHAPSSRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 200

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  100 bits (249), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 70  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 129
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 130 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 181
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 182 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 226

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 61  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 120
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 121 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 172
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 173 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 217

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 47  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 106
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 107 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 159 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 203

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  100 bits (249), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 44  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 103
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 104 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 156 --VHAPSSRRTXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 200

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  100 bits (248), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 44  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 103
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 104 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 156 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 200

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  100 bits (248), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 43  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 102
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 103 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 154
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 155 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 199

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  100 bits (248), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 47  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 106
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 107 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 159 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 203

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  100 bits (248), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 48  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 107
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 108 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 159
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 160 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 204

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  100 bits (248), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 41  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 100
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 101 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 152
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 153 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 197

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 99.8 bits (247), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 105 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 157 --CHAPSSRRTTLSGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 201

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 99.4 bits (246), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 48  TQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 107
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 108 RFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS 159
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 160 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 204

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 99.4 bits (246), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 60/156 (38%), Positives = 85/156 (54%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T E
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPE 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 99.4 bits (246), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 220

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 47  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 106
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 107 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 159 --VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 203

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 85/147 (57%), Gaps = 2/147 (1%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REIS L+ L+HP++I+L+DVI    ++ +V E+   +L D++      +    A+ +  Q
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQ 121
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           ++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       +  Y  
Sbjct: 122 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 180
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE++ G       VD+WS G I   M+
Sbjct: 181 PEVISGKLYAGPEVDVWSCGVILYVML 207

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 85/147 (57%), Gaps = 2/147 (1%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REIS L+ L+HP++I+L+DVI    ++ +V E+   +L D++      +    A+ +  Q
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQ 120
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           ++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       +  Y  
Sbjct: 121 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 179
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE++ G       VD+WS G I   M+
Sbjct: 180 PEVISGKLYAGPEVDVWSCGVILYVML 206

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 70  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 129
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 130 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 181
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 182 --VHAPSSRRDDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 226

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/158 (37%), Positives = 89/158 (56%), Gaps = 15/158 (9%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ +++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYT 123
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +  M  Y 
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY- 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 186 --VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 220

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 99.0 bits (245), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 56/168 (33%), Positives = 90/168 (53%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 49  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 108
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 109 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 160
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE + G + +   VD+WS G +  E +
Sbjct: 161 --VHAPSSRRTTLCGTLDYLPPEXIEG-RXHDEKVDLWSLGVLCYEFL 205

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 85/147 (57%), Gaps = 2/147 (1%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REIS L+ L+HP++I+L+DVI    ++ +V E+   +L D++      +    A+ +  Q
Sbjct: 53  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQ 111
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           ++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       +  Y  
Sbjct: 112 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 170
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE++ G       VD+WS G I   M+
Sbjct: 171 PEVISGKLYAGPEVDVWSCGVILYVML 197

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 46  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 106 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 157
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 158 --VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 85/147 (57%), Gaps = 2/147 (1%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REIS L+ L+HP++I+L+DVI    ++ +V E+   +L D++      +    A+ +  Q
Sbjct: 57  REISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQ 115
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           ++ A+ YCH  +I+HRDLKP+N+L+++   +K+ADFGLS   T   N       +  Y  
Sbjct: 116 IISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 174
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE++ G       VD+WS G I   M+
Sbjct: 175 PEVISGKLYAGPEVDVWSCGVILYVML 201

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 220

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 46  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 105
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+A+FG S
Sbjct: 106 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS 157
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 158 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 202

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 44  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 103
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 104 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 156 --VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 200

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 98.6 bits (244), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 60/158 (37%), Positives = 86/158 (54%), Gaps = 15/158 (9%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYT 123
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +  M  Y 
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY- 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 186 --VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 220

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 98.6 bits (244), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 92/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 47  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 106
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+A+FG S
Sbjct: 107 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWS 158
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 159 --VHAPSSRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 203

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 47  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 106
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 107 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 159 --VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 203

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 44  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 103
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 104 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 155
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 156 --VHAPSSRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 200

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 47  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 106
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 107 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 158
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 159 --VHAPSSRRDDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 203

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 45  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 105 KFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 157 --VHAPSSRRDTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 201

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 220

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 60/158 (37%), Positives = 86/158 (54%), Gaps = 15/158 (9%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYT 123
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +  M  Y 
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY- 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 186 --VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 220

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ---MELDHE 119
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 120 RMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPY 178
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 179 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 213

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 57/152 (37%), Positives = 92/152 (60%), Gaps = 10/152 (6%)
Query: 14  REISVLKELKH-PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
           REI +L+ L+  PN+I L D++  PV     LVFE +   D K   QT    +     + 
Sbjct: 80  REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRF 135
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 128
           Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V +
Sbjct: 136 YMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVAS 194
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +++ PE+L+  ++Y  ++D+WS GC+ + MI
Sbjct: 195 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 226

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 98.2 bits (243), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 86/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L    Q   + +   
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIQMELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 220

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 54/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 44  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLS 103
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+++IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 104 KFDEQRTA--------TYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWS 155
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 156 --VHAPSSRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 200

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 51/149 (34%), Positives = 85/149 (57%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+L+ E+    ++ D+L      +    A+S  
Sbjct: 59  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKF 117
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+     T    +  Y
Sbjct: 118 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTF-CGSPPY 176
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 177 AAPELFQGKKYDGPEVDVWSLGVILYTLV 205

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 56/164 (34%), Positives = 94/164 (57%), Gaps = 19/164 (11%)
Query: 14  REISVLKELK---HPNVIRLHDVIPV-------DFKLFLVFEF----LRQDLKDFLQTTP 59
           RE+ ++++L    HPN+++L             D  L +V E+    L +  +++ +   
Sbjct: 65  RELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQV 124
Query: 60  VPVPPALAKSYLYQLLEALRYCH--SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFT 116
            P PP L K +L+QL+ ++   H  S  + HRD+KP N+L+N++ G LKL DFG ++  +
Sbjct: 125 AP-PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            P       + + +YR PE++ G + Y+T VDIWS GCIF+EM+
Sbjct: 184 -PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 97.4 bits (241), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 55/168 (32%), Positives = 91/168 (54%), Gaps = 19/168 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL--------RQDLK 52
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+          Q L 
Sbjct: 48  TQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 107
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS 112
            F +            +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S
Sbjct: 108 RFDEQRTA--------TYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWS 159
Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                P +R      TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 160 --VHAPSSRRDTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 204

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 60/158 (37%), Positives = 86/158 (54%), Gaps = 15/158 (9%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYT 123
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +  M  Y 
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY- 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 186 --VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 220

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 97.1 bits (240), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 164
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 223
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 224 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 258

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 96.7 bits (239), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 164
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 223
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 224 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 258

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 120
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 121 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 179
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 180 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 214

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 127
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 186
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 221

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 56/155 (36%), Positives = 82/155 (52%), Gaps = 7/155 (4%)
Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPP 64
           +  ++EI +LK+L HPNVI+ +     D +L +V E      L + +K F +   + +P 
Sbjct: 77  ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRL-IPE 135
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
                Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+        
Sbjct: 136 RTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS 195
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            V T +Y  PE  +    Y+   DIWS GC+  EM
Sbjct: 196 LVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 69  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 125
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 126 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 184
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 185 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 219

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+L+ E+    ++ D+L      +    A+S  
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYL-VAHGRMKEKEARSKF 120
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+   +         Y
Sbjct: 121 RQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPY 179
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLV 208

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 96.7 bits (239), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 127
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 186
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 220

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 119
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 178
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 179 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 213

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ +LK + H N+I L +V        +F+ ++LV E +  +L    Q   + +   
Sbjct: 70  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIHMELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y+  VDIWS GCI  E+++
Sbjct: 186 VVTRYYRAPEVILGMG-YAANVDIWSVGCIMGELVK 220

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 120
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 121 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 179
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 180 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 214

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 96.3 bits (238), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EM++
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 220

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHE 127
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 186
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 84/156 (53%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 220

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 59/156 (37%), Positives = 87/156 (55%), Gaps = 11/156 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ +LK + H N+I L +V        +F+ ++LV E +  +L    Q   + +   
Sbjct: 68  AYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANL---CQVIHMELDHE 124
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R  +      T  
Sbjct: 125 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF-MMTPY 183
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVT +YR PE++LG   Y   VDIWS GCI  E+++
Sbjct: 184 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVK 218

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 96.3 bits (238), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L    Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R           E
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPE 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT +YR PE++LG   Y   VDIWS GCI  EM+
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMV 219

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 51/147 (34%), Positives = 83/147 (56%), Gaps = 2/147 (1%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REIS LK L+HP++I+L+DVI     + +V E+   +L D++      +     + +  Q
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKKRMTEDEGRRFFQQ 116
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           ++ A+ YCH  +I+HRDLKP+N+L++ +  +K+ADFGLS   T   N       +  Y  
Sbjct: 117 IICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT-DGNFLKTSCGSPNYAA 175
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE++ G       VD+WS G +   M+
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVML 202

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 95.9 bits (237), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 85/149 (57%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 120
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT+  N+      +  Y
Sbjct: 121 RQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-NKLDTFCGSPPY 179
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLV 208

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 92/161 (57%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           DV+ ++  L  V E + +  + +    QT PV
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +  
Sbjct: 122 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 176
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 177 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 95.5 bits (236), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 48/115 (41%), Positives = 72/115 (62%), Gaps = 3/115 (2%)
Query: 47  LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALK 105
           L + LK F+++    +P  L   Y+YQL  A+ + HS  I HRD+KPQN+L+N K   LK
Sbjct: 124 LHKVLKSFIRSG-RSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLK 182
Query: 106 LADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           L DFG ++   IP       + + +YR PE++LGA  Y+ ++D+WS GC+F E+I
Sbjct: 183 LCDFGSAKKL-IPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 59/158 (37%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ +++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYT 123
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +  M  Y 
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY- 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             VVT +YR PE++LG   Y   VDIWS G I  EMI+
Sbjct: 186 --VVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIK 220

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDEFCGSPPY 178
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLV 207

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/158 (37%), Positives = 88/158 (55%), Gaps = 15/158 (9%)
Query: 12  ALREISVLKELKHPNVIRLHDVIP-----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ +++V E +  +L   +Q   + +   
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ---MELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYT 123
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R    +  M  Y 
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPY- 185
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             VVT +YR PE++LG   Y   VDIWS G I  EMI+
Sbjct: 186 --VVTRYYRAPEVILGMG-YKENVDIWSVGVIMGEMIK 220

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 95.1 bits (235), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 82/155 (52%), Gaps = 11/155 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L    Q   + +   
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL---CQVIQMELDHE 126
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R           E
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMEPE 185
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT +YR PE++LG   Y   VD+WS GCI  EM+
Sbjct: 186 VVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMV 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 94.7 bits (234), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 59/161 (36%), Positives = 85/161 (52%), Gaps = 21/161 (13%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 72  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHE 128
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-----FTIPMN 120
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R        +P  
Sbjct: 129 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPF- 187
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
                VVT +YR PE++LG   Y   VDIWS GCI  EMI+
Sbjct: 188 -----VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK 222

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPY 178
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLV 207

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPY 178
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLV 207

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 94.4 bits (233), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPY 178
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLV 207

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 83/155 (53%), Gaps = 11/155 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 64  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHE 120
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 121 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 179
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT +YR PE++LG   Y   VD+WS GCI  EM+
Sbjct: 180 VVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMV 213

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 83/155 (53%), Gaps = 11/155 (7%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V      L      ++V E +  +L   +Q   + +   
Sbjct: 75  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ---MELDHE 131
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 132 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPY 190
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT +YR PE++LG   Y   VD+WS GCI  EM+
Sbjct: 191 VVTRYYRAPEVILGMG-YKENVDLWSVGCIMGEMV 224

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 94.0 bits (232), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGRMKEKEARAKF 119
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+         Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDAFCGAPPY 178
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLV 207

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 92/161 (57%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 141 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 200
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++      
Sbjct: 201 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 256
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 257 PNVSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 296

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 92/161 (57%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++      
Sbjct: 156 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 211
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 212 PNVSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 91/158 (57%), Gaps = 13/158 (8%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           RE+ ++++L H N++RL           D + ++  L  V E + +  + + +     +P
Sbjct: 67  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LP 125
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 122
               K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         
Sbjct: 126 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 185
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 186 SY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 222

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 92/161 (57%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 98  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 157
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++      
Sbjct: 158 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 213
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 214 PNVSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 92/161 (57%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 90  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 149
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++      
Sbjct: 150 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 205
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 206 PNVSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 85/138 (61%), Gaps = 7/138 (5%)
Query: 26  NVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 83
           N+I+L D +  PV     LVFE++     DF Q   +     + + Y+Y+LL+AL YCHS
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEYINN--TDFKQLYQILTDFDI-RFYMYELLKALDYCHS 150
Query: 84  RRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
           + I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  ++
Sbjct: 151 KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQM 209
Query: 143 YSTTVDIWSAGCIFSEMI 160
           Y  ++D+WS GC+ + MI
Sbjct: 210 YDYSLDMWSLGCMLASMI 227

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 94.0 bits (232), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 91/161 (56%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +  
Sbjct: 156 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 210
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 211 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 92/161 (57%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 100 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 159
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++      
Sbjct: 160 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 215
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 216 PNVSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 92/161 (57%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++      
Sbjct: 122 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 178 PNVSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 92/161 (57%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++      
Sbjct: 122 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 178 PNVSY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 90/158 (56%), Gaps = 13/158 (8%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           RE+ ++++L H N++RL           D + ++  L  V E + +  + + +     +P
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LP 132
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 122
               K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +     
Sbjct: 133 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPN 191
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 93.6 bits (231), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 51/138 (36%), Positives = 85/138 (61%), Gaps = 7/138 (5%)
Query: 26  NVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS 83
           N+I+L D +  PV     LVFE++     DF Q   +     + + Y+Y+LL+AL YCHS
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEYINN--TDFKQLYQILTDFDI-RFYMYELLKALDYCHS 155
Query: 84  RRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
           + I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  ++
Sbjct: 156 KGIMHRDVKPHNVMIDHQQKKLRLIDWGLAE-FYHPAQEYNVRVASRYFKGPELLVDYQM 214
Query: 143 YSTTVDIWSAGCIFSEMI 160
           Y  ++D+WS GC+ + MI
Sbjct: 215 YDYSLDMWSLGCMLASMI 232

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 90/158 (56%), Gaps = 13/158 (8%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           RE+ ++++L H N++RL           D + ++  L  V E + +  + + +     +P
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LP 132
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 122
               K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +     
Sbjct: 133 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPN 191
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 192 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 91/158 (57%), Gaps = 13/158 (8%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           RE+ ++++L H N++RL           D + ++  L  V E + +  + + +     +P
Sbjct: 75  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LP 133
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 122
               K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         
Sbjct: 134 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 193
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 194 SY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++K L HPN+++L +VI  +  L+LV E+    ++ D+L      +    A++  
Sbjct: 54  FREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-VAHGWMKEKEARAKF 112
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+      +  Y
Sbjct: 113 RQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-NKLDTFCGSPPY 171
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 172 AAPELFQGKKYDGPEVDVWSLGVILYTLV 200

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 91/158 (57%), Gaps = 13/158 (8%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           RE+ ++++L H N++RL           D + ++  L  V E + +  + + +     +P
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LP 120
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 122
               K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++         
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV 180
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           ++ + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 181 SY-ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 91/161 (56%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 70  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 129
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +  
Sbjct: 130 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 184
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 185 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 93.6 bits (231), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 53/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N+LI+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 91/161 (56%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 81  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 140
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +  
Sbjct: 141 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 195
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 196 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 91/161 (56%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 66  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 125
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +  
Sbjct: 126 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 180
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 181 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 90/158 (56%), Gaps = 13/158 (8%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           RE+ ++++L H N++RL           D + ++  L  V E + +  + + +     +P
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LP 120
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 122
               K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +     
Sbjct: 121 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPN 179
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 180 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 54/161 (33%), Positives = 91/161 (56%), Gaps = 19/161 (11%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFL---QTTPV 60
           RE+ ++++L H N++RL           D + ++  L  V E + +  + +    QT PV
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPM 119
                  K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +  
Sbjct: 122 ----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRG 176
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 177 EPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 93.2 bits (230), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 90/158 (56%), Gaps = 13/158 (8%)
Query: 14  REISVLKELKHPNVIRLH----------DVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           RE+ ++++L H N++RL           D + ++  L  V E + +  + + +     +P
Sbjct: 63  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT-LP 121
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRY 122
               K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   +     
Sbjct: 122 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPN 180
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 181 VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 92.8 bits (229), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 97  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 152
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 211
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 212 QMYDYSLDMWSLGCMLASMI 231

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 146
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 206 QMYDYSLDMWSLGCMLASMI 225

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 92.8 bits (229), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 146
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 205
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 206 QMYDYSLDMWSLGCMLASMI 225

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 92.8 bits (229), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTDYDIRFYMYEILKALDYC 145
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 205 QMYDYSLDMWSLGCMLASMI 224

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 92.4 bits (228), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 52/140 (37%), Positives = 84/140 (60%), Gaps = 9/140 (6%)
Query: 25  PNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           PN+I L D++  PV     LVFE +   D K   QT    +     + Y+Y++L+AL YC
Sbjct: 92  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLRQT----LTDYDIRFYMYEILKALDYC 147
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V + +++ PE+L+  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-EFYHPGQEYNVRVASRYFKGPELLVDY 206
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           ++Y  ++D+WS GC+ + MI
Sbjct: 207 QMYDYSLDMWSLGCMLASMI 226

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 91.7 bits (226), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 81/149 (54%), Gaps = 3/149 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ + K L HPN+++L +VI  +  L+LV E+    ++ D+L           A++  
Sbjct: 61  FREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYL-VAHGRXKEKEARAKF 119
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++ A++YCH + I+HRDLK +N+L++    +K+ADFG S  FT   N+         Y
Sbjct: 120 RQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFG-NKLDAFCGAPPY 178
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+  G K     VD+WS G I   ++
Sbjct: 179 AAPELFQGKKYDGPEVDVWSLGVILYTLV 207

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 87/162 (53%), Gaps = 21/162 (12%)
Query: 14  REISVLKELKHPNVIRLHDV--------------IPVDFKLFLVFEFLRQDLKDFLQTTP 59
           RE+ ++++L H N++RL                 + +D+    V+   R       QT P
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARH-YSRAKQTLP 120
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIP 118
           V       K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++   + 
Sbjct: 121 V----IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VR 175
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                  + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 176 GEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 107 PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 163
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 164 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 222
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 223 DYDYSLDMWSLGCMFAGMI 241

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 143
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 203 DYDYSLDMWSLGCMFAGMI 221

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 87  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 143
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 144 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 202
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 203 DYDYSLDMWSLGCMFAGMI 221

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 142
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 202 DYDYSLDMWSLGCMFAGMI 220

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 142
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 202 DYDYSLDMWSLGCMFAGMI 220

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 90.1 bits (222), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 142
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 202 DYDYSLDMWSLGCMFAGMI 220

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 90.1 bits (222), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 88  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 144
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 145 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 203
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 204 DYDYSLDMWSLGCMFAGMI 222

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 142
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 202 DYDYSLDMWSLGCMFAGMI 220

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 142
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 202 DYDYSLDMWSLGCMFAGMI 220

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 83/139 (59%), Gaps = 7/139 (5%)
Query: 25  PNVIRLHDVIPVDFKLF--LVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           PN+++L D++         L+FE++     DF    P      + + Y+Y+LL+AL YCH
Sbjct: 86  PNIVKLLDIVRDQHSKTPSLIFEYVNN--TDFKVLYPTLTDYDI-RYYIYELLKALDYCH 142
Query: 83  SRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           S+ I+HRD+KP N++I+     L+L D+GL+  F  P   Y   V + +++ PE+L+  +
Sbjct: 143 SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 201
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  ++D+WS GC+F+ MI
Sbjct: 202 DYDYSLDMWSLGCMFAGMI 220

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 53/157 (33%), Positives = 89/157 (56%), Gaps = 9/157 (5%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPV 60
           +Q  G      +EI++LK+L HPNV++L +V+  P +  L++VFE + Q     +   P 
Sbjct: 74  IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGP---VMEVPT 130
Query: 61  --PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
             P+    A+ Y   L++ + Y H ++IIHRD+KP N+L+ + G +K+ADFG+S  F   
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 119 MNRYTHEVVTLWYRPPEILLGA-KVYST-TVDIWSAG 153
               ++ V T  +  PE L    K++S   +D+W+ G
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG 227

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.7 bits (221), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 49/150 (32%), Positives = 87/150 (58%), Gaps = 6/150 (4%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKSYL 71
           RE+    +L H N++ + DV   D   +LV E++    L +++++  P+ V  A+  ++ 
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAI--NFT 117
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTLW 130
            Q+L+ +++ H  RI+HRD+KPQNILI+ +  LK+ DFG+++A +   + +  H + T+ 
Sbjct: 118 NQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQ 177
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE   G      T DI+S G +  EM+
Sbjct: 178 YFSPEQAKGEATDECT-DIYSIGIVLYEML 206

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 82/150 (54%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 122
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYW 182
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EMI+
Sbjct: 183 MAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 211

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 87.8 bits (216), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 76/148 (51%), Gaps = 3/148 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 71
           RE++VL  +KHPN+++  +    +  L++V ++       K       V         + 
Sbjct: 72  REVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q+  AL++ H R+I+HRD+K QNI + K G ++L DFG++R     +      + T +Y
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI    K Y+   DIW+ GC+  E+
Sbjct: 192 LSPEICEN-KPYNNKSDIWALGCVLYEL 218

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 55/161 (34%), Positives = 92/161 (57%), Gaps = 5/161 (3%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP 59
           S+++ EGV     REI +   L HPN++RL++      +++L+ E+  R +L   LQ + 
Sbjct: 59  SQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKS- 117
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
                    + + +L +AL YCH +++IHRD+KP+N+L+   G LK+ADFG S     P 
Sbjct: 118 CTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWS--VHAPS 175
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            R      TL Y PPE++ G ++++  VD+W  G +  E++
Sbjct: 176 LRRKTMCGTLDYLPPEMIEG-RMHNEKVDLWCIGVLCYELL 215

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 82/150 (54%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 123
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 124 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 183
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EMI+
Sbjct: 184 MAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 212

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 87.4 bits (215), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 52/147 (35%), Positives = 84/147 (57%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTPVP-VPPALAKSY 70
           +EI +L+ L+H NVI+L DV+  + K  +++V E+    +++ L + P    P   A  Y
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGY 114
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRYTHEVV 127
             QL++ L Y HS+ I+H+D+KP N+L+   G LK++  G++ A   F       T +  
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ-G 173
Query: 128 TLWYRPPEILLGAKVYST-TVDIWSAG 153
           +  ++PPEI  G   +S   VDIWSAG
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAG 200

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 82/150 (54%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 122
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYW 182
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EMI+
Sbjct: 183 MAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 211

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 82/150 (54%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 122
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EMI+
Sbjct: 183 MAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 211

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDL--KDFLQTTPVPVPPAL 66
           RE  + ++L+HPN++RLHD I  +   +LVF+      L +D+  ++F          A 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------AD 129
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   
Sbjct: 130 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAW 187
Query: 124 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
           H    T  Y  PE+ L    YS  VDIW+ G I 
Sbjct: 188 HGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 220

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 53/152 (34%), Positives = 76/152 (50%), Gaps = 12/152 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL------QTTPVPVPPALA 67
           RE S+   LKHP+++ L +    D  L++VFEF+  D  D                 A+A
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFM--DGADLCFEIVKRADAGFVYSEAVA 132
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTH 124
             Y+ Q+LEALRYCH   IIHRD+KP+N+L+     S  +KL DFG++            
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
            V T  +  PE+ +  + Y   VD+W  G I 
Sbjct: 193 RVGTPHFMAPEV-VKREPYGKPVDVWGCGVIL 223

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDL--KDFLQTTPVPVPPAL 66
           RE  + ++L+HPN++RLHD I  +   +LVF+      L +D+  ++F          A 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------AD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   
Sbjct: 107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAW 164
Query: 124 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
           H    T  Y  PE+ L    YS  VDIW+ G I 
Sbjct: 165 HGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 197

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 86.3 bits (212), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDL--KDFLQTTPVPVPPAL 66
           RE  + ++L+HPN++RLHD I  +   +LVF+      L +D+  ++F          A 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------AD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   
Sbjct: 107 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAW 164
Query: 124 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
           H    T  Y  PE+ L    YS  VDIW+ G I 
Sbjct: 165 HGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 86.3 bits (212), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 85/154 (55%), Gaps = 21/154 (13%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDL--KDFLQTTPVPVPPAL 66
           RE  + ++L+HPN++RLHD I  +   +LVF+      L +D+  ++F          A 
Sbjct: 53  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE-------AD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   + Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL  A  +  +   
Sbjct: 106 ASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAW 163
Query: 124 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
           H    T  Y  PE+ L    YS  VDIW+ G I 
Sbjct: 164 HGFAGTPGYLSPEV-LKKDPYSKPVDIWACGVIL 196

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/150 (33%), Positives = 82/150 (54%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T   +      +  
Sbjct: 66  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVC 123
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHR++K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 124 RECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 183
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++   K Y   VDIWS G +  EMI+
Sbjct: 184 MAPEVVT-RKAYGPKVDIWSLGIMAIEMIE 212

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/148 (34%), Positives = 78/148 (52%), Gaps = 3/148 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           REI  LK  +HP++I+L+ VI      F+V E++   +L D++      V    A+    
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQ 118
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           Q+L A+ YCH   ++HRDLKP+N+L++     K+ADFGLS   +      T    +  Y 
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT-SCGSPNYA 177
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE++ G       VDIWS G I   ++
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYLYQ 73
           EI +L    HPN+++L D    +  L+++ EF      D  +     P+  +  +    Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
            L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++  
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMA 203
Query: 134 PEILLGA----KVYSTTVDIWSAGCIFSEMIQI 162
           PE+++      + Y    D+WS G    EM +I
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 82/147 (55%), Gaps = 3/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L E+ HP +++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 77  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 135
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 136 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 195
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +  + ++ + D WS G +  EM+
Sbjct: 196 PEV-VNRRGHTQSADWWSFGVLMFEML 221

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 82/147 (55%), Gaps = 3/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L E+ HP +++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 134
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +  + ++ + D WS G +  EM+
Sbjct: 195 PEV-VNRRGHTQSADWWSFGVLMFEML 220

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYLYQ 73
           EI +L    HPN+++L D    +  L+++ EF      D  +     P+  +  +    Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
            L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++  
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMA 203
Query: 134 PEILLGA----KVYSTTVDIWSAGCIFSEMIQI 162
           PE+++      + Y    D+WS G    EM +I
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 76/153 (49%), Gaps = 5/153 (3%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYLYQ 73
           EI +L    HPN+++L D    +  L+++ EF      D  +     P+  +  +    Q
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
            L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++  
Sbjct: 144 TLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMA 203
Query: 134 PEILLGA----KVYSTTVDIWSAGCIFSEMIQI 162
           PE+++      + Y    D+WS G    EM +I
Sbjct: 204 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEI 236

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 82/147 (55%), Gaps = 3/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L E+ HP +++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 134
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 135 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMA 194
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +  + ++ + D WS G +  EM+
Sbjct: 195 PEV-VNRRGHTQSADWWSFGVLMFEML 220

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 3/148 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           REI  LK  +HP++I+L+ VI      F+V E++   +L D++      V    A+    
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKHGRVEEMEARRLFQ 118
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           Q+L A+ YCH   ++HRDLKP+N+L++     K+ADFGLS   +           +  Y 
Sbjct: 119 QILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRDSCGSPNYA 177
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE++ G       VDIWS G I   ++
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALL 205

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 81/147 (55%), Gaps = 3/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  +L ++ HP V++LH     + KL+L+ +FLR  DL   L +  V       K YL +
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAE 138
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           L   L + HS  II+RDLKP+NIL+++ G +KL DFGLS+       +      T+ Y  
Sbjct: 139 LALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMA 198
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +  + +S + D WS G +  EM+
Sbjct: 199 PEV-VNRQGHSHSADWWSYGVLMFEML 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 84.3 bits (207), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/160 (34%), Positives = 86/160 (53%), Gaps = 9/160 (5%)
Query: 4   QVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP 61
           Q+E V     RE  +L+++  HP++I L D       +FLVF+ +R+ +L D+L T  V 
Sbjct: 138 QLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVA 196
Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +     +S +  LLEA+ + H+  I+HRDLKP+NIL++ +  ++L+DFG S     P  +
Sbjct: 197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS-CHLEPGEK 255
Query: 122 YTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCIF 156
                 T  Y  PEIL  +       Y   VD+W+ G I 
Sbjct: 256 LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 84.0 bits (206), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAK 68
           ST LRE+ +LK+L HPN+++L +++      ++V E +   +L D +           A 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAA 124
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 125
             + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     +    
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
           + T +Y  PE+L G   Y    D+WSAG I
Sbjct: 184 IGTAYYIAPEVLRG--TYDEKCDVWSAGVI 211

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 71
           RE  + + LKHPN++RLHD I  +   +LVF+ +      +D +         A A   +
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCI 109
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+LE++ +CH   I+HRDLKP+N+L+   +K  A+KLADFGL+         +     T
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
             Y  PE+L     Y   VD+W+ G I 
Sbjct: 170 PGYLSPEVLR-KDPYGKPVDMWACGVIL 196

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 51/148 (34%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 71
           RE  + + LKHPN++RLHD I  +   +L+F+ +      +D +         A A   +
Sbjct: 70  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--EADASHCI 127
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+LEA+ +CH   ++HRDLKP+N+L+    K  A+KLADFGL+         +     T
Sbjct: 128 QQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 187
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
             Y  PE+L     Y   VD+W+ G I 
Sbjct: 188 PGYLSPEVLR-KDPYGKPVDLWACGVIL 214

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 71
           RE  + + LKHPN++RLHD I  +   +LVF+ +      +D +         A A   +
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCI 109
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+LE++ +CH   I+HRDLKP+N+L+   +K  A+KLADFGL+         +     T
Sbjct: 110 QQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
             Y  PE+L     Y   VD+W+ G I 
Sbjct: 170 PGYLSPEVLR-KDPYGKPVDMWACGVIL 196

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 83.2 bits (204), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAK 68
           ST LRE+ +LK+L HPN+++L +++      ++V E +   +L D +           A 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAA 124
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 125
             + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     +    
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
           + T +Y  PE+L G   Y    D+WSAG I
Sbjct: 184 IGTAYYIAPEVLRG--TYDEKCDVWSAGVI 211

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 51/150 (34%), Positives = 78/150 (52%), Gaps = 8/150 (5%)
Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAK 68
           ST LRE+ +LK+L HPN+++L +++      ++V E +   +L D +           A 
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAA 124
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 125
             + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     +    
Sbjct: 125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDR 183
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
           + T +Y  PE+L G   Y    D+WSAG I
Sbjct: 184 IGTAYYIAPEVLRG--TYDEKCDVWSAGVI 211

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 82.8 bits (203), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 71
           RE  + + LKH N++RLHD I  +   +LVF+ +      +D +         A A   +
Sbjct: 52  REARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCI 109
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+LEA+ +CH   ++HRDLKP+N+L+    K  A+KLADFGL+         +     T
Sbjct: 110 QQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGT 169
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
             Y  PE+L   + Y   VDIW+ G I 
Sbjct: 170 PGYLSPEVLR-KEAYGKPVDIWACGVIL 196

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 82.4 bits (202), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 8/148 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAKSYL 71
           LRE+ +LK+L HPN+++L++        +LV E +   +L D +  +        A   +
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII 132
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGT 191
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
            +Y  PE+L G   Y    D+WS G I 
Sbjct: 192 AYYIAPEVLHG--TYDEKCDVWSTGVIL 217

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 2/151 (1%)
Query: 7   GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPA 65
           G+      E+ +  +LKHP+++ L++       ++LV E     ++  +L+    P    
Sbjct: 53  GMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSEN 112
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            A+ +++Q++  + Y HS  I+HRDL   N+L+ ++  +K+ADFGL+    +P  ++   
Sbjct: 113 EARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL 172
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
             T  Y  PEI   +  +    D+WS GC+F
Sbjct: 173 CGTPNYISPEIATRS-AHGLESDVWSLGCMF 202

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           ++E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  +
Sbjct: 102 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 161
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
             L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++ 
Sbjct: 162 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWM 217
Query: 133 PPEILLG--AKVYSTTVDIWSAG--CI 155
            PE++L      Y   VD+WS G  CI
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCI 244

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           ++E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  +
Sbjct: 63  IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
             L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG S +   P N +   V T ++ 
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANXF---VGTPYWM 178
Query: 133 PPEILLG--AKVYSTTVDIWSAGCIFSEMIQ 161
            PE++L      Y   VD+WS G    E+ +
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAE 209

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 3/148 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           REI  LK  +HP++I+L+ VI     +F+V E++   +L D++      +    ++    
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQ 123
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           Q+L  + YCH   ++HRDLKP+N+L++     K+ADFGLS   +           +  Y 
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFLRXSCGSPNYA 182
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE++ G       VDIWS+G I   ++
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALL 210

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 71
           RE  + + LKHPN++RLHD I  +   +LVF+ +      +D +         A A   +
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYS--EADASHCI 136
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVT 128
           +Q+LE++ + H   I+HRDLKP+N+L+    K  A+KLADFGL+         +     T
Sbjct: 137 HQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGT 196
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
             Y  PE+L     Y   VDIW+ G I 
Sbjct: 197 PGYLSPEVLR-KDPYGKPVDIWACGVIL 223

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 8/148 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD--LKDFLQTTPVPVPPALAKSYL 71
           RE  + + LKHPN++RLHD I  +   +L+F+ +      +D +         A A   +
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYS--EADASHCI 116
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+LEA+ +CH   ++HR+LKP+N+L+    K  A+KLADFGL+         +     T
Sbjct: 117 QQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGT 176
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
             Y  PE+L     Y   VD+W+ G I 
Sbjct: 177 PGYLSPEVLR-KDPYGKPVDLWACGVIL 203

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 79/147 (53%), Gaps = 8/147 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAKSYL 71
           LRE+ +LK+L HPN+++L++        +LV E +   +L D +  +        A   +
Sbjct: 80  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII 138
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 139 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGT 197
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
            +Y  PE+L G   Y    D+WS G I
Sbjct: 198 AYYIAPEVLHG--TYDEKCDVWSTGVI 222

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 81/162 (50%), Gaps = 12/162 (7%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKD--FLQT 57
           S V         L E++VLK+L HPN+++L++        +LV E  R  +L D   L+ 
Sbjct: 40  SSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ 99
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRA 114
               V  A+    + Q+L    Y H   I+HRDLKP+N+L+   ++   +K+ DFGLS  
Sbjct: 100 KFSEVDAAVI---MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAH 156
Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
           F +   +    + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 157 FEVG-GKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVIL 195

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 1   SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L T 
Sbjct: 46  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TE 104
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P
Sbjct: 105 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-P 163
Query: 119 MNRYTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCI 155
             +      T  Y  PEI+  +       Y   VD+WS G I
Sbjct: 164 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 205

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 15  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY-- 70
           E+++L+ELKHPN++R +D I    +  L++V E+        + T        L + +  
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 71  --LYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +   
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK 174
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             V T +Y  PE  +    Y+   DIWS GC+  E+  +
Sbjct: 175 EFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCAL 212

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 1   SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L T 
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TE 117
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-P 176
Query: 119 MNRYTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCI 155
             +      T  Y  PEI+  +       Y   VD+WS G I
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD--FLQTTPVPVPPALAKSYLY 72
           EI +L    HP +++L      D KL+++ EF      D   L+       P + +    
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-QVVCR 116
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T ++ 
Sbjct: 117 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 176
Query: 133 PPEILLGAKV----YSTTVDIWSAGCIFSEMIQI 162
            PE+++   +    Y    DIWS G    EM QI
Sbjct: 177 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 210

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 59
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 52  AKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFT 116
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+   
Sbjct: 112 FYTERD-ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 169
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            P +  +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 170 DPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 207

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 81/162 (50%), Gaps = 12/162 (7%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKD--FLQT 57
           S V         L E++VLK+L HPN+++L++        +LV E  R  +L D   L+ 
Sbjct: 57  SSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ 116
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRA 114
               V  A+    + Q+L    Y H   I+HRDLKP+N+L+   ++   +K+ DFGLS  
Sbjct: 117 KFSEVDAAVI---MKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAH 173
Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
           F +   +    + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 174 FEVG-GKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVIL 212

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD--FLQTTPVPVPPALAKSYLY 72
           EI +L    HP +++L      D KL+++ EF      D   L+       P + +    
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-QVVCR 124
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T ++ 
Sbjct: 125 QMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWM 184
Query: 133 PPEILLGAKV----YSTTVDIWSAGCIFSEMIQI 162
            PE+++   +    Y    DIWS G    EM QI
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 78/148 (52%), Gaps = 8/148 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAKSYL 71
           LRE+ +LK+L HPN+ +L++        +LV E +   +L D +  +        A   +
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARII 132
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 133 RQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKXKDKIGT 191
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
            +Y  PE+L G   Y    D+WS G I 
Sbjct: 192 AYYIAPEVLHG--TYDEKCDVWSTGVIL 217

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 59
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 52  AKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFT 116
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+   
Sbjct: 112 FYTERD-ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 169
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            P +  +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 170 DPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 207

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 59
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 52  AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFT 116
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+   
Sbjct: 112 FYTERD-ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 169
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            P +  +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 170 DPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 86/159 (54%), Gaps = 7/159 (4%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 59
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 52  AKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 111
Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL---INKSGALKLADFGLSRAFT 116
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L   +++   + ++DFGLS+   
Sbjct: 112 FYTERD-ASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 169
Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            P +  +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 170 DPGSVLSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 207

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EI++ K L +P+V+  H     D  +++V E  R+     L      V    A+ ++ Q 
Sbjct: 76  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 135
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T  Y  P
Sbjct: 136 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 195
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L   K +S  VDIWS GCI   ++
Sbjct: 196 EVLC-KKGHSFEVDIWSLGCILYTLL 220

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL------QTTPVPVPPALA 67
           RE S+   LKHP+++ L +    D  L++VFEF+  D  D                 A+A
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGMLYMVFEFM--DGADLCFEIVKRADAGFVYSEAVA 134
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTH 124
             Y+ Q+LEALRYCH   IIHRD+KP  +L+     S  +KL  FG++            
Sbjct: 135 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 194
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
            V T  +  PE+ +  + Y   VD+W  G I 
Sbjct: 195 RVGTPHFMAPEV-VKREPYGKPVDVWGCGVIL 225

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 9/162 (5%)
Query: 1   SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L T 
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TE 117
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-P 176
Query: 119 MNRYTHEVVTLWYRPPEILLGAK-----VYSTTVDIWSAGCI 155
             +      T  Y  PEI+  +       Y   VD+WS G I
Sbjct: 177 GEKLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 15  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY-- 70
           E+++L+ELKHPN++R +D I    +  L++V E+        + T        L + +  
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 71  --LYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +   
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             V T +Y  PE  +    Y+   DIWS GC+  E+  +
Sbjct: 175 AFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCAL 212

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL------QTTPVPVPPALA 67
           RE S+   LKHP+++ L +    D  L++VFEF+  D  D                 A+A
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFM--DGADLCFEIVKRADAGFVYSEAVA 132
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTH 124
             Y+ Q+LEALRYCH   IIHRD+KP  +L+     S  +KL  FG++            
Sbjct: 133 SHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG 192
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
            V T  +  PE+ +  + Y   VD+W  G I 
Sbjct: 193 RVGTPHFMAPEV-VKREPYGKPVDVWGCGVIL 223

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 80/159 (50%), Gaps = 12/159 (7%)
Query: 15  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY-- 70
           E+++L+ELKHPN++R +D I    +  L++V E+        + T        L + +  
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 71  --LYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
             + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +   
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             V T +Y  PE  +    Y+   DIWS GC+  E+  +
Sbjct: 175 TFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCAL 212

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 1/142 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EI++ K L +P+V+  H     D  +++V E  R+     L      V    A+ ++ Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAP 211
Query: 135 EILLGAKVYSTTVDIWSAGCIF 156
           E+L   K +S  VDIWS GCI 
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCIL 232

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 80.1 bits (196), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 74/146 (50%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EI++ K L +P+V+  H     D  +++V E  R+     L      V    A+ ++ Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAP 211
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L   K +S  VDIWS GCI   ++
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCILYTLL 236

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 1/142 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EI++ K L +P+V+  H     D  +++V E  R+     L      V    A+ ++ Q 
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           ++ ++Y H+ R+IHRDLK  N+ +N    +K+ DFGL+        R      T  Y  P
Sbjct: 152 IQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAP 211
Query: 135 EILLGAKVYSTTVDIWSAGCIF 156
           E+L   K +S  VDIWS GCI 
Sbjct: 212 EVLC-KKGHSFEVDIWSLGCIL 232

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.7 bits (195), Expect = 6e-16,   Method: Composition-based stats.
 Identities = 53/145 (36%), Positives = 76/145 (52%), Gaps = 8/145 (5%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV-PVPPALAKSYLYQ 73
           EIS+LK L HPN+I+L DV       +LV EF  +  + F Q           A + + Q
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY-EGGELFEQIINRHKFDECDAANIMKQ 154
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPMNRYTHEVVTLW 130
           +L  + Y H   I+HRD+KP+NIL+    +L   K+ DFGLS  F+    +    + T +
Sbjct: 155 ILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY-KLRDRLGTAY 213
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCI 155
           Y  PE+L   K Y+   D+WS G I
Sbjct: 214 YIAPEVL--KKKYNEKCDVWSCGVI 236

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 8/148 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAKSYL 71
           LRE+ +LK+L HPN+++L++        +LV E +   +L D + +         A   +
Sbjct: 97  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARII 155
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 156 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGT 214
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
            +Y  PE+L G   Y    D+WS G I 
Sbjct: 215 AYYIAPEVLHG--TYDEKCDVWSTGVIL 240

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 79.3 bits (194), Expect = 8e-16,   Method: Composition-based stats.
 Identities = 48/148 (32%), Positives = 79/148 (53%), Gaps = 8/148 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-FLRQDLKDFLQTTPVPVPPALAKSYL 71
           LRE+ +LK+L HPN+++L++        +LV E +   +L D + +         A   +
Sbjct: 98  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARII 156
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 157 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGT 215
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIF 156
            +Y  PE+L G   Y    D+WS G I 
Sbjct: 216 AYYIAPEVLHG--TYDEKCDVWSTGVIL 241

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 85/182 (46%), Gaps = 36/182 (19%)
Query: 2   RVQVEGVPSTALR-------EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDF 54
           R+ ++ +P    R       EI++ K LKH N+++           F    F+    K F
Sbjct: 49  RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY-------LGSFSENGFI----KIF 97
Query: 55  LQTTPVPVPPALAKS--------------YLYQLLEALRYCHSRRIIHRDLKPQNILINK 100
           ++  P     AL +S              Y  Q+LE L+Y H  +I+HRD+K  N+LIN 
Sbjct: 98  MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 101 -SGALKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEIL-LGAKVYSTTVDIWSAGCIFS 157
            SG LK++DFG S+     +N  T     TL Y  PEI+  G + Y    DIWS GC   
Sbjct: 158 YSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTII 216
Query: 158 EM 159
           EM
Sbjct: 217 EM 218

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 79.3 bits (194), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/171 (33%), Positives = 83/171 (48%), Gaps = 14/171 (8%)
Query: 2   RVQVEGVPSTALR-------EISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQDLKD 53
           R+ ++ +P    R       EI++ K LKH N+++ L       F    + +     L  
Sbjct: 35  RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSA 94
Query: 54  FLQT--TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFG 110
            L++   P+         Y  Q+LE L+Y H  +I+HRD+K  N+LIN  SG LK++DFG
Sbjct: 95  LLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFG 154
Query: 111 LSRAFTIPMNRYTHEVV-TLWYRPPEIL-LGAKVYSTTVDIWSAGCIFSEM 159
            S+     +N  T     TL Y  PEI+  G + Y    DIWS GC   EM
Sbjct: 155 TSKRLA-GINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 204

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 83/148 (56%), Gaps = 5/148 (3%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPV-PPALAKSYLYQ 73
           E ++L+E+KHP ++ L        KL+L+ E+L    + F+Q     +     A  YL +
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG-ELFMQLEREGIFMEDTACFYLAE 129
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 132
           +  AL + H + II+RDLKP+NI++N  G +KL DFGL +  +I     TH    T+ Y 
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHXFCGTIEYM 188
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PEIL+ +  ++  VD WS G +  +M+
Sbjct: 189 APEILMRSG-HNRAVDWWSLGALMYDML 215

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/148 (35%), Positives = 83/148 (56%), Gaps = 5/148 (3%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPV-PPALAKSYLYQ 73
           E ++L+E+KHP ++ L        KL+L+ E+L    + F+Q     +     A  YL +
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGG-ELFMQLEREGIFMEDTACFYLAE 129
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 132
           +  AL + H + II+RDLKP+NI++N  G +KL DFGL +  +I     TH    T+ Y 
Sbjct: 130 ISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYM 188
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PEIL+ +  ++  VD WS G +  +M+
Sbjct: 189 APEILMRSG-HNRAVDWWSLGALMYDML 215

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 21/162 (12%)
Query: 12  ALREISVLKELKHP------NVIRLHDVIPVDFKLFLVFEFLRQDL-----KDFLQTTPV 60
           A  EI +L+ L+        NVI + +       + + FE L  +L     K+  Q   +
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIP 118
           P    L + + + +L+ L   H  RIIH DLKP+NIL+ + G   +K+ DFG S      
Sbjct: 200 P----LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYE 252
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             R    + + +YR PE++LGA+ Y   +D+WS GCI +E++
Sbjct: 253 HQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL 293

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 21/162 (12%)
Query: 12  ALREISVLKELKHP------NVIRLHDVIPVDFKLFLVFEFLRQDL-----KDFLQTTPV 60
           A  EI +L+ L+        NVI + +       + + FE L  +L     K+  Q   +
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIP 118
           P    L + + + +L+ L   H  RIIH DLKP+NIL+ + G   +K+ DFG S      
Sbjct: 200 P----LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYE 252
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             R    + + +YR PE++LGA+ Y   +D+WS GCI +E++
Sbjct: 253 HQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL 293

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/162 (32%), Positives = 83/162 (51%), Gaps = 21/162 (12%)
Query: 12  ALREISVLKELKHP------NVIRLHDVIPVDFKLFLVFEFLRQDL-----KDFLQTTPV 60
           A  EI +L+ L+        NVI + +       + + FE L  +L     K+  Q   +
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSL 199
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIP 118
           P    L + + + +L+ L   H  RIIH DLKP+NIL+ + G   +K+ DFG S      
Sbjct: 200 P----LVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---CYE 252
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             R    + + +YR PE++LGA+ Y   +D+WS GCI +E++
Sbjct: 253 HQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL 293

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 72
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 74  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 131
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 132 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 191
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE+ +    Y +  DIWS G    E+
Sbjct: 192 APEV-IKQSAYDSKADIWSLGITAIEL 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 4/147 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 72
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 111
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 112 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 171
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE++  +  Y +  DIWS G    E+
Sbjct: 172 APEVIKQS-AYDSKADIWSLGITAIEL 197

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Composition-based stats.
 Identities = 51/151 (33%), Positives = 76/151 (50%), Gaps = 8/151 (5%)
Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           S  L E++VLK L HPN+++L+D        +LV E  +  +L D +    +      A 
Sbjct: 81  SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAA 139
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 125
             + Q+L  + Y H   I+HRDLKP+N+L+    K   +K+ DFGLS  F     +    
Sbjct: 140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKER 198
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
           + T +Y  PE+L   K Y    D+WS G I 
Sbjct: 199 LGTAYYIAPEVL--RKKYDEKCDVWSIGVIL 227

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 14  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 128 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  Y  PE   G  V + + D++S GC+  E++
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVL 213

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 14  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 78  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 136
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 196
Query: 128 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  Y  PE   G  V + + D++S GC+  E++
Sbjct: 197 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVL 230

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 14  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 128 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  Y  PE   G  V + + D++S GC+  E++
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVL 213

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 14  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 128 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  Y  PE   G  V + + D++S GC+  E++
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVL 213

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 4/147 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 72
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 126
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 127 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWM 186
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE++  +  Y +  DIWS G    E+
Sbjct: 187 APEVIKQS-AYDSKADIWSLGITAIEL 212

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/147 (31%), Positives = 79/147 (53%), Gaps = 4/147 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 72
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P P+      + L 
Sbjct: 54  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE--PGPLDETQIATILR 111
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 112 EILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWM 171
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEM 159
            PE++  +  Y +  DIWS G    E+
Sbjct: 172 APEVIKQS-AYDSKADIWSLGITAIEL 197

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 69/138 (50%), Gaps = 1/138 (0%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
            HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 83  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 139 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED- 197
Query: 143 YSTTVDIWSAGCIFSEMI 160
           Y  +VD W+ G +  EM+
Sbjct: 198 YGFSVDWWALGVLMFEMM 215

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 69/138 (50%), Gaps = 1/138 (0%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
            HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 83  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED- 182
Query: 143 YSTTVDIWSAGCIFSEMI 160
           Y  +VD W+ G +  EM+
Sbjct: 183 YGFSVDWWALGVLMFEMM 200

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE+++L+E++HPN+I LHD+      + L+ E +   +L DFL      +    A  +L 
Sbjct: 64  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLK 122
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L+ + Y HS+RI H DLKP+NI++         +KL DFG++       N + +   T
Sbjct: 123 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGT 181
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 182 PEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE+++L+E++HPN+I LHD+      + L+ E +   +L DFL      +    A  +L 
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLK 136
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L+ + Y HS+RI H DLKP+NI++         +KL DFG++       N + +   T
Sbjct: 137 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGT 195
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 196 PEFVAPEI-VNYEPLGLEADMWSIGVI 221

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 69/138 (50%), Gaps = 1/138 (0%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
            HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 83  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED- 229
Query: 143 YSTTVDIWSAGCIFSEMI 160
           Y  +VD W+ G +  EM+
Sbjct: 230 YGFSVDWWALGVLMFEMM 247

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE+++L+E++HPN+I LHD+      + L+ E +   +L DFL      +    A  +L 
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLK 115
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L+ + Y HS+RI H DLKP+NI++         +KL DFG++       N + +   T
Sbjct: 116 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEFKNIFGT 174
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 175 PEFVAPEI-VNYEPLGLEADMWSIGVI 200

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 45/138 (32%), Positives = 69/138 (50%), Gaps = 1/138 (0%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
            HP ++ LH     + +LF V E++      F       +P   A+ Y  ++  AL Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 83  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
            R II+RDLK  N+L++  G +KL D+G+ +    P +  +    T  Y  PEIL G   
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGED- 186
Query: 143 YSTTVDIWSAGCIFSEMI 160
           Y  +VD W+ G +  EM+
Sbjct: 187 YGFSVDWWALGVLMFEMM 204

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 14  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           RE      L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
             +    +AL + H   IIHRD+KP NILI+ + A+K+ DFG++RA     N        
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAV 179
Query: 128 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  Y  PE   G  V + + D++S GC+  E++
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVL 213

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D         L+ E +   QDL DF+ T    +   LA+S+
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFI-TERGALQEELARSF 119
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 177
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 28/179 (15%)
Query: 10  STALREISVLKELKHPNVIRLH-------------DVIPVDFKLFLVFEFLRQD-LKDFL 55
           ST L E+ +L  L H  V+R +               +     LF+  E+     L D +
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS--- 112
            +  +            Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL+   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 113 -RAFTI----------PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            R+  I            +  T  + T  Y   E+L G   Y+  +D++S G IF EMI
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+ L  K +S  VD+WS GCI   ++
Sbjct: 187 EV-LSKKGHSFEVDVWSIGCIMYTLL 211

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 186
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+ L  K +S  VD+WS GCI   ++
Sbjct: 187 EV-LSKKGHSFEVDVWSIGCIMYTLL 211

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +   L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIG-SFDETCTRFYTA 139
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 199
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K  S + D+W+ GCI  +++
Sbjct: 200 YVSPE-LLTEKSASKSSDLWALGCIIYQLV 228

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 56/179 (31%), Positives = 82/179 (45%), Gaps = 28/179 (15%)
Query: 10  STALREISVLKELKHPNVIRLH-------------DVIPVDFKLFLVFEFL-RQDLKDFL 55
           ST L E+ +L  L H  V+R +               +     LF+  E+   + L D +
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI 106
Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS--- 112
            +  +            Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL+   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166
Query: 113 -RAFTI----------PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            R+  I            +  T  + T  Y   E+L G   Y+  +D++S G IF EMI
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 130
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 131 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAP 190
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+ L  K +S  VD+WS GCI   ++
Sbjct: 191 EV-LSKKGHSFEVDVWSIGCIMYTLL 215

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 115
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG        +  YT    T 
Sbjct: 116 FWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 173
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+ L  K +S  VD+WS GCI   ++
Sbjct: 185 EV-LSKKGHSFEVDVWSIGCIMYTLL 209

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 83/147 (56%), Gaps = 4/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ ++    V  +L+++ EFL+   L D +  + V +      +    
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV--SQVRLNEEQIATVCEA 149
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 150 VLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMA 209
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +   +Y+T VDIWS G +  EM+
Sbjct: 210 PEV-ISRSLYATEVDIWSLGIMVIEMV 235

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 115
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 173
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 149 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 208
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+ L  K +S  VD+WS GCI   ++
Sbjct: 209 EV-LSKKGHSFEVDVWSIGCIMYTLL 233

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 120
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 178
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 60  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 118
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG        +  YT    T 
Sbjct: 119 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 176
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 177 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 115
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 116 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 173
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/146 (32%), Positives = 72/146 (49%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           EIS+ + L H +V+  H     +  +F+V E  R+     L      +    A+ YL Q+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           +   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R      T  Y  P
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+ L  K +S  VD+WS GCI   ++
Sbjct: 211 EV-LSKKGHSFEVDVWSIGCIMYTLL 235

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 46  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 104
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 105 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 159
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/153 (33%), Positives = 75/153 (49%), Gaps = 20/153 (13%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPAL 66
           +EI ++K L HPN+IRL++    +  ++LV E       F R   K   + +        
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD------- 107
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   +  +L A+ YCH   + HRDLKP+N L    +    LKL DFGL+  F  P     
Sbjct: 108 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMR 166
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
            +V T +Y  P++L G  +Y    D WSAG + 
Sbjct: 167 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMM 197

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 120
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 178
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 142
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 143 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 200
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 120
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 178
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 179 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 76/155 (49%), Gaps = 10/155 (6%)
Query: 14  REISVLKELKHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           RE      L HP ++ ++       P     ++V E++    L+D + T   P+ P  A 
Sbjct: 61  REAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAI 119
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
             +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T     
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 128 --TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  Y  PE   G  V + + D++S GC+  E++
Sbjct: 180 IGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVL 213

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 136
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 137 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 196
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 197 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 225

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 119
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG        +  YT    T 
Sbjct: 120 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 177
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 178 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 135
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 193
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 200 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 228

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 85/156 (54%), Gaps = 15/156 (9%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 68
           L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++   +  P+P  +  
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-- 287
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-HEVV 127
            +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT  E  
Sbjct: 288 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGA 345
Query: 128 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                W  P  I  G+  ++   D+WS G +  E++
Sbjct: 346 KFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIV 379

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 75/152 (49%), Gaps = 20/152 (13%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPAL 66
           +EI ++K L HPN+IRL++    +  ++LV E       F R   K   + +        
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD------- 124
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   +  +L A+ YCH   + HRDLKP+N L    +    LKL DFGL+  F  P     
Sbjct: 125 AARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMR 183
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            +V T +Y  P++L G  +Y    D WSAG +
Sbjct: 184 TKVGTPYYVSPQVLEG--LYGPECDEWSAGVM 213

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 162
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 220
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 148
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 206
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 148
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 206
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 200 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 228

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 147
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 205
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 147
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 205
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 200 YVSPE-LLTEKSAXKSSDLWALGCIIYQLV 228

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 137
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQ 197
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 198 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 226

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 85/156 (54%), Gaps = 15/156 (9%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 68
           L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++   +  P+P  +  
Sbjct: 58  LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-- 114
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-HEVV 127
            +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT  E  
Sbjct: 115 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGA 172
Query: 128 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                W  P  I  G+  ++   D+WS G +  E++
Sbjct: 173 KFPIKWTAPEAINFGS--FTIKSDVWSFGILLMEIV 206

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 147
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 205
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 82/163 (50%), Gaps = 6/163 (3%)
Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV 60
           +V VE      ++EIS++++   P+V++ +     +  L++V E+     + D ++    
Sbjct: 61  QVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK 120
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
            +      + L   L+ L Y H  R IHRD+K  NIL+N  G  KLADFG++   T  M 
Sbjct: 121 TLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMA 180
Query: 121 RYTHEVVTLWYRPPEIL--LGAKVYSTTVDIWSAGCIFSEMIQ 161
           +    + T ++  PE++  +G   Y+   DIWS G    EM +
Sbjct: 181 KRNXVIGTPFWMAPEVIQEIG---YNCVADIWSLGITAIEMAE 220

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 89  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 147
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 148 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 205
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 206 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 96  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 154
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 155 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 212
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 213 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 140
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 141 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 200
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 201 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 229

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 148
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 206
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 200 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 228

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 63  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 122 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 181
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 182 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 210

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 78  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 136
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 137 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 196
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 197 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 225

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 90  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 148
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 149 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 206
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 207 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 134
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG        +  YT    T 
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 192
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 162
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 220
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 109 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 167
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T 
Sbjct: 168 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG--SGALLKDTVYTDFDGTR 225
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 226 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 84  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 142
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 143 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 202
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 203 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 231

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 137
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 198 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 226

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 137
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 198 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 226

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 79  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 137
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 197
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 198 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 226

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 104 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 162
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG        +  YT    T 
Sbjct: 163 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 220
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 221 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 135
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG        +  YT    T 
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 193
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 77/149 (51%), Gaps = 4/149 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 72
           +EI+VL +   P + R         KL+++ E+L      D L+  P P+      + L 
Sbjct: 66  QEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK--PGPLEETYIATILR 123
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS R IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 124 EILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWM 183
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            PE++  +  Y    DIWS G    E+ +
Sbjct: 184 APEVIKQS-AYDFKADIWSLGITAIELAK 211

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 82  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 140
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 141 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 200
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 201 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 229

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 77  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 135
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG        +  YT    T 
Sbjct: 136 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 193
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 194 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/140 (33%), Positives = 73/140 (52%), Gaps = 6/140 (4%)
Query: 24  HPNVIRLHDVIPVDFKLFLVFE--FLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           HP VIRL D         LV E     QDL D++ T   P+    ++ +  Q++ A+++C
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 82  HSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA 140
           HSR ++HRD+K +NILI+ + G  KL DFG      +    YT    T  Y PPE +   
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPYTDFDGTRVYSPPEWISRH 213
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
           + ++    +WS G +  +M+
Sbjct: 214 QYHALPATVWSLGILLYDMV 233

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 47  CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 105
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 106 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 160
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 14/160 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 48  PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 106
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 125
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 161
Query: 126 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                  TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 81  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 139
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 199
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 200 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 228

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/151 (35%), Positives = 81/151 (53%), Gaps = 8/151 (5%)
Query: 15  EISVLKELKH--PNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           E+ +LK++      VIRL D    P  F L L      QDL DF+ T    +   LA+S+
Sbjct: 76  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI-TERGALQEELARSF 134
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG        +  YT    T 
Sbjct: 135 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV--YTDFDGTR 192
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y PPE +   + +  +  +WS G +  +M+
Sbjct: 193 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 86  RERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 144
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 145 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 204
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 205 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 233

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 14/160 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 49  PENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 107
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 125
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 108 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 162
Query: 126 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                  TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 163 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 82/160 (51%), Gaps = 14/160 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P    +EI + K L H NV++ +         +L  E+    +L D ++   + +P   A
Sbjct: 48  PENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDA 106
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE-- 125
           + + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +   
Sbjct: 107 QRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRER 161
Query: 126 -----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                  TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 LLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 56  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 114
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 115 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 175 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 203

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 57  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 115
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 176 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 204

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQY 122
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVKEPG 180
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                WY  PE L  +K +S   D+WS G +  E+ 
Sbjct: 181 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 14/150 (9%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ--TTPVPVPPALAKSY-- 70
           EI VLK L HPN+I++ +V      +++V E       + L+   +      AL++ Y  
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG--ELLERIVSAQARGKALSEGYVA 127
Query: 71  --LYQLLEALRYCHSRRIIHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHE 125
             + Q++ AL Y HS+ ++H+DLKP+NIL   +     +K+ DFGL+  F       T+ 
Sbjct: 128 ELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNA 186
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
             T  Y  PE+    +  +   DIWSAG +
Sbjct: 187 AGTALYMAPEVF--KRDVTFKCDIWSAGVV 214

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 58  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 116
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 117 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 177 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 205

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 137
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 195
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 196 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 78  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 137
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 195
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 196 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 228

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 5/150 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y  
Sbjct: 59  RERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTA 117
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT--IPMNRYTHEVVTLW 130
           +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +      R    V T  
Sbjct: 118 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE LL  K    + D+W+ GCI  +++
Sbjct: 178 YVSPE-LLTEKSACKSSDLWALGCIIYQLV 206

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 3/142 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           REI   + L+HPN++R  +VI     L ++ E+                    A+ +  Q
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQ 124
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVVTLWY 131
           LL  + YCHS +I HRDLK +N L++ S A  LK+ DFG S++ ++  ++    V T  Y
Sbjct: 125 LLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTPAY 183
Query: 132 RPPEILLGAKVYSTTVDIWSAG 153
             PE+LL  +      D+WS G
Sbjct: 184 IAPEVLLRQEYDGKIADVWSCG 205

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 91  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 208
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                WY  PE L  +K +S   D+WS G +  E+ 
Sbjct: 209 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 242

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 58  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 117
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 118 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 175
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 176 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 208

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 177
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 178 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 66  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 125
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 126 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK--VLPQDKEXXKVKEPG 183
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                WY  PE L  +K +S   D+WS G +  E+ 
Sbjct: 184 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 217

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 122
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 180
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 181 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 213

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 59  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 118
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 119 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 176
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 177 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 209

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 67  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 126
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 127 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 184
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                WY  PE L  +K +S   D+WS G +  E+ 
Sbjct: 185 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 218

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 65  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 124
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 125 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 182
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                WY  PE L  +K +S   D+WS G +  E+ 
Sbjct: 183 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 216

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 77/157 (49%), Gaps = 3/157 (1%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           E + +   REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 56  EKIAANVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 123
            A+ +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+ DFG S++ ++  ++  
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 174
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T  Y  PE+LL  +      D+WS G     M+
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 177
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 178 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 210

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 74.3 bits (181), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 52/145 (35%), Positives = 76/145 (52%), Gaps = 5/145 (3%)
Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 76
           +LK +KHP ++ LH       KL+ V +++   +L   LQ     + P  A+ Y  ++  
Sbjct: 92  LLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR-ARFYAAEIAS 150
Query: 77  ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPE 135
           AL Y HS  I++RDLKP+NIL++  G + L DFGL +   I  N  T     T  Y  PE
Sbjct: 151 ALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPE 209
Query: 136 ILLGAKVYSTTVDIWSAGCIFSEMI 160
           + L  + Y  TVD W  G +  EM+
Sbjct: 210 V-LHKQPYDRTVDWWCLGAVLYEML 233

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 79/155 (50%), Gaps = 13/155 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 64  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 123
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 124 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 181
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                WY  PE L  +K +S   D+WS G +  E+
Sbjct: 182 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYEL 214

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 84/157 (53%), Gaps = 6/157 (3%)
Query: 3   VQVEGVPSTALR-EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV 60
           V+V+G     ++ EIS+L   +H N++ LH+      +L ++FEF+   D+ + + T+  
Sbjct: 38  VKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAF 97
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL--INKSGALKLADFGLSRAFTIP 118
            +      SY++Q+ EAL++ HS  I H D++P+NI+    +S  +K+ +FG +R    P
Sbjct: 98  ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-P 156
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            + +        Y  PE+     V ST  D+WS G +
Sbjct: 157 GDNFRLLFTAPEYYAPEV-HQHDVVSTATDMWSLGTL 192

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 3/157 (1%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           E +     REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 55  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 114
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 123
            A+ +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+ DFG S++ ++  ++  
Sbjct: 115 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 173
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T  Y  PE+LL  +      D+WS G     M+
Sbjct: 174 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 210

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ EFL    L+++LQ     +       Y
Sbjct: 63  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQY 122
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEXXKVKEPG 180
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                WY  PE L  +K +S   D+WS G +  E+ 
Sbjct: 181 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 214

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 74/139 (53%), Gaps = 3/139 (2%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           +HP +  +         LF V E+L   DL   +Q+       + A  Y  +++  L++ 
Sbjct: 77  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL 135
Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           HS+ I++RDLK  NIL++K G +K+ADFG+ +   +   +      T  Y  PEILLG K
Sbjct: 136 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y+ +VD WS G +  EM+
Sbjct: 196 -YNHSVDWWSFGVLLYEML 213

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 77/147 (52%), Gaps = 4/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++  H NV+ ++    V  +L++V EFL    L D +  T   +      +    
Sbjct: 92  EVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLS 149
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++  
Sbjct: 150 VLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMA 209
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE+ +    Y T VDIWS G +  EMI
Sbjct: 210 PEV-ISRLPYGTEVDIWSLGIMVIEMI 235

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 79/156 (50%), Gaps = 13/156 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 60  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++   +P ++   +V    
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV--LPQDKEFFKVKEPG 177
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                WY  PE L  +K +S   D+WS G +  E+ 
Sbjct: 178 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 211

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 73.6 bits (179), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 75/148 (50%), Gaps = 5/148 (3%)
Query: 11  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKS 69
           T   EIS++ +L HP +I LHD     +++ L+ EFL   +L D +      +  A   +
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNIL--INKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           Y+ Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+     P         
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTA 212
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
           T  +  PEI+    V   T D+W+ G +
Sbjct: 213 TAEFAAPEIVDREPVGFYT-DMWAIGVL 239

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/139 (33%), Positives = 74/139 (53%), Gaps = 3/139 (2%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           +HP +  +         LF V E+L   DL   +Q+       + A  Y  +++  L++ 
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL 134
Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           HS+ I++RDLK  NIL++K G +K+ADFG+ +   +   +      T  Y  PEILLG K
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y+ +VD WS G +  EM+
Sbjct: 195 -YNHSVDWWSFGVLLYEML 212

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 78/143 (54%), Gaps = 4/143 (2%)
Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA 77
           +L  + HP +IR+        ++F++ +++       L       P  +AK Y  ++  A
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLA 118
Query: 78  LRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL 137
           L Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++   +P   Y     T  Y  PE+ 
Sbjct: 119 LEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKY--VPDVTYXL-CGTPDYIAPEV- 174
Query: 138 LGAKVYSTTVDIWSAGCIFSEMI 160
           +  K Y+ ++D WS G +  EM+
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEML 197

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 80/156 (51%), Gaps = 13/156 (8%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       Y
Sbjct: 61  REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 120
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT-- 128
             Q+ + + Y  ++R IHR+L  +NIL+     +K+ DFGL++   +P ++  ++V    
Sbjct: 121 TSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKV--LPQDKEYYKVKEPG 178
Query: 129 ----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                WY  PE L  +K +S   D+WS G +  E+ 
Sbjct: 179 ESPIFWY-APESLTESK-FSVASDVWSFGVVLYELF 212

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.2 bits (178), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 81/161 (50%), Gaps = 14/161 (8%)
Query: 8   VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL 66
            P    +EI +   L H NV++ +         +L  E+    +L D ++   + +P   
Sbjct: 48  CPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPD 106
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE- 125
           A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F     RY +  
Sbjct: 107 AQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF-----RYNNRE 161
Query: 126 ------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PAFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSY 70
           REI +LK L    +++   V   P    L LV E+L    L+DFLQ     +  +    Y
Sbjct: 73  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 132
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 126
             Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      + 
Sbjct: 133 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              WY P    L   ++S   D+WS G +  E+ 
Sbjct: 193 PIFWYAPES--LSDNIFSRQSDVWSFGVVLYELF 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           +EI +L+ L H N+++   +   D    + L+ EFL    LK++L      +       Y
Sbjct: 60  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 119
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 126
             Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A        T     + 
Sbjct: 120 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 179
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              WY  PE L+ +K Y  + D+WS G    E++
Sbjct: 180 PVFWY-APECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 120
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 179
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 180 PEFVAPEI-VNYEPLGLEADMWSIGVI 205

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           +EI +L+ L H N+++   +   D    + L+ EFL    LK++L      +       Y
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 126
             Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A        T     + 
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDS 191
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              WY  PE L+ +K Y  + D+WS G    E++
Sbjct: 192 PVFWY-APECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 34/172 (19%)
Query: 15  EISVLKELKHPN------VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT---PVPVPPA 65
           EI+VLK++K  +       + + D       + + FE L ++  +FL+     P P+P  
Sbjct: 98  EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHV 157
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-IN------------------KSGALKL 106
             +   YQL  ALR+ H  ++ H DLKP+NIL +N                  K+ ++++
Sbjct: 158 --RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 215
Query: 107 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
           ADFG   + T     +T  V T  YRPPE++L    ++   D+WS GCI  E
Sbjct: 216 ADFG---SATFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFE 263

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 73.2 bits (178), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSY 70
           REI +LK L    +++   V   P    L LV E+L    L+DFLQ     +  +    Y
Sbjct: 60  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 119
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 126
             Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      + 
Sbjct: 120 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 179
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              WY P    L   ++S   D+WS G +  E+ 
Sbjct: 180 PIFWYAPES--LSDNIFSRQSDVWSFGVVLYELF 211

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 120
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 179
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 180 PEFVAPEI-VNYEPLGLEADMWSIGVI 205

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 34/172 (19%)
Query: 15  EISVLKELKHPN------VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT---PVPVPPA 65
           EI+VLK++K  +       + + D       + + FE L ++  +FL+     P P+P  
Sbjct: 75  EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHV 134
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-IN------------------KSGALKL 106
             +   YQL  ALR+ H  ++ H DLKP+NIL +N                  K+ ++++
Sbjct: 135 --RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 192
Query: 107 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
           ADFG   + T     +T  V T  YRPPE++L    ++   D+WS GCI  E
Sbjct: 193 ADFG---SATFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFE 240

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/151 (36%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI VL  L HPN+I+L ++     ++ LV E +   +L D +           A + + Q
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA-VKQ 156
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVV--- 127
           +LEA+ Y H   I+HRDLKP+N+L         LK+ADFGLS+          H+V+   
Sbjct: 157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV-------EHQVLMKT 209
Query: 128 ---TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
              T  Y  PEIL G   Y   VD+WS G I
Sbjct: 210 VCGTPGYCAPEILRGC-AYGPEVDMWSVGII 239

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 84/172 (48%), Gaps = 34/172 (19%)
Query: 15  EISVLKELKHPN------VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT---PVPVPPA 65
           EI+VLK++K  +       + + D       + + FE L ++  +FL+     P P+P  
Sbjct: 66  EINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHV 125
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-IN------------------KSGALKL 106
             +   YQL  ALR+ H  ++ H DLKP+NIL +N                  K+ ++++
Sbjct: 126 --RHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRV 183
Query: 107 ADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
           ADFG   + T     +T  V T  YRPPE++L    ++   D+WS GCI  E
Sbjct: 184 ADFG---SATFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFE 231

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 81/153 (52%), Gaps = 10/153 (6%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V  ++   ++V E++   +L D+L+        A+   Y+
Sbjct: 76  LKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYM 135
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-HEVVTL 129
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT H     
Sbjct: 136 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT--GDTYTAHAGAKF 193
Query: 130 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              W  P    L    +S   D+W+ G +  E+
Sbjct: 194 PIKWTAPES--LAYNTFSIKSDVWAFGVLLWEI 224

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 9/154 (5%)
Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSY 70
           REI +LK L    +++   V   P    L LV E+L    L+DFLQ     +  +    Y
Sbjct: 61  REIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 120
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT----HEV 126
             Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y      + 
Sbjct: 121 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 180
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              WY P    L   ++S   D+WS G +  E+ 
Sbjct: 181 PIFWYAPES--LSDNIFSRQSDVWSFGVVLYELF 212

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 72.8 bits (177), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 47  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 104
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-H 124
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 105 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 162
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           E       W  P  I  G   ++   D+WS G + +E++
Sbjct: 163 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 199

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 3/157 (1%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           E +     REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 123
            A+ +  QL+  + Y H+ ++ HRDLK +N L++ S A  LK+ADFG S+A ++  ++  
Sbjct: 116 EARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA-SVLHSQPK 174
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T  Y  PE+LL  +      D+WS G     M+
Sbjct: 175 SAVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 71  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 130
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 131 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 187
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 188 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 215

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 205

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/152 (34%), Positives = 72/152 (47%), Gaps = 7/152 (4%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLY 72
            E  ++     P V++L      D  L++V E++   DL + +      VP   A+ Y  
Sbjct: 123 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTA 180
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWY 131
           +++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T  Y
Sbjct: 181 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 240
Query: 132 RPPEILL---GAKVYSTTVDIWSAGCIFSEMI 160
             PE+L    G   Y    D WS G    EM+
Sbjct: 241 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 109
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-H 124
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 167
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           E       W  P  I  G   ++   D+WS G + +E++
Sbjct: 168 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 204

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 57  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 114
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-H 124
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 115 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 172
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           E       W  P  I  G   ++   D+WS G + +E++
Sbjct: 173 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 209

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+S+LKE++HPNVI LH+V      + L+ E +   +L DFL      +    A  +L 
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKE-SLTEEEATEFLK 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGT 180
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +  PEI +  +      D+WS G I
Sbjct: 181 PEFVAPEI-VNYEPLGLEADMWSIGVI 206

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 14/156 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 68
           L E +++K L+H  ++RL+ V+  +  ++++ EF+ +  L DFL++     V +P  +  
Sbjct: 55  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLI-- 112
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-HEVV 127
            +  Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT  E  
Sbjct: 113 DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGA 170
Query: 128 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                W  P  I  G   ++   ++WS G +  E++
Sbjct: 171 KFPIKWTAPEAINFG--CFTIKSNVWSFGILLYEIV 204

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 55  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 114
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 115 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEF---VGTRS 171
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 172 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 199

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 115
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-H 124
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 173
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           E       W  P  I  G   ++   D+WS G + +E++
Sbjct: 174 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 210

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLYQ 73
           E  ++     P V++L      D  L++V E++   DL + +      VP   A+ Y  +
Sbjct: 124 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAE 181
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYR 132
           ++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T  Y 
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 133 PPEILL---GAKVYSTTVDIWSAGCIFSEMI 160
            PE+L    G   Y    D WS G    EM+
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEML 272

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 16/170 (9%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPP 64
           E    T L+E+ V++ L+HPNV++   V+  D +L  + E+++   L+  +++     P 
Sbjct: 48  EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW 107
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS------------ 112
           +   S+   +   + Y HS  IIHRDL   N L+ ++  + +ADFGL+            
Sbjct: 108 SQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167
Query: 113 -RAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            R+   P  +  + VV   ++  PE++ G + Y   VD++S G +  E+I
Sbjct: 168 LRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEII 216

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSY 70
           REI +LK L    +++   V   P   +L LV E+L    L+DFLQ     +  +    Y
Sbjct: 57  REIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLY 116
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEV 126
             Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  +    R   + 
Sbjct: 117 SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQS 176
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              WY P    L   ++S   D+WS G +  E+ 
Sbjct: 177 PIFWYAPES--LSDNIFSRQSDVWSFGVVLYELF 208

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 72/151 (47%), Gaps = 7/151 (4%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLYQ 73
           E  ++     P V++L      D  L++V E++   DL + +      VP   A+ Y  +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAE 176
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYR 132
           ++ AL   HS   IHRD+KP N+L++KSG LKLADFG         M R    V T  Y 
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 133 PPEILL---GAKVYSTTVDIWSAGCIFSEMI 160
            PE+L    G   Y    D WS G    EM+
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 84/156 (53%), Gaps = 14/156 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPPALAK 68
           L E +++K L+H  ++RL+ V+  +  ++++ E++ +  L DFL++     V +P  +  
Sbjct: 56  LEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI-- 113
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-HEVV 127
            +  Q+ E + Y   +  IHRDL+  N+L+++S   K+ADFGL+R   I  N YT  E  
Sbjct: 114 DFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR--VIEDNEYTAREGA 171
Query: 128 TL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                W  P  I  G   ++   D+WS G +  E++
Sbjct: 172 KFPIKWTAPEAINFGC--FTIKSDVWSFGILLYEIV 205

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 82/155 (52%), Gaps = 7/155 (4%)
Query: 5   VEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVP 63
           ++G  S+   EI+VL+++KH N++ L D+      L+LV + +   +L D +        
Sbjct: 60  LKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTE 119
Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMN 120
              A + + Q+L+A+ Y H   I+HRDLKP+N+L    ++   + ++DFGLS+      +
Sbjct: 120 KD-ASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGD 177
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
             +    T  Y  PE+ L  K YS  VD WS G I
Sbjct: 178 VMSTACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 211

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 62  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 119
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-H 124
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 120 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 177
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           E       W  P  I  G   ++   D+WS G + +E++
Sbjct: 178 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 214

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 111
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 168
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 196

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 111
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 168
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 196

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 111
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 168
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 111
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 168
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 196

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 138
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 139 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 195
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 196 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 223

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 117
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 118 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 175
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             + PPE+L+ +K +S+  DIW+ G +  E+  +
Sbjct: 176 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 164
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             + PPE+L+ +K +S+  DIW+ G +  E+  +
Sbjct: 165 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 197

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 205

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 179
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 180 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 210

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 83/161 (51%), Gaps = 9/161 (5%)
Query: 1   SRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           SR    GV    + RE+S+L+++ HPN+I LHDV      + L+ E +   +L DFL   
Sbjct: 50  SRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK 109
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSRA 114
              +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+  
Sbjct: 110 E-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
               +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 169 IEDGVE-FKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 52  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 111
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 112 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 168
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 169 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 196

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 51  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 110
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 111 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 168
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             + PPE+L+ +K +S+  DIW+ G +  E+  +
Sbjct: 169 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 201

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 184
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             + PPE+L+ +K +S+  DIW+ G +  E+  +
Sbjct: 185 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 217

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 121
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 179
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 180 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 210

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 71  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 128
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 129 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 188
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE L+    Y   VDIWS G +  EM+
Sbjct: 189 PE-LISRLPYGPEVDIWSLGIMVIEMV 214

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 82/153 (53%), Gaps = 19/153 (12%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT---TPVPVPPALAK 68
           L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++   +  P+P  +  
Sbjct: 225 LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI-- 281
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPMNRYTHEVV 127
            +  Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R     P+        
Sbjct: 282 DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIK------- 334
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I  G+  ++   D+WS G +  E++
Sbjct: 335 --WTAPEAINFGS--FTIKSDVWSFGILLMEIV 363

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 205

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 114 IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI 173
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 174 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 230
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    EM
Sbjct: 231 YMSPERLQGTH-YSVQSDIWSMGLSLVEM 258

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 81/154 (52%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V + + 
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 169
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             + PPE+L+ +K +S+  DIW+ G +  E+  +
Sbjct: 170 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 202

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 67  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 124
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 125 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 184
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE L+    Y   VDIWS G +  EM+
Sbjct: 185 PE-LISRLPYGPEVDIWSLGIMVIEMV 210

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 78  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 135
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 136 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 195
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE L+    Y   VDIWS G +  EM+
Sbjct: 196 PE-LISRLPYGPEVDIWSLGIMVIEMV 221

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 76  EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 133
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 134 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 193
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE L+    Y   VDIWS G +  EM+
Sbjct: 194 PE-LISRLPYGPEVDIWSLGIMVIEMV 219

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/161 (36%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 15  EISVLKELKHPNVIR-------LHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPV 62
           EI ++K+L HPNV+        L  + P D  L L  E+     LR+ L  F     +  
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKE 120
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPM 119
            P   ++ L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++      
Sbjct: 121 GPI--RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QG 177
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              T  V TL Y  PE LL  K Y+ TVD WS G +  E I
Sbjct: 178 ELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECI 217

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 205

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/161 (36%), Positives = 77/161 (47%), Gaps = 20/161 (12%)
Query: 15  EISVLKELKHPNVIR-------LHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPV 62
           EI ++K+L HPNV+        L  + P D  L L  E+     LR+ L  F     +  
Sbjct: 63  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKE 121
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL---KLADFGLSRAFTIPM 119
            P   ++ L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++      
Sbjct: 122 GPI--RTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QG 178
Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              T  V TL Y  PE LL  K Y+ TVD WS G +  E I
Sbjct: 179 ELCTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECI 218

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 116
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 174
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 205

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 176
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 177 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 179
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 180 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 210

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 84/175 (48%), Gaps = 30/175 (17%)
Query: 12  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPP-ALAKS 69
           AL EI +L E   HPNVIR +     D  L++  E    +L+D +++  V      L K 
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 70  Y-----LYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 111
           Y     L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 112 SRAFTIPMNRY----THEVVTLWYRPPEILLGAKVYST------TVDIWSAGCIF 156
            +      + +     +   T  +R PE+L  +    T      ++DI+S GC+F
Sbjct: 175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 176
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 177 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 207

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 120
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 178
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 179 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 209

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 70  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 129
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 130 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 187
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 188 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 218

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTL 129
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 KWTAPESLAYNK-FSIKSDVWAFGVLLWEI 203

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 179
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 180 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 210

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 5/153 (3%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPP 64
           E    T  +EI  +  L+HP ++ LHD    D ++ +++EF+   +L + +      +  
Sbjct: 89  ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 148
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRY 122
             A  Y+ Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+ A   P    
Sbjct: 149 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSV 207
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
                T  +  PE+  G  V   T D+WS G +
Sbjct: 208 KVTTGTAEFAAPEVAEGKPVGYYT-DMWSVGVL 239

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 121 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 178
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 179 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 238
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE L+    Y   VDIWS G +  EM+
Sbjct: 239 PE-LISRLPYGPEVDIWSLGIMVIEMV 264

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 74  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 181
Query: 131 YRPPEIL--LGAKVYSTTVDIWSAGCIF 156
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 47/180 (26%), Positives = 87/180 (48%), Gaps = 39/180 (21%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT--------------- 57
           RE +++ E  +PN+++L  V  V   + L+FE++   DL +FL++               
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 158
Query: 58  ------TPVPVPPALAKSYLY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
                 +P P P + A+      Q+   + Y   R+ +HRDL  +N L+ ++  +K+ADF
Sbjct: 159 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF 218
Query: 110 GLSRAFTIPMNRYT--------HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           GLSR      N Y+        ++ + + + PPE +   + Y+T  D+W+ G +  E+  
Sbjct: 219 GLSR------NIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFS 271

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTL 129
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 177
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +  PE L   K +S   D+W+ G +  E+
Sbjct: 178 KWTAPESLAYNK-FSIKSDVWAFGVLLWEI 206

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 9/148 (6%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLW 130
           +L A++Y H   IIHRDLKP+N+L++       +K+ DFG S+         T    T  
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 181
Query: 131 YRPPEIL--LGAKVYSTTVDIWSAGCIF 156
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 84/171 (49%), Gaps = 26/171 (15%)
Query: 12  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPP-ALAKS 69
           AL EI +L E   HPNVIR +     D  L++  E    +L+D +++  V      L K 
Sbjct: 73  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 70  Y-----LYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 111
           Y     L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 112 SRAFTIPMNRYTHEV----VTLWYRPPEILLGA--KVYSTTVDIWSAGCIF 156
            +        +   +     T  +R PE+L  +  +  + ++DI+S GC+F
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVF 243

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/171 (32%), Positives = 84/171 (49%), Gaps = 26/171 (15%)
Query: 12  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPP-ALAKS 69
           AL EI +L E   HPNVIR +     D  L++  E    +L+D +++  V      L K 
Sbjct: 73  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 132
Query: 70  Y-----LYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 111
           Y     L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 133 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 192
Query: 112 SRAFTIPMNRYTHEV----VTLWYRPPEILLGA--KVYSTTVDIWSAGCIF 156
            +        +   +     T  +R PE+L  +  +  + ++DI+S GC+F
Sbjct: 193 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVF 243

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 9/148 (6%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 64  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 121
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLW 130
           +L A++Y H   IIHRDLKP+N+L++       +K+ DFG S+         T    T  
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 180
Query: 131 YRPPEIL--LGAKVYSTTVDIWSAGCIF 156
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 208

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 129
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPI 174
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 KWTAPESLAYNK-FSIKSDVWAFGVLLWEI 203

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 9/148 (6%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 71  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 128
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLW 130
           +L A++Y H   IIHRDLKP+N+L++       +K+ DFG S+         T    T  
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 187
Query: 131 YRPPEIL--LGAKVYSTTVDIWSAGCIF 156
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 215

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 109
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 110 LDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 167
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE+   ++ YS+  D+WS G +  E+ 
Sbjct: 168 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEVF 198

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 5/153 (3%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPP 64
           E    T  +EI  +  L+HP ++ LHD    D ++ +++EF+   +L + +      +  
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 254
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRY 122
             A  Y+ Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+ A   P    
Sbjct: 255 DEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLT-AHLDPKQSV 313
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
                T  +  PE+  G  V   T D+WS G +
Sbjct: 314 KVTTGTAEFAAPEVAEGKPVGYYT-DMWSVGVL 345

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 85/159 (53%), Gaps = 13/159 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 48  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 105
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT-H 124
           K      Q+ E + +   R  IHR+L+  NIL++ + + K+ADFGL+R   I  N YT  
Sbjct: 106 KLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLAR--LIEDNEYTAR 163
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           E       W  P  I  G   ++   D+WS G + +E++
Sbjct: 164 EGAKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 200

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 70.9 bits (172), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 76/148 (51%), Gaps = 9/148 (6%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 65  EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 122
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLW 130
           +L A++Y H   IIHRDLKP+N+L++       +K+ DFG S+         T    T  
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 181
Query: 131 YRPPEIL--LGAKVYSTTVDIWSAGCIF 156
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 114
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 129
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 115 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 174
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +  PE L   K +S   D+W+ G +  E+
Sbjct: 175 KWTAPESLAYNK-FSIKSDVWAFGVLLWEI 203

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 117
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 118 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAPAGAKF 175
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 176 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 206

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 3/157 (1%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           E +     REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 123
            A+ +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+  FG S++ ++  ++  
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPK 174
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T  Y  PE+LL  +      D+WS G     M+
Sbjct: 175 DTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 3/157 (1%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           E +     REI   + L+HPN++R  +VI     L +V E+                   
Sbjct: 56  EKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 115
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYT 123
            A+ +  QL+  + YCH+ ++ HRDLK +N L++ S A  LK+  FG S++ ++  ++  
Sbjct: 116 EARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKS-SVLHSQPK 174
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T  Y  PE+LL  +      D+WS G     M+
Sbjct: 175 STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVML 211

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 XSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           S+   EI+VLK++KH N++ L D+       +LV + +   +L D +    V      A 
Sbjct: 51  SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD-AS 109
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 125
             + Q+L A++Y H   I+HRDLKP+N+L     ++  + + DFGLS+   +  N     
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQNGIMST 166
Query: 126 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
              T  Y  PE+ L  K YS  VD WS G I
Sbjct: 167 ACGTPGYVAPEV-LAQKPYSKAVDCWSIGVI 196

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 118
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 119 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAPAGAKF 176
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 177 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 207

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 83/171 (48%), Gaps = 25/171 (14%)
Query: 8   VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTT 58
           + +   +EI+ LK  + HPN+++LH+V       FLV E L         +  K F +T 
Sbjct: 48  MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE 107
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAF 115
                   A   + +L+ A+ + H   ++HRDLKP+N+L    N +  +K+ DFG +R  
Sbjct: 108 --------ASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR-L 158
Query: 116 TIPMNR-YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI--QIP 163
             P N+       TL Y  PE LL    Y  + D+WS G I   M+  Q+P
Sbjct: 159 KPPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 49/125 (39%), Positives = 66/125 (52%), Gaps = 9/125 (7%)
Query: 40  LFLVFEFLRQDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNI 96
           L LVFE L  +L D L+ T    V   L + +  Q+  AL +  +    IIH DLKP+NI
Sbjct: 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 97  LIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC 154
           L+   K  A+K+ DFG S        R    + + +YR PE+LLG   Y   +D+WS GC
Sbjct: 191 LLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-YDLAIDMWSLGC 246
Query: 155 IFSEM 159
           I  EM
Sbjct: 247 ILVEM 251

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.5 bits (171), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 80/179 (44%), Gaps = 28/179 (15%)
Query: 10  STALREISVLKELKHPNVIRLH-------------DVIPVDFKLFLVFEFL-RQDLKDFL 55
           ST L E+ +L  L H  V+R +               +     LF+  E+   + L D +
Sbjct: 47  STILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLI 106
Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS--- 112
            +  +            Q+LEAL Y HS+ IIHR+LKP NI I++S  +K+ DFGL+   
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNV 166
Query: 113 -RAFTI----------PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            R+  I            +  T  + T  Y   E+L G   Y+  +D +S G IF E I
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 83/175 (47%), Gaps = 30/175 (17%)
Query: 12  ALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPP-ALAKS 69
           AL EI +L E   HPNVIR +     D  L++  E    +L+D +++  V      L K 
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKE 114
Query: 70  Y-----LYQLLEALRYCHSRRIIHRDLKPQNILINKS---------GALKL----ADFGL 111
           Y     L Q+   + + HS +IIHRDLKPQNIL++ S         GA  L    +DFGL
Sbjct: 115 YNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL 174
Query: 112 SRAFTIPMNRYTHEV----VTLWYRPPEILLGAKVYST------TVDIWSAGCIF 156
            +        +   +     T  +R PE+L  +    T      ++DI+S GC+F
Sbjct: 175 CKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 4/147 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLYQ 73
           E+ ++++ +H NV+ +++   V  +L++V EFL    L D +  T +      A      
Sbjct: 198 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA--VCLA 255
Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           +L+AL   H++ +IHRD+K  +IL+   G +KL+DFG     +  + R    V T ++  
Sbjct: 256 VLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMA 315
Query: 134 PEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PE L+    Y   VDIWS G +  EM+
Sbjct: 316 PE-LISRLPYGPEVDIWSLGIMVIEMV 341

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 1   SRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL   
Sbjct: 50  SRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK 109
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSRA 114
              +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+  
Sbjct: 110 E-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
               +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 169 IEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 6/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  +      
Sbjct: 62  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI 121
Query: 73  QLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLW 130
            +L  L Y   + +I+HRD+KP NIL+N  G +KL DFG+S      M N +   V T  
Sbjct: 122 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRS 178
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE L G   YS   DIWS G    E+
Sbjct: 179 YMAPERLQGTH-YSVQSDIWSMGLSLVEL 206

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 61  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 120
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 181 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 218

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 190 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 227

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 78/149 (52%), Gaps = 11/149 (7%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 204 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 261
Query: 74  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAF-TIPMNRYTHEVVTL 129
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+      + R      T 
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT- 320
Query: 130 WYRPPEIL--LGAKVYSTTVDIWSAGCIF 156
            Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 321 -YLAPEVLVSVGTAGYNRAVDCWSLGVIL 348

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 49/125 (39%), Positives = 66/125 (52%), Gaps = 9/125 (7%)
Query: 40  LFLVFEFLRQDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNI 96
           L LVFE L  +L D L+ T    V   L + +  Q+  AL +  +    IIH DLKP+NI
Sbjct: 112 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 171
Query: 97  LIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC 154
           L+   K  A+K+ DFG S        R    + + +YR PE+LLG   Y   +D+WS GC
Sbjct: 172 LLCNPKRSAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-YDLAIDMWSLGC 227
Query: 155 IFSEM 159
           I  EM
Sbjct: 228 ILVEM 232

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 80/150 (53%), Gaps = 4/150 (2%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 121
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTL 129
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T      +      +
Sbjct: 122 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 181
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +  PE L   K +S   D+W+ G +  E+
Sbjct: 182 KWTAPESLAYNK-FSIKSDVWAFGVLLWEI 210

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 72/152 (47%), Gaps = 7/152 (4%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLY 72
            E  ++     P V++L      D  L++V E++   DL + +      VP   AK Y  
Sbjct: 124 EERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTA 181
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWY 131
           +++ AL   HS  +IHRD+KP N+L++K G LKLADFG   +     M      V T  Y
Sbjct: 182 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY 241
Query: 132 RPPEILL---GAKVYSTTVDIWSAGCIFSEMI 160
             PE+L    G   Y    D WS G    EM+
Sbjct: 242 ISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 85/175 (48%), Gaps = 28/175 (16%)
Query: 13  LREISVLKELKHPNVIRLHD----------VIPVDFKLFLVFEFL---RQDLKDFL--QT 57
           +RE+  L +L+HP ++R  +          + P   K++L  +     +++LKD++  + 
Sbjct: 51  MREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC 110
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT- 116
           T      ++      Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A   
Sbjct: 111 TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 117 --------IPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                    PM    R+T +V T  Y  PE + G   YS  VDI+S G I  E++
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 1   SRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL   
Sbjct: 50  SRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK 109
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSRA 114
              +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+  
Sbjct: 110 E-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
               +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 169 IEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDINNIDXXKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 109
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 110 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 167
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE+   ++ YS+  D+WS G +  E+ 
Sbjct: 168 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEVF 198

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 50/148 (33%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           EI +LK+L HP +I++ +    +   ++V E +   +L D +      +  A  K Y YQ
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNK-RLKEATCKLYFYQ 247
Query: 74  LLEALRYCHSRRIIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
           +L A++Y H   IIHRDLKP+N+L++   +   +K+ DFG S+         T    T  
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL-CGTPT 306
Query: 131 YRPPEIL--LGAKVYSTTVDIWSAGCIF 156
           Y  PE+L  +G   Y+  VD WS G I 
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 1   SRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL   
Sbjct: 50  SRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK 109
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSRA 114
              +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+  
Sbjct: 110 E-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
               +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 169 IEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 1   SRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL   
Sbjct: 50  SRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK 109
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSRA 114
              +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+  
Sbjct: 110 E-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
               +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 169 IEDGVE-FKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 51/161 (31%), Positives = 82/161 (50%), Gaps = 9/161 (5%)
Query: 1   SRVQVEGVPSTAL-REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           SR    GV    + RE+S+L+++ H NVI LHDV      + L+ E +   +L DFL   
Sbjct: 50  SRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK 109
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG----ALKLADFGLSRA 114
              +    A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+  
Sbjct: 110 E-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
               +  + +   T  +  PEI +  +      D+WS G I
Sbjct: 169 IEDGV-EFKNIFGTPEFVAPEI-VNYEPLGLEADMWSIGVI 207

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARE---PPGLE 134
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 135 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 195 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 248

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 165
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE+   ++ YS+  D+WS G +  E+ 
Sbjct: 166 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEVF 196

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 53  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 112
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 113 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 170
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE+   ++ YS+  D+WS G +  E+ 
Sbjct: 171 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEVF 201

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 78/152 (51%), Gaps = 7/152 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 70  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 129
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 130 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 187
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE+   ++ YS+  D+WS G +  E+ 
Sbjct: 188 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEVF 218

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 49/125 (39%), Positives = 66/125 (52%), Gaps = 9/125 (7%)
Query: 40  LFLVFEFLRQDLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNI 96
           L LVFE L  +L D L+ T    V   L + +  Q+  AL +  +    IIH DLKP+NI
Sbjct: 131 LCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENI 190
Query: 97  LIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC 154
           L+   K  A+K+ DFG S        R    + + +YR PE+LLG   Y   +D+WS GC
Sbjct: 191 LLCNPKRXAIKIVDFGSSCQLG---QRIYQXIQSRFYRSPEVLLGMP-YDLAIDMWSLGC 246
Query: 155 IFSEM 159
           I  EM
Sbjct: 247 ILVEM 251

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 124
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 125 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 185 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 216

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 381
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 382 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 412

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 141
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 142 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 201
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 202 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 233

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   D+   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 53  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 110
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 111 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 170
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +    W  P  I  G   ++   D+WS G + +E++
Sbjct: 171 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 205

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 109
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +    W  P  I  G   ++   D+WS G + +E++
Sbjct: 170 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 204

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 76/149 (51%), Gaps = 4/149 (2%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYLY 72
           +EI+VL +     V + +       KL+++ E+L      D L+  P         + L 
Sbjct: 70  QEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFD--EFQIATMLK 127
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T ++ 
Sbjct: 128 EILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWM 187
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            PE++  +  Y +  DIWS G    E+ +
Sbjct: 188 APEVIQQS-AYDSKADIWSLGITAIELAK 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 78/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   D+   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 71  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 127
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 128 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 187
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 188 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 241

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 54  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 111
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 112 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 171
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +    W  P  I  G   ++   D+WS G + +E++
Sbjct: 172 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 206

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 134
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 135 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 195 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 248

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 111
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT    + + 
Sbjct: 112 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSRGSKFP 169
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             + PPE+L+ +K +S+  DIW+ G +  E+  +
Sbjct: 170 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 202

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 109
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYT 123
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREG 169
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +    W  P  I  G   ++   D+WS G + +E++
Sbjct: 170 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 204

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 61  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 118
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 119 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 178
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +    W  P  I  G   ++   D+WS G + +E++
Sbjct: 179 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 213

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 175
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 176 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 235
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 236 GLARDIHHIDYYKKTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFTL 289

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 67  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 123
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 124 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 183
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 184 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 237

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 58  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 115
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 116 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 175
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +    W  P  I  G   ++   D+WS G + +E++
Sbjct: 176 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 210

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 69.3 bits (168), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 60  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 117
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 118 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 177
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +    W  P  I  G   ++   D+WS G + +E++
Sbjct: 178 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 212

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 82/157 (52%), Gaps = 9/157 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           P   L E +++K+L+H  ++RL+ V+  +  ++++ E++    L DFL+T P  +   + 
Sbjct: 52  PDAFLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKT-PSGIKLTIN 109
Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           K      Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R         R  
Sbjct: 110 KLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREG 169
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +    W  P  I  G   ++   D+WS G + +E++
Sbjct: 170 AKFPIKWTAPEAINYG--TFTIKSDVWSFGILLTEIV 204

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 82/152 (53%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+        A+   Y+
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYM 362
Query: 72  Y-QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR  T   + YT      +
Sbjct: 363 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKF 420
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              +  PE L   K +S   D+W+ G +  E+
Sbjct: 421 PIKWTAPESLAYNK-FSIKSDVWAFGVLLWEI 451

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 151
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 152 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 211
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 212 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 243

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 189 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 226

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 70  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 126
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 127 YSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 186
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 187 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 240

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 70  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 129
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 189
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 190 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 227

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 183 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 220

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 74  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 130
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 131 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 190
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 191 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 244

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 77/151 (50%), Gaps = 6/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVTL 129
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR    +        ++   
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W  P  I    + +++  D+W  G    E++
Sbjct: 178 WMAPESINF--RRFTSASDVWMFGVCMWEIL 206

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAK--- 68
           L E +VLK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 69  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                               S+ +Q+ + ++Y    +++HRDL  +NIL+ +   +K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 109 FGLSRAF---TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           FGLSR        + R    +   W     +     +Y+T  D+WS G +  E++ +
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 69  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 128
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 189 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 226

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 77  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 133
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 134 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 193
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 194 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 247

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 135
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 196 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 233

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 82/159 (51%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT-------TPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L++        PV  PP
Sbjct: 66  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 125
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 126 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 185
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 186 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 223

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 72  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 128
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 129 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADF 188
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 189 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 242

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 98  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 157
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 217
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 218 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 255

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 81/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 67  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 126
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 187 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 224

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 187
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 188 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 248 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 301

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 88/176 (50%), Gaps = 28/176 (15%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 110 GLSRAFTIPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R     ++ Y   T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDIN-NIDYYKNTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 82/159 (51%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQT-------TPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L++        PV  PP
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R    T    
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 196 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 233

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 87  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 145
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 146 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 204
Query: 130 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            W  P  I    + +++  D+W  G    E++
Sbjct: 205 KWMAPESINF--RRFTSASDVWMFGVCMWEIL 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 181
Query: 130 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            W  P  I    + +++  D+W  G    E++
Sbjct: 182 KWMAPESINF--RRFTSASDVWMFGVCMWEIL 211

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 55  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 113
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTL 129
             +LEA+   H   I+H DLKP N LI   G LKL DFG++            +  V T+
Sbjct: 114 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 172
Query: 130 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEM 159
            Y PPE +                S   D+WS GCI   M
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 212

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 59  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 117
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTL 129
             +LEA+   H   I+H DLKP N LI   G LKL DFG++            +  V T+
Sbjct: 118 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 176
Query: 130 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEM 159
            Y PPE +                S   D+WS GCI   M
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 216

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 133
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTL 129
             +LEA+   H   I+H DLKP N LI   G LKL DFG++            +  V T+
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 192
Query: 130 WYRPPEILLGAK----------VYSTTVDIWSAGCIFSEM 159
            Y PPE +                S   D+WS GCI   M
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYA 117
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 118 YQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 176
Query: 130 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            W  P  I    + +++  D+W  G    E++
Sbjct: 177 KWMAPESI--NFRRFTSASDVWMFGVCMWEIL 206

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAK--- 68
           L E +VLK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 69  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                               S+ +Q+ + ++Y    +++HRDL  +NIL+ +   +K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193
Query: 109 FGLSRAFTIP---MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           FGLSR        + R    +   W     +     +Y+T  D+WS G +  E++ +
Sbjct: 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 56  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 114
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTL 129
             +LEA+   H   I+H DLKP N LI   G LKL DFG++            +  V T+
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
Query: 130 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEM 159
            Y PPE +                S   D+WS GCI   M
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 213

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 61  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 119
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 120 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 178
Query: 130 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            W  P  I    + +++  D+W  G    E++
Sbjct: 179 KWMAPESINF--RRFTSASDVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 62  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 120
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 121 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 179
Query: 130 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            W  P  I    + +++  D+W  G    E++
Sbjct: 180 KWMAPESINF--RRFTSASDVWMFGVCMWEIL 209

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 72/153 (47%), Gaps = 7/153 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+       +V E++    L  FL+T             L
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   +RY      +HRDL  +N+L++ +   K++DFGLSR     P   YT    ++ 
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +S+  D+WS G +  E++
Sbjct: 218 IRWTAPEAIAF--RTFSSASDVWSFGVVMWEVL 248

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/154 (24%), Positives = 82/154 (53%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
            +E   + +L HP +++ + V   ++ +++V E++    L ++L++    + P+      
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           Y + E + +  S + IHRDL  +N L+++   +K++DFG++R   +  ++Y   V T + 
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTR--YVLDDQYVSSVGTKFP 168
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             +  PE+    K YS+  D+W+ G +  E+  +
Sbjct: 169 VKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSL 201

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 80/154 (51%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  +  T  V + + 
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEETSSVGSKFP 184
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
             + PPE+L+ +K +S+  DIW+ G +  E+  +
Sbjct: 185 VRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSL 217

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 134
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            S+                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 135 FSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 195 GLARDIHHIDXXKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 248

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPP 64
           + V    L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL 110
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           A    Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y  
Sbjct: 111 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKA 169
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               L   W  P  I    + +++  D+W  G    E++
Sbjct: 170 SKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 8/152 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  A    Y 
Sbjct: 56  LQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 114
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y      L  
Sbjct: 115 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPI 173
Query: 130 -WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            W  P  I    + +++  D+W  G    E++
Sbjct: 174 KWMAPESINF--RRFTSASDVWMFGVCMWEIL 203

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPP 64
           + V    L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  
Sbjct: 52  DSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL 110
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           A    Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y  
Sbjct: 111 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKA 169
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               L   W  P  I    + +++  D+W  G    E++
Sbjct: 170 SKGKLPIKWMAPESI--NFRRFTSASDVWMFGVCMWEIL 206

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTL 129
             +LEA+   H   I+H DLKP N LI   G LKL DFG++            +  V T+
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 130 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEM 159
            Y PPE +                S   D+WS GCI   M
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 260

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGL+R     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTL 129
             +LEA+   H   I+H DLKP N LI   G LKL DFG++            +  V T+
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 220
Query: 130 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEM 159
            Y PPE +                S   D+WS GCI   M
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 260

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPP 64
           + V    L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDL 490
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           A    Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y  
Sbjct: 491 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKA 549
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               L   W  P  I    + +++  D+W  G    E++
Sbjct: 550 SKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEIL 586

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 8/159 (5%)
Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPP 64
           + V    L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  
Sbjct: 432 DSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDL 490
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           A    Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR +      Y  
Sbjct: 491 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKA 549
Query: 125 EVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               L   W  P  I    + +++  D+W  G    E++
Sbjct: 550 SKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEIL 586

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 75  NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 133
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTL 129
             +LEA+   H   I+H DLKP N LI   G LKL DFG++            +  V T+
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTV 192
Query: 130 WYRPPEILLGAK----------VYSTTVDIWSAGCIFSEM 159
            Y PPE +                S   D+WS GCI   M
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 232

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 15/155 (9%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ----DLKDFLQTTPVPVPPALAK 68
           L+EI  + +  HPN++  +    V  +L+LV + L      D+   +          L +
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120
Query: 69  SY----LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           S     L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S AF       T 
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITR 179
Query: 125 E------VVTLWYRPPEILLGAKVYSTTVDIWSAG 153
                  V T  +  PE++   + Y    DIWS G
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 86/175 (49%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +++ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADF 201
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 75/161 (46%), Gaps = 15/161 (9%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ----DLKDFLQTTPVPVPPALAK 68
           L+EI  + +  HPN++  +    V  +L+LV + L      D+   +          L +
Sbjct: 56  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 115
Query: 69  SY----LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           S     L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S AF       T 
Sbjct: 116 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVS-AFLATGGDITR 174
Query: 125 E------VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                  V T  +  PE++   + Y    DIWS G    E+
Sbjct: 175 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIEL 215

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGL R     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 78/186 (41%), Gaps = 47/186 (25%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-----------------LKDFLQT 57
           E+ ++K+L HPN+ RL++V   +  + LV E                        D ++T
Sbjct: 78  EVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKT 137
Query: 58  TPVPVPPA-----------------------LAKSYLYQLLEALRYCHSRRIIHRDLKPQ 94
              P P                         L  + + Q+  AL Y H++ I HRD+KP+
Sbjct: 138 QICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197
Query: 95  NILI--NKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEIL-LGAKVYSTTV 147
           N L   NKS  +KL DFGLS+ F    N      T +  T ++  PE+L    + Y    
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 148 DIWSAG 153
           D WSAG
Sbjct: 258 DAWSAG 263

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 81/177 (45%), Gaps = 29/177 (16%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAK--- 68
           L E +VLK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133
Query: 69  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                               S+ +Q+ + ++Y     ++HRDL  +NIL+ +   +K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISD 193
Query: 109 FGLSRAF---TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           FGLSR        + R    +   W     +     +Y+T  D+WS G +  E++ +
Sbjct: 194 FGLSRDVYEEDSXVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVTL 248

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E +    L  FL+              L
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 124
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 125 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 184
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 185 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E +    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 85/174 (48%), Gaps = 27/174 (15%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDL--------- 51
            ++ ++        E+ ++ ++K+   +    +I    ++++++E++  D          
Sbjct: 79  DKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFF 138
Query: 52  ---KDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLA 107
              K++    P+ V   + KS    +L +  Y H+ + I HRD+KP NIL++K+G +KL+
Sbjct: 139 VLDKNYTCFIPIQVIKCIIKS----VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLS 194
Query: 108 DFGLSRAFT---IPMNRYTHEVVTLWYRPPEILLGAKVYS-TTVDIWSAG-CIF 156
           DFG S       I  +R T+E +     PPE       Y+   VDIWS G C++
Sbjct: 195 DFGESEYMVDKKIKGSRGTYEFM-----PPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 6/154 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L+E  +LK+  HPN++RL  V      +++V E ++  D   FL+T    +        +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT---HEVVT 128
                 + Y  S+  IHRDL  +N L+ +   LK++DFG+SR     +   +    +V  
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPV 279
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            W  P  +  G   YS+  D+WS G +  E   +
Sbjct: 280 KWTAPEALNYGR--YSSESDVWSFGILLWETFSL 311

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 79/154 (51%), Gaps = 5/154 (3%)
Query: 11  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKS 69
              +E+ +++ L+HP ++ L      +  +F+V + L   DL+  LQ   V       K 
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKL 119
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           ++ +L+ AL Y  ++RIIHRD+KP NIL+++ G + + DF ++ A      + T    T 
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA-AMLPRETQITTMAGTK 178
Query: 130 WYRPPEILLGAK--VYSTTVDIWSAGCIFSEMIQ 161
            Y  PE+    K   YS  VD WS G    E+++
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/166 (33%), Positives = 79/166 (47%), Gaps = 27/166 (16%)
Query: 10  STALREISVLKEL-KHPNVIRLH--------DVIPVDFKLFLVFEFLRQDLKDFLQTTPV 60
           S A RE+ +L+E  +HPNVIR            I ++     + E++ Q  KDF      
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQ--KDFAHLGLE 119
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALK--LADFGLSRAF 115
           P+      + L Q    L + HS  I+HRDLKP NILI   N  G +K  ++DFGL +  
Sbjct: 120 PI------TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173
Query: 116 TIPMNRYTHEV----VTLWYRPPEILLGAKVYST-TVDIWSAGCIF 156
            +  + ++          W  P  +    K   T TVDI+SAGC+F
Sbjct: 174 AVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 13/159 (8%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL-------QTTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L       +  PV  PP
Sbjct: 63  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPP 122
Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMN 120
           +L+K      ++ + + Y ++ + +HRDL  +N  + +   +K+ DFG++R    T    
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +    ++ + +  PE L    V++T  D+WS G +  E+
Sbjct: 183 KGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEI 220

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 78  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 134
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
             Y                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 135 YCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 195 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 248

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/154 (28%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E +    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 214 IRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMS 245

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 16/161 (9%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPV-------PP 64
           RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+   P  V       P 
Sbjct: 64  REAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPT 123
Query: 65  ALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFTIPM 119
            L +S +     Q+   + Y  S+  +HRDL  +N L+ ++  +K+ DFG+SR  ++   
Sbjct: 124 ELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY 183
Query: 120 NRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            R   H ++ + + PPE ++  K ++T  D+WS G +  E+
Sbjct: 184 YRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEI 223

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 84/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ      PP L 
Sbjct: 63  SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLE 119
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
             Y                   YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADF
Sbjct: 120 YCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 179
Query: 110 GLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   ++Y+   D+WS G +  E+  +
Sbjct: 180 GLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTL 233

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 6/154 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L+E  +LK+  HPN++RL  V      +++V E ++  D   FL+T    +        +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA---FTIPMNRYTHEVVT 128
                 + Y  S+  IHRDL  +N L+ +   LK++DFG+SR         +    +V  
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPV 279
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            W  P  +  G   YS+  D+WS G +  E   +
Sbjct: 280 KWTAPEALNYGR--YSSESDVWSFGILLWETFSL 311

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 72/156 (46%), Gaps = 11/156 (7%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E S++ + +HPN+IRL  V+     + ++ EF+    L  FL+              L
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 124
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
             +   +RY      +HRDL  +NIL+N +   K++DFGLSR F    +    E  +L  
Sbjct: 125 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSR-FLEENSSDPTETSSLGG 183
Query: 130 -----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                W  P  I    + +++  D WS G +  E++
Sbjct: 184 KIPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVM 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E S++ + +HPN+IRL  V+     + ++ EF+    L  FL+              L
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGML 122
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------E 125
             +   +RY      +HRDL  +NIL+N +   K++DFGLSR      +  T+      +
Sbjct: 123 RGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +   W  P  I    + +++  D WS G +  E++
Sbjct: 183 IPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVM 215

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/164 (28%), Positives = 81/164 (49%), Gaps = 19/164 (11%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------VPVPPAL 66
           RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+         V   P  
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125
Query: 67  AKSYL---------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR-AFT 116
           AK  L          Q+   + Y  S+  +HRDL  +N L+  +  +K+ DFG+SR  ++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
Query: 117 IPMNRY-THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               R   H ++ + + PPE ++  K ++T  D+WS G I  E+
Sbjct: 186 TDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEI 228

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 78/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.6 bits (161), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+I L  V+     + +V E++    L  FL+              L
Sbjct: 71  LGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGML 130
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NILIN +   K++DFGLSR     P   YT    ++ 
Sbjct: 131 RGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIP 190
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +++  D+WS G +  E++
Sbjct: 191 IRWTAPEAIAF--RKFTSASDVWSYGIVMWEVV 221

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++  +  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTL 255

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFL-RQDLKDFLQTTPV 60
           ++ +      L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++   
Sbjct: 52  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 111
Query: 61  PV--PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V     L K  L  + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +  
Sbjct: 112 SVLGGDCLLKFSL-DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +  T ++   W  P    L  K +ST  D+WS G +  E+
Sbjct: 171 QD--TGKLPVKWTAPEA--LREKKFSTKSDVWSFGILLWEI 207

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/175 (26%), Positives = 85/175 (48%), Gaps = 26/175 (14%)
Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           S  + E+ ++K + KH N+I L      D  L+++  +  + +L+++L+      PP + 
Sbjct: 85  SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRAR---RPPGME 141
Query: 68  KSY------------------LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADF 109
            SY                   YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADF
Sbjct: 142 YSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 110 GLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           GL+R         + T+  + + +  PE L   +VY+   D+WS G +  E+  +
Sbjct: 202 GLARDINNIDYYKKTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFTL 255

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 30/181 (16%)
Query: 4   QVEGVPSTALREISVLKEL--KHPN----VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT 57
            VE     A  EI+VL+++  K P+     +++ D       + + FE L     DFL+ 
Sbjct: 69  NVEKYKEAARLEINVLEKINEKDPDNKNLCVQMFDWFDYHGHMCISFELLGLSTFDFLKD 128
Query: 58  TP-VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-IN---------------- 99
              +P P    +   +QL +A+++ H  ++ H DLKP+NIL +N                
Sbjct: 129 NNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSDYELTYNLEKKRDER 188
Query: 100 --KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS 157
             KS A+++ DFG   + T     ++  V T  YR PE++L    +S   D+WS GCI  
Sbjct: 189 SVKSTAVRVVDFG---SATFDHEHHSTIVSTRHYRAPEVILELG-WSQPCDVWSIGCIIF 244
Query: 158 E 158
           E
Sbjct: 245 E 245

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 77/152 (50%), Gaps = 7/152 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      + LV EF+    L D+L+T              
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R F +  ++YT    T + 
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLD-DQYTSSTGTKFP 168
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE+   ++ YS+  D+WS G +  E+ 
Sbjct: 169 VKWASPEVFSFSR-YSSKSDVWSFGVLMWEVF 199

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           +RE  ++ +L +P ++RL  V   +  L LV E      L  FL      +P +     L
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT      W 
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE  +  + +S+  D+WS G    E +
Sbjct: 177 LKWYAPEC-INFRKFSSRSDVWSYGVTMWEAL 207

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFL-RQDLKDFLQTTPV 60
           ++ +      L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++   
Sbjct: 224 IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 283
Query: 61  PV--PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V     L K  L  + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +  
Sbjct: 284 SVLGGDCLLKFSL-DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +  T ++   W  P    L  K +ST  D+WS G +  E+
Sbjct: 343 QD--TGKLPVKWTAPE--ALREKKFSTKSDVWSFGILLWEI 379

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 7/153 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+       +V E++    L  FL+T             L
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF----TIPMNRYTHEVV 127
             +   +RY      +HRDL  +N+L++ +   K++DFGLSR               ++ 
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +S+  D+WS G +  E++
Sbjct: 218 IRWTAPEAIAF--RTFSSASDVWSFGVVMWEVL 248

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 51/160 (31%), Positives = 71/160 (44%), Gaps = 16/160 (10%)
Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            EI+ L +L+     +IRL+D    D  +++V E    DL  +L+     + P   KSY 
Sbjct: 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYW 161
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTL 129
             +LEA+   H   I+H DLKP N LI   G LKL DFG++            +  V  +
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
Query: 130 WYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEM 159
            Y PPE +                S   D+WS GCI   M
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYM 260

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 84/161 (52%), Gaps = 9/161 (5%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFL-RQDLKDFLQTTPV 60
           ++ +      L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++   
Sbjct: 37  IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR 96
Query: 61  PV--PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V     L K  L  + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +  
Sbjct: 97  SVLGGDCLLKFSL-DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155
Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +  T ++   W  P    L  K +ST  D+WS G +  E+
Sbjct: 156 QD--TGKLPVKWTAPEA--LREKKFSTKSDVWSFGILLWEI 192

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 81/151 (53%), Gaps = 9/151 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVD-FKLFLVFEFL-RQDLKDFLQTTPVPV--PPALAK 68
           L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++    V     L K
Sbjct: 53  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 112
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
             L  + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +  T ++  
Sbjct: 113 FSL-DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPV 169
Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            W  P  +   A  +ST  D+WS G +  E+
Sbjct: 170 KWTAPEALREAA--FSTKSDVWSFGILLWEI 198

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKD-FLQTTPVPVPPALAKSYL 71
           L E S++ +  HPNV+ L  V+     + +V EF+     D FL+              L
Sbjct: 92  LCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGML 151
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   +RY      +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++ 
Sbjct: 152 RGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIP 211
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +++  D+WS G +  E++
Sbjct: 212 VRWTAPEAIQY--RKFTSASDVWSYGIVMWEVM 242

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 9/155 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPNVI L  V+     + ++ EF+    L  FL+              L
Sbjct: 82  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 141
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------E 125
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+      +
Sbjct: 142 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 201
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +   W  P  I    + +++  D+WS G +  E++
Sbjct: 202 IPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVM 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFGL++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLK-DFLQTTPVPVPPALA 67
           + AL E  +L+++    V+ L         L LV   +   DLK           P A A
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-THEV 126
             Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  +P  +     V
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRV 346
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            T+ Y  PE++   + Y+ + D W+ GC+  EMI
Sbjct: 347 GTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI 379

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 6/154 (3%)
Query: 10  STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLK-DFLQTTPVPVPPALA 67
           + AL E  +L+++    V+ L         L LV   +   DLK           P A A
Sbjct: 229 AMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARA 288
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-THEV 126
             Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL  A  +P  +     V
Sbjct: 289 VFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGL--AVHVPEGQTIKGRV 346
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            T+ Y  PE++   + Y+ + D W+ GC+  EMI
Sbjct: 347 GTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI 379

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 5/145 (3%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
            EISV+ +L H N+I+L+D       + LV E++   +L D +      +       ++ 
Sbjct: 135 NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK 194
Query: 73  QLLEALRYCHSRRIIHRDLKPQNIL-INKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLW 130
           Q+ E +R+ H   I+H DLKP+NIL +N+    +K+ DFGL+R +  P  +      T  
Sbjct: 195 QICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTPE 253
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCI 155
           +  PE+ +     S   D+WS G I
Sbjct: 254 FLAPEV-VNYDFVSFPTDMWSVGVI 277

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  ++
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           + AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y  P
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L     Y   VD W  G +  EM+
Sbjct: 175 EVLEDND-YGRAVDWWGLGVVMYEMM 199

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  ++
Sbjct: 60  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 119
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           + AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y  P
Sbjct: 120 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 179
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L     Y   VD W  G +  EM+
Sbjct: 180 EVLEDND-YGRAVDWWGLGVVMYEMM 204

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  ++
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           + AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y  P
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L     Y   VD W  G +  EM+
Sbjct: 175 EVLEDND-YGRAVDWWGLGVVMYEMM 199

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  ++
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           + AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y  P
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAP 174
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L     Y   VD W  G +  EM+
Sbjct: 175 EVLEDND-YGRAVDWWGLGVVMYEMM 199

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  ++
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           + AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y  P
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L     Y   VD W  G +  EM+
Sbjct: 175 EVLEDND-YGRAVDWWGLGVVMYEMM 199

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  ++
Sbjct: 58  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 117
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           + AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y  P
Sbjct: 118 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 177
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L     Y   VD W  G +  EM+
Sbjct: 178 EVLEDND-YGRAVDWWGLGVVMYEMM 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/146 (28%), Positives = 66/146 (45%), Gaps = 1/146 (0%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E  VL+  +HP +  L        +L  V E+       F  +         A+ Y  ++
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 114
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP 134
           + AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y  P
Sbjct: 115 VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAP 174
Query: 135 EILLGAKVYSTTVDIWSAGCIFSEMI 160
           E+L     Y   VD W  G +  EM+
Sbjct: 175 EVLEDND-YGRAVDWWGLGVVMYEMM 199

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/93 (38%), Positives = 54/93 (58%), Gaps = 4/93 (4%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
           A+ Y  Q++    Y HS  +I+RDLKP+N+LI++ G +K+ADFG ++       R     
Sbjct: 144 ARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK---GRTWXLC 200
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            T  Y  PEI+L +K Y+  VD W+ G +  EM
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 168
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 225
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEM 252

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 15  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKS-- 69
           E+ VL +L H PN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 75  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 134
Query: 70  ------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
                       +   +   + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   +
Sbjct: 135 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            + +    +   W       L   VY+T  D+WS G +  E++ +
Sbjct: 195 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 237

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 15  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKS-- 69
           E+ VL +L H PN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 65  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 124
Query: 70  ------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
                       +   +   + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR   +
Sbjct: 125 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 184
Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            + +    +   W       L   VY+T  D+WS G +  E++ +
Sbjct: 185 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 227

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLAGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 17/159 (10%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYLY 72
           +E  +   LKHPN+I L  V   +  L LV EF R   L   L      +PP +  ++  
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAV 112
Query: 73  QLLEALRYCHSRR---IIHRDLKPQNILINK--------SGALKLADFGLSRAFTIPMNR 121
           Q+   + Y H      IIHRDLK  NILI +        +  LK+ DFGL+R +     +
Sbjct: 113 QIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTK 171
Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +      W  P   ++ A ++S   D+WS G +  E++
Sbjct: 172 MSAAGAYAWMAPE--VIRASMFSKGSDVWSYGVLLWELL 208

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 72/141 (51%), Gaps = 4/141 (2%)
Query: 15  EISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           EI++L  ++H N+I++ D+      F+L +       DL  F+   P    P LA     
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP-LASYIFR 137
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           QL+ A+ Y   + IIHRD+K +NI+I +   +KL DFG S A+      +     T+ Y 
Sbjct: 138 QLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG-SAAYLERGKLFYTFCGTIEYC 196
Query: 133 PPEILLGAKVYSTTVDIWSAG 153
            PE+L+G       +++WS G
Sbjct: 197 APEVLMGNPYRGPELEMWSLG 217

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 6/149 (4%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
            L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y
Sbjct: 81  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFY 139
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  
Sbjct: 140 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPE 196
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PEI+L +K Y+  VD W+ G +  EM
Sbjct: 197 YLAPEIIL-SKGYNKAVDWWALGVLIYEM 224

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 6/149 (4%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
            L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y
Sbjct: 83  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPH-ARFY 141
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  
Sbjct: 142 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPE 198
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PEI+L +K Y+  VD W+ G +  EM
Sbjct: 199 YLAPEIIL-SKGYNKAVDWWALGVLIYEM 226

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 1/91 (1%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE+LLG + Y  +VD ++ G    EMI
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMI 383

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 65
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 282 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 338
Query: 126 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                   W  P   L G   ++   D+WS G + +E+
Sbjct: 339 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 374

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 65
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 282 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 338
Query: 126 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                   W  P   L G   ++   D+WS G + +E+
Sbjct: 339 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 374

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 1/91 (1%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE+LLG + Y  +VD ++ G    EMI
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMI 383

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 1/91 (1%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE+LLG + Y  +VD ++ G    EMI
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMI 383

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 65
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 282 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 338
Query: 126 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                   W  P   L G   ++   D+WS G + +E+
Sbjct: 339 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 374

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 63/138 (45%), Gaps = 1/138 (0%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
            HP + +L        +LF V EF+      F          A A+ Y  +++ AL + H
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 83  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
            + II+RDLK  N+L++  G  KLADFG+ +              T  Y  PEIL    +
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQ-EML 200
Query: 143 YSTTVDIWSAGCIFSEMI 160
           Y   VD W+ G +  EM+
Sbjct: 201 YGPAVDWWAMGVLLYEML 218

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 168
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 225
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 226 LAPEIIL-SKGYNKAVDWWALGVLIYEM 252

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 6/149 (4%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
            L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y
Sbjct: 81  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFY 139
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  
Sbjct: 140 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPE 196
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PEI+L +K Y+  VD W+ G +  EM
Sbjct: 197 YLAPEIIL-SKGYNKAVDWWALGVLIYEM 224

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 79/158 (50%), Gaps = 13/158 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 65
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 50  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 108
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 109 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 165
Query: 126 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                   W  P   L G   ++   D+WS G + +E+
Sbjct: 166 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 201

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLXGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 13  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 64
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 122
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 123
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 123 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 124 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             H  V   +  PE  L  + +S   D W  G    EM 
Sbjct: 181 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMF 218

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +++ DFGL++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 6/149 (4%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
            L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y
Sbjct: 75  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFY 133
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  
Sbjct: 134 AAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK---GRTWXLCGTPE 190
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PEI+L +K Y+  VD W+ G +  EM
Sbjct: 191 YLAPEIIL-SKGYNKAVDWWALGVLIYEM 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/149 (29%), Positives = 77/149 (51%), Gaps = 6/149 (4%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
            L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y
Sbjct: 74  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFY 132
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  
Sbjct: 133 AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPE 189
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PEI+L +K Y+  VD W+ G +  EM
Sbjct: 190 YLAPEIIL-SKGYNKAVDWWALGVLIYEM 217

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 13  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 64
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 112
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 123
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 113 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 124 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             H  V   +  PE  L  + +S   D W  G    EM 
Sbjct: 171 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMF 208

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 71/158 (44%), Gaps = 20/158 (12%)
Query: 13  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 64
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 116
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 123
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 117 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 124 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             H  V   +  PE  L  + +S   D W  G    EM
Sbjct: 175 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEM 211

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 13  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 64
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 116
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 123
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 117 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 124 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             H  V   +  PE  L  + +S   D W  G    EM 
Sbjct: 175 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMF 212

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWTLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 81/159 (50%), Gaps = 15/159 (9%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 64
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
            +  S   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT 
Sbjct: 113 LVDMSA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTA 168
Query: 125 EVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                    W  P   L G   ++   D+WS G + +E+
Sbjct: 169 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 205

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 71/159 (44%), Gaps = 20/159 (12%)
Query: 13  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 64
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 112
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT- 123
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  
Sbjct: 113 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 124 --HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             H  V   +  PE  L  + +S   D W  G    EM 
Sbjct: 171 QEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMF 208

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------------V 60
           RE  +L  L+H +++R   V      L +VFE++R  DL  FL++               
Sbjct: 63  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 122
Query: 61  PVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTI 117
           P P  L +  +   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++ 
Sbjct: 123 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 182
Query: 118 PMNRYTHE-VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              R     ++ + + PPE +L  K ++T  D+WS G +  E+ 
Sbjct: 183 DYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIF 225

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 18/164 (10%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------------V 60
           RE  +L  L+H +++R   V      L +VFE++R  DL  FL++               
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 151
Query: 61  PVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTI 117
           P P  L +  +   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++ 
Sbjct: 152 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 118 PMNRYTHE-VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              R     ++ + + PPE +L  K ++T  D+WS G +  E+ 
Sbjct: 212 DYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIF 254

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/152 (29%), Positives = 78/152 (51%), Gaps = 14/152 (9%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 110 LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 168
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      TL  
Sbjct: 169 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGATWTLCG 221
Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              Y  PEI+L +K Y+  VD W+ G +  EM
Sbjct: 222 TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEM 252

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 67/134 (50%), Gaps = 12/134 (8%)
Query: 35  PVDFKLFLVFEFLRQDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLK 92
           P    + +VFE L ++L   ++      +P    K    QLL  L Y H R  IIH D+K
Sbjct: 100 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159
Query: 93  PQNILINKSGA------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT 146
           P+N+L+    +      +K+AD G +  +      YT+ + T  YR PE+LLGA  +   
Sbjct: 160 PENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAP-WGCG 215
Query: 147 VDIWSAGCIFSEMI 160
            DIWS  C+  E+I
Sbjct: 216 ADIWSTACLIFELI 229

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 67/134 (50%), Gaps = 12/134 (8%)
Query: 35  PVDFKLFLVFEFLRQDLKDFLQT-TPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLK 92
           P    + +VFE L ++L   ++      +P    K    QLL  L Y H R  IIH D+K
Sbjct: 100 PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159
Query: 93  PQNILINKSGA------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT 146
           P+N+L+    +      +K+AD G +  +      YT+ + T  YR PE+LLGA  +   
Sbjct: 160 PENVLMEIVDSPENLIQIKIADLGNACWYD---EHYTNSIQTREYRSPEVLLGAP-WGCG 215
Query: 147 VDIWSAGCIFSEMI 160
            DIWS  C+  E+I
Sbjct: 216 ADIWSTACLIFELI 229

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 45/163 (27%), Positives = 78/163 (47%), Gaps = 18/163 (11%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------------V 60
           RE  +L  L+H +++R   V      L +VFE++R  DL  FL++               
Sbjct: 69  REAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVA 128
Query: 61  PVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTI 117
           P P  L +  +   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR  ++ 
Sbjct: 129 PGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 188
Query: 118 PMNRYTHE-VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
              R     ++ + + PPE +L  K ++T  D+WS G +  E+
Sbjct: 189 DYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEI 230

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 65
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL  +T      P 
Sbjct: 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQ 364
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT  
Sbjct: 365 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEYTAR 421
Query: 126 VVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                   W  P   L G   ++   D+WS G + +E+ 
Sbjct: 422 QGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELT 458

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 6/152 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           +RE  ++ +L +P ++RL  V   +  L LV E      L  FL      +P +     L
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y   +  +HR+L  +N+L+      K++DFGLS+A     + YT      W 
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE  +  + +S+  D+WS G    E +
Sbjct: 503 LKWYAPEC-INFRKFSSRSDVWSYGVTMWEAL 533

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 41/131 (31%), Positives = 57/131 (43%), Gaps = 3/131 (2%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH 82
           +HP  +RL         L+L  E     L+   +     +P A    YL   L AL + H
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 83  SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV 142
           S+ ++H D+KP NI +   G  KL DFGL             E     Y  PE+L G+  
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQGS-- 231
Query: 143 YSTTVDIWSAG 153
           Y T  D++S G
Sbjct: 232 YGTAADVFSLG 242

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 76
           +L+  +HPN+I L DV      ++LV E +R  +L D +           A   L+ + +
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGK 132
Query: 77  ALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
            + Y HS+ ++HRDLKP NIL +++SG    L++ DFG ++              T  + 
Sbjct: 133 TVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE+ L  + Y    DIWS G +   M+
Sbjct: 193 APEV-LKRQGYDEGCDIWSLGILLYTML 219

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 6/140 (4%)
Query: 27  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 85
           +  LH     D  L+LV ++ +  DL   L      +P  +A+ YL +++ A+   H   
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 86  IIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVVTLWYRPPEILL----GA 140
            +HRD+KP NIL++ +G ++LADFG   +       + +  V T  Y  PEIL     G 
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255
Query: 141 KVYSTTVDIWSAGCIFSEMI 160
             Y    D WS G    EM+
Sbjct: 256 GRYGPECDWWSLGVCMYEML 275

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 7/148 (4%)
Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 76
           +L+  +HPN+I L DV      ++LV E +R  +L D +           A   L+ + +
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGK 132
Query: 77  ALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
            + Y HS+ ++HRDLKP NIL +++SG    L++ DFG ++              T  + 
Sbjct: 133 TVEYLHSQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE+ L  + Y    DIWS G +   M+
Sbjct: 193 APEV-LKRQGYDEGCDIWSLGILLYTML 219

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P + +L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+I L  V+     + ++ E++    L  FL+              L
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 137
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT    ++ 
Sbjct: 138 RGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 197
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +++  D+WS G +  E++
Sbjct: 198 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVM 228

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+I L  V+     + ++ E++    L  FL+              L
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 116
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT    ++ 
Sbjct: 117 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 176
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             W  P  I    + +++  D+WS G +  E++ 
Sbjct: 177 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 208

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P + +L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+I L  V+     + ++ E++    L  FL+              L
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGML 122
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y      +HRDL  +NIL+N +   K++DFG+SR     P   YT    ++ 
Sbjct: 123 RGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIP 182
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +++  D+WS G +  E++
Sbjct: 183 IRWTAPEAIAY--RKFTSASDVWSYGIVMWEVM 213

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Composition-based stats.
 Identities = 31/91 (34%), Positives = 51/91 (56%), Gaps = 1/91 (1%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +      T 
Sbjct: 294 YTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE+LLG + Y  +VD ++ G    EMI
Sbjct: 354 GFMAPELLLGEE-YDFSVDYFALGVTLYEMI 383

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P + +L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 90  LNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 148
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +K+ DFG ++       R      T  Y
Sbjct: 149 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK---GRTWXLCGTPEY 205
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 206 LAPEIIL-SKGYNKAVDWWALGVLIYEM 232

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E+     L  P ++ L+  +     + +  E L       L      +P   A  YL Q 
Sbjct: 116 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 175
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           LE L Y HSRRI+H D+K  N+L++  G+   L DFG   A  +  +    +++T  Y P
Sbjct: 176 LEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQPDGLGKDLLTGDYIP 233
Query: 134 -------PEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
                  PE++LG +     VD+WS+ C+   M+ 
Sbjct: 234 GTETHMAPEVVLG-RSCDAKVDVWSSCCMMLHMLN 267

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 116 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 169
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 170 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 208

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E+    ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI+L +K Y+  VD W+ G +  +M
Sbjct: 205 LAPEIIL-SKGYNKAVDWWALGVLIYQM 231

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 7/153 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E  ++ +  H N+IRL  VI     + ++ E++    L  FL+              L
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-TIPMNRYT---HEVV 127
             +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR     P   YT    ++ 
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W  P  I    + +++  D+WS G +  E++
Sbjct: 214 IRWTAPEAI--SYRKFTSASDVWSFGIVMWEVM 244

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 15  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV-PVPPALAKS-- 69
           E+ VL +L H PN+I L         L+L  E+    +L DFL+ + V    PA A +  
Sbjct: 72  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 131
Query: 70  ------------YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
                       +   +   + Y   ++ IHR+L  +NIL+ ++   K+ADFGLSR   +
Sbjct: 132 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEV 191
Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            + +    +   W       L   VY+T  D+WS G +  E++ +
Sbjct: 192 YVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIVSL 234

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 72/161 (44%), Gaps = 24/161 (14%)
Query: 13  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 64
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 122
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--- 121
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA  +P N    
Sbjct: 123 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHX 178
Query: 122 --YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               H  V   +  PE  L  + +S   D W  G    EM 
Sbjct: 179 VMQEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMF 218

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/102 (32%), Positives = 55/102 (53%), Gaps = 2/102 (1%)
Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
            +   LA     Q+ + + Y HS+++IHRDLKP NI +  +  +K+ DFGL  +      
Sbjct: 132 KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK 191
Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           R T    TL Y  PE  + ++ Y   VD+++ G I +E++ +
Sbjct: 192 R-TRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHV 231

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQ 115
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 116 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 169
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 170 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 208

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 72/161 (44%), Gaps = 24/161 (14%)
Query: 13  LREISVLKELKHPNVIRLHDVI---PVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPP 64
           +RE++ +  L H N+IRL+ V+   P+        L  + + LR+    FL  T      
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGT------ 112
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--- 121
                Y  Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA  +P N    
Sbjct: 113 --LSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA--LPQNDDHX 168
Query: 122 --YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               H  V   +  PE  L  + +S   D W  G    EM 
Sbjct: 169 VMQEHRKVPFAWCAPES-LKTRTFSHASDTWMFGVTLWEMF 208

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 116 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 169
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 170 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 208

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPNVI L  V+     + ++ EF+    L  FL+              L
Sbjct: 56  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 115
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH------E 125
             +   ++Y      +HR L  +NIL+N +   K++DFGLSR      +  T+      +
Sbjct: 116 RGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 175
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +   W  P  I    + +++  D+WS G +  E++
Sbjct: 176 IPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVM 208

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 116 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 169
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 170 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 208

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 6/155 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV--PVPPALAKS 69
           LRE++++K L+HPN++     +     L +V E+L R  L   L  +     +      S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 70  YLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
             Y + + + Y H+R   I+HRDLK  N+L++K   +K+ DFGLSR              
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAG 201
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           T  +  PE+L        + D++S G I  E+  +
Sbjct: 202 TPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATL 235

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 48  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 106
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 107 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 160
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 161 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 199

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 81/159 (50%), Gaps = 15/159 (9%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP---VPVPP 64
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+      + +P 
Sbjct: 54  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
            +  S   Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N +T 
Sbjct: 113 LVDMSA--QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEWTA 168
Query: 125 EVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                    W  P   L G   ++   D+WS G + +E+
Sbjct: 169 RQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 205

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 46  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 104
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 105 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 158
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 159 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 197

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 224 PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 282
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL R   I  N Y
Sbjct: 283 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGR--LIEDNEY 336
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 337 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 375

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/148 (28%), Positives = 77/148 (52%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N++I++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             PEI++ +K Y+  VD W+ G +  EM
Sbjct: 205 LAPEIII-SKGYNKAVDWWALGVLIYEM 231

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 11/155 (7%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL 74
           E+     L  P ++ L+  +     + +  E L       L      +P   A  YL Q 
Sbjct: 135 ELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQA 194
Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           LE L Y HSRRI+H D+K  N+L++  G+   L DFG   A  +  +     ++T  Y P
Sbjct: 195 LEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG--HAVCLQPDGLGKSLLTGDYIP 252
Query: 134 -------PEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
                  PE++LG +     VD+WS+ C+   M+ 
Sbjct: 253 GTETHMAPEVVLG-RSCDAKVDVWSSCCMMLHMLN 286

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQ 115
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 116 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 169
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 170 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 208

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL---QTTPVPVPP 64
           P + L E  ++K+LKH  +++L+ V+  +  +++V E++ +  L DFL   +   + +P 
Sbjct: 48  PESFLEEAQIMKKLKHDKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPN 106
Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRY 122
            +  +   Q+   + Y      IHRDL+  NIL+      K+ADFGL+R         R 
Sbjct: 107 LVDMAA--QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQ 164
Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +    W  P   L G   ++   D+WS G + +E++
Sbjct: 165 GAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTELV 200

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 76/148 (51%), Gaps = 6/148 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R      T  Y
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK---GRTWXLCGTPEY 204
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             P I+L +K Y+  VD W+ G +  EM
Sbjct: 205 LAPAIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + E+     L  P ++ L+  +     + +  E L       L      +P   A  YL 
Sbjct: 114 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 173
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWY 131
           Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  +  +     ++T  Y
Sbjct: 174 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDY 231
Query: 132 RP-------PEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            P       PE+++G K     VDIWS+ C+   M+ 
Sbjct: 232 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLN 267

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + E+     L  P ++ L+  +     + +  E L       L      +P   A  YL 
Sbjct: 112 VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 171
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWY 131
           Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  +  +     ++T  Y
Sbjct: 172 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDY 229
Query: 132 RP-------PEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            P       PE+++G K     VDIWS+ C+   M+ 
Sbjct: 230 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLN 265

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 71/157 (45%), Gaps = 11/157 (7%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + E+     L  P ++ L+  +     + +  E L       L      +P   A  YL 
Sbjct: 98  VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG 157
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWY 131
           Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG   A  +  +     ++T  Y
Sbjct: 158 QALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFG--HALCLQPDGLGKSLLTGDY 215
Query: 132 RP-------PEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            P       PE+++G K     VDIWS+ C+   M+ 
Sbjct: 216 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLN 251

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 14  REISVLKELKHP-NVIRLHDVI------PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPA 65
           +EI++LK+  H  N+   +          +D +L+LV EF     + D ++ T       
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128
Query: 66  LAKSYL-YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
              +Y+  ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R   
Sbjct: 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188
Query: 125 EVVTLWYRPPEILLGAK----VYSTTVDIWSAGCIFSEMIQ 161
            + T ++  PE++   +     Y    D+WS G    EM +
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAE 229

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 75/148 (50%), Gaps = 7/148 (4%)
Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 76
           +L+  +HPN+I L DV      +++V E ++  +L D +           A + L+ + +
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITK 127
Query: 77  ALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
            + Y H++ ++HRDLKP NIL +++SG   ++++ DFG ++              T  + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFV 187
Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE+ L  + Y    DIWS G +   M+
Sbjct: 188 APEV-LERQGYDAACDIWSLGVLLYTML 214

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 45  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 104
Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N ++    
Sbjct: 105 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 164
Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E+ 
Sbjct: 165 TVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEIT 223
Query: 161 QI 162
            +
Sbjct: 224 SL 225

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N ++    
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 167
Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E+ 
Sbjct: 168 TVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEIT 226
Query: 161 QI 162
            +
Sbjct: 227 SL 228

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 117 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 175
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 176 EPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 207

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N ++    
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 167
Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E+ 
Sbjct: 168 TVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEIT 226
Query: 161 QI 162
            +
Sbjct: 227 SL 228

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 77/152 (50%), Gaps = 14/152 (9%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  +L+ +  P +++L      +  L++V E++   ++   L+       P  A+ Y 
Sbjct: 89  LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARFYA 147
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++       R       L  
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-------RVKGRTWXLCG 200
Query: 132 RP----PEILLGAKVYSTTVDIWSAGCIFSEM 159
            P    PEI+L +K Y+  VD W+ G +  EM
Sbjct: 201 TPEALAPEIIL-SKGYNKAVDWWALGVLIYEM 231

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 62
           P   L+E  V+K+++H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 57  PEAFLQEAQVMKKIRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 116 LVDMAA----QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR--LIEDNEY 169
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 170 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 208

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N ++    
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 167
Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E+ 
Sbjct: 168 TVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEIT 226
Query: 161 QI 162
            +
Sbjct: 227 SL 228

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 76/156 (48%), Gaps = 15/156 (9%)
Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           +EI +L+ L H ++I+            L LV E++    L+D+L    +     LA+  
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSI----GLAQLL 137
Query: 71  LY--QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----TH 124
           L+  Q+ E + Y H++  IHRDL  +N+L++    +K+ DFGL++A       Y      
Sbjct: 138 LFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG 197
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +    WY  PE L   K Y  + D+WS G    E++
Sbjct: 198 DSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 19/161 (11%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT-----PVPV 62
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+        +P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
              +A     Q+   + Y      +HRDL   NIL+ ++   K+ADFGL+R   I  N Y
Sbjct: 116 LVDMAA----QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLAR--LIEDNEY 169
Query: 123 THEVVT----LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           T          W  P   L G   ++   D+WS G + +E+
Sbjct: 170 TARQGAKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 208

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 5/97 (5%)
Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA-FTIP--MNRYTHE 125
           SY +Q+   + +  SR+ IHRDL  +NIL++++  +K+ DFGL+R  +  P  + +    
Sbjct: 203 SYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTR 262
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           +   W  P  I    K+YST  D+WS G +  E+  +
Sbjct: 263 LPLKWMAPESIF--DKIYSTKSDVWSYGVLLWEIFSL 297

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 123 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 181
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 182 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 213

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 124 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 182
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 183 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 214

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 14  REISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           +EI +L+ L H ++I+         +  L LV E++    L+D+L    + +   L   +
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--F 122
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------RYTH 124
             Q+ E + Y HS+  IHR+L  +N+L++    +K+ DFGL++A  +P        R   
Sbjct: 123 AQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDG 180
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +    WY  PE L   K Y  + D+WS G    E++
Sbjct: 181 DSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 74/155 (47%), Gaps = 6/155 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPV--PVPPALAKS 69
           LRE++++K L+HPN++     +     L +V E+L R  L   L  +     +      S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141
Query: 70  YLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
             Y + + + Y H+R   I+HR+LK  N+L++K   +K+ DFGLSR              
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           T  +  PE+L        + D++S G I  E+  +
Sbjct: 202 TPEWMAPEVLRDEPSNEKS-DVYSFGVILWELATL 235

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 125 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 183
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 184 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 215

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 133 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 191
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 192 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 223

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 169 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 227
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 228 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 259

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 163 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 221
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 222 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 253

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 177
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 178 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 209

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 118 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 176
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 177 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 208

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 117 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 175
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 176 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 207

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 47  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 106
Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N ++    
Sbjct: 107 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 166
Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E+ 
Sbjct: 167 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEIT 225
Query: 161 QI 162
            +
Sbjct: 226 SL 227

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 35/93 (37%), Positives = 50/93 (53%), Gaps = 5/93 (5%)
Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLT 177
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF 156
               T +Y  PE+ LG + Y  + D+WS G I 
Sbjct: 178 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVIM 209

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/182 (25%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HRDL  +N ++    
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF 167
Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E+ 
Sbjct: 168 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEIT 226
Query: 161 QI 162
            +
Sbjct: 227 SL 228

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVP--PA 65
           P   L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+         P 
Sbjct: 57  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQ 115
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R         R  
Sbjct: 116 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 174
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +    W  P   L G   ++   D+WS G + +E+
Sbjct: 175 AKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 208

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 55/92 (59%), Gaps = 2/92 (2%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +    V T 
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTH 354
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            Y  PE+L     Y ++ D +S GC+  ++++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 55/92 (59%), Gaps = 2/92 (2%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +    V T 
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTH 354
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            Y  PE+L     Y ++ D +S GC+  ++++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 55/92 (59%), Gaps = 2/92 (2%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +    V T 
Sbjct: 296 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTH 353
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            Y  PE+L     Y ++ D +S GC+  ++++
Sbjct: 354 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 385

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 55/92 (59%), Gaps = 2/92 (2%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +    V T 
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPHASVGTH 354
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            Y  PE+L     Y ++ D +S GC+  ++++
Sbjct: 355 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 386

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 14/144 (9%)
Query: 27  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 85
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ Y+ +++ A+   H   
Sbjct: 152 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 211
Query: 86  IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTHEVVTLWYRPPEILL-- 138
            +HRD+KP N+L++ +G ++LADFG      + MN     + +  V T  Y  PEIL   
Sbjct: 212 YVHRDIKPDNVLLDVNGHIRLADFGS----CLKMNDDGTVQSSVAVGTPDYISPEILQAM 267
Query: 139 --GAKVYSTTVDIWSAGCIFSEMI 160
             G   Y    D WS G    EM+
Sbjct: 268 EDGMGKYGPECDWWSLGVCMYEML 291

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 66  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 125
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 126 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 180
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 181 --DMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 53/93 (56%), Gaps = 2/93 (2%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 128
           Y+ +++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F        ++   T
Sbjct: 164 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223
Query: 129 LWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMI 160
           + Y  P+I+ G    +   VD WS G +  E++
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 15/156 (9%)
Query: 14  REISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +L+ L H ++++         +  + LV E++    L+D+L    V +   L   +
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--F 116
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------RYTH 124
             Q+ E + Y H++  IHR L  +N+L++    +K+ DFGL++A  +P        R   
Sbjct: 117 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDG 174
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +    WY  PE L   K Y  + D+WS G    E++
Sbjct: 175 DSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 69/144 (47%), Gaps = 14/144 (9%)
Query: 27  VIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR 85
           +  LH     +  L+LV ++ +  DL   L      +P  +A+ Y+ +++ A+   H   
Sbjct: 136 ITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLH 195
Query: 86  IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-----RYTHEVVTLWYRPPEILL-- 138
            +HRD+KP N+L++ +G ++LADFG      + MN     + +  V T  Y  PEIL   
Sbjct: 196 YVHRDIKPDNVLLDVNGHIRLADFGS----CLKMNDDGTVQSSVAVGTPDYISPEILQAM 251
Query: 139 --GAKVYSTTVDIWSAGCIFSEMI 160
             G   Y    D WS G    EM+
Sbjct: 252 EDGMGKYGPECDWWSLGVCMYEML 275

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 15/156 (9%)
Query: 14  REISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           REI +L+ L H ++++         +  + LV E++    L+D+L    V +   L   +
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLLL--F 117
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------RYTH 124
             Q+ E + Y H++  IHR L  +N+L++    +K+ DFGL++A  +P        R   
Sbjct: 118 AQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDG 175
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +    WY  PE L   K Y  + D+WS G    E++
Sbjct: 176 DSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 14  REISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSY 70
           +EI +L+ L H ++I+         +  L LV E++    L+D+L    + +   L   +
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLL--F 122
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------RYTH 124
             Q+ E + Y H++  IHR+L  +N+L++    +K+ DFGL++A  +P        R   
Sbjct: 123 AQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKA--VPEGHEYYRVREDG 180
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +    WY  PE L   K Y  + D+WS G    E++
Sbjct: 181 DSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 59.7 bits (143), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 81/169 (47%), Gaps = 20/169 (11%)
Query: 12  ALREISVLKELKHPNVIRLH---DVIPVDFK-------------LFLVFEFL-RQDLKDF 54
           A RE+  L +L H N++  +   D    D +             LF+  EF  +  L+ +
Sbjct: 51  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110
Query: 55  LQTT-PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
           ++      +   LA     Q+ + + Y HS+++I+RDLKP NI +  +  +K+ DFGL  
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170
Query: 114 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           +      R   +  TL Y  PE  + ++ Y   VD+++ G I +E++ +
Sbjct: 171 SLKNDGKRXRSK-GTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHV 217

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 68  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 127
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---- 113
           T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 128 THNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLD 186
Query: 114 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             F    N+   ++   W       L  + ++T  D+WS G +  E++
Sbjct: 187 KEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 232

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 68  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 127
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---- 113
           T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 128 THNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 186
Query: 114 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             F    N+   ++   W       L  + ++T  D+WS G +  E++
Sbjct: 187 KEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 232

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 2/150 (1%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            L E  VL+  +HP +  L        +L  V E+       F  +         A+ Y 
Sbjct: 55  TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 114
Query: 72  YQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
            +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  
Sbjct: 115 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 174
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L     Y   VD W  G +  EM+
Sbjct: 175 YLAPEVLEDND-YGRAVDWWGLGVVMYEMM 203

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 65  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 124
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---- 113
           T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 125 THNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 183
Query: 114 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             F    N+   ++   W       L  + ++T  D+WS G +  E++
Sbjct: 184 KEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 229

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 39/100 (39%), Positives = 52/100 (52%), Gaps = 13/100 (13%)
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT---------IPMNRY- 122
           Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A            PM  Y 
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 123 TH--EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           TH  +V T  Y  PE + G   YS  VDI+S G I  E++
Sbjct: 232 THXGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELL 270

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 67  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 126
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---- 113
           T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 127 THNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 114 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             F    N+   ++   W       L  + ++T  D+WS G +  E++
Sbjct: 186 KEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 231

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPA 65
           P   L+E  V+K+L+H  +++L+ V+  +  + +V E++ +  L DFL  +T      P 
Sbjct: 47  PEAFLQEAQVMKKLRHEKLVQLYAVVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQ 105
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYT 123
           L      Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R         R  
Sbjct: 106 LV-DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQG 164
Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +    W  P   L G   ++   D+WS G + +E+
Sbjct: 165 AKFPIKWTAPEAALYGR--FTIKSDVWSFGILLTEL 198

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 2/150 (1%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            L E  VL+  +HP +  L        +L  V E+       F  +         A+ Y 
Sbjct: 56  TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 115
Query: 72  YQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
            +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  
Sbjct: 116 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 175
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L     Y   VD W  G +  EM+
Sbjct: 176 YLAPEVLEDND-YGRAVDWWGLGVVMYEMM 204

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 2/150 (1%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            L E  VL+  +HP +  L        +L  V E+       F  +         A+ Y 
Sbjct: 57  TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 116
Query: 72  YQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
            +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  
Sbjct: 117 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPE 176
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L     Y   VD W  G +  EM+
Sbjct: 177 YLAPEVLEDND-YGRAVDWWGLGVVMYEMM 205

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 85  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 144
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 145 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 199
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 200 --DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 249

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 58/111 (52%), Gaps = 9/111 (8%)
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGL 111
           D  QT P  +   +A S    +++AL + HS+  +IHRD+KP N+LIN  G +K+ DFG+
Sbjct: 145 DKGQTIPEDILGKIAVS----IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 200
Query: 112 SRAFTIPMNRYTHEVVTLWYRPPEIL---LGAKVYSTTVDIWSAGCIFSEM 159
           S  + +     T +     Y  PE +   L  K YS   DIWS G    E+
Sbjct: 201 S-GYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 67  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 126
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 127 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 181
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 182 --DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 67  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 126
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---- 113
           T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 127 THNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 185
Query: 114 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             F    N+   ++   W       L  + ++T  D+WS G +  E++
Sbjct: 186 KEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 126 NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---- 113
           T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 186 THNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244
Query: 114 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             F    N+   ++   W       L  + ++T  D+WS G +  E++
Sbjct: 245 KEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 290

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 66  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 125
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 126 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 180
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 181 --DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 230

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 67  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 126
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 127 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 181
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 182 --DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 231

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 72  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 131
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---- 113
           T  P    L   +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 132 THNPTVKDLI-GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 190
Query: 114 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             F    N+   ++   W       L  + ++T  D+WS G +  E++
Sbjct: 191 KEFDSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 236

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/168 (25%), Positives = 86/168 (51%), Gaps = 11/168 (6%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---- 113
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 124 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 114 -AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +    N+   ++   W       L  + ++T  D+WS G +  E++
Sbjct: 183 KEYYSVHNKTGAKLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELM 228

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 65  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 124
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 125 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 179
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 180 --DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 229

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 59  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 118
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 119 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 173
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 174 --DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 223

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 86  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 145
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 146 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 200
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 201 --DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 250

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 87/172 (50%), Gaps = 19/172 (11%)
Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT- 57
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 62  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121
Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
           T  P    L   +  Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R    
Sbjct: 122 THNPTVKDLI-GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR---- 176
Query: 118 PMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEMI 160
             + Y  E  ++  +    L         L  + ++T  D+WS G +  E++
Sbjct: 177 --DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELM 226

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 15  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTT-PVPV-PPALAKS 69
           E+  L  + HPN+++L+     PV     LV E+     L + L    P+P    A A S
Sbjct: 52  ELRQLSRVNHPNIVKLYGACLNPV----CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 107
Query: 70  YLYQLLEALRYCHS---RRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHE 125
           +  Q  + + Y HS   + +IHRDLKP N+L+   G  LK+ DFG +      M   T+ 
Sbjct: 108 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNN 164
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  +  PE+  G+  YS   D++S G I  E+I
Sbjct: 165 KGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVI 198

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/148 (32%), Positives = 76/148 (51%), Gaps = 15/148 (10%)
Query: 15  EISVLKELKHPNVIRLHDVIPVDFK----LFLVFEFLRQD-LKDFLQTTPVPVPPALAKS 69
           E   LK L+HPN++R +D      K    + LV E      LK +L+   V     L +S
Sbjct: 75  EAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVL-RS 133
Query: 70  YLYQLLEALRYCHSRR--IIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEV 126
           +  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D GL+   T+    +   V
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAV 190
Query: 127 V-TLWYRPPEILLGAKVYSTTVDIWSAG 153
           + T  +  PE     + Y  +VD+++ G
Sbjct: 191 IGTPEFXAPEXY--EEKYDESVDVYAFG 216

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 2/150 (1%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            L E  VL+  +HP +  L        +L  V E+       F  +         A+ Y 
Sbjct: 198 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 257
Query: 72  YQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
            +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  
Sbjct: 258 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 317
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L     Y   VD W  G +  EM+
Sbjct: 318 YLAPEVLEDND-YGRAVDWWGLGVVMYEMM 346

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 2/150 (1%)
Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            L E  VL+  +HP +  L        +L  V E+       F  +         A+ Y 
Sbjct: 195 TLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYG 254
Query: 72  YQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
            +++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  
Sbjct: 255 AEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE 314
Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L     Y   VD W  G +  EM+
Sbjct: 315 YLAPEVLEDND-YGRAVDWWGLGVVMYEMM 343

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 72/144 (50%), Gaps = 7/144 (4%)
Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLE 76
           +L+  +HPN+I L DV      +++V E  +  +L D +           A + L+ + +
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVLFTITK 127
Query: 77  ALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
            + Y H++ ++HRDLKP NIL +++SG   ++++ DFG ++              T  + 
Sbjct: 128 TVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFV 187
Query: 133 PPEILLGAKVYSTTVDIWSAGCIF 156
            PE+L   + Y    DIWS G + 
Sbjct: 188 APEVLE-RQGYDAACDIWSLGVLL 210

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 50/155 (32%), Positives = 76/155 (49%), Gaps = 17/155 (10%)
Query: 15  EISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTT-PVPV-PPALAKS 69
           E+  L  + HPN+++L+     PV     LV E+     L + L    P+P    A A S
Sbjct: 51  ELRQLSRVNHPNIVKLYGACLNPV----CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106
Query: 70  YLYQLLEALRYCHS---RRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHE 125
           +  Q  + + Y HS   + +IHRDLKP N+L+   G  LK+ DFG +      M   T+ 
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNN 163
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  +  PE+  G+  YS   D++S G I  E+I
Sbjct: 164 KGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWEVI 197

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/83 (40%), Positives = 46/83 (55%), Gaps = 5/83 (6%)
Query: 76  EALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T    T +Y 
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTSHNSLTTPCYTPYYV 230
Query: 133 PPEILLGAKVYSTTVDIWSAGCI 155
            PE+ LG + Y  + D WS G I
Sbjct: 231 APEV-LGPEKYDKSCDXWSLGVI 252

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 36/170 (21%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALA 67
           P++  R + +L+  +H   I             +VFE L     DF++    +P      
Sbjct: 73  PNSTFRCVQMLEWFEHHGHI------------CIVFELLGLSTYDFIKENGFLPFRLDHI 120
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-------------------ALKLAD 108
           +   YQ+ +++ + HS ++ H DLKP+NIL  +S                     +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 109 FGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
           FG   + T     ++  V T  YR PE++L A  +S   D+WS GCI  E
Sbjct: 181 FG---SATYDDEHHSTLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIE 226

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 48  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 107
Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HR+L  +N ++    
Sbjct: 108 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDF 167
Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E+ 
Sbjct: 168 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEIT 226
Query: 161 QI 162
            +
Sbjct: 227 SL 228

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/182 (24%), Positives = 86/182 (47%), Gaps = 21/182 (11%)
Query: 1   SRVQVEGVPSTA--------LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL 51
           +RV V+ V  +A        L E SV+K     +V+RL  V+       +V E +   DL
Sbjct: 49  TRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDL 108
Query: 52  KDFL-------QTTPVPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG 102
           K +L       +  P   PP L +      ++ + + Y ++++ +HR+L  +N ++    
Sbjct: 109 KSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDF 168
Query: 103 ALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+ DFG++R    T    +    ++ + +  PE L    V++T+ D+WS G +  E+ 
Sbjct: 169 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEIT 227
Query: 161 QI 162
            +
Sbjct: 228 SL 229

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 55/110 (50%), Gaps = 7/110 (6%)
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGL 111
           D  QT P  +   +A S    +++AL + HS+  +IHRD+KP N+LIN  G +K+ DFG+
Sbjct: 101 DKGQTIPEDILGKIAVS----IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGI 156
Query: 112 SRAFTIPMNRYTHEVVTLWYRPPEI--LLGAKVYSTTVDIWSAGCIFSEM 159
           S      + +        +  P  I   L  K YS   DIWS G    E+
Sbjct: 157 SGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 13  LREISVLKELK-HPNVIRLHDVIPVD--------FKLFLVFEFLRQDLKDFLQT--TPVP 61
           ++E+  +K+L  HPN+++      +          +  L+ E  +  L +FL+   +  P
Sbjct: 73  IQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP 132
Query: 62  VPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSR------ 113
           +         YQ   A+++ H ++  IIHRDLK +N+L++  G +KL DFG +       
Sbjct: 133 LSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192
Query: 114 --AFTIPMNRYTHEVVTL----WYRPPEILLGAKVYST-----TVDIWSAGCIF 156
             +++        E +T      YR PEI+    +YS        DIW+ GCI 
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEII---DLYSNFPIGEKQDIWALGCIL 243

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 76/157 (48%), Gaps = 24/157 (15%)
Query: 13  LREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQ---------DLKDFLQTTPVPV 62
           L EI+VL+  K  P VI LH+V     ++ L+ E+            +L + +    V  
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI- 134
Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS---GALKLADFGLSRAFTIPM 119
                   + Q+LE + Y H   I+H DLKPQNIL++     G +K+ DFG+SR   I  
Sbjct: 135 ------RLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK--IGH 186
Query: 120 NRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
                E++ T  Y  PEIL    + +T  D+W+ G I
Sbjct: 187 ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGII 222

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 41/139 (29%), Positives = 67/139 (48%), Gaps = 3/139 (2%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC 81
           K P + +LH       +L+ V E++   DL   +Q       P  A  Y  ++   L + 
Sbjct: 78  KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ-AVFYAAEISIGLFFL 136
Query: 82  HSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK 141
           H R II+RDLK  N++++  G +K+ADFG+ +   +          T  Y  PEI +  +
Sbjct: 137 HKRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEI-IAYQ 195
Query: 142 VYSTTVDIWSAGCIFSEMI 160
            Y  +VD W+ G +  EM+
Sbjct: 196 PYGKSVDWWAYGVLLYEML 214

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 73/214 (34%)
Query: 11  TALREISVLKELKH-----PN---VIRLHDVIPVDFKL--------FLVFEFLRQDL-KD 53
           TAL EI +LK ++      PN   V++L D    DFK+         +VFE L   L K 
Sbjct: 73  TALDEIKLLKCVRESDPSDPNKDMVVQLID----DFKISGMNGIHVCMVFEVLGHHLLKW 128
Query: 54  FLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILI-------------- 98
            +++    +P    KS + Q+L+ L Y HS+ +IIH D+KP+NIL+              
Sbjct: 129 IIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEA 188
Query: 99  ---NKSGA------------------------------LKLADFGLSRAFTIPMNRYTHE 125
               K+GA                              +K+AD G +         +T +
Sbjct: 189 TEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNA---CWVHKHFTED 245
Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           + T  YR  E+L+GA  YST  DIWS  C+  E+
Sbjct: 246 IQTRQYRSIEVLIGAG-YSTPADIWSTACMAFEL 278

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 77  ALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           A+++ HS  I HRD+KP+N+L     K   LKL DFG ++  T   N       T +Y  
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVA 197
Query: 134 PEILLGAKVYSTTVDIWSAGCIF 156
           PE+ LG + Y  + D+WS G I 
Sbjct: 198 PEV-LGPEKYDKSCDMWSLGVIM 219

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/83 (38%), Positives = 45/83 (54%), Gaps = 6/83 (7%)
Query: 77  ALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRP 133
           A+++ HS  I HRD+KP+N+L     K   LKL DFG ++  T   N       T +Y  
Sbjct: 121 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVA 178
Query: 134 PEILLGAKVYSTTVDIWSAGCIF 156
           PE+ LG + Y  + D+WS G I 
Sbjct: 179 PEV-LGPEKYDKSCDMWSLGVIM 200

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.0 bits (136), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 44/150 (29%), Positives = 77/150 (51%), Gaps = 6/150 (4%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE      L+ P+V+ +HD   +D +L++    +   DL   L+    P+ P  A + + 
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQG-PLAPPRAVAIVR 141
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWY 131
           Q+  AL   H+    HRD+KP+NIL++      L DFG++ A T   + +  + V TL+Y
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201
Query: 132 RPPEILLGAKVYST-TVDIWSAGCIFSEMI 160
             PE    ++ ++T   DI++  C+  E +
Sbjct: 202 XAPERF--SESHATYRADIYALTCVLYECL 229

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 74/170 (43%), Gaps = 36/170 (21%)
Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALA 67
           P++  R + +L+  +H   I             +VFE L     DF++    +P      
Sbjct: 73  PNSTFRCVQMLEWFEHHGHI------------CIVFELLGLSTYDFIKENGFLPFRLDHI 120
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-------------------ALKLAD 108
           +   YQ+ +++ + HS ++ H DLKP+NIL  +S                     +K+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 109 FGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE 158
           FG   + T     ++  V    YR PE++L A  +S   D+WS GCI  E
Sbjct: 181 FG---SATYDDEHHSTLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIE 226

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/128 (28%), Positives = 63/128 (49%), Gaps = 15/128 (11%)
Query: 46  FLRQDLKDFLQTTPVPVPPALAKSYL---------YQLLEALRYCHSRRIIHRDLKPQNI 96
           +LR    +F+   P   P  L K +L         +Q+ + + +  SR+ IHRDL  +NI
Sbjct: 123 YLRSKRNEFV---PYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 97  LINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC 154
           L+++   +K+ DFGL+R      +  R     + L +  PE +   +VY+   D+WS G 
Sbjct: 180 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGV 238
Query: 155 IFSEMIQI 162
           +  E+  +
Sbjct: 239 LLWEIFSL 246

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 117
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 118 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWP 177
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 178 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 206

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 46/164 (28%), Positives = 80/164 (48%), Gaps = 19/164 (11%)
Query: 15  EISVLKELKHPNVIRLHDV----IPVDFKLFLVFEF-LRQDLKDFLQTTPVP------VP 63
           E+  L  +KH N+++          VD  L+L+  F  +  L DFL+   V       + 
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIA 127
Query: 64  PALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
             +A+  +YL++ +  L+  H   I HRD+K +N+L+  +    +ADFGL+  F    + 
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 122 Y-TH-EVVTLWYRPPEILLGAKVYSTT----VDIWSAGCIFSEM 159
             TH +V T  Y  PE+L GA  +       +D+++ G +  E+
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALR-- 79
           +HP+++ L        ++ L+++++   +LK  L  + +P      +  L   + A R  
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 80  -YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPPEI 136
            Y H+R IIHRD+K  NIL++++   K+ DFG+S+  T     +   VV  TL Y  PE 
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEY 212
Query: 137 LLGAKVYSTTVDIWSAGCIFSEMI 160
            +  ++   + D++S G +  E++
Sbjct: 213 FIKGRLTEKS-DVYSFGVVLFEVL 235

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 38/110 (34%), Positives = 54/110 (49%), Gaps = 7/110 (6%)
Query: 53  DFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGL 111
           D  QT P  +   +A S    +++AL + HS+  +IHRD+KP N+LIN  G +K  DFG+
Sbjct: 128 DKGQTIPEDILGKIAVS----IVKALEHLHSKLSVIHRDVKPSNVLINALGQVKXCDFGI 183
Query: 112 SRAFTIPMNRYTHEVVTLWYRPPEI--LLGAKVYSTTVDIWSAGCIFSEM 159
           S      + +        +  P  I   L  K YS   DIWS G    E+
Sbjct: 184 SGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 113
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 114 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 173
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 174 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 54  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 111
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 112 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 171
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 172 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 200

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 117
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 118 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 177
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 178 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 206

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 123
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 184 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 212

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 69/162 (42%), Gaps = 8/162 (4%)
Query: 7   GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPA 65
           G  S    E  VL       + +LH     +  L+LV E+ +  DL   L      +P  
Sbjct: 103 GEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE 162
Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTH 124
           +A+ YL +++ A+   H    +HRD+KP NIL+++ G ++LADFG           R   
Sbjct: 163 MARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLV 222
Query: 125 EVVTLWYRPPEILLGAKVYSTT------VDIWSAGCIFSEMI 160
            V T  Y  PEIL        T       D W+ G    EM 
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 75/144 (52%), Gaps = 7/144 (4%)
Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALR-- 79
           +HP+++ L        ++ L+++++   +LK  L  + +P      +  L   + A R  
Sbjct: 93  RHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 80  -YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLWYRPPEI 136
            Y H+R IIHRD+K  NIL++++   K+ DFG+S+  T     +   VV  TL Y  PE 
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEY 212
Query: 137 LLGAKVYSTTVDIWSAGCIFSEMI 160
            +  ++   + D++S G +  E++
Sbjct: 213 FIKGRLTEKS-DVYSFGVVLFEVL 235

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + E  ++K L HP++++L  +I  +    ++  +   +L  +L+     +       Y  
Sbjct: 73  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 132
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 129
           Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L   
Sbjct: 133 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK 191
Query: 130 WYRPPEILLGAKVYSTTVDIW 150
           W  P  I    + ++T  D+W
Sbjct: 192 WMSPESI--NFRRFTTASDVW 210

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 213 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 246

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 204 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 237

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 153 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 213 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 246

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 67/141 (47%), Gaps = 6/141 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + E  ++K L HP++++L  +I  +    ++  +   +L  +L+     +       Y  
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 129
           Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L   
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK 179
Query: 130 WYRPPEILLGAKVYSTTVDIW 150
           W  P  I    + ++T  D+W
Sbjct: 180 WMSPESI--NFRRFTTASDVW 198

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 133
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 134 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 194 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 133
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 134 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 193
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 194 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 74  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELV 131
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 132 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 191
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 192 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 220

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 203
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 204 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 237

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + E  ++K L HP++++L  +I  +    ++  +   +L  +L+     +       Y  
Sbjct: 57  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 116
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL--- 129
           Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR +    + Y   V  L   
Sbjct: 117 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIK 175
Query: 130 WYRPPEILLGAKVYSTTVDIWS-AGCIFS 157
           W  P  I    + ++T  D+W  A C++ 
Sbjct: 176 WMSPESI--NFRRFTTASDVWMFAVCMWE 202

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 76/172 (44%), Gaps = 38/172 (22%)
Query: 13  LREISVLKELKHPNVIRLHDV--------IPVDFKLFLVFEFLR-QDLKDFL-----QTT 58
           L E + +K+  HPNVIRL  V        IP   K  ++  F++  DL  +L     +T 
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCIEMSSQGIP---KPMVILPFMKYGDLHTYLLYSRLETG 140
Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
           P  +P      ++  +   + Y  +R  +HRDL  +N ++     + +ADFGLS+     
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI--- 197
Query: 119 MNRYTHEVVTLWYRPPEIL-----------LGAKVYSTTVDIWSAGCIFSEM 159
              Y+ +    +YR   I            L  +VY++  D+W+ G    E+
Sbjct: 198 ---YSGD----YYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 205 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 264
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 265 PLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSL 298

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 203 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 262
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 263 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 296

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARL 212
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 213 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 246

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 214
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 215 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 248

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 258 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 291

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 212
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 213 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 246

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 196 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 255
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 256 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 289

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 75/222 (33%)
Query: 5   VEGVPSTALREISVLKELKH-----PN---VIRLHDVIPVDFKL--------FLVFEFLR 48
            E    TAL EI +LK +++     PN   V++L D    DFK+         +VFE L 
Sbjct: 57  AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD----DFKISGVNGTHICMVFEVLG 112
Query: 49  QDL-KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------- 99
             L K  +++    +P    K  + Q+L+ L Y H++ RIIH D+KP+NIL++       
Sbjct: 113 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 172
Query: 100 ----------KSGA--------------------------------LKLADFGLSRAFTI 117
                     +SGA                                +K+AD G +     
Sbjct: 173 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CW 229
Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               +T ++ T  YR  E+L+G+  Y+T  DIWS  C+  E+
Sbjct: 230 VHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFEL 270

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 249
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 250 PLKWMAPETIF-DRVYTIQSDVWSFGVLLWEIFSL 283

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 419 LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELV 476
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 477 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 536
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 537 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 565

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 204 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 237

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 95/222 (42%), Gaps = 75/222 (33%)
Query: 5   VEGVPSTALREISVLKELKH-----PN---VIRLHDVIPVDFKL--------FLVFEFLR 48
            E    TAL EI +LK +++     PN   V++L D    DFK+         +VFE L 
Sbjct: 73  AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLD----DFKISGVNGTHICMVFEVLG 128
Query: 49  QDL-KDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------- 99
             L K  +++    +P    K  + Q+L+ L Y H++ RIIH D+KP+NIL++       
Sbjct: 129 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIR 188
Query: 100 ----------KSGA--------------------------------LKLADFGLSRAFTI 117
                     +SGA                                +K+AD G +     
Sbjct: 189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CW 245
Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
               +T ++ T  YR  E+L+G+  Y+T  DIWS  C+  E+
Sbjct: 246 VHKHFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFEL 286

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 40/150 (26%), Positives = 70/150 (46%), Gaps = 7/150 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ     V        +
Sbjct: 418 LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELV 475
Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW- 130
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +    W 
Sbjct: 476 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 535
Query: 131 --YRPPEILLGAKVYSTTVDIWSAGCIFSE 158
             +  PE +   K +S+  D+WS G +  E
Sbjct: 536 VKWYAPECINYYK-FSSKSDVWSFGVLMWE 564

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 203
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 204 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 237

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/154 (25%), Positives = 76/154 (49%), Gaps = 7/154 (4%)
Query: 13  LREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
           LRE  +++ L HPNV+ L  ++  P      L+      DL  F+++           S+
Sbjct: 70  LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT----IPMNRYTHEV 126
             Q+   + Y   ++ +HRDL  +N ++++S  +K+ADFGL+R         + ++ H  
Sbjct: 130 GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHAR 189
Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           + + +   E L   + ++T  D+WS G +  E++
Sbjct: 190 LPVKWTALESLQTYR-FTTKSDVWSFGVLLWELL 222

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 209 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 242

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVV 127
           Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +  R     +
Sbjct: 149 YSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
            L +  PE +   +VY+   D+WS G +  E+  +
Sbjct: 209 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSL 242

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 121
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ E + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 122 QIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 181
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 182 WMALESIL--HRIYTHQSDVWSYGVTVWELM 210

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 24/178 (13%)
Query: 4   QVEGVPSTALREISVLK-ELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL------ 55
           + EG      R  ++L+  L+HPNV+ L  V+  D  L ++F +    DL +FL      
Sbjct: 67  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 126
Query: 56  ---------QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL 106
                    +T    + P      + Q+   + Y  S  ++H+DL  +N+L+     +K+
Sbjct: 127 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI 186
Query: 107 ADFGLSRAFTIPMNRYTHEVVTL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +D GL R      + Y     +L    W  P  I+ G   +S   DIWS G +  E+ 
Sbjct: 187 SDLGLFRE-VYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVF 241

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 77/178 (43%), Gaps = 24/178 (13%)
Query: 4   QVEGVPSTALREISVLK-ELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL------ 55
           + EG      R  ++L+  L+HPNV+ L  V+  D  L ++F +    DL +FL      
Sbjct: 50  KAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPH 109
Query: 56  ---------QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL 106
                    +T    + P      + Q+   + Y  S  ++H+DL  +N+L+     +K+
Sbjct: 110 SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKI 169
Query: 107 ADFGLSRAFTIPMNRYTHEVVTL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +D GL R      + Y     +L    W  P  I+ G   +S   DIWS G +  E+ 
Sbjct: 170 SDLGLFRE-VYAADYYKLLGNSLLPIRWMAPEAIMYGK--FSIDSDIWSYGVVLWEVF 224

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 72/156 (46%), Gaps = 15/156 (9%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ----DLKDFLQTTPVPVPPALAKS 69
           +EI V+ + +H N++ L         L LV+ ++      D    L  TP P+   +   
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCK 137
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-----TIPMNRYTH 124
                   + + H    IHRD+K  NIL++++   K++DFGL+RA      T+  +R   
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRI-- 195
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            V T  Y  PE L G    +   DI+S G +  E+I
Sbjct: 196 -VGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 228

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        ++       L D+++     +      ++  
Sbjct: 66  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCV 125
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 186 WMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 54/117 (46%), Gaps = 29/117 (24%)
Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-------------------------KSG 102
           K Y  ++L+AL Y     + H DLKP+NIL++                         KS 
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 103 ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            +KL DFG +   T   + +   + T  YR PE++L    +  + D+WS GC+ +E+
Sbjct: 200 GIKLIDFGCA---TFKSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL 252

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCV 124
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 185 WMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 74/159 (46%), Gaps = 3/159 (1%)
Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP 61
           +Q + V  T + +  +    K P + +LH       +L+ V E++   DL   +Q     
Sbjct: 59  IQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF 118
Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
             P  A  Y  ++   L +  S+ II+RDLK  N++++  G +K+ADFG+ +        
Sbjct: 119 KEPH-AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT 177
Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 T  Y  PEI +  + Y  +VD W+ G +  EM+
Sbjct: 178 TKXFCGTPDYIAPEI-IAYQPYGKSVDWWAFGVLLYEML 215

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 24/172 (13%)
Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFE---------FLRQDLKDFLQTTPVPV 62
           + E+ VL  L  H N++ L     +     ++ E         FLR+    F+ +   P 
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 63  ---------PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
                          S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 114 AFTIPMNRYTHEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
                 N        L   W  P  I     VY+   D+WS G    E+  +
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSL 243

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        ++       L D+++     +      ++  
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 192 WMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 35/146 (23%), Positives = 61/146 (41%), Gaps = 4/146 (2%)
Query: 18  VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEA 77
           VLK    P +++       +  +F+  E +    +   +    P+P  +       +++A
Sbjct: 77  VLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKA 136
Query: 78  LRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI 136
           L Y   +  +IHRD+KP NIL+++ G +KL DFG+S        +        +  P  I
Sbjct: 137 LYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERI 196
Query: 137 LLGAKV---YSTTVDIWSAGCIFSEM 159
                    Y    D+WS G    E+
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVEL 222

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        ++       L D+++     +      ++  
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 187 WMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 24/172 (13%)
Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFE---------FLRQDLKDFLQTTPVPV 62
           + E+ VL  L  H N++ L     +     ++ E         FLR+    F+ +   P 
Sbjct: 92  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 151
Query: 63  ---------PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
                          S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 152 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 211
Query: 114 AFTIPMNRYTHEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
                 N        L   W  P  I     VY+   D+WS G    E+  +
Sbjct: 212 DIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSL 261

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        ++       L D+++     +      ++  
Sbjct: 66  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 125
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 126 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 185
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 186 WMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        ++       L D+++     +      ++  
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 188 WMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 24/172 (13%)
Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFE---------FLRQDLKDFLQTTPVPV 62
           + E+ VL  L  H N++ L     +     ++ E         FLR+    F+ +   P 
Sbjct: 90  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 149
Query: 63  ---------PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
                          S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 150 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 209
Query: 114 AFTIPMNRYTHEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
                 N        L   W  P  I     VY+   D+WS G    E+  +
Sbjct: 210 DIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSL 259

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        ++       L D+++     +      ++  
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 185 WMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 67/151 (44%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        ++       L D+++     +      ++  
Sbjct: 69  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCV 128
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 129 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 188
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 189 WMALESIL--HRIYTHQSDVWSYGVTVWELM 217

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/156 (28%), Positives = 71/156 (45%), Gaps = 15/156 (9%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ----DLKDFLQTTPVPVPPALAKS 69
           +EI V+ + +H N++ L         L LV+ ++      D    L  TP P+   +   
Sbjct: 79  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCK 137
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF-----TIPMNRYTH 124
                   + + H    IHRD+K  NIL++++   K++DFGL+RA      T+   R   
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRI-- 195
Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            V T  Y  PE L G    +   DI+S G +  E+I
Sbjct: 196 -VGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 228

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/177 (20%), Positives = 74/177 (41%), Gaps = 29/177 (16%)
Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAK-- 68
           + E+ ++ +L  H N++ L     +   ++L+FE+    DL ++L++          +  
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 69  --------------------SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                                + YQ+ + + +   +  +HRDL  +N+L+     +K+ D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215
Query: 109 FGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
           FGL+R      N   R    +   W  P  +  G  +Y+   D+WS G +  E+  +
Sbjct: 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG--IYTIKSDVWSYGILLWEIFSL 270

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 192 WMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 24/172 (13%)
Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFE---------FLRQDLKDFLQTTPVPV 62
           + E+ VL  L  H N++ L     +     ++ E         FLR+    F+ +   P 
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 156
Query: 63  ---------PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
                          S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 157 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 216
Query: 114 AFTIPMNRYTHEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
                 N        L   W  P  I     VY+   D+WS G    E+  +
Sbjct: 217 DIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSL 266

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 185 WMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 71  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 130
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 131 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 190
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 191 WMALESIL--HRIYTHQSDVWSYGVTVWELM 219

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 185 WMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 131
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 132 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 191
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 192 WMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 188 WMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 184
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 185 WMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 118
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 179 WMALESIL--HRIYTHQSDVWSYGVTVWELM 207

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 188 WMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 126
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 127 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 186
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 187 WMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 127
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 128 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 187
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 188 WMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/172 (25%), Positives = 67/172 (38%), Gaps = 24/172 (13%)
Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFE---------FLRQDLKDFLQTTPVPV 62
           + E+ VL  L  H N++ L     +     ++ E         FLR+    F+ +   P 
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 156
Query: 63  ---------PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
                          S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 157 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 216
Query: 114 AFTIPMNRYTHEVVTL---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQI 162
                 N        L   W  P  I     VY+   D+WS G    E+  +
Sbjct: 217 HIKNDSNYVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSL 266

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/148 (29%), Positives = 80/148 (54%), Gaps = 18/148 (12%)
Query: 19  LKELKHPNVIRLHDVIP-----VDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           L E+ HP+++++ + +       D   ++V E++  Q LK   ++    +P A A +YL 
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLK---RSKGQKLPVAEAIAYLL 189
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG-LSRAFTIPMNRYTHEVVTLWY 131
           ++L AL Y HS  +++ DLKP+NI++ +   LKL D G +SR     +N + +   T  +
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR-----INSFGYLYGTPGF 243
Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           + PEI+      +T  DI++ G   + +
Sbjct: 244 QAPEIVRTGPTVAT--DIYTVGRTLAAL 269

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 28/78 (35%), Positives = 42/78 (53%), Gaps = 4/78 (5%)
Query: 85  RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL---LGAK 141
           +IIHRD+KP NIL+++SG +KL DFG+S      + + T +     Y  PE +      +
Sbjct: 146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRDAGCRPYMAPERIDPSASRQ 204
Query: 142 VYSTTVDIWSAGCIFSEM 159
            Y    D+WS G    E+
Sbjct: 205 GYDVRSDVWSLGITLYEL 222

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 90  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 149
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 150 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 209
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 210 WMALESIL--HRIYTHQSDVWSYGVTVWELM 238

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 75  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 134
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 135 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 194
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 195 WMALESIL--HRIYTHQSDVWSYGVTVWELM 223

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/151 (23%), Positives = 66/151 (43%), Gaps = 5/151 (3%)
Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 99  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 158
Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE---VVTL 129
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V   
Sbjct: 159 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 218
Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           W     IL   ++Y+   D+WS G    E++
Sbjct: 219 WMALESIL--HRIYTHQSDVWSYGVTVWELM 247

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/157 (27%), Positives = 71/157 (45%), Gaps = 17/157 (10%)
Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ----DLKDFLQTTPVPVPPALAKS 69
           +EI V+ + +H N++ L         L LV+ ++      D    L  TP P+   +   
Sbjct: 73  QEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLSWHMRCK 131
Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-- 127
                   + + H    IHRD+K  NIL++++   K++DFGL+RA      ++   V+  
Sbjct: 132 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA----SEKFAQXVMXX 187
Query: 128 ----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               T  Y  PE L G    +   DI+S G +  E+I
Sbjct: 188 RIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEII 222
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	163
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-107
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-106
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-106
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-105
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-104
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-104
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-104
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-104
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-103
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-100
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-96
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-95
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-93
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-89
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	7e-73
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-70
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-69
3rp9_A	458	Mitogen-activated protein kinase; structural genom	6e-67
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-66
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-60
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-57
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-55
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-55
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-55
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-55
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-54
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	3e-54
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-53
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-53
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-52
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-51
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-48
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-48
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-47
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-46
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-46
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-46
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-45
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-45
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	7e-45
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-44
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-44
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-43
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-43
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-42
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-42
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-42
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-42
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-42
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-42
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-41
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-41
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-41
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	5e-39
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-38
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-38
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	4e-38
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-38
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	6e-38
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-38
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	7e-38
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-38
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-37
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-37
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-37
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	4e-37
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-37
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-37
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	4e-37
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-37
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-36
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-36
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-36
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-36
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-36
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-36
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-36
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-36
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-36
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-36
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	5e-36
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-36
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	8e-36
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-35
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-35
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-35
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-35
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-35
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-35
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-35
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-35
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-35
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-35
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-35
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-34
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-34
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	8e-34
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	9e-34
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-33
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-33
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-33
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-32
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-32
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-32
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-32
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-31
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	7e-31
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	9e-31
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-30
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-30
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-30
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-30
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	3e-30
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-30
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	8e-30
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	5e-29
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-28
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-28
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-28
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-27
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-27
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-27
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-27
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-26
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-26
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-26
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-26
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-26
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-26
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-26
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	4e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	5e-26
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	7e-26
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	9e-26
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-25
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-25
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-25
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-25
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-25
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-25
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-25
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-25
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-25
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-25
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-25
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-25
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-24
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-24
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-24
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-24
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-24
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-24
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-24
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-24
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-24
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-24
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-24
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-23
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-23
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-23
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-23
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-23
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-23
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	6e-23
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-22
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-22
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	8e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-22
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-21
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-21
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-21
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	9e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	9e-21
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-20
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-20
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	8e-20
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-19
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-19
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	1e-19
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-19
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-18
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	8e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	4e-11
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-11
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-10
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-10
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-09

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  306 bits (787), Expect = e-107
 Identities = 95/156 (60%), Positives = 122/156 (78%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PST +REIS+LKELKH N+++L+DVI    +L LVFE L QDLK  L      +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            AKS+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           +VTLWYR P++L+G+K YSTT+DIWS GCIF+EM+ 
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  304 bits (782), Expect = e-106
 Identities = 97/156 (62%), Positives = 127/156 (81%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           + KS+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E+  
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN 197

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  304 bits (781), Expect = e-106
 Identities = 98/156 (62%), Positives = 120/156 (76%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PSTA+REIS+LKEL HPN++ L DVI  +  L LVFEF+ +DLK  L      +  +
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDS 119

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K YLYQLL  + +CH  RI+HRDLKPQN+LIN  GALKLADFGL+RAF IP+  YTHE
Sbjct: 120 QIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHE 179

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVTLWYR P++L+G+K YST+VDIWS GCIF+EMI 
Sbjct: 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT 215

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  302 bits (775), Expect = e-105
 Identities = 87/156 (55%), Positives = 114/156 (73%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG P TA+RE+S+LK+LKH N++ LHD+I  +  L LVFE+L +DLK +L      +   
Sbjct: 41  EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMH 100

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K +L+QLL  L YCH ++++HRDLKPQN+LIN+ G LKLADFGL+RA +IP   Y +E
Sbjct: 101 NVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNE 160

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           VVTLWYRPP+ILLG+  YST +D+W  GCIF EM  
Sbjct: 161 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT 196

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  300 bits (771), Expect = e-104
 Identities = 71/155 (45%), Positives = 106/155 (68%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           +G+  TALREI +L+EL HPN+I L D       + LVF+F+  DL+  ++   + + P+
Sbjct: 53  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS 112

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K+Y+   L+ L Y H   I+HRDLKP N+L++++G LKLADFGL+++F  P   YTH+
Sbjct: 113 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 172

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT WYR PE+L GA++Y   VD+W+ GCI +E++
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  299 bits (769), Expect = e-104
 Identities = 64/155 (41%), Positives = 98/155 (63%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           + V   A+REI +LK+L+H N++ L +V     + +LVFEF+   + D L+  P  +   
Sbjct: 65  KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQ 124

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           + + YL+Q++  + +CHS  IIHRD+KP+NIL+++SG +KL DFG +R    P   Y  E
Sbjct: 125 VVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE 184

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           V T WYR PE+L+G   Y   VD+W+ GC+ +EM 
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMF 219

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  299 bits (767), Expect = e-104
 Identities = 68/155 (43%), Positives = 94/155 (60%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
             +   ALREI +LK+LKHPN++ L +V     +L LVFE+    +   L      VP  
Sbjct: 43  PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEH 102

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           L KS  +Q L+A+ +CH    IHRD+KP+NILI K   +KL DFG +R  T P + Y  E
Sbjct: 103 LVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           V T WYR PE+L+G   Y   VD+W+ GC+F+E++
Sbjct: 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELL 197

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  297 bits (763), Expect = e-103
 Identities = 92/161 (57%), Positives = 123/161 (76%), Gaps = 5/161 (3%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT-----TPV 60
           EG PSTA+REIS++KELKH N++RL+DVI  + KL LVFEF+  DLK ++ +     TP 
Sbjct: 44  EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPR 103

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
            +   L K + +QLL+ L +CH  +I+HRDLKPQN+LINK G LKL DFGL+RAF IP+N
Sbjct: 104 GLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            ++ EVVTLWYR P++L+G++ YST++DIWS GCI +EMI 
Sbjct: 164 TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT 204

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  291 bits (747), Expect = e-100
 Identities = 87/161 (54%), Positives = 120/161 (74%), Gaps = 6/161 (3%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EGVP TA+RE+S+LKEL+H N+I L  VI  + +L L+FE+   DLK ++   P  V   
Sbjct: 74  EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMR 132

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-----GALKLADFGLSRAFTIPMN 120
           + KS+LYQL+  + +CHSRR +HRDLKPQN+L++ S       LK+ DFGL+RAF IP+ 
Sbjct: 133 VIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR 192

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           ++THE++TLWYRPPEILLG++ YST+VDIWS  CI++EM+ 
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  281 bits (720), Expect = 1e-96
 Identities = 84/164 (51%), Positives = 110/164 (67%), Gaps = 11/164 (6%)

Query: 6   EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQT 57
           EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + QDL  +L  
Sbjct: 52  EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 111

Query: 58  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171

Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM 
Sbjct: 172 FQM-ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMF 213

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  275 bits (706), Expect = 9e-95
 Identities = 75/164 (45%), Positives = 105/164 (64%), Gaps = 11/164 (6%)

Query: 6   EGVPSTALREISVLKELK---HPNVIRLHDVI-----PVDFKLFLVFEFLRQDLKDFLQT 57
            G+P + +RE+++L+ L+   HPNV+RL DV        + K+ LVFE + QDL+ +L  
Sbjct: 52  GGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK 111

Query: 58  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            P P +P    K  + Q L  L + H+  I+HRDLKP+NIL+   G +KLADFGL+R ++
Sbjct: 112 APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYS 171

Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             M   T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM 
Sbjct: 172 YQM-ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMF 213

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  273 bits (701), Expect = 2e-93
 Identities = 76/167 (45%), Positives = 100/167 (59%), Gaps = 12/167 (7%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVI--------PVDFKLFLVFEFLRQDLKDFLQT 57
           EG P TALREI +L+ LKH NV+ L ++              ++LVF+F   DL   L  
Sbjct: 57  EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN 116

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
             V    +  K  +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF++
Sbjct: 117 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 176

Query: 118 PMN----RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             N    RYT+ VVTLWYRPPE+LLG + Y   +D+W AGCI +EM 
Sbjct: 177 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  264 bits (677), Expect = 5e-89
 Identities = 71/176 (40%), Positives = 107/176 (60%), Gaps = 17/176 (9%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFL---- 55
           +++  G+  +A REI++L+ELKHPNVI L  V     D K++L+F++   DL   +    
Sbjct: 55  QIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHR 114

Query: 56  ----QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLA 107
                  PV +P  + KS LYQ+L+ + Y H+  ++HRDLKP NIL+     + G +K+A
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174

Query: 108 DFGLSRAFTIPMNRYTH---EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           D G +R F  P+         VVT WYR PE+LLGA+ Y+  +DIW+ GCIF+E++
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  222 bits (569), Expect = 7e-73
 Identities = 57/158 (36%), Positives = 89/158 (56%), Gaps = 11/158 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVI------PVDFKLFLVFEFLRQDLKDFLQTTPV---PVP 63
            RE+ +++ +KHPNV+ L            +  L LV E++ + +    +        +P
Sbjct: 80  NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMP 139

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRY 122
             L K Y+YQLL +L Y HS  I HRD+KPQN+L++  SG LKL DFG ++   I     
Sbjct: 140 MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL-IAGEPN 198

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              + + +YR PE++ GA  Y+T +DIWS GC+ +E++
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  214 bits (548), Expect = 2e-70
 Identities = 56/154 (36%), Positives = 91/154 (59%), Gaps = 10/154 (6%)

Query: 12  ALREISVLKELK-HPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
             REI +L+ L+  PN+I L D++  PV     LVFE +   D K   Q     +     
Sbjct: 77  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDI 132

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEV 126
           + Y+Y++L+AL YCHS  I+HRD+KP N++I+ +   L+L D+GL+  F  P   Y   V
Sbjct: 133 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE-FYHPGQEYNVRV 191

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            + +++ PE+L+  ++Y  ++D+WS GC+ + MI
Sbjct: 192 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 225

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  214 bits (548), Expect = 2e-69
 Identities = 49/158 (31%), Positives = 88/158 (55%), Gaps = 11/158 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLRQDLKDFLQTTPV---PVP 63
            RE+ ++++L H N++RL            +  L LV +++ + +    +        +P
Sbjct: 95  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLP 154

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRY 122
               K Y+YQL  +L Y HS  I HRD+KPQN+L++  +  LKL DFG ++   +     
Sbjct: 155 VIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPN 213

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 214 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  209 bits (534), Expect = 6e-67
 Identities = 63/187 (33%), Positives = 94/187 (50%), Gaps = 33/187 (17%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPV 60
                  LREI++L  L H +V+++ D++       F  L++V E    D K   +T PV
Sbjct: 93  LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRT-PV 151

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
            +     K+ LY LL  ++Y HS  I+HRDLKP N L+N+  ++K+ DFGL+R    P N
Sbjct: 152 YLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211

Query: 121 R---------------------------YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG 153
                                        T  VVT WYR PE++L  + Y+  +D+WS G
Sbjct: 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIG 271

Query: 154 CIFSEMI 160
           CIF+E++
Sbjct: 272 CIFAELL 278

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  203 bits (519), Expect = 9e-66
 Identities = 56/168 (33%), Positives = 90/168 (53%), Gaps = 17/168 (10%)

Query: 9   PSTALREISVLKELK---HPNVIRLHDVI-------PVDFKLFLVFEFLRQDLKDFLQTT 58
           P    RE+ ++++L    HPN+++L             D  L +V E++   L    +  
Sbjct: 60  PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY 119

Query: 59  PV---PVPPALAKSYLYQLLEALRYCH--SRRIIHRDLKPQNILINKS-GALKLADFGLS 112
                  PP L K +L+QL+ ++   H  S  + HRD+KP N+L+N++ G LKL DFG +
Sbjct: 120 YRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSA 179

Query: 113 RAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +    P       + + +YR PE++ G + Y+T VDIWS GCIF+EM+
Sbjct: 180 KKL-SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  189 bits (481), Expect = 7e-60
 Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 43/194 (22%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVI---------------------------------- 34
           P    RE+ ++K L H N+I+L D                                    
Sbjct: 44  PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSV 103

Query: 35  ---PVDFK-LFLVFEFLRQDLKDFLQTTPV---PVPPALAKSYLYQLLEALRYCHSRRII 87
              P   K L ++ E++   L   L++       +P  L   Y+YQL  A+ + HS  I 
Sbjct: 104 IVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGIC 163

Query: 88  HRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTT 146
           HRD+KPQN+L+N K   LKL DFG ++   IP       + + +YR PE++LGA  Y+ +
Sbjct: 164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKL-IPSEPSVAYICSRFYRAPELMLGATEYTPS 222

Query: 147 VDIWSAGCIFSEMI 160
           +D+WS GC+F E+I
Sbjct: 223 IDLWSIGCVFGELI 236

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  182 bits (465), Expect = 1e-57
 Identities = 53/154 (34%), Positives = 81/154 (52%), Gaps = 6/154 (3%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L    HPN++ L D+           L+LV E +R DL   +    + + P  
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
            + ++Y +L  L   H   ++HRDL P NIL+  +  + + DF L+R  T      TH V
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT-ADANKTHYV 194

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              WYR PE+++  K ++  VD+WSAGC+ +EM 
Sbjct: 195 THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF 228

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  177 bits (450), Expect = 2e-55
 Identities = 63/155 (40%), Positives = 88/155 (56%), Gaps = 11/155 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
             RE+ +LK +KH NVI L DV        +F  ++LV   +  DL + ++   +     
Sbjct: 75  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLT--DD 132

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M   T  
Sbjct: 133 HVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM---TGY 189

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           V T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  176 bits (449), Expect = 2e-55
 Identities = 63/155 (40%), Positives = 90/155 (58%), Gaps = 12/155 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ +LK ++H NVI L DV        +F   +LV  F++ DL+  +          
Sbjct: 70  AYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL---KFSEE 126

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             +  +YQ+L+ L+Y HS  ++HRDLKP N+ +N+   LK+ DFGL+R     M   T  
Sbjct: 127 KIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM---TGY 183

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT WYR PE++L    Y+ TVDIWS GCI +EM+
Sbjct: 184 VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML 218

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  176 bits (449), Expect = 3e-55
 Identities = 67/155 (43%), Positives = 90/155 (58%), Gaps = 11/155 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ +LK ++H NVI L DV        DF   +LV  F+  DL   ++   +     
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLG--ED 128

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             +  +YQ+L+ LRY H+  IIHRDLKP N+ +N+   LK+ DFGL+R     M   T  
Sbjct: 129 RIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM---TGY 185

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT WYR PE++L    Y+ TVDIWS GCI +EMI
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  176 bits (448), Expect = 4e-55
 Identities = 61/157 (38%), Positives = 92/157 (58%), Gaps = 10/157 (6%)

Query: 12  ALREISVLKELKHPNVIRLHDVIP----VDFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +L   +H N+I ++D+I        K +++V + +  DL   L+T  +      
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLS--NDH 129

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---T 123
              +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R      +     T
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  176 bits (447), Expect = 3e-54
 Identities = 64/177 (36%), Positives = 92/177 (51%), Gaps = 28/177 (15%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI++L  LK   +IRL+D+I       F  L++V E    DLK   +T P+ +    
Sbjct: 72  ILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKT-PIFLTEEH 130

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---- 122
            K+ LY LL    + H   IIHRDLKP N L+N+  ++K+ DFGL+R      +      
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190

Query: 123 ------------------THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
                             T  VVT WYR PE++L  + Y+ ++DIWS GCIF+E++ 
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  173 bits (441), Expect = 3e-54
 Identities = 55/164 (33%), Positives = 86/164 (52%), Gaps = 17/164 (10%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPAL 66
            LREI +LK  KH N+I + ++       +F  ++++ E ++ DL   + T  +      
Sbjct: 56  TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLS--DDH 113

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---- 122
            + ++YQ L A++  H   +IHRDLKP N+LIN +  LK+ DFGL+R             
Sbjct: 114 IQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 123 ------THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                    V T WYR PE++L +  YS  +D+WS GCI +E+ 
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF 217

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  170 bits (434), Expect = 2e-53
 Identities = 57/167 (34%), Positives = 95/167 (56%), Gaps = 20/167 (11%)

Query: 12  ALREISVLKELKHPNVIRLHDVIP-------------VDFK-LFLVFEFLRQDLKDFLQT 57
           ALREI +++ L H N++++ +++               +   +++V E++  DL + L+ 
Sbjct: 55  ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFT 116
            P+      A+ ++YQLL  L+Y HS  ++HRDLKP N+ IN     LK+ DFGL+R   
Sbjct: 115 GPLL--EEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD 172

Query: 117 IPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              +     +  +VT WYR P +LL    Y+  +D+W+AGCIF+EM+
Sbjct: 173 PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML 219

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  171 bits (434), Expect = 9e-53
 Identities = 60/173 (34%), Positives = 94/173 (54%), Gaps = 26/173 (15%)

Query: 12  ALREISVLKELK-HPNVIRLHDVI-PVDFK-LFLVFEFLRQDLKDFLQTTPVPVPPALAK 68
             REI +L EL  H N++ L +V+   + + ++LVF+++  DL   ++   +   P   +
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILE--PVHKQ 112

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY------ 122
             +YQL++ ++Y HS  ++HRD+KP NIL+N    +K+ADFGLSR+F             
Sbjct: 113 YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 123 ---------------THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                          T  V T WYR PEILLG+  Y+  +D+WS GCI  E++
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  171 bits (436), Expect = 2e-52
 Identities = 59/155 (38%), Positives = 85/155 (54%), Gaps = 11/155 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ ++LV E +  +L   +Q     +   
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHE 164

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 165 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPY 223

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT +YR PE++LG   Y   VDIWS GCI  EM+
Sbjct: 224 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMV 257

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  167 bits (425), Expect = 2e-51
 Identities = 59/155 (38%), Positives = 85/155 (54%), Gaps = 11/155 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPV-----DFK-LFLVFEFLRQDLKDFLQTTPVPVPPA 65
           A RE+ ++K + H N+I L +V        +F+ +++V E +  +L   +Q     +   
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHE 127

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
                LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R         T  
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TSFMMTPY 186

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT +YR PE++LG   Y   VDIWS GCI  EMI
Sbjct: 187 VVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMI 220

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  157 bits (399), Expect = 2e-48
 Identities = 51/162 (31%), Positives = 72/162 (44%), Gaps = 16/162 (9%)

Query: 13  LREISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
             EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSY 132

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--T 128
              +LEA+   H   I+H DLKP N LI   G LKL DFG++            +    T
Sbjct: 133 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 191

Query: 129 LWYRPPEILLGA----------KVYSTTVDIWSAGCIFSEMI 160
           + Y PPE +                S   D+WS GCI   M 
Sbjct: 192 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  156 bits (396), Expect = 6e-48
 Identities = 53/182 (29%), Positives = 79/182 (43%), Gaps = 28/182 (15%)

Query: 10  STALREISVLKELKHPNVIRLHDV-------------IPVDFKLFLVFEFLR-QDLKDFL 55
           ST L E+ +L  L H  V+R +               +     LF+  E+     L D +
Sbjct: 47  STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106

Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
            +  +            Q+LEAL Y HS+ IIHRDLKP NI I++S  +K+ DFGL++  
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNV 166

Query: 116 TIPMNRYTHEVV--------------TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
              ++    +                T  Y   E+L G   Y+  +D++S G IF EMI 
Sbjct: 167 HRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226

Query: 162 IP 163
             
Sbjct: 227 PF 228

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  154 bits (391), Expect = 2e-47
 Identities = 43/170 (25%), Positives = 76/170 (44%), Gaps = 20/170 (11%)

Query: 12  ALREISVLKELKHPNVIRLHD----------------VIPVDFKLFLVFEFL-RQDLKDF 54
           A RE+  L +L H N++  +                        LF+  EF  +  L+ +
Sbjct: 51  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110

Query: 55  L-QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
           + +     +   LA     Q+ + + Y HS+++I+RDLKP NI +  +  +K+ DFGL  
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170

Query: 114 AFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQIP 163
           +      R      TL Y  PE +   + Y   VD+++ G I +E++ + 
Sbjct: 171 SLKNDGKRTRS-KGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVC 218

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  153 bits (389), Expect = 2e-46
 Identities = 51/162 (31%), Positives = 72/162 (44%), Gaps = 16/162 (9%)

Query: 13  LREISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
             EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSY 113

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--T 128
              +LEA+   H   I+H DLKP N LI   G LKL DFG++            +    T
Sbjct: 114 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGT 172

Query: 129 LWYRPPEILLG----------AKVYSTTVDIWSAGCIFSEMI 160
           + Y PPE +                S   D+WS GCI   M 
Sbjct: 173 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  151 bits (383), Expect = 3e-46
 Identities = 42/161 (26%), Positives = 81/161 (50%), Gaps = 2/161 (1%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTP 59
             +   G+      E+ +  +LKHP+++ L++       ++LV E     ++  +L+   
Sbjct: 47  KAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV 106

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
            P     A+ +++Q++  + Y HS  I+HRDL   N+L+ ++  +K+ADFGL+    +P 
Sbjct: 107 KPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH 166

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            ++     T  Y  PEI      +    D+WS GC+F  ++
Sbjct: 167 EKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLL 206

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  151 bits (384), Expect = 5e-46
 Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 4/149 (2%)

Query: 12  ALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
            L E+   +++ +HP  +RL         L+L  E     L+   +     +P A    Y
Sbjct: 103 KLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGY 162

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
           L   L AL + HS+ ++H D+KP NI +   G  KL DFGL             +     
Sbjct: 163 LRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV-QEGDPR 221

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           Y  PE+L G+  Y T  D++S G    E+
Sbjct: 222 YMAPELLQGS--YGTAADVFSLGLTILEV 248

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  152 bits (385), Expect = 2e-45
 Identities = 50/162 (30%), Positives = 71/162 (43%), Gaps = 16/162 (9%)

Query: 13  LREISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
             EI+ L +L+  +  +IRL+D    D  +++V E    DL  +L+     + P   KSY
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSY 160

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--T 128
              +LEA+   H   I+H DLKP N LI   G LKL DFG++            +     
Sbjct: 161 WKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGA 219

Query: 129 LWYRPPEILLGAKV----------YSTTVDIWSAGCIFSEMI 160
           + Y PPE +                S   D+WS GCI   M 
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  149 bits (378), Expect = 4e-45
 Identities = 56/153 (36%), Positives = 80/153 (52%), Gaps = 7/153 (4%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPAL 66
            ++EI +LK+L HPNVI+ +     D +L +V E      L + +K F +     +P   
Sbjct: 79  CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHF-KKQKRLIPERT 137

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
              Y  QL  AL + HSRR++HRD+KP N+ I  +G +KL D GL R F+         V
Sbjct: 138 VWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 197

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            T +Y  PE +     Y+   DIWS GC+  EM
Sbjct: 198 GTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEM 229

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  149 bits (378), Expect = 7e-45
 Identities = 46/150 (30%), Positives = 79/150 (52%), Gaps = 3/150 (2%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-TTPVPVPPALAKS 69
           + RE++VL  +KHPN+++  +    +  L++V ++    DL   +     V         
Sbjct: 70  SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           +  Q+  AL++ H R+I+HRD+K QNI + K G ++L DFG++R     +      + T 
Sbjct: 130 WFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTP 189

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +Y  PEI    K Y+   DIW+ GC+  E+
Sbjct: 190 YYLSPEICEN-KPYNNKSDIWALGCVLYEL 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  149 bits (377), Expect = 5e-44
 Identities = 48/161 (29%), Positives = 77/161 (47%), Gaps = 11/161 (6%)

Query: 10  STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAK 68
           S A RE+ +L+E  +HPNVIR           ++  E     L+++++            
Sbjct: 62  SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPI 121

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYT 123
           + L Q    L + HS  I+HRDLKP NILI+   A       ++DFGL +   +  + ++
Sbjct: 122 TLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS 181

Query: 124 H---EVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEM 159
                  T  +  PE+L     +  + TVDI+SAGC+F  +
Sbjct: 182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (369), Expect = 6e-44
 Identities = 48/177 (27%), Positives = 80/177 (45%), Gaps = 28/177 (15%)

Query: 12  ALREISVLKELKHPNVIRLHDVI------------PVDFKLFLVFEFL-RQDLKDFL--Q 56
            +RE+  L +L+HP ++R  +                   L++  +   +++LKD++  +
Sbjct: 50  VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR 109

Query: 57  TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            T      ++      Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A  
Sbjct: 110 CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169

Query: 117 IPMN------------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
                           R+T +V T  Y  PE + G   YS  VDI+S G I  E++ 
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY 225

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  143 bits (362), Expect = 4e-43
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 12/159 (7%)

Query: 12  ALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPA 65
            + E+++L+ELKHPN++R +D I    +  L++V E+    DL   +         +   
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEE 111

Query: 66  LAKSYLYQLLEALRYCHSRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
                + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R      +
Sbjct: 112 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 171

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                V T +Y  PE +     Y+   DIWS GC+  E+
Sbjct: 172 FAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYEL 209

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  142 bits (361), Expect = 6e-43
 Identities = 51/148 (34%), Positives = 82/148 (55%), Gaps = 5/148 (3%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE+ +   L+HPN++RL+       +++L+ E+     +   LQ            +Y+ 
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYIT 116

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S        R      TL Y 
Sbjct: 117 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDL-CGTLDYL 174

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PPE++ G +++   VD+WS G +  E +
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEFL 201

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  142 bits (359), Expect = 2e-42
 Identities = 50/148 (33%), Positives = 85/148 (57%), Gaps = 9/148 (6%)

Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           +EI++LK+L HPNV++L +V+  P +  L++VFE + Q  + +     P+      A+ Y
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS--EDQARFY 142

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TL 129
              L++ + Y H ++IIHRD+KP N+L+ + G +K+ADFG+S  F    +      V T 
Sbjct: 143 FQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLSNTVGTP 201

Query: 130 WYRPPEILLGA-KVYS-TTVDIWSAGCI 155
            +  PE L    K++S   +D+W+ G  
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVT 229

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  142 bits (360), Expect = 2e-42
 Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 17/164 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQ--TTPVPVPPALA 67
           +RE  VLK+L H N+++L  +          L+ EF     L   L+  +    +P +  
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYT 123
              L  ++  + +     I+HR++KP NI+     +     KL DFG +R         +
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 124 HEVVTLWYRPPEILLGA-------KVYSTTVDIWSAGCIFSEMI 160
               T  Y  P++   A       K Y  TVD+WS G  F    
Sbjct: 175 -LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  142 bits (361), Expect = 3e-42
 Identities = 39/157 (24%), Positives = 74/157 (47%), Gaps = 12/157 (7%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-------TTPVPVPPA 65
            E+ ++ ++K+   +    +I    ++++++E++    +  F +            +P  
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQ 151

Query: 66  LAKSYLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           + K  +  +L +  Y H+ + I HRD+KP NIL++K+G +KL+DFG S  + +       
Sbjct: 152 VIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKG- 209

Query: 125 EVVTLWYRPPEILLGAKVYS-TTVDIWSAGCIFSEMI 160
              T  + PPE       Y+   VDIWS G     M 
Sbjct: 210 SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  141 bits (358), Expect = 3e-42
 Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 7/150 (4%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-LRQDLKDFLQTTPVPVPPALAKSYLY 72
            EIS+ + L H +V+  H     +  +F+V E   R+ L +  +     +    A+ YL 
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLR 122

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLW 130
           Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R   +V+  T  
Sbjct: 123 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPN 180

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L   K +S  VD+WS GCI   ++
Sbjct: 181 YIAPEVLSK-KGHSFEVDVWSIGCIMYTLL 209

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  142 bits (359), Expect = 4e-42
 Identities = 48/150 (32%), Positives = 77/150 (51%), Gaps = 7/150 (4%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYLY 72
            EIS+ + L H +V+  H     +  +F+V E   R+ L +  +     +    A+ YL 
Sbjct: 90  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK-ALTEPEARYYLR 148

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TLW 130
           Q++   +Y H  R+IHRDLK  N+ +N+   +K+ DFGL+        R   +V+  T  
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER--KKVLCGTPN 206

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+L   K +S  VD+WS GCI   ++
Sbjct: 207 YIAPEVLSK-KGHSFEVDVWSIGCIMYTLL 235

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  140 bits (355), Expect = 6e-42
 Identities = 53/148 (35%), Positives = 86/148 (58%), Gaps = 5/148 (3%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           REI +   L+HPN++R+++      +++L+ EF  + +L   LQ          + +++ 
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFME 121

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           +L +AL YCH R++IHRD+KP+N+L+   G LK+ADFG S      + R T    TL Y 
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTM-CGTLDYL 179

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           PPE++ G K +   VD+W AG +  E +
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFL 206

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  143 bits (363), Expect = 7e-42
 Identities = 50/177 (28%), Positives = 80/177 (45%), Gaps = 30/177 (16%)

Query: 10  STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ------TTPVPV 62
             AL EI +L E   HPNVIR +     D  L++  E    +L+D ++            
Sbjct: 53  DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQ 112

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-------------LKLADF 109
                 S L Q+   + + HS +IIHRDLKPQNIL++ S               + ++DF
Sbjct: 113 KEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDF 172

Query: 110 GLSRAFTIPMNRYTHEVV----TLWYRPPEILLGA------KVYSTTVDIWSAGCIF 156
           GL +      + +   +     T  +R PE+L  +      +  + ++DI+S GC+F
Sbjct: 173 GLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVF 229

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  140 bits (355), Expect = 1e-41
 Identities = 41/167 (24%), Positives = 64/167 (38%), Gaps = 19/167 (11%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVD----FKLFLVFEF-LRQDLKDFLQTTPV---PVP 63
           A RE  + +   HPN++RL      +     + +L+  F  R  L + ++        + 
Sbjct: 73  AQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-- 121
                  L  +   L   H++   HRDLKP NIL+   G   L D G      I +    
Sbjct: 133 EDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

Query: 122 -------YTHEVVTLWYRPPEILLGAK--VYSTTVDIWSAGCIFSEM 159
                  +  +  T+ YR PE+       V     D+WS GC+   M
Sbjct: 193 QALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAM 239

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  140 bits (354), Expect = 3e-41
 Identities = 51/149 (34%), Positives = 74/149 (49%), Gaps = 8/149 (5%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPP---ALAKS 69
           RE S+   LKHP+++ L +    D  L++VFEF+   DL   +            A+A  
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEV 126
           Y+ Q+LEALRYCH   IIHRD+KP  +L+     S  +KL  FG++             V
Sbjct: 135 YMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            T  +  PE++   + Y   VD+W  G I
Sbjct: 195 GTPHFMAPEVVKR-EPYGKPVDVWGCGVI 222

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  140 bits (355), Expect = 5e-41
 Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 17/164 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQ--TTPVPVPPALA 67
           +RE  VLK+L H N+++L  +          L+ EF     L   L+  +    +P +  
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEF 114

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYT 123
              L  ++  + +     I+HR++KP NI+     +     KL DFG +R         +
Sbjct: 115 LIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS 174

Query: 124 HEVVTLWYRPPEILLGA-------KVYSTTVDIWSAGCIFSEMI 160
               T  Y  P++   A       K Y  TVD+WS G  F    
Sbjct: 175 -LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  135 bits (343), Expect = 5e-39
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 9/148 (6%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
            EI +LK+L HP +I++ +        ++V E +   +L D +      +  A  K Y Y
Sbjct: 189 TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFY 246

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Q+L A++Y H   IIHRDLKP+N+L+    +   +K+ DFG S+      +       T 
Sbjct: 247 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 305

Query: 130 WYRPPEILLGAKV--YSTTVDIWSAGCI 155
            Y  PE+L+      Y+  VD WS G I
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVI 333

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  132 bits (334), Expect = 1e-38
 Identities = 52/150 (34%), Positives = 81/150 (54%), Gaps = 10/150 (6%)

Query: 14  REISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLR---QDLKDFLQTTPVPVPPALAK 68
           +EI +L+ L+H NVI+L DV+      K+++V E+     Q++ D +     PV    A 
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVC--QAH 112

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV- 127
            Y  QL++ L Y HS+ I+H+D+KP N+L+   G LK++  G++ A        T     
Sbjct: 113 GYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQ 172

Query: 128 -TLWYRPPEILLGAKVYS-TTVDIWSAGCI 155
            +  ++PPEI  G   +S   VDIWSAG  
Sbjct: 173 GSPAFQPPEIANGLDTFSGFKVDIWSAGVT 202

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  133 bits (337), Expect = 2e-38
 Identities = 43/146 (29%), Positives = 73/146 (50%), Gaps = 5/146 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
             EIS++ +L HP +I LHD     +++ L+ EFL   +L D +      +  A   +Y+
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+     P         T 
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTATA 214

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCI 155
            +  PEI+   +      D+W+ G +
Sbjct: 215 EFAAPEIVDR-EPVGFYTDMWAIGVL 239

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  130 bits (330), Expect = 4e-38
 Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 9/162 (5%)

Query: 1   SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L T 
Sbjct: 59  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TE 117

Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P
Sbjct: 118 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-P 176

Query: 119 MNRYTHEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCI 155
             +      T  Y  PEI+  +       Y   VD+WS G I
Sbjct: 177 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVI 218

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  135 bits (342), Expect = 6e-38
 Identities = 52/160 (32%), Positives = 74/160 (46%), Gaps = 16/160 (10%)

Query: 14  REISVLKELKHPNVIRLHDVI------PVDFKLFLVFEFLRQ-DLKDFLQT--TPVPVPP 64
            EI ++K+L HPNV+   +V         +    L  E+    DL+ +L        +  
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE 120

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNR 121
              ++ L  +  ALRY H  RIIHRDLKP+NI++         K+ D G ++        
Sbjct: 121 GPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGE 178

Query: 122 YTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              E V TL Y  PE+L   K Y+ TVD WS G +  E I
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECI 217

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  134 bits (340), Expect = 6e-38
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 5/146 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
            +EI  +  L+HP ++ LHD    D ++ +++EF+   +L + +      +    A  Y+
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYM 261

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+     P         T 
Sbjct: 262 RQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVTTGTA 320

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCI 155
            +  PE+  G K      D+WS G +
Sbjct: 321 EFAAPEVAEG-KPVGYYTDMWSVGVL 345

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  131 bits (330), Expect = 6e-38
 Identities = 41/161 (25%), Positives = 69/161 (42%), Gaps = 16/161 (9%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFL--QTTPVPVPPALAKSYL 71
           +I  +      N +           L++  +   +++LKD++  + +       +     
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---------- 121
            Q+ EA+ + HS+ ++HRDLKP NI       +K+ DFGL  A                 
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230

Query: 122 --YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +T +V T  Y  PE + G   YS  VDI+S G I  E++
Sbjct: 231 ATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELL 270

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  130 bits (330), Expect = 7e-38
 Identities = 43/145 (29%), Positives = 78/145 (53%), Gaps = 5/145 (3%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           +EIS+L   +H N++ LH+      +L ++FEF+   D+ + + T+   +      SY++
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109

Query: 73  QLLEALRYCHSRRIIHRDLKPQNIL-INKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLW 130
           Q+ EAL++ HS  I H D++P+NI+   +  + +K+ +FG +R    P + +        
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-PGDNFRLLFTAPE 168

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCI 155
           Y  PE+     V ST  D+WS G +
Sbjct: 169 YYAPEVHQH-DVVSTATDMWSLGTL 192

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  129 bits (327), Expect = 8e-38
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 20/153 (13%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPAL 66
           RE+++L+E++HPN+I LHD+      + L+ E       F     K+ L           
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESL-------TEDE 109

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRY 122
           A  +L Q+L+ + Y HS+RI H DLKP+NI++      +  +KL DFG++       N +
Sbjct: 110 ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-AGNEF 168

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            +   T  +  PEI+   +      D+WS G I
Sbjct: 169 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVI 200

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  129 bits (327), Expect = 1e-37
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 9/148 (6%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
            EI +LK+L HP +I++ +        ++V E +   +L D +      +  A  K Y Y
Sbjct: 64  TEIEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFY 121

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Q+L A++Y H   IIHRDLKP+N+L+    +   +K+ DFG S+      +       T 
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTP 180

Query: 130 WYRPPEILLGA--KVYSTTVDIWSAGCI 155
            Y  PE+L+      Y+  VD WS G I
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVI 208

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  129 bits (326), Expect = 3e-37
 Identities = 50/147 (34%), Positives = 76/147 (51%), Gaps = 8/147 (5%)

Query: 14  REISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPALAKS 69
            E+ +LK++      VIRL D         L+ E     QDL DF+      +   LA+S
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARS 153

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVT 128
           + +Q+LEA+R+CH+  ++HRD+K +NILI+   G LKL DFG      +    YT    T
Sbjct: 154 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA--LLKDTVYTDFDGT 211

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
             Y PPE +   + +  +  +WS G +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGIL 238

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  131 bits (331), Expect = 4e-37
 Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 30/158 (18%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DL------------KDFLQTTPV 60
           RE  + + LKHPN++RLHD I  +   +L+F+ +   +L             D       
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEAD------- 111

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTI 117
                 A   + Q+LEA+ +CH   ++HR+LKP+N+L+    K  A+KLADFGL+     
Sbjct: 112 ------ASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165

Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
               +     T  Y  PE+L     Y   VD+W+ G I
Sbjct: 166 EQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVI 202

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  129 bits (327), Expect = 4e-37
 Identities = 54/146 (36%), Positives = 81/146 (55%), Gaps = 7/146 (4%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  + ++L+HPN++RLHD I  +   +LVF+ +   +L + +         A A   + 
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQ 135

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL+         +     T 
Sbjct: 136 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTP 194

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCI 155
            Y  PE+L     YS  VDIW+ G I
Sbjct: 195 GYLSPEVLKK-DPYSKPVDIWACGVI 219

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  129 bits (325), Expect = 4e-37
 Identities = 45/144 (31%), Positives = 70/144 (48%), Gaps = 4/144 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ--DLKDFLQTTPVPVPPALAKSYL 71
            EI++L  ++H N+I++ D+        LV E      DL  F+   P  +   LA    
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIF 136

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            QL+ A+ Y   + IIHRD+K +NI+I +   +KL DFG +         YT    T+ Y
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF-CGTIEY 195

Query: 132 RPPEILLGAKVYSTTVDIWSAGCI 155
             PE+L+G       +++WS G  
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVT 219

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  127 bits (322), Expect = 4e-37
 Identities = 45/149 (30%), Positives = 72/149 (48%), Gaps = 10/149 (6%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPP---ALAKS 69
            EI VLK L HPN+I++ +V      +++V E     +L + + +               
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEV 126
            + Q++ AL Y HS+ ++H+DLKP+NIL    +    +K+ DFGL+  F       T+  
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK-SDEHSTNAA 187

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            T  Y  PE+       +   DIWSAG +
Sbjct: 188 GTALYMAPEVFKRD--VTFKCDIWSAGVV 214

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  127 bits (322), Expect = 4e-37
 Identities = 36/172 (20%), Positives = 59/172 (34%), Gaps = 28/172 (16%)

Query: 12  ALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ---TTPVPVPPAL 66
           ALRE+     L +H +V+R       D  + +  E+     L D +            A 
Sbjct: 57  ALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAE 116

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-------------------KLA 107
            K  L Q+   LRY HS  ++H D+KP NI I+++                      K+ 
Sbjct: 117 LKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIG 176

Query: 108 DFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           D G     +   +    E     +   E+L     +    DI++        
Sbjct: 177 DLGHVTRIS---SPQV-EEGDSRFLANEVLQENYTHLPKADIFALALTVVCA 224

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  127 bits (322), Expect = 4e-37
 Identities = 54/146 (36%), Positives = 81/146 (55%), Gaps = 7/146 (4%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           RE  + ++L+HPN++RLHD I  +   +LVF+ +   +L + +         A A   + 
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQ 112

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Q+LE++ YCHS  I+HR+LKP+N+L+    K  A+KLADFGL+         +     T 
Sbjct: 113 QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFAGTP 171

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCI 155
            Y  PE+L     YS  VDIW+ G I
Sbjct: 172 GYLSPEVLKK-DPYSKPVDIWACGVI 196

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  128 bits (323), Expect = 7e-37
 Identities = 50/143 (34%), Positives = 81/143 (56%), Gaps = 3/143 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+ ++K L HPN+++L +VI  +  L+L+ E+    ++ D+L      +    A+S   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFR 121

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           Q++ A++YCH +RI+HRDLK +N+L++    +K+ADFG S  FT+             Y 
Sbjct: 122 QIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF-CGAPPYA 180

Query: 133 PPEILLGAKVYSTTVDIWSAGCI 155
            PE+  G K     VD+WS G I
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVI 203

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  128 bits (323), Expect = 1e-36
 Identities = 46/153 (30%), Positives = 74/153 (48%), Gaps = 20/153 (13%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPAL 66
           RE+S+L+++ HPN+I LHDV      + L+ E       F     K+ L           
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-------SEEE 116

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRY 122
           A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+         +
Sbjct: 117 ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEF 175

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            +   T  +  PEI+   +      D+WS G I
Sbjct: 176 KNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVI 207

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  127 bits (321), Expect = 1e-36
 Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 20/154 (12%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPA 65
            RE+S+L+++ H NVI LHDV      + L+ E       F     K+ L          
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESL-------SEE 115

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNR 121
            A S++ Q+L+ + Y H+++I H DLKP+NI++         +KL DFGL+         
Sbjct: 116 EATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVE 174

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
           + +   T  +  PEI+   +      D+WS G I
Sbjct: 175 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVI 207

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  127 bits (321), Expect = 1e-36
 Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 20/154 (12%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFE-------FLRQDLKDFLQTTPVPVPPA 65
            RE+S+LKE++HPNVI LH+V      + L+ E       F     K+ L          
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESL-------TEE 114

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNR 121
            A  +L Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N 
Sbjct: 115 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNE 173

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
           + +   T  +  PEI+   +      D+WS G I
Sbjct: 174 FKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVI 206

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  130 bits (328), Expect = 1e-36
 Identities = 48/147 (32%), Positives = 78/147 (53%), Gaps = 8/147 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           LRE+ +LK+L HPN+++L++        +LV E     +L D + +         A   +
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARII 132

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+L  + Y H  +I+HRDLKP+N+L+   +K   +++ DFGLS  F     +   ++ T
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-ASKKMKDKIGT 191

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
            +Y  PE+L G   Y    D+WS G I
Sbjct: 192 AYYIAPEVLHGT--YDEKCDVWSTGVI 216

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  127 bits (320), Expect = 2e-36
 Identities = 48/149 (32%), Positives = 77/149 (51%), Gaps = 10/149 (6%)

Query: 14  REISVLKEL----KHPNVIRLHDVIPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPALA 67
            E+++L ++     HP VIRL D         LV E     QDL D++ T   P+    +
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-TEKGPLGEGPS 141

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEV 126
           + +  Q++ A+++CHSR ++HRD+K +NILI+ + G  KL DFG      +    YT   
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA--LLHDEPYTDFD 199

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            T  Y PPE +   + ++    +WS G +
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGIL 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  129 bits (325), Expect = 2e-36
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 17/159 (10%)

Query: 12  ALREISVLKELKH------PNVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTP-VPV 62
           A  EI +L+ L+        NVI + +     F+  + + FE L  +L + ++       
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLEN--FTFRNHICMTFELLSMNLYELIKKNKFQGF 197

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMN 120
              L + + + +L+ L   H  RIIH DLKP+NIL+       +K+ DFG S      + 
Sbjct: 198 SLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            Y   + + +YR PE++LGA+ Y   +D+WS GCI +E+
Sbjct: 258 TY---IQSRFYRAPEVILGAR-YGMPIDMWSLGCILAEL 292

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  129 bits (327), Expect = 3e-36
 Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 8/147 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           L E++VLK L HPN+++L+D        +LV E  +  +L D +    +      A   +
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVII 142

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+L  + Y H   I+HRDLKP+N+L+    K   +K+ DFGLS  F     +    + T
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE-NQKKMKERLGT 201

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
            +Y  PE+L     Y    D+WS G I
Sbjct: 202 AYYIAPEVLRKK--YDEKCDVWSIGVI 226

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  127 bits (321), Expect = 3e-36
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 5/146 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
             EISV+ +L H N+I+L+D       + LV E++   +L D +      +       ++
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFM 193

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNIL-INKSGA-LKLADFGLSRAFTIPMNRYTHEVVTL 129
            Q+ E +R+ H   I+H DLKP+NIL +N+    +K+ DFGL+R +  P  +      T 
Sbjct: 194 KQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-PREKLKVNFGTP 252

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCI 155
            +  PE++      S   D+WS G I
Sbjct: 253 EFLAPEVVNY-DFVSFPTDMWSVGVI 277

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  127 bits (320), Expect = 3e-36
 Identities = 56/162 (34%), Positives = 87/162 (53%), Gaps = 9/162 (5%)

Query: 1   SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           S  Q+E V     RE  +L+++  HP++I L D       +FLVF+ +R+ +L D+L T 
Sbjct: 135 SPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TE 193

Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V +     +S +  LLEA+ + H+  I+HRDLKP+NIL++ +  ++L+DFG S     P
Sbjct: 194 KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE-P 252

Query: 119 MNRYTHEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCI 155
             +      T  Y  PEIL  +       Y   VD+W+ G I
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVI 294

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  129 bits (325), Expect = 4e-36
 Identities = 49/147 (33%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           LRE+ +LK+L HPN+++L +++      ++V E     +L D +           A   +
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARII 127

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     +    + T
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKMKDRIGT 186

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
            +Y  PE+L G   Y    D+WSAG I
Sbjct: 187 AYYIAPEVLRGT--YDEKCDVWSAGVI 211

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  129 bits (325), Expect = 5e-36
 Identities = 51/147 (34%), Positives = 75/147 (51%), Gaps = 8/147 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
             EIS+LK L HPN+I+L DV       +LV EF    +L + +           A + +
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIM 152

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Q+L  + Y H   I+HRD+KP+NIL+   N    +K+ DFGLS  F+    +    + T
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLRDRLGT 211

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCI 155
            +Y  PE+L     Y+   D+WS G I
Sbjct: 212 AYYIAPEVLKKK--YNEKCDVWSCGVI 236

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  126 bits (318), Expect = 8e-36
 Identities = 25/157 (15%), Positives = 41/157 (26%), Gaps = 12/157 (7%)

Query: 13  LREISVLKELKHPNVIRLHDV--IPVDFKLFLVFEFLRQDLKDFLQ------TTPVPVPP 64
           L     +     P   +L             L+      DL+                  
Sbjct: 134 LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGI 193

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
                   QL+       S+ ++H    P N+ I   G L L D            R   
Sbjct: 194 LALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWK---VGTRGPA 250

Query: 125 EVVTLWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMI 160
             V + Y P E L  +   ++  ++ W  G     + 
Sbjct: 251 SSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  124 bits (314), Expect = 8e-36
 Identities = 53/152 (34%), Positives = 76/152 (50%), Gaps = 7/152 (4%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTT--PVPVPPALAKSY 70
            EI++ K LKH N+++       +  + +  E +    L   L++   P+         Y
Sbjct: 68  EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV-T 128
             Q+LE L+Y H  +I+HRD+K  N+LIN  SG LK++DFG S+     +N  T     T
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGT 186

Query: 129 LWYRPPE-ILLGAKVYSTTVDIWSAGCIFSEM 159
           L Y  PE I  G + Y    DIWS GC   EM
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  123 bits (312), Expect = 1e-35
 Identities = 49/146 (33%), Positives = 74/146 (50%), Gaps = 8/146 (5%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           +EI ++K L HPN+IRL++    +  ++LV E     +L + +         + A   + 
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMK 113

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
            +L A+ YCH   + HRDLKP+N L    +    LKL DFGL+  F  P      +V T 
Sbjct: 114 DVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-PGKMMRTKVGTP 172

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCI 155
           +Y  P++L G   Y    D WSAG +
Sbjct: 173 YYVSPQVLEGL--YGPECDEWSAGVM 196

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  125 bits (315), Expect = 1e-35
 Identities = 49/160 (30%), Positives = 83/160 (51%), Gaps = 12/160 (7%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV 60
             ++   +     REIS LK L+HP++I+L+DVI     + +V E+   +L D++     
Sbjct: 45  QLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYI-VEKK 103

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
            +     + +  Q++ A+ YCH  +I+HRDLKP+N+L++ +  +K+ADFGLS   T    
Sbjct: 104 RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---- 159

Query: 121 RYTHEVVTLW-----YRPPEILLGAKVYSTTVDIWSAGCI 155
                 +        Y  PE++ G       VD+WS G +
Sbjct: 160 --DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIV 197

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  123 bits (312), Expect = 2e-35
 Identities = 48/153 (31%), Positives = 73/153 (47%), Gaps = 22/153 (14%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPA 65
           RE+ +LK+L HPN+++L +++      ++V E              K F +         
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSE--------H 121

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRY 122
            A   + Q+   + Y H   I+HRDLKP+NIL+    K   +K+ DFGLS  F     + 
Sbjct: 122 DAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ-QNTKM 180

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
              + T +Y  PE+L G   Y    D+WSAG I
Sbjct: 181 KDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVI 211

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  123 bits (310), Expect = 2e-35
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 4/158 (2%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 59
              +    P    +EI + K L H NV++ +         +L  E+    +L D +    
Sbjct: 41  DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPD 99

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IP 118
           + +P   A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F    
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

Query: 119 MNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
             R  +++  TL Y  PE+L   + ++  VD+WS G +
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  122 bits (309), Expect = 4e-35
 Identities = 52/161 (32%), Positives = 80/161 (49%), Gaps = 13/161 (8%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 59
            +++   V     REI  LK  +HP++I+L+ VI      F+V E++   +L D++    
Sbjct: 47  QKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI-CKH 105

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
             V    A+    Q+L A+ YCH   ++HRDLKP+N+L++     K+ADFGLS   +   
Sbjct: 106 GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--- 162

Query: 120 NRYTHEVVTLW-----YRPPEILLGAKVYSTTVDIWSAGCI 155
                E +        Y  PE++ G       VDIWS G I
Sbjct: 163 ---DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVI 200

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  124 bits (312), Expect = 4e-35
 Identities = 50/189 (26%), Positives = 75/189 (39%), Gaps = 47/189 (24%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPAL------ 66
            E+ ++K+L HPN+ RL++V   +  + LV E      L D L                 
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136

Query: 67  ---------------------------------AKSYLYQLLEALRYCHSRRIIHRDLKP 93
                                              + + Q+  AL Y H++ I HRD+KP
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196

Query: 94  QNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVTL----WYRPPEILLGA-KVYSTT 146
           +N L   NKS  +KL DFGLS+ F    N   + + T     ++  PE+L    + Y   
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256

Query: 147 VDIWSAGCI 155
            D WSAG +
Sbjct: 257 CDAWSAGVL 265

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  123 bits (311), Expect = 5e-35
 Identities = 44/168 (26%), Positives = 72/168 (42%), Gaps = 18/168 (10%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTT 58
           +V  +    + E+     L  P ++ L+  +     + +  E      L Q +K      
Sbjct: 90  KVR-LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG--- 145

Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGAL-KLADFGLSRAFTI 117
              +P   A  YL Q LE L Y H+RRI+H D+K  N+L++  G+   L DFG +     
Sbjct: 146 --CLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203

Query: 118 PMNRYTHEVV-----TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                +         T  +  PE+++G K     VDIWS+ C+   M+
Sbjct: 204 DGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHML 250

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  123 bits (310), Expect = 6e-35
 Identities = 45/158 (28%), Positives = 80/158 (50%), Gaps = 4/158 (2%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP 59
              +    P    +EI + K L H NV++ +         +L  E+    +L D +    
Sbjct: 41  DMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRI-EPD 99

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IP 118
           + +P   A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F    
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159

Query: 119 MNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
             R  +++  TL Y  PE+L   + ++  VD+WS G +
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV 197

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  122 bits (309), Expect = 7e-35
 Identities = 50/151 (33%), Positives = 74/151 (49%), Gaps = 18/151 (11%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT----TPVPVPPALAK 68
            EI+VLK++KH N++ L D+       +LV + +   +L D +      T        A 
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTE-----KDAS 109

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHE 125
             + Q+L A++Y H   I+HRDLKP+N+L     ++  + + DFGLS+      N     
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMST 166

Query: 126 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
              T  Y  PE+L   K YS  VD WS G I
Sbjct: 167 ACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVI 196

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  122 bits (309), Expect = 9e-35
 Identities = 44/175 (25%), Positives = 74/175 (42%), Gaps = 27/175 (15%)

Query: 12  ALREISVLKELK-HPNVIRLHDVIPVD--------FKLFLVFEFLRQDLKDFLQTTPV-- 60
            ++E+  +K+L  HPN+++      +          +  L+ E  +  L +FL+      
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131

Query: 61  PVPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
           P+         YQ   A+++ H ++  IIHRDLK +N+L++  G +KL DFG +   +  
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

Query: 119 MNRYTH------------EVVTLWYRPPEI--LLGAKVYSTTVDIWSAGCIFSEM 159
            +                   T  YR PEI  L          DIW+ GCI   +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  121 bits (307), Expect = 2e-34
 Identities = 47/149 (31%), Positives = 69/149 (46%), Gaps = 8/149 (5%)

Query: 13  LREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPP-ALAKS 69
           L EI+VL+  K  P VI LH+V     ++ L+ E+    ++          +        
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR 135

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEV 126
            + Q+LE + Y H   I+H DLKPQNIL+      G +K+ DFG+SR            +
Sbjct: 136 LIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HACELREIM 194

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
            T  Y  PEIL      +T  D+W+ G I
Sbjct: 195 GTPEYLAPEILNY-DPITTATDMWNIGII 222

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  122 bits (308), Expect = 2e-34
 Identities = 52/161 (32%), Positives = 69/161 (42%), Gaps = 37/161 (22%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFE----------------FLRQDLKDFLQT 57
            EI VL  L HPN+I+L ++     ++ LV E                +  +D       
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD------- 149

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRA 114
                    A   + Q+LEA+ Y H   I+HRDLKP+N+L         LK+ADFGLS+ 
Sbjct: 150 ---------AADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200

Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
                        T  Y  PEIL G   Y   VD+WS G I
Sbjct: 201 VE-HQVLMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGII 239

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  121 bits (305), Expect = 8e-34
 Identities = 51/177 (28%), Positives = 79/177 (44%), Gaps = 35/177 (19%)

Query: 11  TALREISVLKELK-----------HPNVIRLHDVIPVDFK--------LFLVFEFLRQDL 51
            A  EI +L+ +              ++++L D     F         + +VFE L ++L
Sbjct: 61  AAEDEIKLLQRVNDADNTKEDSMGANHILKLLD----HFNHKGPNGVHVVMVFEVLGENL 116

Query: 52  KDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------KSGA 103
              ++      +P    K    QLL  L Y H R  IIH D+KP+N+L+           
Sbjct: 117 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ 176

Query: 104 LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +K+AD G +  +      YT+ + T  YR PE+LLGA  +    DIWS  C+  E+I
Sbjct: 177 IKIADLG-NACWY--DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELI 229

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  121 bits (305), Expect = 9e-34
 Identities = 54/161 (33%), Positives = 80/161 (49%), Gaps = 19/161 (11%)

Query: 12  ALREISVLKELKHP------NVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTP-VPV 62
           A  E+ +L+ +          ++ L       F+  L LVFE L  +L D L+ T    V
Sbjct: 97  AQIEVRLLELMNKHDTEMKYYIVHLKRH--FMFRNHLCLVFEMLSYNLYDLLRNTNFRGV 154

Query: 63  PPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNILI--NKSGALKLADFGLSRAFTIP 118
              L + +  Q+  AL +  +    IIH DLKP+NIL+   K  A+K+ DFG S      
Sbjct: 155 SLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR 214

Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           + +Y   + + +YR PE+LLG   Y   +D+WS GCI  EM
Sbjct: 215 IYQY---IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEM 251

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  120 bits (302), Expect = 1e-33
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 21/154 (13%)

Query: 14  REISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPP 64
           +EI+ LK  + HPN+++LH+V       FLV E L         +  K F +        
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSE-------- 105

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR 121
             A   + +L+ A+ + H   ++HRDLKP+N+L    N +  +K+ DFG +R        
Sbjct: 106 TEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP 165

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
                 TL Y  PE+ L    Y  + D+WS G I
Sbjct: 166 LKTPCFTLHYAAPEL-LNQNGYDESCDLWSLGVI 198

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  121 bits (306), Expect = 2e-33
 Identities = 48/148 (32%), Positives = 77/148 (52%), Gaps = 13/148 (8%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           REI  LK  +HP++I+L+ VI     +F+V E++   +L D++      +    ++    
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG-RLDEKESRRLFQ 123

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW-- 130
           Q+L  + YCH   ++HRDLKP+N+L++     K+ADFGLS   +        E +     
Sbjct: 124 QILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS------DGEFLRTSCG 177

Query: 131 ---YRPPEILLGAKVYSTTVDIWSAGCI 155
              Y  PE++ G       VDIWS+G I
Sbjct: 178 SPNYAAPEVISGRLYAGPEVDIWSSGVI 205

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  118 bits (299), Expect = 2e-33
 Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 4/149 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE      L+ P+V+ +HD   +D +L++    +   DL   L+    P+ P  A + + 
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVR 141

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 131
           Q+  AL   H+    HRD+KP+NIL++      L DFG++ A T          V TL+Y
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYY 201

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE    +   +   DI++  C+  E +
Sbjct: 202 MAPERFSESHA-TYRADIYALTCVLYECL 229

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  120 bits (301), Expect = 2e-33
 Identities = 32/166 (19%), Positives = 58/166 (34%), Gaps = 19/166 (11%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ----TTPVPVPPALA 67
            + +  LK       ++ +          LV E      L + +     T    +P  L 
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLV 174

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-----------KSGALKLADFGLSRAFT 116
            S+  ++L  +   H   IIH D+KP N ++             S  L L D G S    
Sbjct: 175 ISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 117 IPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +      +T +  T  ++  E+L   K ++  +D +        M+
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCML 279

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  118 bits (298), Expect = 5e-33
 Identities = 43/156 (27%), Positives = 75/156 (48%), Gaps = 24/156 (15%)

Query: 14  REISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPP 64
            EI +L +  +HPN+I L DV      +++V E ++           K F +        
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-------- 115

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNIL-INKSG---ALKLADFGLSRAFTIPMN 120
             A + L+ + + + Y H++ ++HRDLKP NIL +++SG   ++++ DFG ++      N
Sbjct: 116 REASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AEN 174

Query: 121 RYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
                   T  +  PE+L   + Y    DIWS G +
Sbjct: 175 GLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVL 209

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  117 bits (295), Expect = 6e-33
 Identities = 48/149 (32%), Positives = 84/149 (56%), Gaps = 4/149 (2%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLY 72
           RE+    +L H N++ + DV   D   +LV E++    L +++++   P+    A ++  
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTN 118

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 131
           Q+L+ +++ H  RI+HRD+KPQNILI+ +  LK+ DFG+++A +      T+ V+ T+ Y
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQY 178

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE   G        DI+S G +  EM+
Sbjct: 179 FSPEQAKGEAT-DECTDIYSIGIVLYEML 206

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  116 bits (293), Expect = 1e-32
 Identities = 47/171 (27%), Positives = 85/171 (49%), Gaps = 19/171 (11%)

Query: 3   VQVEGVPSTALR----EISVLKELKHPNVIRLH----DVIPVDFKLFLVFEFLRQ-DLKD 53
           +Q   +  +  +    E  +LK L+HPN++R +      +     + LV E +    LK 
Sbjct: 59  LQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT 118

Query: 54  FLQTTPVPVPPALAKSYLYQLLEALRYCHSRR--IIHRDLKPQNILIN-KSGALKLADFG 110
           +L+     +   + +S+  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D G
Sbjct: 119 YLKRFK-VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177

Query: 111 LSRAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           L+   T+    +   V+ T  +  PE  +  + Y  +VD+++ G    EM 
Sbjct: 178 LA---TLKRASFAKAVIGTPEFMAPE--MYEEKYDESVDVYAFGMCMLEMA 223

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  117 bits (296), Expect = 1e-32
 Identities = 46/182 (25%), Positives = 78/182 (42%), Gaps = 41/182 (22%)

Query: 12  ALREISVLKELKH-----PNVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTP-VPVP 63
           A  E  +LK++++      N+++ H      +   + L+FE L   L + +         
Sbjct: 78  AKIEADILKKIQNDDINNNNIVKYHGK--FMYYDHMCLIFEPLGPSLYEIITRNNYNGFH 135

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN------------------------ 99
               K Y  ++L+AL Y     + H DLKP+NIL++                        
Sbjct: 136 IEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYR 195

Query: 100 -KSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFS 157
            KS  +KL DFG    F    + Y   ++ T  YR PE++L    +  + D+WS GC+ +
Sbjct: 196 TKSTGIKLIDFG-CATFK---SDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLA 250

Query: 158 EM 159
           E+
Sbjct: 251 EL 252

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  117 bits (295), Expect = 1e-32
 Identities = 46/146 (31%), Positives = 73/146 (50%), Gaps = 7/146 (4%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           REI   + L+HPN++R  +VI     L ++ E+    +L + +           A+ +  
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQ 123

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVV-TL 129
           QLL  + YCHS +I HRDLK +N L+  + +  LK+ DFG S++    ++      V T 
Sbjct: 124 QLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTP 181

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCI 155
            Y  PE+LL  +      D+WS G  
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVT 207

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  118 bits (296), Expect = 1e-32
 Identities = 24/165 (14%), Positives = 61/165 (36%), Gaps = 22/165 (13%)

Query: 13  LREISVLKELKHPNVIRL--HDVIPVDFKLFLVFEFLRQDLKDFLQ------TTPVPVPP 64
           +    ++K+ +   +IR+   +        F ++  ++ +L+ F +      +T   +  
Sbjct: 146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVH 205

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
                   Q++  L   H   ++H  L+P +I++++ G + L  F               
Sbjct: 206 HARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARVV 261

Query: 125 EVVTLWYRPPEIL----------LGAKVYSTTVDIWSAGCIFSEM 159
             V+  + PPE+               + + + D W+ G +   +
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  117 bits (294), Expect = 2e-32
 Identities = 54/176 (30%), Positives = 82/176 (46%), Gaps = 34/176 (19%)

Query: 12  ALREISVLKELKHP------NVIRLHDVIPVDFK--LFLVFEFLRQDLKDFL-QTTPVPV 62
           A  EI+VLK++K          + + D    +F   + + FE L ++  +FL +    P 
Sbjct: 63  ARLEINVLKKIKEKDKENKFLCVLMSDW--FNFHGHMCIAFELLGKNTFEFLKENNFQPY 120

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-------------------KSGA 103
           P    +   YQL  ALR+ H  ++ H DLKP+NIL                     K+ +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTS 180

Query: 104 LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
           +++ADFG S A     +  T  V T  YRPPE++L    ++   D+WS GCI  E 
Sbjct: 181 IRVADFG-S-ATFDHEHHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY 232

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  116 bits (292), Expect = 3e-32
 Identities = 45/173 (26%), Positives = 74/173 (42%), Gaps = 28/173 (16%)

Query: 12  ALREISVLKELKHP------NVIRLHDVIPVDFK--LFLVFEFLRQDLKDFLQTTP-VPV 62
           A  EI VL+ L           +++ +    +    + +VFE L     DF++    +P 
Sbjct: 58  ARSEIQVLEHLNTTDPNSTFRCVQMLEW--FEHHGHICIVFELLGLSTYDFIKENGFLPF 115

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR- 121
                +   YQ+ +++ + HS ++ H DLKP+NIL  +S   +  +  + R     +N  
Sbjct: 116 RLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 122 ----------YTHE-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                     Y  E     V T  YR PE++L    +S   D+WS GCI  E 
Sbjct: 176 IKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEY 227

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  114 bits (287), Expect = 1e-31
 Identities = 46/164 (28%), Positives = 82/164 (50%), Gaps = 18/164 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L+E+ V++ L+HPNV++   V+  D +L  + E+++   L+  +++     P +   S+ 
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR---------------AFT 116
             +   + Y HS  IIHRDL   N L+ ++  + +ADFGL+R                  
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               RYT  V   ++  PE++ G + Y   VD++S G +  E+I
Sbjct: 175 DRKKRYT-VVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEII 216

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  111 bits (280), Expect = 7e-31
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 16/162 (9%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+ ++  L HPN+++L+ +  +     +V EF+   DL   L     P+  ++    +
Sbjct: 71  QREVFIMSNLNHPNIVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128

Query: 72  YQLLEALRYCHSRR--IIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYTH 124
             +   + Y  ++   I+HRDL+  NI +           K+ADFGLS+     +   + 
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV---SG 185

Query: 125 EVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMI--QIP 163
            +    +  PE +    + Y+   D +S   I   ++  + P
Sbjct: 186 LLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  113 bits (285), Expect = 9e-31
 Identities = 45/152 (29%), Positives = 69/152 (45%), Gaps = 12/152 (7%)

Query: 14  REISVLKEL-KHPNVIRLHDV----IPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPAL 66
           RE+ +     + P+++R+ DV          L +V E L   +                 
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 162

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N  T
Sbjct: 163 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNSLT 221

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
               T +Y  PE+ LG + Y  + D+WS G I
Sbjct: 222 TPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVI 252

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  111 bits (281), Expect = 1e-30
 Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 31/165 (18%)

Query: 14  REISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPP 64
           RE+ +L + + H NV+ L +    + + +LVFE +R           + F +        
Sbjct: 59  REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE-------- 110

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR 121
             A   +  +  AL + H++ I HRDLKP+NIL    N+   +K+ DF L     +  + 
Sbjct: 111 LEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC 170

Query: 122 YTHEVV-------TLWYRPPEILLG----AKVYSTTVDIWSAGCI 155
                        +  Y  PE++      A +Y    D+WS G I
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVI 215

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  114 bits (287), Expect = 2e-30
 Identities = 43/155 (27%), Positives = 77/155 (49%), Gaps = 16/155 (10%)

Query: 12  ALREISVLKELKHPNVIRLHDV-----IPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPA 65
           A+ E   L E+ HP+++++ +         D   ++V E++  Q LK         +P A
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVA 182

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            A +YL ++L AL Y HS  +++ DLKP+NI++ +   LKL D G        +N + + 
Sbjct: 183 EAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSR----INSFGYL 237

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  ++ PEI+      +T  DI++ G   + + 
Sbjct: 238 YGTPGFQAPEIVRTGPTVAT--DIYTVGRTLAALT 270

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  110 bits (278), Expect = 2e-30
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 6/162 (3%)

Query: 3   VQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVP 61
           V VE      ++EIS++++   P+V++ +     +  L++V E+     + D ++     
Sbjct: 62  VPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT 121

Query: 62  VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +      + L   L+ L Y H  R IHRD+K  NIL+N  G  KLADFG++   T  M +
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG--CIFSEMIQ 161
               + T ++  PE++     Y+   DIWS G   I  EM +
Sbjct: 182 RNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAI--EMAE 220

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  110 bits (277), Expect = 3e-30
 Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 15/160 (9%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKS 69
           + E+  L  + HPN+++L+        + LV E+     L + L           A A S
Sbjct: 49  IVELRQLSRVNHPNIVKLYGA--CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS 106

Query: 70  YLYQLLEALRYCHSRR---IIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHE 125
           +  Q  + + Y HS +   +IHRDLKP N+L+   G  LK+ DFG +      M   T+ 
Sbjct: 107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM---TNN 163

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI--QIP 163
             +  +  PE+  G   YS   D++S G I  E+I  + P
Sbjct: 164 KGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKP 202

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  110 bits (277), Expect = 3e-30
 Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 13/162 (8%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR----QDLKDFLQTTPVPVPPALAK 68
           L+EI  + +  HPN++  +    V  +L+LV + L      D+   +          L +
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 69  SY----LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           S     L ++LE L Y H    IHRD+K  NIL+ + G++++ADFG+S       +   +
Sbjct: 121 STIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRN 180

Query: 125 E-----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           +     V T  +  PE++   + Y    DIWS G    E+  
Sbjct: 181 KVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELAT 222

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  110 bits (277), Expect = 3e-30
 Identities = 47/148 (31%), Positives = 75/148 (50%), Gaps = 10/148 (6%)

Query: 21  ELKHPNVIRLHDV----IPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLL 75
            L HP ++ ++D      P     ++V E++    L+D + T   P+ P  A   +    
Sbjct: 68  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADAC 126

Query: 76  EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH--EVV-TLWYR 132
           +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA     N  T    V+ T  Y 
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE   G  V     D++S GC+  E++
Sbjct: 187 SPEQARGDSV-DARSDVYSLGCVLYEVL 213

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  110 bits (276), Expect = 3e-30
 Identities = 35/158 (22%), Positives = 72/158 (45%), Gaps = 8/158 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
             E+ VL++ +H N++          +L +V ++     L   L  +             
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR--AFTIPMNRYTHEVVTL 129
            Q    + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +++     ++
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186

Query: 130 WYRPPEILLG--AKVYSTTVDIWSAGCIFSEMI--QIP 163
            +  PE++    +  YS   D+++ G +  E++  Q+P
Sbjct: 187 LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLP 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  111 bits (278), Expect = 6e-30
 Identities = 39/159 (24%), Positives = 64/159 (40%), Gaps = 10/159 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 70
             E+ V K   HPN++        D +L++V  F+     KD + T     +        
Sbjct: 74  QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-------YT 123
           L  +L+AL Y H    +HR +K  +ILI+  G + L+    + +      R         
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 124 HEVVTLWYRPPEILL-GAKVYSTTVDIWSAGCIFSEMIQ 161
           + V  L +  PE+L    + Y    DI+S G    E+  
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELAN 232

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  110 bits (276), Expect = 8e-30
 Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 15/153 (9%)

Query: 14  REISVLKEL-KHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKD-FLQTTPVPVPPAL 66
           +E+    +    P+++ + DV          L ++ E +   +L     +          
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE 129

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   +  +  A+++ HS  I HRD+KP+N+L     K   LKL DFG ++  T       
Sbjct: 130 AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNAL 186

Query: 124 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCI 155
                T +Y  PE+ LG + Y  + D+WS G I
Sbjct: 187 QTPCYTPYYVAPEV-LGPEKYDKSCDMWSLGVI 218

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  108 bits (273), Expect = 1e-29
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 8/158 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFL--QTTPVPVPPALAKS 69
           LRE++++K L+HPN++     +     L +V E+L +  L   L        +      S
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141

Query: 70  YLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
             Y + + + Y H+R   I+HR+LK  N+L++K   +K+ DFGLSR              
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI--QIP 163
           T  +  PE+L   +  +   D++S G I  E+   Q P
Sbjct: 202 TPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQP 238

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (274), Expect = 1e-29
 Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 18/156 (11%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
           +E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  + 
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHG 162

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG----LSRAFTIPMNRYTHEVVTL 129
            L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG    ++ A +         V T 
Sbjct: 163 ALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF--------VGTP 214

Query: 130 WYRPPEILLGAK--VYSTTVDIWSAG--CIFSEMIQ 161
           ++  PE++L      Y   VD+WS G  CI  E+ +
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCI--ELAE 248

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (275), Expect = 2e-29
 Identities = 26/178 (14%), Positives = 59/178 (33%), Gaps = 24/178 (13%)

Query: 2   RVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQ 56
            ++ +      LR I     +K P   ++  V   +        F ++  ++ +L+ F +
Sbjct: 137 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 196

Query: 57  ------TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFG 110
                 +T   +          Q++  L   H   ++H  L+P +I++++ G + L  F 
Sbjct: 197 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 111 LSRAFTIPMNRYTHEVVTLWYRPPEIL---------LGAKVYSTTVDIWSAGCIFSEM 159
                           +   + PPE               + +   D W+ G     +
Sbjct: 257 HLV----RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  108 bits (271), Expect = 2e-29
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 9/156 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           + EI +L    HP +++L      D KL+++ EF     +   +      +     +   
Sbjct: 64  IVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVC 123

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q+LEAL + HS+RIIHRDLK  N+L+   G ++LADFG+S      + +    + T ++
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183

Query: 132 RPPEILLGAKV----YSTTVDIWSAG--CIFSEMIQ 161
             PE+++   +    Y    DIWS G   I  EM Q
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLI--EMAQ 217

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  107 bits (268), Expect = 5e-29
 Identities = 47/153 (30%), Positives = 80/153 (52%), Gaps = 12/153 (7%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY-- 70
           +EI+VL +   P V + +     D KL+++ E+L      D L+  P      L ++   
Sbjct: 69  QEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIA 122

Query: 71  --LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
             L ++L+ L Y HS + IHRD+K  N+L+++ G +KLADFG++   T    +    V T
Sbjct: 123 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 182

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
            ++  PE++  +  Y +  DIWS G    E+ +
Sbjct: 183 PFWMAPEVIKQSA-YDSKADIWSLGITAIELAR 214

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  106 bits (266), Expect = 1e-28
 Identities = 30/167 (17%), Positives = 69/167 (41%), Gaps = 17/167 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE+   ++ +H NV+           L ++    +   L   ++   + +     +   
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
            ++++ + Y H++ I+H+DLK +N+  +  G + + DFGL     +       + + +  
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 130 -WYRP--PEIL--------LGAKVYSTTVDIWSAGCIFSEMI--QIP 163
            W     PEI+             +S   D+++ G I+ E+   + P
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (266), Expect = 2e-28
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 5/151 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            RE  V+  L HP  ++L+     D KL+    + +  +L  +++           + Y 
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS-FDETCTRFYT 136

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLS-RAFTIPMNRYTHEVV-TL 129
            +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG +            +  V T 
Sbjct: 137 AEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y  PE+L   K    + D+W+ GCI  +++
Sbjct: 197 QYVSPELLTE-KSACKSSDLWALGCIIYQLV 226

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (264), Expect = 2e-28
 Identities = 53/152 (34%), Positives = 84/152 (55%), Gaps = 8/152 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
           + EI V++E K+PN++   D   V  +L++V E+L    L D +  T +     +A +  
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD-EGQIA-AVC 122

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 132 RPPEILLGAKVYSTTVDIWSAG--CIFSEMIQ 161
             PE++   K Y   VDIWS G   I  EMI+
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAI--EMIE 211

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  105 bits (264), Expect = 3e-28
 Identities = 44/150 (29%), Positives = 83/150 (55%), Gaps = 4/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
             E+ ++++ +H NV+ ++    V  +L+++ EFL+   L D +    +     +A +  
Sbjct: 90  FNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN-EEQIA-TVC 147

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
             +L+AL Y H++ +IHRD+K  +IL+   G +KL+DFG     +  + +    V T ++
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             PE++  +  Y+T VDIWS G +  EM+ 
Sbjct: 208 MAPEVISRSL-YATEVDIWSLGIMVIEMVD 236

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  104 bits (261), Expect = 3e-28
 Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 19/165 (11%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            +E  +   LKHPN+I L  V   +  L LV EF R   L   L    +P  P +  ++ 
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIP--PDILVNWA 111

Query: 72  YQLLEALRYCHSRR---IIHRDLKPQNILINKSGA--------LKLADFGLSRAFTIPMN 120
            Q+   + Y H      IIHRDLK  NILI +           LK+ DFGL+R       
Sbjct: 112 VQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRT 169

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI--QIP 163
                     +  PE++    ++S   D+WS G +  E++  ++P
Sbjct: 170 TKMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVP 213

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  104 bits (261), Expect = 4e-28
 Identities = 28/160 (17%), Positives = 60/160 (37%), Gaps = 15/160 (9%)

Query: 14  REISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFL-RQDLKDFLQ-TTPVPVPPALAKS 69
            E   L+   HPNV+ +      P      L+  ++    L + L   T   V  + A  
Sbjct: 56  EECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVK 115

Query: 70  YLYQLLEALRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           +   +   + + H+    I    L  ++++I++    +++   +  +F  P   Y     
Sbjct: 116 FALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPA-- 173

Query: 128 TLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMI--QIP 163
              +  PE L          + D+WS   +  E++  ++P
Sbjct: 174 ---WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP 210

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  105 bits (264), Expect = 1e-27
 Identities = 47/152 (30%), Positives = 67/152 (44%), Gaps = 6/152 (3%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  VL       +  LH     D  L+LV ++    DL   L      +P  +A+ YL +
Sbjct: 124 ERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAE 183

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 132
           ++ A+   H    +HRD+KP NIL++ +G ++LADFG            +   V T  Y 
Sbjct: 184 MVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243

Query: 133 PPEILL----GAKVYSTTVDIWSAGCIFSEMI 160
            PEIL     G   Y    D WS G    EM+
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  102 bits (256), Expect = 3e-27
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 9/155 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
            REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++        +  +    
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178

Query: 130 ----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               WY  PE L     +S   D+WS G +  E+ 
Sbjct: 179 SPIFWY-APESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  102 bits (256), Expect = 4e-27
 Identities = 46/155 (29%), Positives = 73/155 (47%), Gaps = 9/155 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
            REI +LK L+H N+++   V     +  L L+ E+L    L+D+LQ     +       
Sbjct: 90  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q+ + + Y  ++R IHRDL  +NIL+     +K+ DFGL++        Y  +    
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGE 209

Query: 130 ----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               WY  PE L     +S   D+WS G +  E+ 
Sbjct: 210 SPIFWY-APESLT-ESKFSVASDVWSFGVVLYELF 242

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  104 bits (260), Expect = 6e-27
 Identities = 43/154 (27%), Positives = 77/154 (50%), Gaps = 10/154 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 70
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+      V   +    
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 323

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 129
             Q+  A+ Y   +  IHR+L  +N L+ ++  +K+ADFGLSR   +  + YT       
Sbjct: 324 ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL--MTGDTYTAHAGAKF 381

Query: 130 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              W  P  +      +S   D+W+ G +  E+ 
Sbjct: 382 PIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIA 413

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  102 bits (255), Expect = 6e-27
 Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 9/155 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
            REI +LK L    +++   V     +  L LV E+L    L+DFLQ     +  +    
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q+ + + Y  SRR +HRDL  +NIL+     +K+ADFGL++   +  + Y       
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQ 191

Query: 130 ----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               WY  PE L    ++S   D+WS G +  E+ 
Sbjct: 192 SPIFWY-APESLS-DNIFSRQSDVWSFGVVLYELF 224

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (256), Expect = 1e-26
 Identities = 50/151 (33%), Positives = 70/151 (46%), Gaps = 7/151 (4%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQ 73
           E  ++     P V++L      D  L++V E++   DL + +    VP     A+ Y  +
Sbjct: 119 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--WARFYTAE 176

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 132
           ++ AL   HS   IHRD+KP N+L++KSG LKLADFG                V T  Y 
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236

Query: 133 PPEILL---GAKVYSTTVDIWSAGCIFSEMI 160
            PE+L    G   Y    D WS G    EM+
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEML 267

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  101 bits (253), Expect = 1e-26
 Identities = 37/151 (24%), Positives = 67/151 (44%), Gaps = 12/151 (7%)

Query: 13  LREISV-LKELKHPNVIRLHDVIPVDFKLFLVFEF----LRQDLKDFLQTTPVPVP-PAL 66
           L ++ V ++    P +++ +  +  +   ++  E       +  K         +P   L
Sbjct: 68  LMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEIL 127

Query: 67  AKSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            K      ++AL +     +IIHRD+KP NIL+++SG +KL DFG+S      + + T +
Sbjct: 128 GK-ITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK-TRD 185

Query: 126 VVTLWYRPPEILLGAKV---YSTTVDIWSAG 153
                Y  PE +  +     Y    D+WS G
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLG 216

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  102 bits (256), Expect = 1e-26
 Identities = 45/154 (29%), Positives = 66/154 (42%), Gaps = 8/154 (5%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  VL       + +LH     +  L+LV E+    DL   L      +P  +A+ YL +
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWYR 132
           ++ A+   H    +HRD+KP NIL+++ G ++LADFG            +   V T  Y 
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230

Query: 133 PPEILLG------AKVYSTTVDIWSAGCIFSEMI 160
            PEIL           Y    D W+ G    EM 
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  100 bits (251), Expect = 2e-26
 Identities = 43/155 (27%), Positives = 74/155 (47%), Gaps = 9/155 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
            +EI +L+ L H N+++   +        + L+ EFL    LK++L      +       
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           Y  Q+ + + Y  SR+ +HRDL  +N+L+     +K+ DFGL++A       YT +    
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 130 ----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               WY  PE L+ +K +    D+WS G    E++
Sbjct: 191 SPVFWY-APECLMQSK-FYIASDVWSFGVTLHELL 223

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  101 bits (253), Expect = 2e-26
 Identities = 48/151 (31%), Positives = 70/151 (46%), Gaps = 10/151 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD---LKDFLQTTPVPVPPALAKS 69
           +RE+ VL E   P ++  +     D ++ +  E +  D   L   L+     +P  +   
Sbjct: 79  IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHM--DGGSLDQVLKKAG-RIPEQILGK 135

Query: 70  YLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
               +++ L Y     +I+HRD+KP NIL+N  G +KL DFG+S      M   +  V T
Sbjct: 136 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-ANSF-VGT 193

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             Y  PE L G   YS   DIWS G    EM
Sbjct: 194 RSYMSPERLQGTH-YSVQSDIWSMGLSLVEM 223

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =   99 bits (250), Expect = 2e-26
 Identities = 37/153 (24%), Positives = 79/153 (51%), Gaps = 9/153 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            +E   + +L HP +++ + V   ++ +++V E++    L ++L++    + P+      
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMC 110

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           Y + E + +  S + IHRDL  +N L+++   +K++DFG++R   +  ++Y   V T   
Sbjct: 111 YDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFP 168

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W   PE+      YS+  D+W+ G +  E+ 
Sbjct: 169 VKWS-APEVFH-YFKYSSKSDVWAFGILMWEVF 199

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 99.7 bits (249), Expect = 3e-26
 Identities = 38/152 (25%), Positives = 59/152 (38%), Gaps = 33/152 (21%)

Query: 14  REISVLKEL-KHPNVIRLHDV----IPVDFKLFLVFEFLRQ-DLKD-FLQTTPVPVPPAL 66
           RE+ +     + P+++R+ DV          L +V E L   +L                
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYT 123
           A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG +           
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA----------- 167

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI 155
                      E     + Y  + D+WS G I
Sbjct: 168 ----------KETT--GEKYDKSCDMWSLGVI 187

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  100 bits (252), Expect = 3e-26
 Identities = 43/147 (29%), Positives = 66/147 (44%), Gaps = 10/147 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L+E  +LK+  HPN++RL  V      +++V E ++  D   FL+T    +        +
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMV 219

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
                 + Y  S+  IHRDL  +N L+ +   LK++DFG+SR        Y         
Sbjct: 220 GDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE--EADGVYAASGGLRQV 277

Query: 130 ---WYRPPEILLGAKVYSTTVDIWSAG 153
              W   PE L     YS+  D+WS G
Sbjct: 278 PVKWT-APEALN-YGRYSSESDVWSFG 302

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  101 bits (252), Expect = 4e-26
 Identities = 56/219 (25%), Positives = 89/219 (40%), Gaps = 75/219 (34%)

Query: 10  STALREISVLKELK-----HPN---VIRLHDVIPVDFKLF--------LVFEFLRQDLKD 53
            TAL EI +LK ++      PN   V++L D    DFK+         +VFE L   L  
Sbjct: 78  ETALDEIRLLKSVRNSDPNDPNREMVVQLLD----DFKISGVNGTHICMVFEVLGHHLLK 133

Query: 54  FLQTTPV-PVPPALAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILIN------------ 99
           ++  +    +P    K  + Q+L+ L Y H++ RIIH D+KP+NIL++            
Sbjct: 134 WIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193

Query: 100 -------------------------------------KSGALKLADFGLSRAFTIPMNRY 122
                                                +   +K+AD G +         +
Sbjct: 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKHF 250

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
           T ++ T  YR  E+L+G+  Y+T  DIWS  C+  E+  
Sbjct: 251 TEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELAT 288

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  100 bits (251), Expect = 5e-26
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 7/152 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
            +E+ +++ L+HP ++ L      +  +F+V + L   DL+  LQ   V       K ++
Sbjct: 63  FKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFI 121

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 130
            +L+ AL Y  ++RIIHRD+KP NIL+++ G + + DF ++    +P       +  T  
Sbjct: 122 CELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKP 179

Query: 131 YRPPEILL--GAKVYSTTVDIWSAGCIFSEMI 160
           Y  PE+        YS  VD WS G    E++
Sbjct: 180 YMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  101 bits (253), Expect = 7e-26
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 6/152 (3%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPV-PPALAKS 69
           AL E  +L+++    V+ L         L LV   +   DLK  +        P A A  
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVF 290

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-T 128
           Y  ++   L   H  RI++RDLKP+NIL++  G ++++D GL+    +P  +     V T
Sbjct: 291 YAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH--VPEGQTIKGRVGT 348

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           + Y  PE++   + Y+ + D W+ GC+  EMI
Sbjct: 349 VGYMAPEVVKNER-YTFSPDWWALGCLLYEMI 379

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 99.4 bits (248), Expect = 8e-26
 Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 24/169 (14%)

Query: 14  REISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAK 68
            EI     ++H N++              +L+L+ ++     L D+L++T +     L  
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSML-- 137

Query: 69  SYLYQLLEALRYCHSRR--------IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
              Y  +  L + H+          I HRDLK +NIL+ K+G   +AD GL+  F    N
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197

Query: 121 RY----THEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMI 160
                    V T  Y PPE+L  +            D++S G I  E+ 
Sbjct: 198 EVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 98.0 bits (245), Expect = 9e-26
 Identities = 41/146 (28%), Positives = 72/146 (49%), Gaps = 9/146 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      + LV EF+    L D+L+T              
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC 110

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R   +  ++YT    T   
Sbjct: 111 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF--VLDDQYTSSTGTKFP 168

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAG 153
             W   PE+   ++ YS+  D+WS G
Sbjct: 169 VKWA-SPEVFSFSR-YSSKSDVWSFG 192

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 98.6 bits (246), Expect = 1e-25
 Identities = 38/154 (24%), Positives = 66/154 (42%), Gaps = 9/154 (5%)

Query: 13  LREISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP-PALAKSY 70
           L ++ V+ K    P +++       +  +F+  E +    +   +    P+P   L K  
Sbjct: 71  LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK-M 129

Query: 71  LYQLLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
              +++AL Y   +  +IHRD+KP NIL+++ G +KL DFG+S        +        
Sbjct: 130 TVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK-DRSAGCA 188

Query: 130 WYRPPEILLGAKV----YSTTVDIWSAGCIFSEM 159
            Y  PE +         Y    D+WS G    E+
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.2 bits (245), Expect = 2e-25
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFK--LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
            +EI +L+ L H ++I+            L LV E++    L+D+L    + +   L   
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLL--L 138

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           +  Q+ E + Y H++  IHRDL  +N+L++    +K+ DFGL++A       Y       
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 130 ----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               WY  PE L   K +    D+WS G    E++
Sbjct: 199 SPVFWY-APECLKEYK-FYYASDVWSFGVTLYELL 231

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 97.3 bits (243), Expect = 3e-25
 Identities = 45/147 (30%), Positives = 75/147 (51%), Gaps = 10/147 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 70
           L+E +V+KE+KHPN+++L  V   +   +++ EF+   +L D+L+      V   +    
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 116

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 129
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR   +  + YT       
Sbjct: 117 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR--LMTGDTYTAHAGAKF 174

Query: 130 ---WYRPPEILLGAKVYSTTVDIWSAG 153
              W   PE L     +S   D+W+ G
Sbjct: 175 PIKWT-APESLA-YNKFSIKSDVWAFG 199

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 96.9 bits (242), Expect = 3e-25
 Identities = 45/153 (29%), Positives = 66/153 (43%), Gaps = 8/153 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           +RE++ +  L H N+IRL+ V+     + +V E      L D L+             Y 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 127

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
            Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y  +      
Sbjct: 128 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 187

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W   PE L     +S   D W  G    EM 
Sbjct: 188 FAWC-APESLKTRT-FSHASDTWMFGVTLWEMF 218

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 97.0 bits (242), Expect = 3e-25
 Identities = 42/169 (24%), Positives = 66/169 (39%), Gaps = 24/169 (14%)

Query: 14  REISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAK 68
            E+     L+H N++              +L+L+  +     L D+LQ T +     L  
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCL-- 108

Query: 69  SYLYQLLEALRYCHSRR--------IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
             +  +   L + H           I HRDLK +NIL+ K+G   +AD GL+   +   N
Sbjct: 109 RIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168

Query: 121 RY----THEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMI 160
           +        V T  Y  PE+L              VDIW+ G +  E+ 
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 99.5 bits (248), Expect = 4e-25
 Identities = 41/154 (26%), Positives = 71/154 (46%), Gaps = 7/154 (4%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEF-----LRQDLKDFLQTTPVPVPPAL 66
           A+ E  +L ++    ++ L         L LV        +R  + +  +  P       
Sbjct: 232 AMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPG-FQEPR 290

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
           A  Y  Q++  L + H R II+RDLKP+N+L++  G ++++D GL+        +     
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA 350

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            T  +  PE+LLG + Y  +VD ++ G    EMI
Sbjct: 351 GTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMI 383

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 97.0 bits (242), Expect = 4e-25
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 7/153 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+       +V E++    L  FL+T             L
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGML 157

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
             +   +RY      +HRDL  +N+L++ +   K++DFGLSR      +           
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIP 217

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W   PE +     +S+  D+WS G +  E++
Sbjct: 218 IRWT-APEAIAFRT-FSSASDVWSFGVVMWEVL 248

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 97.4 bits (243), Expect = 5e-25
 Identities = 44/167 (26%), Positives = 76/167 (45%), Gaps = 28/167 (16%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFL 55
           Q+E      L E  +L+ +  P +++L      +  L++V E++         + +  F 
Sbjct: 84  QIEHT----LNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRF- 138

Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
                      A+ Y  Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++  
Sbjct: 139 -------SEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191

Query: 116 TIPMNRY--THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                    T E        PEI+L  K Y+  VD W+ G +  EM 
Sbjct: 192 KGRTWTLCGTPE-----ALAPEIILS-KGYNKAVDWWALGVLIYEMA 232

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 96.7 bits (241), Expect = 5e-25
 Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 19/166 (11%)

Query: 14  REISVLKELKHPNVIRL--HDVIPVDFK--LFLVFEFL-RQDLKDFLQTTPVPVPPAL-- 66
            E+  L  +KH N+++    +         L+L+  F  +  L DFL+   V        
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHI 126

Query: 67  ----AK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
               A+  +YL++ +  L+  H   I HRD+K +N+L+  +    +ADFGL+  F    +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 121 RY--THEVVTLWYRPPEILLGA----KVYSTTVDIWSAGCIFSEMI 160
                 +V T  Y  PE+L GA    +     +D+++ G +  E+ 
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA 232

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 99.2 bits (247), Expect = 6e-25
 Identities = 41/154 (26%), Positives = 75/154 (48%), Gaps = 9/154 (5%)

Query: 12  ALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
           AL E  +L  +     P ++ +        KL  + + +   DL   L    V    A  
Sbjct: 236 ALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV-FSEADM 294

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           + Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F     +  H  V
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASV 351

Query: 128 -TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            T  Y  PE+L     Y ++ D +S GC+  +++
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 97.2 bits (242), Expect = 6e-25
 Identities = 42/169 (24%), Positives = 65/169 (38%), Gaps = 24/169 (14%)

Query: 14  REISVLKELKHPNVIRL----HDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAK 68
            EI     L+H N++      +       +L+LV ++     L D+L    V V   +  
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI-- 142

Query: 69  SYLYQLLEALRYCHSRR--------IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
                    L + H           I HRDLK +NIL+ K+G   +AD GL+       +
Sbjct: 143 KLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD 202

Query: 121 RY----THEVVTLWYRPPEILLGAKV-----YSTTVDIWSAGCIFSEMI 160
                  H V T  Y  PE+L  +            DI++ G +F E+ 
Sbjct: 203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 97.9 bits (244), Expect = 7e-25
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 11/154 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKSY 70
           L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+  T   +        
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 285

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 129
             Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT       
Sbjct: 286 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF 343

Query: 130 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              W  P   L G   ++   D+WS G + +E+ 
Sbjct: 344 PIKWTAPEAALYG--RFTIKSDVWSFGILLTELT 375

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.4 bits (243), Expect = 7e-25
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 7/153 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPN+IRL  V+     + +V E++    L  FL+              L
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
             +   ++Y      +HRDL  +NILIN +   K++DFGL R                  
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W   PE +   K +++  D+WS G +  E++
Sbjct: 214 IRWT-SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 95.8 bits (239), Expect = 7e-25
 Identities = 43/146 (29%), Positives = 76/146 (52%), Gaps = 9/146 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 126

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR   +  + YT  V +   
Sbjct: 127 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR--YVLDDEYTSSVGSKFP 184

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAG 153
             W  PPE+L+ +K +S+  DIW+ G
Sbjct: 185 VRWS-PPEVLMYSK-FSSKSDIWAFG 208

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 98.0 bits (244), Expect = 9e-25
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 11/154 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKSY 70
           L+E  V+K+L+H  +++L+ V+  +  +++V E++ +  L DFL+  T   +        
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 368

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 129
             Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R   I  N YT       
Sbjct: 369 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL--IEDNEYTARQGAKF 426

Query: 130 ---WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              W  P   L G   ++   D+WS G + +E+ 
Sbjct: 427 PIKWTAPEAALYG--RFTIKSDVWSFGILLTELT 458

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 95.4 bits (238), Expect = 1e-24
 Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 16/156 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           L+E   +++  HP++++L  VI   PV    +++ E     +L+ FLQ     +  A   
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITENPV----WIIMELCTLGELRSFLQVRKYSLDLASLI 119

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR   +  + Y      
Sbjct: 120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKG 177

Query: 129 L----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                W   PE +   + +++  D+W  G    E++
Sbjct: 178 KLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEIL 211

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 96.1 bits (240), Expect = 1e-24
 Identities = 35/145 (24%), Positives = 68/145 (46%), Gaps = 7/145 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  V+  + +P+V RL  +      + L+ + +    L D+++     +      ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
            Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   +  
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 130 -WYRPPEILLGAKVYSTTVDIWSAG 153
            W    E +L  ++Y+   D+WS G
Sbjct: 184 KWM-ALESIL-HRIYTHQSDVWSYG 206

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 95.7 bits (239), Expect = 2e-24
 Identities = 45/156 (28%), Positives = 79/156 (50%), Gaps = 24/156 (15%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPAL 66
           E  +L  + HP +IR+        ++F++ +++         +  + F        P  +
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--------PNPV 107

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY--TH 124
           AK Y  ++  AL Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++           T 
Sbjct: 108 AKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP 167

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +     Y  PE++   K Y+ ++D WS G +  EM+
Sbjct: 168 D-----YIAPEVVST-KPYNKSIDWWSFGILIYEML 197

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 95.0 bits (237), Expect = 2e-24
 Identities = 34/150 (22%), Positives = 61/150 (40%), Gaps = 13/150 (8%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
               S++ +L H +++  + V     +  LV EF++   L  +L+     +         
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGAL--------KLADFGLSRAFTIPMNRYT 123
            QL  A+ +     +IH ++  +NIL+ +            KL+D G+S   T+      
Sbjct: 120 KQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI--TVLPKDIL 177

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAG 153
            E +  W  PPE +   K  +   D WS G
Sbjct: 178 QERIP-WV-PPECIENPKNLNLATDKWSFG 205

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 97.6 bits (243), Expect = 2e-24
 Identities = 45/156 (28%), Positives = 76/156 (48%), Gaps = 16/156 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           L+E   +++  HP++++L  VI   PV    +++ E     +L+ FLQ     +  A   
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVITENPV----WIIMELCTLGELRSFLQVRKFSLDLASLI 494

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR   +  + Y      
Sbjct: 495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKG 552

Query: 129 L----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                W  P  I      +++  D+W  G    E++
Sbjct: 553 KLPIKWMAPESINFR--RFTSASDVWMFGVCMWEIL 586

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 94.6 bits (236), Expect = 2e-24
 Identities = 45/157 (28%), Positives = 81/157 (51%), Gaps = 17/157 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALA 67
           L E +++K+L+H  ++RL+ V+   P+    +++ E++    L DFL+T   + +     
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQEPI----YIITEYMENGSLVDFLKTPSGIKLTINKL 111

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV 127
                Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R   I  N YT    
Sbjct: 112 LDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL--IEDNEYTAREG 169

Query: 128 TL----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 W   PE +     ++   D+WS G + +E++
Sbjct: 170 AKFPIKWT-APEAIN-YGTFTIKSDVWSFGILLTEIV 204

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 95.1 bits (237), Expect = 2e-24
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 17/163 (10%)

Query: 14  REISVLKEL-KHPNVIRLHD------VIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPA 65
           +EI++LK+   H N+   +          +D +L+LV EF     + D ++ T       
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKE 128

Query: 66  LAKSY-LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
              +Y   ++L  L + H  ++IHRD+K QN+L+ ++  +KL DFG+S      + R   
Sbjct: 129 EWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT 188

Query: 125 EVVTLWYRPPEILLGAKV----YSTTVDIWSAG--CIFSEMIQ 161
            + T ++  PE++   +     Y    D+WS G   I  EM +
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI--EMAE 229

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.1 bits (237), Expect = 3e-24
 Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 7/153 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  ++ +  H N+IRL  VI     + ++ E++    L  FL+              L
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTL- 129
             +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR     P   YT     + 
Sbjct: 154 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 213

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             W   PE +   + +++  D+WS G +  E++
Sbjct: 214 IRWT-APEAIS-YRKFTSASDVWSFGIVMWEVM 244

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 94.5 bits (236), Expect = 4e-24
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 19/155 (12%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPAL 66
           E  +L E+ HP +++LH     + KL+L+ +FLR             F            
Sbjct: 76  ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF--------TEED 127

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
            K YL +L  AL + HS  II+RDLKP+NIL+++ G +KL DFGLS+   I   +  +  
Sbjct: 128 VKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKES-IDHEKKAYSF 186

Query: 127 V-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T+ Y  PE++     ++ + D WS G +  EM+
Sbjct: 187 CGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEML 220

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 93.9 bits (234), Expect = 4e-24
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           +RE  ++ +L +P ++RL  V   +  L LV E      L  FL      +P +     L
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 116

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           +Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT        
Sbjct: 117 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 176

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             WY P  I      +S+  D+WS G    E +
Sbjct: 177 LKWYAPECINFR--KFSSRSDVWSYGVTMWEAL 207

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 93.9 bits (234), Expect = 5e-24
 Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 11/150 (7%)

Query: 13  LREISV-LKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT---PVPVP-PALA 67
           L ++ + ++ +  P  +  +  +  +  +++  E +   L  F +        +P   L 
Sbjct: 53  LMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILG 112

Query: 68  KSYLYQLLEALRYCHS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
           K     +++AL + HS   +IHRD+KP N+LIN  G +K+ DFG+S      + +   + 
Sbjct: 113 KI-AVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI-DA 170

Query: 127 VTLWYRPPEILLGAKV---YSTTVDIWSAG 153
               Y  PE +        YS   DIWS G
Sbjct: 171 GCKPYMAPERINPELNQKGYSVKSDIWSLG 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 94.1 bits (235), Expect = 5e-24
 Identities = 51/155 (32%), Positives = 79/155 (50%), Gaps = 19/155 (12%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPAL 66
           E ++L+E+KHP ++ L        KL+L+ E+L         +    F            
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIF--------MEDT 122

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
           A  YL ++  AL + H + II+RDLKP+NI++N  G +KL DFGL +   I     TH  
Sbjct: 123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES-IHDGTVTHTF 181

Query: 127 V-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T+ Y  PEIL+ +  ++  VD WS G +  +M+
Sbjct: 182 CGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDML 215

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 93.1 bits (232), Expect = 8e-24
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 9/146 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E +V+++L +P ++R+  +   +    LV E      L  +LQ         + +  +
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIE-LV 123

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           +Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y  +      
Sbjct: 124 HQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAG 153
             WY  PE +   K +S+  D+WS G
Sbjct: 184 VKWY-APECINYYK-FSSKSDVWSFG 207

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 93.5 bits (233), Expect = 9e-24
 Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 35/164 (21%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-------TTPVPVPP 64
           L E SV+KE    +V+RL  V+       ++ E + + DLK +L+         PV  PP
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 135

Query: 65  ALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
           +L+K      ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R      + Y
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR------DIY 189

Query: 123 THEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 153
             +     YR             PE +  G  V++T  D+WS G
Sbjct: 190 ETDY----YRKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFG 227

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 92.6 bits (231), Expect = 1e-23
 Identities = 41/156 (26%), Positives = 71/156 (45%), Gaps = 16/156 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVI---PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAK 68
           + E  ++K L HP++++L  +I   P     +++ E     +L  +L+     +      
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGIIEEEPT----WIIMELYPYGELGHYLERNKNSLKVLTLV 116

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Y  Q+ +A+ Y  S   +HRD+  +NIL+     +KL DFGLSR   I    Y    VT
Sbjct: 117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY--IEDEDYYKASVT 174

Query: 129 L----WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                W   PE +   + ++T  D+W       E++
Sbjct: 175 RLPIKWM-SPESIN-FRRFTTASDVWMFAVCMWEIL 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 94.7 bits (236), Expect = 1e-23
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 15/148 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKS 69
           L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++     +       
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++         + +    
Sbjct: 294 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGK 347

Query: 130 ----WYRPPEILLGAKVYSTTVDIWSAG 153
               W   PE L   K +ST  D+WS G
Sbjct: 348 LPVKWT-APEALR-EKKFSTKSDVWSFG 373

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 93.2 bits (232), Expect = 1e-23
 Identities = 31/145 (21%), Positives = 63/145 (43%), Gaps = 7/145 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
              +  +  L H +++RL  + P    L LV ++L    L D ++     + P L  ++ 
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
            Q+ + + Y     ++HR+L  +N+L+     +++ADFG++        +  +       
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181

Query: 130 -WYRPPEILLGAKVYSTTVDIWSAG 153
            W    E +     Y+   D+WS G
Sbjct: 182 KWM-ALESIH-FGKYTHQSDVWSYG 204

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 93.2 bits (232), Expect = 1e-23
 Identities = 35/145 (24%), Positives = 68/145 (46%), Gaps = 7/145 (4%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E  V+  + +P+V RL  +      + L+ + +    L D+++     +      ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
            Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   +  
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183

Query: 130 -WYRPPEILLGAKVYSTTVDIWSAG 153
            W    E +L  ++Y+   D+WS G
Sbjct: 184 KWM-ALESIL-HRIYTHQSDVWSYG 206

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 93.6 bits (233), Expect = 3e-23
 Identities = 47/147 (31%), Positives = 75/147 (51%), Gaps = 11/147 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY 70
           L E +V+K L+H  +++LH V+  +  ++++ EF+ +  L DFL++      P      +
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF 289

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL- 129
             Q+ E + +   R  IHRDL+  NIL++ S   K+ADFGL+R   I  N YT       
Sbjct: 290 SAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAREGAKF 347

Query: 130 ---WYRPPEILLGAKVYSTTVDIWSAG 153
              W  P  I  G   ++   D+WS G
Sbjct: 348 PIKWTAPEAINFG--SFTIKSDVWSFG 372

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 91.1 bits (227), Expect = 4e-23
 Identities = 41/148 (27%), Positives = 74/148 (50%), Gaps = 15/148 (10%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQT-TPVPVPPALAKS 69
           L E SV+ +L+H N+++L  VI  +   L++V E++ +  L D+L++     +       
Sbjct: 62  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++         + +    
Sbjct: 122 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGK 175

Query: 130 ----WYRPPEILLGAKVYSTTVDIWSAG 153
               W   PE L   K +ST  D+WS G
Sbjct: 176 LPVKWT-APEALR-EKKFSTKSDVWSFG 201

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.9 bits (233), Expect = 4e-23
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 8/153 (5%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           +RE  ++ +L +P ++RL  V   +  L LV E      L  FL      +P +     L
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 442

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL-- 129
           +Q+   ++Y   +  +HR+L  +N+L+      K++DFGLS+A     + YT        
Sbjct: 443 HQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 502

Query: 130 --WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             WY P  I      +S+  D+WS G    E +
Sbjct: 503 LKWYAPECINFR--KFSSRSDVWSYGVTMWEAL 533

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 91.5 bits (228), Expect = 6e-23
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 13/152 (8%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  VL+  +HP +  L        +L  V E+    +L   L    V      A+ Y  +
Sbjct: 55  ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAE 113

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-----THEVVT 128
           ++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T E   
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE--- 170

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             Y  PE+L     Y   VD W  G +  EM+
Sbjct: 171 --YLAPEVLEDND-YGRAVDWWGLGVVMYEMM 199

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 90.8 bits (226), Expect = 1e-22
 Identities = 41/157 (26%), Positives = 75/157 (47%), Gaps = 19/157 (12%)

Query: 15  EISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPA 65
           E  VL+ ++  P ++ LH     + KL L+ +++            + F           
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF--------TEH 159

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             + Y+ +++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F        ++
Sbjct: 160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 219

Query: 126 VV-TLWYRPPEILLGAKV-YSTTVDIWSAGCIFSEMI 160
              T+ Y  P+I+ G    +   VD WS G +  E++
Sbjct: 220 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 89.4 bits (222), Expect = 2e-22
 Identities = 26/150 (17%), Positives = 44/150 (29%), Gaps = 32/150 (21%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 70
            L     L  +  P V R+ DV+       +V E++R   L++   T+P    P  A   
Sbjct: 78  TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP---SPVGAIRA 134

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
           +  L  A    H   +      P  + ++  G + LA                       
Sbjct: 135 MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------------- 174

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             P          +   DI   G     ++
Sbjct: 175 TMPDA--------NPQDDIRGIGASLYALL 196

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 89.9 bits (223), Expect = 3e-22
 Identities = 40/176 (22%), Positives = 65/176 (36%), Gaps = 31/176 (17%)

Query: 14  REISVLKELKHPNVIRL-----HDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALA 67
           + I  +  ++H N+ R              +  LV E+     L  +L         +  
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC- 114

Query: 68  KSYLYQLLEALRYCHS---------RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
               + +   L Y H+           I HRDL  +N+L+   G   ++DFGLS   T  
Sbjct: 115 -RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 119 MNRY--------THEVVTLWYRPPEILLGA------KVYSTTVDIWSAGCIFSEMI 160
                         EV T+ Y  PE+L GA      +     VD+++ G I+ E+ 
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 90.6 bits (225), Expect = 4e-22
 Identities = 43/148 (29%), Positives = 68/148 (45%), Gaps = 4/148 (2%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQ 73
           E  VL+  +HP +  L        +L  V E+    +L   L    V      A+ Y  +
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV-FSEDRARFYGAE 256

Query: 74  LLEALRYCHSRR-IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++ AL Y HS + +++RDLK +N++++K G +K+ DFGL +              T  Y 
Sbjct: 257 IVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYL 316

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE+L     Y   VD W  G +  EM+
Sbjct: 317 APEVLED-NDYGRAVDWWGLGVVMYEMM 343

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 88.5 bits (220), Expect = 5e-22
 Identities = 36/148 (24%), Positives = 72/148 (48%), Gaps = 9/148 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           L E  ++K+  HPNV+ L  +    +    +V  +++  DL++F++             +
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 133

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVT 128
             Q+ + ++Y  S++ +HRDL  +N ++++   +K+ADFGL+R        + +      
Sbjct: 134 GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193

Query: 129 L---WYRPPEILLGAKVYSTTVDIWSAG 153
           L   W    E L   + ++T  D+WS G
Sbjct: 194 LPVKWM-ALESLQ-TQKFTTKSDVWSFG 219

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 88.9 bits (221), Expect = 8e-22
 Identities = 52/156 (33%), Positives = 75/156 (48%), Gaps = 20/156 (12%)

Query: 15  EISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPA 65
           E +VL K +KHP ++ LH       KL+ V +++         Q  + F           
Sbjct: 88  ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF--------LEP 139

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            A+ Y  ++  AL Y HS  I++RDLKP+NIL++  G + L DFGL +   I  N  T  
Sbjct: 140 RARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKEN-IEHNSTTST 198

Query: 126 VV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              T  Y  PE+L   + Y  TVD W  G +  EM+
Sbjct: 199 FCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEML 233

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.1 bits (219), Expect = 8e-22
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 41/170 (24%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ--------TTPVPVP 63
            RE  +L  L+H ++++ + V      L +VFE+++  DL  FL+               
Sbjct: 65  QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPR 124

Query: 64  PALAKSYLYQLL-------EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            A  +  L Q+L         + Y  S+  +HRDL  +N L+  +  +K+ DFG+SR   
Sbjct: 125 QAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR--- 181

Query: 117 IPMNRYTHEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 153
              + Y+ +     YR            PPE I+     ++T  D+WS G
Sbjct: 182 ---DVYSTDY----YRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFG 222

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 88.7 bits (220), Expect = 1e-21
 Identities = 35/148 (23%), Positives = 72/148 (48%), Gaps = 9/148 (6%)

Query: 13  LREISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           L E  ++K+  HPNV+ L  +    +    +V  +++  DL++F++             +
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGF 197

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVVT 128
             Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R        + +      
Sbjct: 198 GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAK 257

Query: 129 L---WYRPPEILLGAKVYSTTVDIWSAG 153
           L   W    E L   + ++T  D+WS G
Sbjct: 258 LPVKWM-ALESLQ-TQKFTTKSDVWSFG 283

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 87.8 bits (218), Expect = 1e-21
 Identities = 42/165 (25%), Positives = 67/165 (40%), Gaps = 35/165 (21%)

Query: 13  LREISVLKELKHPNVIRLHDV------IPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPP 64
           LRE + +KE  HP+V +L  V              ++  F++  DL  FL  +     P 
Sbjct: 73  LREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF 132

Query: 65  ALAK----SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
            L       ++  +   + Y  SR  IHRDL  +N ++ +   + +ADFGLSR       
Sbjct: 133 NLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR------K 186

Query: 121 RYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
            Y+ +     YR              E L    +Y+   D+W+ G
Sbjct: 187 IYSGDY----YRQGCASKLPVKWLALESLA-DNLYTVHSDVWAFG 226

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 87.3 bits (217), Expect = 1e-21
 Identities = 39/170 (22%), Positives = 64/170 (37%), Gaps = 41/170 (24%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT--------TPVPVP 63
             E  +   L+HPNV+ L  V+  D  L ++F +    DL +FL          +     
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDR 119

Query: 64  PALAKSYLYQLLEALR-------YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
              +       +  +        Y  S  ++H+DL  +N+L+     +K++D GL R   
Sbjct: 120 TVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFR--- 176

Query: 117 IPMNRYTHEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 153
                Y  +     Y+             PE I+ G   +S   DIWS G
Sbjct: 177 ---EVYAADY----YKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYG 217

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 87.3 bits (217), Expect = 3e-21
 Identities = 50/149 (33%), Positives = 79/149 (53%), Gaps = 6/149 (4%)

Query: 15  EISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLY 72
           E  VL    +HP +  +         LF V E+L   DL   +Q+       + A  Y  
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-FDLSRATFYAA 125

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLWY 131
           +++  L++ HS+ I++RDLK  NIL++K G +K+ADFG+ +   +  +  T+    T  Y
Sbjct: 126 EIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN-MLGDAKTNTFCGTPDY 184

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PEILLG + Y+ +VD WS G +  EM+
Sbjct: 185 IAPEILLG-QKYNHSVDWWSFGVLLYEML 212

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 87.0 bits (216), Expect = 3e-21
 Identities = 47/169 (27%), Positives = 70/169 (41%), Gaps = 40/169 (23%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ------------TTP 59
            RE  +L  L+H +++R   V      L +VFE++R  DL  FL+               
Sbjct: 91  QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDV 150

Query: 60  VPVPPALAK--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
            P P  L +  +   Q+   + Y      +HRDL  +N L+ +   +K+ DFG+SR   I
Sbjct: 151 APGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR--DI 208

Query: 118 PMNRYTHEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 153
               Y        YR            PPE IL     ++T  D+WS G
Sbjct: 209 YSTDY--------YRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFG 247

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.2 bits (218), Expect = 4e-21
 Identities = 42/150 (28%), Positives = 68/150 (45%), Gaps = 4/150 (2%)

Query: 13  LREISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           + E  VL    K P + +LH       +L+ V E++   DL   +Q          A  Y
Sbjct: 389 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR-FKEPHAVFY 447

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             ++   L +  S+ II+RDLK  N++++  G +K+ADFG+ +              T  
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 507

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           Y  PEI+     Y  +VD W+ G +  EM+
Sbjct: 508 YIAPEIIAYQP-YGKSVDWWAFGVLLYEML 536

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 85.8 bits (213), Expect = 7e-21
 Identities = 40/164 (24%), Positives = 69/164 (42%), Gaps = 34/164 (20%)

Query: 13  LREISVLKELKHPNVIRLHDVI-----PVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPA 65
           L E + +K+  HPNVIRL  V          K  ++  F++  DL  +L  +     P  
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKH 143

Query: 66  LAK----SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR 121
           +       ++  +   + Y  +R  +HRDL  +N ++     + +ADFGLS+        
Sbjct: 144 IPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK------KI 197

Query: 122 YTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
           Y+ +     YR              E L   +VY++  D+W+ G
Sbjct: 198 YSGDY----YRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFG 236

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 85.7 bits (213), Expect = 9e-21
 Identities = 48/158 (30%), Positives = 72/158 (45%), Gaps = 20/158 (12%)

Query: 13  LREISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVP 63
             E  V  +   HP ++ LH     + +LF V E++         Q  +          P
Sbjct: 57  QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKL--------P 108

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
              A+ Y  ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  T
Sbjct: 109 EEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-T 167

Query: 124 HEVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                T  Y  PEIL G   Y  +VD W+ G +  EM+
Sbjct: 168 STFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMM 204

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 85.7 bits (213), Expect = 9e-21
 Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 27/151 (17%)

Query: 23  KHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVPPALAKSYLYQL 74
           K P + +LH       +L+ V E++         Q +  F            A  Y  ++
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRF--------KEPHAVFYAAEI 130

Query: 75  LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY-----THEVVTL 129
              L +  S+ II+RDLK  N++++  G +K+ADFG+ +              T +    
Sbjct: 131 AIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD---- 186

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y  PEI+     Y  +VD W+ G +  EM+
Sbjct: 187 -YIAPEIIAYQP-YGKSVDWWAFGVLLYEML 215

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 85.7 bits (213), Expect = 9e-21
 Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 28/162 (17%)

Query: 13  LREISVLKE-LKHPNVIRLHDVIPVDFKLFLVFEFLR--------QDLKDFLQTTPVPVP 63
           + E  +L     HP + +L        +LF V EF+         Q  + F         
Sbjct: 71  MTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRF--------D 122

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY- 122
            A A+ Y  +++ AL + H + II+RDLK  N+L++  G  KLADFG+ +          
Sbjct: 123 EARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA 182

Query: 123 ----THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               T +     Y  PEIL     Y   VD W+ G +  EM+
Sbjct: 183 TFCGTPD-----YIAPEILQEML-YGPAVDWWAMGVLLYEML 218

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 85.0 bits (211), Expect = 1e-20
 Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 11/149 (7%)

Query: 13  LREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKS 69
           LRE  +++ L HPNV+ L  + +P +    ++  ++   DL  F+++    P    L  S
Sbjct: 70  LREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI-S 128

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF--TIPMNRYTHEVV 127
           +  Q+   + Y   ++ +HRDL  +N ++++S  +K+ADFGL+R        +   H   
Sbjct: 129 FGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHA 188

Query: 128 TL---WYRPPEILLGAKVYSTTVDIWSAG 153
            L   W    E L     ++T  D+WS G
Sbjct: 189 RLPVKWT-ALESLQ-TYRFTTKSDVWSFG 215

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.5 bits (212), Expect = 2e-20
 Identities = 50/151 (33%), Positives = 75/151 (49%), Gaps = 6/151 (3%)

Query: 13  LREISVL-KELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 70
             E  V  +   HP ++ LH     + +LF V E++   DL   +Q     +P   A+ Y
Sbjct: 100 QTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK-LPEEHARFY 158

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TL 129
             ++  AL Y H R II+RDLK  N+L++  G +KL D+G+ +    P +  T     T 
Sbjct: 159 SAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT-TSTFCGTP 217

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            Y  PEIL G   Y  +VD W+ G +  EM+
Sbjct: 218 NYIAPEILRGED-YGFSVDWWALGVLMFEMM 247

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 84.3 bits (209), Expect = 3e-20
 Identities = 42/164 (25%), Positives = 67/164 (40%), Gaps = 35/164 (21%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKS 69
           L E  ++ +  H N++R   V       F++ E +   DLK FL+ T      P +LA  
Sbjct: 81  LMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAML 140

Query: 70  YL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRY 122
            L      +    +Y      IHRD+  +N L+   G     K+ DFG++R      + Y
Sbjct: 141 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR------DIY 194

Query: 123 THEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 153
                  +YR            PPE  + G  ++++  D WS G
Sbjct: 195 RAS----YYRKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFG 232

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 83.6 bits (207), Expect = 7e-20
 Identities = 39/163 (23%), Positives = 62/163 (38%), Gaps = 33/163 (20%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ----TTPVPVPPALA 67
           L E  ++ +  H N++R   V       F++ E +   DLK FL+        P   A+ 
Sbjct: 122 LMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAML 181

Query: 68  K--SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRY 122
                   +    +Y      IHRD+  +N L+   G     K+ DFG++R   I    Y
Sbjct: 182 DLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD--IYRAGY 239

Query: 123 THEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
                   YR            PPE  +   ++++  D WS G
Sbjct: 240 --------YRKGGCAMLPVKWMPPEAFM-EGIFTSKTDTWSFG 273

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 83.1 bits (206), Expect = 8e-20
 Identities = 42/170 (24%), Positives = 77/170 (45%), Gaps = 40/170 (23%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-----------TP 59
           + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+              
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147

Query: 60  VPVPPALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
                 +    L    YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-- 205

Query: 116 TIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
               +    +    +Y+             PE L   +VY+   D+WS G
Sbjct: 206 ----DINNID----YYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 246

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 82.7 bits (205), Expect = 1e-19
 Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 47/177 (26%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E +VLK++ HP+VI+L+     D  L L+ E+ +   L+ FL+ +    P  L     
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGS 133

Query: 72  -----------------------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                                  +Q+ + ++Y    +++HRDL  +NIL+ +   +K++D
Sbjct: 134 RNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISD 193

Query: 109 FGLSRAFTIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
           FGLSR      + Y  +     Y               E L    +Y+T  D+WS G
Sbjct: 194 FGLSR------DVYEEDS----YVKRSQGRIPVKWMAIESLF-DHIYTTQSDVWSFG 239

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 83.2 bits (206), Expect = 1e-19
 Identities = 42/170 (24%), Positives = 75/170 (44%), Gaps = 40/170 (23%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           + E+ ++K + KH N+I L      D  L+++ E+  + +L+++L+    P         
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 193

Query: 71  L---------------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
                           YQL   + Y  S++ IHRDL  +N+L+ ++  +K+ADFGL+R  
Sbjct: 194 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR-- 251

Query: 116 TIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
               +    +     Y+             PE L   +VY+   D+WS G
Sbjct: 252 ----DINNIDY----YKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 292

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 83.2 bits (206), Expect = 1e-19
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 40/170 (23%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ    P         
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181

Query: 71  L---------------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
                           YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R  
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR-- 239

Query: 116 TIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
               + +  +    +Y+             PE L   ++Y+   D+WS G
Sbjct: 240 ----DIHHID----YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFG 280

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 82.7 bits (205), Expect = 1e-19
 Identities = 48/178 (26%), Positives = 79/178 (44%), Gaps = 49/178 (27%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ--------------- 56
            RE +++ E  +PN+++L  V  V   + L+FE++   DL +FL+               
Sbjct: 98  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 57  ----TTPVPVPPALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                   P PP L+ +       Q+   + Y   R+ +HRDL  +N L+ ++  +K+AD
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 217

Query: 109 FGLSRAFTIPMNRYTHEVVTLWYR------------PPE-ILLGAKVYSTTVDIWSAG 153
           FGLSR      N Y+ +     Y+            PPE I      Y+T  D+W+ G
Sbjct: 218 FGLSR------NIYSADY----YKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYG 263

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 81.5 bits (202), Expect = 2e-19
 Identities = 38/172 (22%), Positives = 63/172 (36%), Gaps = 42/172 (24%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
           + E+ VL  L  H N++ L     +     ++ E+    DL +FL+        +     
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 71  L-----------------YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
           +                 YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 114 AFTIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
                 +          Y              PE +    VY+   D+WS G
Sbjct: 194 ------DIKNDSN----YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 81.6 bits (202), Expect = 3e-19
 Identities = 48/162 (29%), Positives = 67/162 (41%), Gaps = 27/162 (16%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSY 70
             E+ VL +L  HPN+I L         L+L  E+    +L DFL+ + V          
Sbjct: 73  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 132

Query: 71  --------LYQLLEALR-------YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
                     QLL           Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR  
Sbjct: 133 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG- 191

Query: 116 TIPMNRYTHEVVTL----WYRPPEILLGAKVYSTTVDIWSAG 153
                 Y  + +      W    E L    VY+T  D+WS G
Sbjct: 192 ---QEVYVKKTMGRLPVRWM-AIESLN-YSVYTTNSDVWSYG 228

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 79.6 bits (197), Expect = 1e-18
 Identities = 40/171 (23%), Positives = 71/171 (41%), Gaps = 41/171 (23%)

Query: 13  LREISVLKEL-KHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQT-----------T 58
           + E+ +L  +  H NV+ L          L ++ EF +  +L  +L++            
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137

Query: 59  PVPVPPALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRA 114
                  L   +L    +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R 
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR- 196

Query: 115 FTIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
                + Y        Y              PE +   +VY+   D+WS G
Sbjct: 197 -----DIYKDPD----YVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 78.8 bits (195), Expect = 3e-18
 Identities = 35/168 (20%), Positives = 65/168 (38%), Gaps = 38/168 (22%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ----------TTPV 60
           + E+ ++  L +H N++ L         + ++ E+    DL +FL+             +
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156

Query: 61  PVPPALAKSYL---YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
               A  +  L    Q+ + + +  S+  IHRD+  +N+L+      K+ DFGL+R    
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR---- 212

Query: 118 PMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
             +          Y              PE +    VY+   D+WS G
Sbjct: 213 --DIMNDS----NYIVKGNARLPVKWMAPESIF-DCVYTVQSDVWSYG 253

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.9 bits (195), Expect = 3e-18
 Identities = 36/177 (20%), Positives = 69/177 (38%), Gaps = 47/177 (26%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT------------- 57
           + E+ ++ +L  H N++ L     +   ++L+FE+    DL ++L++             
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155

Query: 58  -----TPVPVPPALAKSYL----YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                        L    L    YQ+ + + +   +  +HRDL  +N+L+     +K+ D
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 215

Query: 109 FGLSRAFTIPMNRYTHEVVTLWYR------------PPEILLGAKVYSTTVDIWSAG 153
           FGL+R      +  +       Y              PE L    +Y+   D+WS G
Sbjct: 216 FGLAR------DIMSDSN----YVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYG 261

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.5 bits (169), Expect = 8e-15
 Identities = 41/191 (21%), Positives = 61/191 (31%), Gaps = 55/191 (28%)

Query: 9   PSTALREISVLKEL---------KHPNVIRLHDVIPV----------------------- 36
               L EI + KEL         +    I L+ V  V                       
Sbjct: 67  FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAN 126

Query: 37  -------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIH 88
                  D +LF+V EF      D  Q        A AKS L+QL  +L    +  R  H
Sbjct: 127 DRPDFFKDDQLFIVLEFEF-GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEH 185

Query: 89  RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVD 148
           RDL   N+L+ K+   KL      ++ TIP       ++               Y+ +  
Sbjct: 186 RDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID--------------YTLSRL 231

Query: 149 IWSAGCIFSEM 159
                 +F ++
Sbjct: 232 ERDGIVVFCDV 242

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 62.2 bits (152), Expect = 2e-12
 Identities = 32/122 (26%), Positives = 57/122 (46%), Gaps = 22/122 (18%)

Query: 15  EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPP--------- 64
           EI  L   +HP+++ L        ++ L+++++   +LK  L  + +P            
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEI 144

Query: 65  AL--AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
            +  A+         L Y H+R IIHRD+K  NIL++++   K+ DFG+S+         
Sbjct: 145 CIGAAR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKG--TELDQ 194

Query: 123 TH 124
           TH
Sbjct: 195 TH 196

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 60.3 bits (147), Expect = 1e-11
 Identities = 46/172 (26%), Positives = 70/172 (40%), Gaps = 45/172 (26%)

Query: 13  LREISVLKELKHPNVIRLH----DVIPVDFKLFLVFEFL-RQDLKDFL----QTTPVPVP 63
            +EI V+ + +H N++ L     D       L LV+ ++    L D L     T P+   
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSD----GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133

Query: 64  P----AL--AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
                A   A          + + H    IHRD+K  NIL++++   K++DFGL+RA   
Sbjct: 134 MRCKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARAS-- 183

Query: 118 PMNRYTH---EVV-TLWYRPPEILLGAKVYST---TV--DIWSAGCIFSEMI 160
                T     +V T  Y  PE             T   DI+S G +  E+I
Sbjct: 184 EKFAQTVMTSRIVGTTAYMAPE-------ALRGEITPKSDIYSFGVVLLEII 228

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.8 bits (145), Expect = 2e-11
 Identities = 18/86 (20%), Positives = 35/86 (40%), Gaps = 3/86 (3%)

Query: 41  FLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK 100
           F++ +    DL+   +                ++L+ L Y H    +H D+K  N+L+N 
Sbjct: 128 FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187

Query: 101 SGALK--LADFGLSRAFTIPMNRYTH 124
               +  L D+GL+  +  P   +  
Sbjct: 188 KNPDQVYLVDYGLAYRY-CPEGVHKA 212

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.9 bits (143), Expect = 4e-11
 Identities = 24/113 (21%), Positives = 42/113 (37%), Gaps = 4/113 (3%)

Query: 13  LREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
             E  + K ++    +  +           +V E L   L+D                  
Sbjct: 52  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 111

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNR 121
            Q++  + Y HS+  IHRD+KP N L+    K   + + DFGL++ +      
Sbjct: 112 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 4e-11
 Identities = 20/82 (24%), Positives = 37/82 (45%), Gaps = 11/82 (13%)

Query: 41  FLVFEFLRQDLKDFLQTTPVPVPPA-----LAKSYLYQLLEALRYCHSRRIIHRDLKPQN 95
           FLV   L + L+  L  +P  V        +A     +LL+AL + H    +H ++  +N
Sbjct: 134 FLVLPSLGRSLQSALDVSPKHVLSERSVLQVAC----RLLDALEFLHENEYVHGNVTAEN 189

Query: 96  ILINKSGALK--LADFGLSRAF 115
           I ++     +  LA +G +  +
Sbjct: 190 IFVDPEDQSQVTLAGYGFAFRY 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 59.0 bits (143), Expect = 4e-11
 Identities = 23/88 (26%), Positives = 35/88 (39%), Gaps = 19/88 (21%)

Query: 41  FLVFEFLRQDLKDF--------LQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLK 92
           F+V E L  DL+            T        L      ++L+ L Y H    +H D+K
Sbjct: 128 FMVMERLGIDLQKISGQNGTFKKSTVLQ-----LGI----RMLDVLEYIHENEYVHGDIK 178

Query: 93  PQNILINKSGALK--LADFGLSRAFTIP 118
             N+L+      +  LAD+GLS  +   
Sbjct: 179 AANLLLGYKNPDQVYLADYGLSYRYCPN 206

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.7 bits (139), Expect = 1e-10
 Identities = 22/108 (20%), Positives = 45/108 (41%), Gaps = 4/108 (3%)

Query: 13  LREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
           L E  + + L+    +  +           LV + L   L+D        +         
Sbjct: 50  LYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLA 109

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFT 116
            Q++  + + HS+  +HRD+KP N L+    ++  + + DFGL++ + 
Sbjct: 110 DQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 56.8 bits (138), Expect = 2e-10
 Identities = 43/167 (25%), Positives = 70/167 (41%), Gaps = 31/167 (18%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQTTPVPVPP------- 64
             E+ ++    H N++RL        +  LV+ ++    +   L+  P   PP       
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQ 134

Query: 65  --AL--AKSYLYQLLEALRYCH---SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
             AL  A+         L Y H     +IIHRD+K  NIL+++     + DFGL++    
Sbjct: 135 RIALGSAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD- 185

Query: 118 PMNRYTH---EVV-TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              + TH    V  T+ +  PE L   K  S   D++  G +  E+I
Sbjct: 186 --YKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELI 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.1 bits (135), Expect = 4e-10
 Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 3/87 (3%)

Query: 69  SYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
            Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R      +        
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256

Query: 129 LWYR--PPEILLGAKVYSTTVDIWSAG 153
           L  +   PE +   +VY+   D+WS G
Sbjct: 257 LPLKWMAPETIFD-RVYTIQSDVWSFG 282

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 55.5 bits (134), Expect = 6e-10
 Identities = 16/48 (33%), Positives = 28/48 (58%), Gaps = 5/48 (10%)

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILI-----NKSGALKLADFGLSRAF 115
           QL+  + Y HS+ +I+RD+KP+N LI          + + DF L++ +
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 54.7 bits (132), Expect = 1e-09
 Identities = 23/115 (20%), Positives = 43/115 (37%), Gaps = 12/115 (10%)

Query: 10  STALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAK 68
                E    K L     +  ++          LV + L   L+D L            K
Sbjct: 50  PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSV---K 106

Query: 69  SYL---YQLLEALRYCHSRRIIHRDLKPQNILINKSGALK-----LADFGLSRAF 115
           +      Q+L  ++  H + +++RD+KP N LI +  +       + DFG+ + +
Sbjct: 107 TVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	163
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.98
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.98
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.98
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.98
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.98
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.97
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.97
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.97
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.97
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.96
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.96
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.78
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.65
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.37
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.06
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.01
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.71
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.5
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.43
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.04
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.65
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.26
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.2
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.05
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.89
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.79
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.75
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.64
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.29
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.58
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	94.56
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	94.56
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	94.31
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	93.33
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	93.21
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	92.84
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.68
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.82
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	90.66
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	88.43
3mes_A	424	Choline kinase; malaria, structural genomics, stru	87.85
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	86.54

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.6e-46  Score=261.96  Aligned_cols=153  Identities=34%  Similarity=0.606  Sum_probs=129.1

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....++.+|++++++++||||+++++++.+++.+|+||||++|+|.+.+...+ .+++..+..++.|++.|++|||++|+
T Consensus        55 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~~I  133 (275)
T 3hyh_A           55 DMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFDYIVQRD-KMSEQEARRFFQQIISAVEYCHRHKI  133 (275)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCEEHHHHHHHSC-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            44567899999999999999999999999999999999999999999988754 79999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||||+||+++.++.+||+|||+++.... .......+||+.|+|||++.+...++.++||||+||++|+|+|
T Consensus       134 iHRDiKP~NILl~~~~~vkl~DFGla~~~~~-~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~llt  207 (275)
T 3hyh_A          134 VHRDLKPENLLLDEHLNVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLC  207 (275)
T ss_dssp             CCCCCCTTTEEECTTCCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHH
T ss_pred             ccccCChHHeEECCCCCEEEeecCCCeecCC-CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHH
Confidence            9999999999999999999999999976543 2344567899999999999876655689999999999999997

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4e-46  Score=267.88  Aligned_cols=153  Identities=28%  Similarity=0.514  Sum_probs=139.6

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+.+.+|+++|++++|||||++++++.+++.+|+|||||+| +|.+++..  +.+++..+..++.|++.||+|||++
T Consensus       112 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~  189 (346)
T 4fih_A          112 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ  189 (346)
T ss_dssp             CSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34556789999999999999999999999999999999999985 88888865  3689999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+||||||+||+++.+|.+||+|||+++............+||+.|+|||++.+.. |+.++||||+||++|||++
T Consensus       190 ~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~  265 (346)
T 4fih_A          190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVD  265 (346)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999987765555667789999999999987654 7999999999999999996

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.5e-46  Score=264.18  Aligned_cols=154  Identities=29%  Similarity=0.527  Sum_probs=138.7

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +...+.+.+|++++++++||||+++++++++++.+|+|||||+| +|.+++.+.+ .+++..+..++.|++.|++|||++
T Consensus        73 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~-~l~e~~~~~~~~qi~~al~ylH~~  151 (311)
T 4aw0_A           73 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK  151 (311)
T ss_dssp             TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34456789999999999999999999999999999999999985 9999987654 799999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+||||||+||+++.++.+||+|||+++.....  .......+||+.|+|||++.+.. ++.++||||+||++|+|+|
T Consensus       152 ~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~  229 (311)
T 4aw0_A          152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVA  229 (311)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999876432  23345678999999999998754 7999999999999999997

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.7e-46  Score=268.48  Aligned_cols=152  Identities=30%  Similarity=0.577  Sum_probs=136.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|++++++++||||+++++++++++.+|+|||||+| +|.+++...+ ..+++..++.++.|++.||.|||++||
T Consensus        67 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~I  146 (350)
T 4b9d_A           67 REESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKI  146 (350)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            45688999999999999999999999999999999999985 9999997544 467999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||||+||+++.+|.+||+|||+++............+||+.|+|||++.+.. |+.++|||||||++|||+|
T Consensus       147 iHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemlt  220 (350)
T 4b9d_A          147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCT  220 (350)
T ss_dssp             EETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHH
Confidence            9999999999999999999999999987653333345568999999999998754 7999999999999999997

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=268.97  Aligned_cols=153  Identities=28%  Similarity=0.514  Sum_probs=139.5

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+.+.+|+++|++++|||||++++++.+++.+|+|||||+| +|.+++..  +.+++..+..++.|++.||+|||++
T Consensus       189 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~  266 (423)
T 4fie_A          189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQ  266 (423)
T ss_dssp             CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34456789999999999999999999999999999999999985 88888765  3689999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+||||||+|||++.+|.+||+|||++.............+||+.|+|||++.+.. |+.++|||||||++|||++
T Consensus       267 ~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~  342 (423)
T 4fie_A          267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVD  342 (423)
T ss_dssp             TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999987765556667789999999999987654 7999999999999999996

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.8e-46  Score=262.69  Aligned_cols=151  Identities=34%  Similarity=0.481  Sum_probs=129.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++||||+++++++++++.+|+|||||+| +|.+++.+.+ .+++..+..++.|++.|++|||++|++
T Consensus        70 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~Ii  148 (304)
T 3ubd_A           70 RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGII  148 (304)
T ss_dssp             CC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence            34678899999999999999999999999999999999985 9999987654 799999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||||+||+++.+|.+||+|||+++............+||+.|+|||++.+.. ++.++||||+||++|||+|
T Consensus       149 HRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemlt  221 (304)
T 3ubd_A          149 YRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLT  221 (304)
T ss_dssp             CSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHh
Confidence            999999999999999999999999986654445556778999999999998754 7999999999999999997

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-44  Score=256.08  Aligned_cols=152  Identities=21%  Similarity=0.345  Sum_probs=130.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .++|.+|++++++++|||||++++++.. +.+++|||||+| +|.+++....+.+++..+..++.|++.|+.|||+++|+
T Consensus        76 ~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~Ii  154 (307)
T 3omv_A           76 FQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNII  154 (307)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            3568899999999999999999998865 568999999984 99999988777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||||+||+++.++.+||+|||+++.....  .......+||+.|+|||++.+  ..+++.++||||+||++|||+|
T Consensus       155 HRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ellt  232 (307)
T 3omv_A          155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMT  232 (307)
T ss_dssp             CSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHH
Confidence            9999999999999999999999999765432  223455689999999999864  2357999999999999999997

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.3e-44  Score=251.38  Aligned_cols=148  Identities=30%  Similarity=0.471  Sum_probs=130.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .+++.+|++++++++|||||++++++.+    ++.+|+|||||+| +|.+++.+.+ .+++..+..++.|++.|+.|||+
T Consensus        69 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~ylH~  147 (290)
T 3fpq_A           69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT  147 (290)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence            3568899999999999999999999865    3578999999985 9999887654 78999999999999999999999


Q ss_pred             CC--ceecCCCCCcEEEc-cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          84 RR--IIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        84 ~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +|  |+||||||+||+++ .++.+||+|||+++...  .......+||+.|+|||++.+  .++.++||||+||++|||+
T Consensus       148 ~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyell  223 (290)
T 3fpq_A          148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMA  223 (290)
T ss_dssp             SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC--CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHH
Confidence            98  99999999999997 47899999999997543  234456789999999999865  3799999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      |
T Consensus       224 t  224 (290)
T 3fpq_A          224 T  224 (290)
T ss_dssp             H
T ss_pred             H
Confidence            7

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-44  Score=258.75  Aligned_cols=148  Identities=28%  Similarity=0.433  Sum_probs=129.7

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   90 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~   90 (163)
                      ..+|++++++++|||||++++++.+++.+|+|||||+| +|.+++...+ .+++..+..++.|++.||+|||++||+|||
T Consensus        97 ~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~ylH~~~IiHRD  175 (336)
T 4g3f_A           97 RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG-CLPEDRALYYLGQALEGLEYLHTRRILHGD  175 (336)
T ss_dssp             CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTEECSC
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCceecc
Confidence            35799999999999999999999999999999999985 9999987654 799999999999999999999999999999


Q ss_pred             CCCCcEEEccCC-ceEEeecccccccccCCC-----cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          91 LKPQNILINKSG-ALKLADFGLSRAFTIPMN-----RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        91 i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |||+||+++.+| .+||+|||+++.......     .....+||+.|+|||++.+.. ++.++||||+||++|||+|
T Consensus       176 lKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemlt  251 (336)
T 4g3f_A          176 VKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLN  251 (336)
T ss_dssp             CCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             cCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHH
Confidence            999999999987 699999999976543211     122357999999999998754 7999999999999999997

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-44  Score=254.41  Aligned_cols=152  Identities=27%  Similarity=0.502  Sum_probs=134.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC------------CCCCCHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT------------PVPVPPALAKSYLYQLL   75 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~~i~   75 (163)
                      .++|.+|+++|++++|||||++++++.+++.+++|||||+ |+|.+++...            ...+++..+..++.|++
T Consensus        59 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia  138 (299)
T 4asz_A           59 RKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIA  138 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHH
Confidence            4568999999999999999999999999999999999998 5999998653            34789999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          76 EALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        76 ~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      .|+.|||+++++||||||+||+++.++.+||+|||+++.......  ......||+.|+|||.+.+.. ++.++||||+|
T Consensus       139 ~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~G  217 (299)
T 4asz_A          139 AGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLG  217 (299)
T ss_dssp             HHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHH
T ss_pred             HHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHH
Confidence            999999999999999999999999999999999999976542211  122346799999999998755 79999999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      |++|||+|
T Consensus       218 vvl~Ellt  225 (299)
T 4asz_A          218 VVLWEIFT  225 (299)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHc
Confidence            99999997

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.3e-43  Score=253.14  Aligned_cols=152  Identities=28%  Similarity=0.503  Sum_probs=128.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC--------------CCCCCHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT--------------PVPVPPALAKSYLYQ   73 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--------------~~~~~~~~~~~~~~~   73 (163)
                      .++|.+|+++|++++|||||++++++.+++.+++|||||+ |+|.+++...              .+++++..++.++.|
T Consensus        87 ~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q  166 (329)
T 4aoj_A           87 RQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ  166 (329)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHH
Confidence            4568999999999999999999999999999999999998 4999998653              246899999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      ++.|+.|||+++++||||||+||+++.++.+||+|||+++......  .......||+.|+|||.+.+.. ++.++||||
T Consensus       167 ia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS  245 (329)
T 4aoj_A          167 VAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWS  245 (329)
T ss_dssp             HHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHH
T ss_pred             HHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccc
Confidence            9999999999999999999999999999999999999997654221  2233457899999999998755 799999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +||++|||+|
T Consensus       246 ~Gvvl~Ellt  255 (329)
T 4aoj_A          246 FGVVLWEIFT  255 (329)
T ss_dssp             HHHHHHHHHT
T ss_pred             hHHHHHHHHc
Confidence            9999999997

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.2e-43  Score=251.18  Aligned_cols=153  Identities=25%  Similarity=0.466  Sum_probs=135.3

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC---------------CCCCHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYL   71 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------------~~~~~~~~~~~~   71 (163)
                      ..++|.+|+.++++++|||||++++++.+++.+++|||||+ |+|.+++....               ..+++..+..++
T Consensus        72 ~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~  151 (308)
T 4gt4_A           72 LREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV  151 (308)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHH
Confidence            34679999999999999999999999999999999999998 59999986432               368999999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCCcCCCcchhh
Q psy7820          72 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        72 ~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      .|++.|++|||+++++||||||.||+++.++.+||+|||+++.....  ........||+.|+|||.+.+.. ++.++||
T Consensus       152 ~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDV  230 (308)
T 4gt4_A          152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDI  230 (308)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchh
Confidence            99999999999999999999999999999999999999998765422  12234567899999999998755 7999999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+||++|||+|
T Consensus       231 wSfGvvl~El~t  242 (308)
T 4gt4_A          231 WSYGVVLWEVFS  242 (308)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHh
Confidence            999999999997

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.7e-43  Score=249.26  Aligned_cols=152  Identities=32%  Similarity=0.543  Sum_probs=123.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------------EEEEEecchhc-cHHHHHhcCCC--CCCHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF------------KLFLVFEFLRQ-DLKDFLQTTPV--PVPPALAKSYLYQ   73 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------------~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~   73 (163)
                      .+++.+|+++|++++||||+++++++.+.+            ++|+|||||+| +|.+++.....  ..++..++.++.|
T Consensus        47 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~q  126 (299)
T 4g31_A           47 REKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ  126 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHH
Confidence            356889999999999999999999986543            47999999985 99999876542  3456778899999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC------------cccccccCccccCcccccCCc
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------------RYTHEVVTLWYRPPEILLGAK  141 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~pe~~~~~~  141 (163)
                      ++.|++|||++||+||||||+||+++.++.+||+|||+++.......            .....+||+.|+|||++.+..
T Consensus       127 i~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~  206 (299)
T 4g31_A          127 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS  206 (299)
T ss_dssp             HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred             HHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence            99999999999999999999999999999999999999976543211            123457999999999998754


Q ss_pred             CCCcchhhHHHHHHHHHHhc
Q psy7820         142 VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       142 ~~~~~~Di~slG~~l~~ll~  161 (163)
                       ++.++||||+||++|||++
T Consensus       207 -y~~~~DiwSlGvilyell~  225 (299)
T 4g31_A          207 -YSHKVDIFSLGLILFELLY  225 (299)
T ss_dssp             -CCTHHHHHHHHHHHHHHHS
T ss_pred             -CCCHHHHHHHHHHHHHHcc
Confidence             7999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.6e-42  Score=250.68  Aligned_cols=152  Identities=38%  Similarity=0.798  Sum_probs=133.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee------CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+++|+.++||||+++++++..      .+.+|+|||||+|+|.+.+...+ .+++..+..++.|++.||.|||
T Consensus        97 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~-~l~~~~~~~~~~qil~al~ylH  175 (398)
T 4b99_A           97 AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQ-PLTLEHVRYFLYQLLRGLKYMH  175 (398)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSS-CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999998764      35799999999999999887654 8999999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccC----CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP----MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      ++||+|+||||+||+++.++.+||+|||+++.....    .......+||+.|+|||++.+...++.++||||+||++||
T Consensus       176 ~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~e  255 (398)
T 4b99_A          176 SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGE  255 (398)
T ss_dssp             HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHH
T ss_pred             HCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHH
Confidence            999999999999999999999999999999765322    2234567899999999998877667999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |++
T Consensus       256 ll~  258 (398)
T 4b99_A          256 MLA  258 (398)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            996

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-40  Score=241.74  Aligned_cols=152  Identities=26%  Similarity=0.455  Sum_probs=131.3

Q ss_pred             CCchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           6 EGVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .....++.+|+++|+.+ +||||+++++++.+++++|+||||++| +|.+.+.    .+++..++.++.|++.|++|||+
T Consensus        60 ~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~  135 (361)
T 4f9c_A           60 TSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQ  135 (361)
T ss_dssp             TSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHH
Confidence            44556788999999999 699999999999999999999999985 8988874    58899999999999999999999


Q ss_pred             CCceecCCCCCcEEEccC-CceEEeecccccccccCC----------------------------CcccccccCccccCc
Q psy7820          84 RRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPM----------------------------NRYTHEVVTLWYRPP  134 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~p  134 (163)
                      +||+||||||+||+++.+ +.+||+|||+++......                            ......+||+.|+||
T Consensus       136 ~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP  215 (361)
T 4f9c_A          136 FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP  215 (361)
T ss_dssp             TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCH
T ss_pred             CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCH
Confidence            999999999999999877 799999999997543221                            112345799999999


Q ss_pred             ccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         135 EILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       135 e~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++.+...++.++||||+||++|||++
T Consensus       216 E~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          216 EVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             HHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            999876668999999999999999997

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.2e-41  Score=243.81  Aligned_cols=152  Identities=26%  Similarity=0.478  Sum_probs=131.3

Q ss_pred             hhhHHHHHHHHhcCCC-CCeeeeeeeeee-CcEEEEEecchh-ccHHHHHhcC---------------CCCCCHHHHHHH
Q psy7820           9 PSTALREISVLKELKH-PNVIRLHDVIPV-DFKLFLVFEFLR-QDLKDFLQTT---------------PVPVPPALAKSY   70 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h-~~i~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~---------------~~~~~~~~~~~~   70 (163)
                      ..++.+|+++|++++| ||||+++++|.+ ++.+++|||||+ |+|.+++...               ...+++..+..+
T Consensus       111 ~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  190 (353)
T 4ase_A          111 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY  190 (353)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHH
Confidence            3468899999999965 899999999865 457899999998 5999998653               235889999999


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchh
Q psy7820          71 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVD  148 (163)
Q Consensus        71 ~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D  148 (163)
                      +.|++.|++|||+++++||||||.||+++.++.+||+|||+++.......  ......||+.|+|||.+.+.. ++.++|
T Consensus       191 ~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksD  269 (353)
T 4ase_A          191 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSD  269 (353)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHH
T ss_pred             HHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCccc
Confidence            99999999999999999999999999999999999999999976543322  233457899999999998754 799999


Q ss_pred             hHHHHHHHHHHhc
Q psy7820         149 IWSAGCIFSEMIQ  161 (163)
Q Consensus       149 i~slG~~l~~ll~  161 (163)
                      |||+||++|||+|
T Consensus       270 VwS~Gv~l~El~t  282 (353)
T 4ase_A          270 VWSFGVLLWEIFS  282 (353)
T ss_dssp             HHHHHHHHHHHTT
T ss_pred             EeehHHHHHHHHh
Confidence            9999999999997

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.3e-40  Score=255.13  Aligned_cols=144  Identities=25%  Similarity=0.447  Sum_probs=129.7

Q ss_pred             HHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCC
Q psy7820          15 EISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKP   93 (163)
Q Consensus        15 e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~   93 (163)
                      ++.+++.++||||++++++|++.+.+|+|||||.| +|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||
T Consensus       242 ~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~-~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKP  320 (689)
T 3v5w_A          242 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP  320 (689)
T ss_dssp             HHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSG
T ss_pred             HHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCccccCCch
Confidence            35667778999999999999999999999999985 9999987654 799999999999999999999999999999999


Q ss_pred             CcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          94 QNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        94 ~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+++.+|.+||+|||++.....  ......+||+.|+|||++.+...|+.++|||||||++|||++
T Consensus       321 eNILld~~G~vKL~DFGlA~~~~~--~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLt  386 (689)
T 3v5w_A          321 ANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR  386 (689)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSS--CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             HHeEEeCCCCEEecccceeeecCC--CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999976553  334567999999999998755558999999999999999996

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7e-40  Score=250.01  Aligned_cols=151  Identities=26%  Similarity=0.458  Sum_probs=137.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|+++|+.++||||++++++|.+++.+|+|||||+| +|.+++....+.+++..+..++.||+.||.|||++|++
T Consensus       198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ii  277 (573)
T 3uto_A          198 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV  277 (573)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            45678999999999999999999999999999999999985 99999988777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccC--CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKS--GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.+  +.+||+|||+++.... .......+||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       278 HRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~-~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~  351 (573)
T 3uto_A          278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLS  351 (573)
T ss_dssp             CCCCCGGGEEESSSSCCCEEECCCSSCEECCT-TSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHH
T ss_pred             eccCChhhccccCCCCCCEEEeeccceeEccC-CCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHH
Confidence            99999999999854  8999999999987653 34455678999999999998754 7999999999999999996

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.5e-40  Score=234.07  Aligned_cols=146  Identities=29%  Similarity=0.370  Sum_probs=121.0

Q ss_pred             HHHHHHhcCCCCCeeeeeeeeeeCc----EEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----
Q psy7820          14 REISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR----   84 (163)
Q Consensus        14 ~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~----   84 (163)
                      .|+..+.+++||||+++++++.+++    .+|+||||++ |+|.+++...  .+++..+..++.|++.|+.|||++    
T Consensus        46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~~~~~  123 (303)
T 3hmm_A           46 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGT  123 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCST
T ss_pred             HHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHhhhhc
Confidence            4555556789999999999997653    6899999998 5999998764  588999999999999999999987    


Q ss_pred             ----CceecCCCCCcEEEccCCceEEeecccccccccCCC----cccccccCccccCcccccCCc-----CCCcchhhHH
Q psy7820          85 ----RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLGAK-----VYSTTVDIWS  151 (163)
Q Consensus        85 ----~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~-----~~~~~~Di~s  151 (163)
                          +|+||||||+||+++.++.+||+|||+++.......    .....+||+.|+|||++.+..     .++.++||||
T Consensus       124 ~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS  203 (303)
T 3hmm_A          124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA  203 (303)
T ss_dssp             TCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHH
T ss_pred             cCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhh
Confidence                999999999999999999999999999876654322    123457899999999986532     2577999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +||++|||+|
T Consensus       204 ~Gvvl~El~t  213 (303)
T 3hmm_A          204 MGLVFWEIAR  213 (303)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHH
Confidence            9999999997

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-38  Score=222.64  Aligned_cols=153  Identities=61%  Similarity=1.116  Sum_probs=140.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++|+||+++++++.+++.+++|||++++++.+.+....+.+++..+..++.|++.++.|||++|++|
T Consensus        45 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH  124 (292)
T 3o0g_A           45 PSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLH  124 (292)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             chHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            46678999999999999999999999999999999999999999998887778999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       125 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  197 (292)
T 3o0g_A          125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN  197 (292)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred             CCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHH
Confidence            9999999999999999999999998766555555666789999999999876667999999999999999985

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.2e-38  Score=224.67  Aligned_cols=153  Identities=63%  Similarity=1.059  Sum_probs=139.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++||||+++++++.+++..++|||++++++.+.+......+++..+..++.|++.++.|||++|++|
T Consensus        63 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH  142 (311)
T 3niz_A           63 PSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILH  142 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            45688999999999999999999999999999999999999999999888778999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.++.++|+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       143 ~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  215 (311)
T 3niz_A          143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMIT  215 (311)
T ss_dssp             CCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHh
Confidence            9999999999999999999999998766555555566789999999998775667999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.7e-38  Score=221.66  Aligned_cols=154  Identities=60%  Similarity=1.083  Sum_probs=135.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ....+.+|++++++++||||+++++++.+++..++|||++++++.+.+....+.+++..+..++.|++.++.|||++|++
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  122 (288)
T 1ob3_A           43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL  122 (288)
T ss_dssp             CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34678899999999999999999999999999999999999999999988777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.+||+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       123 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  196 (288)
T 1ob3_A          123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN  196 (288)
T ss_dssp             CSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999987765444445556789999999998765567999999999999999996

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.7e-37  Score=222.78  Aligned_cols=153  Identities=27%  Similarity=0.427  Sum_probs=137.1

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .....+.+|.++++.++||||+++++++.+.+.+|+||||++| +|.+++...+ .+++..++.++.|++.+++|||++|
T Consensus        47 ~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~  125 (337)
T 1o6l_A           47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD  125 (337)
T ss_dssp             TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999999999999999999999999999999986 8888887644 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.+|.++|+|||++.............+|++.|+|||.+.+.. ++.++|+||+|+++|||++
T Consensus       126 ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  200 (337)
T 1o6l_A          126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMC  200 (337)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHH
T ss_pred             eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhc
Confidence            99999999999999999999999999876544444556678999999999987654 7999999999999999996

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.2e-37  Score=221.45  Aligned_cols=154  Identities=58%  Similarity=1.059  Sum_probs=137.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTT-----PVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ....+.+|++++++++||||+++++++.+++..++|||+++++|.+++...     ...+++..+..++.|++.|+.|||
T Consensus        46 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH  125 (317)
T 2pmi_A           46 TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH  125 (317)
T ss_dssp             SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            446788999999999999999999999999999999999999999887643     246899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||+|+||+++.++.+||+|||.+..............+++.|+|||.+.+...++.++||||+|+++|+|++
T Consensus       126 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  204 (317)
T 2pmi_A          126 ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMIT  204 (317)
T ss_dssp             HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999999998766544445566789999999998765567999999999999999996

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.6e-37  Score=216.92  Aligned_cols=152  Identities=33%  Similarity=0.538  Sum_probs=136.9

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.+.+|+.++++++||||+++++++.+++..++||||++| +|.+++...  .+++..+..++.|++.++.|||++|
T Consensus        59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~  136 (297)
T 3fxz_A           59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ  136 (297)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456688999999999999999999999999999999999975 998888764  5889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus       137 i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  211 (297)
T 3fxz_A          137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIE  211 (297)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHH
T ss_pred             ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999877665555555678899999999987755 7999999999999999996

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.3e-37  Score=221.01  Aligned_cols=151  Identities=33%  Similarity=0.646  Sum_probs=135.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+++++.++||||+++++++.+++.+|+||||+++ +|.+++...+ .+++..+..++.|++.++.|||++|++
T Consensus        58 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~~iv  136 (328)
T 3fe3_A           58 LQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIV  136 (328)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            34578999999999999999999999999999999999975 9998887654 789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.++|+|||++...... ......+|++.|+|||.+.+....+.++||||+|+++|+|++
T Consensus       137 HrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  209 (328)
T 3fe3_A          137 HRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVS  209 (328)
T ss_dssp             CSCCCGGGEEECTTSCEEECSTTCCGGGSSS-CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCHHHEEEcCCCCEEEeeccCceecCCC-CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHh
Confidence            9999999999999999999999998765533 345566889999999999876654689999999999999996

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=6.1e-37  Score=220.81  Aligned_cols=152  Identities=34%  Similarity=0.592  Sum_probs=136.3

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...++.+|+++++.++||||+++++++.+.+..++||||++|++.+.+...+ .+++..+..++.|++.++.|||+.|++
T Consensus        52 ~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~~g~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~giv  130 (336)
T 3h4j_B           52 MHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIV  130 (336)
T ss_dssp             CSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            3457889999999999999999999999999999999999989999887654 789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||++..... .......+|++.|+|||.+.+....++++||||+|+++|+|++
T Consensus       131 H~Dlkp~NIll~~~~~~kl~DFG~s~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  203 (336)
T 3h4j_B          131 HRDLKPENLLLDDNLNVKIADFGLSNIMTD-GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV  203 (336)
T ss_dssp             CCCCSTTTEEECTTCCEEECCSSCTBTTTT-SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH
T ss_pred             ecCCchhhEEEcCCCCEEEEEeccceeccC-CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh
Confidence            999999999999999999999999876543 2334556789999999999876645789999999999999996

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.9e-37  Score=225.90  Aligned_cols=152  Identities=32%  Similarity=0.514  Sum_probs=136.2

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+.+|..+++++ +||||+++++++.+++.+|+||||++| +|.+++...+ .+++..++.++.|++.|++|||++|
T Consensus        95 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~g  173 (396)
T 4dc2_A           95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERG  173 (396)
T ss_dssp             -CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345678999999887 899999999999999999999999986 8888887654 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.+||+|||+++............+||+.|+|||++.+.. ++.++|+||+|+++|+|++
T Consensus       174 ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~  248 (396)
T 4dc2_A          174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMA  248 (396)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             EEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999976554555566778999999999998755 7999999999999999996

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.5e-36  Score=216.35  Aligned_cols=153  Identities=29%  Similarity=0.516  Sum_probs=134.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++++++++||||+++++++.+++..++||||+++ +|.+++......+++..+..++.|++.++.|||++|+
T Consensus        50 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  129 (310)
T 3s95_A           50 TQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNI  129 (310)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            345678999999999999999999999999999999999986 9999998877789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCc--------------ccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--------------YTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--------------~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      +|+||+|+||+++.++.++|+|||.+.........              .....|++.|+|||.+.+.. ++.++||||+
T Consensus       130 vH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~sl  208 (310)
T 3s95_A          130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSF  208 (310)
T ss_dssp             ECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHH
T ss_pred             cCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHH
Confidence            99999999999999999999999998765432221              11457899999999997754 7999999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      |+++|+|++
T Consensus       209 G~~l~el~~  217 (310)
T 3s95_A          209 GIVLCEIIG  217 (310)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHhc
Confidence            999999985

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.8e-37  Score=223.22  Aligned_cols=152  Identities=31%  Similarity=0.436  Sum_probs=130.6

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+.+|.++++.+ +||||+++++++.+.+.+|+||||++| +|.+++...+ .+++..++.++.|++.+++|||++|
T Consensus        66 ~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~g  144 (353)
T 3txo_A           66 DVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSR-RFDEARARFYAAEIISALMFLHDKG  144 (353)
T ss_dssp             THHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            445678899999998 799999999999999999999999985 8988887654 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.++|+|||++.............+|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       145 ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  219 (353)
T 3txo_A          145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLC  219 (353)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHH
T ss_pred             CcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHh
Confidence            99999999999999999999999999876544444556678999999999987654 7999999999999999996

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.4e-37  Score=220.83  Aligned_cols=151  Identities=32%  Similarity=0.523  Sum_probs=135.0

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|.++++++ +||||+++++++.+++.+|+||||++| +|.+++...+ .+++..++.++.|++.+++|||++|+
T Consensus        53 ~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~~i  131 (345)
T 3a8x_A           53 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHERGI  131 (345)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            34577899999998 899999999999999999999999975 8988887644 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.++.++|+|||++.............+|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       132 vHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  205 (345)
T 3a8x_A          132 IYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMA  205 (345)
T ss_dssp             BCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             eecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHh
Confidence            9999999999999999999999999876544444555678899999999998754 7999999999999999996

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=220.17  Aligned_cols=152  Identities=30%  Similarity=0.519  Sum_probs=134.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++.++||||+++++++.+.+.+|+||||+.| +|.+++... ..+++..+..++.|++.|+.|||++|+
T Consensus        58 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~gi  136 (384)
T 4fr4_A           58 EVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN-VHFKEETVKLFICELVMALDYLQNQRI  136 (384)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            446788999999999999999999999999999999999975 888887764 479999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCC--cCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.+|.++|+|||++..... .......+|++.|+|||++.+.  ..++.++||||||+++|+|++
T Consensus       137 vHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~ellt  212 (384)
T 4fr4_A          137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR  212 (384)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECCT-TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHH
T ss_pred             eeccCcHHHeEECCCCCEEEeccceeeeccC-CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHh
Confidence            9999999999999999999999999976543 3344567889999999998642  347899999999999999996

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.3e-36  Score=225.60  Aligned_cols=154  Identities=31%  Similarity=0.444  Sum_probs=136.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|..+++.++|+||+++++++.+++.+|+||||++| +|.+++....+.+++..++.++.|++.|+.|||++|+
T Consensus       117 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gi  196 (437)
T 4aw2_A          117 ETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY  196 (437)
T ss_dssp             TTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            344588999999999999999999999999999999999974 9999998866789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCccccc----CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~----~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.++.+||+|||++........ .....+||+.|+|||++.    +...++.++||||+|+++|||++
T Consensus       197 iHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt  276 (437)
T 4aw2_A          197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY  276 (437)
T ss_dssp             ECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH
T ss_pred             EecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh
Confidence            9999999999999999999999999876543322 233467899999999986    23347999999999999999996

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=221.29  Aligned_cols=151  Identities=56%  Similarity=1.006  Sum_probs=131.0

Q ss_pred             hHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecC
Q psy7820          11 TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRD   90 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~   90 (163)
                      .+.+|++++++++|+||+++++++.+++..++|||++++++.+++...+..+++..+..++.|++.++.|||+.|++|+|
T Consensus        46 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D  125 (324)
T 3mtl_A           46 TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRD  125 (324)
T ss_dssp             CCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred             hHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCC
Confidence            45679999999999999999999999999999999999999999988877899999999999999999999999999999


Q ss_pred             CCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          91 LKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        91 i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|+||+++.++.++|+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       126 ikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  196 (324)
T 3mtl_A          126 LKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMAT  196 (324)
T ss_dssp             CCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             cCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999987666555555566789999999998775667999999999999999996

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-37  Score=220.90  Aligned_cols=153  Identities=46%  Similarity=0.888  Sum_probs=139.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++|+||+++++++.+++..++|||++++++.+.+......+++..+..++.|++.++.|||+.|++|
T Consensus        56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  135 (346)
T 1ua2_A           56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  135 (346)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEEC
Confidence            35678999999999999999999999999999999999999999999887778899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       136 ~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  208 (346)
T 1ua2_A          136 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL  208 (346)
T ss_dssp             CCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHH
Confidence            9999999999999999999999998766555555566789999999998765557999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-36  Score=219.17  Aligned_cols=153  Identities=33%  Similarity=0.496  Sum_probs=136.0

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .....+..|.++++.+ +||||+++++++.+.+.+|+||||++| +|.+++...+ .+++..+..++.|++.|++|||++
T Consensus        59 ~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~  137 (345)
T 1xjd_A           59 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK  137 (345)
T ss_dssp             TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3455678899999987 899999999999999999999999975 9988887644 789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.+|.++|+|||++.............+|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       138 ~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  213 (345)
T 1xjd_A          138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLI  213 (345)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhc
Confidence            999999999999999999999999999876544444456678999999999998754 7999999999999999996

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-36  Score=216.00  Aligned_cols=150  Identities=30%  Similarity=0.513  Sum_probs=134.4

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.+.+|..+++.++||||+++++++.+...+|+||||++| +|.+++.... .+++..+..++.|++.+++|||++|
T Consensus        48 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~  126 (318)
T 1fot_A           48 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSKD  126 (318)
T ss_dssp             TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             hHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456678899999999999999999999999999999999985 9999887654 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.+|.++|+|||++.....   .....+|++.|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus       127 ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  198 (318)
T 1fot_A          127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLA  198 (318)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHH
T ss_pred             ccccCCChheEEEcCCCCEEEeecCcceecCC---ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHh
Confidence            99999999999999999999999999876442   234567899999999987654 7999999999999999996

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-36  Score=216.45  Aligned_cols=151  Identities=28%  Similarity=0.476  Sum_probs=135.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|+++++.++||||+++++++.+.+.+++||||++| +|.+.+......+++..+..++.|++.++.|||++|++
T Consensus        45 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~giv  124 (321)
T 1tki_A           45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG  124 (321)
T ss_dssp             HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            34578999999999999999999999999999999999986 99999987777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEcc--CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINK--SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.  ++.++|+|||.+..... ........|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       125 H~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~  198 (321)
T 1tki_A          125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLS  198 (321)
T ss_dssp             CCCCCGGGEEESSSSCCCEEECCCTTCEECCT-TCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEccCCCCCEEEEECCCCeECCC-CCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999987  78999999999876543 23345567899999999987654 6999999999999999996

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.7e-36  Score=223.69  Aligned_cols=151  Identities=33%  Similarity=0.536  Sum_probs=135.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++||||+++++++.+++..|+|||++.| +|.+.+...+ .+++..+..++.|++.++.|||++|++
T Consensus        54 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~e~~~~~i~~qil~aL~~lH~~giv  132 (444)
T 3soa_A           54 HQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVV  132 (444)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred             HHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678999999999999999999999999999999999986 9988887764 799999999999999999999999999


Q ss_pred             ecCCCCCcEEEc---cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++   .++.+||+|||++..............|++.|+|||++.+.. ++.++||||+|+++|+|++
T Consensus       133 HrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~  208 (444)
T 3soa_A          133 HRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLV  208 (444)
T ss_dssp             CCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             ccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHh
Confidence            999999999998   457899999999977665545555678899999999987654 7999999999999999996

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.1e-36  Score=218.41  Aligned_cols=153  Identities=27%  Similarity=0.386  Sum_probs=136.5

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...+.+..|.++++.+ +||+|+++++++.+.+.+|+||||++| +|.+++...+ .+++..++.++.|++.|++|||++
T Consensus        62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~  140 (353)
T 2i0e_A           62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK  140 (353)
T ss_dssp             TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3456678999999998 799999999999999999999999985 9998887654 789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||||+||+++.+|.++|+|||++.............+|++.|+|||.+.+.. ++.++|+||||+++|||++
T Consensus       141 givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  216 (353)
T 2i0e_A          141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLA  216 (353)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHH
T ss_pred             CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHc
Confidence            999999999999999999999999999876544444556678999999999987654 7999999999999999996

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-36  Score=226.02  Aligned_cols=152  Identities=39%  Similarity=0.748  Sum_probs=129.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee-----CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|++++++++|+||+++++++..     ...+|+|||+++++|.+.+... ..+++..++.++.|++.||.|||+
T Consensus        96 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~  174 (458)
T 3rp9_A           96 CKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHS  174 (458)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccC-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence            3567899999999999999999999843     3579999999999999988764 479999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCC---------------------------CcccccccCccccCccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM---------------------------NRYTHEVVTLWYRPPEI  136 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~pe~  136 (163)
                      .|++|+||||+||+++.++.+||+|||+++......                           ......+||+.|+|||+
T Consensus       175 ~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  254 (458)
T 3rp9_A          175 AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL  254 (458)
T ss_dssp             TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHH
T ss_pred             CCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHH
Confidence            999999999999999999999999999997654221                           12334577999999998


Q ss_pred             ccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         137 LLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       137 ~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.....++.++||||+||++|||++
T Consensus       255 ~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          255 ILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             HTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             hhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            7655558999999999999999996

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.9e-36  Score=217.53  Aligned_cols=152  Identities=32%  Similarity=0.456  Sum_probs=125.6

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++++++++|+||+++++++.+++.+|+||||++| +|.+++...+ .+++..+..++.|++.++.|||++|+
T Consensus        64 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~i  142 (327)
T 3a62_A           64 DTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREG-IFMEDTACFYLAEISMALGHLHQKGI  142 (327)
T ss_dssp             -------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            345577899999999999999999999999999999999985 8988887644 78899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       143 vH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~  216 (327)
T 3a62_A          143 IYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLT  216 (327)
T ss_dssp             CCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHH
T ss_pred             EcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHH
Confidence            9999999999999999999999999876544444445567899999999987654 6999999999999999996

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=8e-36  Score=215.87  Aligned_cols=154  Identities=48%  Similarity=0.865  Sum_probs=135.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeee--------CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPV--------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ....+.+|++++++++|+||+++++++.+        ++.+++|||++++++.+.+......+++..++.++.|++.++.
T Consensus        59 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~  138 (351)
T 3mi9_A           59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLY  138 (351)
T ss_dssp             SCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            34567899999999999999999999877        4568999999999999999888778999999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccC----CCcccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP----MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                      +||++|++|+||+|+||+++.++.++|+|||.+......    ........|++.|+|||.+.+...++.++||||+|++
T Consensus       139 ~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  218 (351)
T 3mi9_A          139 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI  218 (351)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred             HHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHH
Confidence            999999999999999999999999999999998765422    2233455779999999998776667999999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|+|++
T Consensus       219 l~ell~  224 (351)
T 3mi9_A          219 MAEMWT  224 (351)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.4e-36  Score=218.02  Aligned_cols=150  Identities=27%  Similarity=0.459  Sum_probs=134.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....++.+|+++++.++||||+++++++.+++.+|+||||++| +|.+++...+ .+++..++.++.|++.+++|||++|
T Consensus        83 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~  161 (350)
T 1rdq_E           83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD  161 (350)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999999999999999999999999999999975 9998887654 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||++.....   .....+|++.|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus       162 ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  233 (350)
T 1rdq_E          162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAA  233 (350)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             cccccCccceEEECCCCCEEEcccccceeccC---CcccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhh
Confidence            99999999999999999999999999876542   234567899999999987754 7999999999999999996

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-36  Score=223.76  Aligned_cols=153  Identities=31%  Similarity=0.438  Sum_probs=135.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|.+++..++|+||+++++++.+++.+|+||||++ |+|.+++.+.+..+++..++.++.|++.+++|||++|++
T Consensus       105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~gii  184 (412)
T 2vd5_A          105 VSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYV  184 (412)
T ss_dssp             GCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            4557899999999999999999999999999999999997 599999987666899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccC------CcCCCcchhhHHHHHHHHHHh
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLG------AKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~------~~~~~~~~Di~slG~~l~~ll  160 (163)
                      |+||||+||+++.++.+||+|||++........ .....+||+.|+|||++..      ...++.++|+||+|+++|||+
T Consensus       185 HrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyell  264 (412)
T 2vd5_A          185 HRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF  264 (412)
T ss_dssp             CCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHH
T ss_pred             ecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHH
Confidence            999999999999999999999999876553322 2334688999999999863      234799999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       265 t  265 (412)
T 2vd5_A          265 Y  265 (412)
T ss_dssp             H
T ss_pred             h
Confidence            6

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-36  Score=217.79  Aligned_cols=152  Identities=55%  Similarity=1.063  Sum_probs=127.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++|+||+++++++.+++.+++||||++++|.+++...+ .+++..++.++.|++.++.|||++|++|
T Consensus        77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~LH~~~ivH  155 (329)
T 3gbz_A           77 PGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFCHSRRCLH  155 (329)
T ss_dssp             ---CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             chhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCEEC
Confidence            456789999999999999999999999999999999999999999988765 6899999999999999999999999999


Q ss_pred             cCCCCCcEEEc-----cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILIN-----KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~-----~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++     .++.++|+|||.+..............+++.|+|||.+.+...++.++||||+|+++|+|++
T Consensus       156 ~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  233 (329)
T 3gbz_A          156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM  233 (329)
T ss_dssp             SCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHH
Confidence            99999999994     44559999999998766555555566779999999999876667999999999999999986

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=3e-36  Score=218.34  Aligned_cols=153  Identities=33%  Similarity=0.541  Sum_probs=134.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..+++.+|+++++.++||||+++++++.+++.+|+||||++| +|.+.+..   .+..+++..+..++.|++.++.|||+
T Consensus        69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~  148 (351)
T 3c0i_A           69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD  148 (351)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            356788999999999999999999999999999999999985 88877754   23468999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCc---eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          84 RRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +|++|+||||+||+++.++.   ++|+|||.+..............|++.|+|||.+.+.. ++.++||||+|+++|+|+
T Consensus       149 ~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll  227 (351)
T 3c0i_A          149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILL  227 (351)
T ss_dssp             TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHH
T ss_pred             CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHH
Confidence            99999999999999987655   99999999977665444445567899999999987654 799999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       228 ~  228 (351)
T 3c0i_A          228 S  228 (351)
T ss_dssp             H
T ss_pred             H
Confidence            6

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.5e-36  Score=217.29  Aligned_cols=150  Identities=31%  Similarity=0.536  Sum_probs=133.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|++++++++||||+++++++.++..+++|||+++ |+|.+++... +.+++..+..++.|++.++.|||++|++
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giv  137 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIA  137 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTC-SCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            4678899999999999999999999999999999999997 5999988664 4799999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCC----ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++    .++|+|||++...... ......+|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       138 HrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~  213 (361)
T 2yab_A          138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLS  213 (361)
T ss_dssp             CCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTT-CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCC-CccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHh
Confidence            999999999998877    7999999998765532 3345567899999999987654 7999999999999999996

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.6e-36  Score=213.29  Aligned_cols=153  Identities=44%  Similarity=0.820  Sum_probs=128.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++|+||+++++++.+++..++|||+++++++..+......+++..+..++.|++.++.+||++|++|
T Consensus        46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH  125 (311)
T 4agu_A           46 KKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH  125 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcC
Confidence            34567899999999999999999999999999999999998555555555567999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       126 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  198 (311)
T 4agu_A          126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS  198 (311)
T ss_dssp             CCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh
Confidence            9999999999999999999999997766444445566789999999999775667999999999999999996

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.9e-36  Score=218.64  Aligned_cols=156  Identities=20%  Similarity=0.260  Sum_probs=136.6

Q ss_pred             cCCchhhHHHHHHHHhcCC---CCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhc----CCCCCCHHHHHHHHHHHHH
Q psy7820           5 VEGVPSTALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQT----TPVPVPPALAKSYLYQLLE   76 (163)
Q Consensus         5 ~~~~~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~~~~~i~~   76 (163)
                      ......++..|.++++.++   |+|++++++++..++..++||||++ |+|.+++..    ....+++..++.++.|++.
T Consensus       104 ~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~  183 (365)
T 3e7e_A          104 KPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY  183 (365)
T ss_dssp             SSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHH
T ss_pred             CCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHH
Confidence            3455677889999999997   8999999999999999999999998 599999864    3457999999999999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEcc-----------CCceEEeecccccccc--cCCCcccccccCccccCcccccCCcCC
Q psy7820          77 ALRYCHSRRIIHRDLKPQNILINK-----------SGALKLADFGLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVY  143 (163)
Q Consensus        77 ~l~~lh~~~i~h~~i~~~ni~~~~-----------~~~~~l~d~~~~~~~~--~~~~~~~~~~~~~~~~~pe~~~~~~~~  143 (163)
                      |++|||++|++|+||||+||+++.           ++.+||+|||++....  .........+||+.|+|||++.+.. +
T Consensus       184 ~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~  262 (365)
T 3e7e_A          184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-W  262 (365)
T ss_dssp             HHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-B
T ss_pred             HHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-C
Confidence            999999999999999999999998           8999999999996543  2233445667899999999998755 7


Q ss_pred             CcchhhHHHHHHHHHHhc
Q psy7820         144 STTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       144 ~~~~Di~slG~~l~~ll~  161 (163)
                      +.++||||+|+++|+|+|
T Consensus       263 ~~~~DiwslG~il~ellt  280 (365)
T 3e7e_A          263 NYQIDYFGVAATVYCMLF  280 (365)
T ss_dssp             STHHHHHHHHHHHHHHHH
T ss_pred             CccccHHHHHHHHHHHHh
Confidence            999999999999999997

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.8e-36  Score=215.46  Aligned_cols=154  Identities=23%  Similarity=0.326  Sum_probs=137.5

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|+++++++ +|+||+++++++.+++..++|||++.++|.+++......+++..++.++.|++.+++|||+.|
T Consensus        46 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  125 (330)
T 2izr_A           46 SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN  125 (330)
T ss_dssp             CSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3456789999999999 899999999999999999999999977999999877678999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCc-----eEEeecccccccccCCC-------cccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          86 IIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMN-------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~-----~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      ++|+||||+||+++.++.     ++|+|||.+........       ......|++.|+|||.+.+.. ++.++|+||||
T Consensus       126 iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG  204 (330)
T 2izr_A          126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALG  204 (330)
T ss_dssp             EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHH
T ss_pred             eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHH
Confidence            999999999999998887     99999999986543322       124567899999999998755 69999999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      +++|+|++
T Consensus       205 ~il~ell~  212 (330)
T 2izr_A          205 HMFMYFLR  212 (330)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHhc
Confidence            99999996

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.5e-36  Score=221.22  Aligned_cols=153  Identities=33%  Similarity=0.478  Sum_probs=133.9

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .....+.+|.++++.++||||+++++++.+++.+|+||||++| +|.+++...  .+++..++.++.|++.|++|||++|
T Consensus       111 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~--~~~e~~~~~~~~qi~~aL~~LH~~g  188 (410)
T 3v8s_A          111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSMG  188 (410)
T ss_dssp             CCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3445688999999999999999999999999999999999975 999888653  6899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCc---CCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAK---VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~---~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.+||+|||++........ .....+||+.|+|||++.+..   .++.++||||+|+++|+|++
T Consensus       189 ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~  268 (410)
T 3v8s_A          189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV  268 (410)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHH
T ss_pred             eEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHh
Confidence            99999999999999999999999999876543321 234568899999999987543   15789999999999999996

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3e-36  Score=213.56  Aligned_cols=151  Identities=31%  Similarity=0.534  Sum_probs=129.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+.++++++||||+++++++.+++..++||||++| +|.+++...+ .+++..+..++.|++.++.+||++|++
T Consensus        55 ~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~  133 (294)
T 4eqm_A           55 LKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQILDGIKHAHDMRIV  133 (294)
T ss_dssp             HHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678999999999999999999999999999999999986 9998887654 789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+....... .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       134 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~  207 (294)
T 4eqm_A          134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLV  207 (294)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHh
Confidence            99999999999999999999999987654332 2233456899999999998755 6999999999999999996

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.7e-36  Score=220.13  Aligned_cols=151  Identities=33%  Similarity=0.495  Sum_probs=127.3

Q ss_pred             hhhHHHHHHH-HhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISV-LKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~-l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|..+ ++.++||||+++++++.+.+.+|+||||++| +|.+++.... .+++..++.++.|++.+++|||++|+
T Consensus        82 ~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~gi  160 (373)
T 2r5t_A           82 EKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER-CFLEPRARFYAAEIASALGYLHSLNI  160 (373)
T ss_dssp             ---------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            3455667776 4667999999999999999999999999986 8988887644 78899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.+|.++|+|||+++............+|++.|+|||.+.+.. ++.++|+||||+++|||++
T Consensus       161 vHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  234 (373)
T 2r5t_A          161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLY  234 (373)
T ss_dssp             CCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             eecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHc
Confidence            9999999999999999999999999876554444556678999999999987754 7999999999999999996

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.3e-35  Score=224.90  Aligned_cols=154  Identities=26%  Similarity=0.403  Sum_probs=136.9

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .....+.+|.+++++++||||+++++++.+...+|+||||++| +|.+++...   ...+++..++.++.|++.|++|||
T Consensus       227 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH  306 (543)
T 3c4z_A          227 KGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH  306 (543)
T ss_dssp             TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence            3445688999999999999999999999999999999999985 998888654   346899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||||+||+++.+|.+||+|||++.............+||+.|+|||++.+.. ++.++|+||+|+++|||++
T Consensus       307 ~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyellt  384 (543)
T 3c4z_A          307 QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIA  384 (543)
T ss_dssp             HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHh
Confidence            99999999999999999999999999999987654444444568999999999998754 7999999999999999996

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-35  Score=211.73  Aligned_cols=152  Identities=29%  Similarity=0.526  Sum_probs=135.5

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.+.+|+.++++++|+||+++++++..++..++||||+++ +|.+++..  ..+++..+..++.|++.++.|||+.|
T Consensus        84 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~  161 (321)
T 2c30_A           84 QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQG  161 (321)
T ss_dssp             CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456688999999999999999999999999999999999986 88887654  36899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       162 ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~  236 (321)
T 2c30_A          162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVD  236 (321)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999877654444455667899999999987654 7999999999999999996

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.1e-36  Score=221.39  Aligned_cols=152  Identities=41%  Similarity=0.740  Sum_probs=130.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC-----cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|++++++++|+||+++++++...     ..+|+|||+++++|.+.+... ..+++..++.++.|++.|+.|||+
T Consensus        69 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qil~aL~~LH~  147 (432)
T 3n9x_A           69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTP-IFLTEEHIKTILYNLLLGENFIHE  147 (432)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSS-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999766     579999999999999988764 478999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCC----------------------cccccccCccccCcccccCCc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----------------------RYTHEVVTLWYRPPEILLGAK  141 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----------------------~~~~~~~~~~~~~pe~~~~~~  141 (163)
                      .|++|+||||+||+++.++.+||+|||++........                      .....+||+.|+|||.+....
T Consensus       148 ~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  227 (432)
T 3n9x_A          148 SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE  227 (432)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCS
T ss_pred             CCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC
Confidence            9999999999999999999999999999976543221                      235667899999999976556


Q ss_pred             CCCcchhhHHHHHHHHHHhc
Q psy7820         142 VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       142 ~~~~~~Di~slG~~l~~ll~  161 (163)
                      .++.++||||+||++|||++
T Consensus       228 ~~~~~~DiwSlG~il~ell~  247 (432)
T 3n9x_A          228 NYTKSIDIWSTGCIFAELLN  247 (432)
T ss_dssp             CCCTHHHHHHHHHHHHHHHT
T ss_pred             CCCcccccchHHHHHHHHHh
Confidence            68999999999999999995

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.4e-36  Score=214.62  Aligned_cols=152  Identities=30%  Similarity=0.552  Sum_probs=117.0

Q ss_pred             chhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+.+|+++++.+. ||||+++++++.++...++|||++++ +|.+.+.... .+++..+..++.|++.++.|||++|
T Consensus        48 ~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~  126 (325)
T 3kn6_A           48 MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVG  126 (325)
T ss_dssp             GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4466789999999996 99999999999999999999999986 9999887754 7999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCC---ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++   .++|+|||.+.............++++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       127 ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~  204 (325)
T 3kn6_A          127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLS  204 (325)
T ss_dssp             EECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CC-CCHHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHh
Confidence            99999999999998766   799999999976655445555667899999999987654 7999999999999999996

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.2e-35  Score=213.46  Aligned_cols=152  Identities=41%  Similarity=0.842  Sum_probs=128.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      ..+.+|++++++++|+||+++++++.+++..++|||+++++++..+......+++..+..++.|++.++.+||+.|++|+
T Consensus        69 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  148 (331)
T 4aaa_A           69 KIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHR  148 (331)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEcc
Confidence            44678999999999999999999999999999999999986666665555689999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       149 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  220 (331)
T 4aaa_A          149 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM  220 (331)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred             CcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence            999999999999999999999987765544445566789999999999776567999999999999999996

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1e-35  Score=215.39  Aligned_cols=148  Identities=30%  Similarity=0.525  Sum_probs=133.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .++.+|++++++++||||+++++++.+++..++||||+.|++.+.+......+++..+..++.|++.++.|||++|++|+
T Consensus        99 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  178 (348)
T 1u5q_A           99 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR  178 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence            46789999999999999999999999999999999999999999887666789999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+|+||+++.++.++|+|||.+.....    .....|++.|+|||.+.+  ...++.++||||+|+++|+|++
T Consensus       179 Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~  248 (348)
T 1u5q_A          179 DVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  248 (348)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEECCCCCEEEeeccCceecCC----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999876442    234578999999999852  3447999999999999999996

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.9e-36  Score=214.38  Aligned_cols=151  Identities=28%  Similarity=0.474  Sum_probs=124.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC-
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV--PVPPALAKSYLYQLLEALRYCHSRR-   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~-   85 (163)
                      .++.+|++++++++|+||+++++++.+.+..++||||+++ +|.+++...+.  .+++..++.++.|++.++.|||++| 
T Consensus        79 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~  158 (309)
T 3p86_A           79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP  158 (309)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC
Confidence            4678999999999999999999999999999999999985 99998876542  3899999999999999999999999 


Q ss_pred             -ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 -IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 -i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                       ++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus       159 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt  234 (309)
T 3p86_A          159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELAT  234 (309)
T ss_dssp             CCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHH
T ss_pred             CEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence             99999999999999999999999999876554444455667899999999998755 6999999999999999996

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.9e-35  Score=215.03  Aligned_cols=149  Identities=36%  Similarity=0.593  Sum_probs=131.9

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      +.+.+|++++++++||||+++++++.+++..|+|||++.| +|.+.+.... .+++..+..++.|++.++.|||++|++|
T Consensus        73 ~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~~ivH  151 (362)
T 2bdw_A           73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVH  151 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS-CCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence            5678999999999999999999999999999999999986 8988887654 7899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCC---ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++   .+||+|||++...... .......|++.|+|||++.+.. ++.++||||+|+++|+|++
T Consensus       152 ~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~  225 (362)
T 2bdw_A          152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLV  225 (362)
T ss_dssp             CCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC-CSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             ccCchHHEEEecCCCCCCEEEeecCcceEecCC-cccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHH
Confidence            99999999997654   5999999998765532 3334567899999999987654 7999999999999999996

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-35  Score=212.07  Aligned_cols=150  Identities=33%  Similarity=0.548  Sum_probs=133.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++.++...++|||++++ +|.+++... ..+++..+..++.|++.++.|||+.|++
T Consensus        58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iv  136 (326)
T 2y0a_A           58 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIA  136 (326)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTS-SCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            46788999999999999999999999999999999999975 999888654 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCC----ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++    .++|+|||.+...... .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       137 H~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~  212 (326)
T 2y0a_A          137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLS  212 (326)
T ss_dssp             CCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTT-SCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCC-CccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHH
Confidence            999999999998887    7999999998765432 3344567899999999987654 7999999999999999996

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.5e-35  Score=208.03  Aligned_cols=153  Identities=27%  Similarity=0.527  Sum_probs=117.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...++.+|++++++++||||+++++++.+++..++|||++++ +|.+++......+++..++.++.|++.++.+||++|+
T Consensus        54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  133 (278)
T 3cok_A           54 MVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGI  133 (278)
T ss_dssp             CHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            346788999999999999999999999999999999999975 9999988776789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       134 ~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  207 (278)
T 3cok_A          134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLI  207 (278)
T ss_dssp             ECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999877654444444567899999999987654 6899999999999999986

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.4e-36  Score=214.27  Aligned_cols=152  Identities=27%  Similarity=0.455  Sum_probs=131.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+||+++++++.+++..++||||+++ +|.+++....+.+++..+..++.|++.++.|||+.|++
T Consensus        94 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv  173 (325)
T 3kul_A           94 RRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYV  173 (325)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            35688999999999999999999999999999999999975 99999987777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+.........   .....+++.|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus       174 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~  249 (325)
T 3kul_A          174 HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLA  249 (325)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             CCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHc
Confidence            9999999999999999999999998765433221   22233466899999987654 6999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-35  Score=215.94  Aligned_cols=152  Identities=28%  Similarity=0.513  Sum_probs=132.3

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYL   71 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~   71 (163)
                      ..++.+|+++++++ +||||+++++++.+++.+|+||||+++ +|.+++....               ..+++..++.++
T Consensus       130 ~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  209 (370)
T 2psq_A          130 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT  209 (370)
T ss_dssp             HHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHH
Confidence            34678999999999 899999999999999999999999985 9999987643               357899999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhh
Q psy7820          72 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        72 ~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      .|++.|++|||++|++|+||||+||+++.++.+||+|||++.......  .......+++.|+|||.+.+.. ++.++||
T Consensus       210 ~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Dv  288 (370)
T 2psq_A          210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDV  288 (370)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHH
T ss_pred             HHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHH
Confidence            999999999999999999999999999999999999999987654322  1223345578899999987654 7999999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+|+++|||++
T Consensus       289 wslG~il~ellt  300 (370)
T 2psq_A          289 WSFGVLMWEIFT  300 (370)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHc
Confidence            999999999997

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-35  Score=221.10  Aligned_cols=152  Identities=32%  Similarity=0.570  Sum_probs=135.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++.++||||+++++++.+.+.+++||||++| +|.+++... +.+++..+..++.|++.|++|||++|+
T Consensus        59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gi  137 (476)
T 2y94_A           59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-GRLDEKESRRLFQQILSGVDYCHRHMV  137 (476)
T ss_dssp             THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSS-SSCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            345788999999999999999999999999999999999975 999888754 479999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||++...... ......+|++.|+|||.+.+....+.++|+||+|+++|+|++
T Consensus       138 vHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ellt  211 (476)
T 2y94_A          138 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLC  211 (476)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred             CcccccHHHEEEecCCCeEEEeccchhhcccc-ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhh
Confidence            99999999999999999999999998765432 334556889999999999876545789999999999999996

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.5e-36  Score=223.51  Aligned_cols=152  Identities=28%  Similarity=0.425  Sum_probs=126.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-RR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~   85 (163)
                      ...++.+|+++++.++||||+++++++.+++.+++||||+++ +|.+.+.... .+++..+..++.|++.||+|||+ .|
T Consensus       191 ~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~g  269 (446)
T 4ejn_A          191 EVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKN  269 (446)
T ss_dssp             ----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence            345677899999999999999999999999999999999986 8888876654 78999999999999999999998 99


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.++|+|||++.............+|++.|+|||++.+.. ++.++||||+|+++|+|++
T Consensus       270 iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  344 (446)
T 4ejn_A          270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMC  344 (446)
T ss_dssp             CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHH
T ss_pred             EEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhh
Confidence            99999999999999999999999999876554445556678999999999987654 7999999999999999996

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-35  Score=216.14  Aligned_cols=151  Identities=28%  Similarity=0.486  Sum_probs=134.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++|+||+++++++.+++..++||||+.| +|.+.+......+++..+..++.|++.++.|||++|++
T Consensus        92 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv  171 (387)
T 1kob_A           92 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV  171 (387)
T ss_dssp             HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            34678999999999999999999999999999999999985 99999887777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEcc--CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINK--SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.  ++.++|+|||++...... .......|++.|+|||++.+.. ++.++||||+|+++|+|++
T Consensus       172 HrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt  245 (387)
T 1kob_A          172 HLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLS  245 (387)
T ss_dssp             CCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHH
T ss_pred             ecccchHHeEEecCCCCceEEEecccceecCCC-cceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHh
Confidence            9999999999974  467999999998765532 2334557899999999987654 7999999999999999996

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.4e-35  Score=216.45  Aligned_cols=152  Identities=28%  Similarity=0.429  Sum_probs=134.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+++.+|++++++++|+||+++++++.+.+..++||||+++ +|.+.+......+++..+..++.|++.++.|||+.|+
T Consensus       129 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i  208 (373)
T 2x4f_A          129 DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYI  208 (373)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            346788999999999999999999999999999999999985 8988887776689999999999999999999999999


Q ss_pred             eecCCCCCcEEE--ccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||++  +.++.++|+|||++...... .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       209 vH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt  283 (373)
T 2x4f_A          209 LHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR-EKLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLS  283 (373)
T ss_dssp             ECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-CBCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHHHHHHHHHH
T ss_pred             ccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-cccccccCCCcEeChhhccCCC-CCcHHhHHHHHHHHHHHHh
Confidence            999999999999  56678999999998765532 3334557899999999987644 7999999999999999996

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=210.63  Aligned_cols=151  Identities=31%  Similarity=0.584  Sum_probs=129.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee--CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .+++.+|++++++++||||+++++++.+  ++.+++|||++++ +|.+...  ...+++..+..++.|++.++.|||++|
T Consensus        80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~  157 (298)
T 2zv2_A           80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQK  157 (298)
T ss_dssp             -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4678999999999999999999999986  5689999999985 6655432  347899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcC--CCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+...  .+.++|+||+|+++|+|++
T Consensus       158 ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~  235 (298)
T 2zv2_A          158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF  235 (298)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred             eeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence            999999999999999999999999998776544444455678999999999876432  3788999999999999996

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.8e-35  Score=206.91  Aligned_cols=153  Identities=26%  Similarity=0.453  Sum_probs=134.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+++.+|++++++++||||+++++++.+++..++|||++++ +|.+++....+.+++..++.++.|++.++.+||+.|+
T Consensus        48 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i  127 (269)
T 4hcu_A           48 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV  127 (269)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            346789999999999999999999999999999999999985 8999998877789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       128 ~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~  202 (269)
T 4hcu_A          128 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFS  202 (269)
T ss_dssp             CCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             ecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhc
Confidence            999999999999999999999999987554221 1223344567899999987655 7999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.6e-35  Score=224.15  Aligned_cols=153  Identities=29%  Similarity=0.457  Sum_probs=135.6

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .....+.+|.+++++++|+||+++++++.+++.+|+||||++| +|.+++...+ ..+++..++.++.|++.|++|||++
T Consensus       226 ~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~  305 (576)
T 2acx_A          226 KGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE  305 (576)
T ss_dssp             TCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3445678999999999999999999999999999999999975 9988887654 3589999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||||+||+++.+|.++|+|||++...... ......+|++.|+|||++.+.. ++.++|+||+|+++|+|++
T Consensus       306 gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~-~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLlt  380 (576)
T 2acx_A          306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG-QTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIA  380 (576)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT-CCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHH
T ss_pred             CEeccCCchheEEEeCCCCeEEEecccceecccC-ccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHh
Confidence            9999999999999999999999999998765432 2334568899999999998754 7999999999999999996

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-35  Score=215.37  Aligned_cols=151  Identities=40%  Similarity=0.780  Sum_probs=129.6

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCc--EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDF--KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~--~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..++.+|+.+++.+. |+||+++++++...+  .+|+|||+++++|...+..  ..+++..+..++.|++.|+.|||+.|
T Consensus        52 ~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~  129 (388)
T 3oz6_A           52 AQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGG  129 (388)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            455778999999997 999999999997544  7999999999999988876  36889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccC---------------------CCcccccccCccccCcccccCCcCCC
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIP---------------------MNRYTHEVVTLWYRPPEILLGAKVYS  144 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---------------------~~~~~~~~~~~~~~~pe~~~~~~~~~  144 (163)
                      ++|+||||+||+++.++.+||+|||+++.....                     .......+||+.|+|||++.+...++
T Consensus       130 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  209 (388)
T 3oz6_A          130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT  209 (388)
T ss_dssp             EECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCC
T ss_pred             EEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCC
Confidence            999999999999999999999999998754321                     11233457899999999998756689


Q ss_pred             cchhhHHHHHHHHHHhc
Q psy7820         145 TTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       145 ~~~Di~slG~~l~~ll~  161 (163)
                      .++||||+||++|+|++
T Consensus       210 ~~~DiwSlG~il~ell~  226 (388)
T 3oz6_A          210 KGIDMWSLGCILGEILC  226 (388)
T ss_dssp             THHHHHHHHHHHHHHHH
T ss_pred             ChhhHHHHHHHHHHHHh
Confidence            99999999999999997

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.3e-35  Score=217.24  Aligned_cols=156  Identities=46%  Similarity=0.915  Sum_probs=127.1

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeee--eCcEEEEEecchhccHHHHHhcC--------CCCCCHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFLRQDLKDFLQTT--------PVPVPPALAKSYLYQLL   75 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~~l~~~~~~~--------~~~~~~~~~~~~~~~i~   75 (163)
                      ......+.+|++++++++||||+++++++.  .+..+++||||+++++.+.+...        ...+++..++.++.|++
T Consensus        59 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~  138 (405)
T 3rgf_A           59 TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL  138 (405)
T ss_dssp             SSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHH
Confidence            344567889999999999999999999995  46789999999999988887532        23589999999999999


Q ss_pred             HHHHHHHhCCceecCCCCCcEEE----ccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchh
Q psy7820          76 EALRYCHSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVD  148 (163)
Q Consensus        76 ~~l~~lh~~~i~h~~i~~~ni~~----~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~D  148 (163)
                      .|+.|||++|++|+||||+||++    +.++.++|+|||++.......   .......|++.|+|||.+.+...++.++|
T Consensus       139 ~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  218 (405)
T 3rgf_A          139 DGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAID  218 (405)
T ss_dssp             HHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHH
T ss_pred             HHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhh
Confidence            99999999999999999999999    677899999999997654322   22344578999999999987666899999


Q ss_pred             hHHHHHHHHHHhc
Q psy7820         149 IWSAGCIFSEMIQ  161 (163)
Q Consensus       149 i~slG~~l~~ll~  161 (163)
                      |||+||++|+|++
T Consensus       219 iwSlG~il~ell~  231 (405)
T 3rgf_A          219 IWAIGCIFAELLT  231 (405)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHh
Confidence            9999999999996

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.8e-35  Score=207.92  Aligned_cols=155  Identities=29%  Similarity=0.479  Sum_probs=138.8

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +....++.+|++++++++|+||+++++++..++..++|||++++ +|.+++......+++..+..++.+++.++.+||+.
T Consensus        65 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~  144 (314)
T 3com_A           65 ESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM  144 (314)
T ss_dssp             TSCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34457789999999999999999999999999999999999986 99998876666899999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       145 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  220 (314)
T 3com_A          145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAE  220 (314)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHH
T ss_pred             CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHh
Confidence            999999999999999999999999999877654444455567899999999987754 6999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-35  Score=209.36  Aligned_cols=151  Identities=21%  Similarity=0.291  Sum_probs=134.0

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|++++++++|+||+++++++.+++..++||||++ ++|.+++...+..+++..+..++.|++.++.|||++|
T Consensus        54 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~  133 (289)
T 4fvq_A           54 NYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT  133 (289)
T ss_dssp             GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            344668899999999999999999999999999999999998 5999999887766999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCc--------eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          86 IIHRDLKPQNILINKSGA--------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~--------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      ++|+||+|+||+++.++.        ++++|||.+....    ......+++.|+|||.+.+...++.++||||+|+++|
T Consensus       134 ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  209 (289)
T 4fvq_A          134 LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL----PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLW  209 (289)
T ss_dssp             CCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTS----CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHH
T ss_pred             eECCCcCcceEEEecCCcccccccceeeeccCccccccc----CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHH
Confidence            999999999999998887        9999999876543    2233456888999999987455799999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       210 el~~  213 (289)
T 4fvq_A          210 EICS  213 (289)
T ss_dssp             HHHT
T ss_pred             HHHc
Confidence            9997

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4e-35  Score=213.30  Aligned_cols=149  Identities=17%  Similarity=0.240  Sum_probs=128.1

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeC----cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVD----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...|+..++.++|+||+++++++...    ...++|||++.++|.+++......+++..++.++.|++.++.|||++|++
T Consensus        95 ~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ii  174 (364)
T 3op5_A           95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYV  174 (364)
T ss_dssp             HHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence            44566677778899999999998764    56899999996699999988777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEc--cCCceEEeecccccccccCC-------CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          88 HRDLKPQNILIN--KSGALKLADFGLSRAFTIPM-------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        88 h~~i~~~ni~~~--~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      |+||||+||+++  .++.++|+|||++.......       .......|++.|+|||.+.+.. ++.++||||+|+++|+
T Consensus       175 HrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~e  253 (364)
T 3op5_A          175 HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQ  253 (364)
T ss_dssp             CCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHH
T ss_pred             EecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHH
Confidence            999999999999  88999999999997654221       1123445899999999998755 7999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |+|
T Consensus       254 l~~  256 (364)
T 3op5_A          254 WLT  256 (364)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            997

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2e-35  Score=215.60  Aligned_cols=152  Identities=26%  Similarity=0.473  Sum_probs=124.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++|+||+++++++.+++..++||||++ ++|.+++...+..+++..+..++.|++.++.|||++|++
T Consensus        90 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~iv  169 (373)
T 2qol_A           90 RRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYV  169 (373)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            3568899999999999999999999999999999999997 599999988777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcc---cccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~---~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.+||+|||++..........   ....++..|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       170 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt  245 (373)
T 2qol_A          170 HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMS  245 (373)
T ss_dssp             CSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHh
Confidence            99999999999999999999999987654332111   1223366799999987654 7999999999999999886

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.3e-35  Score=212.86  Aligned_cols=152  Identities=30%  Similarity=0.523  Sum_probs=132.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|+.+++.++|+||+++++++.+++..++||||+++ +|.+.+... ..+++..+..++.|++.++.|||++|++
T Consensus        49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~giv  127 (323)
T 3tki_A           49 PENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGIT  127 (323)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            46688999999999999999999999999999999999986 887777544 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+.......  .......|++.|+|||.+.+...++.++||||+|+++|+|++
T Consensus       128 H~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  203 (323)
T 3tki_A          128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA  203 (323)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHh
Confidence            99999999999999999999999987654222  223356789999999999876645789999999999999996

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.3e-35  Score=209.18  Aligned_cols=154  Identities=31%  Similarity=0.507  Sum_probs=129.3

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------------------------------------------------
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDF------------------------------------------------   38 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------------------------------------------------   38 (163)
                      ...+.+.+|++++++++||||+++++++.+..                                                
T Consensus        46 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  125 (332)
T 3qd2_B           46 LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG  125 (332)
T ss_dssp             THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------------------------
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccc
Confidence            34567889999999999999999999985533                                                


Q ss_pred             ---------EEEEEecchhc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEE
Q psy7820          39 ---------KLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKL  106 (163)
Q Consensus        39 ---------~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l  106 (163)
                               ..++|||++++ +|.+++....  ...++..++.++.|++.+++|||++|++|+||||+||+++.++.++|
T Consensus       126 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL  205 (332)
T 3qd2_B          126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKV  205 (332)
T ss_dssp             ------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEE
T ss_pred             cccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEE
Confidence                     48999999986 9999887654  23456678999999999999999999999999999999999999999


Q ss_pred             eecccccccccCC------------CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         107 ADFGLSRAFTIPM------------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       107 ~d~~~~~~~~~~~------------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|||.+.......            .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       206 ~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~  271 (332)
T 3qd2_B          206 GDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLY  271 (332)
T ss_dssp             CCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHS
T ss_pred             eecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHH
Confidence            9999987765432            1223456899999999987754 7999999999999999986

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=5.2e-35  Score=208.64  Aligned_cols=148  Identities=29%  Similarity=0.415  Sum_probs=128.0

Q ss_pred             hHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          11 TALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        11 ~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      +...|...+.++ +|+||+++++++.+++..++|||++++++.+.+...+..+++..++.++.|++.+++|||+.+++|+
T Consensus       102 ~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~  181 (311)
T 3p1a_A          102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHL  181 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence            345566555555 8999999999999999999999999999999998877789999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||+||+++.++.+||+|||.+...... .......|++.|+|||++.+  .++.++||||+|+++|+|++
T Consensus       182 Dikp~NIll~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~  250 (311)
T 3p1a_A          182 DVKPANIFLGPRGRCKLGDFGLLVELGTA-GAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVAC  250 (311)
T ss_dssp             CCSGGGEEECGGGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEECCCCCEEEccceeeeecccC-CCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999998765432 23344568999999999875  37999999999999999986

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=8.3e-35  Score=209.53  Aligned_cols=152  Identities=30%  Similarity=0.474  Sum_probs=135.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+.+|++++++++|+||+++++++.+++..++|||++++ +|.+++... ..+++..++.++.|++.++.|||++|+
T Consensus        84 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i  162 (335)
T 2owb_A           84 QREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRV  162 (335)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            345678999999999999999999999999999999999985 888877654 478999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+..............|+..|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus       163 vH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  236 (335)
T 2owb_A          163 IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLV  236 (335)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHH
T ss_pred             EecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHH
Confidence            9999999999999999999999999987654444455667899999999987654 6999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.2e-34  Score=205.15  Aligned_cols=155  Identities=20%  Similarity=0.278  Sum_probs=137.0

Q ss_pred             CCchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ......+.+|+++++.+ +|++++++++++.++...++|||++.++|.+++...+..+++..+..++.|++.++.+||++
T Consensus        46 ~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  125 (298)
T 1csn_A           46 RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK  125 (298)
T ss_dssp             CTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            34556789999999999 79999999999999999999999997799999988777899999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCc-----eEEeecccccccccCCC-------cccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          85 RIIHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMN-------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~-----~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      |++|+||+|+||+++.++.     ++|+|||.+........       ......|++.|+|||.+.+.. ++.++||||+
T Consensus       126 ~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~sl  204 (298)
T 1csn_A          126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEAL  204 (298)
T ss_dssp             TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHH
T ss_pred             CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHH
Confidence            9999999999999987776     99999999876654322       234557899999999987755 6999999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      |+++|+|++
T Consensus       205 G~il~el~~  213 (298)
T 1csn_A          205 GHVFMYFLR  213 (298)
T ss_dssp             HHHHHHHHH
T ss_pred             HHHHHHHHc
Confidence            999999996

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1e-34  Score=206.66  Aligned_cols=151  Identities=48%  Similarity=0.889  Sum_probs=131.7

Q ss_pred             hhhHHHHHHHHhcCC---CCCeeeeeeeeeeCc-----EEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELK---HPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ...+.+|+++++.++   ||||+++++++.+..     ..+++||+++++|.+++.... ..+++..+..++.|++.+++
T Consensus        55 ~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~  134 (308)
T 3g33_A           55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLD  134 (308)
T ss_dssp             CHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHH
Confidence            456778888888775   999999999997754     589999999999999987765 34899999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      |||++|++|+||+|+||+++.++.++|+|||.+...... .......|++.|+|||.+.+.. ++.++||||+|+++|+|
T Consensus       135 ~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l  212 (308)
T 3g33_A          135 FLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ-MALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEM  212 (308)
T ss_dssp             HHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTC-CCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHT
T ss_pred             HHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCC-cccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHH
Confidence            999999999999999999999999999999998765432 3344567899999999987755 79999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       213 ~~  214 (308)
T 3g33_A          213 FR  214 (308)
T ss_dssp             TT
T ss_pred             Hh
Confidence            86

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=5.5e-35  Score=210.55  Aligned_cols=152  Identities=28%  Similarity=0.442  Sum_probs=134.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-c-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-Q-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...++.+|++++++++|+||+++++++.+.+..++|||++. | ++.+++...+ .+++..+..++.|++.++.|||++|
T Consensus        72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~  150 (335)
T 3dls_A           72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKD  150 (335)
T ss_dssp             TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34567889999999999999999999999999999999985 5 8888877654 7999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+...... .......|++.|+|||.+.+....+.++||||+|+++|+|++
T Consensus       151 ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  225 (335)
T 3dls_A          151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF  225 (335)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECCTT-CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHH
T ss_pred             eEEeccCHHHEEEcCCCcEEEeecccceECCCC-CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHh
Confidence            999999999999999999999999998765533 333456789999999999876645889999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.4e-35  Score=226.12  Aligned_cols=153  Identities=27%  Similarity=0.386  Sum_probs=137.2

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...+.+..|.+++..+ +|++|+++++++.+.+.+|+||||++| +|.+++...+ .+++..++.++.|++.||+|||++
T Consensus       383 ~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~  461 (674)
T 3pfq_A          383 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFLQSK  461 (674)
T ss_dssp             TTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            4456678899999998 799999999999999999999999985 9988887654 799999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+|+||||+||+++.++.+||+|||+++............+||+.|+|||++.+.. ++.++||||||+++|||++
T Consensus       462 gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyellt  537 (674)
T 3pfq_A          462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLA  537 (674)
T ss_dssp             SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHH
T ss_pred             CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHc
Confidence            999999999999999999999999999986554445566778999999999997654 7999999999999999996

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.3e-34  Score=204.78  Aligned_cols=151  Identities=30%  Similarity=0.481  Sum_probs=134.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|++++++++|+||+++++++.+++..++|||++++ +|.+++... ..+++..+..++.|++.++++||++|++
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~  137 (294)
T 2rku_A           59 REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVI  137 (294)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45678899999999999999999999999999999999985 888877654 3789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       138 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~  210 (294)
T 2rku_A          138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLV  210 (294)
T ss_dssp             CCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHH
T ss_pred             ccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999877654444455667899999999987654 6999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=6.1e-35  Score=211.96  Aligned_cols=151  Identities=36%  Similarity=0.713  Sum_probs=126.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeee-----CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .++.+|++++++++||||+++++++..     ...+++|||+++|++.+.+......+++..+..++.|++.++.|||++
T Consensus        74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  153 (362)
T 3pg1_A           74 KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEA  153 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            678899999999999999999999843     347899999999999999998877899999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       154 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~  229 (362)
T 3pg1_A          154 GVVHRDLHPGNILLADNNDITICDFNLAREDTAD-ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN  229 (362)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred             cCEecCCChHHEEEcCCCCEEEEecCcccccccc-cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh
Confidence            9999999999999999999999999998754422 233445678999999998775557999999999999999986

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.2e-34  Score=212.41  Aligned_cols=153  Identities=25%  Similarity=0.326  Sum_probs=132.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...+.+|++++++++||||+++++++.+++.+++|||++++ +|.+++... ...+++..+..++.|++.|+.|||++|+
T Consensus        70 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i  149 (389)
T 3gni_B           70 VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGY  149 (389)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            35577899999999999999999999999999999999985 898888764 3578999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-------CcccccccCccccCcccccCC-cCCCcchhhHHHHHHHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-------NRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~  158 (163)
                      +|+||||+||+++.++.++|+|||.+.......       .......|++.|+|||.+.+. ..++.++||||+|+++|+
T Consensus       150 vHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~e  229 (389)
T 3gni_B          150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACE  229 (389)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHH
Confidence            999999999999999999999999875443211       122334678899999998763 347999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |++
T Consensus       230 l~~  232 (389)
T 3gni_B          230 LAN  232 (389)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.7e-34  Score=202.56  Aligned_cols=151  Identities=32%  Similarity=0.544  Sum_probs=133.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|++++++++||||+++++++.+++..++|||++++ +|.+.+.... .+++..+..++.|++.++++||++|
T Consensus        48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lH~~~  126 (277)
T 3f3z_A           48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLN  126 (277)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999999999999999999999999999999986 8888876644 6899999999999999999999999


Q ss_pred             ceecCCCCCcEEE---ccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||++   +.++.++|+|||.+...... .......+++.|+|||.+.+.  ++.++|+||+|+++|+|++
T Consensus       127 i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~  202 (277)
T 3f3z_A          127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLC  202 (277)
T ss_dssp             EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-cchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHH
Confidence            9999999999999   78899999999998765532 334456789999999998653  7999999999999999996

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.4e-35  Score=204.75  Aligned_cols=153  Identities=22%  Similarity=0.467  Sum_probs=133.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+++.+|++++++++||||+++++++.+++..++|||++++ +|.+++...+..+++..++.++.|++.++.+||+.|+
T Consensus        46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  125 (268)
T 3sxs_A           46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF  125 (268)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            346688999999999999999999999999999999999975 8999988776679999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       126 ~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  200 (268)
T 3sxs_A          126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFS  200 (268)
T ss_dssp             EESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHT
T ss_pred             ecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHc
Confidence            9999999999999999999999999876543321 122334466799999987654 6999999999999999997

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.7e-35  Score=212.41  Aligned_cols=152  Identities=32%  Similarity=0.537  Sum_probs=123.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+.+|+.+++.++||||+++++++.+++.+++||||+.+ +|.+.+...+ .+++..++.++.|++.|+.|||++|+
T Consensus        59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i  137 (361)
T 3uc3_A           59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQI  137 (361)
T ss_dssp             SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            346688999999999999999999999999999999999975 9988886644 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCc--eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.++.  +||+|||++..... ........|++.|+|||.+.+....+.++||||+|+++|+|++
T Consensus       138 vH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  213 (361)
T 3uc3_A          138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLV  213 (361)
T ss_dssp             CSCCCCGGGEEECSSSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCHHHEEEcCCCCceEEEeecCccccccc-cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHh
Confidence            99999999999987765  99999998864332 2233456789999999998776543445999999999999996

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7e-35  Score=218.02  Aligned_cols=148  Identities=39%  Similarity=0.670  Sum_probs=125.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+.+++.++|+||+++++++...      ..+|+||||+++++.+.+..   .+++..+..++.|++.|+.|||
T Consensus       105 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~lH  181 (464)
T 3ttj_A          105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  181 (464)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999998654      46899999999998888764   5889999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|++|+||||+||+++.++.+||+|||++..... ........|++.|+|||++.+.. ++.++||||+|+++|+|++
T Consensus       182 ~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~  258 (464)
T 3ttj_A          182 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR  258 (464)
T ss_dssp             HTTCCCCCCCGGGEEECTTSCEEECCCCCC------CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHH
T ss_pred             HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC-CcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999976553 23345567899999999998754 7999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.8e-35  Score=207.20  Aligned_cols=153  Identities=26%  Similarity=0.507  Sum_probs=133.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...++.+|++++++++|+||+++++++.+.  ..+++|||++++ +|.+++......+++..++.++.|++.++.+||++
T Consensus        66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~  145 (302)
T 4e5w_A           66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR  145 (302)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence            346788999999999999999999999876  578999999975 99999977667899999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||.+........   ......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       146 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  224 (302)
T 4e5w_A          146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLT  224 (302)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHH
Confidence            999999999999999999999999999876653321   233445677899999987655 6899999999999999997

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6e-35  Score=205.48  Aligned_cols=153  Identities=26%  Similarity=0.472  Sum_probs=133.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+++.+|++++++++|+||+++++++.+++..++|||++++ +|.+++......+++..++.++.|++.++.+||++|+
T Consensus        62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  141 (283)
T 3gen_A           62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF  141 (283)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            346788999999999999999999999999999999999975 9999998766689999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+.. ++.++|+||+|+++|+|+|
T Consensus       142 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t  216 (283)
T 3gen_A          142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS  216 (283)
T ss_dssp             CCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHT
T ss_pred             cCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999987554221 1122334567899999987654 6999999999999999986

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-35  Score=211.11  Aligned_cols=152  Identities=28%  Similarity=0.553  Sum_probs=131.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-----------------------CCCCH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-----------------------VPVPP   64 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------------------~~~~~   64 (163)
                      ..++.+|++++++++||||+++++++.+++..++||||+++ +|.+++....                       ..+++
T Consensus        94 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  173 (343)
T 1luf_A           94 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC  173 (343)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCH
Confidence            45678999999999999999999999999999999999985 9999987642                       57899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcC
Q psy7820          65 ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKV  142 (163)
Q Consensus        65 ~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~  142 (163)
                      ..++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+.......  .......+++.|+|||.+.+.. 
T Consensus       174 ~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-  252 (343)
T 1luf_A          174 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-  252 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-
Confidence            9999999999999999999999999999999999999999999999987653221  2223445688899999987654 


Q ss_pred             CCcchhhHHHHHHHHHHhc
Q psy7820         143 YSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       143 ~~~~~Di~slG~~l~~ll~  161 (163)
                      ++.++|+||+|+++|+|+|
T Consensus       253 ~~~~~Di~slG~il~el~t  271 (343)
T 1luf_A          253 YTTESDVWAYGVVLWEIFS  271 (343)
T ss_dssp             CCHHHHHHHHHHHHHHHHT
T ss_pred             cCcccccHHHHHHHHHHHh
Confidence            7999999999999999997

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.1e-34  Score=205.41  Aligned_cols=153  Identities=35%  Similarity=0.526  Sum_probs=127.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee-------------CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV-------------DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQL   74 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~-------------~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i   74 (163)
                      .+.+.+|++++++++||||+++++++.+             .+..++|||++++ +|.+++...+..+++..++.++.|+
T Consensus        46 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi  125 (303)
T 1zy4_A           46 LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI  125 (303)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHH
Confidence            3567899999999999999999998754             4578999999975 9999998777778899999999999


Q ss_pred             HHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccC--------------CCcccccccCccccCcccccCC
Q psy7820          75 LEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--------------MNRYTHEVVTLWYRPPEILLGA  140 (163)
Q Consensus        75 ~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--------------~~~~~~~~~~~~~~~pe~~~~~  140 (163)
                      +.++++||++|++|+||+|+||+++.++.++|+|||.+......              ........|++.|+|||.+.+.
T Consensus       126 ~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  205 (303)
T 1zy4_A          126 LEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT  205 (303)
T ss_dssp             HHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred             HHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence            99999999999999999999999999999999999988765421              1223345678899999998765


Q ss_pred             cCCCcchhhHHHHHHHHHHhc
Q psy7820         141 KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       141 ~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ..++.++|+||+|+++|+|++
T Consensus       206 ~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          206 GHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             SCCCTHHHHHHHHHHHHHHHS
T ss_pred             CCCcchhhHHHHHHHHHHHHh
Confidence            557999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-34  Score=207.13  Aligned_cols=154  Identities=27%  Similarity=0.425  Sum_probs=131.6

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCc--EEEEEecchhc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ...+.+.+|++++++++|+||+++++++....  ..++||||+++ +|.+++....  ..+++..++.++.|++.++.||
T Consensus        49 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~L  128 (319)
T 4euu_A           49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL  128 (319)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            34566789999999999999999999987655  78999999985 9999887643  2389999999999999999999


Q ss_pred             HhCCceecCCCCCcEEE----ccCCceEEeecccccccccCCCcccccccCccccCcccccC-------CcCCCcchhhH
Q psy7820          82 HSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-------AKVYSTTVDIW  150 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-------~~~~~~~~Di~  150 (163)
                      |++|++|+||+|+||++    +.++.++|+|||.+...... .......|++.|+|||.+..       ...++.++|||
T Consensus       129 H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diw  207 (319)
T 4euu_A          129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW  207 (319)
T ss_dssp             HHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHH
T ss_pred             HHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC-CceeecccCCCccCHHHhhhccccccccCCCCcHHHHH
Confidence            99999999999999999    77778999999998765533 33345578999999999752       24479999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       208 slG~il~el~~  218 (319)
T 4euu_A          208 SIGVTFYHAAT  218 (319)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHh
Confidence            99999999996

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-35  Score=217.03  Aligned_cols=151  Identities=28%  Similarity=0.463  Sum_probs=131.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++||||+++++++.+++..++|||+++ |+|.+++...+..+++..+..++.|++.|++|||++|++|
T Consensus       157 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH  236 (377)
T 3cbl_A          157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH  236 (377)
T ss_dssp             TTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCC
Confidence            467899999999999999999999999999999999997 5999999876667899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.+||+|||++.........  .....++..|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       237 rDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t  310 (377)
T 3cbl_A          237 RDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFS  310 (377)
T ss_dssp             SCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             cccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999998754322111  11123466799999987654 7999999999999999997

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=7.8e-35  Score=210.80  Aligned_cols=151  Identities=35%  Similarity=0.511  Sum_probs=118.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+.+|++++++++|+||+++++++.+++..++||||+++ +|.+.+...+ .+++..+..++.|++.++.|||+.|+
T Consensus        91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i  169 (349)
T 2w4o_A           91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG-YYSERDAADAVKQILEAVAYLHENGI  169 (349)
T ss_dssp             --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            345678899999999999999999999999999999999985 9988887654 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEcc---CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.   ++.++|+|||.+...... .......|++.|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus       170 vH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  245 (349)
T 2w4o_A          170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLC  245 (349)
T ss_dssp             CCCCCCGGGEEESSSSTTCCEEECCCC-----------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             EecCCCcccEEEecCCCCCCEEEccCccccccCcc-cccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHh
Confidence            99999999999975   889999999998765432 2234567899999999998754 7999999999999999996

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.9e-35  Score=212.48  Aligned_cols=151  Identities=28%  Similarity=0.533  Sum_probs=132.9

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      .++.+|+++++++ +|+||+++++++.+++..++|||++++ +|.+++....               ..+++..++.++.
T Consensus       119 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  198 (382)
T 3tt0_A          119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY  198 (382)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHH
Confidence            5678999999999 899999999999999999999999985 9999987653               3589999999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      |++.++.+||++|++|+||||+||+++.++.+||+|||.+.......  .......+++.|+|||.+.+.. ++.++|||
T Consensus       199 qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Diw  277 (382)
T 3tt0_A          199 QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVW  277 (382)
T ss_dssp             HHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHH
T ss_pred             HHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHH
Confidence            99999999999999999999999999999999999999987654322  2233445578899999987754 79999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       278 slG~il~ellt  288 (382)
T 3tt0_A          278 SFGVLLWEIFT  288 (382)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHHHHHHHh
Confidence            99999999987

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-34  Score=205.68  Aligned_cols=150  Identities=31%  Similarity=0.517  Sum_probs=133.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++.+++..++|||++++ +|.+++... ..+++..+..++.|++.++.+||+.|++
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~iv  137 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIA  137 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCEEHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45688999999999999999999999999999999999975 999888764 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCC----ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++    .++|+|||.+...... .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       138 H~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  213 (321)
T 2a2a_A          138 HFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLS  213 (321)
T ss_dssp             CCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTT-CCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             cCCCChHHEEEecCCCCcCCEEEccCccceecCcc-ccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHH
Confidence            999999999999888    7999999998765532 2334567899999999987654 6999999999999999996

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-35  Score=209.78  Aligned_cols=153  Identities=23%  Similarity=0.467  Sum_probs=132.5

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCC----------------------CCC
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV----------------------PVP   63 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~----------------------~~~   63 (163)
                      ....+.+|+++++++ +||||+++++++...+..++|||++++ +|.+++.....                      .++
T Consensus        91 ~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  170 (344)
T 1rjb_A           91 EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT  170 (344)
T ss_dssp             -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CC
T ss_pred             HHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCC
Confidence            456788999999999 899999999999999999999999975 99999976543                      378


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCc
Q psy7820          64 PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAK  141 (163)
Q Consensus        64 ~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~  141 (163)
                      +..++.++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+........  ......+++.|+|||.+.+..
T Consensus       171 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~  250 (344)
T 1rjb_A          171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI  250 (344)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC
Confidence            999999999999999999999999999999999999999999999999876543322  123345577899999987654


Q ss_pred             CCCcchhhHHHHHHHHHHhc
Q psy7820         142 VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       142 ~~~~~~Di~slG~~l~~ll~  161 (163)
                       ++.++||||||+++|+|+|
T Consensus       251 -~~~~~Di~slG~il~el~t  269 (344)
T 1rjb_A          251 -YTIKSDVWSYGILLWEIFS  269 (344)
T ss_dssp             -CCHHHHHHHHHHHHHHHTT
T ss_pred             -CChhHhHHHHHHHHHHHHc
Confidence             7999999999999999996

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-34  Score=204.99  Aligned_cols=152  Identities=25%  Similarity=0.438  Sum_probs=132.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEE-EEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKL-FLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~-~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+.+.+|++++++++|+||+++++++.+.+.. ++++|++. ++|.+++......+++..+..++.|++.++++||++|+
T Consensus        66 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i  145 (298)
T 3pls_A           66 VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKF  145 (298)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            35678999999999999999999999776654 89999996 59999998877789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccC----CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIP----MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~----~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+......    ........+++.|.|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       146 ~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  223 (298)
T 3pls_A          146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLT  223 (298)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhh
Confidence            99999999999999999999999998654321    22233456688999999997654 6999999999999999987

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.4e-35  Score=204.71  Aligned_cols=151  Identities=27%  Similarity=0.525  Sum_probs=121.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|+.++++++||||+++++++. ++..++|||++++ +|.+++......+++..+..++.|++.++.+||++|++
T Consensus        60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  138 (281)
T 1mp8_A           60 REKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV  138 (281)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            456789999999999999999999985 4568899999985 99999987777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       139 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~  212 (281)
T 1mp8_A          139 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILM  212 (281)
T ss_dssp             CSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHT
T ss_pred             cccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHh
Confidence            999999999999999999999999876543221 122334577899999987644 6999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.4e-35  Score=211.14  Aligned_cols=150  Identities=27%  Similarity=0.509  Sum_probs=131.2

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+..+|++++.++ +||||+++++++.+++.+|+||||+.| +|.+.+...+ .+++..+..++.|++.++.|||++|++
T Consensus        60 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~giv  138 (342)
T 2qr7_A           60 RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK-FFSEREASAVLFTITKTVEYLHAQGVV  138 (342)
T ss_dssp             CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCT-TCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcE
Confidence            3467899999888 799999999999999999999999975 9999887654 789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccC----CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKS----GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~----~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||++..+    +.++|+|||.+.............+|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       139 HrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~  215 (342)
T 2qr7_A          139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLT  215 (342)
T ss_dssp             CSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHH
T ss_pred             eccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhc
Confidence            99999999998443    3599999999987655444455678899999999987644 6899999999999999996

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.1e-35  Score=207.49  Aligned_cols=151  Identities=29%  Similarity=0.521  Sum_probs=127.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .++.+|++++++++|+||+++++++...  ..+++|||++++ +|.+++......+++..+..++.|++.++.|||+.|+
T Consensus        56 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i  135 (295)
T 3ugc_A           56 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRY  135 (295)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCc
Confidence            4678999999999999999999998543  468999999975 9999998877779999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+........   ......++..|+|||.+.+.. ++.++||||+|+++|+|+|
T Consensus       136 vH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~  212 (295)
T 3ugc_A          136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT  212 (295)
T ss_dssp             CCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHh
Confidence            9999999999999999999999999876543221   122334567799999987655 7999999999999999997

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.8e-36  Score=227.98  Aligned_cols=149  Identities=19%  Similarity=0.108  Sum_probs=115.2

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...+++.+|+++|+++ .|+||+++++++++++..||||||++| +|.+.+...+ .+++.   +++.||+.||.|+|++
T Consensus       283 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~-~l~~~---~I~~QIl~AL~ylH~~  358 (569)
T 4azs_A          283 RNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE-EIDRE---KILGSLLRSLAALEKQ  358 (569)
T ss_dssp             HHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC-CCCHH---HHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC-CCCHH---HHHHHHHHHHHHHHHC
Confidence            3446789999999999 799999999999999999999999997 9999887654 67765   4789999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+||||||+||+++.+|.+||+|||+++............+||+.|++||++.+.  +...+|+||+|++++++.+
T Consensus       359 GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~  433 (569)
T 4azs_A          359 GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQ  433 (569)
T ss_dssp             TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCT
T ss_pred             CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcc
Confidence            99999999999999999999999999998776666666778899999999998764  4778999999998877643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-34  Score=207.66  Aligned_cols=151  Identities=25%  Similarity=0.448  Sum_probs=127.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++|+||+++++++.+.+..++|||++++ +|.+++....+.+++..++.++.|++.++++||++|++|
T Consensus        91 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  170 (333)
T 1mqb_A           91 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH  170 (333)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence            4578999999999999999999999999999999999986 999999887778999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+.........   .....++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       171 ~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt  245 (333)
T 1mqb_A          171 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMT  245 (333)
T ss_dssp             SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHc
Confidence            999999999999999999999998765432211   11223467899999987654 7999999999999999986

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-34  Score=216.90  Aligned_cols=152  Identities=32%  Similarity=0.597  Sum_probs=134.5

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ......+.+|++++++++||||+++++++.+.+..++|||++.+ +|.+.+.... .+++..+..++.|++.++.|||++
T Consensus        67 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~  145 (484)
T 3nyv_A           67 KTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKN  145 (484)
T ss_dssp             SSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS-CCBHHHHHHHHHHHHHHHHHHHHT
T ss_pred             chHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34566789999999999999999999999999999999999975 8988887654 789999999999999999999999


Q ss_pred             CceecCCCCCcEEE---ccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||++   +.++.++|+|||++...... .......|++.|+|||.+.+  .++.++||||+|+++|+|++
T Consensus       146 ~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~  222 (484)
T 3nyv_A          146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLS  222 (484)
T ss_dssp             TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC-CSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHH
T ss_pred             CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc-cccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHH
Confidence            99999999999999   56789999999998765532 33455678999999999876  37999999999999999996

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-35  Score=212.97  Aligned_cols=152  Identities=23%  Similarity=0.426  Sum_probs=130.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP------VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ..++.+|+.++++++|+||+++++++.+++..++|||++++ +|.+++....      ..+++..++.++.|++.++.||
T Consensus       118 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  197 (367)
T 3l9p_A          118 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL  197 (367)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHH
Confidence            34678999999999999999999999999999999999975 9999987543      4689999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEccCC---ceEEeecccccccccC--CCcccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          82 HSRRIIHRDLKPQNILINKSG---ALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      |++|++|+||||+||+++.++   .++|+|||.+......  ........+++.|+|||.+.+.. ++.++||||||+++
T Consensus       198 H~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il  276 (367)
T 3l9p_A          198 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLL  276 (367)
T ss_dssp             HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             HhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHH
Confidence            999999999999999998555   5999999998754322  22233456688999999987654 79999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|++
T Consensus       277 ~ellt  281 (367)
T 3l9p_A          277 WEIFS  281 (367)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            99996

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.8e-34  Score=212.35  Aligned_cols=151  Identities=32%  Similarity=0.480  Sum_probs=123.4

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ...+.+|++++.++ +|+||+++++++..    ...+|+||||++| +|.+++...+ ..+++..+..++.|++.|+.||
T Consensus        98 ~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~L  177 (400)
T 1nxk_A           98 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL  177 (400)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence            45678899987554 89999999999876    5689999999985 9999998754 4689999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEcc---CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          82 HSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      |+.|++|+||||+||+++.   ++.+||+|||++..... .......+|++.|+|||++.+.. ++.++||||+|+++|+
T Consensus       178 H~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~e  255 (400)
T 1nxk_A          178 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS-HNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYI  255 (400)
T ss_dssp             HHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCC-SSSHHHHHHHHHHHHH
T ss_pred             HHCCccccCcCcceEEEecCCCCccEEEEecccccccCC-CCccccCCCCCCccCHhhcCCCC-CCCcccHHHHHHHHHH
Confidence            9999999999999999987   78899999999876542 23344567899999999987654 7999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |++
T Consensus       256 ll~  258 (400)
T 1nxk_A          256 LLC  258 (400)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            996

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-34  Score=205.30  Aligned_cols=152  Identities=25%  Similarity=0.452  Sum_probs=130.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeee-eeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~-~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|++++++++|+||+++++++ ..++..+++||++++ +|.+++......+++..+..++.|++.++.+||++|+
T Consensus        70 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i  149 (298)
T 3f66_A           70 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKF  149 (298)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            35678999999999999999999985 556688999999986 9999998877789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC----CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+.......    .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       150 ~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  227 (298)
T 3f66_A          150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT  227 (298)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999987554221    2233445577899999987654 6999999999999999987

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3e-34  Score=201.66  Aligned_cols=150  Identities=35%  Similarity=0.615  Sum_probs=129.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|++++++++||||+++++++.+.+..++|||++++ ++.+.+.... .+++..+..++.|++.++.+||+.|+
T Consensus        52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~i  130 (279)
T 3fdn_A           52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSKRV  130 (279)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence            345688999999999999999999999999999999999985 8888876653 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+.....  .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       131 ~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  202 (279)
T 3fdn_A          131 IHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV  202 (279)
T ss_dssp             EECCCCGGGEEECTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHH
T ss_pred             ecccCChHhEEEcCCCCEEEEeccccccCCc--ccccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHH
Confidence            9999999999999999999999998755432  2334557799999999987654 6899999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.4e-34  Score=201.26  Aligned_cols=150  Identities=35%  Similarity=0.616  Sum_probs=133.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...++.+|++++++++|+||+++++++.+++..++|||++++ +|.+.+...+ .+++..+..++.|++.++.+||++|+
T Consensus        57 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i  135 (284)
T 2vgo_A           57 VEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHERKV  135 (284)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             HHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            446788999999999999999999999999999999999975 9988887654 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+.....  .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       136 ~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  207 (284)
T 2vgo_A          136 IHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLV  207 (284)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCTTCEECSS--SCBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHH
T ss_pred             eecCCCHHHEEEcCCCCEEEecccccccCcc--cccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHH
Confidence            9999999999999999999999998865442  2234557899999999987754 6999999999999999986

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-34  Score=210.98  Aligned_cols=151  Identities=36%  Similarity=0.695  Sum_probs=129.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeee--------------------------------------CcEEEEEecchhccH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPV--------------------------------------DFKLFLVFEFLRQDL   51 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~l   51 (163)
                      ....+|+++++.++|+||+++++++..                                      +.++++||||++++|
T Consensus        45 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L  124 (383)
T 3eb0_A           45 RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTL  124 (383)
T ss_dssp             TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEH
T ss_pred             chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccH
Confidence            345589999999999999999999843                                      345899999999987


Q ss_pred             HHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEc-cCCceEEeecccccccccCCCccccccc
Q psy7820          52 KDFLQ---TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVV  127 (163)
Q Consensus        52 ~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~  127 (163)
                      .+.+.   ..+..+++..++.++.|++.|+.|||+.|++|+||+|+||+++ .++.++|+|||.+...... .......+
T Consensus       125 ~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~  203 (383)
T 3eb0_A          125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS-EPSVAYIC  203 (383)
T ss_dssp             HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT-SCCCCCCC
T ss_pred             HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC-CCCcCccc
Confidence            77664   3456899999999999999999999999999999999999998 6889999999998765432 33445567


Q ss_pred             CccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       128 ~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++.|+|||.+.+...++.++||||+|+++|+|++
T Consensus       204 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  237 (383)
T 3eb0_A          204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL  237 (383)
T ss_dssp             CSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHh
Confidence            9999999998876668999999999999999996

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-35  Score=213.49  Aligned_cols=152  Identities=24%  Similarity=0.443  Sum_probs=123.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeee-eCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|+.++++++||||+++++++. .++..++||||+++ +|.+++......+++..+..++.|++.++.|||++|+
T Consensus       134 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  213 (373)
T 3c1x_A          134 VSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF  213 (373)
T ss_dssp             HHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence            456889999999999999999999864 45688999999985 9999998877788999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC----CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.+||+|||++.......    .......+++.|+|||.+.+.. ++.++||||+|+++|+|+|
T Consensus       214 vHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt  291 (373)
T 3c1x_A          214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT  291 (373)
T ss_dssp             CCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             ecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            999999999999999999999999987553221    1122345577899999987654 7999999999999999997

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.4e-34  Score=202.08  Aligned_cols=152  Identities=30%  Similarity=0.502  Sum_probs=135.4

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....++.+|+.++++++|+||+++++++.+++..++|||++++ +|.+++..  +.+++..+..++.|++.++.+||+.|
T Consensus        62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~  139 (303)
T 3a7i_A           62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEK  139 (303)
T ss_dssp             TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456789999999999999999999999999999999999986 88888764  47899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       140 i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  214 (303)
T 3a7i_A          140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAR  214 (303)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             CccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHcc
Confidence            99999999999999999999999999877654433445567899999999987654 6899999999999999986

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-34  Score=210.29  Aligned_cols=148  Identities=44%  Similarity=0.752  Sum_probs=131.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+++++.++|+||+++++++...+      .+|+|||+++++|.+++..  ..+++..+..++.|++.|+.|||
T Consensus        68 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH  145 (367)
T 1cm8_A           68 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH  145 (367)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Confidence            356789999999999999999999997653      4699999998899988876  36889999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|++|+||+|+||+++.++.+||+|||++.....   ......+++.|+|||.+.+...++.++|+||+||++|+|++
T Consensus       146 ~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  221 (367)
T 1cm8_A          146 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT  221 (367)
T ss_dssp             HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH
T ss_pred             HCCccccCcCHHHEEEcCCCCEEEEeeeccccccc---ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999876542   23455779999999998875558999999999999999996

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.1e-35  Score=208.76  Aligned_cols=151  Identities=22%  Similarity=0.399  Sum_probs=129.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|+.++++++|+||+++++++.+ +..++|+|++. |+|.+++....+.+++..+..++.|++.++.|||++|++
T Consensus        59 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv  137 (325)
T 3kex_A           59 FQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV  137 (325)
T ss_dssp             BCSCCHHHHHHHTCCCTTBCCEEEEECB-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhcCCCCCcCeEEEEEcC-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            4567889999999999999999999874 56889999998 599999987767889999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.++|+|||.+........  ......++..|+|||.+.+.. ++.++|+||+|+++|+|+|
T Consensus       138 H~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~  212 (325)
T 3kex_A          138 HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMT  212 (325)
T ss_dssp             CSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHh
Confidence            999999999999999999999999977643322  223445677899999987655 7999999999999999987

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.1e-35  Score=206.76  Aligned_cols=155  Identities=30%  Similarity=0.482  Sum_probs=130.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....++.+|++++++++||||+++++++.+++..++|||++++ ++.+++......+++..+..++.|++.++.+||+.|
T Consensus        58 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  137 (302)
T 2j7t_A           58 EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR  137 (302)
T ss_dssp             CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            3456788999999999999999999999999999999999986 888887766668999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc----CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.    ....++.++|+||+|+++|+|++
T Consensus       138 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~  217 (302)
T 2j7t_A          138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ  217 (302)
T ss_dssp             CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhc
Confidence            99999999999999999999999998754332222233456799999999984    23447899999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1e-34  Score=207.80  Aligned_cols=153  Identities=25%  Similarity=0.361  Sum_probs=132.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..+++.+|++++++++||||+++++++.+++..++||||+++ +|.+++....   ..+++..++.++.|++.++.+||+
T Consensus        78 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  157 (321)
T 2qkw_B           78 GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT  157 (321)
T ss_dssp             HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC
Confidence            346788999999999999999999999999999999999985 8888876543   358999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+|+||+++.++.++|+|||.+.......  .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       158 ~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~  236 (321)
T 2qkw_B          158 RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLC  236 (321)
T ss_dssp             TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHH
T ss_pred             CCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHh
Confidence            999999999999999999999999999987644221  2223445789999999987654 7999999999999999986

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.8e-34  Score=215.14  Aligned_cols=151  Identities=34%  Similarity=0.614  Sum_probs=131.2

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .....+.+|++++++++||||+++++++.+...+++|||++.+ +|.+.+.... .+++..+..++.|++.++.|||++|
T Consensus        63 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~  141 (486)
T 3mwu_A           63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN  141 (486)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999999999999999999999999999999985 8888886654 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEc---cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++   .++.++|+|||++..... ........|++.|+|||++.+.  ++.++||||+|+++|+|++
T Consensus       142 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwslG~il~~ll~  217 (486)
T 3mwu_A          142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ-NTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS  217 (486)
T ss_dssp             CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC-C----CCTTGGGGCCGGGGGSC--CCHHHHHHHHHHHHHHHHH
T ss_pred             eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC-CCccCCCcCCCCCCCHHHhCCC--CCchhhHHHHHHHHHHHHh
Confidence            99999999999995   456799999999876543 2334556789999999998753  7999999999999999996

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.3e-34  Score=207.92  Aligned_cols=150  Identities=19%  Similarity=0.214  Sum_probs=130.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeee----CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+.+|+..++.++|+||+++++++.+    +...++|||++.++|.+++...+ .+++..++.++.|++.|++|||++|
T Consensus        93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~  171 (345)
T 2v62_A           93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYIHENE  171 (345)
T ss_dssp             HHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            346778889999999999999999987    77899999999669999887655 8899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCC--ceEEeecccccccccCC-------CcccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          86 IIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPM-------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      ++|+||+|+||+++.++  .++|+|||.+.......       .......|++.|+|||.+.+.. ++.++||||||+++
T Consensus       172 ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il  250 (345)
T 2v62_A          172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCM  250 (345)
T ss_dssp             EECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHH
T ss_pred             eeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHH
Confidence            99999999999999887  99999999987653221       1124457899999999988754 79999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|++
T Consensus       251 ~ell~  255 (345)
T 2v62_A          251 LRWLC  255 (345)
T ss_dssp             HHHHH
T ss_pred             HHHHh
Confidence            99996

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.8e-34  Score=206.82  Aligned_cols=151  Identities=25%  Similarity=0.361  Sum_probs=133.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhC-
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---VPVPPALAKSYLYQLLEALRYCHSR-   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lh~~-   84 (163)
                      .++.+|++++++++|+||+++++++.+++..++|||++++ +|.+++....   ..+++..+..++.|++.++.+||+. 
T Consensus        72 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  151 (326)
T 3uim_A           72 LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC  151 (326)
T ss_dssp             CHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4688999999999999999999999999999999999986 9999887643   3489999999999999999999999 


Q ss_pred             --CceecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 --RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 --~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                        |++|+||+|+||+++.++.++|+|||.+........ ......|++.|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus       152 ~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  230 (326)
T 3uim_A          152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELIT  230 (326)
T ss_dssp             SSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHh
Confidence              999999999999999999999999999876543322 233445899999999987655 6999999999999999996

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.8e-34  Score=216.00  Aligned_cols=151  Identities=33%  Similarity=0.576  Sum_probs=134.0

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|++++++++||||+++++++.++..+++||||++| +|.+.+.... .+++..+..++.|++.++.|||++|
T Consensus        88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~  166 (504)
T 3q5i_A           88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGICYLHKHN  166 (504)
T ss_dssp             CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4456788999999999999999999999999999999999985 8988887654 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCC---ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++   .++|+|||++...... .......|++.|+|||.+.+  .++.++||||+|+++|+|++
T Consensus       167 ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~  242 (504)
T 3q5i_A          167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLC  242 (504)
T ss_dssp             EECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHH
T ss_pred             eEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-CccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHh
Confidence            99999999999998876   6999999998765532 33456678999999999864  37999999999999999996

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4e-35  Score=209.16  Aligned_cols=150  Identities=29%  Similarity=0.506  Sum_probs=123.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCc----EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .++.+|++++++++||||+++++++....    ..|+||||++| +|.+++...+ .+++..++.++.|++.+++|||++
T Consensus        57 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~  135 (311)
T 3ork_A           57 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN  135 (311)
T ss_dssp             HHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            46789999999999999999999987654    45999999975 9988887654 789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||.+.......   .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       136 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~  214 (311)
T 3ork_A          136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLT  214 (311)
T ss_dssp             TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHh
Confidence            99999999999999999999999999987654322   2223456799999999997754 7999999999999999996

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.8e-34  Score=205.61  Aligned_cols=151  Identities=28%  Similarity=0.525  Sum_probs=131.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC-----------------------CCCCHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-----------------------VPVPPA   65 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----------------------~~~~~~   65 (163)
                      .++.+|++++++++||||+++++++.+++..++|||+++ ++|.+++....                       ..+++.
T Consensus        71 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  150 (314)
T 2ivs_A           71 RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG  150 (314)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHH
T ss_pred             HHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHH
Confidence            567899999999999999999999999999999999998 59999987643                       237899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCC
Q psy7820          66 LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVY  143 (163)
Q Consensus        66 ~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~  143 (163)
                      .++.++.|++.++.|||++|++|+||+|+||+++.++.++|+|||.+........  ......+++.|+|||.+.+.. +
T Consensus       151 ~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~  229 (314)
T 2ivs_A          151 DLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-Y  229 (314)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-E
T ss_pred             HHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC-c
Confidence            9999999999999999999999999999999999999999999999876543322  122335578899999987654 6


Q ss_pred             CcchhhHHHHHHHHHHhc
Q psy7820         144 STTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       144 ~~~~Di~slG~~l~~ll~  161 (163)
                      +.++|+||+|+++|+|++
T Consensus       230 ~~~~Di~slG~il~el~t  247 (314)
T 2ivs_A          230 TTQSDVWSFGVLLWEIVT  247 (314)
T ss_dssp             CHHHHHHHHHHHHHHHHT
T ss_pred             CchhhHHHHHHHHHHHHh
Confidence            999999999999999997

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-34  Score=201.88  Aligned_cols=152  Identities=26%  Similarity=0.438  Sum_probs=133.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++.+++..+++||++++ +|.+++......+++..+..++.|++.++.+||++|++
T Consensus        47 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  126 (267)
T 3t9t_A           47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI  126 (267)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            46788999999999999999999999999999999999985 99999988777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+....... .......++..|+|||...+.. ++.++|+||+|+++|+|++
T Consensus       127 H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  200 (267)
T 3t9t_A          127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFS  200 (267)
T ss_dssp             CSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhc
Confidence            99999999999999999999999887553211 1122344577899999987654 6999999999999999987

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.1e-34  Score=209.15  Aligned_cols=148  Identities=39%  Similarity=0.670  Sum_probs=122.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+.+++.++||||+++++++...+      .+++|||++++++.+.+..   .+++..+..++.|++.|+.|||
T Consensus        68 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~lH  144 (371)
T 2xrw_A           68 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHLH  144 (371)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHHH
Confidence            345789999999999999999999997654      7899999999999988863   5889999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||+|+||+++.++.+||+|||.+...... .......|++.|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus       145 ~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~  221 (371)
T 2xrw_A          145 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIK  221 (371)
T ss_dssp             HTTCCCSCCCGGGEEECTTSCEEECCCCC-----------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHH
T ss_pred             HCCeecccCCHHHEEEcCCCCEEEEEeecccccccc-cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHh
Confidence            999999999999999999999999999998765422 2234457899999999998754 7999999999999999996

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.5e-34  Score=213.55  Aligned_cols=151  Identities=27%  Similarity=0.499  Sum_probs=129.8

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-EEEEEecchhc-cHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ...+++.+|++++++++|+||+++++++...+ .+++||||+++ +|.+++...+. .+++..++.++.|++.+++|||+
T Consensus       228 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~  307 (450)
T 1k9a_A          228 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG  307 (450)
T ss_dssp             TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            45677899999999999999999999976654 79999999985 99999976543 46899999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||+|+||+++.++.+||+|||++......   .....++..|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       308 ~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t  381 (450)
T 1k9a_A          308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYS  381 (450)
T ss_dssp             TTEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999998754322   22235578899999997654 7999999999999999996

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.5e-34  Score=206.28  Aligned_cols=153  Identities=28%  Similarity=0.444  Sum_probs=130.0

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHH
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKS   69 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~   69 (163)
                      ....++.+|+++++++ +||||+++++++.+++..++|||++++ +|.+++....               ..+++..++.
T Consensus        67 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  146 (327)
T 1fvr_A           67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH  146 (327)
T ss_dssp             ---CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHH
Confidence            3456688999999999 899999999999999999999999975 9999987653               4789999999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhh
Q psy7820          70 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        70 ~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      ++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+.+.. ++.++|+
T Consensus       147 i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di  224 (327)
T 1fvr_A          147 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSV-YTTNSDV  224 (327)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCE-ECHHHHH
T ss_pred             HHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-ccccCCCCCccccChhhhcccc-CCchhcc
Confidence            9999999999999999999999999999999999999999988643322 2223345578899999987654 6999999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+|+++|+|++
T Consensus       225 ~slG~il~ellt  236 (327)
T 1fvr_A          225 WSYGVLLWEIVS  236 (327)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHc
Confidence            999999999996

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-34  Score=205.89  Aligned_cols=153  Identities=22%  Similarity=0.405  Sum_probs=126.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....++.+|++++++++||||+++++++.++. .+++++++. |+|.+++......+++..++.++.|++.++.|||++|
T Consensus        59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  137 (327)
T 3lzb_A           59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  137 (327)
T ss_dssp             CCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            45567889999999999999999999998765 677888887 5999999887778999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.++|+|||.+........  ......+++.|+|||.+.+.. ++.++||||+|+++|+|++
T Consensus       138 ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~  214 (327)
T 3lzb_A          138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             CCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999999976543322  122334577899999988654 7999999999999999987

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.7e-34  Score=206.26  Aligned_cols=153  Identities=22%  Similarity=0.404  Sum_probs=130.9

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....++.+|++++++++|+||+++++++.++. .+++++++. |+|.+++......+++..++.++.|++.++.|||++|
T Consensus        59 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  137 (327)
T 3poz_A           59 KANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  137 (327)
T ss_dssp             -CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC
Confidence            34567889999999999999999999998765 667888887 5999999887778999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.+||+|||++.........  .....++..|+|||.+.+.. ++.++||||+|+++|+|+|
T Consensus       138 ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt  214 (327)
T 3poz_A          138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMT  214 (327)
T ss_dssp             CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             eeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHh
Confidence            999999999999999999999999998766533222  22334577899999988654 7999999999999999987

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.9e-34  Score=213.95  Aligned_cols=154  Identities=32%  Similarity=0.415  Sum_probs=126.8

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++++ +||||+++++++.+....|+|||+++|+|.+++.......++..+..++.|++.|+.|||++|+
T Consensus        60 ~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i  139 (432)
T 3p23_A           60 CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNI  139 (432)
T ss_dssp             TEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcC
Confidence            345578999999999 7999999999999999999999999999999998877666666678899999999999999999


Q ss_pred             eecCCCCCcEEEcc---C--CceEEeecccccccccCC---CcccccccCccccCcccccC--CcCCCcchhhHHHHHHH
Q psy7820          87 IHRDLKPQNILINK---S--GALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        87 ~h~~i~~~ni~~~~---~--~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l  156 (163)
                      +|+||||+||+++.   +  ..++|+|||++.......   .......|++.|+|||.+.+  ...++.++||||+|+++
T Consensus       140 vHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il  219 (432)
T 3p23_A          140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF  219 (432)
T ss_dssp             CCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred             EeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence            99999999999953   2  357899999987655332   22344578999999999874  23357899999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|++
T Consensus       220 ~ellt  224 (432)
T 3p23_A          220 YYVIS  224 (432)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            99997

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.5e-34  Score=206.79  Aligned_cols=149  Identities=29%  Similarity=0.483  Sum_probs=132.0

Q ss_pred             hhhHHHHHHHHhcCC-----CCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELK-----HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-----h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ...+..|+++++.+.     |+||+++++++...+..++|||+++++|.+++.... ..+++..+..++.|++.|+.|||
T Consensus        75 ~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH  154 (360)
T 3llt_A           75 TRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLR  154 (360)
T ss_dssp             HHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            345678999999996     999999999999999999999999779999987654 46899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEcc-------------------------CCceEEeecccccccccCCCcccccccCccccCcccc
Q psy7820          83 SRRIIHRDLKPQNILINK-------------------------SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEIL  137 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~-------------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  137 (163)
                      ++|++|+||||+||+++.                         ++.++|+|||.+.....   ......|++.|+|||.+
T Consensus       155 ~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~  231 (360)
T 3llt_A          155 KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVI  231 (360)
T ss_dssp             HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHH
T ss_pred             HCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHH
Confidence            999999999999999975                         78899999999876442   23456789999999999


Q ss_pred             cCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         138 LGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       138 ~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .+.. ++.++||||+|+++|+|++
T Consensus       232 ~~~~-~~~~~DiwslG~il~ell~  254 (360)
T 3llt_A          232 LNLG-WDVSSDMWSFGCVLAELYT  254 (360)
T ss_dssp             TTCC-CCTTHHHHHHHHHHHHHHH
T ss_pred             cCCC-CCCccchHHHHHHHHHHHH
Confidence            8755 7999999999999999996

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-34  Score=210.57  Aligned_cols=149  Identities=38%  Similarity=0.710  Sum_probs=127.6

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQ---TTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..+|+++++.++|+||+++++++...      ..+++||||+++++...+.   .....+++..++.++.|++.|+.|||
T Consensus        79 ~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH  158 (394)
T 4e7w_A           79 KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH  158 (394)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            45799999999999999999998543      3489999999987666543   33568899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEc-cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||||+||+++ .++.+||+|||.+...... .......+++.|+|||.+.+...++.++||||+|+++|+|++
T Consensus       159 ~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  237 (394)
T 4e7w_A          159 SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQ  237 (394)
T ss_dssp             HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCC-CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999 7899999999998765432 233455679999999998776668999999999999999996

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.6e-34  Score=215.12  Aligned_cols=150  Identities=33%  Similarity=0.562  Sum_probs=132.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+++++.++||||+++++++.+.+.+++||||+++ +|.+.+.... .+++..+..++.|++.++.|||++|+
T Consensus        79 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i  157 (494)
T 3lij_A           79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSGVTYLHKHNI  157 (494)
T ss_dssp             TTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            456788999999999999999999999999999999999985 8888876654 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccC---CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++..   +.++|+|||++...... .......|++.|+|||++.+  .++.++||||+|+++|+|++
T Consensus       158 vH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~  232 (494)
T 3lij_A          158 VHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLA  232 (494)
T ss_dssp             ECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHH
T ss_pred             eeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHh
Confidence            999999999999764   45999999998765532 34455678999999999864  37999999999999999996

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2e-34  Score=205.25  Aligned_cols=152  Identities=26%  Similarity=0.432  Sum_probs=132.6

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCC-----------------CCCHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV-----------------PVPPALAKS   69 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-----------------~~~~~~~~~   69 (163)
                      .+.+.+|+++++++ +||||+++++++.+++..++|||++++ +|.+++.....                 .+++..++.
T Consensus        70 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (313)
T 1t46_A           70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS  149 (313)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHH
Confidence            35688999999999 899999999999999999999999975 99999876543                 489999999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcch
Q psy7820          70 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTV  147 (163)
Q Consensus        70 ~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~  147 (163)
                      ++.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+.........  .....+++.|+|||.+.+.. ++.++
T Consensus       150 ~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~  228 (313)
T 1t46_A          150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFES  228 (313)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHH
T ss_pred             HHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHH
Confidence            9999999999999999999999999999999999999999998765533221  22344577899999987654 79999


Q ss_pred             hhHHHHHHHHHHhc
Q psy7820         148 DIWSAGCIFSEMIQ  161 (163)
Q Consensus       148 Di~slG~~l~~ll~  161 (163)
                      |+||+|+++|+|+|
T Consensus       229 Di~slG~il~ellt  242 (313)
T 1t46_A          229 DVWSYGIFLWELFS  242 (313)
T ss_dssp             HHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHh
Confidence            99999999999986

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.2e-34  Score=201.61  Aligned_cols=151  Identities=30%  Similarity=0.531  Sum_probs=127.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..+.+.+|++++++++||||+++++++.+.+..++|||++++ +|.+.+...   +..+++..++.++.|++.++++||+
T Consensus        63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~  142 (285)
T 3is5_A           63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS  142 (285)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence            346788999999999999999999999999999999999985 888887542   3578999999999999999999999


Q ss_pred             CCceecCCCCCcEEE---ccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          84 RRIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +|++|+||+|+||++   +.++.++|+|||.+...... .......|++.|+|||.+.+  .++.++|+||+|+++|+|+
T Consensus       143 ~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll  219 (285)
T 3is5_A          143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLL  219 (285)
T ss_dssp             TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHH
T ss_pred             CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc-ccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHH
Confidence            999999999999999   45678999999998765432 23345678999999999864  3699999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       220 ~  220 (285)
T 3is5_A          220 T  220 (285)
T ss_dssp             H
T ss_pred             h
Confidence            6

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.1e-34  Score=200.40  Aligned_cols=153  Identities=29%  Similarity=0.520  Sum_probs=133.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+.+.+|+++++.++|+||+++++++.+++..++|+|++++ +|.+.+... ..+++..+..++.|++.++.+||++|+
T Consensus        48 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i  126 (276)
T 2yex_A           48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGI  126 (276)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             hhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            346788999999999999999999999999999999999986 888776543 478999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+.......  .......|++.|+|||.+.+....+.++|+||+|+++|+|++
T Consensus       127 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  203 (276)
T 2yex_A          127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA  203 (276)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred             eccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence            999999999999999999999999987654222  123345679999999998776545789999999999999996

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.9e-34  Score=200.10  Aligned_cols=152  Identities=34%  Similarity=0.581  Sum_probs=126.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...++.+|+++++.++|+||+++++++.+++..++|||++++ +|.+++.... .+++..+..++.|++.++.+||++|+
T Consensus        54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i  132 (276)
T 2h6d_A           54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMV  132 (276)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred             HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            345788999999999999999999999999999999999975 9998887654 68999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+.+....+.++|+||+|+++|+|++
T Consensus       133 ~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~  206 (276)
T 2h6d_A          133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLC  206 (276)
T ss_dssp             SCCCCCGGGEEECTTSCEEECCCCGGGCCCC--------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCChhhEEECCCCCEEEeecccccccCCC-cceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHh
Confidence            99999999999999999999999988765432 223345678999999998875544689999999999999996

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.9e-34  Score=217.20  Aligned_cols=153  Identities=29%  Similarity=0.485  Sum_probs=133.3

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+++.+|++++++++|+||+++++++.+++.+++|||+++ |+|.+++... ...+++..++.++.|++.+++|||++|
T Consensus       259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~  338 (495)
T 1opk_A          259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  338 (495)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            45678999999999999999999999999999999999998 5999999764 356899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.+||+|||++....... .......++..|+|||.+.... ++.++||||+|+++|||+|
T Consensus       339 ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t  414 (495)
T 1opk_A          339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT  414 (495)
T ss_dssp             EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHh
Confidence            9999999999999999999999999987654221 1122334467899999987654 7999999999999999997

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.7e-34  Score=199.57  Aligned_cols=149  Identities=35%  Similarity=0.587  Sum_probs=131.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++|+||+++++++.+++..++|||++++ ++.+.+.... .+++..+..++.|++.++.+||++|++|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i~H  128 (284)
T 3kk8_A           50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVH  128 (284)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCcCc
Confidence            5577899999999999999999999999999999999986 8888876654 7899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCc---eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.   ++|+|||.+...... .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       129 ~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~  202 (284)
T 3kk8_A          129 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLV  202 (284)
T ss_dssp             SCCCGGGEEESSSSTTCCEEECCCTTCEECCSS-CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEecCCCCCcEEEeeceeeEEcccC-ccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHH
Confidence            999999999977655   999999998765533 2334467899999999987754 6999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.6e-34  Score=202.60  Aligned_cols=153  Identities=29%  Similarity=0.491  Sum_probs=133.7

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+++.+|++++++++|+||+++++++.+++..++|||+++ ++|.+++.... ..+++..++.++.+++.++.+||++|
T Consensus        52 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  131 (288)
T 3kfa_A           52 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  131 (288)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC
Confidence            34668899999999999999999999999999999999998 59999987643 46899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       132 i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~  207 (288)
T 3kfa_A          132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT  207 (288)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999987655332 2223345577899999987654 6999999999999999997

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=5.1e-34  Score=207.46  Aligned_cols=150  Identities=40%  Similarity=0.764  Sum_probs=131.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC-----cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .++.+|++++++++|+||+++++++...     ...++|||+++++|.+.+...  .+++..+..++.|++.++.|||++
T Consensus        70 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~LH~~  147 (364)
T 3qyz_A           70 QRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA  147 (364)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            5678999999999999999999998654     478999999999999988763  689999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||.+........   ......|++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       148 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  227 (364)
T 3qyz_A          148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS  227 (364)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence            999999999999999999999999999876543221   12445789999999997766667999999999999999996

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.7e-34  Score=209.29  Aligned_cols=151  Identities=26%  Similarity=0.473  Sum_probs=129.1

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCc-EEEEEecchhc-cHHHHHhcCCC--------------------------
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQTTPV--------------------------   60 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~--------------------------   60 (163)
                      .++.+|+++++++ +||||+++++++.+.+ .+++||||+++ +|.+++.....                          
T Consensus        70 ~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (359)
T 3vhe_A           70 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDL  149 (359)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------
T ss_pred             HHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhh
Confidence            4588999999999 7899999999987755 58999999985 99999876532                          


Q ss_pred             ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccC
Q psy7820          61 ---------------------------------------PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS  101 (163)
Q Consensus        61 ---------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~  101 (163)
                                                             .+++..++.++.|++.++.|||++|++|+||||+||+++.+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~  229 (359)
T 3vhe_A          150 KRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  229 (359)
T ss_dssp             ----------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             hccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence                                                   18899999999999999999999999999999999999999


Q ss_pred             CceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         102 GALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       102 ~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.++|+|||.+.......  .......+++.|+|||.+.+.. ++.++||||+|+++|+|+|
T Consensus       230 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt  290 (359)
T 3vhe_A          230 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFS  290 (359)
T ss_dssp             GCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTT
T ss_pred             CcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHh
Confidence            999999999987654322  2233456688999999987654 7999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.2e-34  Score=212.16  Aligned_cols=151  Identities=32%  Similarity=0.664  Sum_probs=127.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeee------CcEEEEEecchhccHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLRQDLKDFLQ---TTPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~------~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ....+|++++++++|+||+++++++..      ..++++||||+++++.+.+.   .....+++..++.++.|++.||.|
T Consensus        92 ~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  171 (420)
T 1j1b_A           92 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY  171 (420)
T ss_dssp             TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            334579999999999999999999843      22578999999987776654   345689999999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccC-CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          81 CHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      ||++|++|+||||+||+++.+ +.+||+|||+++..... .......+++.|+|||++.+...++.++||||+||++|||
T Consensus       172 LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el  250 (420)
T 1j1b_A          172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL  250 (420)
T ss_dssp             HHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccC-CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHH
Confidence            999999999999999999965 56899999999765432 2334457799999999987665589999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       251 l~  252 (420)
T 1j1b_A          251 LL  252 (420)
T ss_dssp             HH
T ss_pred             Hh
Confidence            96

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.9e-34  Score=202.85  Aligned_cols=152  Identities=36%  Similarity=0.607  Sum_probs=123.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..++.+|++++++++|+||+++++++..++..++|||++++ +|.+++..   ....+++..++.++.|++.++.+||+.
T Consensus        76 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  155 (310)
T 2wqm_A           76 RADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR  155 (310)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC
Confidence            45678999999999999999999999999999999999986 88888754   455789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||.+..............+++.|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus       156 ~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~  231 (310)
T 2wqm_A          156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAA  231 (310)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999876654444444556799999999987654 6999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.4e-34  Score=202.39  Aligned_cols=152  Identities=22%  Similarity=0.383  Sum_probs=120.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++|+||++++++. .....++|||++++ +|.+.+......+++..++.++.|++.++.+||+.|++
T Consensus        64 ~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~  142 (289)
T 3og7_A           64 LQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSII  142 (289)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            35678999999999999999999965 44568999999985 99999987777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCccccc--CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+......  ........|++.|+|||.+.  ....++.++|+||+|+++|+|++
T Consensus       143 H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  220 (289)
T 3og7_A          143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT  220 (289)
T ss_dssp             CSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH
T ss_pred             cccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH
Confidence            9999999999999999999999998754421  22233456799999999986  23347889999999999999996

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-34  Score=220.50  Aligned_cols=153  Identities=26%  Similarity=0.427  Sum_probs=129.8

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|++++++++|+||+++++++.. +.+++||||+++ +|.+++......+++..+..++.|++.|++|||++|
T Consensus       378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~  456 (613)
T 2ozo_A          378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN  456 (613)
T ss_dssp             TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            345778999999999999999999999976 568999999985 999999877778999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.+||+|||++.........   .....+++.|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       457 iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt  534 (613)
T 2ozo_A          457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALS  534 (613)
T ss_dssp             CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999765432211   11223457899999987654 7999999999999999996

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-34  Score=207.04  Aligned_cols=155  Identities=32%  Similarity=0.506  Sum_probs=128.0

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC---------------------------
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---------------------------   58 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---------------------------   58 (163)
                      ...+++.+|++++++++||||+++++++.+++..++||||++| +|.+.+...                           
T Consensus        70 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (345)
T 3hko_A           70 KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA  149 (345)
T ss_dssp             CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccc
Confidence            3446788999999999999999999999999999999999975 998887421                           


Q ss_pred             ------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCC--ceEEeecccccccccCCC----
Q psy7820          59 ------------PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMN----  120 (163)
Q Consensus        59 ------------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~----  120 (163)
                                  ...+++..++.++.|++.++.|||++|++|+||+|+||+++.++  .++|+|||.+........    
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  229 (345)
T 3hko_A          150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY  229 (345)
T ss_dssp             HHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---
T ss_pred             cccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccc
Confidence                        11235777889999999999999999999999999999998776  899999999876543221    


Q ss_pred             cccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHHhc
Q psy7820         121 RYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       121 ~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ......|++.|+|||.+.+. ..++.++||||||+++|+|++
T Consensus       230 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~  271 (345)
T 3hko_A          230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLM  271 (345)
T ss_dssp             -----CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHH
T ss_pred             cccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHH
Confidence            23456789999999998642 447899999999999999996

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.4e-34  Score=202.47  Aligned_cols=150  Identities=29%  Similarity=0.472  Sum_probs=123.4

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++||||+++++++..++..++++|++++ +|.+++...+ .+++..++.++.|++.++.+||+.|++|
T Consensus        79 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~i~H  157 (309)
T 2h34_A           79 TRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG-PLAPPRAVAIVRQIGSALDAAHAAGATH  157 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCcCCc
Confidence            5678999999999999999999999999999999999986 9998887643 7899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+....... .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       158 ~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  230 (309)
T 2h34_A          158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLT  230 (309)
T ss_dssp             SCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHH
T ss_pred             CCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHHHHHHH
Confidence            9999999999999999999999887654322 2233456789999999987654 6999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-34  Score=200.83  Aligned_cols=151  Identities=27%  Similarity=0.440  Sum_probs=131.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++ ..+..++|||++++ +|.+++......+++..+..++.|++.++.+||+.|++
T Consensus        54 ~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~  132 (287)
T 1u59_A           54 TEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV  132 (287)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            45688999999999999999999999 45568999999986 99999887777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+.........   .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       133 H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt  208 (287)
T 1u59_A          133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALS  208 (287)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             eCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHc
Confidence            9999999999999999999999998765433221   22334578899999987654 6999999999999999996

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.1e-33  Score=198.90  Aligned_cols=151  Identities=32%  Similarity=0.572  Sum_probs=129.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+++.+|++++++++||||+++++++.++...++|||+++ ++|.+++.... .+++..+..++.|++.++.+||++|+
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~i  129 (283)
T 3bhy_A           51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE-SLTEDEATQFLKQILDGVHYLHSKRI  129 (283)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            35678999999999999999999999999999999999997 49988886543 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCC----ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++    .++|+|||.+...... .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       130 ~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  206 (283)
T 3bhy_A          130 AHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLS  206 (283)
T ss_dssp             ECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             cCCCCChHHEEEecCCCCCCceEEEecccceeccCC-CcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHH
Confidence            9999999999998877    7999999998765432 2234456799999999987654 6999999999999999996

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=9.6e-34  Score=201.42  Aligned_cols=153  Identities=27%  Similarity=0.383  Sum_probs=132.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT--PVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .....+.+|++++++++||||+++++++.+++..++|||++++ +|.+++...  ...+++..++.++.|++.++.+||+
T Consensus        72 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~  151 (307)
T 2nru_A           72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE  151 (307)
T ss_dssp             THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc
Confidence            3456788999999999999999999999999999999999974 998888642  3468999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .|++|+||+|+||+++.++.++|+|||.+.........  .....|++.|+|||.+.+.  ++.++|+||+|+++|+|++
T Consensus       152 ~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG~il~~l~~  229 (307)
T 2nru_A          152 NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIIT  229 (307)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHHHHHHHHHH
T ss_pred             CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC--CCccchhHHHHHHHHHHHH
Confidence            99999999999999999999999999998765432211  2334679999999998753  6899999999999999996

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-33  Score=199.05  Aligned_cols=151  Identities=28%  Similarity=0.509  Sum_probs=131.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee----------------CcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV----------------DFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSY   70 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~----------------~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~   70 (163)
                      .+.+.+|++++++++||||+++++++..                ...+++|||++++ +|.+++... ...+++..++.+
T Consensus        48 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i  127 (284)
T 2a19_B           48 NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL  127 (284)
T ss_dssp             SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHH
T ss_pred             cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHH
Confidence            3678899999999999999999998854                4568999999986 999998654 357899999999


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhH
Q psy7820          71 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        71 ~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      +.|++.++.+||++|++|+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+.+.. ++.++|+|
T Consensus       128 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~  205 (284)
T 2a19_B          128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGTLRYMSPEQISSQD-YGKEVDLY  205 (284)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCC-SCCCCCCSCCTTSCHHHHHCSC-CCTHHHHH
T ss_pred             HHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheecccc-ccccccCCcccccChhhhccCC-CcchhhhH
Confidence            999999999999999999999999999999999999999998765533 2334456799999999987654 69999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       206 slG~il~~l~~  216 (284)
T 2a19_B          206 ALGLILAELLH  216 (284)
T ss_dssp             HHHHHHHHHHS
T ss_pred             HHHHHHHHHHh
Confidence            99999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=199.81  Aligned_cols=154  Identities=32%  Similarity=0.460  Sum_probs=130.5

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+.+|+.+++.++|+||+++++++.+.+..++|||++++ +|.+++....  ...++..+..++.|++.++.+||++
T Consensus        62 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  141 (295)
T 2clq_A           62 YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN  141 (295)
T ss_dssp             --HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC
Confidence            356688999999999999999999999999999999999975 9998887653  3557888999999999999999999


Q ss_pred             CceecCCCCCcEEEcc-CCceEEeecccccccccCCCcccccccCccccCcccccCCc-CCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++. ++.++|+|||.+..............|++.|+|||.+.+.. .++.++|+||+|+++|+|++
T Consensus       142 ~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~  220 (295)
T 2clq_A          142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMAT  220 (295)
T ss_dssp             TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHH
T ss_pred             CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHH
Confidence            9999999999999988 89999999999876554333344557799999999986532 36899999999999999996

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-34  Score=208.44  Aligned_cols=153  Identities=28%  Similarity=0.465  Sum_probs=131.9

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....+.+|+++++++ +|+||+++++++.+++..++||||+++ +|.+++.... .+++..+..++.|++.++.|||++|
T Consensus       101 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~  179 (355)
T 1vzo_A          101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG  179 (355)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            445677899999999 699999999999999999999999985 9988887654 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccC-CCcccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.++|+|||++...... ........|++.|+|||.+.+. ..++.++||||||+++|+|++
T Consensus       180 ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~  257 (355)
T 1vzo_A          180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT  257 (355)
T ss_dssp             CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence            999999999999999999999999998765322 2223445789999999998753 346899999999999999996

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.7e-34  Score=205.75  Aligned_cols=150  Identities=35%  Similarity=0.535  Sum_probs=125.9

Q ss_pred             hhHHHHHHHHhcCCC--CCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELKH--PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h--~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..+.+|++++++++|  +||+++++++.++..+++|||+..++|.+++.... .+++..+..++.|++.++.|||++|++
T Consensus        52 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~~ii  130 (343)
T 3dbq_A           52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIV  130 (343)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHSC-CCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            567899999999976  99999999999999999999977789999998754 789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccC----------CcCCCcchhhHHHHHH
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLG----------AKVYSTTVDIWSAGCI  155 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~----------~~~~~~~~Di~slG~~  155 (163)
                      |+||+|+||+++ ++.++|+|||++........  ......|++.|+|||.+.+          ...++.++||||+|++
T Consensus       131 HrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~i  209 (343)
T 3dbq_A          131 HSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI  209 (343)
T ss_dssp             CCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHH
T ss_pred             cCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHH
Confidence            999999999996 68899999999876543322  2335578999999999853          2347899999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|+|++
T Consensus       210 l~ell~  215 (343)
T 3dbq_A          210 LYYMTY  215 (343)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            999996

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-33  Score=198.92  Aligned_cols=150  Identities=25%  Similarity=0.319  Sum_probs=129.8

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ...++.+|+..+..+ +||||+++++++.+++..++|||++++ +|.+++...   ...+++..++.++.|++.++.|||
T Consensus        53 ~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH  132 (289)
T 1x8b_A           53 DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH  132 (289)
T ss_dssp             HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHH
Confidence            345678899999999 899999999999999999999999976 999988654   257899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccC-------------------CceEEeecccccccccCCCcccccccCccccCcccccCCcCC
Q psy7820          83 SRRIIHRDLKPQNILINKS-------------------GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVY  143 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~-------------------~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~  143 (163)
                      ++|++|+||+|+||+++.+                   ..++++|||.+......    ....|++.|+|||.+.+...+
T Consensus       133 ~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~  208 (289)
T 1x8b_A          133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENYTH  208 (289)
T ss_dssp             HTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCCTT
T ss_pred             hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc----cccCCCccccChhHhcCCCCC
Confidence            9999999999999999854                   47899999988765532    234579999999999876556


Q ss_pred             CcchhhHHHHHHHHHHhc
Q psy7820         144 STTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       144 ~~~~Di~slG~~l~~ll~  161 (163)
                      +.++||||+|+++|+|++
T Consensus       209 ~~~~Di~slG~il~~l~~  226 (289)
T 1x8b_A          209 LPKADIFALALTVVCAAG  226 (289)
T ss_dssp             HHHHHHHHHHHHHHHHTT
T ss_pred             CchhhHHHHHHHHHHHhc
Confidence            789999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.9e-34  Score=204.64  Aligned_cols=151  Identities=24%  Similarity=0.451  Sum_probs=130.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------CCCCHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------~~~~~~~~~~~~~~i~~~l~   79 (163)
                      .++.+|++++++++|+||+++++++.+++..++|||++++ +|.+++....         ..+++..++.++.|++.++.
T Consensus        73 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  152 (322)
T 1p4o_A           73 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA  152 (322)
T ss_dssp             HHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999999999999999985 9998886422         35689999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      +||++|++|+||+|+||+++.++.++|+|||.+........  ......+++.|+|||.+.+.. ++.++|+||+|+++|
T Consensus       153 ~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  231 (322)
T 1p4o_A          153 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLW  231 (322)
T ss_dssp             HHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred             HHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHH
Confidence            99999999999999999999999999999999875543221  122334578899999987654 699999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       232 el~~  235 (322)
T 1p4o_A          232 EIAT  235 (322)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            9987

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.2e-34  Score=204.85  Aligned_cols=149  Identities=27%  Similarity=0.392  Sum_probs=127.4

Q ss_pred             hHHHHHHHHhcCCCCCeeeeeeeeeeCc----EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q psy7820          11 TALREISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-   84 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-   84 (163)
                      ....|+.++++++||||+++++++..+.    .+++||||+++ +|.+++...  .+++..++.++.|++.++.|||+. 
T Consensus        64 ~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~LH~~~  141 (322)
T 3soc_A           64 QNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAYLHEDI  141 (322)
T ss_dssp             HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHTCCE
T ss_pred             HHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhhc
Confidence            4566888899999999999999998743    57999999985 999998764  589999999999999999999999 


Q ss_pred             ---------CceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCC----cCCCcchhh
Q psy7820          85 ---------RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGA----KVYSTTVDI  149 (163)
Q Consensus        85 ---------~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~----~~~~~~~Di  149 (163)
                               |++|+||||+||+++.++.+||+|||.+........  ......|++.|+|||.+.+.    ..++.++||
T Consensus       142 ~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Di  221 (322)
T 3soc_A          142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDM  221 (322)
T ss_dssp             EEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHH
T ss_pred             cccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchh
Confidence                     999999999999999999999999999976553322  23345789999999998763    235678899


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+|+++|+|+|
T Consensus       222 wslG~il~el~t  233 (322)
T 3soc_A          222 YAMGLVLWELAS  233 (322)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHh
Confidence            999999999997

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-34  Score=204.45  Aligned_cols=151  Identities=30%  Similarity=0.488  Sum_probs=131.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeee--eCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      +.+.+|++++++++|+||+++++++.  +....++|||++++ +|.+++......+++..++.++.|++.++++||+.|+
T Consensus        69 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  148 (327)
T 3lxl_A           69 RDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRC  148 (327)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            45789999999999999999999886  45679999999964 9999988766679999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+........   ......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       149 vH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~  225 (327)
T 3lxl_A          149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFT  225 (327)
T ss_dssp             ECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             cCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHh
Confidence            9999999999999999999999999876543322   122345677899999987654 6999999999999999997

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.4e-33  Score=205.28  Aligned_cols=151  Identities=33%  Similarity=0.594  Sum_probs=132.7

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+.+.+|+++++++ +||||+++++++...+..++||||++| +|.+++... ..+++..+..++.|++.++.|||+.|+
T Consensus       143 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi  221 (365)
T 2y7j_A          143 REATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNI  221 (365)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            34678899999999 799999999999999999999999986 898888754 378999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC-----CcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-----AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+|++|+||+++.++.++++|||.+...... .......|++.|+|||.+.+     ...++.++|+||||+++|+|++
T Consensus       222 ~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~  300 (365)
T 2y7j_A          222 VHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA  300 (365)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEECCCCCEEEEecCcccccCCC-cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH
Confidence            99999999999999999999999988765532 33455678999999999853     2246889999999999999996

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.1e-33  Score=197.95  Aligned_cols=147  Identities=24%  Similarity=0.426  Sum_probs=129.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR--I   86 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i   86 (163)
                      .++.+|++++++++|+||+++++++.+..  ++|||+++ ++|.+.+......+++..++.++.|++.++++||+.|  +
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i  145 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI  145 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence            67889999999999999999999997766  68999998 5999999888778999999999999999999999999  9


Q ss_pred             eecCCCCCcEEEccCCc-----eEEeecccccccccCCCcccccccCccccCcccccC-CcCCCcchhhHHHHHHHHHHh
Q psy7820          87 IHRDLKPQNILINKSGA-----LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-AKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~-----~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +|+||+|+||+++.++.     ++|+|||.+....   .......|++.|+|||.+.. ...++.++|+||+|+++|+|+
T Consensus       146 vH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~  222 (287)
T 4f0f_A          146 VHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV---HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTIL  222 (287)
T ss_dssp             BCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS---SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHH
T ss_pred             ecCCCCcceEEEeccCCCCceeEEeCCCCcccccc---ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHH
Confidence            99999999999988776     9999999887543   23445678999999999843 234689999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       223 ~  223 (287)
T 4f0f_A          223 T  223 (287)
T ss_dssp             H
T ss_pred             c
Confidence            6

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.6e-34  Score=206.47  Aligned_cols=152  Identities=22%  Similarity=0.419  Sum_probs=131.3

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-------------CCCCCHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-------------PVPVPPALAKSYLYQ   73 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-------------~~~~~~~~~~~~~~~   73 (163)
                      .+.+.+|+++++++ +||||+++++++.+++..++|||++++ +|.+++...             ...+++..++.++.|
T Consensus        93 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  172 (333)
T 2i1m_A           93 KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ  172 (333)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHH
Confidence            35678999999999 899999999999999999999999985 999988643             346789999999999


Q ss_pred             HHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhHH
Q psy7820          74 LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWS  151 (163)
Q Consensus        74 i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~s  151 (163)
                      ++.++.+||++|++|+||+|+||+++.++.++|+|||.+........  ......+++.|+|||.+.+.. ++.++||||
T Consensus       173 i~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s  251 (333)
T 2i1m_A          173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWS  251 (333)
T ss_dssp             HHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHH
T ss_pred             HHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHH
Confidence            99999999999999999999999999999999999999876543322  122344577899999987654 799999999


Q ss_pred             HHHHHHHHhc
Q psy7820         152 AGCIFSEMIQ  161 (163)
Q Consensus       152 lG~~l~~ll~  161 (163)
                      +|+++|+|+|
T Consensus       252 lG~il~el~t  261 (333)
T 2i1m_A          252 YGILLWEIFS  261 (333)
T ss_dssp             HHHHHHHHTT
T ss_pred             HHHHHHHHHc
Confidence            9999999996

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.4e-33  Score=204.11  Aligned_cols=151  Identities=36%  Similarity=0.699  Sum_probs=129.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC-----cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD-----FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|++++++++|+||+++++++...     ...+++||+++++|.+.+..  ..+++..+..++.|++.++.+||+
T Consensus        53 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~  130 (353)
T 2b9h_A           53 ALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHG  130 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHH
Confidence            34567999999999999999999987654     67999999999999998876  368999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCC----------cccccccCccccCcccccCCcCCCcchhhHHHH
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAG  153 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG  153 (163)
                      +|++|+||+|+||+++.++.++|+|||.+........          ......|++.|+|||.+.+...++.++|+||+|
T Consensus       131 ~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG  210 (353)
T 2b9h_A          131 SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCG  210 (353)
T ss_dssp             TTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHH
T ss_pred             CCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHH
Confidence            9999999999999999999999999999876542211          122346799999999987655579999999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      +++|+|++
T Consensus       211 ~il~~l~~  218 (353)
T 2b9h_A          211 CILAELFL  218 (353)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5.3e-34  Score=204.10  Aligned_cols=152  Identities=26%  Similarity=0.451  Sum_probs=121.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEE------EEEecchhc-cHHHHHhcC-----CCCCCHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQ-DLKDFLQTT-----PVPVPPALAKSYLYQLLE   76 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~------~lv~e~~~~-~l~~~~~~~-----~~~~~~~~~~~~~~~i~~   76 (163)
                      .+++.+|++++++++|+||+++++++......      ++++|++.+ +|.+++...     ...+++..+..++.|++.
T Consensus        69 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~  148 (323)
T 3qup_A           69 IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC  148 (323)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHH
Confidence            46688999999999999999999999876654      999999986 898888542     225899999999999999


Q ss_pred             HHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          77 ALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        77 ~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      ++.|||++|++|+||||+||+++.++.++|+|||.+.......  .......+++.|+|||.+.+.. ++.++||||+|+
T Consensus       149 al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  227 (323)
T 3qup_A          149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGV  227 (323)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHH
T ss_pred             HHHHHHcCCcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHH
Confidence            9999999999999999999999999999999999987654322  1122334577899999987654 799999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       228 il~ell~  234 (323)
T 3qup_A          228 TMWEIMT  234 (323)
T ss_dssp             HHHHHHT
T ss_pred             HHHHHHh
Confidence            9999987

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.2e-34  Score=204.11  Aligned_cols=154  Identities=28%  Similarity=0.447  Sum_probs=122.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhc-------CCCCCCHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT-------TPVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ...++.+|++++++++||||+++++++..++..++|||++++ +|.+++..       ..+.+++..+..++.|++.++.
T Consensus        56 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  135 (303)
T 2vwi_A           56 SMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE  135 (303)
T ss_dssp             ----------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999999999999999999975 88888864       3456899999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC-----CcccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      +||++|++|+||+|+||+++.++.++|+|||.+.......     .......|++.|+|||.+.+...++.++|+||+|+
T Consensus       136 ~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  215 (303)
T 2vwi_A          136 YLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGI  215 (303)
T ss_dssp             HHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHH
T ss_pred             HHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHH
Confidence            9999999999999999999999999999999886554221     11234567899999999875444799999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       216 il~~l~~  222 (303)
T 2vwi_A          216 TAIELAT  222 (303)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999986

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.6e-34  Score=200.05  Aligned_cols=151  Identities=23%  Similarity=0.432  Sum_probs=128.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++.++ ..++|||++++ +|.+++......+++..+..++.|++.++.+||++|++
T Consensus        57 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  135 (281)
T 3cc6_A           57 KEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCV  135 (281)
T ss_dssp             HHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            45688999999999999999999998765 46899999985 99999987777799999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+........ ......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       136 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt  209 (281)
T 3cc6_A          136 HRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILS  209 (281)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHh
Confidence            999999999999999999999999876543221 223345577899999987654 6999999999999999986

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.3e-34  Score=202.76  Aligned_cols=154  Identities=27%  Similarity=0.474  Sum_probs=127.3

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....++.+|+++++++ +|+||+++++++.+++.+++|||+++ ++|.+++.... .+++..+..++.|++.++.|||++
T Consensus        52 ~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~lH~~  130 (316)
T 2ac3_A           52 HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNK  130 (316)
T ss_dssp             CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            3456788999999996 79999999999999999999999998 59999887654 789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCc---eEEeecccccccccCC-------CcccccccCccccCcccccC----CcCCCcchhhH
Q psy7820          85 RIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPM-------NRYTHEVVTLWYRPPEILLG----AKVYSTTVDIW  150 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~---~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~  150 (163)
                      |++|+||+|+||+++.++.   ++|+|||++.......       .......|++.|+|||.+.+    ...++.++|||
T Consensus       131 ~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diw  210 (316)
T 2ac3_A          131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLW  210 (316)
T ss_dssp             TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHH
T ss_pred             CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccH
Confidence            9999999999999988776   9999999886543211       11234468999999999864    12368999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       211 slG~il~~l~~  221 (316)
T 2ac3_A          211 SLGVILYILLS  221 (316)
T ss_dssp             HHHHHHHHHHH
T ss_pred             hHHHHHHHHHH
Confidence            99999999996

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.7e-34  Score=208.54  Aligned_cols=148  Identities=41%  Similarity=0.717  Sum_probs=117.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+++++.++|+||+++++++...      ..+++++|+++++|.+.+..  ..+++..+..++.|++.|+.|||
T Consensus        72 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH  149 (367)
T 2fst_X           72 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIH  149 (367)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Confidence            35677999999999999999999998654      56899999998888887765  47899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|++|+||+|+||+++.++.+||+|||++.....   ......+++.|+|||.+.+...++.++||||+|+++|+|++
T Consensus       150 ~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  225 (367)
T 2fst_X          150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD---EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT  225 (367)
T ss_dssp             HTTCCCCCCCGGGEEECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHH
T ss_pred             HCCeeeCCCCHhhEEECCCCCEEEeeccccccccc---cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999876542   23456779999999998875568999999999999999996

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.1e-33  Score=207.45  Aligned_cols=151  Identities=34%  Similarity=0.518  Sum_probs=127.5

Q ss_pred             hhhHHHHHHHHhcCC--CCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|++++++++  |+||+++++++..++.+++|||+..++|.+++.... .+++..+..++.|++.++.|||++|+
T Consensus        98 ~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~i  176 (390)
T 2zmd_A           98 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGI  176 (390)
T ss_dssp             HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             HHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence            356789999999996  599999999999999999999976679999988765 78899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCC----------cCCCcchhhHHHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGA----------KVYSTTVDIWSAGC  154 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~----------~~~~~~~Di~slG~  154 (163)
                      +|+||||+||+++ ++.+||+|||++........  ......|++.|+|||++.+.          ..++.++||||+|+
T Consensus       177 vHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGv  255 (390)
T 2zmd_A          177 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC  255 (390)
T ss_dssp             CCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHH
T ss_pred             eecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHH
Confidence            9999999999995 68999999999876543221  23355789999999998641          24789999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       256 il~ell~  262 (390)
T 2zmd_A          256 ILYYMTY  262 (390)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHH
Confidence            9999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=1.6e-33  Score=201.51  Aligned_cols=150  Identities=27%  Similarity=0.466  Sum_probs=129.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.+|++++++++|+||+++++++.+.  ..+++|||++++ +|.+++...  .+++..++.++.|++.++.+||+.|
T Consensus        77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~  154 (318)
T 3lxp_A           77 RSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH  154 (318)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34578999999999999999999999874  589999999985 999988764  4889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+........   ......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       155 ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~  232 (318)
T 3lxp_A          155 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLT  232 (318)
T ss_dssp             EECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999876653322   123345677899999987655 6899999999999999997

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=9.8e-34  Score=203.77  Aligned_cols=151  Identities=28%  Similarity=0.516  Sum_probs=131.0

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC---------------CCCCHHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP---------------VPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~---------------~~~~~~~~~~~~~   72 (163)
                      .++.+|+++++++ +||||+++++++.+++..++|||++++ +|.+++....               ..+++..++.++.
T Consensus        85 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  164 (334)
T 2pvf_A           85 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY  164 (334)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHH
Confidence            4578999999999 899999999999999999999999985 9999987653               2488999999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhhH
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      |++.++.+||++|++|+||+|+||+++.++.++|+|||.+........  ......+++.|+|||.+.+.. ++.++|+|
T Consensus       165 qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~  243 (334)
T 2pvf_A          165 QLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVW  243 (334)
T ss_dssp             HHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHH
T ss_pred             HHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHH
Confidence            999999999999999999999999999999999999999876543221  122334577899999987654 69999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       244 slG~il~ellt  254 (334)
T 2pvf_A          244 SFGVLMWEIFT  254 (334)
T ss_dssp             HHHHHHHHHHT
T ss_pred             HHHHHHHHHHh
Confidence            99999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.2e-33  Score=201.40  Aligned_cols=151  Identities=34%  Similarity=0.688  Sum_probs=131.3

Q ss_pred             CCchhhHHHHHHHHhcCC-CCCeeeeeeeeee--CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELK-HPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      .....++.+|++++++++ |+||+++++++.+  ....++|||++.+ ++.+.+.    .+++..+..++.|++.++.||
T Consensus        71 ~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~l  146 (330)
T 3nsz_A           71 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYC  146 (330)
T ss_dssp             SCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHH
Confidence            445677899999999997 9999999999987  6689999999986 7777764    478999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEccCC-ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          82 HSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      |++|++|+||+|+||+++.++ .++|+|||.+...... .......++..|+|||.+.+...++.++||||+|+++|+|+
T Consensus       147 H~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  225 (330)
T 3nsz_A          147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI  225 (330)
T ss_dssp             HHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             HhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC-CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHH
Confidence            999999999999999999777 8999999998765432 33445577899999999877566899999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       226 ~  226 (330)
T 3nsz_A          226 F  226 (330)
T ss_dssp             H
T ss_pred             h
Confidence            6

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.6e-33  Score=200.15  Aligned_cols=149  Identities=32%  Similarity=0.498  Sum_probs=130.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++||||+++++++.+++..++|||++++ +|.+.+...+ .+++..+..++.|++.++.+||+.|++
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~  128 (304)
T 2jam_A           50 DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-VYTEKDASLVIQQVLSAVKYLHENGIV  128 (304)
T ss_dssp             --HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence            35678999999999999999999999999999999999975 9988886544 789999999999999999999999999


Q ss_pred             ecCCCCCcEEE---ccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILI---NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||++   +.++.++|+|||.+.....  .......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  202 (304)
T 2jam_A          129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQN--GIMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLC  202 (304)
T ss_dssp             CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC--BTTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCHHHEEEecCCCCCCEEEccCCcceecCC--CccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHH
Confidence            99999999999   7788999999998865432  2233456799999999987654 7999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-33  Score=197.38  Aligned_cols=149  Identities=32%  Similarity=0.547  Sum_probs=122.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR-   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-   85 (163)
                      ..+.+.+|+++++.++||||+++++++.+++..++|||++++ +|.+++..  ..+++..+..++.|++.++.+||++| 
T Consensus        49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~~  126 (271)
T 3dtc_A           49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNYLHDEAI  126 (271)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHSSS
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence            346788999999999999999999999999999999999975 88777753  47899999999999999999999999 


Q ss_pred             --ceecCCCCCcEEEcc--------CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820          86 --IIHRDLKPQNILINK--------SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus        86 --i~h~~i~~~ni~~~~--------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                        ++|+||+|+||+++.        ++.++|+|||.+......  ......|++.|+|||.+.+.. ++.++|+||+|++
T Consensus       127 ~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  203 (271)
T 3dtc_A          127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT--TKMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVL  203 (271)
T ss_dssp             SCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHH
T ss_pred             CceeecCCchHHEEEecccccccccCcceEEccCCcccccccc--cccCCCCccceeCHHHhccCC-CCchhhHHHHHHH
Confidence              889999999999986        678999999998765432  223456799999999987654 6999999999999


Q ss_pred             HHHHhc
Q psy7820         156 FSEMIQ  161 (163)
Q Consensus       156 l~~ll~  161 (163)
                      +|+|++
T Consensus       204 l~~l~~  209 (271)
T 3dtc_A          204 LWELLT  209 (271)
T ss_dssp             HHHHHH
T ss_pred             HHHHHh
Confidence            999996

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.8e-33  Score=197.87  Aligned_cols=155  Identities=21%  Similarity=0.243  Sum_probs=131.1

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeee-eeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHD-VIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~-~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .....++.+|+++++.++|++++..+. ++..+...+++||++.++|.+++......+++..+..++.|++.++.|||++
T Consensus        45 ~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~  124 (296)
T 4hgt_A           45 KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK  124 (296)
T ss_dssp             ---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            344567899999999998776655555 4577788999999997799999987777899999999999999999999999


Q ss_pred             CceecCCCCCcEEE---ccCCceEEeecccccccccCCC-------cccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          85 RIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMN-------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        85 ~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      |++|+||+|+||++   +.++.++|+|||.+........       ......|++.|+|||.+.+.. ++.++||||+|+
T Consensus       125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~  203 (296)
T 4hgt_A          125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGY  203 (296)
T ss_dssp             TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHH
T ss_pred             CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHH
Confidence            99999999999999   7889999999999876553322       233557899999999988755 799999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       204 il~~l~~  210 (296)
T 4hgt_A          204 VLMYFNL  210 (296)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHhc
Confidence            9999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.9e-33  Score=196.42  Aligned_cols=148  Identities=30%  Similarity=0.471  Sum_probs=128.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ...+.+|++++++++||||+++++++..    +..+++|||++++ +|.+++... ..+++..+..++.|++.++.|||+
T Consensus        69 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~  147 (290)
T 1t4h_A           69 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHT  147 (290)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHc
Confidence            3557899999999999999999999865    4578999999975 999888764 378899999999999999999999


Q ss_pred             CC--ceecCCCCCcEEEc-cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          84 RR--IIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        84 ~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      .+  ++|+||+|+||+++ .++.++|+|||.+.....  .......|++.|+|||.+.+.  ++.++|+||+|+++|+|+
T Consensus       148 ~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~  223 (290)
T 1t4h_A          148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--SFAKAVIGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMA  223 (290)
T ss_dssp             SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT--TSBEESCSSCCCCCGGGGGTC--CCTHHHHHHHHHHHHHHH
T ss_pred             CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc--cccccccCCcCcCCHHHHhcc--CCCcchHHHHHHHHHHHH
Confidence            99  99999999999997 789999999999865442  233455689999999998643  799999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       224 ~  224 (290)
T 1t4h_A          224 T  224 (290)
T ss_dssp             H
T ss_pred             h
Confidence            6

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-33  Score=201.21  Aligned_cols=154  Identities=27%  Similarity=0.452  Sum_probs=125.6

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeee------CcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPV------DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~------~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l   78 (163)
                      ...++.+|+++++++ +|+||+++++++..      .+..++|||++++ +|.+++.... ..+++..+..++.|++.++
T Consensus        63 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l  142 (326)
T 2x7f_A           63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL  142 (326)
T ss_dssp             TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence            456788999999999 79999999999976      4689999999986 9999987643 5789999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGC  154 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~  154 (163)
                      .+||+.|++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+..    ...++.++|+||||+
T Consensus       143 ~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~  222 (326)
T 2x7f_A          143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI  222 (326)
T ss_dssp             HHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHH
T ss_pred             HHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHH
Confidence            9999999999999999999999999999999998765543333445578999999999862    234789999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       223 il~~l~~  229 (326)
T 2x7f_A          223 TAIEMAE  229 (326)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.1e-33  Score=200.48  Aligned_cols=153  Identities=27%  Similarity=0.389  Sum_probs=127.0

Q ss_pred             chhhHHHHHHHHhc--CCCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKE--LKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         8 ~~~~~~~e~~~l~~--~~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ....+..|.+++..  ++||||+++++++.+    ....++||||+++ +|.+++..  ..+++..+..++.|++.++.|
T Consensus        43 ~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~  120 (301)
T 3q4u_A           43 DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASGLAH  120 (301)
T ss_dssp             GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHHHHH
T ss_pred             cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHHHHH
Confidence            44556678888777  689999999998644    3468999999985 99998854  478999999999999999999


Q ss_pred             HH--------hCCceecCCCCCcEEEccCCceEEeecccccccccCCCc----ccccccCccccCcccccCCc-----CC
Q psy7820          81 CH--------SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR----YTHEVVTLWYRPPEILLGAK-----VY  143 (163)
Q Consensus        81 lh--------~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~-----~~  143 (163)
                      ||        +.+++|+||||+||+++.++.+||+|||.+.........    .....|++.|+|||.+.+..     .+
T Consensus       121 lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  200 (301)
T 3q4u_A          121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDS  200 (301)
T ss_dssp             HHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHH
T ss_pred             HHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccC
Confidence            99        999999999999999999999999999998765433222    22347899999999987642     23


Q ss_pred             CcchhhHHHHHHHHHHhcC
Q psy7820         144 STTVDIWSAGCIFSEMIQI  162 (163)
Q Consensus       144 ~~~~Di~slG~~l~~ll~~  162 (163)
                      +.++||||+|+++|+|+|.
T Consensus       201 ~~~~DvwslG~il~el~tg  219 (301)
T 3q4u_A          201 YKRVDIWAFGLVLWEVARR  219 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHTT
T ss_pred             CchhhHHHHHHHHHHHHhh
Confidence            4799999999999999963

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.9e-33  Score=198.08  Aligned_cols=151  Identities=32%  Similarity=0.605  Sum_probs=132.3

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+.+.+|+++++++. ||||+++++++.+++..++|||++++ +|.+++... ..+++..+..++.|++.++.+||+.|+
T Consensus        67 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i  145 (298)
T 1phk_A           67 REATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNI  145 (298)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            456789999999995 99999999999999999999999985 999988764 478999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc-----CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL-----GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-----~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+.     ....++.++|+||+|+++|+|++
T Consensus       146 ~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~  224 (298)
T 1phk_A          146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA  224 (298)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCcceEEEcCCCcEEEecccchhhcCCC-cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHH
Confidence            99999999999999999999999988765432 3344567899999999975     23346899999999999999986

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.8e-33  Score=197.26  Aligned_cols=155  Identities=21%  Similarity=0.243  Sum_probs=131.9

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeee-eeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHD-VIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~-~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+++.+|+++++.++|++++..+. +...++..++|||+++++|.+++......+++..++.++.|++.++.|||++
T Consensus        45 ~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  124 (296)
T 3uzp_A           45 KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK  124 (296)
T ss_dssp             CSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            344567899999999998877555444 4567778999999997799999987777899999999999999999999999


Q ss_pred             CceecCCCCCcEEE---ccCCceEEeecccccccccCCC-------cccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          85 RIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMN-------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        85 ~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      |++|+||+|+||++   +.++.++|+|||.+........       ......|++.|+|||.+.+.. ++.++||||+|+
T Consensus       125 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~  203 (296)
T 3uzp_A          125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGY  203 (296)
T ss_dssp             TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHH
T ss_pred             CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHH
Confidence            99999999999999   5889999999999876654322       234557899999999988755 799999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       204 il~~l~~  210 (296)
T 3uzp_A          204 VLMYFNL  210 (296)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-33  Score=199.20  Aligned_cols=148  Identities=25%  Similarity=0.414  Sum_probs=117.7

Q ss_pred             HHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-Ccee
Q psy7820          13 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCHSR-RIIH   88 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h   88 (163)
                      ..+...++.++||||+++++++.+++..++|||++++++.+++..   ....+++..++.++.|++.++.+||++ |++|
T Consensus        54 ~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H  133 (290)
T 3fme_A           54 MDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIH  133 (290)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCC
T ss_pred             HHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence            345555778899999999999999999999999999988777643   556899999999999999999999998 9999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc---CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||.+...... .......|++.|+|||.+.   ....++.++|+||+|+++|+|++
T Consensus       134 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~  208 (290)
T 3fme_A          134 RDVKPSNVLINALGQVKMCDFGISGYLVDD-VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI  208 (290)
T ss_dssp             CCCSGGGCEECTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEECCCCCEEEeecCCccccccc-ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH
Confidence            999999999999999999999998765433 2233346799999999972   33447899999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-33  Score=205.93  Aligned_cols=147  Identities=42%  Similarity=0.746  Sum_probs=126.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEE------EEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKL------FLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~------~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+.+++.++|+||+++++++...+..      ++|||++.+++.+.+..   .+++..+..++.|++.++.|||
T Consensus        85 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~LH  161 (371)
T 4exu_A           85 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGM---EFSEEKIQYLVYQMLKGLKYIH  161 (371)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTTS---CCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhhc---CCCHHHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999876654      99999999998887743   5899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||+|+||+++.++.++|+|||.+.....   ......+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       162 ~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  237 (371)
T 4exu_A          162 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT  237 (371)
T ss_dssp             HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH
T ss_pred             HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc---CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999876543   23445679999999998875557999999999999999996

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-33  Score=202.61  Aligned_cols=152  Identities=29%  Similarity=0.509  Sum_probs=131.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc--EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..++.+|++++++++|+||+++++++...+  .+++|||++++ +|.+++......+++..++.++.|++.++.+||+.|
T Consensus        86 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~  165 (326)
T 2w1i_A           86 LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR  165 (326)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            356889999999999999999999986644  78999999985 999999887778999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+.........   .....++..|+|||.+.+.. ++.++|+||||+++|+|+|
T Consensus       166 ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t  243 (326)
T 2w1i_A          166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFT  243 (326)
T ss_dssp             EECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHH
T ss_pred             EeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999998766533221   12234567799999987654 6899999999999999997

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=7.7e-34  Score=206.10  Aligned_cols=149  Identities=31%  Similarity=0.513  Sum_probs=130.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-Cc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i   86 (163)
                      ...+.+|++++++++|+||+++++++.+++..++||||+++ +|.+++...+ .+++..+..++.+++.++.|||+. |+
T Consensus        75 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lh~~~~i  153 (360)
T 3eqc_A           75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKHKI  153 (360)
T ss_dssp             HHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence            35678999999999999999999999999999999999986 9998887654 788999999999999999999986 99


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.++|+|||.+......  ......|++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       154 ~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  225 (360)
T 3eqc_A          154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAV  225 (360)
T ss_dssp             CCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHHHHHHHH
T ss_pred             EcCCccHHHEEECCCCCEEEEECCCCcccccc--cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999988654322  223457799999999987754 7999999999999999996

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3e-33  Score=200.30  Aligned_cols=151  Identities=52%  Similarity=0.948  Sum_probs=130.7

Q ss_pred             hhhHHHHHHHHhcC---CCCCeeeeeeeee-----eCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL---KHPNVIRLHDVIP-----VDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~---~h~~i~~~~~~~~-----~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ...+.+|+++++.+   +||||+++++++.     .....++|||+++++|.+++.... ..+++..+..++.|++.++.
T Consensus        55 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~  134 (326)
T 1blx_A           55 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLD  134 (326)
T ss_dssp             BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHH
T ss_pred             CchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHH
Confidence            45677888888777   8999999999987     556899999999999999987654 45899999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      +||+.|++|+||+|+||+++.++.++|+|||.+...... .......+++.|+|||.+.+.. ++.++|+||+|+++|+|
T Consensus       135 ~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l  212 (326)
T 1blx_A          135 FLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-MALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEM  212 (326)
T ss_dssp             HHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-GGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHH
T ss_pred             HHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCC-CCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHH
Confidence            999999999999999999999999999999998765422 2334556799999999987654 79999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       213 ~~  214 (326)
T 1blx_A          213 FR  214 (326)
T ss_dssp             HH
T ss_pred             Hc
Confidence            86

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.4e-34  Score=209.48  Aligned_cols=154  Identities=27%  Similarity=0.430  Sum_probs=130.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCc--EEEEEecchhc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDF--KLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~--~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ...+.+.+|++++++++|+||+++++++.+..  ..++||||+++ +|.+++....  ..+++..++.++.|++.++.||
T Consensus        49 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~L  128 (396)
T 4eut_A           49 RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL  128 (396)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            34566789999999999999999999988755  78999999975 9999887643  2389999999999999999999


Q ss_pred             HhCCceecCCCCCcEEE----ccCCceEEeecccccccccCCCcccccccCccccCcccccCC-------cCCCcchhhH
Q psy7820          82 HSRRIIHRDLKPQNILI----NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGA-------KVYSTTVDIW  150 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~----~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-------~~~~~~~Di~  150 (163)
                      |++|++|+||||+||++    +.++.+||+|||.+...... .......|++.|+|||.+.+.       ..++.++|+|
T Consensus       129 H~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diw  207 (396)
T 4eut_A          129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLW  207 (396)
T ss_dssp             HHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG-GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHH
T ss_pred             HHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC-CccccccCCccccCHHHhhccccccccccCCCcHHHHH
Confidence            99999999999999999    77778999999998765432 233456789999999997541       2368899999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       208 SlG~il~el~t  218 (396)
T 4eut_A          208 SIGVTFYHAAT  218 (396)
T ss_dssp             HHHHHHHHHHH
T ss_pred             HHHHHHHHHHH
Confidence            99999999996

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.2e-33  Score=198.75  Aligned_cols=151  Identities=38%  Similarity=0.787  Sum_probs=127.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeee--------------eCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIP--------------VDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQL   74 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~--------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i   74 (163)
                      ..++.+|++++++++|+||+++++++.              +....++|||+++++|.+.+..  +.+++..++.++.|+
T Consensus        52 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi  129 (320)
T 2i6l_A           52 VKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQL  129 (320)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHH
Confidence            456789999999999999999999873              4468899999999999998864  468899999999999


Q ss_pred             HHHHHHHHhCCceecCCCCCcEEEc-cCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhH
Q psy7820          75 LEALRYCHSRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        75 ~~~l~~lh~~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      +.++++||++|++|+||+|+||+++ .++.++|+|||.+.......   .......++..|+|||.+.+...++.++|+|
T Consensus       130 ~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  209 (320)
T 2i6l_A          130 LRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMW  209 (320)
T ss_dssp             HHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHH
T ss_pred             HHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhH
Confidence            9999999999999999999999997 46789999999987654221   1223445688899999987655579999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|+|++
T Consensus       210 slG~il~el~~  220 (320)
T 2i6l_A          210 AAGCIFAEMLT  220 (320)
T ss_dssp             HHHHHHHHHHH
T ss_pred             hHHHHHHHHHh
Confidence            99999999996

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1e-34  Score=212.05  Aligned_cols=150  Identities=17%  Similarity=0.300  Sum_probs=123.1

Q ss_pred             chhhHHHHHH---HHhcCCCCCeeeee-------eeeeeCc-----------------EEEEEecchhccHHHHHhcCCC
Q psy7820           8 VPSTALREIS---VLKELKHPNVIRLH-------DVIPVDF-----------------KLFLVFEFLRQDLKDFLQTTPV   60 (163)
Q Consensus         8 ~~~~~~~e~~---~l~~~~h~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~l~~~~~~~~~   60 (163)
                      ..+.+.+|++   ++++++||||++++       +++++.+                 ..|++||+++|+|.+++...+.
T Consensus       116 ~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~  195 (377)
T 3byv_A          116 AIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS  195 (377)
T ss_dssp             HHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccc
Confidence            4467889994   55555799999998       5555443                 2889999999999999875431


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCc
Q psy7820          61 ------PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPP  134 (163)
Q Consensus        61 ------~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~p  134 (163)
                            .+++..++.++.|++.|++|||++|++|+||||+||+++.++.+||+|||++....   .......| +.|+||
T Consensus       196 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~---~~~~~~~g-~~y~aP  271 (377)
T 3byv_A          196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG---ARVVSSVS-RGFEPP  271 (377)
T ss_dssp             TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETT---CEEECCCC-TTCCCH
T ss_pred             cccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecC---CcccCCCC-cCccCh
Confidence                  22347888899999999999999999999999999999999999999999987533   23445567 999999


Q ss_pred             ccccCC----------cCCCcchhhHHHHHHHHHHhc
Q psy7820         135 EILLGA----------KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       135 e~~~~~----------~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |.+.+.          ..++.++||||||+++|+|++
T Consensus       272 E~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~ellt  308 (377)
T 3byv_A          272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC  308 (377)
T ss_dssp             HHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHH
T ss_pred             hhhcccccccccccccccCChhhhHHHHHHHHHHHHH
Confidence            998765          247999999999999999996

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.3e-33  Score=198.41  Aligned_cols=154  Identities=31%  Similarity=0.570  Sum_probs=129.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeee--eeCcEEEEEecchhccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFLRQDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+.+|++++++++|+||+++++++  .++...++|||++++++.+.+... ...+++..+..++.|++.++.+||++
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~  128 (305)
T 2wtk_C           49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ  128 (305)
T ss_dssp             HHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC
Confidence            446788999999999999999999998  455689999999998887777653 45789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCCc-CCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~-~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||.+......  ........|++.|+|||.+.+.. ..+.++|+||+|+++|+|++
T Consensus       129 ~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~  208 (305)
T 2wtk_C          129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT  208 (305)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH
T ss_pred             CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999999998765422  12233456799999999987533 24779999999999999996

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.8e-34  Score=212.58  Aligned_cols=152  Identities=28%  Similarity=0.497  Sum_probs=129.6

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+++.+|++++++++||||+++++++. .+..++|||++.+ +|.+++.... ..++...+..++.|++.++.|||+++
T Consensus       226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~  304 (454)
T 1qcf_A          226 SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN  304 (454)
T ss_dssp             CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            3567899999999999999999999986 5678999999975 9999987543 36788999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.+||+|||++....... .......++..|+|||.+.... ++.++||||+|+++|||+|
T Consensus       305 ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t  380 (454)
T 1qcf_A          305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVT  380 (454)
T ss_dssp             CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHh
Confidence            9999999999999999999999999987654211 1122334467899999987654 7999999999999999997

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=9.1e-34  Score=209.67  Aligned_cols=149  Identities=32%  Similarity=0.550  Sum_probs=120.6

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|++++++++||||+++++++.. +..++|||++++ +|.+.+... ..+++..+..++.|++.++.|||++|++|
T Consensus       185 ~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH  262 (419)
T 3i6u_A          185 LNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIH  262 (419)
T ss_dssp             CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence            357899999999999999999999865 457899999985 887777654 47899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCC---ceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSG---ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~---~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.++   .+||+|||.+...... .......|++.|+|||.+.+  ...++.++|+||+|+++|+|++
T Consensus       263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt  339 (419)
T 3i6u_A          263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS  339 (419)
T ss_dssp             SCCCGGGEEESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCChHhEEEecCCCcceEEEeecccceecCCC-ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH
Confidence            99999999997554   5999999998765532 33445678999999999853  3346889999999999999996

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.9e-34  Score=200.91  Aligned_cols=152  Identities=33%  Similarity=0.586  Sum_probs=129.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeee--eCcEEEEEecchhc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIP--VDFKLFLVFEFLRQ-DLKDFLQTT---PVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~--~~~~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .+.+.+|++++++++|+||+++++++.  .++..++||||+++ +|.+++...   ...+++..++.++.|++.++++||
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH  128 (279)
T 2w5a_A           49 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH  128 (279)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHh
Confidence            356789999999999999999999874  46689999999985 999888653   345899999999999999999999


Q ss_pred             hCC-----ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          83 SRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        83 ~~~-----i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      +.+     ++|+||+|+||+++.++.++|+|||.+..............|++.|+|||.+.+.. ++.++|+||+|+++|
T Consensus       129 ~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  207 (279)
T 2w5a_A          129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLY  207 (279)
T ss_dssp             HHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHH
T ss_pred             cccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHH
Confidence            999     99999999999999999999999999876554333334457799999999987654 699999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      +|++
T Consensus       208 ~l~~  211 (279)
T 2w5a_A          208 ELCA  211 (279)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.3e-33  Score=217.99  Aligned_cols=150  Identities=26%  Similarity=0.424  Sum_probs=126.6

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++|+||+++++++.. +..++||||+++ +|.+++... ..+++..++.++.|++.++.|||++|++
T Consensus       414 ~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ii  491 (635)
T 4fl3_A          414 KDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFV  491 (635)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence            4678999999999999999999999975 458899999985 899988764 4789999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.+||+|||++.......   .......+++.|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       492 HrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt  567 (635)
T 4fl3_A          492 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFS  567 (635)
T ss_dssp             CSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999987654322   1122334567899999997654 7999999999999999996

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.3e-33  Score=198.30  Aligned_cols=150  Identities=27%  Similarity=0.426  Sum_probs=128.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++ ..+..++|||++++ +|.+++.... .+++..++.++.|++.++.+||+.|++
T Consensus        62 ~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~i~  139 (291)
T 1xbb_A           62 KDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV  139 (291)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCc-CCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence            45688999999999999999999999 55678999999985 8998887654 689999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+.........   .....+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       140 H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  215 (291)
T 1xbb_A          140 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFS  215 (291)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             cCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHh
Confidence            9999999999999999999999998765433221   12233467899999987654 6899999999999999997

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=8.7e-34  Score=204.77  Aligned_cols=150  Identities=27%  Similarity=0.524  Sum_probs=132.8

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHH------HhcC-CCCCCHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDF------LQTT-PVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~------~~~~-~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      +.+.+|++++++++|+||+++++++.+++..++|||++++ +|.++      +... ...+++..++.++.|++.++.+|
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  167 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI  167 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence            7889999999999999999999999999999999999986 88877      4432 46789999999999999999999


Q ss_pred             Hh-CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCc-chhhHHHHHHHHHH
Q psy7820          82 HS-RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST-TVDIWSAGCIFSEM  159 (163)
Q Consensus        82 h~-~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~~Di~slG~~l~~l  159 (163)
                      |+ .|++|+||+|+||+++.++.++|+|||.+......  ......++..|+|||.+.+...++. ++|+||+|+++|+|
T Consensus       168 H~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l  245 (348)
T 2pml_X          168 HNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM  245 (348)
T ss_dssp             HHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred             hccCCEeecCCChHhEEEcCCCcEEEeccccccccccc--cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence            99 99999999999999999999999999998765432  3445677999999999987644555 99999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       246 ~~  247 (348)
T 2pml_X          246 FY  247 (348)
T ss_dssp             HH
T ss_pred             Hh
Confidence            86

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.5e-33  Score=199.09  Aligned_cols=151  Identities=25%  Similarity=0.429  Sum_probs=122.7

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCc-----EEEEEecchhc-cHHHHHhc-----CCCCCCHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQ-DLKDFLQT-----TPVPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~~~~~i~~~l   78 (163)
                      +++.+|++++++++||||+++++++.+.+     ..++|+|++++ +|.+++..     ....+++..++.++.|++.++
T Consensus        81 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL  160 (313)
T 3brb_A           81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM  160 (313)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHH
Confidence            55889999999999999999999987654     35999999985 99888843     345789999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      .|||++|++|+||+|+||+++.++.++|+|||.+.......  .......+++.|+|||.+.+.. ++.++|+||+|+++
T Consensus       161 ~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  239 (313)
T 3brb_A          161 EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTM  239 (313)
T ss_dssp             HHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHH
T ss_pred             HHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHH
Confidence            99999999999999999999999999999999987654322  1223345577899999987654 79999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|++
T Consensus       240 ~el~~  244 (313)
T 3brb_A          240 WEIAT  244 (313)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            99997

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.5e-34  Score=206.42  Aligned_cols=151  Identities=17%  Similarity=0.234  Sum_probs=130.1

Q ss_pred             hhHHHHHHHHhcCCCCCeee---------------eeeeeee-CcEEEEEecchhccHHHHHhcC-CCCCCHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIR---------------LHDVIPV-DFKLFLVFEFLRQDLKDFLQTT-PVPVPPALAKSYLY   72 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~   72 (163)
                      ..+.+|++++++++|+|+++               +++++.. ++..++|||++.++|.+++... ...+++..++.++.
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~  166 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVAC  166 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHH
Confidence            56889999999999998887               5666665 6789999999977999999875 35799999999999


Q ss_pred             HHHHHHHHHHhCCceecCCCCCcEEEccCC--ceEEeecccccccccCCC-------cccccccCccccCcccccCCcCC
Q psy7820          73 QLLEALRYCHSRRIIHRDLKPQNILINKSG--ALKLADFGLSRAFTIPMN-------RYTHEVVTLWYRPPEILLGAKVY  143 (163)
Q Consensus        73 ~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~  143 (163)
                      |++.|+.|||++|++|+||+|+||+++.++  .++|+|||.+........       ......|++.|+|||.+.+.. +
T Consensus       167 qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~  245 (352)
T 2jii_A          167 RLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-P  245 (352)
T ss_dssp             HHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-C
T ss_pred             HHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-C
Confidence            999999999999999999999999999998  899999999876543211       123347899999999987754 7


Q ss_pred             CcchhhHHHHHHHHHHhc
Q psy7820         144 STTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       144 ~~~~Di~slG~~l~~ll~  161 (163)
                      +.++|+||||+++|+|++
T Consensus       246 ~~~~Di~slG~il~el~~  263 (352)
T 2jii_A          246 SRRSDLQSLGYCMLKWLY  263 (352)
T ss_dssp             CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhHHHHHHHHHHHHh
Confidence            999999999999999996

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.2e-33  Score=201.52  Aligned_cols=153  Identities=35%  Similarity=0.675  Sum_probs=129.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-------EEEEEecchhccHHHHHh---cCCCCCCHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDF-------KLFLVFEFLRQDLKDFLQ---TTPVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-------~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~~i~~~   77 (163)
                      ...+..++++.++.++|+||+++++++...+       .+++||||+++++...+.   .....+++..+..++.|++.+
T Consensus        62 ~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~a  141 (360)
T 3e3p_A           62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS  141 (360)
T ss_dssp             CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence            3456778888899999999999999986533       389999999998776554   355678999999999999999


Q ss_pred             HHHHH--hCCceecCCCCCcEEEcc-CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          78 LRYCH--SRRIIHRDLKPQNILINK-SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        78 l~~lh--~~~i~h~~i~~~ni~~~~-~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      +.+||  +.|++|+||+|+||+++. ++.++|+|||.+...... .......|++.|+|||.+.+...++.++||||+|+
T Consensus       142 l~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~  220 (360)
T 3e3p_A          142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGC  220 (360)
T ss_dssp             HHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT-SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC-CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHH
Confidence            99999  999999999999999997 899999999998765532 23345567999999999876666799999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       221 il~ell~  227 (360)
T 3e3p_A          221 IFAEMML  227 (360)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999996

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=2.8e-33  Score=200.45  Aligned_cols=149  Identities=33%  Similarity=0.570  Sum_probs=127.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|++++++++|+||+++++++..+. .++|||++++ +|.+.+... ..+++..+..++.|++.++.|||++|++|
T Consensus        60 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH  137 (322)
T 2ycf_A           60 LNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIH  137 (322)
T ss_dssp             -CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence            45789999999999999999999997765 8999999975 888887654 47899999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCc---eEEeecccccccccCCCcccccccCccccCccccc--CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL--GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.   ++|+|||.+...... .......|++.|+|||.+.  +...++.++|+||+|+++|+|++
T Consensus       138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~  214 (322)
T 2ycf_A          138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS  214 (322)
T ss_dssp             CCCSGGGEEESSSSSSCCEEECCCTTCEECCCC-HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHH
T ss_pred             cCCCHHHEEEecCCCCCeEEEccCccceecccc-cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHh
Confidence            999999999987664   999999998765422 2233456799999999974  23447899999999999999996

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.9e-33  Score=206.82  Aligned_cols=148  Identities=33%  Similarity=0.622  Sum_probs=130.5

Q ss_pred             hhHHHHHHHHhcC------CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKEL------KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        10 ~~~~~e~~~l~~~------~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..+.+|+++++.+      +|+||+++++.+.....+++|||+++++|.+++.... ..+++..+..++.|++.+++|||
T Consensus       138 ~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH  217 (429)
T 3kvw_A          138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH  217 (429)
T ss_dssp             HHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            4567788888887      4679999999999999999999999999999987654 45899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCc--eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          83 SRRIIHRDLKPQNILINKSGA--LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ++|++|+||||+||+++.++.  ++|+|||++.....   ......|++.|+|||++.+.. ++.++||||+||++|+|+
T Consensus       218 ~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell  293 (429)
T 3kvw_A          218 KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELL  293 (429)
T ss_dssp             HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHH
T ss_pred             HCCeecCCCCHHHeEEccCCCcceEEeecccceecCC---cccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHH
Confidence            999999999999999999987  99999999865442   233457899999999998755 799999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       294 t  294 (429)
T 3kvw_A          294 T  294 (429)
T ss_dssp             H
T ss_pred             h
Confidence            7

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.5e-33  Score=202.28  Aligned_cols=152  Identities=22%  Similarity=0.406  Sum_probs=129.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP------VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~------~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ..++.+|+.++++++||||+++++++.+++..++|||+++ ++|.+++....      ..+++..++.++.|++.++.+|
T Consensus        77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~L  156 (327)
T 2yfx_A           77 ELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL  156 (327)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999999999999999996 59999987654      4588999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEcc---CCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          82 HSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      |+.|++|+||+|+||+++.   +..++|+|||.+.......  .......+++.|+|||.+.+.. ++.++|+||||+++
T Consensus       157 H~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  235 (327)
T 2yfx_A          157 EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLL  235 (327)
T ss_dssp             HHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             hhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHH
Confidence            9999999999999999984   4469999999887544222  2223445688999999987654 79999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|+|
T Consensus       236 ~ellt  240 (327)
T 2yfx_A          236 WEIFS  240 (327)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            99996

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.6e-34  Score=211.32  Aligned_cols=152  Identities=26%  Similarity=0.457  Sum_probs=126.1

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+++.+|++++++++||||+++++++.+ +..++|||++++ +|.+++... +..+++..+..++.|++.|++|||++|
T Consensus       222 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  300 (452)
T 1fmk_A          222 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN  300 (452)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            34678999999999999999999999876 678999999985 999998753 346899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.+||+|||++....... .......++..|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       301 ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t  376 (452)
T 1fmk_A          301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTT  376 (452)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHh
Confidence            9999999999999999999999999987654221 1222334577899999987654 7999999999999999997

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-33  Score=199.01  Aligned_cols=150  Identities=31%  Similarity=0.487  Sum_probs=123.1

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPV--PVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      +....++.+|++++++++||||+++++++.+.  .++||||+++ +|.+++.....  .++...++.++.|++.++.|||
T Consensus        42 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH  119 (307)
T 2eva_A           42 ESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH  119 (307)
T ss_dssp             TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH
Confidence            34456788999999999999999999998743  7899999985 99999876542  4688999999999999999999


Q ss_pred             h---CCceecCCCCCcEEEccCCc-eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          83 S---RRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        83 ~---~~i~h~~i~~~ni~~~~~~~-~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      +   +|++|+||+|+||+++.++. +||+|||.+......   .....|++.|+|||.+.+.. ++.++||||+|+++|+
T Consensus       120 ~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~e  195 (307)
T 2eva_A          120 SMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEVFEGSN-YSEKCDVFSWGIILWE  195 (307)
T ss_dssp             TCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCC-CCTHHHHHHHHHHHHH
T ss_pred             hCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---cccCCCCCceEChhhhCCCC-CCcHHHHHHHHHHHHH
Confidence            9   89999999999999998887 799999998654422   23446799999999987654 7999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |++
T Consensus       196 l~~  198 (307)
T 2eva_A          196 VIT  198 (307)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            996

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.6e-33  Score=200.41  Aligned_cols=151  Identities=31%  Similarity=0.470  Sum_probs=128.4

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..++.+|+.+++.+ .|+||+++++++.+++..++||||+.+ +|.+++... ...+++..++.++.|++.++++||++|
T Consensus        72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g  151 (327)
T 3lm5_A           72 RAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN  151 (327)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45788999999999 469999999999999999999999986 888877543 357899999999999999999999999


Q ss_pred             ceecCCCCCcEEEcc---CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.   ++.++|+|||.+...... .......|++.|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus       152 ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~  228 (327)
T 3lm5_A          152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLT  228 (327)
T ss_dssp             EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             eecCcCChHHEEEecCCCCCcEEEeeCccccccCCc-cccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999987   789999999998765532 2334567899999999987654 7999999999999999996

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.4e-33  Score=199.01  Aligned_cols=151  Identities=30%  Similarity=0.442  Sum_probs=129.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++|+||+++++++.++. .++|+|+++ ++|.+.+......+++..+..++.|++.++.+||++|++
T Consensus        65 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~  143 (291)
T 1u46_A           65 MDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI  143 (291)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence            456789999999999999999999998765 889999998 499999887666799999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.++|+|||.+.........   .....++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       144 H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  219 (291)
T 1u46_A          144 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT  219 (291)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             cCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHh
Confidence            9999999999999999999999998765433221   22335577899999987654 6899999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.4e-33  Score=200.51  Aligned_cols=153  Identities=28%  Similarity=0.505  Sum_probs=116.7

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeee--------eeCcEEEEEecchhccHHHHHhc--CCCCCCHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVI--------PVDFKLFLVFEFLRQDLKDFLQT--TPVPVPPALAKSYLYQLLEA   77 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~--------~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~   77 (163)
                      ...+.+|+.+++++. |+||+++++++        .....++++||++.|+|.+++..  ..+.+++..++.++.|++.+
T Consensus        69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~  148 (337)
T 3ll6_A           69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA  148 (337)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHH
Confidence            356789999999995 99999999998        34456899999999999998864  44579999999999999999


Q ss_pred             HHHHHhCC--ceecCCCCCcEEEccCCceEEeecccccccccCCC------------cccccccCccccCccccc--CCc
Q psy7820          78 LRYCHSRR--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN------------RYTHEVVTLWYRPPEILL--GAK  141 (163)
Q Consensus        78 l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~------------~~~~~~~~~~~~~pe~~~--~~~  141 (163)
                      +.|||+.|  ++|+||+|+||+++.++.++|+|||.+........            ......+++.|+|||.+.  ...
T Consensus       149 l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (337)
T 3ll6_A          149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF  228 (337)
T ss_dssp             HHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTS
T ss_pred             HHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccC
Confidence            99999999  99999999999999999999999999876543221            112345788999999983  233


Q ss_pred             CCCcchhhHHHHHHHHHHhc
Q psy7820         142 VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       142 ~~~~~~Di~slG~~l~~ll~  161 (163)
                      .++.++||||||+++|+|++
T Consensus       229 ~~~~~~Dv~slG~il~el~~  248 (337)
T 3ll6_A          229 PIGEKQDIWALGCILYLLCF  248 (337)
T ss_dssp             CSSHHHHHHHHHHHHHHHHH
T ss_pred             CCChHHhHHHHHHHHHHHHh
Confidence            47899999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2e-33  Score=205.86  Aligned_cols=149  Identities=34%  Similarity=0.591  Sum_probs=130.0

Q ss_pred             hhhHHHHHHHHhcCC--------CCCeeeeeeeee----eCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELK--------HPNVIRLHDVIP----VDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLL   75 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~--------h~~i~~~~~~~~----~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~   75 (163)
                      .+.+.+|+++++.++        |+||+++++.+.    .+..+++|||++++++.+.+.... ..+++..++.++.|++
T Consensus        77 ~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~  156 (397)
T 1wak_A           77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVL  156 (397)
T ss_dssp             HHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHH
Confidence            456789999999995        778999999987    456899999999988888887654 5799999999999999


Q ss_pred             HHHHHHHhC-CceecCCCCCcEEEccCC-------------------------------------------------ceE
Q psy7820          76 EALRYCHSR-RIIHRDLKPQNILINKSG-------------------------------------------------ALK  105 (163)
Q Consensus        76 ~~l~~lh~~-~i~h~~i~~~ni~~~~~~-------------------------------------------------~~~  105 (163)
                      .|+.|||++ |++|+||||+||+++.++                                                 .++
T Consensus       157 ~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k  236 (397)
T 1wak_A          157 QGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK  236 (397)
T ss_dssp             HHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEE
T ss_pred             HHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceE
Confidence            999999998 999999999999998775                                                 799


Q ss_pred             EeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820         106 LADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       106 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+|||.+.....   ......|++.|+|||.+.+.. ++.++||||||+++|+|++
T Consensus       237 l~DfG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt  288 (397)
T 1wak_A          237 IADLGNACWVHK---HFTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELAT  288 (397)
T ss_dssp             ECCGGGCEETTB---CSCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHH
T ss_pred             eccccccccccc---cCccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhh
Confidence            999999876543   234557899999999998755 7999999999999999996

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=9.3e-34  Score=202.38  Aligned_cols=153  Identities=19%  Similarity=0.334  Sum_probs=128.9

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....+.+|+.++++++|+||+++++++.+.+..++++|++++ +|.+++...+..+++..+..++.|++.++.+||++|+
T Consensus        72 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i  151 (319)
T 2y4i_B           72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI  151 (319)
T ss_dssp             CCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            345678899999999999999999999999999999999985 9999988777789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccC-----CCcccccccCccccCcccccC--------CcCCCcchhhHHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIP-----MNRYTHEVVTLWYRPPEILLG--------AKVYSTTVDIWSAG  153 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-----~~~~~~~~~~~~~~~pe~~~~--------~~~~~~~~Di~slG  153 (163)
                      +|+||+|+||+++ ++.++|+|||.+......     ........|++.|+|||.+.+        ...++.++||||+|
T Consensus       152 ~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG  230 (319)
T 2y4i_B          152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG  230 (319)
T ss_dssp             CCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHH
T ss_pred             cccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHH
Confidence            9999999999998 789999999987654311     122334457889999999864        23468899999999


Q ss_pred             HHHHHHhc
Q psy7820         154 CIFSEMIQ  161 (163)
Q Consensus       154 ~~l~~ll~  161 (163)
                      +++|+|++
T Consensus       231 ~il~el~~  238 (319)
T 2y4i_B          231 TIWYELHA  238 (319)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHh
Confidence            99999986

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.2e-33  Score=208.40  Aligned_cols=153  Identities=33%  Similarity=0.497  Sum_probs=121.3

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCC------CHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPV------PPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~------~~~~~~~~~~~i~~~l~~l   81 (163)
                      .+.+.+|+++++++ +||||+++++++.+++.+++|||+++|+|.+++.......      ++..++.++.|++.|+.||
T Consensus        52 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  131 (434)
T 2rio_A           52 CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL  131 (434)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHH
Confidence            45678899999986 8999999999999999999999999999999987654211      2234567999999999999


Q ss_pred             HhCCceecCCCCCcEEEccC-------------CceEEeecccccccccCCC----cccccccCccccCcccccC-----
Q psy7820          82 HSRRIIHRDLKPQNILINKS-------------GALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLG-----  139 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~-------------~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~-----  139 (163)
                      |++|++|+||||+||+++.+             +.++|+|||++........    ......|++.|+|||.+.+     
T Consensus       132 H~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  211 (434)
T 2rio_A          132 HSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ  211 (434)
T ss_dssp             HHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTS
T ss_pred             HHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccc
Confidence            99999999999999999754             4799999999876653322    1234578999999999865     


Q ss_pred             -CcCCCcchhhHHHHHHHHHHhc
Q psy7820         140 -AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       140 -~~~~~~~~Di~slG~~l~~ll~  161 (163)
                       ...++.++||||+|+++|+|+|
T Consensus       212 ~~~~~~~~~DiwSlG~il~ellt  234 (434)
T 2rio_A          212 TKRRLTRSIDIFSMGCVFYYILS  234 (434)
T ss_dssp             CCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccCcchhhhhHhHHHHHHHHHh
Confidence             2347999999999999999997

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.5e-33  Score=196.83  Aligned_cols=152  Identities=26%  Similarity=0.495  Sum_probs=129.4

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+.+.+|++++++++|+||+++++++.. +..++|||++++ +|.+++.... ..+++..+..++.|++.++.+||++|
T Consensus        51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~  129 (279)
T 1qpc_A           51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN  129 (279)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678899999999999999999999875 458899999975 9999886543 26889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.++|+|||.+........ ......++..|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       130 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~  205 (279)
T 1qpc_A          130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVT  205 (279)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHh
Confidence            99999999999999999999999999876543321 122334577899999987644 6999999999999999997

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-33  Score=198.53  Aligned_cols=152  Identities=27%  Similarity=0.493  Sum_probs=122.6

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeee-CcEEEEEecchhc-cHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      +...+++.+|++++++++|+|++++++++.+ ++..++|||++++ +|.+++...+. .+++..+..++.|++.++.+||
T Consensus        55 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH  134 (278)
T 1byg_A           55 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE  134 (278)
T ss_dssp             CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHH
Confidence            3455678999999999999999999998654 4578999999986 99998875432 3788999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||+|+||+++.++.++|+|||.+......   .....+++.|+|||.+.+.. ++.++|+||+|+++|+|+|
T Consensus       135 ~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~---~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t  209 (278)
T 1byg_A          135 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST---QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYS  209 (278)
T ss_dssp             HTTCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             hCCccccCCCcceEEEeCCCcEEEeecccccccccc---ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHh
Confidence            999999999999999999999999999988754422   22335678899999987654 6999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.6e-32  Score=205.96  Aligned_cols=155  Identities=19%  Similarity=0.288  Sum_probs=134.6

Q ss_pred             CCchhhHHHHHHHHhcCCC-CCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      .....++.+|+++++.++| +++..+..++..++..++|||++.++|.+++......+++..++.++.||+.+|.|||++
T Consensus        43 ~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~  122 (483)
T 3sv0_A           43 KTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK  122 (483)
T ss_dssp             TCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            3445678999999999976 667777777788889999999998799999987777899999999999999999999999


Q ss_pred             CceecCCCCCcEEE---ccCCceEEeecccccccccCCC-------cccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          85 RIIHRDLKPQNILI---NKSGALKLADFGLSRAFTIPMN-------RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        85 ~i~h~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~-------~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      |++|+||||+||++   +.++.++|+|||++........       ......|+..|+|||.+.+.. ++.++||||||+
T Consensus       123 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGv  201 (483)
T 3sv0_A          123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGY  201 (483)
T ss_dssp             TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHH
T ss_pred             CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHH
Confidence            99999999999999   6889999999999976654322       223567899999999998755 699999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       202 il~ellt  208 (483)
T 3sv0_A          202 VLMYFLR  208 (483)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999996

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.4e-33  Score=199.91  Aligned_cols=151  Identities=26%  Similarity=0.490  Sum_probs=129.6

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeeeCc-EEEEEecchhc-cHHHHHhcCCCC---------------CCHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPVDF-KLFLVFEFLRQ-DLKDFLQTTPVP---------------VPPALAKSYL   71 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~-~~~lv~e~~~~-~l~~~~~~~~~~---------------~~~~~~~~~~   71 (163)
                      .++.+|+++++++ +||||+++++++...+ .+++|||++++ +|.+++......               +++..+..++
T Consensus        75 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (316)
T 2xir_A           75 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS  154 (316)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHH
T ss_pred             HHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHH
Confidence            4578999999999 6899999999987654 58999999985 999998765432               7899999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhh
Q psy7820          72 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        72 ~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      .|++.++.+||+.|++|+||+|+||+++.++.++|+|||.+........  ......+++.|+|||.+.+.. ++.++|+
T Consensus       155 ~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di  233 (316)
T 2xir_A          155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDV  233 (316)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHH
T ss_pred             HHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHH
Confidence            9999999999999999999999999999999999999999876543222  223445678899999987654 7999999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+|+++|+|+|
T Consensus       234 ~slG~il~~l~t  245 (316)
T 2xir_A          234 WSFGVLLWEIFS  245 (316)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHh
Confidence            999999999986

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-32  Score=197.30  Aligned_cols=151  Identities=28%  Similarity=0.435  Sum_probs=125.2

Q ss_pred             hhhHHHHHHHHhcC--CCCCeeeeeeeeeeC----cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL--KHPNVIRLHDVIPVD----FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~--~h~~i~~~~~~~~~~----~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ......|.+++...  +|+||+++++++...    ...++||||+++ +|.+++...  .+++..++.++.|++.++.||
T Consensus        73 ~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~l  150 (337)
T 3mdy_A           73 EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHL  150 (337)
T ss_dssp             HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHH
T ss_pred             cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHH
Confidence            34556677777766  899999999999877    789999999986 999998654  689999999999999999999


Q ss_pred             HhC--------CceecCCCCCcEEEccCCceEEeecccccccccCCCc----ccccccCccccCcccccCCcCCCc----
Q psy7820          82 HSR--------RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR----YTHEVVTLWYRPPEILLGAKVYST----  145 (163)
Q Consensus        82 h~~--------~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~----~~~~~~~~~~~~pe~~~~~~~~~~----  145 (163)
                      |++        |++|+||||+||+++.++.+||+|||.+.........    .....|++.|+|||.+.+.. ...    
T Consensus       151 H~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~  229 (337)
T 3mdy_A          151 HTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQS  229 (337)
T ss_dssp             HSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHH
T ss_pred             HHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccC
Confidence            998        9999999999999999999999999998665433222    12457899999999987644 244    


Q ss_pred             --chhhHHHHHHHHHHhcC
Q psy7820         146 --TVDIWSAGCIFSEMIQI  162 (163)
Q Consensus       146 --~~Di~slG~~l~~ll~~  162 (163)
                        ++||||+|+++|||+|.
T Consensus       230 ~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          230 YIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHTT
T ss_pred             ccccchHHHHHHHHHHHhc
Confidence              39999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.5e-33  Score=202.99  Aligned_cols=147  Identities=41%  Similarity=0.747  Sum_probs=125.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcE------EEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFK------LFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~------~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+.++++++|+||+++++++...+.      ++++||+++++|.+.+.   ..+++..+..++.|++.++.+||
T Consensus        67 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH  143 (353)
T 3coi_A           67 AKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYIH  143 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999987653      59999999998877654   35899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||+|+||+++.++.++|+|||.+.....   ......+++.|+|||.+.+...++.++|+||+|+++|+|++
T Consensus       144 ~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~  219 (353)
T 3coi_A          144 SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT  219 (353)
T ss_dssp             HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH
T ss_pred             HCCcccCCCCHHHEeECCCCcEEEeecccccCCCC---CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHh
Confidence            99999999999999999999999999999876442   23345679999999998775557999999999999999996

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.4e-33  Score=198.51  Aligned_cols=149  Identities=30%  Similarity=0.513  Sum_probs=130.1

Q ss_pred             hhhHHHHHHHHhcCCCC------CeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHP------NVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~------~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      .+.+.+|+++++.++|+      +++++++++.+++..++|||++++++.+++...+ ..+++..+..++.|++.++.||
T Consensus        55 ~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~l  134 (339)
T 1z57_A           55 CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL  134 (339)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH
Confidence            35678899999998654      4999999999999999999999889999987654 4688999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEcc-------------------CCceEEeecccccccccCCCcccccccCccccCcccccCCcC
Q psy7820          82 HSRRIIHRDLKPQNILINK-------------------SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  142 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~-------------------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  142 (163)
                      |++|++|+||+|+||+++.                   ++.++|+|||.+.....   ......|++.|+|||.+.+.. 
T Consensus       135 H~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-  210 (339)
T 1z57_A          135 HSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALG-  210 (339)
T ss_dssp             HHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSC-
T ss_pred             HHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCC-
Confidence            9999999999999999987                   66899999999876442   233457799999999997654 


Q ss_pred             CCcchhhHHHHHHHHHHhc
Q psy7820         143 YSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       143 ~~~~~Di~slG~~l~~ll~  161 (163)
                      ++.++|+||+|+++|+|++
T Consensus       211 ~~~~~Di~slG~il~el~~  229 (339)
T 1z57_A          211 WSQPCDVWSIGCILIEYYL  229 (339)
T ss_dssp             CCTHHHHHHHHHHHHHHHH
T ss_pred             CCcchhhHHHHHHHHHHHh
Confidence            7999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=5.3e-33  Score=194.10  Aligned_cols=148  Identities=16%  Similarity=0.258  Sum_probs=127.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..++.+|++++++++||||+++++++.+.  +..++|||++++ +|.+++..... .+++..++.++.|++.++.|||+.
T Consensus        51 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~  130 (271)
T 3kmu_A           51 SRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL  130 (271)
T ss_dssp             HHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS
T ss_pred             HHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC
Confidence            34688999999999999999999999877  788999999985 99999987653 589999999999999999999999


Q ss_pred             C--ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcC--CCcchhhHHHHHHHHHHh
Q psy7820          85 R--IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV--YSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        85 ~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~--~~~~~Di~slG~~l~~ll  160 (163)
                      +  ++|+||+|+||+++.++.+++.|++......     .....+++.|+|||.+.+...  ++.++|+||+|+++|+|+
T Consensus       131 ~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~  205 (271)
T 3kmu_A          131 EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELV  205 (271)
T ss_dssp             SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHH
T ss_pred             CCceecCCCccceEEEcCCcceeEEeccceeeec-----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHH
Confidence            9  9999999999999999999999888764422     223467899999999876432  234899999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       206 ~  206 (271)
T 3kmu_A          206 T  206 (271)
T ss_dssp             H
T ss_pred             h
Confidence            6

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.9e-33  Score=197.49  Aligned_cols=154  Identities=26%  Similarity=0.442  Sum_probs=129.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeee----eCcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIP----VDFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~----~~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ..+.+.+|++++++++|+||+++++++.    .....++|+|++.+ +|.+++..   .+..+++..++.++.|++.++.
T Consensus        69 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~  148 (317)
T 2buj_A           69 DREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE  148 (317)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            3456789999999999999999999986    33478999999986 99888865   4567999999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC---------cccccccCccccCcccccCCc--CCCcchh
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN---------RYTHEVVTLWYRPPEILLGAK--VYSTTVD  148 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---------~~~~~~~~~~~~~pe~~~~~~--~~~~~~D  148 (163)
                      +||++|++|+||+|+||+++.++.++|+|||.+........         ......|++.|+|||.+.+..  .++.++|
T Consensus       149 ~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~D  228 (317)
T 2buj_A          149 AIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTD  228 (317)
T ss_dssp             HHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHH
T ss_pred             HHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhh
Confidence            99999999999999999999999999999998765432111         112335688999999986432  2588999


Q ss_pred             hHHHHHHHHHHhc
Q psy7820         149 IWSAGCIFSEMIQ  161 (163)
Q Consensus       149 i~slG~~l~~ll~  161 (163)
                      |||+|+++|+|++
T Consensus       229 i~slG~il~el~~  241 (317)
T 2buj_A          229 VWSLGCVLYAMMF  241 (317)
T ss_dssp             HHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHh
Confidence            9999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.8e-33  Score=205.04  Aligned_cols=148  Identities=19%  Similarity=0.248  Sum_probs=110.3

Q ss_pred             hhHHHHH---HHHhcCCCCCeeeee-------eeeeeC-----------------cEEEEEecchhccHHHHHhcCCCCC
Q psy7820          10 STALREI---SVLKELKHPNVIRLH-------DVIPVD-----------------FKLFLVFEFLRQDLKDFLQTTPVPV   62 (163)
Q Consensus        10 ~~~~~e~---~~l~~~~h~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~l~~~~~~~~~~~   62 (163)
                      ..+.+|+   ++|+. +|||+++++       +++...                 ..+|+||||++++|.+++...+..+
T Consensus       107 ~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~  185 (371)
T 3q60_A          107 ERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVY  185 (371)
T ss_dssp             HHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhcccc
Confidence            4456774   45555 699988755       344322                 3489999999999999998654444


Q ss_pred             CHHHH------HHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccc
Q psy7820          63 PPALA------KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEI  136 (163)
Q Consensus        63 ~~~~~------~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~  136 (163)
                      ++..+      ..++.|++.|+.|||++|++|+||||+||+++.++.+||+|||++.....   ......+++.|+|||.
T Consensus       186 ~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~  262 (371)
T 3q60_A          186 VFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREF  262 (371)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHH
T ss_pred             chhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhh
Confidence            55555      67779999999999999999999999999999999999999999876542   2224556799999999


Q ss_pred             ccC-CcCCCcchhhHHHHHHHHHHhc
Q psy7820         137 LLG-AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       137 ~~~-~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.+ ...++.++||||+|+++|+|++
T Consensus       263 ~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          263 LNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             HTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             ccCCCCCcCccccHHHHHHHHHHHHh
Confidence            975 2347999999999999999996

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2e-33  Score=213.41  Aligned_cols=151  Identities=26%  Similarity=0.462  Sum_probs=129.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      .+++.+|++++++++|+||+++++++.+ +.+++||||+.+ +|.+++... +..+++..++.++.|++.+|.|||++++
T Consensus       306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i  384 (535)
T 2h8h_A          306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY  384 (535)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            4678999999999999999999999876 678999999985 999998753 3468899999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+|+||+++.++.+||+|||++....... .......++..|+|||.+.... ++.++||||||+++|||++
T Consensus       385 vHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t  459 (535)
T 2h8h_A          385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTT  459 (535)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTT
T ss_pred             eCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999987654211 1122334467899999987654 7999999999999999997

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.2e-33  Score=214.48  Aligned_cols=150  Identities=27%  Similarity=0.525  Sum_probs=128.1

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      +++.+|+.++++++||||+++++++.+ +..++||||++ |+|.+++...+..+++..++.++.|++.|+.|||++|++|
T Consensus       436 ~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  514 (656)
T 2j0j_A          436 EKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH  514 (656)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEec-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            568899999999999999999999854 56899999998 5999999877778999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC-cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN-RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.++.++|+|||++........ ......+++.|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       515 rDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt  587 (656)
T 2j0j_A          515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILM  587 (656)
T ss_dssp             SCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHHHHHHH
Confidence            99999999999999999999999876543221 122334577899999987654 7999999999999999985

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.9e-32  Score=193.25  Aligned_cols=151  Identities=33%  Similarity=0.609  Sum_probs=130.9

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .....+.+|++++++++|+||+++++++.+.+..++|+|++++ +|.+.+.... .+++..++.++.|++.++.+||++|
T Consensus        63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~  141 (287)
T 2wei_A           63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHN  141 (287)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456788999999999999999999999999999999999975 8888876544 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccC---CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKS---GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~---~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.+   +.++|+|||.+...... .......+++.|+|||.+.+.  ++.++|+||+|+++|+|++
T Consensus       142 i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~  217 (287)
T 2wei_A          142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLS  217 (287)
T ss_dssp             CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-SSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHH
T ss_pred             eeccCCChhhEEEecCCCcccEEEeccCcceeecCC-CccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHh
Confidence            9999999999999764   46999999988765432 233344678899999998753  6999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-32  Score=198.78  Aligned_cols=149  Identities=34%  Similarity=0.587  Sum_probs=130.3

Q ss_pred             hhhHHHHHHHHhcCCCCC------eeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPN------VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~------i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      .+.+.+|++++++++|++      ++.+++++...+..++|||++++++.+.+.... ..+++..++.++.|++.++.||
T Consensus        60 ~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~l  139 (355)
T 2eu9_A           60 REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL  139 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            456778999999997654      899999999999999999999988888887654 5789999999999999999999


Q ss_pred             HhCCceecCCCCCcEEE-------------------ccCCceEEeecccccccccCCCcccccccCccccCcccccCCcC
Q psy7820          82 HSRRIIHRDLKPQNILI-------------------NKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKV  142 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~-------------------~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  142 (163)
                      |++|++|+||+|+||++                   +.++.++|+|||.+.....   ......|++.|+|||.+.+.. 
T Consensus       140 H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~-  215 (355)
T 2eu9_A          140 HENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELG-  215 (355)
T ss_dssp             HTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCC-
T ss_pred             HHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCC-
Confidence            99999999999999999                   6678999999999876442   234557899999999997654 


Q ss_pred             CCcchhhHHHHHHHHHHhc
Q psy7820         143 YSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       143 ~~~~~Di~slG~~l~~ll~  161 (163)
                      ++.++|+||+|+++|+|++
T Consensus       216 ~~~~~Di~slG~il~el~~  234 (355)
T 2eu9_A          216 WAQPCDVWSIGCILFEYYR  234 (355)
T ss_dssp             CCTHHHHHHHHHHHHHHHH
T ss_pred             CCCccchHHHHHHHHHHHh
Confidence            7999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.9e-32  Score=196.28  Aligned_cols=152  Identities=28%  Similarity=0.384  Sum_probs=129.9

Q ss_pred             chhhHHHHHHHHhc--CCCCCeeeeeeeeeeCc----EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKE--LKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         8 ~~~~~~~e~~~l~~--~~h~~i~~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ...++.+|.++++.  ++|+||+++++++....    ..++|||++++ +|.+++...  .+++..++.++.|++.++.+
T Consensus        77 ~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~  154 (342)
T 1b6c_B           77 EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAH  154 (342)
T ss_dssp             GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHHHHH
Confidence            44567889999988  68999999999998775    89999999986 999998763  68899999999999999999


Q ss_pred             HH--------hCCceecCCCCCcEEEccCCceEEeecccccccccCCC----cccccccCccccCcccccCCcC-----C
Q psy7820          81 CH--------SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLGAKV-----Y  143 (163)
Q Consensus        81 lh--------~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~-----~  143 (163)
                      ||        +.+++|+||+|+||+++.++.++|+|||.+........    ......|++.|+|||.+.+...     +
T Consensus       155 lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  234 (342)
T 1b6c_B          155 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES  234 (342)
T ss_dssp             HHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHH
T ss_pred             HHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccccccccccc
Confidence            99        89999999999999999999999999999876654332    2244578999999999876421     2


Q ss_pred             CcchhhHHHHHHHHHHhc
Q psy7820         144 STTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       144 ~~~~Di~slG~~l~~ll~  161 (163)
                      +.++||||+|+++|+|+|
T Consensus       235 ~~~~Di~slG~il~el~t  252 (342)
T 1b6c_B          235 FKRADIYAMGLVFWEIAR  252 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHT
T ss_pred             CCcccHHHHHHHHHHHHh
Confidence            378999999999999996

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=9.8e-33  Score=198.42  Aligned_cols=151  Identities=27%  Similarity=0.406  Sum_probs=120.8

Q ss_pred             hhhHHHHHHHHh--cCCCCCeeeeeeeee-----eCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLK--ELKHPNVIRLHDVIP-----VDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         9 ~~~~~~e~~~l~--~~~h~~i~~~~~~~~-----~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ...+..|.+++.  .++|+||+++++.+.     ....+++||||+++ +|.+++....  .++..+..++.|++.++.|
T Consensus        49 ~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~i~~qi~~~L~~  126 (336)
T 3g2f_A           49 RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTRGLAY  126 (336)
T ss_dssp             HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC--BCHHHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc--cchhHHHHHHHHHHHHHHH
Confidence            344555655544  479999999997543     33468999999975 9999987653  4888899999999999999


Q ss_pred             HHhC---------CceecCCCCCcEEEccCCceEEeecccccccccC--------CCcccccccCccccCcccccCC---
Q psy7820          81 CHSR---------RIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--------MNRYTHEVVTLWYRPPEILLGA---  140 (163)
Q Consensus        81 lh~~---------~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--------~~~~~~~~~~~~~~~pe~~~~~---  140 (163)
                      ||+.         |++|+||||+||+++.++.+||+|||.+......        ........|++.|+|||.+.+.   
T Consensus       127 LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  206 (336)
T 3g2f_A          127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNL  206 (336)
T ss_dssp             HHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCG
T ss_pred             HHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccc
Confidence            9999         9999999999999999999999999998765422        1222344689999999998752   


Q ss_pred             ---cCCCcchhhHHHHHHHHHHhc
Q psy7820         141 ---KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       141 ---~~~~~~~Di~slG~~l~~ll~  161 (163)
                         ..++.++||||+|+++|||++
T Consensus       207 ~~~~~~~~~~DiwslG~il~ell~  230 (336)
T 3g2f_A          207 RDXESALKQVDMYALGLIYWEIFM  230 (336)
T ss_dssp             GGHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccchHHHHHHHHHHHh
Confidence               235678999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.98  E-value=3.9e-32  Score=194.76  Aligned_cols=150  Identities=24%  Similarity=0.436  Sum_probs=111.0

Q ss_pred             hHHHHHH-HHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q psy7820          11 TALREIS-VLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQT----TPVPVPPALAKSYLYQLLEALRYCHSR-   84 (163)
Q Consensus        11 ~~~~e~~-~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~----~~~~~~~~~~~~~~~~i~~~l~~lh~~-   84 (163)
                      ++..|.. +++.++|+||+++++++.+++..++|||++++++.+++..    ....+++..+..++.+++.++.+||+. 
T Consensus        66 ~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~  145 (327)
T 3aln_A           66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL  145 (327)
T ss_dssp             HHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC
Confidence            4555665 6777799999999999999999999999999988877653    345789999999999999999999998 


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc---CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL---GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~---~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++.++.++|+|||.+...... .......|++.|+|||.+.   ....++.++|+||+|+++|+|++
T Consensus       146 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~  224 (327)
T 3aln_A          146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELAT  224 (327)
T ss_dssp             SCCCSCCCGGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHH
T ss_pred             CEeECCCCHHHEEEcCCCCEEEccCCCceecccc-cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHH
Confidence            9999999999999999999999999998765432 2223346789999999983   22347899999999999999996

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.98  E-value=1.5e-32  Score=196.66  Aligned_cols=150  Identities=34%  Similarity=0.533  Sum_probs=131.2

Q ss_pred             hhhHHHHHHHHhcCC--CCCeeeeeeeeeeCcEEEEEecchh--ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           9 PSTALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLR--QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ..++.+|+.++++++  |+|++++++++..++..++++|++.  ++|.+++... +.+++..++.++.|++.+++|||+.
T Consensus        90 ~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~  168 (320)
T 3a99_A           90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNC  168 (320)
T ss_dssp             CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence            356778999999996  5999999999999999999999996  5899888764 3789999999999999999999999


Q ss_pred             CceecCCCCCcEEEc-cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||+|+||+++ .++.++|+|||.+......  ......|++.|+|||.+.+....+.++|+||||+++|+|++
T Consensus       169 ~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~  244 (320)
T 3a99_A          169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  244 (320)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS--CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc--cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHH
Confidence            999999999999999 7789999999998765532  23345689999999998765545788999999999999996

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.98  E-value=5.9e-32  Score=192.90  Aligned_cols=148  Identities=24%  Similarity=0.435  Sum_probs=117.7

Q ss_pred             HHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CceecCC
Q psy7820          13 LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-RIIHRDL   91 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~~i   91 (163)
                      ..+..+++.++|+||+++++++.+++..++|||++++.+..........+++..+..++.+++.++.+||++ |++|+||
T Consensus        72 ~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl  151 (318)
T 2dyl_A           72 MDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDV  151 (318)
T ss_dssp             HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_pred             HHHHHHHHhcCCCceeeEEEEEecCCcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCC
Confidence            345556788899999999999999999999999997666666665556899999999999999999999995 9999999


Q ss_pred             CCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC----CcCCCcchhhHHHHHHHHHHhc
Q psy7820          92 KPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG----AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        92 ~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~----~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||+++.++.++|+|||.+...... .......+++.|+|||.+..    ...++.++|+||+|+++|+|++
T Consensus       152 kp~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~  224 (318)
T 2dyl_A          152 KPSNILLDERGQIKLCDFGISGRLVDD-KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELAT  224 (318)
T ss_dssp             CGGGEEECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHH
T ss_pred             CHHHEEECCCCCEEEEECCCchhccCC-ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHh
Confidence            999999999999999999988665432 22334567999999999852    3347899999999999999996

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.98  E-value=7e-32  Score=192.42  Aligned_cols=151  Identities=34%  Similarity=0.522  Sum_probs=125.0

Q ss_pred             hhhHHHHHHHHhcCC--CCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           9 PSTALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..++.+|++++++++  |+||+++++++.+++..+++||+..++|.+++.... .+++..+..++.|++.++.+||++|+
T Consensus        70 ~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~i  148 (313)
T 3cek_A           70 LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGI  148 (313)
T ss_dssp             HHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECCCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            356789999999996  599999999999999999999977789999988754 78999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCC----------cCCCcchhhHHHHH
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGA----------KVYSTTVDIWSAGC  154 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~----------~~~~~~~Di~slG~  154 (163)
                      +|+||+|+||+++ ++.++|+|||.+........  ......|++.|+|||.+.+.          ..++.++|+||||+
T Consensus       149 vH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~  227 (313)
T 3cek_A          149 VHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC  227 (313)
T ss_dssp             CCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHH
T ss_pred             eecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHH
Confidence            9999999999996 58999999999876543221  12344679999999998641          34788999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       228 il~el~~  234 (313)
T 3cek_A          228 ILYYMTY  234 (313)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999986

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=3.6e-32  Score=211.56  Aligned_cols=142  Identities=27%  Similarity=0.442  Sum_probs=122.0

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcE-----EEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFK-----LFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-----~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..+.+|++++++++||||+++++++...+.     .|+||||++| +|.+.+..   .+++..++.++.|++.++.|||+
T Consensus       124 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~  200 (681)
T 2pzi_A          124 AMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHS  200 (681)
T ss_dssp             HHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999987654     7999999986 77766543   78999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||||+||+++.+ .+||+|||.+......    ....|++.|+|||++.+.  ++.++||||+|+++|+|++
T Consensus       201 ~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~----~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~  271 (681)
T 2pzi_A          201 IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF----GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTL  271 (681)
T ss_dssp             TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC----SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHS
T ss_pred             CCCeecccChHHeEEeCC-cEEEEecccchhcccC----CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHh
Confidence            999999999999999875 8999999998765432    445689999999998754  4899999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.97  E-value=1.4e-31  Score=195.78  Aligned_cols=148  Identities=36%  Similarity=0.597  Sum_probs=128.6

Q ss_pred             hhHHHHHHHHhcCC-CC-----CeeeeeeeeeeCcEEEEEecchhccHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELK-HP-----NVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h~-----~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .++..|+++++.++ |+     +++++++++...+..++|||+++++|.+.+.... ..+++..+..++.|++.++.|||
T Consensus        95 ~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH  174 (382)
T 2vx3_A           95 NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA  174 (382)
T ss_dssp             HHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhc
Confidence            45677888988885 55     4999999999999999999999999999987764 56899999999999999999999


Q ss_pred             --hCCceecCCCCCcEEEc--cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          83 --SRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        83 --~~~i~h~~i~~~ni~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                        +.|++|+||||+||+++  .++.+||+|||.+.....   ......|++.|+|||.+.+.. ++.++||||+|+++|+
T Consensus       175 ~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~e  250 (382)
T 2vx3_A          175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ---RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVE  250 (382)
T ss_dssp             STTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC---CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             cCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc---ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHH
Confidence              57999999999999995  477899999999876543   234567899999999998755 7999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |+|
T Consensus       251 llt  253 (382)
T 2vx3_A          251 MHT  253 (382)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            996

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.97  E-value=2.2e-32  Score=194.84  Aligned_cols=150  Identities=33%  Similarity=0.547  Sum_probs=124.9

Q ss_pred             hhhHHHHHHHHhcC----CCCCeeeeeeeeeeCcEEEEEecc-hh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL----KHPNVIRLHDVIPVDFKLFLVFEF-LR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~----~h~~i~~~~~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ...+.+|+++++++    +|+||+++++++.+.+..++|+|+ +. ++|.+++.... .+++..++.++.|++.++.+||
T Consensus        78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH  156 (312)
T 2iwi_A           78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG-PLGEGPSRCFFGQVVAAIQHCH  156 (312)
T ss_dssp             -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Confidence            34566799999998    899999999999999999999998 55 59999887644 7899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEc-cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +.|++|+||+|+||+++ .++.++|+|||.+......  ......|+..|+|||.+.+....+.++|+||+|+++|+|++
T Consensus       157 ~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~  234 (312)
T 2iwi_A          157 SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVC  234 (312)
T ss_dssp             HHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS--CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             HCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC--cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHH
Confidence            99999999999999999 7899999999998765532  33455679999999998765544568999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.97  E-value=7e-32  Score=196.34  Aligned_cols=149  Identities=34%  Similarity=0.562  Sum_probs=128.0

Q ss_pred             hhhHHHHHHHHhcCC-----------CCCeeeeeeeeeeCc----EEEEEecchhccHHHHHhcC-CCCCCHHHHHHHHH
Q psy7820           9 PSTALREISVLKELK-----------HPNVIRLHDVIPVDF----KLFLVFEFLRQDLKDFLQTT-PVPVPPALAKSYLY   72 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-----------h~~i~~~~~~~~~~~----~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~~~~~   72 (163)
                      ...+.+|++++++++           |+||+++++++...+    .++++||++.++|.+++... ...+++..+..++.
T Consensus        59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~  138 (373)
T 1q8y_A           59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK  138 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred             hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHH
Confidence            355778999999886           789999999987654    78999999988999998764 34689999999999


Q ss_pred             HHHHHHHHHHhC-CceecCCCCCcEEEcc------CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCc
Q psy7820          73 QLLEALRYCHSR-RIIHRDLKPQNILINK------SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  145 (163)
Q Consensus        73 ~i~~~l~~lh~~-~i~h~~i~~~ni~~~~------~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  145 (163)
                      |++.++.|||++ |++|+||+|+||+++.      .+.++|+|||.+.....   ......|++.|+|||.+.+.. ++.
T Consensus       139 qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~  214 (373)
T 1q8y_A          139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAP-WGC  214 (373)
T ss_dssp             HHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCC-CCT
T ss_pred             HHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC---CCCCCCCCccccCcHHHhCCC-CCc
Confidence            999999999998 9999999999999954      34799999999876543   233457799999999998755 799


Q ss_pred             chhhHHHHHHHHHHhc
Q psy7820         146 TVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       146 ~~Di~slG~~l~~ll~  161 (163)
                      ++||||+|+++|+|++
T Consensus       215 ~~Di~slG~il~el~~  230 (373)
T 1q8y_A          215 GADIWSTACLIFELIT  230 (373)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             hHhHHHHHHHHHHHHh
Confidence            9999999999999997

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.97  E-value=2.5e-31  Score=204.67  Aligned_cols=151  Identities=34%  Similarity=0.519  Sum_probs=130.5

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee------CcEEEEEecchhc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLRQ-DLKDFLQTTP--VPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~i~~~l~   79 (163)
                      .+++.+|++++++++||||+++++++..      ++..++||||++| +|.+++....  ..+++..++.++.+++.++.
T Consensus        56 ~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~  135 (676)
T 3qa8_A           56 RERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR  135 (676)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHH
Confidence            4557889999999999999999999765      6678999999975 9999987643  36888999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCc---eEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIF  156 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~---~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l  156 (163)
                      |||+.|++|+||+|+||+++.++.   ++|+|||.+...... .......|++.|+|||.+.+.. ++.++|+||+|+++
T Consensus       136 yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviL  213 (676)
T 3qa8_A          136 YLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLA  213 (676)
T ss_dssp             HHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSC-CCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHH
T ss_pred             HHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccc-cccccccCCcccCChHHhccCC-CCchhHHHHHHHHH
Confidence            999999999999999999997765   899999998765533 2334567899999999987654 79999999999999


Q ss_pred             HHHhc
Q psy7820         157 SEMIQ  161 (163)
Q Consensus       157 ~~ll~  161 (163)
                      |+|++
T Consensus       214 yeLlt  218 (676)
T 3qa8_A          214 FECIT  218 (676)
T ss_dssp             HHHHS
T ss_pred             HHHHH
Confidence            99997

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.97  E-value=4.1e-31  Score=190.39  Aligned_cols=144  Identities=27%  Similarity=0.439  Sum_probs=105.9

Q ss_pred             HHHHHhcCCCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          15 EISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        15 e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ....++.++|+|++++++++..    +..+++||||++| +|.+++.... ..+++..++.++.|++.++.|||++|++|
T Consensus        72 ~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH  151 (336)
T 3fhr_A           72 VDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAH  151 (336)
T ss_dssp             HHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            3344566799999999999876    4568999999986 9999997654 46899999999999999999999999999


Q ss_pred             cCCCCCcEEEcc---CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||+|+||+++.   ++.++|+|||.+.....  .......+++.|+|||.+.+.. ++.++|+||+|+++|+|++
T Consensus       152 ~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~  224 (336)
T 3fhr_A          152 RDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ--NALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLC  224 (336)
T ss_dssp             SCCSGGGEEESCSSTTCCEEECCCTTCEEC------------------------CH-HHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEEecCCCceEEEeccccceeccc--cccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHH
Confidence            999999999976   45599999999876542  2334556799999999986654 6899999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=5.3e-32  Score=194.86  Aligned_cols=137  Identities=30%  Similarity=0.277  Sum_probs=114.1

Q ss_pred             hhHHHHHHHHhcCC---------CCCeeeeeee-----------------eee-------------CcEEEEEecchhc-
Q psy7820          10 STALREISVLKELK---------HPNVIRLHDV-----------------IPV-------------DFKLFLVFEFLRQ-   49 (163)
Q Consensus        10 ~~~~~e~~~l~~~~---------h~~i~~~~~~-----------------~~~-------------~~~~~lv~e~~~~-   49 (163)
                      +.+.+|++++++++         |+|++++.+.                 +.+             ++.+|+||||+.+ 
T Consensus        68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g  147 (336)
T 2vuw_A           68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG  147 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred             HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence            67889999999886         5555555544                 443             6789999999975 


Q ss_pred             cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEccCC--------------------ceEEee
Q psy7820          50 DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH-SRRIIHRDLKPQNILINKSG--------------------ALKLAD  108 (163)
Q Consensus        50 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~~i~~~ni~~~~~~--------------------~~~l~d  108 (163)
                      ++++.+.+  ..+++..++.++.|++.|+.||| ++|++|+||||+||+++.++                    .+||+|
T Consensus       148 ~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D  225 (336)
T 2vuw_A          148 IDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID  225 (336)
T ss_dssp             EETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred             ccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence            56666644  46899999999999999999999 99999999999999999887                    899999


Q ss_pred             cccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820         109 FGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                      ||+++.....     ...|++.|+|||++.+..  +.++||||++.+
T Consensus       226 FG~a~~~~~~-----~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~  265 (336)
T 2vuw_A          226 YTLSRLERDG-----IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKK  265 (336)
T ss_dssp             CTTCBEEETT-----EEECCCCTTCSGGGCCCS--SHHHHHHHHHHH
T ss_pred             ccccEecCCC-----cEEEeecccChhhhcCCC--ccceehhhhhCC
Confidence            9999865532     347899999999998653  899999998777

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.96  E-value=7.3e-29  Score=175.12  Aligned_cols=121  Identities=21%  Similarity=0.245  Sum_probs=107.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++|+||+++++++.+++..|+||||++| +|.+++...   .....+..++.|++.+++|||++|++|
T Consensus        76 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~i~~ql~~aL~~lH~~givH  152 (286)
T 3uqc_A           76 QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRAGVAL  152 (286)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC---CChHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            6788999999999999999999999999999999999985 898888542   356678889999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.+|.++|++.+                    |++        +++.++||||||+++|+|+|
T Consensus       153 ~Dikp~NIll~~~g~~kl~~~~--------------------~~~--------~~~~~~Di~slG~il~ellt  197 (286)
T 3uqc_A          153 SIDHPSRVRVSIDGDVVLAYPA--------------------TMP--------DANPQDDIRGIGASLYALLV  197 (286)
T ss_dssp             CCCSGGGEEEETTSCEEECSCC--------------------CCT--------TCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCcccEEEcCCCCEEEEecc--------------------ccC--------CCCchhHHHHHHHHHHHHHH
Confidence            9999999999999999997432                    222        26899999999999999996

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.96  E-value=5.3e-29  Score=176.60  Aligned_cols=130  Identities=32%  Similarity=0.516  Sum_probs=113.4

Q ss_pred             hhhHHHHHHHH-hcCCCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVL-KELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l-~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ...+.+|++++ +..+|+||+++++++..    +..+++||||+++ +|.+++.... ..+++..+..++.|++.++.||
T Consensus        54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l  133 (299)
T 3m2w_A           54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL  133 (299)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            45678899998 55589999999999887    6789999999985 9999987754 4689999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEcc---CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          82 HSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      |++|++|+||+|+||+++.   ++.++|+|||.+....                      + ..++.++|+||+|+++|+
T Consensus       134 H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~-~~~~~~~DiwslG~il~e  190 (299)
T 3m2w_A          134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------------------G-EKYDKSCDMWSLGVIMYI  190 (299)
T ss_dssp             HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT----------------------T-CGGGGHHHHHHHHHHHHH
T ss_pred             HhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc----------------------c-ccCCchhhHHHHHHHHHH
Confidence            9999999999999999998   7889999999875422                      1 226889999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |++
T Consensus       191 l~t  193 (299)
T 3m2w_A          191 LLC  193 (299)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            996

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.96  E-value=1.4e-29  Score=186.89  Aligned_cols=149  Identities=17%  Similarity=0.231  Sum_probs=115.6

Q ss_pred             hhhHHHHHHHHhcCCC-CCee---------------------eeeeeeee-----CcEEEEEecchhccHHHHHh-----
Q psy7820           9 PSTALREISVLKELKH-PNVI---------------------RLHDVIPV-----DFKLFLVFEFLRQDLKDFLQ-----   56 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h-~~i~---------------------~~~~~~~~-----~~~~~lv~e~~~~~l~~~~~-----   56 (163)
                      .+.+.+|+.+++.++| .+..                     .+..++..     ...++++|+.+.++|.+++.     
T Consensus       122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~  201 (413)
T 3dzo_A          122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH  201 (413)
T ss_dssp             CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcc
Confidence            5668899999999976 2211                     11111111     22478889988888888883     


Q ss_pred             -cCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcc
Q psy7820          57 -TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPE  135 (163)
Q Consensus        57 -~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe  135 (163)
                       ..+..+++..++.++.|++.++.|||++|++|+||||+||+++.++.+||+|||++......   ....+| +.|+|||
T Consensus       202 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE  277 (413)
T 3dzo_A          202 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPE  277 (413)
T ss_dssp             TTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHH
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCch
Confidence             33446778889999999999999999999999999999999999999999999998765432   445567 9999999


Q ss_pred             ccc---------CCcCCCcchhhHHHHHHHHHHhc
Q psy7820         136 ILL---------GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       136 ~~~---------~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      .+.         ....++.++||||+|+++|+|+|
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          278 TTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             HHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             hhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            983         23346889999999999999996

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.4e-26  Score=175.85  Aligned_cols=139  Identities=19%  Similarity=0.207  Sum_probs=114.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      +++.+|++++++++|+||+++..++.+.+..|+||||++ ++|.+++..         +..++.|++++++|||++|++|
T Consensus       384 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiH  454 (540)
T 3en9_A          384 SRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIH  454 (540)
T ss_dssp             HHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCcc
Confidence            457899999999999999966666667777899999998 599988775         5678999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCc-------ccccccCccccCcccccCC-cCCCcchhhHHHHHHHHHH
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNR-------YTHEVVTLWYRPPEILLGA-KVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-------~~~~~~~~~~~~pe~~~~~-~~~~~~~Di~slG~~l~~l  159 (163)
                      +||||+||+++.  .+||+|||+++........       .....||+.|+|||++... ..|+...|+|+...-..+-
T Consensus       455 rDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~  531 (540)
T 3en9_A          455 NDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKD  531 (540)
T ss_dssp             TTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHH
T ss_pred             CCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHH
Confidence            999999999998  9999999999876532211       2356789999999998651 2267888999987665554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.78  E-value=1.2e-19  Score=127.69  Aligned_cols=93  Identities=22%  Similarity=0.293  Sum_probs=77.2

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ..++.+|++++++++  | +++.+++.. +..++||||++| +|.+ +..       .....++.|++.++.+||+.|++
T Consensus       148 ~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~gii  215 (282)
T 1zar_A          148 IRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIV  215 (282)
T ss_dssp             HHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCE
Confidence            346789999999999  5 677776644 456999999986 8776 321       12446899999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      |+||||+||+++ ++.++|+|||++..
T Consensus       216 HrDlkp~NILl~-~~~vkl~DFG~a~~  241 (282)
T 1zar_A          216 HGDLSQYNVLVS-EEGIWIIDFPQSVE  241 (282)
T ss_dssp             CSCCSTTSEEEE-TTEEEECCCTTCEE
T ss_pred             eCCCCHHHEEEE-CCcEEEEECCCCeE
Confidence            999999999999 99999999998864

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.65  E-value=1.5e-16  Score=110.50  Aligned_cols=96  Identities=18%  Similarity=0.261  Sum_probs=76.1

Q ss_pred             hHHHHHHHHhcCCCCCe--eeeeeeeeeCcEEEEEecchhc------cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          11 TALREISVLKELKHPNV--IRLHDVIPVDFKLFLVFEFLRQ------DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        11 ~~~~e~~~l~~~~h~~i--~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .+.+|+++++.+.|+++  +++++.    +..++||||+++      .|.+....    .++..+..++.|++.++.+||
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH  187 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLY  187 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHH
Confidence            57899999999987754  444432    346899999953      56665432    224456789999999999999


Q ss_pred             -hCCceecCCCCCcEEEccCCceEEeecccccccc
Q psy7820          83 -SRRIIHRDLKPQNILINKSGALKLADFGLSRAFT  116 (163)
Q Consensus        83 -~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~  116 (163)
                       +.|++|+|++|.||+++.  .++|+|||++....
T Consensus       188 ~~~givHrDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          188 QEAELVHADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             HTSCEECSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             HHCCEEeCCCCHHHEEEcC--cEEEEECcccccCC
Confidence             999999999999999988  89999999987654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.37  E-value=5.2e-13  Score=97.26  Aligned_cols=93  Identities=15%  Similarity=0.200  Sum_probs=65.7

Q ss_pred             HHHHHHHhcCCCCCe--eeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          13 LREISVLKELKHPNV--IRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i--~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .+|.+.|.++.+.++  ++.++.  .  ..++||||++| .+.....       ......++.|++.++.+||+.|++|+
T Consensus       161 ~kE~~nL~rL~~~gv~vp~p~~~--~--~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHr  229 (397)
T 4gyi_A          161 IKEFAFMKALYEEGFPVPEPIAQ--S--RHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHG  229 (397)
T ss_dssp             HHHHHHHHHHHHTTCSCCCEEEE--E--TTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             HHHHHHHHHHHhcCCCCCeeeec--c--CceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCC
Confidence            356777777754443  222222  1  23699999987 5433211       11235678999999999999999999


Q ss_pred             CCCCCcEEEccCC----------ceEEeecccccccc
Q psy7820          90 DLKPQNILINKSG----------ALKLADFGLSRAFT  116 (163)
Q Consensus        90 ~i~~~ni~~~~~~----------~~~l~d~~~~~~~~  116 (163)
                      |+||.||+++.++          .+.|+||+.+....
T Consensus       230 DLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          230 DFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            9999999998876          38999999775544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.25  E-value=2.6e-11  Score=84.01  Aligned_cols=101  Identities=18%  Similarity=0.111  Sum_probs=80.1

Q ss_pred             chhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--
Q psy7820           8 VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS--   83 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~--   83 (163)
                      ...++.+|+++++.+. +..+++++++..+.+..|+|||+++| ++.+.+..      ......++.++..++..||+  
T Consensus        52 ~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~  125 (263)
T 3tm0_A           52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED------EQSPEKIIELYAECIRLFHSID  125 (263)
T ss_dssp             STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCC
Confidence            3457899999999994 67788999999999999999999998 66654211      11223577889999999998  


Q ss_pred             ---------------------------------------------------------CCceecCCCCCcEEEccCCceEE
Q psy7820          84 ---------------------------------------------------------RRIIHRDLKPQNILINKSGALKL  106 (163)
Q Consensus        84 ---------------------------------------------------------~~i~h~~i~~~ni~~~~~~~~~l  106 (163)
                                                                               ..++|+|++|.||+++.++.+.+
T Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~l  205 (263)
T 3tm0_A          126 ISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGF  205 (263)
T ss_dssp             CTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEE
T ss_pred             cccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEE
Confidence                                                                     45899999999999987655679


Q ss_pred             eecccccc
Q psy7820         107 ADFGLSRA  114 (163)
Q Consensus       107 ~d~~~~~~  114 (163)
                      +||+.+..
T Consensus       206 IDwe~a~~  213 (263)
T 3tm0_A          206 IDLGRSGR  213 (263)
T ss_dssp             CCCTTCEE
T ss_pred             EEchhccc
Confidence            99987644

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.06  E-value=3e-10  Score=78.31  Aligned_cols=97  Identities=19%  Similarity=0.184  Sum_probs=73.4

Q ss_pred             hhHHHHHHHHhcCCCCC--eeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q psy7820          10 STALREISVLKELKHPN--VIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR-   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~--i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-   85 (163)
                      ..+.+|+++++.+.+.+  +++++++...++..++|||+++| ++ . ..    ..+.   ..++.+++..+..||+.. 
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l-~-~~----~~~~---~~~~~~l~~~l~~lh~~~~  128 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL-L-SS----HLAP---AEKVSIMADAMRRLHTLDP  128 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET-T-TS----CCCH---HHHHHHHHHHHHHHTTSCG
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCccc-C-cC----cCCH---hHHHHHHHHHHHHHhCCCC
Confidence            56789999999995434  67789988888889999999998 55 3 11    1222   245667777788888643 


Q ss_pred             ---------------------------------------------------------ceecCCCCCcEEEccCCceEEee
Q psy7820          86 ---------------------------------------------------------IIHRDLKPQNILINKSGALKLAD  108 (163)
Q Consensus        86 ---------------------------------------------------------i~h~~i~~~ni~~~~~~~~~l~d  108 (163)
                                                                               ++|+|++|.||+++.++.+.++|
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD  208 (264)
T 1nd4_A          129 ATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFID  208 (264)
T ss_dssp             GGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECC
T ss_pred             CCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEc
Confidence                                                                     89999999999998766667999


Q ss_pred             ccccccc
Q psy7820         109 FGLSRAF  115 (163)
Q Consensus       109 ~~~~~~~  115 (163)
                      |+.+...
T Consensus       209 ~~~a~~g  215 (264)
T 1nd4_A          209 CGRLGVA  215 (264)
T ss_dssp             CTTCEEE
T ss_pred             chhcccC
Confidence            9976543

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.01  E-value=7.5e-10  Score=80.11  Aligned_cols=103  Identities=20%  Similarity=0.305  Sum_probs=80.5

Q ss_pred             hhhHHHHHHHHhcCC--CCCeeeeeeeeeeC---cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELK--HPNVIRLHDVIPVD---FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~---~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+++++.+.  +..+++++.++.+.   +..|+|||+++| .+.+.   ....++......++.+++..+..||
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~---~~~~l~~~~~~~~~~~l~~~La~LH  156 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ---SLPGMSPAERTAIYDEMNRVIAAMH  156 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT---TCTTCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC---ccccCCHHHHHHHHHHHHHHHHHHh
Confidence            357889999999996  45688999988776   458999999998 33221   1124667778888999999999999


Q ss_pred             h----------------------------------------------------------CCceecCCCCCcEEEccCCc-
Q psy7820          83 S----------------------------------------------------------RRIIHRDLKPQNILINKSGA-  103 (163)
Q Consensus        83 ~----------------------------------------------------------~~i~h~~i~~~ni~~~~~~~-  103 (163)
                      +                                                          ..++|+|+++.||+++.++. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~  236 (359)
T 3dxp_A          157 TVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPR  236 (359)
T ss_dssp             HSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSC
T ss_pred             CCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCc
Confidence            6                                                          46899999999999987754 


Q ss_pred             -eEEeecccccc
Q psy7820         104 -LKLADFGLSRA  114 (163)
Q Consensus       104 -~~l~d~~~~~~  114 (163)
                       +.++||+.+..
T Consensus       237 v~~viDwe~a~~  248 (359)
T 3dxp_A          237 VLAVLDWELSTL  248 (359)
T ss_dssp             EEEECCCTTCEE
T ss_pred             EEEEECcccccc
Confidence             68999997754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.71  E-value=1.6e-08  Score=71.56  Aligned_cols=104  Identities=19%  Similarity=0.225  Sum_probs=72.4

Q ss_pred             hhhHHHHHHHHhcC-CCCC--eeeeeeeeeeCc---EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPN--VIRLHDVIPVDF---KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~--i~~~~~~~~~~~---~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ..++.+|+++++.+ .+..  +++++.....++   ..|+||++++| .+.....   ..++......++.+++..+..|
T Consensus        54 ~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~L  130 (304)
T 3sg8_A           54 STNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSEL  130 (304)
T ss_dssp             HHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHH
Confidence            35678999999888 3332  455655544333   34889999998 4443222   1455666667777777777777


Q ss_pred             Hh----------------------------------------------------------CCceecCCCCCcEEEcc--C
Q psy7820          82 HS----------------------------------------------------------RRIIHRDLKPQNILINK--S  101 (163)
Q Consensus        82 h~----------------------------------------------------------~~i~h~~i~~~ni~~~~--~  101 (163)
                      |+                                                          ..++|+|++|.|++++.  +
T Consensus       131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~  210 (304)
T 3sg8_A          131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKN  210 (304)
T ss_dssp             HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTT
T ss_pred             HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCC
Confidence            74                                                          24699999999999988  4


Q ss_pred             CceEEeeccccccc
Q psy7820         102 GALKLADFGLSRAF  115 (163)
Q Consensus       102 ~~~~l~d~~~~~~~  115 (163)
                      +.+.++||+.+...
T Consensus       211 ~~~~~iD~~~~~~~  224 (304)
T 3sg8_A          211 TICGIIDFGDAAIS  224 (304)
T ss_dssp             EEEEECCCTTCEEE
T ss_pred             CEEEEEeCCCCccC
Confidence            56789999977543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=9.3e-07  Score=61.23  Aligned_cols=101  Identities=17%  Similarity=0.181  Sum_probs=71.2

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR--   84 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~--   84 (163)
                      ..++..|.+.|+.+. +--+++++.++.+.+..|+|||+++| ++.+......     .....+..++...+..||+.  
T Consensus        63 ~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-----~~~~~~~~~l~~~L~~Lh~~~~  137 (272)
T 4gkh_A           63 ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-----DSGENIVDALAVFLRRLHSIPV  137 (272)
T ss_dssp             HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-----GGHHHHHHHHHHHHHHHHTSCG
T ss_pred             HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH-----HHHHHHHHHHHHHHHHhcCCCc
Confidence            345778999999884 44578999999999999999999988 5554433211     11123444555555555521  


Q ss_pred             --------------------------------------------------------CceecCCCCCcEEEccCCceEEee
Q psy7820          85 --------------------------------------------------------RIIHRDLKPQNILINKSGALKLAD  108 (163)
Q Consensus        85 --------------------------------------------------------~i~h~~i~~~ni~~~~~~~~~l~d  108 (163)
                                                                              .++|+|+.+.|++++.++.+-|+|
T Consensus       138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viD  217 (272)
T 4gkh_A          138 CNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCID  217 (272)
T ss_dssp             GGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECC
T ss_pred             ccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEE
Confidence                                                                    158999999999998877777999


Q ss_pred             cccccc
Q psy7820         109 FGLSRA  114 (163)
Q Consensus       109 ~~~~~~  114 (163)
                      |+.+..
T Consensus       218 we~a~~  223 (272)
T 4gkh_A          218 VGRVGI  223 (272)
T ss_dssp             CTTCEE
T ss_pred             Cccccc
Confidence            987654

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.43  E-value=2.2e-06  Score=60.74  Aligned_cols=104  Identities=22%  Similarity=0.216  Sum_probs=66.3

Q ss_pred             hhhHHHHHHHHhcCCCC---Ceeeeeeeee-eCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHP---NVIRLHDVIP-VDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~---~i~~~~~~~~-~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ...+.+|+++|+.+.+.   .+++.+.+.. ..+..+++||+++| .+......   .++......++.++...+..||+
T Consensus        53 ~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~La~LH~  129 (306)
T 3tdw_A           53 ADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEFMNELSA  129 (306)
T ss_dssp             HHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHHHHHHhc
Confidence            35678999999999642   3567766664 44567899999998 44432111   22333333333444444433332


Q ss_pred             ------------------------------------------------------------CCceecCCCCCcEEEcc---
Q psy7820          84 ------------------------------------------------------------RRIIHRDLKPQNILINK---  100 (163)
Q Consensus        84 ------------------------------------------------------------~~i~h~~i~~~ni~~~~---  100 (163)
                                                                                  ..++|+|++|.|++++.   
T Consensus       130 ~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~  209 (306)
T 3tdw_A          130 FPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSR  209 (306)
T ss_dssp             SCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCS
T ss_pred             CCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCC
Confidence                                                                        24689999999999987   


Q ss_pred             CCc-eEEeeccccccc
Q psy7820         101 SGA-LKLADFGLSRAF  115 (163)
Q Consensus       101 ~~~-~~l~d~~~~~~~  115 (163)
                      ++. +.++||+.+...
T Consensus       210 ~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          210 QTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             SCCEEEECCCTTCEEE
T ss_pred             CCceEEEEehhhcCCC
Confidence            355 479999876543

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.94  E-value=7.4e-06  Score=58.98  Aligned_cols=40  Identities=10%  Similarity=0.133  Sum_probs=31.0

Q ss_pred             hhHHHHHHHHhcCC-C--CCeeeeeeeeeeC---cEEEEEecchhc
Q psy7820          10 STALREISVLKELK-H--PNVIRLHDVIPVD---FKLFLVFEFLRQ   49 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h--~~i~~~~~~~~~~---~~~~lv~e~~~~   49 (163)
                      .++.+|+++++.+. +  -.+++++.+..++   +..|+|||+++|
T Consensus        72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G  117 (357)
T 3ats_A           72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEG  117 (357)
T ss_dssp             CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCC
T ss_pred             hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCC
Confidence            56789999999984 3  4578888887665   356899999986

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.65  E-value=0.00045  Score=46.40  Aligned_cols=96  Identities=22%  Similarity=0.162  Sum_probs=65.8

Q ss_pred             cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccC
Q psy7820          50 DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH-SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVT  128 (163)
Q Consensus        50 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~  128 (163)
                      +|.+.+...++++++++++.++.|++..+..+- +..-...=+.|..+++..+|++...+ ..+.            ...
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~  100 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE  100 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence            888888888889999999999999999987762 11212344557899999999887764 1110            012


Q ss_pred             ccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820         129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus       129 ~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ..+.|||...  ...+.+.=|||||+++|..+
T Consensus       101 ~~~~~pe~~~--~~~te~~~IysLG~tLY~AL  130 (229)
T 2yle_A          101 PPPVAGKLGY--SQCMETEVIESLGIIIYKAL  130 (229)
T ss_dssp             ------CCSS--SSSCHHHHHHHHHHHHHHHH
T ss_pred             cCCCChhhcc--ccchHHHHHHHHHHHHHHHh
Confidence            2357888764  22478999999999999877

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.26  E-value=0.0011  Score=48.35  Aligned_cols=30  Identities=23%  Similarity=0.361  Sum_probs=25.0

Q ss_pred             hCCceecCCCCCcEEEccCCceEEeeccccc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSR  113 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~  113 (163)
                      ...++|||+.|.||+++.+ .+.++||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            4578999999999999765 48999997654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.20  E-value=0.00073  Score=47.44  Aligned_cols=29  Identities=21%  Similarity=0.237  Sum_probs=24.4

Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .++|+|+.+.|++ ..++.+.++||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4799999999999 5677789999987654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.05  E-value=0.0017  Score=46.16  Aligned_cols=33  Identities=24%  Similarity=0.335  Sum_probs=27.3

Q ss_pred             hCCceecCCCCCcEEEccC----CceEEeeccccccc
Q psy7820          83 SRRIIHRDLKPQNILINKS----GALKLADFGLSRAF  115 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~----~~~~l~d~~~~~~~  115 (163)
                      ...++|+|+.+.|++++.+    +.+.++||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4578999999999999874    67899999876543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.89  E-value=0.0017  Score=47.32  Aligned_cols=102  Identities=20%  Similarity=0.218  Sum_probs=62.0

Q ss_pred             hhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHH----------HHH-------hcCC----CCCC--
Q psy7820           9 PSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLK----------DFL-------QTTP----VPVP--   63 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~----------~~~-------~~~~----~~~~--   63 (163)
                      ...+.+|.++++.+. +.-.+++++.+.++    +|+||++| .+.          ..+       ....    ....  
T Consensus        97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l  172 (379)
T 3feg_A           97 VDSLVLESVMFAILAERSLGPQLYGVFPEG----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL  172 (379)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSCCEEEEETTE----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence            355678999999884 33347777776542    88999876 221          001       1111    1111  


Q ss_pred             HHHHHHHHHHHHH-------------------HHHH----HH----hCCceecCCCCCcEEEccC----CceEEeecccc
Q psy7820          64 PALAKSYLYQLLE-------------------ALRY----CH----SRRIIHRDLKPQNILINKS----GALKLADFGLS  112 (163)
Q Consensus        64 ~~~~~~~~~~i~~-------------------~l~~----lh----~~~i~h~~i~~~ni~~~~~----~~~~l~d~~~~  112 (163)
                      +.++.++..++-.                   .+..    |.    ...++|+|+.+.||+++.+    +.+.++||..+
T Consensus       173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred             HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence            3444545443321                   1222    22    2358999999999999876    68999999876


Q ss_pred             cc
Q psy7820         113 RA  114 (163)
Q Consensus       113 ~~  114 (163)
                      ..
T Consensus       253 ~~  254 (379)
T 3feg_A          253 SY  254 (379)
T ss_dssp             EE
T ss_pred             Cc
Confidence            53

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.79  E-value=0.0026  Score=45.07  Aligned_cols=32  Identities=19%  Similarity=0.286  Sum_probs=27.9

Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ..+++|+|+++.|++++.++.+.++||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            36899999999999998888899999987643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.64  E-value=0.003  Score=44.79  Aligned_cols=41  Identities=24%  Similarity=0.115  Sum_probs=33.7

Q ss_pred             hhhHHHHHHHHhcCC---CCCeeeeeeeeeeCcEEEEEecchhc
Q psy7820           9 PSTALREISVLKELK---HPNVIRLHDVIPVDFKLFLVFEFLRQ   49 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~---h~~i~~~~~~~~~~~~~~lv~e~~~~   49 (163)
                      ...+..|++.|+.+.   ...+++++......+..++|||+++|
T Consensus        72 ~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           72 RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            456788999999883   35688899888888899999999976

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.29  E-value=0.0049  Score=45.35  Aligned_cols=32  Identities=19%  Similarity=0.373  Sum_probs=27.7

Q ss_pred             HhCCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          82 HSRRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      +...++|||++|.||+++.++ +.++||+.+..
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            467899999999999998776 99999987654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.58  E-value=0.012  Score=41.49  Aligned_cols=31  Identities=26%  Similarity=0.320  Sum_probs=25.8

Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .+++|+|+++.|++++.++.+.++||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            4689999999999998776668999986643

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=94.56  E-value=0.038  Score=39.45  Aligned_cols=31  Identities=16%  Similarity=0.352  Sum_probs=27.0

Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ..++|+|+.+.|++++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4689999999999999888899999986644

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=94.56  E-value=0.045  Score=38.57  Aligned_cols=30  Identities=23%  Similarity=0.266  Sum_probs=24.9

Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ...++|+|+++.||+++ + .+.++||+.+..
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            34688999999999998 4 899999986643

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=94.31  E-value=0.2  Score=33.55  Aligned_cols=82  Identities=13%  Similarity=0.152  Sum_probs=58.9

Q ss_pred             CCCCeeeeeeeeeeCcEEEEEecchh-c-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc
Q psy7820          23 KHPNVIRLHDVIPVDFKLFLVFEFLR-Q-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK  100 (163)
Q Consensus        23 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~  100 (163)
                      .||++  -..+-.+++.+.+.++.-+ + +.. .+.    ..+....++++.+++..... |...-.+--++|+|++++.
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~-~i~----~~~~~eKlrll~nl~~L~~~-~~~~r~tf~l~P~NL~f~~  119 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFA-AIR----KTTLLSRIRAAIHLVSKVKH-HSARRLIFIVCPENLMFNR  119 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHH-HHH----TSCHHHHHHHHHHHHHHHSS-CCSSSEECCCCGGGEEECT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHH-HHH----hcCHHHHHHHHHHHHHHHHH-hhhCceeEEEeCceEEEeC
Confidence            46777  4444567777877777654 3 444 443    56688888888888876551 2345578899999999999


Q ss_pred             CCceEEeecccc
Q psy7820         101 SGALKLADFGLS  112 (163)
Q Consensus       101 ~~~~~l~d~~~~  112 (163)
                      ++.+++.-.|+-
T Consensus       120 ~~~p~i~hRGi~  131 (219)
T 4ano_A          120 ALEPFFLHVGVK  131 (219)
T ss_dssp             TCCEEESCCEET
T ss_pred             CCcEEEEEcCCc
Confidence            999999988864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=93.33  E-value=0.036  Score=39.93  Aligned_cols=29  Identities=34%  Similarity=0.477  Sum_probs=23.6

Q ss_pred             CCceecCCCCCcEEEccCCceEEeeccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSR  113 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~  113 (163)
                      ..++|+|+.+.||+++.++ +.++||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            3589999999999997654 8999998664

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=93.21  E-value=0.12  Score=38.62  Aligned_cols=33  Identities=18%  Similarity=0.099  Sum_probs=23.7

Q ss_pred             HHHHHHHhcCCCCCe-eeeeeeeeeCcEEEEEecchhc
Q psy7820          13 LREISVLKELKHPNV-IRLHDVIPVDFKLFLVFEFLRQ   49 (163)
Q Consensus        13 ~~e~~~l~~~~h~~i-~~~~~~~~~~~~~~lv~e~~~~   49 (163)
                      .+|..+++.+...++ +++++.+.. +   .|+||++|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~~-G---~v~e~I~G  185 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFTN-G---RIEEFMDG  185 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEETT-E---EEEECCCS
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeCC-e---EEEEeeCC
Confidence            589999999964444 677777742 2   48898865

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=92.84  E-value=0.046  Score=40.43  Aligned_cols=36  Identities=14%  Similarity=0.154  Sum_probs=25.8

Q ss_pred             hhHHHHHHHHhcCCCCC-eeeeeeeeeeCcEEEEEecchhc
Q psy7820          10 STALREISVLKELKHPN-VIRLHDVIPVDFKLFLVFEFLRQ   49 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~lv~e~~~~   49 (163)
                      +.+.+|..+++.+...+ .+++++.+.++    +|+||++|
T Consensus       120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~g----~v~e~l~G  156 (429)
T 1nw1_A          120 SHLVAESVIFTLLSERHLGPKLYGIFSGG----RLEEYIPS  156 (429)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETTE----EEECCCCE
T ss_pred             HHHHHHHHHHHHHHhCCCCCcEEEEeCCC----EEEEEeCC
Confidence            67778999999885333 47777766532    78898876

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.68  E-value=0.26  Score=32.91  Aligned_cols=82  Identities=11%  Similarity=0.193  Sum_probs=60.0

Q ss_pred             CCCCeeeeeeeeeeCcEEEEEecchh-c-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEcc
Q psy7820          23 KHPNVIRLHDVIPVDFKLFLVFEFLR-Q-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK  100 (163)
Q Consensus        23 ~h~~i~~~~~~~~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~  100 (163)
                      .+|+++.. .+-.+.+.+.+.++.-+ + +... +.    ..+....++++.+|+....+++  .=+|--++|+|++++.
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik----~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~  114 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK----SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR  114 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG----GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH----hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence            47888877 56667777777777554 3 3322 33    4567888889998888764443  3467899999999999


Q ss_pred             CCceEEeecccc
Q psy7820         101 SGALKLADFGLS  112 (163)
Q Consensus       101 ~~~~~l~d~~~~  112 (163)
                      ++.+++.-.|+.
T Consensus       115 ~~~p~i~~RGik  126 (215)
T 4ann_A          115 DGLPIAKTRGLQ  126 (215)
T ss_dssp             TSCEEESCCEET
T ss_pred             CCCEEEEEccCc
Confidence            999999988753

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=90.82  E-value=0.14  Score=37.47  Aligned_cols=31  Identities=32%  Similarity=0.349  Sum_probs=24.9

Q ss_pred             CceecCCCCCcEEEc------cCCceEEeeccccccc
Q psy7820          85 RIIHRDLKPQNILIN------KSGALKLADFGLSRAF  115 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~------~~~~~~l~d~~~~~~~  115 (163)
                      .++|+|+.+.||++.      .++.+.++||..+...
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n  281 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN  281 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence            367999999999993      4567999999877543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=87.85  E-value=0.27  Score=36.36  Aligned_cols=29  Identities=24%  Similarity=0.505  Sum_probs=25.3

Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .++|+|+.+.|++ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4789999999999 7788899999987753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=86.54  E-value=0.27  Score=33.96  Aligned_cols=24  Identities=33%  Similarity=0.358  Sum_probs=20.1

Q ss_pred             CceecCCCCCcEEEccCCceEEeec
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADF  109 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~  109 (163)
                      .++|+|+.+.|++++.++ ..++|-
T Consensus       189 ~LvHGDlw~gNvl~~~~g-~~~iDp  212 (288)
T 3f7w_A          189 ARIHGDLWNGNVLWQDDG-AVVIDP  212 (288)
T ss_dssp             EEECSCCSGGGEEEETTE-EEECSC
T ss_pred             eeeecCCCCCcEEEcCCC-eEEEec
Confidence            689999999999999887 456663

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	163
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-48
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-48
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-46
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-45
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-43
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-43
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	9e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-42
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-42
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-42
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-41
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-40
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	5e-38
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-38
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-37
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-37
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-37
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-37
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-36
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-35
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-35
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-35
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-35
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-35
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-34
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-34
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-34
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	4e-34
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-34
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	7e-34
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-33
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-33
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-33
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-33
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-33
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-32
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-32
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-31
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-31
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	5e-31
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-30
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-30
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	5e-30
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-26
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-26
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-22
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-20
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-20

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 2e-48
 Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 5/153 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + EI +L    HPN+++L D    +  L+++ EF     +   +     P+  +  +   
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVC 116

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q L+AL Y H  +IIHRDLK  NIL    G +KLADFG+S   T  + R    + T ++
Sbjct: 117 KQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYW 176

Query: 132 RPPEILLG----AKVYSTTVDIWSAGCIFSEMI 160
             PE+++      + Y    D+WS G    EM 
Sbjct: 177 MAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 209

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 5e-48
 Identities = 45/156 (28%), Positives = 70/156 (44%), Gaps = 4/156 (2%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
             + +  +RE+ VL E   P ++  +     D ++ +  E +     D +      +P  
Sbjct: 45  PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ 104

Query: 66  LAKSYLYQLLEALRYCHSR-RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           +       +++ L Y   + +I+HRD+KP NIL+N  G +KL DFG+S       +    
Sbjct: 105 ILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS 162

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            V T  Y  PE L G   YS   DIWS G    EM 
Sbjct: 163 FVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMA 197

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 3e-46
 Identities = 43/159 (27%), Positives = 75/159 (47%), Gaps = 2/159 (1%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           +    P    +EI + K L H NV++ +         +L  E+             + +P
Sbjct: 42  RAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMP 101

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-- 121
              A+ + +QL+  + Y H   I HRD+KP+N+L+++   LK++DFGL+  F        
Sbjct: 102 EPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 161

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 TL Y  PE+L   + ++  VD+WS G + + M+
Sbjct: 162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 200

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 4e-46
 Identities = 53/160 (33%), Positives = 88/160 (55%), Gaps = 3/160 (1%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV 60
           ++++  GV     RE+ +   L+HPN++RL+       +++L+ E+              
Sbjct: 42  AQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 101

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN 120
                   +Y+ +L  AL YCHS+R+IHRD+KP+N+L+  +G LK+ADFG S     P +
Sbjct: 102 KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVH--APSS 159

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           R T    TL Y PPE++ G +++   VD+WS G +  E +
Sbjct: 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFL 198

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-45
 Identities = 71/155 (45%), Positives = 106/155 (68%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           +G+  TALREI +L+EL HPN+I L D       + LVF+F+  DL+  ++   + + P+
Sbjct: 41  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS 100

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
             K+Y+   L+ L Y H   I+HRDLKP N+L++++G LKLADFGL+++F  P   YTH+
Sbjct: 101 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVT WYR PE+L GA++Y   VD+W+ GCI +E++
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 195

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (366), Expect = 2e-44
 Identities = 95/155 (61%), Positives = 122/155 (78%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EG+PST +REIS+LKELKH N+++L+DVI    +L LVFE L QDLK  L      +   
Sbjct: 41  EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESV 100

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
            AKS+L QLL  + YCH RR++HRDLKPQN+LIN+ G LK+ADFGL+RAF IP+ +YTHE
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +VTLWYR P++L+G+K YSTT+DIWS GCIF+EM+
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMV 195

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 3e-44
 Identities = 49/148 (33%), Positives = 79/148 (53%), Gaps = 2/148 (1%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           + EI V++E K+PN++   D   V  +L++V E+L       + T    +      +   
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCR 123

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           + L+AL + HS ++IHRD+K  NIL+   G++KL DFG     T   ++ +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE++   K Y   VDIWS G +  EMI
Sbjct: 184 APEVVTR-KAYGPKVDIWSLGIMAIEMI 210

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  142 bits (360), Expect = 4e-43
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 6/151 (3%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            ++E+  L++L+HPN I+       +   +LV E+      D L+    P+      +  
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVT 121

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
           +  L+ L Y HS  +IHRD+K  NIL+++ G +KL DFG +      M      V T ++
Sbjct: 122 HGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS----IMAPANSFVGTPYW 177

Query: 132 RPPEILLGA--KVYSTTVDIWSAGCIFSEMI 160
             PE++L      Y   VD+WS G    E+ 
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  143 bits (362), Expect = 5e-43
 Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 5/155 (3%)

Query: 9   PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALA 67
             T  +EI  +  L+HP ++ LHD    D ++ +++EF+   +L + +      +    A
Sbjct: 67  KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA 126

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHE 125
             Y+ Q+ + L + H    +H DLKP+NI+    +S  LKL DFGL+     P       
Sbjct: 127 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-PKQSVKVT 185

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             T  +  PE+  G K      D+WS G +   ++
Sbjct: 186 TGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILL 219

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  143 bits (361), Expect = 9e-43
 Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 5/153 (3%)

Query: 11  TALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKS 69
           T   EIS++ +L HP +I LHD     +++ L+ EFL   +L D +      +  A   +
Sbjct: 72  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 131

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVV 127
           Y+ Q  E L++ H   I+H D+KP+NI+    K+ ++K+ DFGL+     P         
Sbjct: 132 YMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-PDEIVKVTTA 190

Query: 128 TLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           T  +  PEI+   +      D+W+ G +   ++
Sbjct: 191 TAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLL 222

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 1e-42
 Identities = 105/158 (66%), Positives = 128/158 (81%), Gaps = 1/158 (0%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL-QTTPVPV 62
           + EGVPSTA+REIS+LKEL HPN+++L DVI  + KL+LVFEFL QDLK F+  +    +
Sbjct: 40  ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGI 99

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
           P  L KSYL+QLL+ L +CHS R++HRDLKPQN+LIN  GA+KLADFGL+RAF +P+  Y
Sbjct: 100 PLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY 159

Query: 123 THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           THEVVTLWYR PEILLG K YST VDIWS GCIF+EM+
Sbjct: 160 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-42
 Identities = 51/165 (30%), Positives = 80/165 (48%), Gaps = 12/165 (7%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVI--PVDFKLFLVFEFL-RQDLKDFLQ---TTP 59
           E      + E+++L+ELKHPN++R +D I    +  L++V E+    DL   +       
Sbjct: 44  EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER 103

Query: 60  VPVPPALAKSYLYQLLEALRYCHSR-----RIIHRDLKPQNILINKSGALKLADFGLSRA 114
             +        + QL  AL+ CH R      ++HRDLKP N+ ++    +KL DFGL+R 
Sbjct: 104 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163

Query: 115 FTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
                +     V T +Y  PE +     Y+   DIWS GC+  E+
Sbjct: 164 LNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYEL 207

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-42
 Identities = 97/155 (62%), Positives = 127/155 (81%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPA 65
           EGVPS+ALREI +LKELKH N++RLHDV+  D KL LVFEF  QDLK +  +    + P 
Sbjct: 42  EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPE 101

Query: 66  LAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE 125
           + KS+L+QLL+ L +CHSR ++HRDLKPQN+LIN++G LKLA+FGL+RAF IP+  Y+ E
Sbjct: 102 IVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE 161

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           VVTLWYRPP++L GAK+YST++D+WSAGCIF+E+ 
Sbjct: 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA 196

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 1e-41
 Identities = 34/153 (22%), Positives = 68/153 (44%), Gaps = 6/153 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYL 71
             E+ VL++ +H N++          +L +V ++     L   L                
Sbjct: 52  KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIA 110

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV--TL 129
            Q  + + Y H++ IIHRDLK  NI +++   +K+ DFGL+   +     +  E +  ++
Sbjct: 111 RQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170

Query: 130 WYRPPEILLGAK--VYSTTVDIWSAGCIFSEMI 160
            +  PE++       YS   D+++ G +  E++
Sbjct: 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 2e-41
 Identities = 76/169 (44%), Positives = 101/169 (59%), Gaps = 12/169 (7%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVI--------PVDFKLFLVFEFLRQDLKDFL 55
           + EG P TALREI +L+ LKH NV+ L ++              ++LVF+F   DL   L
Sbjct: 48  EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL 107

Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
               V    +  K  +  LL  L Y H  +I+HRD+K  N+LI + G LKLADFGL+RAF
Sbjct: 108 SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167

Query: 116 TIP----MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           ++      NRYT+ VVTLWYRPPE+LLG + Y   +D+W AGCI +EM 
Sbjct: 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 216

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  137 bits (346), Expect = 2e-41
 Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 9/167 (5%)

Query: 1   SRVQVEGVPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT 58
           S  +V+ +    L+E+ +L+++  HPN+I+L D    +   FLVF+ +++ +L D+L   
Sbjct: 45  SAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE- 103

Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
            V +     +  +  LLE +   H   I+HRDLKP+NIL++    +KL DFG S     P
Sbjct: 104 KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD-P 162

Query: 119 MNRYTHEVVTLWYRPPEILLGA-----KVYSTTVDIWSAGCIFSEMI 160
             +      T  Y  PEI+  +       Y   VD+WS G I   ++
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 209

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 2e-40
 Identities = 43/152 (28%), Positives = 77/152 (50%), Gaps = 5/152 (3%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSY 70
             +EIS+L   +H N++ LH+      +L ++FEF+   D+ + + T+   +      SY
Sbjct: 48  VKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY 107

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILI--NKSGALKLADFGLSRAFTIPMNRYTHEVVT 128
           ++Q+ EAL++ HS  I H D++P+NI+    +S  +K+ +FG +R      N        
Sbjct: 108 VHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +Y P        V ST  D+WS G +   ++
Sbjct: 168 EYYAPEV--HQHDVVSTATDMWSLGTLVYVLL 197

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 2e-40
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 3/162 (1%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPV 60
             +  E       RE  V+  L HP  ++L+     D KL+    + +            
Sbjct: 44  RHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG 103

Query: 61  PVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP-- 118
                  + Y  +++ AL Y H + IIHRDLKP+NIL+N+   +++ DFG ++  +    
Sbjct: 104 SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163

Query: 119 MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             R    V T  Y  PE+L   K    + D+W+ GCI  +++
Sbjct: 164 QARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLV 204

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  129 bits (326), Expect = 5e-38
 Identities = 51/164 (31%), Positives = 87/164 (53%), Gaps = 7/164 (4%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP 59
           ++  +EG   +   EI+VL ++KHPN++ L D+      L+L+ + +   +L D +    
Sbjct: 43  AKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 102

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILI---NKSGALKLADFGLSRAFT 116
                  A   ++Q+L+A++Y H   I+HRDLKP+N+L    ++   + ++DFGLS+   
Sbjct: 103 -FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK-ME 160

Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            P +  +    T  Y  PE+L   K YS  VD WS G I   ++
Sbjct: 161 DPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILL 203

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 6e-38
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 11/155 (7%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFK----LFLVFEFLRQDLKDFLQTTPVPVPPALAK 68
             E  +LK L+HPN++R +D      K    + LV E +              +   + +
Sbjct: 56  KEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR 115

Query: 69  SYLYQLLEALRYCHSR--RIIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHE 125
           S+  Q+L+ L++ H+R   IIHRDLK  NI I   +G++K+ D GL+       +     
Sbjct: 116 SWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK--RASFAKAV 173

Query: 126 VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           + T  +  PE+      Y  +VD+++ G    EM 
Sbjct: 174 IGTPEFMAPEMYEEK--YDESVDVYAFGMCMLEMA 206

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  129 bits (326), Expect = 1e-37
 Identities = 35/158 (22%), Positives = 75/158 (47%), Gaps = 2/158 (1%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVP 63
           Q E +       +S++     P ++ +        KL  + + +      +  +      
Sbjct: 46  QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS 105

Query: 64  PALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT 123
            A  + Y  +++  L + H+R +++RDLKP NIL+++ G ++++D GL+  F+    +  
Sbjct: 106 EADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS--KKKPH 163

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ 161
             V T  Y  PE+L     Y ++ D +S GC+  ++++
Sbjct: 164 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR 201

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 2e-37
 Identities = 40/151 (26%), Positives = 78/151 (51%), Gaps = 7/151 (4%)

Query: 13  LREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQ-DLKDFLQTTPV-PVPPALAKS 69
           L E SV+ +L+H N+++L  V +     L++V E++ +  L D+L++     +       
Sbjct: 48  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 107

Query: 70  YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTL 129
           +   + EA+ Y      +HRDL  +N+L+++    K++DFGL++  +   +      + +
Sbjct: 108 FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---STQDTGKLPV 164

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE L   K +ST  D+WS G +  E+ 
Sbjct: 165 KWTAPEALRE-KKFSTKSDVWSFGILLWEIY 194

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 3e-37
 Identities = 62/168 (36%), Positives = 92/168 (54%), Gaps = 10/168 (5%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFL 55
           S  + +      LREI +L   +H N+I ++D+I          ++LV   +  DL   L
Sbjct: 42  SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL 101

Query: 56  QTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
           +T  +         +LYQ+L  L+Y HS  ++HRDLKP N+L+N +  LK+ DFGL+R  
Sbjct: 102 KTQHLS--NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159

Query: 116 T---IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                     T  V T WYR PEI+L +K Y+ ++DIWS GCI +EM+
Sbjct: 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 207

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 4e-37
 Identities = 42/152 (27%), Positives = 71/152 (46%), Gaps = 6/152 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           +RE  ++ +L +P ++RL  V      L LV E      L  FL      +P +     L
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV---T 128
           +Q+   ++Y   +  +HRDL  +N+L+      K++DFGLS+A     + YT        
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           L +  PE +   + +S+  D+WS G    E +
Sbjct: 176 LKWYAPECINF-RKFSSRSDVWSYGVTMWEAL 206

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 9e-37
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 3/156 (1%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPP 64
           + V  T + +  +    +HP +  +         LF V E+L   DL   +Q+       
Sbjct: 44  DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDL 102

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           + A  Y  +++  L++ HS+ I++RDLK  NIL++K G +K+ADFG+ +   +   +   
Sbjct: 103 SRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 162

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              T  Y  PEILLG + Y+ +VD WS G +  EM+
Sbjct: 163 FCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEML 197

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 2e-36
 Identities = 83/164 (50%), Positives = 109/164 (66%), Gaps = 11/164 (6%)

Query: 6   EGVPSTALREISVLKELK---HPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDFLQT 57
           EG+P + +RE++VL+ L+   HPNV+RL DV  V     + KL LVFE + QDL  +L  
Sbjct: 48  EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK 107

Query: 58  TPVP-VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            P P VP    K  ++QLL  L + HS R++HRDLKPQNIL+  SG +KLADFGL+R ++
Sbjct: 108 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 167

Query: 117 IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 T  VVTLWYR PE+LL +  Y+T VD+WS GCIF+EM 
Sbjct: 168 -FQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMF 209

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-36
 Identities = 39/150 (26%), Positives = 72/150 (48%), Gaps = 3/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + E  V+ +L HP +++L+ V      + LVFEF+    L D+L+T              
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMC 107

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVV-TLW 130
             + E + Y     +IHRDL  +N L+ ++  +K++DFG++R         +      + 
Sbjct: 108 LDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVK 167

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +  PE+   ++ YS+  D+WS G +  E+ 
Sbjct: 168 WASPEVFSFSR-YSSKSDVWSFGVLMWEVF 196

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 1e-35
 Identities = 50/157 (31%), Positives = 87/157 (55%), Gaps = 11/157 (7%)

Query: 14  REISVLKELKHPNVIRLHDVI------PVDFKLFLVFEFLRQDLKDFLQ---TTPVPVPP 64
           RE+ ++++L H N++RL            +  L LV +++ + +    +        +P 
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 121

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGA-LKLADFGLSRAFTIPMNRYT 123
              K Y+YQL  +L Y HS  I HRD+KPQN+L++   A LKL DFG ++          
Sbjct: 122 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNV 180

Query: 124 HEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             + + +YR PE++ GA  Y++++D+WSAGC+ +E++
Sbjct: 181 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 1e-35
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 6/152 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
            RE+S+LKE++HPNVI LH+V      + L+ E +              +    A  +L 
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLK 120

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGA----LKLADFGLSRAFTIPMNRYTHEVVT 128
           Q+L  + Y HS +I H DLKP+NI++         +K+ DFGL+       N + +   T
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGT 179

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PEI+   +      D+WS G I   ++
Sbjct: 180 PEFVAPEIVNY-EPLGLEADMWSIGVITYILL 210

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  123 bits (310), Expect = 1e-35
 Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 4/148 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
             E  +L  + HP +IR+        ++F++ +++       L       P  +AK Y  
Sbjct: 52  NDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA 111

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYR 132
           ++  AL Y HS+ II+RDLKP+NIL++K+G +K+ DFG ++                 Y 
Sbjct: 112 EVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTP---DYI 168

Query: 133 PPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            PE++   K Y+ ++D WS G +  EM+
Sbjct: 169 APEVVST-KPYNKSIDWWSFGILIYEML 195

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 3e-35
 Identities = 46/152 (30%), Positives = 69/152 (45%), Gaps = 6/152 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTTPVPVPPALAKSYL 71
           +RE++ +  L H N+IRL+ V+ +   + +V E      L D L+             Y 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 117

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVT 128
            Q+ E + Y  S+R IHRDL  +N+L+     +K+ DFGL RA     + Y    H  V 
Sbjct: 118 VQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVP 177

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  PE L   + +S   D W  G    EM 
Sbjct: 178 FAWCAPESLKT-RTFSHASDTWMFGVTLWEMF 208

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 3e-35
 Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 5/151 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E +V+++L +P ++R+  +   +    LV E       +        V        ++
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVH 114

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVTL 129
           Q+   ++Y      +HRDL  +N+L+      K++DFGLS+A     N Y   TH    +
Sbjct: 115 QVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE +   K +S+  D+WS G +  E  
Sbjct: 175 KWYAPECINYYK-FSSKSDVWSFGVLMWEAF 204

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (302), Expect = 6e-35
 Identities = 40/150 (26%), Positives = 74/150 (49%), Gaps = 3/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           + E  V+  L H  +++L+ V      +F++ E++    L ++L+               
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMC 106

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTLW 130
             + EA+ Y  S++ +HRDL  +N L+N  G +K++DFGLSR                + 
Sbjct: 107 KDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVR 166

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           + PPE+L+ +K +S+  DIW+ G +  E+ 
Sbjct: 167 WSPPEVLMYSK-FSSKSDIWAFGVLMWEIY 195

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-34
 Identities = 48/158 (30%), Positives = 75/158 (47%), Gaps = 12/158 (7%)

Query: 12  ALREISVL-KELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQT-TPVPVPP 64
           A RE+ +  +  + P+++R+ DV    +     L +V E L   +L   +Q         
Sbjct: 51  ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNR 121
             A   +  + EA++Y HS  I HRD+KP+N+L      +  LKL DFG ++  T   N 
Sbjct: 111 REASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-SHNS 169

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
            T    T +Y  PE+L   K Y  + D+WS G I   +
Sbjct: 170 LTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYIL 206

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 1e-34
 Identities = 51/154 (33%), Positives = 79/154 (51%), Gaps = 8/154 (5%)

Query: 12  ALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFL--RQDLKDFLQTTPVPVPPALA 67
              E+ +LK++      VIRL D         L+ E     QDL DF+      +   LA
Sbjct: 54  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELA 112

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEV 126
           +S+ +Q+LEA+R+CH+  ++HRD+K +NILI+ + G LKL DFG           YT   
Sbjct: 113 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTDFD 170

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            T  Y PPE +   + +  +  +WS G +  +M+
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 1e-34
 Identities = 39/151 (25%), Positives = 78/151 (51%), Gaps = 5/151 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQD-LKDFLQT-TPVPVPPALAKSY 70
           L E +++K+L+H  ++RL+ V+     ++++ E++    L DFL+T + + +        
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDM 114

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI-PMNRYTHEVVTL 129
             Q+ E + +   R  IHRDL+  NIL++ + + K+ADFGL+R                +
Sbjct: 115 AAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPI 174

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE +     ++   D+WS G + +E++
Sbjct: 175 KWTAPEAINYGT-FTIKSDVWSFGILLTEIV 204

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (299), Expect = 4e-34
 Identities = 39/153 (25%), Positives = 68/153 (44%), Gaps = 5/153 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYL 71
           L E S++ +  HPNVI L  V+     + ++ EF+    L  FL+              L
Sbjct: 75  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGML 134

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
             +   ++Y      +HRDL  +NIL+N +   K++DFGLSR      +  T+       
Sbjct: 135 RGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 132 RPPEIL----LGAKVYSTTVDIWSAGCIFSEMI 160
            P        +  + +++  D+WS G +  E++
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVM 227

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 4e-34
 Identities = 41/149 (27%), Positives = 67/149 (44%), Gaps = 1/149 (0%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            + E  VL+  +HP +  L        +L  V E+       F  +         A+ Y 
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYG 111

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            +++ AL Y HSR +++RD+K +N++++K G +K+ DFGL +              T  Y
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEY 171

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PE+L     Y   VD W  G +  EM+
Sbjct: 172 LAPEVLED-NDYGRAVDWWGLGVVMYEMM 199

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 5e-34
 Identities = 40/156 (25%), Positives = 75/156 (48%), Gaps = 2/156 (1%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPP 64
           + V    L+E   +++  HP++++L  VI  +  ++++ E     +L+ FLQ     +  
Sbjct: 49  DSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDL 107

Query: 65  ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTH 124
           A    Y YQL  AL Y  S+R +HRD+  +N+L++ +  +KL DFGLSR           
Sbjct: 108 ASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKAS 167

Query: 125 EVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +            +  + +++  D+W  G    E++
Sbjct: 168 KGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 7e-34
 Identities = 34/174 (19%), Positives = 73/174 (41%), Gaps = 27/174 (15%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQT------------- 57
           + E+ ++ +L  H N++ L     +   ++L+FE+    DL ++L++             
Sbjct: 88  MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147

Query: 58  ---------TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLAD 108
                        +       + YQ+ + + +   +  +HRDL  +N+L+     +K+ D
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICD 207

Query: 109 FGLSRAFT--IPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           FGL+R            +  + + +  PE L    +Y+   D+WS G +  E+ 
Sbjct: 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIF 260

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (295), Expect = 3e-33
 Identities = 55/154 (35%), Positives = 91/154 (59%), Gaps = 10/154 (6%)

Query: 12  ALREISVLKELK-HPNVIRLHDVI--PVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALA 67
             REI +L+ L+  PN+I L D++  PV     LVFE +   D K   Q     +     
Sbjct: 76  IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ----TLTDYDI 131

Query: 68  KSYLYQLLEALRYCHSRRIIHRDLKPQNILI-NKSGALKLADFGLSRAFTIPMNRYTHEV 126
           + Y+Y++L+AL YCHS  I+HRD+KP N++I ++   L+L D+GL+  +  P   Y   V
Sbjct: 132 RFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRV 190

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            + +++ PE+L+  ++Y  ++D+WS GC+ + MI
Sbjct: 191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI 224

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  117 bits (293), Expect = 3e-33
 Identities = 44/181 (24%), Positives = 83/181 (45%), Gaps = 27/181 (14%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQTT------ 58
             + +   RE +++ E  +PN+++L  V  V   + L+FE++   DL +FL++       
Sbjct: 57  ADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVC 116

Query: 59  -----------------PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKS 101
                            P P+  A       Q+   + Y   R+ +HRDL  +N L+ ++
Sbjct: 117 SLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGEN 176

Query: 102 GALKLADFGLSRAF--TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM 159
             +K+ADFGLSR            ++ + + + PPE +   + Y+T  D+W+ G +  E+
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEI 235

Query: 160 I 160
            
Sbjct: 236 F 236

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 3e-33
 Identities = 35/151 (23%), Positives = 70/151 (46%), Gaps = 5/151 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ--TTPVPVPPALAKSY 70
           L+E  V+K+L+H  +++L+ V+  +  +++V E++ +          T   +        
Sbjct: 60  LQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT-IPMNRYTHEVVTL 129
             Q+   + Y      +HRDL+  NIL+ ++   K+ADFGL+R                +
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178

Query: 130 WYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  PE  L  + ++   D+WS G + +E+ 
Sbjct: 179 KWTAPEAALYGR-FTIKSDVWSFGILLTELT 208

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  115 bits (290), Expect = 5e-33
 Identities = 45/167 (26%), Positives = 73/167 (43%), Gaps = 8/167 (4%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDVI----PVDFKLFLVFEFLRQDLKDFLQ 56
              +         RE      L HP ++ ++D      P     ++V E++       + 
Sbjct: 43  DLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 102

Query: 57  TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
            T  P+ P  A   +    +AL + H   IIHRD+KP NI+I+ + A+K+ DFG++RA  
Sbjct: 103 HTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162

Query: 117 IPMNRYTHE---VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              N  T     + T  Y  PE   G        D++S GC+  E++
Sbjct: 163 DSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVL 208

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 6e-33
 Identities = 67/163 (41%), Positives = 91/163 (55%), Gaps = 11/163 (6%)

Query: 4   QVEGVPSTALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQT 57
           Q E     A RE+ +LK ++H NVI L DV   D         +LV  F+  DL   ++ 
Sbjct: 56  QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH 115

Query: 58  TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTI 117
             +       +  +YQ+L+ LRY H+  IIHRDLKP N+ +N+   LK+ DFGL+R    
Sbjct: 116 EKLG--EDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---Q 170

Query: 118 PMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +  T  VVT WYR PE++L    Y+ TVDIWS GCI +EMI
Sbjct: 171 ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 213

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  115 bits (288), Expect = 1e-32
 Identities = 32/161 (19%), Positives = 58/161 (36%), Gaps = 14/161 (8%)

Query: 13  LREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
             E    K L     +  ++          LV + L   L+D L                
Sbjct: 48  RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAA 107

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINK-----SGALKLADFGLSRAF-------TIPM 119
            Q+L  ++  H + +++RD+KP N LI +     +  + + DFG+ + +        IP 
Sbjct: 108 KQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY 167

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
               +   T  Y      LG +  S   D+ + G +F   +
Sbjct: 168 REKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFL 207

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-32
 Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 3/150 (2%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLY 72
           L E  V+  + +P+V RL  +        +        L D+++     +      ++  
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 118

Query: 73  QLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHE--VVTLW 130
           Q+ + + Y   RR++HRDL  +N+L+     +K+ DFGL++        Y  E   V + 
Sbjct: 119 QIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +   E +L  ++Y+   D+WS G    E++
Sbjct: 179 WMALESILH-RIYTHQSDVWSYGVTVWELM 207

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (280), Expect = 2e-31
 Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 2/150 (1%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFL--QTTPVPVPPALAKSY 70
           L+E +V+KE+KHPN+++L  V   +   +++ EF+          +     V   +    
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM 120

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLW 130
             Q+  A+ Y   +  IHRDL  +N L+ ++  +K+ADFGLSR  T              
Sbjct: 121 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180

Query: 131 YRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                  L    +S   D+W+ G +  E+ 
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIA 210

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (282), Expect = 3e-31
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 4/149 (2%)

Query: 12  ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
            L E  +L+ +  P +++L      +  L++V E++                   A+ Y 
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYA 147

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWY 131
            Q++    Y HS  +I+RDLKP+N+LI++ G +++ DFG ++                  
Sbjct: 148 AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EA 204

Query: 132 RPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             PEI+L  K Y+  VD W+ G +  EM 
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMA 232

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  111 bits (278), Expect = 5e-31
 Identities = 34/159 (21%), Positives = 55/159 (34%), Gaps = 12/159 (7%)

Query: 13  LREISVLKELKHPNVIR-LHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYL 71
             E  + K ++    I  +           +V E L   L+D                  
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLA 109

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGA---LKLADFGLSRAFT-------IPMNR 121
            Q++  + Y HS+  IHRD+KP N L+        + + DFGL++ +        IP   
Sbjct: 110 DQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRE 169

Query: 122 YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
             +   T  Y      LG +  S   D+ S G +     
Sbjct: 170 NKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFN 207

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 1e-30
 Identities = 43/167 (25%), Positives = 67/167 (40%), Gaps = 20/167 (11%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPAL-- 66
            EI     L+H N++        D     +L+LV ++     L D+L    V V   +  
Sbjct: 46  AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKL 105

Query: 67  ----AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY 122
               A    +  +E +       I HRDLK +NIL+ K+G   +AD GL+       +  
Sbjct: 106 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 165

Query: 123 ----THEVVTLWYRPPEILLGAKV-----YSTTVDIWSAGCIFSEMI 160
                H V T  Y  PE+L  +            DI++ G +F E+ 
Sbjct: 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 3e-30
 Identities = 39/166 (23%), Positives = 82/166 (49%), Gaps = 7/166 (4%)

Query: 1   SRVQVEGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLR-QDLKDFLQTT 58
           +R+   G  S  L E  ++K+  HPNV+ L  + +  +    +V  +++  DL++F++  
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 123

Query: 59  PVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP 118
                      +  Q+ + +++  S++ +HRDL  +N ++++   +K+ADFGL+R     
Sbjct: 124 THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183

Query: 119 MNRYTHE----VVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                H      + + +   E L   K ++T  D+WS G +  E++
Sbjct: 184 EFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELM 228

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 4e-30
 Identities = 36/152 (23%), Positives = 69/152 (45%), Gaps = 5/152 (3%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLK-DFLQTTPVPVPPALAKSYL 71
           L E  ++ +  H N+IRL  VI     + ++ E++       FL+              L
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 116

Query: 72  YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY---THEVVT 128
             +   ++Y  +   +HRDL  +NIL+N +   K++DFGLSR            +   + 
Sbjct: 117 RGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           + +  PE +   + +++  D+WS G +  E++
Sbjct: 177 IRWTAPEAISY-RKFTSASDVWSFGIVMWEVM 207

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 5e-30
 Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 19/165 (11%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQ-------------- 56
             E+ VL +L  HPN+I L         L+L  E+    +L DFL+              
Sbjct: 58  AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA 117

Query: 57  -TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
            +T   +       +   +   + Y   ++ IHRDL  +NIL+ ++   K+ADFGLSR  
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177

Query: 116 TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            + + +     + + +   E L    VY+T  D+WS G +  E++
Sbjct: 178 EVYVKKTMG-RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIV 220

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 1e-29
 Identities = 40/169 (23%), Positives = 70/169 (41%), Gaps = 22/169 (13%)

Query: 13  LREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQ-------------- 56
           + E+ VL  L  H N++ L     +     ++ E+    DL +FL+              
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133

Query: 57  ---TTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSR 113
                 + +      S+ YQ+ + + +  S+  IHRDL  +NIL+      K+ DFGL+R
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193

Query: 114 AFTIPMNRY--THEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                 N     +  + + +  PE +    VY+   D+WS G    E+ 
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELF 241

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 2e-28
 Identities = 37/152 (24%), Positives = 68/152 (44%), Gaps = 3/152 (1%)

Query: 12  ALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSY 70
              E  VL+ ++  P ++ LH     + KL L+ +++         +          + Y
Sbjct: 75  TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 134

Query: 71  LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYT--HEVVT 128
           + +++ AL + H   II+RD+K +NIL++ +G + L DFGLS+ F               
Sbjct: 135 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194

Query: 129 LWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +  P  +  G   +   VD WS G +  E++
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 226

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (259), Expect = 6e-28
 Identities = 59/154 (38%), Positives = 81/154 (52%), Gaps = 9/154 (5%)

Query: 12  ALREISVLKELKHPNVIRLHDVI-----PVDFKLFLVFEFLRQDLKDFLQTTPVPVPPAL 66
             RE+ +LK +KH NVI L DV        +F    +   L     + +      +    
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDH 122

Query: 67  AKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEV 126
            +  +YQ+L  L+Y HS  IIHRDLKP N+ +N+   LK+ DFGL+R     M  Y    
Sbjct: 123 VQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 180

Query: 127 VTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            T WYR PEI+L    Y+ TVDIWS GCI +E++
Sbjct: 181 -TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 8e-27
 Identities = 58/161 (36%), Positives = 84/161 (52%), Gaps = 11/161 (6%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDV------IPVDFKLFLVFEFLRQDLKDFLQTTP 59
           +     A RE+ ++K + H N+I L +V      +     ++LV E +  +L   +Q   
Sbjct: 57  QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-- 114

Query: 60  VPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM 119
             +        LYQ+L  +++ HS  IIHRDLKP NI++     LK+ DFGL+R      
Sbjct: 115 -ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-TS 172

Query: 120 NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              T  VVT +YR PE++LG   Y   VDIWS GCI  EM+
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMV 212

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.6 bits (247), Expect = 1e-26
 Identities = 43/167 (25%), Positives = 81/167 (48%), Gaps = 20/167 (11%)

Query: 13  LREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVP--------- 61
           + E+ ++K + KH N+I L      D  L+++ E+  + +L+++LQ    P         
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 62  ------VPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAF 115
                 +      S  YQ+   + Y  S++ IHRDL  +N+L+ +   +K+ADFGL+R  
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 116 --TIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
                  + T+  + + +  PE L   ++Y+   D+WS G +  E+ 
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIF 231

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.5 bits (247), Expect = 2e-26
 Identities = 38/160 (23%), Positives = 74/160 (46%), Gaps = 13/160 (8%)

Query: 13  LREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFL-RQDLKDFLQ---------TTPVPV 62
           L E SV+KE    +V+RL  V+       ++ E + R DLK +L+             P 
Sbjct: 71  LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130

Query: 63  PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MN 120
             +       ++ + + Y ++ + +HRDL  +N ++ +   +K+ DFG++R         
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190

Query: 121 RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
           +    ++ + +  PE L    V++T  D+WS G +  E+ 
Sbjct: 191 KGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIA 229

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.8 bits (219), Expect = 2e-22
 Identities = 38/166 (22%), Positives = 71/166 (42%), Gaps = 20/166 (12%)

Query: 14  REISVLKELKHPNVIRLHDVI-PVDFKLFLVFEFLR-QDLKDFLQT-------------- 57
               ++    H NV+ L          L ++ EF +  +L  +L++              
Sbjct: 66  ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 125

Query: 58  -TPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFT 116
                +       Y +Q+ + + +  SR+ IHRDL  +NIL+++   +K+ DFGL+R   
Sbjct: 126 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY 185

Query: 117 IPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
              +  R     + L +  PE +   +VY+   D+WS G +  E+ 
Sbjct: 186 KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIF 230

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 80.6 bits (198), Expect = 3e-20
 Identities = 26/144 (18%), Positives = 51/144 (35%), Gaps = 24/144 (16%)

Query: 14  REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQ 73
            E   L++L+   V +++          ++ E +       ++              L  
Sbjct: 63  NEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRVRVENP-------DEVLDM 111

Query: 74  LLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRY----THEVVTL 129
           +LE +   + R I+H DL   N+L+++ G + + DF  S        R         +  
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNIIT 170

Query: 130 WYRPPEILLGAKVYSTTVDIWSAG 153
           ++         + Y T  DI SA 
Sbjct: 171 YFS--------RTYRTEKDINSAI 186

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 82.0 bits (201), Expect = 9e-20
 Identities = 47/178 (26%), Positives = 72/178 (40%), Gaps = 27/178 (15%)

Query: 6   EGVPSTALREISVLKELKHPNVIRLHDV-IPVDFKLFLVFEFLRQD-------------- 50
           +     A  EI +L+ +   +  +   +      KL   F     +              
Sbjct: 50  KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN 109

Query: 51  -LKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR-IIHRDLKPQNILINKSGA----- 103
            L    +     +P    K    QLL  L Y H R  IIH D+KP+N+L+    +     
Sbjct: 110 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169

Query: 104 -LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI 160
            +K+AD G +  +      YT+ + T  YR PE+LLGA  +    DIWS  C+  E+I
Sbjct: 170 QIKIADLGNACWY---DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELI 223

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	163
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.95
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.77
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.31
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.06
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.25
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.88
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.68
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	92.05

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-44  Score=250.16  Aligned_cols=152  Identities=33%  Similarity=0.538  Sum_probs=137.4

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.+.+|++++++++||||+++++++.+++.+|+|||||+| +|.+++...  .+++..++.++.|++.|++|||++|
T Consensus        59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~  136 (293)
T d1yhwa1          59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQ  136 (293)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            3456789999999999999999999999999999999999985 888876653  6899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.+||+|||++.............+||+.|+|||++.+.. ++.++||||+||++|+|+|
T Consensus       137 iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemlt  211 (293)
T d1yhwa1         137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIE  211 (293)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHH
T ss_pred             CcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhh
Confidence            99999999999999999999999999987765555566778999999999998754 7999999999999999996

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-44  Score=251.17  Aligned_cols=153  Identities=29%  Similarity=0.520  Sum_probs=134.0

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+++.+|++++++++||||+++++++.+++.+|+|||||+| +|.+++... +.+++..++.++.|+++|++|||++|+
T Consensus        46 ~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~i~~qi~~al~ylH~~~I  124 (271)
T d1nvra_          46 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMAGVVYLHGIGI  124 (271)
T ss_dssp             ---CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTT-TBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence            446789999999999999999999999999999999999985 888887644 489999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.++.+||+|||+++......  ......+||+.|+|||++.+...++.++||||+||++|+|++
T Consensus       125 iHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~  201 (271)
T d1nvra_         125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA  201 (271)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred             ccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh
Confidence            999999999999999999999999998654332  223456789999999999876645678999999999999997

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=252.53  Aligned_cols=155  Identities=31%  Similarity=0.520  Sum_probs=137.4

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|++++++++||||+++++++.+++.+++||||++| +|.+++.+....+++..+..++.|++.|+.|||++|
T Consensus        51 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~  130 (288)
T d2jfla1          51 EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK  130 (288)
T ss_dssp             GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            4456789999999999999999999999999999999999985 888887766668999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCccccc----CCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILL----GAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~----~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.+||+|||++..............||+.|+|||++.    ....++.++||||+||++|+|+|
T Consensus       131 ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemlt  210 (288)
T d2jfla1         131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE  210 (288)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHH
T ss_pred             EEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhh
Confidence            99999999999999999999999999876553333445678899999999984    23447899999999999999997

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=246.26  Aligned_cols=152  Identities=36%  Similarity=0.620  Sum_probs=136.6

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ......+.+|++++++++||||+++++++.+++.+|+|||||++ +|.+.+...+ .+++..+..++.|++.|+.|||++
T Consensus        47 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~  125 (263)
T d2j4za1          47 AGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK  125 (263)
T ss_dssp             TTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence            34556788999999999999999999999999999999999985 8888887644 789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||||+||+++.++.+||+|||++.....  .......||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       126 ~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--~~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~  199 (263)
T d2j4za1         126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--SRRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLV  199 (263)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC--CCCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHH
T ss_pred             CeeeeeeccccceecCCCCEeecccceeeecCC--CcccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhc
Confidence            999999999999999999999999999876543  3345668899999999998754 7999999999999999997

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-43  Score=249.16  Aligned_cols=153  Identities=27%  Similarity=0.427  Sum_probs=139.2

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ....++.+|+.+|++++||||+++++++.+++.+|+||||++| +|.+++...+ .+++..++.++.|++.|++|||++|
T Consensus        47 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~~  125 (337)
T d1o6la_          47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSRD  125 (337)
T ss_dssp             TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc-CCcHHHHHHHHHHHhhhhhhhhhcC
Confidence            4456788999999999999999999999999999999999985 8888877654 7899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++||||||+||+++.+|.+||+|||+++............+||+.|+|||++.+.. ++.++|+||+||++|||++
T Consensus       126 iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~  200 (337)
T d1o6la_         126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMC  200 (337)
T ss_dssp             CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHH
T ss_pred             ccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHH
Confidence            99999999999999999999999999987665555566788999999999998765 7999999999999999996

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-43  Score=245.05  Aligned_cols=154  Identities=29%  Similarity=0.527  Sum_probs=134.0

Q ss_pred             CCchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +...+.+.+|++++++++||||+++++++.+++.+|+||||++| +|.+++...+ .+++..++.++.|++.|+.|||++
T Consensus        49 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~  127 (288)
T d1uu3a_          49 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK  127 (288)
T ss_dssp             TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC-CCCHHHHHHHHHHHHHHHHhhccc
Confidence            34456789999999999999999999999999999999999985 8888877654 799999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||||+||+++.++.++|+|||+++.....  .......+||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       128 ~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~  205 (288)
T d1uu3a_         128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVA  205 (288)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHH
T ss_pred             cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhh
Confidence            9999999999999999999999999999766432  22334567999999999998755 7999999999999999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.5e-43  Score=246.79  Aligned_cols=148  Identities=30%  Similarity=0.525  Sum_probs=131.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceec
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHR   89 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~   89 (163)
                      .++.+|++++++++||||+++++++.+++.+|+|||||.++.++........+++..++.++.|++.|+.|||++|++||
T Consensus        60 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHr  139 (309)
T d1u5ra_          60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR  139 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEecc
Confidence            45789999999999999999999999999999999999975555555555689999999999999999999999999999


Q ss_pred             CCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC--CcCCCcchhhHHHHHHHHHHhc
Q psy7820          90 DLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG--AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        90 ~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||+||+++.++.+||+|||++.....    .....||+.|+|||++.+  ...++.++||||+||++|||++
T Consensus       140 DiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~  209 (309)
T d1u5ra_         140 DVKAGNILLSEPGLVKLGDFGSASIMAP----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE  209 (309)
T ss_dssp             CCSGGGEEEETTTEEEECCCTTCBSSSS----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcceEEECCCCCEEEeecccccccCC----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHH
Confidence            9999999999999999999999876442    345678999999999864  2347999999999999999996

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=241.93  Aligned_cols=154  Identities=21%  Similarity=0.350  Sum_probs=130.5

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|++++++++||||+++++++.. +.+++||||++ |+|.+++....+.+++..+..++.|+++|++|||+++
T Consensus        46 ~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~  124 (276)
T d1uwha_          46 QQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS  124 (276)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence            344678899999999999999999998754 56899999998 5999999877778999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccC--CCcccccccCccccCcccccCC--cCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIP--MNRYTHEVVTLWYRPPEILLGA--KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~--~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.+||+|||++......  ........||+.|+|||.+.+.  ..++.++||||+||++|||+|
T Consensus       125 ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~t  204 (276)
T d1uwha_         125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMT  204 (276)
T ss_dssp             CCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred             EeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHH
Confidence            999999999999999999999999998765432  2233456789999999998642  347899999999999999997

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-42  Score=244.53  Aligned_cols=153  Identities=46%  Similarity=0.888  Sum_probs=139.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ...+.+|++++++++||||+++++++.+++.+|+||||+.+++...+......+++..+..++.|++.|++|||++|++|
T Consensus        44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH  123 (299)
T d1ua2a_          44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH  123 (299)
T ss_dssp             CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence            45688999999999999999999999999999999999998777777777778999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.++.+||+|||.+.............+||+.|+|||.+.+...++.++||||+||++|||+|
T Consensus       124 rDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~  196 (299)
T d1ua2a_         124 RDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLL  196 (299)
T ss_dssp             CCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHh
Confidence            9999999999999999999999998766555555566889999999998776668999999999999999996

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-43  Score=248.99  Aligned_cols=151  Identities=30%  Similarity=0.511  Sum_probs=133.5

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-C
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS-R   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~-~   84 (163)
                      ....++.+|+++|++++||||++++++|.+++.+|+||||++| +|.+++.+.+ .+++..+..++.|++.|+.|||+ +
T Consensus        46 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~  124 (322)
T d1s9ja_          46 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH  124 (322)
T ss_dssp             THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            4456788999999999999999999999999999999999985 8888887654 78999999999999999999997 5


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||+||||||+||+++.++.+||+|||++.....  ......+||+.|+|||++.+.. ++.++||||+||++|||++
T Consensus       125 ~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~--~~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~  198 (322)
T d1s9ja_         125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SMANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAV  198 (322)
T ss_dssp             CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--HTC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHH
T ss_pred             CEEccccCHHHeeECCCCCEEEeeCCCccccCC--CccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHH
Confidence            999999999999999999999999999986543  2234568999999999998755 7999999999999999997

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-42  Score=243.69  Aligned_cols=152  Identities=26%  Similarity=0.468  Sum_probs=125.8

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|+++|++++||||+++++++.+++.+++||||+++ +|.+++....+.+++..++.++.|+++|+.|||+++++
T Consensus        71 ~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~ii  150 (299)
T d1jpaa_          71 RRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYV  150 (299)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCc
Confidence            35688999999999999999999999999999999999985 89888888777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc-----ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR-----YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~-----~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ||||||+||+++.++.+||+|||+++........     .....+++.|+|||.+.+.. ++.++||||+||++|||+|
T Consensus       151 HrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t  228 (299)
T d1jpaa_         151 HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMS  228 (299)
T ss_dssp             CSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHh
Confidence            9999999999999999999999998765432211     22245688999999987654 7999999999999999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-42  Score=243.43  Aligned_cols=150  Identities=30%  Similarity=0.511  Sum_probs=133.8

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.+.+|+.++++++||||+++++++.+++.+|+||||+.| ++...+... ..+++..+..++.|++.|++|||++|
T Consensus        46 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~  124 (316)
T d1fota_          46 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKD  124 (316)
T ss_dssp             TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccc-ccccccHHHHHHHHHHHhhhhhccCc
Confidence            4456788999999999999999999999999999999999986 666666554 47889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.+|.+||+|||+++....   .....+||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       125 iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemlt  196 (316)
T d1fota_         125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLA  196 (316)
T ss_dssp             EECCCCCGGGEEECTTSCEEECCCSSCEECSS---CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHH
T ss_pred             EEccccCchheeEcCCCCEEEecCccceEecc---ccccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHh
Confidence            99999999999999999999999999977553   334568999999999987654 7999999999999999997

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-42  Score=241.58  Aligned_cols=152  Identities=33%  Similarity=0.581  Sum_probs=121.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee--CcEEEEEecchhc-cHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV--DFKLFLVFEFLRQ-DLKDFLQT---TPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .+.+.+|++++++++||||+++++++.+  ++.+|+|||||+| +|.+++.+   .+..+++..++.++.|++.|+.|||
T Consensus        47 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH  126 (269)
T d2java1          47 KQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH  126 (269)
T ss_dssp             HHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            3457899999999999999999999854  4578999999985 99988753   3457999999999999999999999


Q ss_pred             hCC-----ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          83 SRR-----IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        83 ~~~-----i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      +++     ++|+||||+||+++.++.+||+|||+++.............||+.|+|||++.+.. ++.++||||+||++|
T Consensus       127 ~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvily  205 (269)
T d2java1         127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLY  205 (269)
T ss_dssp             HHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHH
T ss_pred             HhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHH
Confidence            876     99999999999999999999999999987665545556678899999999997654 799999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      ||+|
T Consensus       206 el~t  209 (269)
T d2java1         206 ELCA  209 (269)
T ss_dssp             HHHH
T ss_pred             HHhh
Confidence            9997

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.9e-42  Score=243.28  Aligned_cols=150  Identities=31%  Similarity=0.510  Sum_probs=120.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++||||+++++++.+++.+|+|||||+| +|.+++... +.+++..+..++.|++.|++|||++|++
T Consensus        51 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~ii  129 (307)
T d1a06a_          51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIV  129 (307)
T ss_dssp             ----CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcc-cCCCHHHHHHHHHHHHHHHHhhhhceee
Confidence            45677899999999999999999999999999999999984 999998764 4899999999999999999999999999


Q ss_pred             ecCCCCCcEEEc---cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILIN---KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~---~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||++.   .++.+||+|||++..... .......+||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       130 HrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~-~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~  204 (307)
T d1a06a_         130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLC  204 (307)
T ss_dssp             CSCCCGGGEEESSSSTTCCEEECCC-------------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHH
T ss_pred             eEEecccceeecccCCCceEEEeccceeEEccC-CCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHh
Confidence            999999999994   578999999999876543 23344567999999999998754 7999999999999999996

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-42  Score=238.47  Aligned_cols=153  Identities=26%  Similarity=0.448  Sum_probs=128.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ..+++.+|++++++++||||+++++++.+++.+++||||++ |+|.+++......+++..+..++.|++.|+.|||++++
T Consensus        43 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~i  122 (263)
T d1sm2a_          43 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV  122 (263)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccce
Confidence            45678999999999999999999999999999999999998 59999988877789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       123 iHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t  197 (263)
T d1sm2a_         123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFS  197 (263)
T ss_dssp             CCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             eecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHH
Confidence            999999999999999999999999987654332 2233456789999999987755 7999999999999999997

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.2e-41  Score=244.55  Aligned_cols=151  Identities=27%  Similarity=0.463  Sum_probs=136.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|++++++++||||+++++++.+++.+|+||||++| +|.+++....+.+++..+..++.||+.||.|||++|++
T Consensus        67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii  146 (350)
T d1koaa2          67 KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV  146 (350)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCe
Confidence            45678999999999999999999999999999999999985 99999987777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEcc--CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINK--SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~--~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.  ++.+||+|||++..... ........||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       147 HrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~-~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~  220 (350)
T d1koaa2         147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDP-KQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLS  220 (350)
T ss_dssp             CCCCCGGGEEESSTTSCCEEECCCTTCEECCT-TSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHH
T ss_pred             eeeechhHeeeccCCCCeEEEeecchheeccc-ccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHh
Confidence            9999999999954  57899999999877653 33445678899999999998754 7999999999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=235.73  Aligned_cols=148  Identities=30%  Similarity=0.471  Sum_probs=129.4

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .+++.+|++++++++||||+++++++.+    +..+|+||||+++ +|.+++.+.. .+++..++.++.|+++|++|||+
T Consensus        52 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~  130 (270)
T d1t4ha_          52 RQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHT  130 (270)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccc-cccHHHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999865    4578999999985 8888887654 78999999999999999999999


Q ss_pred             CC--ceecCCCCCcEEEc-cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          84 RR--IIHRDLKPQNILIN-KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        84 ~~--i~h~~i~~~ni~~~-~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ++  ++|+||||+||+++ .++.+||+|||+++...  ........||+.|+|||++.+  .++.++||||+||++|||+
T Consensus       131 ~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~--~~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~  206 (270)
T d1t4ha_         131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMA  206 (270)
T ss_dssp             SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC--TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc--CCccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHH
Confidence            98  99999999999996 57899999999987543  233446689999999999865  3799999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       207 ~  207 (270)
T d1t4ha_         207 T  207 (270)
T ss_dssp             H
T ss_pred             H
Confidence            6

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-41  Score=244.06  Aligned_cols=151  Identities=28%  Similarity=0.488  Sum_probs=136.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      ...+.+|++++++++||||+++++++.+++.+|+|||||+| +|.+.+...+..+++..++.++.|++.|+.|||++|++
T Consensus        70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~ii  149 (352)
T d1koba_          70 KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV  149 (352)
T ss_dssp             HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence            34577899999999999999999999999999999999985 99998888777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEc--cCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILIN--KSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++  .++.+||+|||++..... ........|++.|+|||++.+.. ++.++||||+||++|+|+|
T Consensus       150 HRDiKp~NILl~~~~~~~vkL~DFGla~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyellt  223 (352)
T d1koba_         150 HLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLS  223 (352)
T ss_dssp             CCCCCGGGEEESSTTCCCEEECCCTTCEECCT-TSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHH
T ss_pred             ecccccccccccccCCCeEEEeecccceecCC-CCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHh
Confidence            999999999997  568999999999977653 33445667899999999997754 7999999999999999997

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-41  Score=238.09  Aligned_cols=151  Identities=27%  Similarity=0.461  Sum_probs=132.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++.++ .+|+||||+++ +|.+++......+++..+..++.|++.|+.|||+++++
T Consensus        53 ~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~ii  131 (285)
T d1u59a_          53 TEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV  131 (285)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence            45688999999999999999999999754 57899999985 99998877777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.+||+|||+++.......   ......|++.|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       132 HrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt  207 (285)
T d1u59a_         132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALS  207 (285)
T ss_dssp             CCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             cCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHh
Confidence            999999999999999999999999976653321   123446788999999987654 7999999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-41  Score=237.92  Aligned_cols=153  Identities=29%  Similarity=0.491  Sum_probs=134.8

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+++.+|++++++++||||+++++++.+++.+++||||++ |++.+++... ...+++..+..++.|++.|+.|||++|
T Consensus        56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~  135 (287)
T d1opja_          56 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN  135 (287)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC
Confidence            45678999999999999999999999999999999999998 5898888653 457899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       136 iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~  211 (287)
T d1opja_         136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT  211 (287)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHT
T ss_pred             cccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHh
Confidence            9999999999999999999999999997654332 2233345688999999987755 7999999999999999997

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9e-41  Score=239.98  Aligned_cols=150  Identities=27%  Similarity=0.459  Sum_probs=135.2

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+.+.+|+++|+.++||||+++++++.+...+++|||++.| ++.+.+...+ .+++..++.++.|++.||.|||++|
T Consensus        83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~~  161 (350)
T d1rdqe_          83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSLD  161 (350)
T ss_dssp             TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Confidence            4456788999999999999999999999999999999999985 8888876654 7999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.+|.+||+|||+++....   ......||+.|+|||++.+.. ++.++|||||||++|+|+|
T Consensus       162 iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemlt  233 (350)
T d1rdqe_         162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAA  233 (350)
T ss_dssp             EECCCCSGGGEEECTTSCEEECCCTTCEECSS---CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             EecCcCCHHHcccCCCCCEEeeeceeeeeccc---ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHh
Confidence            99999999999999999999999999987552   234567899999999998754 7999999999999999997

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-40  Score=234.27  Aligned_cols=150  Identities=33%  Similarity=0.551  Sum_probs=134.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|++++++++||||+++++++.+++.+|+|||||+| +|.+++...+ .+++..++.++.|++.|+.|||+++++
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~~iv  135 (293)
T d1jksa_          57 REDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSLQIA  135 (293)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhcccc-ccchhHHHHHHHHHHHHHHhhhhccee
Confidence            45688999999999999999999999999999999999985 9998887654 799999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCC----ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSG----ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~----~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++    .+|++|||++...... .......|++.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~-~~~~~~~~t~~y~APE~~~~~~-~~~~~DiwSlGvilyell~  211 (293)
T d1jksa_         136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLS  211 (293)
T ss_dssp             CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTS-CBCSCCCCCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             ecccccceEEEecCCCcccceEecchhhhhhcCCC-ccccccCCCCcccCHHHHcCCC-CCCcccchhhhHHHHHHHc
Confidence            999999999998776    4999999998766532 3445567899999999998654 7999999999999999996

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-41  Score=239.41  Aligned_cols=154  Identities=23%  Similarity=0.465  Sum_probs=132.8

Q ss_pred             CchhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC----------------------CCC
Q psy7820           7 GVPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP----------------------VPV   62 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~----------------------~~~   62 (163)
                      .....+.+|+++++++ +||||+++++++.+.+.+++|||||++ +|.+++....                      ..+
T Consensus        82 ~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  161 (325)
T d1rjba_          82 SEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL  161 (325)
T ss_dssp             --CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------C
T ss_pred             HHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCC
Confidence            3445688999999998 899999999999999999999999985 9999986543                      347


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCC
Q psy7820          63 PPALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGA  140 (163)
Q Consensus        63 ~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~  140 (163)
                      ++..++.++.|+++|+.|||+++++||||||+||+++.++.+||+|||+++........  .....||+.|+|||.+.+.
T Consensus       162 ~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~  241 (325)
T d1rjba_         162 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG  241 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC
Confidence            88999999999999999999999999999999999999999999999999765543322  2345679999999998765


Q ss_pred             cCCCcchhhHHHHHHHHHHhc
Q psy7820         141 KVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       141 ~~~~~~~Di~slG~~l~~ll~  161 (163)
                      . ++.++||||+||++|||+|
T Consensus       242 ~-~~~~~DiwS~Gvil~emlt  261 (325)
T d1rjba_         242 I-YTIKSDVWSYGILLWEIFS  261 (325)
T ss_dssp             C-CCHHHHHHHHHHHHHHHTT
T ss_pred             C-CCcceeccchhHHHHHHHh
Confidence            4 7999999999999999986

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-41  Score=234.56  Aligned_cols=151  Identities=25%  Similarity=0.448  Sum_probs=128.2

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      .++.+|++++++++||||+++++++.+.+..++|||++.+ ++.+.+......+++..+..++.|++.|++|||+++++|
T Consensus        54 ~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiH  133 (283)
T d1mqba_          54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVH  133 (283)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhcccccccc
Confidence            4688999999999999999999999999999999999985 788888777778999999999999999999999999999


Q ss_pred             cCCCCCcEEEccCCceEEeecccccccccCCC---cccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKSGALKLADFGLSRAFTIPMN---RYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.++.+||+|||+++.......   ......|++.|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       134 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t  208 (283)
T d1mqba_         134 RDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMT  208 (283)
T ss_dssp             SCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             CccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHh
Confidence            99999999999999999999999976543221   223346788999999987754 7999999999999999986

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-40  Score=234.10  Aligned_cols=154  Identities=67%  Similarity=1.168  Sum_probs=139.2

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQ-TTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ...++.+|++++++++||||+++++++.+++.+|+|||++.+++.+.+. .....+++..+..++.|++.|++|||++|+
T Consensus        44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~I  123 (298)
T d1gz8a_          44 VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRV  123 (298)
T ss_dssp             CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence            4567889999999999999999999999999999999999987776664 445679999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.++.+|++|||.+..............|++.|+|||.......++.++|+||+|+++|+|++
T Consensus       124 iHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~  198 (298)
T d1gz8a_         124 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT  198 (298)
T ss_dssp             CCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHH
T ss_pred             EccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhh
Confidence            999999999999999999999999998776655666667889999999998776666899999999999999996

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-41  Score=234.33  Aligned_cols=150  Identities=27%  Similarity=0.445  Sum_probs=129.1

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++.++ ..++||||+++ +|.+++.... .+++..++.++.|++.|++|||+++++
T Consensus        52 ~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~~ii  129 (277)
T d1xbba_          52 KDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEESNFV  129 (277)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHhhHHhCCcc
Confidence            45789999999999999999999999764 56899999985 8888877654 799999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.++++|||+++........   .....|++.|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       130 HrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt  205 (277)
T d1xbba_         130 HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFS  205 (277)
T ss_dssp             CSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             cCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhh
Confidence            9999999999999999999999999765433221   23346789999999987655 7999999999999999986

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.8e-40  Score=239.53  Aligned_cols=145  Identities=25%  Similarity=0.439  Sum_probs=129.4

Q ss_pred             HHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Q psy7820          14 REISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDLK   92 (163)
Q Consensus        14 ~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i~   92 (163)
                      +|+++++.++||||+++++++.+++.+|+||||++| +|.+++.... .+++..++.++.|++.|++|||++|++|+|||
T Consensus        56 ~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlK  134 (364)
T d1omwa3          56 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNRFVVYRDLK  134 (364)
T ss_dssp             HHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred             HHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcc-cccHHHHHHHHHHHHHHHHHHHHCCccceeec
Confidence            347777888899999999999999999999999985 9988887654 78899999999999999999999999999999


Q ss_pred             CCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          93 PQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        93 ~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+++.+|.+||+|||+++....  .......||+.|+|||++.....++.++||||+||++|+|+|
T Consensus       135 P~NILl~~~g~iKl~DFGla~~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemlt  201 (364)
T d1omwa3         135 PANILLDEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLR  201 (364)
T ss_dssp             GGGEEECSSSCEEECCCTTCEECSS--SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred             cceeEEcCCCcEEEeeeceeeecCC--CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHh
Confidence            9999999999999999999976553  334556899999999998765557999999999999999997

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-40  Score=228.23  Aligned_cols=154  Identities=26%  Similarity=0.458  Sum_probs=137.0

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|+.++++++||||+++++++.+++.+++||||++ |++.+++......+++..+..++.|+++|+.|||++|
T Consensus        41 ~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~  120 (258)
T d1k2pa_          41 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ  120 (258)
T ss_dssp             SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC
Confidence            345789999999999999999999999999999999999997 5888888777778999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+||+++.++.+||+|||++....... .......+++.|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       121 iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t  196 (258)
T d1k2pa_         121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS  196 (258)
T ss_dssp             BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHh
Confidence            9999999999999999999999999987654332 2233456789999999998655 7999999999999999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.2e-40  Score=230.38  Aligned_cols=150  Identities=32%  Similarity=0.594  Sum_probs=134.4

Q ss_pred             hhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820          10 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      +++.+|+.++++++ ||||+++++++.+++.+|+||||++| +|.+++...+ .+++..+..++.|++.|++|||++|++
T Consensus        54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~~iv  132 (277)
T d1phka_          54 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIV  132 (277)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCc
Confidence            46889999999996 99999999999999999999999985 9999987654 899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccC-----CcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLG-----AKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-----~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||+|+||+++.++.+||+|||++...... .......||+.|++||.+.+     ...++.++||||+|+++|+|++
T Consensus       133 HrDlkp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~  210 (277)
T d1phka_         133 HRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLA  210 (277)
T ss_dssp             CSCCSGGGEEECTTCCEEECCCTTCEECCTT-CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHH
T ss_pred             ccccccceEEEcCCCCeEEccchheeEccCC-CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhcc
Confidence            9999999999999999999999999876543 34456788999999999852     2346889999999999999996

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-40  Score=233.25  Aligned_cols=153  Identities=33%  Similarity=0.503  Sum_probs=136.1

Q ss_pred             CchhhHHHHHHHHh-cCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLK-ELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...+.+..|..++. .++||||+++++++.+++.+|+||||++| +|.+++.... .+++..+..++.|++.|++|||++
T Consensus        44 ~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~  122 (320)
T d1xjda_          44 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK  122 (320)
T ss_dssp             TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            44456777777765 68999999999999999999999999985 8988886544 789999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |++|+||||+||+++.++.+|++|||.++.............||+.|+|||++.+.. ++.++||||+||++|+|++
T Consensus       123 ~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemlt  198 (320)
T d1xjda_         123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLI  198 (320)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHH
T ss_pred             CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHh
Confidence            999999999999999999999999999987665555566678999999999998755 7999999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-40  Score=233.38  Aligned_cols=150  Identities=27%  Similarity=0.474  Sum_probs=134.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIH   88 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h   88 (163)
                      ..+.+|+++|+.++||||+++++++.+++.+|+|||||+| +|.+.+...+..+++..+..++.|++.|++|||++|++|
T Consensus        46 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiH  125 (321)
T d1tkia_          46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGH  125 (321)
T ss_dssp             HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCc
Confidence            3577999999999999999999999999999999999985 999999887778999999999999999999999999999


Q ss_pred             cCCCCCcEEEccC--CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          89 RDLKPQNILINKS--GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        89 ~~i~~~ni~~~~~--~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +||||+||+++.+  +.++++|||++..... ........+++.|++||...+.. ++.++||||+||++|+|++
T Consensus       126 rDlKp~NIll~~~~~~~ikl~DFG~~~~~~~-~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~  198 (321)
T d1tkia_         126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKP-GDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLS  198 (321)
T ss_dssp             CCCCGGGEEESSSSCCCEEECCCTTCEECCT-TCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHH
T ss_pred             ccccccceeecCCCceEEEEcccchhhcccc-CCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHh
Confidence            9999999999854  4799999999876543 33445567899999999987755 7999999999999999996

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=231.35  Aligned_cols=153  Identities=26%  Similarity=0.488  Sum_probs=131.1

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ...+++.+|++++++++||||+++++++.+ +..++||||+++ +|.+++.... ..+++..++.++.|++.|+.|||++
T Consensus        50 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~  128 (272)
T d1qpca_          50 MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER  128 (272)
T ss_dssp             SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence            345678999999999999999999998865 457899999985 8888765433 3689999999999999999999999


Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +++||||||+||+++.++.+||+|||+++...... .......|++.|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       129 ~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt  205 (272)
T d1qpca_         129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVT  205 (272)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHT
T ss_pred             CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHh
Confidence            99999999999999999999999999998665332 2233456788999999987654 7999999999999999997

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-40  Score=229.45  Aligned_cols=151  Identities=27%  Similarity=0.517  Sum_probs=122.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+.+.+|++++++++||||+++++++.+ +.+++||||++ |++.+++......+++..++.++.|+++|+.|||+++++
T Consensus        52 ~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ii  130 (273)
T d1mp8a_          52 REKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFV  130 (273)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCee
Confidence            4568899999999999999999999964 57899999998 488888887777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.+|++|||+++...... .......|++.|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       131 HrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt  204 (273)
T d1mp8a_         131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILM  204 (273)
T ss_dssp             CSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHT
T ss_pred             ccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHh
Confidence            99999999999999999999999987654322 2233456789999999987654 7999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-39  Score=230.66  Aligned_cols=153  Identities=22%  Similarity=0.397  Sum_probs=130.1

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ...+++.+|++++++++||||+++++++.++.. +++++++. |+|.+.+......+++..++.++.|++.|+.|||+++
T Consensus        53 ~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~-~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~  131 (317)
T d1xkka_          53 KANKEILDEAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR  131 (317)
T ss_dssp             CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSE-EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            345678999999999999999999999987654 55566665 6999999888889999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.+||+|||+++........  .....||+.|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       132 iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t  208 (317)
T d1xkka_         132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMT  208 (317)
T ss_dssp             CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHH
Confidence            999999999999999999999999999765433222  22345789999999987754 7999999999999999997

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-39  Score=226.93  Aligned_cols=155  Identities=61%  Similarity=1.091  Sum_probs=136.3

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....++.+|+.+|++++||||+++++.+.+++..++++|++.+++...+....+.+++..+..++.|++.|++|||+.|+
T Consensus        42 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~I  121 (286)
T d1ob3a_          42 GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV  121 (286)
T ss_dssp             CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcE
Confidence            34567899999999999999999999999999999999999998888887777799999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.++.+|++|||.+..............+++.|++||.+.+...++.++|+||+|+++|||++
T Consensus       122 vHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~  196 (286)
T d1ob3a_         122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN  196 (286)
T ss_dssp             CCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred             EecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH
Confidence            999999999999999999999999998776555555566789999999999877778999999999999999996

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.3e-39  Score=227.44  Aligned_cols=151  Identities=29%  Similarity=0.495  Sum_probs=123.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc----EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|++++++++||||+++++++.+.+    .+|+||||++| +|.+.+...+ .+++..++.++.|++.|++|||+
T Consensus        51 ~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~  129 (277)
T d1o6ya_          51 YLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ  129 (277)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence            346889999999999999999999987643    58999999986 8887776544 79999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +|++|+||||+||+++.++..+++|||.+.......   .......||+.|+|||++.+.. +++++||||+||++|+|+
T Consensus       130 ~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyell  208 (277)
T d1o6ya_         130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVL  208 (277)
T ss_dssp             TTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHH
T ss_pred             CCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHH
Confidence            999999999999999999999999999876543322   2344567899999999987654 799999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      |
T Consensus       209 t  209 (277)
T d1o6ya_         209 T  209 (277)
T ss_dssp             H
T ss_pred             h
Confidence            7

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-39  Score=231.12  Aligned_cols=151  Identities=32%  Similarity=0.480  Sum_probs=130.9

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeee----CcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPV----DFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~----~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      ...+.+|++++.++ +||||+++++++++    +..+|+|||||+| +|.+++.+.+ ..+++..++.++.|++.|+.||
T Consensus        48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl  127 (335)
T d2ozaa1          48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL  127 (335)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH
Confidence            45678899987655 89999999999876    4579999999985 9999997653 5799999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEcc---CCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          82 HSRRIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      |++|++||||||+||+++.   ++.+||+|||+++..... .......|++.|+|||++.+.. ++.++||||+||++|+
T Consensus       128 H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~  205 (335)
T d2ozaa1         128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYI  205 (335)
T ss_dssp             HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC-CCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHH
T ss_pred             HHcCCccccccccccccccccccccccccccceeeeccCC-CccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHH
Confidence            9999999999999999975   457999999999766533 3445668899999999987654 7999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |+|
T Consensus       206 llt  208 (335)
T d2ozaa1         206 LLC  208 (335)
T ss_dssp             HTT
T ss_pred             Hhh
Confidence            997

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-39  Score=225.73  Aligned_cols=152  Identities=26%  Similarity=0.457  Sum_probs=125.6

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTT-PVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+.+.+|+.++++++|+||+++++++.+ +.+++||||+++ ++...+... ...+++..++.++.|++.|+.|||++|
T Consensus        55 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~  133 (285)
T d1fmka3          55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN  133 (285)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh
Confidence            34679999999999999999999999965 457899999985 777776543 346899999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCC-CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM-NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++++||+|||+++...... .......|++.|+|||.+.+.. ++.++||||+|+++|||++
T Consensus       134 ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t  209 (285)
T d1fmka3         134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTT  209 (285)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             eecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHh
Confidence            9999999999999999999999999987654222 2233456799999999997655 6999999999999999986

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-39  Score=225.04  Aligned_cols=149  Identities=34%  Similarity=0.531  Sum_probs=129.6

Q ss_pred             hhHHHHHHHHhcCC--CCCeeeeeeeeeeCcEEEEEecchhc--cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820          10 STALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQ--DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus        10 ~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      .++.+|+.++++++  ||||+++++++.+++..++|||++.+  ++.+.+... ..+++..++.++.|++.|++|||++|
T Consensus        52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~  130 (273)
T d1xwsa_          52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCG  130 (273)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence            44678999999996  89999999999999999999999964  677766654 47999999999999999999999999


Q ss_pred             ceecCCCCCcEEEccC-CceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKS-GALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~-~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.+ +.+||+|||.+.....  .......||+.|+|||++.+...++.++||||+||++|+|+|
T Consensus       131 iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~--~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~  205 (273)
T d1xwsa_         131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKD--TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC  205 (273)
T ss_dssp             EECSCCSGGGEEEETTTTEEEECCCTTCEECCS--SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CccccCcccceEEecCCCeEEECccccceeccc--ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhh
Confidence            9999999999999865 7899999999876442  334456789999999999876655678999999999999996

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-39  Score=225.13  Aligned_cols=151  Identities=30%  Similarity=0.449  Sum_probs=130.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRII   87 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~   87 (163)
                      .+++.+|++++++++||||+++++++.++ ..++||||++ |++.+.+....+.+++..++.++.|++.|+.|||++|++
T Consensus        55 ~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ii  133 (273)
T d1u46a_          55 MDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI  133 (273)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEeec-chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEe
Confidence            45789999999999999999999999764 6789999998 488888877777899999999999999999999999999


Q ss_pred             ecCCCCCcEEEccCCceEEeecccccccccCCCc---ccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          88 HRDLKPQNILINKSGALKLADFGLSRAFTIPMNR---YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        88 h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      |+||||+||+++.++.+|++|||++.........   .....++..|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       134 HrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt  209 (273)
T d1u46a_         134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFT  209 (273)
T ss_dssp             CSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHT
T ss_pred             eeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHh
Confidence            9999999999999999999999999876433221   22345678899999998754 7999999999999999996

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-38  Score=223.71  Aligned_cols=153  Identities=24%  Similarity=0.434  Sum_probs=133.6

Q ss_pred             chhhHHHHHHHHhcCCCCCeeeeeeeeee-CcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKHPNVIRLHDVIPV-DFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+++.+|++++++++||||+++++++.+ ++..++||||+++ ++.+++.......++..++.++.|++.|+.|+|+.+
T Consensus        71 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~  150 (311)
T d1r0pa_          71 EVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK  150 (311)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC
Confidence            34668999999999999999999999765 5689999999985 888888888778889999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccCC----CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++||||||+||+++.++.+||+|||+++......    .......|++.|+|||.+.+.. ++.++||||+|+++|||+|
T Consensus       151 iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t  229 (311)
T d1r0pa_         151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMT  229 (311)
T ss_dssp             CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHT
T ss_pred             cccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHH
Confidence            9999999999999999999999999987654322    1222346788999999987655 7999999999999999996

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-39  Score=222.63  Aligned_cols=154  Identities=27%  Similarity=0.487  Sum_probs=124.9

Q ss_pred             ccCCchhhHHHHHHHHhcCCCCCeeeeeeeee-eCcEEEEEecchhc-cHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHH
Q psy7820           4 QVEGVPSTALREISVLKELKHPNVIRLHDVIP-VDFKLFLVFEFLRQ-DLKDFLQTTP-VPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus         4 ~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ..+...+++.+|++++++++||||+++++++. ..+.+++||||+++ +|.+++.... ..+++..++.++.|++.|+.|
T Consensus        39 ~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~y  118 (262)
T d1byga_          39 KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY  118 (262)
T ss_dssp             CCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccc
Confidence            34556678999999999999999999999885 45678999999985 9999886543 358899999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          81 CHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      ||+.+++|+||+|+||+++.++.++++|||.++....   ......++..|+|||.+.+.. +++++||||+|+++|||+
T Consensus       119 lH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~---~~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~  194 (262)
T d1byga_         119 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIY  194 (262)
T ss_dssp             HHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHH
T ss_pred             cccCceeccccchHhheecCCCCEeecccccceecCC---CCccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHH
Confidence            9999999999999999999999999999999876442   223445688999999987654 799999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      |
T Consensus       195 t  195 (262)
T d1byga_         195 S  195 (262)
T ss_dssp             T
T ss_pred             H
Confidence            7

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-38  Score=224.69  Aligned_cols=152  Identities=28%  Similarity=0.444  Sum_probs=131.6

Q ss_pred             chhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC---------------CCCCCHHHHHHH
Q psy7820           8 VPSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT---------------PVPVPPALAKSY   70 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---------------~~~~~~~~~~~~   70 (163)
                      ..+++.+|+++|+++ +||||+++++++.+++..++||||++ |+|.+++...               ...+++..+..+
T Consensus        53 ~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  132 (309)
T d1fvra_          53 DHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF  132 (309)
T ss_dssp             --CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHH
Confidence            456789999999999 79999999999999999999999998 5999988643               357899999999


Q ss_pred             HHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhH
Q psy7820          71 LYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIW  150 (163)
Q Consensus        71 ~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~  150 (163)
                      +.|++.|+.|+|+++++|+||||+||+++.++.+||+|||+++..... .......|+..|+|||.+.+.. ++.++|||
T Consensus       133 ~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~-~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvw  210 (309)
T d1fvra_         133 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSV-YTTNSDVW  210 (309)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCE-ECHHHHHH
T ss_pred             HHHHHHHHHhhhcCCccccccccceEEEcCCCceEEcccccccccccc-ccccceecCCcccchHHhccCC-CCccceee
Confidence            999999999999999999999999999999999999999998755432 2233456789999999997755 79999999


Q ss_pred             HHHHHHHHHhc
Q psy7820         151 SAGCIFSEMIQ  161 (163)
Q Consensus       151 slG~~l~~ll~  161 (163)
                      |+|+++|||++
T Consensus       211 SfGvil~ell~  221 (309)
T d1fvra_         211 SYGVLLWEIVS  221 (309)
T ss_dssp             HHHHHHHHHHT
T ss_pred             hhHHHHHHHHh
Confidence            99999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.6e-38  Score=220.31  Aligned_cols=152  Identities=28%  Similarity=0.555  Sum_probs=130.9

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC-----------------------CCCCH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP-----------------------VPVPP   64 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----------------------~~~~~   64 (163)
                      ..++.+|++++++++|+|++++++++.+.+..++++|+++ |+|.+++....                       ..+++
T Consensus        60 ~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  139 (301)
T d1lufa_          60 QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC  139 (301)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCH
T ss_pred             HHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCH
Confidence            4568999999999999999999999999999999999998 59999885432                       24788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcC
Q psy7820          65 ALAKSYLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKV  142 (163)
Q Consensus        65 ~~~~~~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~  142 (163)
                      ..++.++.|++.|++|||+++++|+||||+||+++.++.+||+|||+++......  .......+++.|+|||.+.+.. 
T Consensus       140 ~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-  218 (301)
T d1lufa_         140 AEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-  218 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-
T ss_pred             HHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-
Confidence            9999999999999999999999999999999999999999999999987553221  2223456788999999998754 


Q ss_pred             CCcchhhHHHHHHHHHHhc
Q psy7820         143 YSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       143 ~~~~~Di~slG~~l~~ll~  161 (163)
                      ++.++||||+|+++|||++
T Consensus       219 ~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         219 YTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             CCHHHHHHHHHHHHHHHHT
T ss_pred             CChhhhhccchhhHHHHHc
Confidence            7999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-37  Score=218.82  Aligned_cols=152  Identities=51%  Similarity=0.922  Sum_probs=128.7

Q ss_pred             chhhHHHHHHHHhcC---CCCCeeeeeeeeee-----CcEEEEEecchhccHHHH-HhcCCCCCCHHHHHHHHHHHHHHH
Q psy7820           8 VPSTALREISVLKEL---KHPNVIRLHDVIPV-----DFKLFLVFEFLRQDLKDF-LQTTPVPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~---~h~~i~~~~~~~~~-----~~~~~lv~e~~~~~l~~~-~~~~~~~~~~~~~~~~~~~i~~~l   78 (163)
                      ....+.+|+++++.+   +||||++++++|..     ...+++++|++.+++... .......+++..++.++.|++.|+
T Consensus        50 ~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL  129 (305)
T d1blxa_          50 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL  129 (305)
T ss_dssp             CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHH
Confidence            345677888887766   79999999999853     347899999999865544 445556789999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSE  158 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~  158 (163)
                      +|||++|++|+||||+||+++.++.+|++|||.+..... ........||+.|+|||++.+.. ++.++||||+||++||
T Consensus       130 ~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~-~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~e  207 (305)
T d1blxa_         130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAE  207 (305)
T ss_dssp             HHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCG-GGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHH
T ss_pred             HHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhcc-cccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHH
Confidence            999999999999999999999999999999998865442 23455678899999999987754 7999999999999999


Q ss_pred             Hhc
Q psy7820         159 MIQ  161 (163)
Q Consensus       159 ll~  161 (163)
                      |++
T Consensus       208 ll~  210 (305)
T d1blxa_         208 MFR  210 (305)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            996

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-37  Score=214.83  Aligned_cols=155  Identities=62%  Similarity=1.123  Sum_probs=138.3

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRI   86 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i   86 (163)
                      ....++.+|+.+++.++|+||+++++++.+....+++++++.+..+..+....+.+++..+..++.|++.|++|||++|+
T Consensus        43 ~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~I  122 (292)
T d1unla_          43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV  122 (292)
T ss_dssp             THHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred             HHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCE
Confidence            34567889999999999999999999999999999999999986666666666789999999999999999999999999


Q ss_pred             eecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          87 IHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        87 ~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|+||||+||+++.++.+|++|||.+..............+++.|.|||.+.+...++.++||||+||++|||++
T Consensus       123 vHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~  197 (292)
T d1unla_         123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELAN  197 (292)
T ss_dssp             ECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTT
T ss_pred             eeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhh
Confidence            999999999999999999999999998776555555556678889999998876667999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-37  Score=220.54  Aligned_cols=151  Identities=32%  Similarity=0.660  Sum_probs=128.5

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeee------CcEEEEEecchhccHHHHHh---cCCCCCCHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLRQDLKDFLQ---TTPVPVPPALAKSYLYQLLEALRY   80 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~------~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~~~~~i~~~l~~   80 (163)
                      ....+|+++|++++|+||++++++|..      ..++++||||+++++...+.   .....+++..++.++.|++.||+|
T Consensus        58 ~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~y  137 (350)
T d1q5ka_          58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY  137 (350)
T ss_dssp             SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            344589999999999999999999853      33689999999987655543   355689999999999999999999


Q ss_pred             HHhCCceecCCCCCcEEEccCC-ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHH
Q psy7820          81 CHSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEM  159 (163)
Q Consensus        81 lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~l  159 (163)
                      ||++||+||||||+||+++.++ .+||+|||++...... .......|++.|+|||.+.+...++.++||||+||++|||
T Consensus       138 LH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el  216 (350)
T d1q5ka_         138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL  216 (350)
T ss_dssp             HHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT-SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC-cccccccccccccChHHhhcccCCCcceeecccceEEEeh
Confidence            9999999999999999999775 8999999998765432 3344567899999999987766689999999999999999


Q ss_pred             hc
Q psy7820         160 IQ  161 (163)
Q Consensus       160 l~  161 (163)
                      ++
T Consensus       217 ~~  218 (350)
T d1q5ka_         217 LL  218 (350)
T ss_dssp             HH
T ss_pred             hh
Confidence            86

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-36  Score=214.11  Aligned_cols=155  Identities=20%  Similarity=0.276  Sum_probs=136.2

Q ss_pred             CCchhhHHHHHHHHhcCCC-CCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      ....+.+.+|++.++.++| +|++++++++.++...++|||+++++|.+.+...+..++...+..++.|++.++++||++
T Consensus        41 ~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~  120 (293)
T d1csna_          41 RSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK  120 (293)
T ss_dssp             CTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred             ccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC
Confidence            3445678899999999965 899999999999999999999999999999988777899999999999999999999999


Q ss_pred             CceecCCCCCcEEEcc-----CCceEEeecccccccccCC-------CcccccccCccccCcccccCCcCCCcchhhHHH
Q psy7820          85 RIIHRDLKPQNILINK-----SGALKLADFGLSRAFTIPM-------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSA  152 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~-----~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~sl  152 (163)
                      |++|+||||+||+++.     ++.++++|||+++......       .......||+.|+|||.+.+.. ++.++|+||+
T Consensus       121 giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSl  199 (293)
T d1csna_         121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEAL  199 (293)
T ss_dssp             TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHH
T ss_pred             CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHh
Confidence            9999999999999964     5789999999997764332       2233457899999999998754 7999999999


Q ss_pred             HHHHHHHhc
Q psy7820         153 GCIFSEMIQ  161 (163)
Q Consensus       153 G~~l~~ll~  161 (163)
                      |+++|||+|
T Consensus       200 G~~l~ellt  208 (293)
T d1csna_         200 GHVFMYFLR  208 (293)
T ss_dssp             HHHHHHHHH
T ss_pred             hHHHHHHHh
Confidence            999999996

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-36  Score=216.38  Aligned_cols=155  Identities=48%  Similarity=0.875  Sum_probs=133.7

Q ss_pred             CchhhHHHHHHHHhcCCCCCeeeeeeeeee--------CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Q psy7820           7 GVPSTALREISVLKELKHPNVIRLHDVIPV--------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEAL   78 (163)
Q Consensus         7 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l   78 (163)
                      ....++.+|+++|++++|+|++++++++..        ++.++++||++++++..........+++..++.++.|++.|+
T Consensus        51 ~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l  130 (318)
T d3blha1          51 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL  130 (318)
T ss_dssp             SSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHH
Confidence            445668899999999999999999999854        346899999999888888777777899999999999999999


Q ss_pred             HHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC----CcccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          79 RYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM----NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        79 ~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      .|||++|++|+||||+||+++.++.++++|||++.......    .......||+.|+|||.+.+...++.++||||+||
T Consensus       131 ~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGv  210 (318)
T d3blha1         131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC  210 (318)
T ss_dssp             HHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCc
Confidence            99999999999999999999999999999999987654221    22334568999999999887666899999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|+|++
T Consensus       211 il~el~~  217 (318)
T d3blha1         211 IMAEMWT  217 (318)
T ss_dssp             HHHHHHH
T ss_pred             eeeeHhh
Confidence            9999986

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-37  Score=216.77  Aligned_cols=152  Identities=28%  Similarity=0.519  Sum_probs=132.8

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcCC---------------CCCCHHHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTTP---------------VPVPPALAKSYL   71 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---------------~~~~~~~~~~~~   71 (163)
                      ..++.+|...+.++ +||||+++++++.+++.+++||||+. |++.+++....               ..+++..++.++
T Consensus        62 ~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  141 (299)
T d1fgka_          62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA  141 (299)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHH
Confidence            35677899999888 79999999999999999999999998 59999886543               458999999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcchhh
Q psy7820          72 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        72 ~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      .|++.|++|||+++++||||||+||+++.++.+||+|||.+.......  .......+++.|+|||.+.+.. ++.++||
T Consensus       142 ~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~Di  220 (299)
T d1fgka_         142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDV  220 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHH
T ss_pred             HHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhh
Confidence            999999999999999999999999999999999999999987665332  2234456788999999987654 7999999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+|+++|||++
T Consensus       221 wS~Gvvl~ell~  232 (299)
T d1fgka_         221 WSFGVLLWEIFT  232 (299)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHhHHHHHHhcc
Confidence            999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-37  Score=219.92  Aligned_cols=148  Identities=44%  Similarity=0.752  Sum_probs=131.3

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc------EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF------KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~------~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .+.+.+|+++|++++|||+++++++|...+      .+|+|||+++.++......  ..+++..++.++.|++.|++|||
T Consensus        61 ~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH  138 (346)
T d1cm8a_          61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIH  138 (346)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHH
Confidence            346789999999999999999999997654      5799999998788777654  36899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||||+||+++.++.++++|||.+.....   ......|++.|+|||.+.+...++.++||||+||++|+|++
T Consensus       139 ~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~  214 (346)
T d1cm8a_         139 AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS---EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT  214 (346)
T ss_dssp             HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS---SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH
T ss_pred             hCCCcccccCcchhhcccccccccccccceeccCC---ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHH
Confidence            99999999999999999999999999999976553   34456789999999998876667999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-37  Score=217.65  Aligned_cols=151  Identities=26%  Similarity=0.487  Sum_probs=122.2

Q ss_pred             hhHHHHHHHHhcC-CCCCeeeeeeeeee-CcEEEEEecchh-ccHHHHHhcC---------------CCCCCHHHHHHHH
Q psy7820          10 STALREISVLKEL-KHPNVIRLHDVIPV-DFKLFLVFEFLR-QDLKDFLQTT---------------PVPVPPALAKSYL   71 (163)
Q Consensus        10 ~~~~~e~~~l~~~-~h~~i~~~~~~~~~-~~~~~lv~e~~~-~~l~~~~~~~---------------~~~~~~~~~~~~~   71 (163)
                      ..+.+|...+.++ +|+||+++++++.. +..+++|||||+ |+|.+++...               ...+++..+..++
T Consensus        61 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  140 (299)
T d1ywna1          61 RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS  140 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHH
Confidence            4567788888877 68999999998765 457899999998 5999998643               2358899999999


Q ss_pred             HHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCC--cccccccCccccCcccccCCcCCCcchhh
Q psy7820          72 YQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN--RYTHEVVTLWYRPPEILLGAKVYSTTVDI  149 (163)
Q Consensus        72 ~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~Di  149 (163)
                      .|+++|+.|||+++++||||||+||+++.++.+||+|||+++.......  ......||+.|+|||.+.+.. ++.++||
T Consensus       141 ~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDi  219 (299)
T d1ywna1         141 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDV  219 (299)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccce
Confidence            9999999999999999999999999999999999999999976543322  233457899999999997754 7999999


Q ss_pred             HHHHHHHHHHhc
Q psy7820         150 WSAGCIFSEMIQ  161 (163)
Q Consensus       150 ~slG~~l~~ll~  161 (163)
                      ||+||++|||+|
T Consensus       220 wS~Gvil~ellt  231 (299)
T d1ywna1         220 WSFGVLLWEIFS  231 (299)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             eehHHHHHHHHh
Confidence            999999999996

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-37  Score=217.67  Aligned_cols=152  Identities=25%  Similarity=0.428  Sum_probs=133.0

Q ss_pred             hhhHHHHHHHHhcC-CCCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCC-----------------CCCCHHHHHH
Q psy7820           9 PSTALREISVLKEL-KHPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTP-----------------VPVPPALAKS   69 (163)
Q Consensus         9 ~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-----------------~~~~~~~~~~   69 (163)
                      ..++.+|+.+++++ +||||+++++++.+++..++|||||++ ++.+++....                 ..+++..+..
T Consensus        70 ~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  149 (311)
T d1t46a_          70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS  149 (311)
T ss_dssp             HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHH
Confidence            34678999999999 699999999999999999999999985 8888886532                 3588999999


Q ss_pred             HHHHHHHHHHHHHhCCceecCCCCCcEEEccCCceEEeecccccccccCC--CcccccccCccccCcccccCCcCCCcch
Q psy7820          70 YLYQLLEALRYCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM--NRYTHEVVTLWYRPPEILLGAKVYSTTV  147 (163)
Q Consensus        70 ~~~~i~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~  147 (163)
                      ++.|++.|+.|||+++++|+||||+||+++.++.++++|||.++......  .......|++.|+|||.+.+.. ++.++
T Consensus       150 ~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~  228 (311)
T d1t46a_         150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFES  228 (311)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHH
T ss_pred             HHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcc
Confidence            99999999999999999999999999999999999999999997665332  2233457799999999987654 79999


Q ss_pred             hhHHHHHHHHHHhc
Q psy7820         148 DIWSAGCIFSEMIQ  161 (163)
Q Consensus       148 Di~slG~~l~~ll~  161 (163)
                      ||||+|+++|||+|
T Consensus       229 DIwS~G~~l~ellt  242 (311)
T d1t46a_         229 DVWSYGIFLWELFS  242 (311)
T ss_dssp             HHHHHHHHHHHHHT
T ss_pred             cccchHHHHHHHHh
Confidence            99999999999997

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-36  Score=216.50  Aligned_cols=151  Identities=40%  Similarity=0.746  Sum_probs=129.7

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeeeCc-----EEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPVDF-----KLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-----~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      ..++.+|+++|++++|||++++++++....     .++++++.++|+|.+++...  .+++..++.++.|++.|++|||+
T Consensus        50 ~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~  127 (345)
T d1pmea_          50 CQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHS  127 (345)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999999986543     46777777777999998764  68999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCC---CcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPM---NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      +|++||||||+||+++.++.+||+|||++.......   .......|++.|+|||.+.....++.++||||+|+++|+|+
T Consensus       128 ~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml  207 (345)
T d1pmea_         128 ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML  207 (345)
T ss_dssp             TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHH
T ss_pred             CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHh
Confidence            999999999999999999999999999987654321   22345568999999999876666789999999999999999


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       208 ~  208 (345)
T d1pmea_         208 S  208 (345)
T ss_dssp             H
T ss_pred             h
Confidence            6

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-36  Score=212.56  Aligned_cols=151  Identities=28%  Similarity=0.360  Sum_probs=122.8

Q ss_pred             hhHHHHHH--HHhcCCCCCeeeeeeeeeeCc----EEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820          10 STALREIS--VLKELKHPNVIRLHDVIPVDF----KLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus        10 ~~~~~e~~--~l~~~~h~~i~~~~~~~~~~~----~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      .++..|.+  .+.+++||||+++++++.+++    .+++||||+++ +|.+++.+.  .+++..++.++.+++.++.++|
T Consensus        40 ~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH  117 (303)
T d1vjya_          40 RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLH  117 (303)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Confidence            34444554  445678999999999987643    68999999975 999999764  6889999999999999999999


Q ss_pred             h--------CCceecCCCCCcEEEccCCceEEeecccccccccCCC----cccccccCccccCcccccCCc-----CCCc
Q psy7820          83 S--------RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMN----RYTHEVVTLWYRPPEILLGAK-----VYST  145 (163)
Q Consensus        83 ~--------~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~-----~~~~  145 (163)
                      +        +|++|+||||+||+++.++.+||+|||+++.......    ......||+.|+|||.+.+..     .++.
T Consensus       118 ~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  197 (303)
T d1vjya_         118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK  197 (303)
T ss_dssp             CCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHH
T ss_pred             HhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCc
Confidence            6        5999999999999999999999999999887654332    233457899999999986432     2467


Q ss_pred             chhhHHHHHHHHHHhcC
Q psy7820         146 TVDIWSAGCIFSEMIQI  162 (163)
Q Consensus       146 ~~Di~slG~~l~~ll~~  162 (163)
                      ++||||+|+++|||+|.
T Consensus       198 k~Di~S~Gvvl~el~tg  214 (303)
T d1vjya_         198 RADIYAMGLVFWEIARR  214 (303)
T ss_dssp             HHHHHHHHHHHHHHHHT
T ss_pred             chhhhhhHHHHHHHhhC
Confidence            89999999999999973

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-36  Score=213.27  Aligned_cols=151  Identities=24%  Similarity=0.432  Sum_probs=130.7

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchh-ccHHHHHhcC---------CCCCCHHHHHHHHHHHHHHHH
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLR-QDLKDFLQTT---------PVPVPPALAKSYLYQLLEALR   79 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---------~~~~~~~~~~~~~~~i~~~l~   79 (163)
                      ..+.+|++++++++||||+++++++..++..++|||++. |++.+++...         ...+++..+..++.++++|+.
T Consensus        68 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~  147 (308)
T d1p4oa_          68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA  147 (308)
T ss_dssp             HHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHH
Confidence            357899999999999999999999999999999999998 5888887532         134688999999999999999


Q ss_pred             HHHhCCceecCCCCCcEEEccCCceEEeecccccccccCCCc--ccccccCccccCcccccCCcCCCcchhhHHHHHHHH
Q psy7820          80 YCHSRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNR--YTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFS  157 (163)
Q Consensus        80 ~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~  157 (163)
                      |||+++++|+||||+||+++.++++||+|||+++........  .....+++.|++||.+.+.. ++.++|+||+|+++|
T Consensus       148 ~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~  226 (308)
T d1p4oa_         148 YLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLW  226 (308)
T ss_dssp             HHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHH
T ss_pred             HHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHH
Confidence            999999999999999999999999999999998765433222  23335789999999987754 799999999999999


Q ss_pred             HHhc
Q psy7820         158 EMIQ  161 (163)
Q Consensus       158 ~ll~  161 (163)
                      ||+|
T Consensus       227 El~t  230 (308)
T d1p4oa_         227 EIAT  230 (308)
T ss_dssp             HHHH
T ss_pred             HHHh
Confidence            9996

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-36  Score=214.37  Aligned_cols=153  Identities=28%  Similarity=0.472  Sum_probs=132.4

Q ss_pred             chhhHHHHHHHHhcCCC-CCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7820           8 VPSTALREISVLKELKH-PNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRR   85 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~h-~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~   85 (163)
                      ..+.+.+|++++++++| |||+++++++.+...++++||++.+ +|.+.+...+ .+++..+..++.|++.|++|+|++|
T Consensus        71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~~  149 (322)
T d1vzoa_          71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKLG  149 (322)
T ss_dssp             SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHHHHhhcCC
Confidence            44667899999999976 8999999999999999999999985 8888887655 6788999999999999999999999


Q ss_pred             ceecCCCCCcEEEccCCceEEeecccccccccC-CCcccccccCccccCcccccCCc-CCCcchhhHHHHHHHHHHhc
Q psy7820          86 IIHRDLKPQNILINKSGALKLADFGLSRAFTIP-MNRYTHEVVTLWYRPPEILLGAK-VYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        86 i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~-~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|+||||+||+++.++.++|+|||.+...... ........|++.|++||.+.+.. .++.++||||+||++|+|++
T Consensus       150 ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt  227 (322)
T d1vzoa_         150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT  227 (322)
T ss_dssp             CCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred             EEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence            999999999999999999999999998765432 33344567899999999987543 46889999999999999996

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-35  Score=207.39  Aligned_cols=155  Identities=20%  Similarity=0.236  Sum_probs=132.1

Q ss_pred             CCchhhHHHHHHHHhcCCCCC-eeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7820           6 EGVPSTALREISVLKELKHPN-VIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR   84 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~h~~-i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~   84 (163)
                      +....++..|+++++.++|++ ++.+.+++.+++..++|||++++++.+.+......+++..+..++.|++.|++|||++
T Consensus        43 ~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~  122 (299)
T d1ckia_          43 KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK  122 (299)
T ss_dssp             CTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred             hccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHC
Confidence            344567889999999997655 5666677788889999999999999888888778899999999999999999999999


Q ss_pred             CceecCCCCCcEEEcc---CCceEEeecccccccccCC-------CcccccccCccccCcccccCCcCCCcchhhHHHHH
Q psy7820          85 RIIHRDLKPQNILINK---SGALKLADFGLSRAFTIPM-------NRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGC  154 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~---~~~~~l~d~~~~~~~~~~~-------~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~  154 (163)
                      |++|+||||+||+++.   +..++++|||+++......       .......||+.|+|||.+.+.. ++.++||||+|+
T Consensus       123 ~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~  201 (299)
T d1ckia_         123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGY  201 (299)
T ss_dssp             TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHH
T ss_pred             CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCH
Confidence            9999999999999854   4579999999998765332       1234557899999999998755 799999999999


Q ss_pred             HHHHHhc
Q psy7820         155 IFSEMIQ  161 (163)
Q Consensus       155 ~l~~ll~  161 (163)
                      ++|||+|
T Consensus       202 ~l~el~t  208 (299)
T d1ckia_         202 VLMYFNL  208 (299)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9999997

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-35  Score=212.14  Aligned_cols=151  Identities=34%  Similarity=0.670  Sum_probs=128.5

Q ss_pred             CCchhhHHHHHHHHhcCC-CCCeeeeeeeeeeC--cEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH
Q psy7820           6 EGVPSTALREISVLKELK-HPNVIRLHDVIPVD--FKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYC   81 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~--~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l   81 (163)
                      .....++.+|+++|++++ ||||+++++++...  ..+++||||+++ +|...    ...+++..++.++.|++.||.||
T Consensus        70 ~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~----~~~l~e~~i~~i~~qil~aL~~L  145 (328)
T d3bqca1          70 PVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL----YQTLTDYDIRFYMYEILKALDYC  145 (328)
T ss_dssp             SSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGT----TTSCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHH----hcCCCHHHHHHHHHHHHHHHHHH
Confidence            344567889999999995 99999999999753  579999999986 65443    24789999999999999999999


Q ss_pred             HhCCceecCCCCCcEEEccCC-ceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHh
Q psy7820          82 HSRRIIHRDLKPQNILINKSG-ALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMI  160 (163)
Q Consensus        82 h~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll  160 (163)
                      |++|++|+||||+||+++.++ .++++|||.+...... .......+|+.|+|||.+.+...++.++|+||+|+++|+|+
T Consensus       146 H~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~  224 (328)
T d3bqca1         146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG-QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMI  224 (328)
T ss_dssp             HHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT-CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred             hhcccccccccccceEEcCCCCeeeecccccceeccCC-CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhc
Confidence            999999999999999998765 5899999998765432 33455678999999999887666899999999999999998


Q ss_pred             c
Q psy7820         161 Q  161 (163)
Q Consensus       161 ~  161 (163)
                      +
T Consensus       225 ~  225 (328)
T d3bqca1         225 F  225 (328)
T ss_dssp             H
T ss_pred             c
Confidence            6

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-34  Score=207.96  Aligned_cols=148  Identities=39%  Similarity=0.663  Sum_probs=122.0

Q ss_pred             hhhHHHHHHHHhcCCCCCeeeeeeeeee------CcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7820           9 PSTALREISVLKELKHPNVIRLHDVIPV------DFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCH   82 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh   82 (163)
                      ..++.+|+.++++++||||++++++|..      ...+|+||||+.+++++.+.   ..+++..++.++.|++.|+.|||
T Consensus        60 ~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH  136 (355)
T d2b1pa1          60 AKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLH  136 (355)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhh
Confidence            3457899999999999999999999853      36899999999998887765   36899999999999999999999


Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      ++|++|+||||+||+++.++..+++|||.+..... ........+|+.|+|||++.+.. +++++||||+||++++|++
T Consensus       137 ~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~-~~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~ell~  213 (355)
T d2b1pa1         137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT-SFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVR  213 (355)
T ss_dssp             HTTCCCSCCCGGGEEECTTCCEEECCCCC----------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHH
T ss_pred             hcccccccCCccccccccccceeeechhhhhcccc-ccccccccccccccChhhhcCCC-CCCCcccccccchHHHHhh
Confidence            99999999999999999999999999998876553 33445567899999999998754 7999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-34  Score=206.86  Aligned_cols=147  Identities=41%  Similarity=0.733  Sum_probs=122.3

Q ss_pred             hhHHHHHHHHhcCCCCCeeeeeeeeeeC------cEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7820          10 STALREISVLKELKHPNVIRLHDVIPVD------FKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHS   83 (163)
Q Consensus        10 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~   83 (163)
                      .++.+|+++|++++|+|++++++++...      ...+++++.++|+|.+++..  ..+++..++.++.|++.||.|||+
T Consensus        62 ~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~  139 (348)
T d2gfsa1          62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS  139 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHh
Confidence            4578999999999999999999998532      23555555555699888754  369999999999999999999999


Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHHHHHHhc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCIFSEMIQ  161 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~l~~ll~  161 (163)
                      +|++|+||||+||+++.++.++++|||.+....   .......|++.|+|||...+...++.++|+||+|+++|+|++
T Consensus       140 ~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~  214 (348)
T d2gfsa1         140 ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT  214 (348)
T ss_dssp             TTCCCCCCCGGGEEECTTCCEEECCC----CCT---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHH
T ss_pred             CCCcccccCCccccccccccccccccchhcccC---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHh
Confidence            999999999999999999999999999886544   334456778999999998776667899999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.95  E-value=9.6e-28  Score=172.54  Aligned_cols=149  Identities=32%  Similarity=0.520  Sum_probs=118.5

Q ss_pred             hhhHHHHHHHHhcCC-----------CCCeeeeeeeeeeC--cEEEEEecchh--ccHHH-HHhcCCCCCCHHHHHHHHH
Q psy7820           9 PSTALREISVLKELK-----------HPNVIRLHDVIPVD--FKLFLVFEFLR--QDLKD-FLQTTPVPVPPALAKSYLY   72 (163)
Q Consensus         9 ~~~~~~e~~~l~~~~-----------h~~i~~~~~~~~~~--~~~~lv~e~~~--~~l~~-~~~~~~~~~~~~~~~~~~~   72 (163)
                      .+.+.+|+++++.++           |+||+++++++...  ...+.+++++.  ++... ........+++..++.++.
T Consensus        53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~  132 (362)
T d1q8ya_          53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK  132 (362)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHH
Confidence            356678999998885           47899999988653  35556665553  33333 3344456789999999999


Q ss_pred             HHHHHHHHHHh-CCceecCCCCCcEEEccCCc------eEEeecccccccccCCCcccccccCccccCcccccCCcCCCc
Q psy7820          73 QLLEALRYCHS-RRIIHRDLKPQNILINKSGA------LKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYST  145 (163)
Q Consensus        73 ~i~~~l~~lh~-~~i~h~~i~~~ni~~~~~~~------~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~  145 (163)
                      |++.|+.|||+ .|++|+||||+||+++.++.      ++++|||.+.....   ......|++.|+|||.+.... ++.
T Consensus       133 qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~-~~~  208 (362)
T d1q8ya_         133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAP-WGC  208 (362)
T ss_dssp             HHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCC-CCT
T ss_pred             HHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc---ccccccccccccChhhccccC-CCc
Confidence            99999999997 89999999999999987654      89999999875443   334567899999999988655 699


Q ss_pred             chhhHHHHHHHHHHhc
Q psy7820         146 TVDIWSAGCIFSEMIQ  161 (163)
Q Consensus       146 ~~Di~slG~~l~~ll~  161 (163)
                      ++|+||+|+++++|++
T Consensus       209 ~~DiwSlG~il~el~~  224 (362)
T d1q8ya_         209 GADIWSTACLIFELIT  224 (362)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             cccccchHHHHHHHHH
Confidence            9999999999999996

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.77  E-value=1e-19  Score=119.65  Aligned_cols=128  Identities=22%  Similarity=0.148  Sum_probs=88.8

Q ss_pred             HHHHHHHHhcCCCCCeeeeeeeeeeCcEEEEEecchhccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCceecCC
Q psy7820          12 ALREISVLKELKHPNVIRLHDVIPVDFKLFLVFEFLRQDLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSRRIIHRDL   91 (163)
Q Consensus        12 ~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~~i   91 (163)
                      ..+|.+.+.++.|.++++.+++..    .+++||++++....       .++......++.|++.++.+||++|++|+||
T Consensus        61 ~~~e~~~l~~l~~~~v~~~~~~~~----~~lvme~~~~~~~~-------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDi  129 (191)
T d1zara2          61 ARNEFRALQKLQGLAVPKVYAWEG----NAVLMELIDAKELY-------RVRVENPDEVLDMILEEVAKFYHRGIVHGDL  129 (191)
T ss_dssp             HHHHHHHHHHTTTSSSCCEEEEET----TEEEEECCCCEEGG-------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred             HHHHHHHHHHccCCCcceEEEecC----CEEEEEeecccccc-------chhhHHHHHHHHHHHHHHHHHhhCCEEEccC
Confidence            456889999999999998886642    26899999873221       2334445678999999999999999999999


Q ss_pred             CCCcEEEccCCceEEeecccccccccCCCcccccccCccccCcccccCCcCCCcchhhHHHHHH
Q psy7820          92 KPQNILINKSGALKLADFGLSRAFTIPMNRYTHEVVTLWYRPPEILLGAKVYSTTVDIWSAGCI  155 (163)
Q Consensus        92 ~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Di~slG~~  155 (163)
                      ||+||++++++ ++++|||.+.....+...... ..+... ..+.+.  +.|..++|+||+.--
T Consensus       130 KP~NILv~~~~-~~liDFG~a~~~~~~~~~~~l-~rd~~~-~~~~f~--r~y~~~~d~~s~~~~  188 (191)
T d1zara2         130 SQYNVLVSEEG-IWIIDFPQSVEVGEEGWREIL-ERDVRN-IITYFS--RTYRTEKDINSAIDR  188 (191)
T ss_dssp             STTSEEEETTE-EEECCCTTCEETTSTTHHHHH-HHHHHH-HHHHHH--HHHCCCCCHHHHHHH
T ss_pred             ChhheeeeCCC-EEEEECCCcccCCCCCcHHHH-HHHHHH-HHHHHc--CCCCCcccHHHHHHH
Confidence            99999998654 899999988665433221100 000000 012222  236889999997643

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.31  E-value=2.2e-06  Score=57.34  Aligned_cols=101  Identities=19%  Similarity=0.136  Sum_probs=68.1

Q ss_pred             chhhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q psy7820           8 VPSTALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ-DLKDFLQTTPVPVPPALAKSYLYQLLEALRYCHSR-   84 (163)
Q Consensus         8 ~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~-   84 (163)
                      ...++.+|...++.+. +--+++++.+.+.++..++||++++| .+.......   ....   .++.++...+..||+. 
T Consensus        52 ~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~---~~~~---~~~~~l~~~l~~lH~~~  125 (263)
T d1j7la_          52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE---QSPE---KIIELYAECIRLFHSID  125 (263)
T ss_dssp             STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC---SCHH---HHHHHHHHHHHHHHTSC
T ss_pred             chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc---ccHH---HHHHHHHHHHHHHhccC
Confidence            3446788999988874 44578888888888999999999988 554332211   1111   1233333334444421 


Q ss_pred             ----------------------------------------------------------CceecCCCCCcEEEccCCceEE
Q psy7820          85 ----------------------------------------------------------RIIHRDLKPQNILINKSGALKL  106 (163)
Q Consensus        85 ----------------------------------------------------------~i~h~~i~~~ni~~~~~~~~~l  106 (163)
                                                                                .++|+|+.|.|++++.++.+-+
T Consensus       126 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~l  205 (263)
T d1j7la_         126 ISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGF  205 (263)
T ss_dssp             CTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEE
T ss_pred             ccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEE
Confidence                                                                      2589999999999987766779


Q ss_pred             eecccccc
Q psy7820         107 ADFGLSRA  114 (163)
Q Consensus       107 ~d~~~~~~  114 (163)
                      +||+.+..
T Consensus       206 IDwe~a~~  213 (263)
T d1j7la_         206 IDLGRSGR  213 (263)
T ss_dssp             CCCTTCEE
T ss_pred             eechhccc
Confidence            99987654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.06  E-value=5.7e-06  Score=55.03  Aligned_cols=44  Identities=16%  Similarity=0.087  Sum_probs=34.2

Q ss_pred             CCchhhHHHHHHHHhcCC--CCCeeeeeeeeeeCcEEEEEecchhc
Q psy7820           6 EGVPSTALREISVLKELK--HPNVIRLHDVIPVDFKLFLVFEFLRQ   49 (163)
Q Consensus         6 ~~~~~~~~~e~~~l~~~~--h~~i~~~~~~~~~~~~~~lv~e~~~~   49 (163)
                      +.....+..|.+.++.+.  .-.+++++....+++..+++|++++|
T Consensus        45 ~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          45 SGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPG   90 (255)
T ss_dssp             SCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSS
T ss_pred             ccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeec
Confidence            344456788999998884  33467888888888889999999976

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.25  E-value=0.00026  Score=50.12  Aligned_cols=29  Identities=24%  Similarity=0.322  Sum_probs=24.4

Q ss_pred             CceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          85 RIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        85 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .++|||+.|.|||++.++ ++++|+..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            589999999999998765 89999976643

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.88  E-value=0.00067  Score=47.87  Aligned_cols=36  Identities=14%  Similarity=0.066  Sum_probs=26.2

Q ss_pred             hhHHHHHHHHhcCC-CCCeeeeeeeeeeCcEEEEEecchhc
Q psy7820          10 STALREISVLKELK-HPNVIRLHDVIPVDFKLFLVFEFLRQ   49 (163)
Q Consensus        10 ~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~   49 (163)
                      -+..+|..+++.+. +.-.+++++++.+    +.|+||++|
T Consensus        89 idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g  125 (395)
T d1nw1a_          89 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPS  125 (395)
T ss_dssp             HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCE
T ss_pred             hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEecc
Confidence            34568999999984 4445788888754    478888775

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.68  E-value=0.0017  Score=44.16  Aligned_cols=32  Identities=25%  Similarity=0.314  Sum_probs=27.5

Q ss_pred             hCCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          83 SRRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        83 ~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      ..|++|+|+.++|++++.+...-++||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            35789999999999999888788999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=92.05  E-value=0.1  Score=35.28  Aligned_cols=29  Identities=28%  Similarity=0.328  Sum_probs=22.9

Q ss_pred             CCceecCCCCCcEEEccCCceEEeecccccc
Q psy7820          84 RRIIHRDLKPQNILINKSGALKLADFGLSRA  114 (163)
Q Consensus        84 ~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~  114 (163)
                      .+++|+|+.+.|++++. + ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            46899999999999964 3 45899986644